data_2yh0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2yh0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.77 0.319 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.576 ' HG2' HG23 ' A' ' 205' ' ' VAL . 98.6 mtt180 -117.67 9.4 13.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.044 0.45 . . . . 0.0 110.621 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 87.1 mtt180 -106.87 133.23 51.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.91 -0.586 . . . . 6.9800000000000004 110.37 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 52.3 mt -97.2 150.44 20.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.283 -0.417 . . . . 5.6100000000000003 110.546 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -100.66 105.26 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.912 -0.586 . . . . 6.2599999999999998 109.443 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.3 p -107.71 129.33 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.232 0.539 . . . . 4.25 110.446 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -129.74 -177.53 14.93 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.484 -0.78 . . . . 5.3099999999999996 111.78 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 61.78 38.77 14.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.84 0.829 . . . . 0.0 109.375 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.401 HG23 HD23 ' A' ' 224' ' ' LEU . 34.0 pt -84.34 152.34 60.92 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 5.6100000000000003 111.009 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.427 ' O ' HG23 ' A' ' 160' ' ' ILE . 11.6 Cg_exo -71.32 123.08 9.26 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.011 2.474 . . . . 6.1600000000000001 112.165 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -75.89 113.7 13.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 8.8200000000000003 109.828 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 132.21 -33.51 2.68 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.784 -0.722 . . . . 7.3300000000000001 112.283 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 157' ' ' PRO . 11.4 tp -71.26 153.92 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.616 0.246 . . . . 6.0999999999999996 110.634 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 p -88.9 161.09 16.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.85 0.357 . . . . 7.0 111.223 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.803 ' HA ' HD13 ' A' ' 191' ' ' ILE . 41.6 mt-10 -66.05 -37.94 87.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 5.6900000000000004 109.71 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.16 -48.82 80.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.023 -0.99 . . . . 7.29 111.296 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.23 90.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.253 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.2 ttm -65.1 -39.88 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 4.5700000000000003 110.53 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.684 ' HE2' ' HB3' ' A' ' 281' ' ' SER . 23.5 ttt -62.28 -46.22 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.356 . . . . 6.1100000000000003 110.81 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.66 -38.6 88.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 6.5099999999999998 110.472 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -57.62 -48.16 80.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.848 -0.615 . . . . 5.8700000000000001 110.58 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 173' ' ' MET . 33.2 m-85 -64.47 -47.16 80.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 5.0300000000000002 111.14 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -54.89 -46.3 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.165 0.291 . . . . 6.2999999999999998 110.945 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.7 84.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.036 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.3 -37.65 86.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 6.3200000000000003 111.11 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 33.0 mmt -62.6 -42.25 99.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 7.0300000000000002 110.177 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.18 -52.75 17.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 9.3100000000000005 111.007 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.62 -34.05 77.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 8.9600000000000009 111.697 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.85 -16.81 71.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.509 -0.853 . . . . 8.1099999999999994 112.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.06 29.85 30.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 8.7200000000000006 112.137 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.437 HD21 ' HG3' ' A' ' 210' ' ' GLN . 5.9 mp -86.89 -18.8 29.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 7.7199999999999998 110.092 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.68 HG23 ' HG3' ' A' ' 185' ' ' PRO . 13.2 p -69.27 128.2 35.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.501 -0.772 . . . . 8.7300000000000004 111.168 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.454 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.8 pt20 -94.09 -1.04 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 9.8900000000000006 109.322 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -160.07 155.43 21.84 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.082 -0.963 . . . . 9.9700000000000006 109.476 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.7 168.78 15.9 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.503 2.135 . . . . 11.119999999999999 112.136 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.87 -138.61 14.15 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.029 -0.605 . . . . 9.0600000000000005 112.509 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 90.5 m-20 -116.44 118.05 37.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.588 0.232 . . . . 7.7400000000000002 110.574 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.68 ' HG3' HG23 ' A' ' 179' ' ' THR . 18.3 Cg_exo -66.61 -26.52 46.36 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.866 2.377 . . . . 6.6699999999999999 111.864 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.54 127.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.949 -0.568 . . . . 5.4699999999999998 110.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 284' ' ' PRO . 45.0 tp -91.8 -40.4 11.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.232 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -143.34 121.16 11.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.012 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.36 115.4 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.89 -0.595 . . . . 4.7699999999999996 110.144 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -128.67 106.41 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 6.6500000000000004 110.157 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.803 HD13 ' HA ' ' A' ' 162' ' ' GLU . 66.5 mt -113.97 123.06 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.241 -0.436 . . . . 5.8499999999999996 111.655 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -100.54 99.62 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 7.7599999999999998 108.732 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -85.51 -16.93 37.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.69 . . . . 7.6100000000000003 110.167 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.57 -47.55 83.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.616 -0.72 . . . . 9.1199999999999992 110.957 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.484 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 45.1 mmtm -105.57 9.04 33.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.286 -0.415 . . . . 9.2799999999999994 111.207 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.01 48.58 5.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.412 -0.813 . . . . 6.9299999999999997 111.82 171.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 37.1 p90 -148.19 142.83 26.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.818 -0.438 . . . . 7.1100000000000003 109.818 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.549 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -134.28 150.46 50.99 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.921 0.391 . . . . 4.6600000000000001 111.354 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.592 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 74.8 m-85 -117.37 108.47 15.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.63 -0.713 . . . . 6.5899999999999999 109.889 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 87.3 mt -94.85 114.54 26.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.08 -0.509 . . . . 4.7699999999999996 109.63 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 36.1 tt0 -94.06 119.49 33.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.814 -0.439 . . . . 6.5499999999999998 109.814 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.13 164.21 13.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.181 0.515 . . . . 6.5099999999999998 111.213 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -73.31 -11.65 60.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.355 -0.839 . . . . 8.5399999999999991 111.089 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 76.0 p -141.68 -166.75 2.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.198 -0.456 . . . . 8.3000000000000007 110.219 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 149' ' ' ARG . 21.8 t -116.58 -30.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.268 -0.642 . . . . 9.0099999999999998 109.268 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.59 -60.44 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.085 -0.962 . . . . 8.7799999999999994 111.377 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.454 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 42.4 mt-10 -58.88 -40.32 84.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4800000000000004 110.078 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 m -52.45 -52.14 55.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.633 -0.712 . . . . 6.3899999999999997 110.835 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.7 m -63.0 -34.23 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.522 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.437 ' HG3' HD21 ' A' ' 178' ' ' LEU . 9.3 tp-100 -71.17 -30.9 67.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.137 -0.483 . . . . 7.9400000000000004 110.215 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.1 -15.03 62.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.523 . . . . 5.5 111.273 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.31 -16.02 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 6.46 111.117 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.25 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 6.3600000000000003 111.55 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 217' ' ' ILE . 69.7 m-85 -93.04 21.47 5.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.444 -0.344 . . . . 5.9299999999999997 111.577 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.15 109.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 5.9199999999999999 110.369 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.97 13.25 22.11 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.933 -0.651 . . . . 5.7400000000000002 112.233 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 214' ' ' PHE . 17.6 tt -66.41 141.8 17.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 5.6299999999999999 111.2 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.2 tp -82.45 114.1 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.508 0.67 . . . . 7.2300000000000004 111.098 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.27 112.77 10.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.589 -0.732 . . . . 5.79 110.701 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 59.57 31.41 20.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.863 -0.608 . . . . 7.3200000000000003 111.737 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.53 -24.76 29.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.855 -0.688 . . . . 7.5899999999999999 112.585 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.95 167.28 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.879 0.371 . . . . 7.5300000000000002 110.777 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -118.15 99.79 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.385 -0.598 . . . . 6.4500000000000002 109.385 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.401 HD23 HG23 ' A' ' 156' ' ' ILE . 82.6 mt -66.14 112.93 4.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 4.9000000000000004 111.59 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.3 tttt -81.83 124.73 29.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.517 -0.765 . . . . 7.5700000000000003 109.91 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -118.76 106.22 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.029 0.443 . . . . 5.3700000000000001 110.741 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -134.51 171.63 14.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 7.1900000000000004 110.301 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 20.2 mtp180 -83.62 134.97 43.87 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.788 -0.449 . . . . 7.7599999999999998 109.788 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 32.1 Cg_exo -60.28 165.9 10.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.004 2.469 . . . . 7.9800000000000004 112.762 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.884 -179.673 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.448 ' CE1' ' HA ' ' A' ' 310' ' ' ILE . 13.2 t60 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.95 0.405 . . . . 9.1300000000000008 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.673 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.2 ttmt -78.09 129.97 35.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.908 -0.587 . . . . 6.3600000000000003 110.541 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.8 mt -96.07 140.78 30.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.201 0.524 . . . . 5.5899999999999999 110.792 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -103.45 115.12 29.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.249 -0.887 . . . . 5.0300000000000002 108.627 171.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 263' ' ' ILE . 4.3 mp -105.43 110.05 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.909 -0.587 . . . . 4.21 109.674 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -122.1 171.74 15.37 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.025 -0.607 . . . . 4.5800000000000001 111.814 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.78 27.51 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.664 -0.779 . . . . 5.6299999999999999 111.923 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 96.8 mt -106.36 142.06 24.11 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.646 0.26 . . . . 5.9199999999999999 110.569 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 15.1 Cg_exo -70.36 160.41 49.63 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.771 2.314 . . . . 7.3099999999999996 111.507 173.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -88.42 -9.52 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.033 0.383 . . . . 8.8100000000000005 112.033 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -83.08 -2.14 54.6 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.45 -0.5 . . . . 9.0700000000000003 110.97 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.68 117.4 19.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 7.7199999999999998 110.108 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.38 160.11 22.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.062 -0.517 . . . . 8.8000000000000007 110.817 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.468 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 4.7 m-20 -52.23 -44.45 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 7.8899999999999997 112.584 -173.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.83 -45.26 92.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.816 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.5 -46.49 88.19 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.64 0.257 . . . . 8.7300000000000004 111.012 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.46 -44.57 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 6.7300000000000004 110.646 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -62.94 -48.08 80.46 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.378 -0.374 . . . . 8.1199999999999992 110.82 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.5 -47.82 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 9.3800000000000008 110.653 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.72 -54.74 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 7.2300000000000004 110.584 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.523 HD13 ' HE2' ' A' ' 288' ' ' PHE . 99.3 mt -69.46 -32.15 70.88 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.879 0.325 . . . . 6.8899999999999997 111.879 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 36.1 m -72.2 -19.74 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 9.2400000000000002 110.926 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.684 ' HB3' ' HE2' ' A' ' 166' ' ' MET . 50.5 m -79.63 -0.83 35.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.439 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.68 14.46 11.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 9.1799999999999997 110.917 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 143.7 159.93 8.21 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.567 -0.825 . . . . 9.5600000000000005 112.517 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.453 ' HB3' HD22 ' A' ' 187' ' ' LEU . 55.5 Cg_endo -71.37 122.39 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.658 2.239 . . . . 10.51 112.31 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.96 135.46 33.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 8.3000000000000007 110.436 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.521 ' HB3' HG23 ' A' ' 308' ' ' VAL . 17.9 ptpt -99.33 -26.83 14.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.577 -0.527 . . . . 8.9399999999999995 109.577 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -145.24 136.66 25.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.453 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.523 ' HE2' HD13 ' A' ' 279' ' ' LEU . 16.6 t80 -144.84 110.12 5.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.869 -0.605 . . . . 6.4900000000000002 109.553 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . 0.631 HD22 ' HB2' ' A' ' 304' ' ' PHE . 3.3 p-10 -127.59 116.97 21.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.287 0.565 . . . . 6.0300000000000002 110.44 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 303' ' ' ALA . 64.7 tp -93.23 130.04 39.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.469 -0.787 . . . . 6.5300000000000002 109.973 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.65 112.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.017 0.437 . . . . 6.8700000000000001 110.457 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.468 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 63.0 mttm -106.96 167.83 9.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.605 . . . . 8.2100000000000009 110.124 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.47 128.06 34.92 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.192 -0.67 . . . . 10.33 109.192 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.3 m -63.87 -28.65 69.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.072 0.397 . . . . 10.93 112.072 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -95.47 -51.99 4.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 12.34 111.121 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.8 m -68.6 -51.46 42.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 11.460000000000001 111.227 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 108.77 -25.09 20.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.742 -0.742 . . . . 10.210000000000001 112.172 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.62 164.38 26.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 10.4 110.775 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.502 ' HG ' HD12 ' A' ' 290' ' ' LEU . 42.6 t -68.18 154.24 42.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.971 -0.559 . . . . 7.8700000000000001 110.581 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -86.86 -8.69 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 8.4100000000000001 109.93 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.27 17.16 35.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.791 -0.719 . . . . 6.0899999999999999 113.209 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -156.44 155.94 32.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.682 0.277 . . . . 6.7599999999999998 110.513 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -151.51 166.41 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.193 -0.458 . . . . 4.6399999999999997 111.368 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.673 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.5 m-85 -115.75 127.47 55.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.043 -0.725 . . . . 5.1900000000000004 109.043 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.4 m -144.19 131.18 20.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.66 0.267 . . . . 5.0899999999999999 110.681 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.43 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 32.5 tt0 -116.08 130.16 56.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.899 0.381 . . . . 7.0300000000000002 110.399 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -83.34 158.44 22.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 7.8899999999999997 110.574 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 286' ' ' LYS . 62.9 t -78.63 -55.88 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 10.42 110.464 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.27 147.87 44.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 10.81 110.837 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.776 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -94.03 -4.03 10.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.039999999999999 112.065 -175.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' A' ' 315' ' ' GLN . 37.1 m-80 -93.85 -50.72 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.732 0.301 . . . . 10.98 110.526 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.68 -24.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 9.9100000000000001 112.172 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 317' ' ' ILE . 31.3 m -59.54 -50.68 72.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.931 0.345 . . . . 8.0600000000000005 111.931 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -75.09 -29.04 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 8.9399999999999995 110.63 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 311' ' ' ASN . 84.8 mt-30 -68.64 -39.25 80.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 10.880000000000001 110.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.32 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.769 -0.651 . . . . 7.5300000000000002 110.231 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.476 HG12 HG13 ' A' ' 332' ' ' VAL . 78.8 mt -61.95 -46.06 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 6.5800000000000001 110.4 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.52 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.845 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -91.91 -54.68 1.86 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.536 -0.84 . . . . 7.7699999999999996 113.241 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.26 -50.23 48.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.683 0.253 . . . . 6.5199999999999996 111.683 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.714 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.8 t30 -63.79 114.04 3.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.727 -0.472 . . . . 6.6100000000000003 109.727 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.67 7.08 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.8 -0.714 . . . . 6.7699999999999996 111.815 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.7 mtt -74.16 170.49 15.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.725 -0.472 . . . . 7.6900000000000004 109.725 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -134.56 118.76 17.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.028 0.442 . . . . 8.2400000000000002 110.891 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.71 99.1 10.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.292 -0.633 . . . . 7.0300000000000002 109.292 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.5 2.12 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.732 -0.747 . . . . 8.25 111.516 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -110.52 2.38 18.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.878 0.371 . . . . 8.9800000000000004 110.582 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -105.06 135.51 46.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 7.4299999999999997 110.687 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.48 127.25 35.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.738 -0.468 . . . . 7.4500000000000002 109.738 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.47 115.34 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 5.8399999999999999 110.664 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 54.5 tp -106.72 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.507 -0.77 . . . . 5.8099999999999996 109.887 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 61.9 t -126.42 120.51 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.274 -0.421 . . . . 5.21 110.094 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.33 176.83 11.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.138 -0.69 . . . . 6.1699999999999999 109.138 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -82.29 147.39 28.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.598 -0.441 . . . . 7.7999999999999998 109.875 175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.4 67.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 6.04 112.271 -173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--N 1.324 -0.5 0 C-N-CA 121.096 -0.242 . . . . 7.7000000000000002 111.341 -177.806 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.746 0.308 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 202' ' ' PHE . 37.3 ptt180 -90.87 -1.4 57.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 68.5 mtt180 -98.12 164.28 12.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.049 0.452 . . . . 6.9800000000000004 111.4 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 64.0 mt -136.86 158.41 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.268 -0.878 . . . . 5.6100000000000003 109.86 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.94 113.47 26.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.831 -0.622 . . . . 6.2599999999999998 109.519 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.8 p -113.19 129.1 69.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.233 0.539 . . . . 4.25 110.763 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.03 177.8 16.46 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.629 -0.714 . . . . 5.3099999999999996 111.759 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.48 63.59 1.67 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.352 0.596 . . . . 0.0 110.4 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.67 155.56 36.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.568 -0.742 . . . . 5.6100000000000003 110.264 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.644 ' HB2' ' HB ' ' A' ' 160' ' ' ILE . 16.1 Cg_exo -69.07 131.03 21.3 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.724 2.282 . . . . 6.1600000000000001 112.013 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -79.47 102.46 8.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 8.8200000000000003 109.674 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.27 20.64 6.18 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.953 -0.642 . . . . 7.3300000000000001 111.895 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 157' ' ' PRO . 11.0 tp -94.03 146.33 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.769 -0.456 . . . . 6.0999999999999996 109.769 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.2 p -86.68 154.05 21.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 7.0 111.5 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.518 -0.765 . . . . 5.6900000000000004 110.288 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.78 -48.1 80.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.719 -0.673 . . . . 7.29 110.408 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.45 -50.8 70.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.225 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 94.5 mmm -63.14 -48.88 76.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.194 -0.457 . . . . 4.5700000000000003 110.958 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.631 ' HE1' ' HA ' ' A' ' 281' ' ' SER . 1.9 tmt? -61.13 -51.6 68.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 6.1100000000000003 110.787 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.46 -36.26 83.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 6.5099999999999998 111.536 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.86 -48.72 80.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.681 0.277 . . . . 5.8700000000000001 111.28 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.452 ' HE1' HD12 ' A' ' 226' ' ' ILE . 60.4 m-85 -64.3 -35.91 82.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.571 -0.286 . . . . 5.0300000000000002 110.728 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 82.5 m-20 -60.22 -50.4 73.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.91 -0.404 . . . . 6.2999999999999998 109.91 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.54 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.473 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -62.99 -39.47 94.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.606 -0.27 . . . . 6.3200000000000003 111.072 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.836 ' HB3' HG21 ' A' ' 179' ' ' THR . 26.4 mmt -62.74 -41.75 99.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 7.0300000000000002 110.54 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 84.8 mtt180 -67.29 -52.2 43.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 9.3100000000000005 111.0 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.38 -33.91 73.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.86 -0.609 . . . . 8.9600000000000009 111.693 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.19 -21.46 45.31 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.334 -0.936 . . . . 8.1099999999999994 112.284 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.03 27.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.983 -0.627 . . . . 8.7200000000000006 111.981 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.747 HD21 ' HB3' ' A' ' 210' ' ' GLN . 4.2 mp -97.93 -5.32 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 7.7199999999999998 110.505 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.836 HG21 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -79.3 156.46 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 8.7300000000000004 111.049 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.429 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -87.79 -14.9 38.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.255 0.55 . . . . 9.8900000000000006 109.94 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -156.2 144.89 14.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 9.9700000000000006 109.84 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.57 113.26 2.22 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.647 2.231 . . . . 11.119999999999999 111.835 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.46 -137.77 5.08 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.655 -0.783 . . . . 9.0600000000000005 112.381 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -112.06 108.34 55.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.539 0.209 . . . . 7.7400000000000002 110.665 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 45.1 Cg_endo -68.69 -34.63 18.5 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.749 2.299 . . . . 6.6699999999999999 111.85 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.76 128.7 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 5.4699999999999998 109.514 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 284' ' ' PRO . 26.6 tp -105.25 -33.24 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.978 0.418 . . . . 0.0 110.361 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 201' ' ' GLU . . . -152.32 155.01 36.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.321 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.02 133.1 22.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.926 0.393 . . . . 4.7699999999999996 110.604 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.33 106.73 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 6.6500000000000004 110.047 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.35 130.56 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.05 -0.523 . . . . 5.8499999999999996 111.428 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -121.59 96.8 5.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.837 -0.801 . . . . 7.7599999999999998 108.837 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -83.48 -6.68 59.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.044 -0.525 . . . . 7.6100000000000003 110.962 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -66.66 -51.91 50.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 9.1199999999999992 110.619 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.507 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.4 mmtm -102.89 -0.24 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.22 -0.445 . . . . 9.2799999999999994 110.406 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 66.76 61.52 0.53 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.345 -0.843 . . . . 6.9299999999999997 111.924 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 48.6 p90 -149.43 163.52 37.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 7.1100000000000003 109.506 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -146.61 153.27 40.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.943 0.402 . . . . 4.6600000000000001 111.095 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.05 122.65 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.852 -0.613 . . . . 6.5899999999999999 110.161 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 75.2 mt -100.69 116.0 31.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 4.7699999999999996 110.279 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.453 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 5.2 tt0 -101.34 113.75 27.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.682 -0.488 . . . . 6.5499999999999998 109.682 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.405 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 69.9 m-85 -90.59 160.11 16.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.077 -0.51 . . . . 6.5099999999999998 110.825 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.74 -25.08 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 8.5399999999999991 110.877 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 93.2 p -132.16 -178.29 4.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.171 -0.468 . . . . 8.3000000000000007 110.053 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.89 -16.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.707 0.765 . . . . 9.0099999999999998 109.032 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.54 -54.65 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.998 -1.001 . . . . 8.7799999999999994 111.078 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.429 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 36.2 mt-10 -66.45 -30.32 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 7.4800000000000004 110.897 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -50.71 -45.31 58.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 6.3899999999999997 112.02 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 m -56.37 -43.46 79.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.688 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.747 ' HB3' HD21 ' A' ' 178' ' ' LEU . 2.2 mp0 -73.64 -28.06 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.51 -0.313 . . . . 7.9400000000000004 110.853 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.5 66.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 5.5 110.617 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.58 -14.83 62.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 6.46 111.22 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.01 -13.56 62.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 6.3600000000000003 110.879 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.704 ' HD2' HD13 ' A' ' 217' ' ' ILE . 68.7 m-85 -100.02 17.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 5.9299999999999997 110.753 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.59 107.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 5.9199999999999999 110.392 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.74 14.23 23.8 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.955 -0.64 . . . . 5.7400000000000002 112.194 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.704 HD13 ' HD2' ' A' ' 214' ' ' PHE . 16.1 tt -68.01 135.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.045 0.45 . . . . 5.6299999999999999 110.689 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.79 114.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.386 0.612 . . . . 7.2300000000000004 111.045 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -134.58 118.65 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.639 -0.709 . . . . 5.79 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 59.63 26.72 15.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.025 -0.534 . . . . 7.3200000000000003 111.516 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 91.87 -5.48 79.26 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.682 -0.77 . . . . 7.5899999999999999 112.881 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.564 0.221 . . . . 7.5300000000000002 110.691 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.1 t -101.0 95.1 6.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.428 -0.582 . . . . 6.4500000000000002 109.428 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.45 106.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 4.9000000000000004 111.459 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 88.4 tttt -82.22 113.92 20.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.709 -0.678 . . . . 7.5700000000000003 109.715 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.452 HD12 ' HE1' ' A' ' 169' ' ' PHE . 67.3 mt -109.1 107.22 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.053 0.454 . . . . 5.3700000000000001 110.625 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -124.9 170.38 11.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.764 -0.653 . . . . 7.1900000000000004 109.74 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -87.73 154.58 53.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 121.043 -0.263 . . . . 7.7599999999999998 110.71 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 55.8 Cg_endo -69.76 173.42 11.0 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.744 2.296 . . . . 7.9800000000000004 111.809 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 35.1 m-70 . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.572 ' HB3' HG22 ' A' ' 313' ' ' THR . 47.2 m80 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.077 -0.712 . . . . 9.1300000000000008 109.077 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.7 ttmt -59.22 125.12 22.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.096 -0.957 . . . . 6.3600000000000003 111.809 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.3 mt -100.29 135.58 41.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.326 -0.852 . . . . 5.5899999999999999 110.001 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -93.09 111.13 22.66 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.145 -0.687 . . . . 5.0300000000000002 109.145 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.734 HG21 HD12 ' A' ' 330' ' ' LEU . 2.3 mp -91.45 109.09 20.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.838 -0.619 . . . . 4.21 109.637 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.86 112.16 2.17 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.623 -0.798 . . . . 4.5800000000000001 112.298 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 137.06 45.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.828 -0.701 . . . . 5.6299999999999999 112.21 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.41 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.9 mt -110.51 144.58 30.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 5.9199999999999999 110.998 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.4 158.28 22.61 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.158 2.572 . . . . 7.3099999999999996 111.694 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -83.95 -13.08 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.572 0.225 . . . . 8.8100000000000005 111.305 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -81.67 -6.78 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 9.0700000000000003 110.21 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.8 120.66 29.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 7.7199999999999998 109.597 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.556 ' O ' HG21 ' A' ' 275' ' ' VAL . 33.4 p30 -91.0 174.21 7.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 8.8000000000000007 111.284 -176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 5.7 m-20 -61.58 -32.1 72.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.691 -0.686 . . . . 7.8899999999999997 111.417 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.18 -54.62 38.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.683 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.75 -34.95 77.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.672 -0.694 . . . . 8.7300000000000004 111.742 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 271' ' ' ASN . 62.9 t -63.0 -48.84 86.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.778 0.323 . . . . 6.7300000000000004 110.465 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.04 -42.7 94.07 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.558 -0.292 . . . . 8.1199999999999992 110.616 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.0 -46.85 84.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.02 -0.536 . . . . 9.3800000000000008 111.249 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -46.94 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 7.2300000000000004 110.116 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.3 mt -69.8 -36.05 75.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.175 -0.466 . . . . 6.8899999999999997 111.236 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.1 m -68.31 -19.71 64.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.03 0.443 . . . . 9.2400000000000002 110.995 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.631 ' HA ' ' HE1' ' A' ' 166' ' ' MET . 38.3 m -68.39 -12.28 60.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.92 11.58 8.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.404 . . . . 9.1799999999999997 111.307 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 145.93 163.95 10.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.442 -0.885 . . . . 9.5600000000000005 113.115 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.66 ' HB3' HD12 ' A' ' 187' ' ' LEU . 86.3 Cg_endo -83.52 134.88 6.76 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.94 2.427 . . . . 10.51 112.642 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.2 mt -90.8 142.14 28.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.381 -0.372 . . . . 8.3000000000000007 110.568 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.451 ' HB3' HG23 ' A' ' 308' ' ' VAL . 7.8 ptpp? -103.18 -22.86 13.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.385 -0.598 . . . . 8.9399999999999995 109.385 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.1 132.49 23.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -145.77 123.52 11.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.224 -0.444 . . . . 6.4900000000000002 110.586 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.91 118.49 12.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.388 0.614 . . . . 6.0300000000000002 109.955 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 303' ' ' ALA . 62.5 tp -91.83 125.43 36.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.658 -0.701 . . . . 6.5300000000000002 109.172 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 112.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.356 -0.538 . . . . 6.8700000000000001 110.137 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 65.9 mttm -101.58 153.17 19.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.475 -0.784 . . . . 8.2100000000000009 109.985 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.652 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 21.2 t70 -64.68 145.53 56.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.349 -0.387 . . . . 10.33 110.237 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.1 m -63.64 -28.33 69.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.033 -0.53 . . . . 10.93 111.738 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -116.62 -40.99 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.99 0.367 . . . . 12.34 111.99 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 30.0 m -69.1 -46.91 66.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.719 0.295 . . . . 11.460000000000001 111.362 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.63 70.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 10.210000000000001 112.962 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.51 170.36 9.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.008 -0.367 . . . . 10.4 110.008 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.7 t -58.08 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.12 0.485 . . . . 7.8700000000000001 111.022 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' ' 293' ' ' ASP . 31.9 mmmt -85.81 -3.45 58.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 8.4100000000000001 109.982 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 103.4 -3.84 47.22 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.805 -0.712 . . . . 6.0899999999999999 112.245 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 18.4 p90 -141.62 157.12 45.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 6.7599999999999998 111.436 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.723 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -156.91 167.06 31.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.824 -0.626 . . . . 4.6399999999999997 110.844 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.487 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.6 m-85 -116.27 125.61 52.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.205 -0.665 . . . . 5.1900000000000004 109.205 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 28.9 m -144.32 136.65 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.646 0.26 . . . . 5.0899999999999999 111.009 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.68 132.29 49.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.758 0.313 . . . . 7.0300000000000002 110.253 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 42.3 m-85 -79.11 166.61 22.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.057 -0.52 . . . . 7.8899999999999997 110.78 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 286' ' ' LYS . 56.9 t -76.32 -51.65 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.197 -0.456 . . . . 10.42 110.23 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 312' ' ' VAL . 16.5 t70 -92.47 156.11 17.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.755 -0.657 . . . . 10.81 110.262 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.686 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -78.86 -30.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.52 -0.309 . . . . 10.039999999999999 111.462 -176.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -67.4 -49.34 64.22 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 110.211 -0.292 . . . . 10.98 110.211 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.602 HG22 ' HD2' ' A' ' 284' ' ' PRO . 19.8 m -65.56 -26.06 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 9.9100000000000001 111.542 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 259' ' ' HIS . 86.1 m -64.47 -49.81 69.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.324 0.583 . . . . 8.0600000000000005 110.11 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.1 -24.46 58.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 8.9399999999999995 110.991 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 312' ' ' VAL . 45.4 mt-30 -63.42 -40.25 96.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 10.880000000000001 110.17 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 320' ' ' LEU . . . -62.22 -44.91 95.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 7.5300000000000002 110.516 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.36 -36.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 6.5800000000000001 111.297 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -83.82 -52.39 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.778 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.55 -37.19 24.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.035 -0.602 . . . . 7.7699999999999996 113.956 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 330' ' ' LEU . 80.3 mt -83.92 -36.91 22.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.257 0.528 . . . . 6.5199999999999996 111.993 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 6.4 t30 -61.97 119.94 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.732 0.301 . . . . 6.6100000000000003 110.529 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.03 -22.47 20.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.926 -0.654 . . . . 6.7699999999999996 112.297 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 23.9 ttt -71.31 123.26 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.298 -0.26 . . . . 7.6900000000000004 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 328' ' ' LYS . 51.4 mt-30 -82.98 117.5 22.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 8.2400000000000002 111.466 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -91.03 94.86 9.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.559 -0.904 . . . . 7.0300000000000002 108.559 171.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.23 -87.36 1.29 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.547 -0.835 . . . . 8.25 111.181 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -126.51 -25.1 3.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.764 0.316 . . . . 8.9800000000000004 110.865 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 324' ' ' GLN . 94.7 mttt -85.79 134.98 33.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 7.4299999999999997 110.92 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 92.8 mttt -77.47 126.29 30.68 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.454 -0.573 . . . . 7.4500000000000002 109.454 172.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 263' ' ' ILE . 30.8 tp -67.77 102.56 1.24 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.954 0.407 . . . . 5.8399999999999999 110.258 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 53.4 tp -93.57 111.82 23.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.888 -0.596 . . . . 5.8099999999999996 109.674 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.07 108.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 5.21 109.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -124.04 124.32 42.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.104 -0.498 . . . . 6.1699999999999999 110.216 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -72.16 123.03 22.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.966 -0.383 . . . . 7.7999999999999998 109.966 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -111.32 95.48 5.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.532 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 7.7000000000000002 110.358 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.6 -3.36 16.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.215 0.531 . . . . 0.0 109.638 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 98.7 mtt180 -101.66 146.64 27.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.507 -0.769 . . . . 6.9800000000000004 110.655 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.9 mt -110.14 147.08 34.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.241 -0.436 . . . . 5.6100000000000003 110.05 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -102.62 103.55 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 6.2599999999999998 110.062 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.516 ' CG1' ' HB1' ' A' ' 198' ' ' ALA . 7.6 p -105.33 133.72 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.236 0.541 . . . . 4.25 110.691 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -131.77 -179.66 16.37 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 5.3099999999999996 111.984 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.09 29.77 14.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.367 0.603 . . . . 0.0 109.999 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.1 pt -74.77 151.52 86.78 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 5.6100000000000003 111.02 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 20.9 Cg_endo -62.38 137.18 63.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.8 2.333 . . . . 6.1600000000000001 111.899 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -81.62 114.32 20.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.934 0.397 . . . . 8.8200000000000003 110.043 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.02 21.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 7.3300000000000001 112.153 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.3 tp -76.48 140.87 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.967 -0.383 . . . . 6.0999999999999996 109.967 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -88.56 154.62 20.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.783 0.325 . . . . 7.0 110.608 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.882 ' HA ' HD13 ' A' ' 191' ' ' ILE . 39.8 mt-10 -60.44 -38.49 84.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 5.6900000000000004 110.071 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.1 -55.63 30.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.257 -0.883 . . . . 7.29 111.295 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.38 93.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.406 ' O ' ' HD2' ' A' ' 169' ' ' PHE . 46.5 ttm -67.95 -42.22 81.3 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.998 -0.281 . . . . 4.5700000000000003 110.476 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.563 ' HE2' ' HA ' ' A' ' 281' ' ' SER . 26.8 ttt -62.95 -45.82 90.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 6.1100000000000003 110.422 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.16 -41.4 75.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.559 . . . . 6.5099999999999998 110.985 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 78.0 t80 -57.83 -51.9 67.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 5.8700000000000001 110.95 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.406 ' HD2' ' O ' ' A' ' 165' ' ' MET . 68.1 m-85 -66.38 -39.87 89.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 5.0300000000000002 111.226 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.2 m-20 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 6.2999999999999998 110.384 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.91 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 15.8 mm100 -61.85 -42.19 98.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.558 -0.292 . . . . 6.3200000000000003 110.969 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.504 ' HB3' HG21 ' A' ' 179' ' ' THR . 86.2 mmm -66.04 -36.65 83.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.292 -0.413 . . . . 7.0300000000000002 110.968 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 66.9 mtt180 -72.47 -52.3 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.524 -0.307 . . . . 9.3100000000000005 110.961 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.06 -36.01 77.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 8.9600000000000009 111.51 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.08 -21.01 80.15 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.87 -0.681 . . . . 8.1099999999999994 112.532 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.88 39.33 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 8.7200000000000006 112.5 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.24 9.33 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 7.7199999999999998 110.192 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.504 HG21 ' HB3' ' A' ' 173' ' ' MET . 1.6 p -114.62 105.19 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 8.7300000000000004 111.504 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.74 -22.96 39.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 9.8900000000000006 109.972 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -112.65 137.81 21.84 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.956 -0.566 . . . . 9.9700000000000006 110.238 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 161.1 37.73 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.798 2.332 . . . . 11.119999999999999 112.108 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.09 -152.78 18.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.824 -0.703 . . . . 9.0600000000000005 112.099 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 94.6 m-20 -109.22 122.72 38.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.786 -0.244 . . . . 7.7400000000000002 111.094 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 19.7 Cg_endo -60.75 -36.68 83.41 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.946 2.431 . . . . 6.6699999999999999 111.374 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.9 t -81.33 127.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.827 -0.805 . . . . 5.4699999999999998 108.827 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 20.5 tp -90.92 -39.19 12.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.06 153.66 33.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.606 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.433 HG21 HD21 ' A' ' 200' ' ' LEU . 7.4 p -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.27 -0.423 . . . . 4.7699999999999996 110.804 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -130.65 106.87 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 6.6500000000000004 109.699 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.882 HD13 ' HA ' ' A' ' 162' ' ' GLU . 51.5 mt -110.95 126.92 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.162 0.506 . . . . 5.8499999999999996 111.578 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -101.91 101.31 11.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 7.7599999999999998 108.388 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.19 -27.83 53.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 7.6100000000000003 110.648 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.92 -49.03 72.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 9.1199999999999992 111.281 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.17 -6.89 54.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 9.2799999999999994 111.068 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 64.51 56.36 1.24 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.833 -0.621 . . . . 6.9299999999999997 111.321 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -149.04 149.12 30.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.047 -0.524 . . . . 7.1100000000000003 109.879 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.579 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -134.19 140.19 46.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.775 0.321 . . . . 4.6600000000000001 111.087 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.545 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 42.5 m-85 -108.32 109.02 20.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.868 -0.606 . . . . 6.5899999999999999 110.139 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.7 mt -93.27 114.01 26.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 4.7699999999999996 109.32 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.69 114.64 26.3 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.136 -0.32 . . . . 6.5499999999999998 110.136 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.46 ' HB2' ' HG1' ' A' ' 208' ' ' THR . 70.4 m-85 -89.7 155.96 18.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.257 -0.428 . . . . 6.5099999999999998 110.892 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.7 -22.6 60.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.734 -0.666 . . . . 8.5399999999999991 110.972 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 94.6 p -148.18 142.85 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.964 -0.384 . . . . 8.3000000000000007 109.964 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.408 ' HA ' ' OG1' ' A' ' 208' ' ' THR . 94.6 t -63.94 -28.62 45.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.021 0.439 . . . . 9.0099999999999998 110.373 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.68 -40.94 69.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 8.7799999999999994 110.581 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.3 -29.62 26.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 7.4800000000000004 110.965 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.46 ' HG1' ' HB2' ' A' ' 202' ' ' PHE . 32.2 m -54.06 -51.52 63.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.923 0.392 . . . . 6.3899999999999997 110.803 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.72 -24.9 67.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.707 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -68.09 -35.55 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.958 0.408 . . . . 7.9400000000000004 110.196 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.639 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -74.78 -14.28 60.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 5.5 110.91 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.2 mtp -69.43 -20.54 63.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 6.46 110.289 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.37 -15.21 61.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.92 -0.582 . . . . 6.3600000000000003 110.801 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.639 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 90.7 m-85 -92.86 6.5 47.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 5.9299999999999997 110.945 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.48 124.23 20.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.699 0.285 . . . . 5.9199999999999999 110.244 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.68 35.2 11.93 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.686 -0.768 . . . . 5.7400000000000002 111.56 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.87 137.89 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.941 -0.392 . . . . 5.6299999999999999 109.941 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.04 119.15 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.301 0.572 . . . . 7.2300000000000004 110.756 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -133.01 112.28 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.085 -0.507 . . . . 5.79 110.985 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 56.66 35.02 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.769 -0.651 . . . . 7.3200000000000003 111.94 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.86 78.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 7.5899999999999999 113.045 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.7 mm-40 -118.04 124.1 47.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.334 . . . . 7.5300000000000002 110.64 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.6 t -77.3 115.89 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.158 -0.682 . . . . 6.4500000000000002 109.158 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.5 118.69 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 4.9000000000000004 110.98 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.0 tttt -88.36 114.15 24.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 7.5700000000000003 109.642 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.0 mt -109.52 106.56 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.078 0.466 . . . . 5.3700000000000001 110.428 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -114.92 170.09 8.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.892 -0.594 . . . . 7.1900000000000004 110.508 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -83.94 125.13 73.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.268 -0.641 . . . . 7.7599999999999998 109.268 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.545 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 18.1 Cg_endo -58.55 129.63 33.42 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.607 2.205 . . . . 7.9800000000000004 111.379 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.88 0.372 . . . . 0.0 110.595 -177.07 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 43.0 m80 . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.771 -0.825 . . . . 9.1300000000000008 108.771 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 304' ' ' PHE . 35.2 ttmt -59.1 119.49 7.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.104 -1.407 . . . . 6.3600000000000003 110.113 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.0 141.63 29.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.863 -0.608 . . . . 5.5899999999999999 110.792 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.72 110.0 21.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.489 -0.778 . . . . 5.0300000000000002 109.317 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.76 HG21 HD12 ' A' ' 330' ' ' LEU . 3.9 mp -101.77 103.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.321 -0.622 . . . . 4.21 109.321 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.91 164.13 21.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 4.5800000000000001 112.605 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 102.09 15.71 25.29 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.782 -0.723 . . . . 5.6299999999999999 111.895 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 270' ' ' LEU . 83.4 mt -92.57 148.74 36.83 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.655 0.264 . . . . 5.9199999999999999 110.545 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 270' ' ' LEU . 46.0 Cg_endo -69.23 153.74 70.89 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.687 2.258 . . . . 7.3099999999999996 112.276 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.7 -22.6 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 8.8100000000000005 111.368 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -83.64 1.04 44.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.948 0.404 . . . . 9.0700000000000003 111.187 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 267' ' ' PRO . 11.6 tp -87.11 99.37 11.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.859 -0.793 . . . . 7.7199999999999998 108.859 176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 275' ' ' VAL . 34.2 p-10 -89.68 -179.0 5.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 8.8000000000000007 111.686 -172.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.497 ' CG ' ' HZ3' ' A' ' 292' ' ' LYS . 2.7 m-20 -52.31 -41.02 62.59 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.595 -0.729 . . . . 7.8899999999999997 112.158 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.89 -47.75 81.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.19 -42.92 71.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 8.7300000000000004 111.431 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 271' ' ' ASN . 82.1 t -64.62 -49.38 80.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.555 -0.293 . . . . 6.7300000000000004 111.7 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -65.21 -43.36 91.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.841 -0.344 . . . . 8.1199999999999992 111.228 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.49 -46.97 83.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 9.3800000000000008 110.638 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.66 -52.82 62.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 7.2300000000000004 110.501 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.65 -38.62 80.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.043 0.386 . . . . 6.8899999999999997 112.043 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.4 m -61.58 -34.77 76.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.3 . . . . 9.2400000000000002 111.106 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.563 ' HA ' ' HE2' ' A' ' 166' ' ' MET . 49.0 m -62.74 -23.2 67.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.864 -178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -106.38 12.55 29.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.073 0.397 . . . . 9.1799999999999997 112.073 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 154.58 155.41 7.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.762 -1.209 . . . . 9.5600000000000005 113.462 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.699 ' HD2' HG22 ' A' ' 312' ' ' VAL . 6.9 Cg_exo -72.78 120.69 6.82 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.243 2.629 . . . . 10.51 112.064 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 305' ' ' CYS . 96.1 mt -94.4 141.29 28.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.099 -0.501 . . . . 8.3000000000000007 110.698 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.551 ' HB3' HG23 ' A' ' 308' ' ' VAL . 19.7 ptpt -110.94 -32.73 6.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.019 0.438 . . . . 8.9399999999999995 110.155 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -132.4 111.5 11.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.536 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.3 124.09 41.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 6.4900000000000002 110.183 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -140.34 114.87 9.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.308 0.575 . . . . 6.0300000000000002 110.351 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 303' ' ' ALA . 64.5 tp -90.34 125.49 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 6.5300000000000002 110.247 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.1 116.51 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.127 0.489 . . . . 6.8700000000000001 110.116 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.497 ' HZ3' ' CG ' ' A' ' 272' ' ' ASP . 61.4 mttm -110.73 154.31 24.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.74 -0.664 . . . . 8.2100000000000009 110.86 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.453 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 13.5 t70 -83.29 129.71 35.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.984 -0.747 . . . . 10.33 108.984 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.4 m -85.19 -13.27 50.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.426 -0.352 . . . . 10.93 111.887 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.11 -56.43 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.987 0.422 . . . . 12.34 111.095 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.462 HG23 ' HG ' ' A' ' 298' ' ' LEU . 48.1 m -83.27 -30.42 27.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 11.460000000000001 110.627 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.02 22.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.585 -0.817 . . . . 10.210000000000001 112.59 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 296' ' ' THR . 84.3 mt -110.11 161.54 15.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.73 0.3 . . . . 10.4 110.418 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.9 t -69.52 133.75 48.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.28 -0.637 . . . . 7.8700000000000001 109.28 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.51 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.2 mmmp? -74.82 -15.88 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 8.4100000000000001 110.858 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 97.76 14.78 39.11 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.612 -0.804 . . . . 6.0899999999999999 113.049 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 11.0 p90 -154.89 146.62 23.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 6.7599999999999998 110.779 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.536 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -145.3 168.02 21.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.882 -0.599 . . . . 4.6399999999999997 110.718 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.471 ' HB3' ' HG2' ' A' ' 260' ' ' LYS . 91.8 m-85 -114.54 130.21 56.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 5.1900000000000004 109.557 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 35.5 m -141.98 116.57 9.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 5.0899999999999999 111.608 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 286' ' ' LYS . 39.9 tt0 -100.24 130.62 46.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.821 -0.437 . . . . 7.0300000000000002 109.821 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -88.67 158.51 18.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 7.8899999999999997 111.07 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 286' ' ' LYS . 58.6 t -79.1 -46.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 10.42 111.118 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.553 ' HB3' HG23 ' A' ' 312' ' ' VAL . 12.6 t70 -93.91 132.55 38.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 10.81 110.446 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.506 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -64.79 -28.49 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 112.263 0.468 . . . . 10.039999999999999 112.263 -176.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -71.79 -50.05 33.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.891 -0.411 . . . . 10.98 109.891 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.699 HG22 ' HD2' ' A' ' 284' ' ' PRO . 20.8 m -66.27 -24.68 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 9.9100000000000001 110.856 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 317' ' ' ILE . 47.3 m -61.85 -48.16 81.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.13 0.49 . . . . 8.0600000000000005 110.132 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.81 -35.13 64.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.007 -0.542 . . . . 8.9399999999999995 110.516 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -63.53 -40.22 96.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 10.880000000000001 110.773 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.12 97.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 7.5300000000000002 110.47 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 313' ' ' THR . 71.7 mt -59.08 -45.38 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 6.5800000000000001 110.674 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.51 78.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.749 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.31 -49.36 6.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 7.7699999999999996 113.51 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.504 ' HB3' HD21 ' A' ' 330' ' ' LEU . 98.6 mt -73.57 -49.07 28.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.302 . . . . 6.5199999999999996 111.814 -173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 7.3 t30 -63.05 115.22 4.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 6.6100000000000003 110.44 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.92 -20.55 14.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.853 -0.689 . . . . 6.7699999999999996 112.389 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 20.9 ttt -75.22 141.41 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.146 -0.316 . . . . 7.6900000000000004 110.146 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -88.66 118.87 28.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.785 0.326 . . . . 8.2400000000000002 110.525 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 330' ' ' LEU . 4.6 mm? -101.79 96.52 7.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.124 -0.489 . . . . 7.0300000000000002 109.852 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.2 -85.57 0.81 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.901 -0.666 . . . . 8.25 112.058 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.63 -41.06 2.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.737 0.303 . . . . 8.9800000000000004 111.281 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -91.29 165.64 13.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 7.4299999999999997 110.807 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.66 136.1 37.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 7.4500000000000002 109.536 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.834 ' HB2' HD21 ' A' ' 325' ' ' LEU . 33.0 tp -73.83 125.45 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.173 0.511 . . . . 5.8399999999999999 111.316 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.67 118.63 37.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 5.8099999999999996 109.614 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 91.1 t -127.32 113.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.185 -0.461 . . . . 5.21 109.779 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -138.04 171.87 13.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.122 -0.49 . . . . 6.1699999999999999 110.01 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -86.59 136.83 32.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.402 -0.222 . . . . 7.7999999999999998 110.402 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -62.91 -44.55 95.77 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.115 0.483 . . . . 6.04 110.092 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 7.7000000000000002 109.406 172.177 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.88 ' HB2' HG23 ' A' ' 205' ' ' VAL . 56.1 ttp85 75.99 -24.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.773 0.67 . . . . 0.0 111.991 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 148' ' ' ALA . 59.4 mtt180 -97.53 150.91 20.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 6.9800000000000004 111.392 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.532 ' HG ' HG21 ' A' ' 208' ' ' THR . 23.7 mt -113.19 149.43 33.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.861 -0.609 . . . . 5.6100000000000003 111.186 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -107.98 102.9 12.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.125 -0.943 . . . . 6.2599999999999998 108.702 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.543 HG22 ' HZ ' ' A' ' 169' ' ' PHE . 7.4 p -104.11 127.44 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.488 . . . . 4.25 110.301 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.37 -178.75 15.44 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.803 -0.635 . . . . 5.3099999999999996 111.777 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 10.2 m120 62.01 28.85 17.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.085 0.469 . . . . 0.0 110.899 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.512 HG23 HD23 ' A' ' 224' ' ' LEU . 31.8 pt -78.52 153.61 78.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.466 -0.788 . . . . 5.6100000000000003 110.728 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 32.7 Cg_endo -64.35 136.71 52.37 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.556 2.171 . . . . 6.1600000000000001 112.056 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.19 123.34 20.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 8.8200000000000003 109.913 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.29 4.43 53.35 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.576 -0.821 . . . . 7.3300000000000001 112.421 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.3 tp -66.07 130.85 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 6.0999999999999996 110.147 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.8 p -92.24 155.21 18.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.765 0.317 . . . . 7.0 110.751 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -53.69 -46.47 70.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 5.6900000000000004 110.186 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.96 -55.81 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.325 -0.852 . . . . 7.29 111.153 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.94 93.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.288 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.81 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 0.7 OUTLIER -64.94 -47.67 76.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 4.5700000000000003 110.598 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.2 ttt -60.92 -48.83 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 6.1100000000000003 110.769 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.46 -38.78 88.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 6.5099999999999998 111.524 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.49 -49.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.614 -0.267 . . . . 5.8700000000000001 111.068 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.543 ' HZ ' HG22 ' A' ' 153' ' ' VAL . 50.4 m-85 -65.1 -44.22 89.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.593 -0.276 . . . . 5.0300000000000002 111.093 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.03 -33.45 75.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.557 -0.292 . . . . 6.2999999999999998 110.985 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.74 -49.93 68.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.227 175.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.09 -35.36 75.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 6.3200000000000003 111.113 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.847 ' HA ' ' HE3' ' A' ' 173' ' ' MET . 6.0 mmt -60.88 -50.16 74.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 7.0300000000000002 110.529 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -71.06 -44.29 66.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 9.3100000000000005 111.269 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 78.1 mt -65.13 -35.18 80.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.383 . . . . 8.9600000000000009 110.985 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.95 -34.38 38.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.627 -0.796 . . . . 8.1099999999999994 112.104 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.37 47.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.624 . . . . 8.7200000000000006 111.926 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 6.0 mp -96.19 82.83 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 7.7199999999999998 109.672 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.426 HG21 ' HG3' ' A' ' 185' ' ' PRO . 14.2 m -154.93 143.13 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.908 -0.587 . . . . 8.7300000000000004 109.425 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.535 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -93.24 -22.1 19.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.734 -0.387 . . . . 9.8900000000000006 111.442 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.3 145.91 19.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.592 -0.277 . . . . 9.9700000000000006 110.599 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.91 114.17 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.734 2.29 . . . . 11.119999999999999 112.003 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.6 -152.57 24.6 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.825 -0.702 . . . . 9.0600000000000005 111.942 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -114.54 117.73 42.32 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.548 0.213 . . . . 7.7400000000000002 110.865 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.426 ' HG3' HG21 ' A' ' 179' ' ' THR . 28.0 Cg_exo -63.09 -37.83 49.75 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.66 2.24 . . . . 6.6699999999999999 111.53 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 52.8 t -89.72 112.55 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.836 -0.62 . . . . 5.4699999999999998 109.824 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HB3' HG23 ' A' ' 280' ' ' THR . 86.4 mt -89.96 -39.28 13.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.729 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.1 168.94 19.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.46 116.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 4.7699999999999996 110.753 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -98.15 106.96 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 6.6500000000000004 109.614 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.0 mt -91.66 136.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.232 0.539 . . . . 5.8499999999999996 110.958 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -119.55 96.77 5.34 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.732 -0.84 . . . . 7.7599999999999998 108.732 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -70.5 -23.97 62.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.569 -0.741 . . . . 7.6100000000000003 111.697 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.76 -49.92 75.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 9.1199999999999992 111.498 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.506 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 35.2 mmtm -106.19 7.09 31.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 9.2799999999999994 111.028 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.04 61.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.795 . . . . 6.9299999999999997 111.5 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 52.3 p90 -148.99 171.31 16.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.092 -0.504 . . . . 7.1100000000000003 109.676 173.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.94 142.46 28.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.357 . . . . 4.6600000000000001 111.158 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 70.2 m-85 -92.8 113.44 25.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 6.5899999999999999 109.869 175.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 151' ' ' LEU . 97.0 mt -83.35 115.76 22.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.211 -0.449 . . . . 4.7699999999999996 110.253 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.84 108.45 19.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 6.5499999999999998 109.695 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 37.1 m-85 -99.02 157.33 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 6.5099999999999998 111.287 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -82.94 -24.32 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.387 -0.824 . . . . 8.5399999999999991 110.765 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 98.5 p -134.06 163.0 30.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 8.3000000000000007 109.991 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 149' ' ' ARG . 15.7 t -92.1 -15.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.875 0.845 . . . . 9.0099999999999998 108.841 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.99 -56.14 6.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.773 -1.103 . . . . 8.7799999999999994 111.183 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.535 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.5 mt-10 -65.79 -24.28 66.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 7.4800000000000004 111.704 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.532 HG21 ' HG ' ' A' ' 151' ' ' LEU . 13.3 m -48.97 -49.75 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.636 0.585 . . . . 6.3899999999999997 111.508 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.8 m -61.46 -36.23 79.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.012 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 1.9 mp0 -70.11 -28.98 65.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.056 -0.258 . . . . 7.9400000000000004 111.189 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.42 -23.52 62.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.313 0.578 . . . . 5.5 110.337 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.404 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 86.8 mtp -70.8 -14.77 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.704 -0.68 . . . . 6.46 110.794 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.89 2.54 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 6.3600000000000003 111.254 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -113.02 19.69 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 5.9299999999999997 110.436 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.83 117.63 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.927 -0.579 . . . . 5.9199999999999999 111.039 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 97.93 16.62 32.69 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.827 -0.702 . . . . 5.7400000000000002 112.498 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.89 135.61 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 110.036 -0.357 . . . . 5.6299999999999999 110.036 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 tp -84.27 116.43 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 7.2300000000000004 111.004 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -135.18 118.67 16.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.796 -0.638 . . . . 5.79 110.288 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 60.84 32.47 20.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 7.3200000000000003 111.414 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.91 78.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.844 -0.693 . . . . 7.5899999999999999 112.632 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 32.6 mm-40 -110.08 132.35 54.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.258 -0.275 . . . . 7.5300000000000002 110.258 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.5 m -86.37 106.78 17.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.871 -0.418 . . . . 6.4500000000000002 109.871 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 156' ' ' ILE . 75.9 mt -66.1 111.89 3.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 4.9000000000000004 110.896 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 86.5 tttt -87.76 114.61 24.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.742 -0.663 . . . . 7.5700000000000003 109.528 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.6 mt -110.92 105.64 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.937 0.399 . . . . 5.3700000000000001 110.423 -173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -129.25 171.2 12.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.067 -0.515 . . . . 7.1900000000000004 110.324 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.404 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 45.8 mtp180 -104.42 143.68 27.17 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.594 0.235 . . . . 7.7599999999999998 111.109 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.09 160.98 14.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.462 2.108 . . . . 7.9800000000000004 110.769 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.516 -175.101 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 108.87 -0.789 . . . . 9.1300000000000008 108.87 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 35.3 ttmt -62.33 125.38 23.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.462 -1.245 . . . . 6.3600000000000003 109.934 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.409 HD13 ' CE1' ' A' ' 307' ' ' TYR . 69.6 mt -98.86 142.31 30.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.113 -0.494 . . . . 5.5899999999999999 110.797 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.663 ' HB2' ' HA ' ' A' ' 335' ' ' ALA . 87.3 t80 -95.99 109.47 21.85 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.294 -0.866 . . . . 5.0300000000000002 108.897 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.34 106.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.863 -0.421 . . . . 4.21 109.863 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.95 171.1 19.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.898 -0.668 . . . . 4.5800000000000001 111.511 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.2 27.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.654 -0.784 . . . . 5.6299999999999999 112.068 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.4 mt -101.42 143.86 27.42 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.259 -0.275 . . . . 5.9199999999999999 110.259 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.663 ' HD2' HD23 ' A' ' 270' ' ' LEU . 30.5 Cg_exo -62.33 143.42 93.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.569 2.179 . . . . 7.3099999999999996 111.98 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.66 -24.43 66.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.615 0.228 . . . . 8.8100000000000005 111.615 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -85.02 -7.17 59.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.754 0.312 . . . . 9.0700000000000003 110.836 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.663 HD23 ' HD2' ' A' ' 267' ' ' PRO . 12.1 tp -71.81 106.5 4.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.617 -0.512 . . . . 7.7199999999999998 109.617 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.528 ' O ' HG21 ' A' ' 275' ' ' VAL . 30.6 p-10 -85.9 172.18 10.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 8.8000000000000007 111.012 -175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.07 -37.69 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 7.8899999999999997 111.94 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.17 -54.39 44.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.758 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.62 -42.59 95.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 8.7300000000000004 111.643 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 271' ' ' ASN . 38.9 t -61.49 -47.03 95.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.561 0.22 . . . . 6.7300000000000004 110.728 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -58.56 -54.0 51.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.586 -0.279 . . . . 8.1199999999999992 110.72 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.75 -51.02 70.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.073 -0.512 . . . . 9.3800000000000008 111.591 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.0 -42.89 81.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 7.2300000000000004 110.693 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 320' ' ' LEU . 62.1 mt -80.32 -29.05 38.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.484 -0.325 . . . . 6.8899999999999997 111.26 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.4 m -71.54 -16.73 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 9.2400000000000002 110.796 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 16.3 m -59.97 -15.03 18.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.917 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.85 9.29 11.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.614 0.245 . . . . 9.1799999999999997 111.23 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.75 146.27 4.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.946 -0.645 . . . . 9.5600000000000005 112.395 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.539 ' HA ' HG21 ' A' ' 280' ' ' THR . 50.4 Cg_endo -69.78 141.75 46.0 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.682 2.254 . . . . 10.51 112.733 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.57 130.76 44.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 8.3000000000000007 110.883 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.65 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.5 ptpt -93.5 -29.24 15.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.131 0.491 . . . . 8.9399999999999995 110.028 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 306' ' ' GLU . . . -136.42 115.07 11.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.541 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -125.82 122.21 35.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 6.4900000000000002 110.759 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -140.87 111.6 6.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.51 0.671 . . . . 6.0300000000000002 110.472 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.645 HD12 ' HG ' ' A' ' 299' ' ' SER . 57.0 tp -85.18 140.11 31.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.386 -0.825 . . . . 6.5300000000000002 109.778 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' A' ' 302' ' ' TYR . 58.4 t -88.81 111.34 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.077 0.465 . . . . 6.8700000000000001 110.123 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -102.35 155.24 18.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 8.2100000000000009 111.099 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.76 135.42 34.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.66 -0.7 . . . . 10.33 109.907 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.6 m -74.45 -12.94 60.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 10.93 112.036 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.03 -68.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 12.34 111.324 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 17.4 m -77.9 -32.35 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 11.460000000000001 111.426 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.04 6.97 62.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.54 -0.838 . . . . 10.210000000000001 112.414 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.32 173.34 11.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.618 0.247 . . . . 10.4 110.339 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.645 ' HG ' HD12 ' A' ' 290' ' ' LEU . 47.4 t -79.38 144.7 33.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.408 -0.36 . . . . 7.8700000000000001 110.1 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 300' ' ' LYS . 30.8 mmtp -79.15 0.34 28.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 8.4100000000000001 110.436 175.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 97.71 17.13 31.62 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 6.0899999999999999 113.069 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.495 ' CE2' HG22 ' A' ' 291' ' ' VAL . 43.6 p90 -162.73 157.03 21.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.329 0.585 . . . . 6.7599999999999998 111.261 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.607 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -147.46 160.17 42.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.314 -0.857 . . . . 4.6399999999999997 110.24 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.523 ' HD2' ' HB2' ' A' ' 335' ' ' ALA . 81.8 m-85 -107.43 122.65 47.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.853 -0.795 . . . . 5.1900000000000004 108.853 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 56.9 m -139.01 115.24 10.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 5.0899999999999999 111.412 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 33.5 tt0 -98.25 135.43 39.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.916 -0.584 . . . . 7.0300000000000002 110.155 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.409 ' CE1' HD13 ' A' ' 261' ' ' LEU . 26.1 m-85 -90.14 147.31 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.213 -0.448 . . . . 7.8899999999999997 111.238 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.65 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 52.5 t -66.32 -53.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 10.42 110.578 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 312' ' ' VAL . 27.0 t70 -88.64 137.16 32.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.997 -0.547 . . . . 10.81 110.374 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.54 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -79.2 -18.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.148 0.425 . . . . 10.039999999999999 112.148 -174.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.61 -40.22 23.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.761 0.315 . . . . 10.98 110.401 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 309' ' ' ASP . 34.5 m -69.49 -22.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 9.9100000000000001 111.439 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 317' ' ' ILE . 21.4 m -55.3 -50.6 69.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.68 0.276 . . . . 8.0600000000000005 111.563 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.92 -32.82 72.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.014 0.435 . . . . 8.9399999999999995 110.789 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -66.12 -41.39 90.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 10.880000000000001 110.443 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.34 94.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 7.5300000000000002 110.734 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 313' ' ' THR . 64.4 mt -57.36 -41.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 6.5800000000000001 110.495 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.54 -43.52 59.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.741 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -75.43 -47.54 12.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.018 -0.611 . . . . 7.7699999999999996 113.469 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.577 HD11 HD23 ' A' ' 279' ' ' LEU . 87.1 mt -70.56 -43.11 70.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.647 0.261 . . . . 6.5199999999999996 111.61 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 8.9 t30 -66.43 115.44 6.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.75 0.31 . . . . 6.6100000000000003 110.272 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.41 -21.55 14.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.925 -0.655 . . . . 6.7699999999999996 111.514 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.5 ttt -73.85 141.86 46.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.039 -0.356 . . . . 7.6900000000000004 110.039 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 26.1 tt0 -105.59 125.18 50.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.833 0.349 . . . . 8.2400000000000002 110.599 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.539 HD13 ' HG2' ' A' ' 267' ' ' PRO . 0.4 OUTLIER -117.14 113.4 22.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.94 -0.763 . . . . 7.0300000000000002 108.94 177.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.86 -88.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.939 -0.648 . . . . 8.25 112.849 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.69 0.26 3.57 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.854 -0.203 . . . . 8.9800000000000004 111.396 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -130.61 152.08 50.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.915 0.388 . . . . 7.4299999999999997 111.147 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 91.3 mttt -103.83 129.7 51.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 7.4500000000000002 109.647 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.72 122.77 18.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.037 0.446 . . . . 5.8399999999999999 112.121 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.53 107.43 19.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.334 -0.987 . . . . 5.8099999999999996 108.334 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 320' ' ' LEU . 59.4 t -110.81 121.87 64.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 5.21 111.643 -173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 13.9 pt20 -139.69 -169.09 2.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 6.1699999999999999 108.77 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -87.14 141.33 28.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.878 -0.416 . . . . 7.7999999999999998 109.878 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.663 ' HA ' ' HB2' ' A' ' 262' ' ' PHE . . . -70.51 -38.18 74.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 6.04 111.272 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 7.7000000000000002 110.044 177.705 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' ' NH2' ' A' ' 228' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.525 ' HB3' HG23 ' A' ' 205' ' ' VAL . 23.4 ptt85 -117.67 20.64 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.883 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.88 139.91 39.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.978 -0.555 . . . . 6.9800000000000004 109.91 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.24 137.21 48.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.847 0.356 . . . . 5.6100000000000003 110.293 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.621 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 74.7 t80 -94.94 104.66 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.847 -0.615 . . . . 6.2599999999999998 109.46 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 5.8 p -107.32 125.08 63.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.315 0.578 . . . . 4.25 110.642 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.69 -178.86 15.48 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.516 -0.765 . . . . 5.3099999999999996 111.632 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.1 t30 59.8 41.31 18.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.029 0.919 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.679 HG23 HD23 ' A' ' 224' ' ' LEU . 32.6 pt -90.42 156.95 45.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.949 . . . . 5.6100000000000003 110.712 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.579 ' HG3' ' HB2' ' A' ' 220' ' ' GLN . 29.6 Cg_endo -63.84 142.32 81.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.669 2.246 . . . . 6.1600000000000001 112.26 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -80.32 126.99 31.85 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.612 -0.514 . . . . 8.8200000000000003 109.612 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.49 21.18 41.65 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.623 -0.798 . . . . 7.3300000000000001 111.999 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.557 HD11 ' HG3' ' A' ' 220' ' ' GLN . 9.3 tp -78.97 139.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.868 0.366 . . . . 6.0999999999999996 110.691 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 164' ' ' ALA . 24.7 m -75.52 128.07 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 7.0 110.293 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.512 ' HA ' HD13 ' A' ' 191' ' ' ILE . 44.1 mt-10 -59.69 -47.9 83.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.506 -0.315 . . . . 5.6900000000000004 110.765 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.96 -42.48 89.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.953 -0.567 . . . . 7.29 110.53 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 161' ' ' THR . . . -63.15 -44.17 96.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.2 ttm -64.94 -45.72 84.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.507 -0.315 . . . . 4.5700000000000003 110.653 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.425 ' HE2' ' HA ' ' A' ' 281' ' ' SER . 27.1 ttt -61.33 -50.95 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.153 -0.476 . . . . 6.1100000000000003 111.004 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.02 -32.78 74.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 6.5099999999999998 110.958 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.488 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 86.3 t80 -59.32 -52.58 65.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 5.8700000000000001 110.579 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -63.67 -41.69 98.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 5.0300000000000002 110.786 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.4 m-20 -55.77 -48.86 74.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 6.2999999999999998 110.43 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.5 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.22 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 17.4 mm100 -64.25 -37.35 87.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.3200000000000003 111.267 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.431 ' HE2' ' HB3' ' A' ' 207' ' ' GLU . 86.7 mtp -69.83 -34.87 74.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.998 -0.281 . . . . 7.0300000000000002 110.583 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 98.6 mtt180 -64.7 -50.9 65.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.013 0.435 . . . . 9.3100000000000005 110.196 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.27 -35.52 81.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 8.9600000000000009 111.911 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.05 -21.37 59.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.603 -0.808 . . . . 8.1099999999999994 112.59 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.91 40.94 7.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.592 -0.813 . . . . 8.7200000000000006 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.66 3.31 34.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.087 0.47 . . . . 7.7199999999999998 110.259 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 p -92.34 140.14 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 8.7300000000000004 110.827 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.423 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.0 pt20 -95.02 -10.71 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.087 0.47 . . . . 9.8900000000000006 110.287 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.11 158.71 33.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 9.9700000000000006 110.227 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 154.06 62.59 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.559 2.172 . . . . 11.119999999999999 111.822 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.37 -145.77 16.1 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.669 -0.777 . . . . 9.0600000000000005 112.599 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.58 122.5 37.2 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 120.462 0.172 . . . . 7.7400000000000002 110.571 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.82 -38.61 47.39 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.737 2.291 . . . . 6.6699999999999999 111.69 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.91 137.26 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.41 -0.589 . . . . 5.4699999999999998 109.41 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 284' ' ' PRO . 50.9 tp -105.1 -41.63 5.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.644 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -142.56 134.25 26.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.76 117.37 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 4.7699999999999996 110.159 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -124.58 105.81 9.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.823 -0.436 . . . . 6.6500000000000004 109.823 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 162' ' ' GLU . 55.4 mt -107.23 134.16 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 5.8499999999999996 111.453 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -109.91 113.85 26.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.542 . . . . 7.7599999999999998 109.538 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -82.97 -10.91 58.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 7.6100000000000003 110.81 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.91 -59.08 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.161 -0.472 . . . . 9.1199999999999992 111.051 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.0 mmtm -91.16 -0.79 57.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.405 -0.361 . . . . 9.2799999999999994 110.686 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 62.2 61.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 6.9299999999999997 110.912 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 42.7 p90 -148.87 158.68 44.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 7.1100000000000003 109.446 175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -139.57 147.63 41.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.942 0.401 . . . . 4.6600000000000001 110.856 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.12 109.55 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.772 -0.649 . . . . 6.5899999999999999 110.008 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.247 -0.649 . . . . 4.7699999999999996 109.247 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 127.36 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.642 . . . . 6.5499999999999998 109.268 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -99.03 162.85 12.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.977 0.417 . . . . 6.5099999999999998 111.203 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -71.93 -25.78 62.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.405 -0.816 . . . . 8.5399999999999991 110.329 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.1 p -124.56 -170.32 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.582 -0.736 . . . . 8.3000000000000007 109.595 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 149' ' ' ARG . 39.2 t -113.78 -28.78 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.644 0.735 . . . . 9.0099999999999998 109.281 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.15 -51.04 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.896 . . . . 8.7799999999999994 111.34 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HB3' ' HE2' ' A' ' 173' ' ' MET . 50.4 mt-10 -65.24 -35.12 80.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.076 -0.511 . . . . 7.4800000000000004 110.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -55.12 -50.14 70.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.316 0.579 . . . . 6.3899999999999997 110.351 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 24.1 m -60.06 -34.13 73.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.698 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -31.59 64.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 7.9400000000000004 110.277 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -76.03 -7.43 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.023 -0.535 . . . . 5.5 111.206 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 85.8 mtp -69.85 -16.65 63.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.411 . . . . 6.46 110.021 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.59 50.38 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.674 -0.694 . . . . 6.3600000000000003 111.049 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.483 ' HD1' HD13 ' A' ' 217' ' ' ILE . 93.3 m-85 -93.75 7.14 45.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 5.9299999999999997 110.812 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.28 114.29 3.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.98 -0.378 . . . . 5.9199999999999999 109.98 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.36 12.51 44.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.859 -0.686 . . . . 5.7400000000000002 112.11 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.483 HD13 ' HD1' ' A' ' 214' ' ' PHE . 16.6 tt -71.53 137.19 24.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 5.6299999999999999 110.044 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -85.55 112.03 21.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.459 0.647 . . . . 7.2300000000000004 110.056 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -133.09 119.4 19.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 5.79 110.579 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 80.9 mm-40 60.82 29.54 19.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.522 -0.763 . . . . 7.3200000000000003 111.273 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.78 7.97 83.36 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.857 -0.687 . . . . 7.5899999999999999 112.857 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -124.76 132.74 53.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.568 -0.372 . . . . 7.5300000000000002 110.824 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 t -78.86 112.33 15.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.147 -0.686 . . . . 6.4500000000000002 109.147 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.679 HD23 HG23 ' A' ' 156' ' ' ILE . 46.4 mt -81.9 120.71 25.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.885 0.374 . . . . 4.9000000000000004 111.352 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.5 tttt -84.78 115.97 23.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 7.5700000000000003 109.543 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.9 mt -121.98 105.89 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.415 . . . . 5.3700000000000001 110.886 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -132.68 167.5 19.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.045 -0.525 . . . . 7.1900000000000004 110.412 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 15.7 mtp180 -79.34 128.17 76.38 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.738 -0.467 . . . . 7.7599999999999998 109.738 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.621 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 3.6 Cg_exo -73.07 153.81 52.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.797 2.331 . . . . 7.9800000000000004 112.241 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.015 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.862 ' HB3' HG22 ' A' ' 313' ' ' THR . 52.6 m80 . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 111.792 0.293 . . . . 9.1300000000000008 111.792 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 305' ' ' CYS . 40.3 ttmt -66.44 121.49 15.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.681 -0.488 . . . . 6.3600000000000003 109.681 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.43 142.09 31.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.313 0.577 . . . . 5.5899999999999999 111.476 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.97 107.19 19.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.781 -1.099 . . . . 5.0300000000000002 108.684 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 3.6 mp -100.3 104.58 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.954 -0.566 . . . . 4.21 109.529 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -118.84 120.5 4.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.589 -0.815 . . . . 4.5800000000000001 112.691 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 139.2 9.71 0.9 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.096 -0.573 . . . . 5.6299999999999999 112.296 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.4 144.76 74.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.481 0.182 . . . . 5.9199999999999999 110.65 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 270' ' ' LEU . 41.2 Cg_exo -57.63 135.88 72.21 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.77 2.314 . . . . 7.3099999999999996 112.292 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 9.1 p30 -62.39 -23.55 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.918 -0.583 . . . . 8.8100000000000005 111.137 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -100.59 12.58 37.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.551 . . . . 9.0700000000000003 111.34 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 267' ' ' PRO . 26.8 tp -89.32 125.2 35.02 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.779 -0.452 . . . . 7.7199999999999998 109.779 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.532 ' O ' HG21 ' A' ' 275' ' ' VAL . 29.8 p-10 -85.09 157.01 20.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 8.8000000000000007 111.186 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 2.8 m-20 -52.5 -36.16 54.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.663 -0.699 . . . . 7.8899999999999997 112.055 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.25 -53.06 58.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.431 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -72.62 -40.09 66.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 8.7300000000000004 111.081 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 271' ' ' ASN . 59.9 t -56.83 -47.81 82.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.428 -0.351 . . . . 6.7300000000000004 110.716 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.4 mtmm -59.96 -47.53 85.44 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.477 -0.328 . . . . 8.1199999999999992 110.815 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -49.74 76.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.106 -0.237 . . . . 9.3800000000000008 110.965 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.23 -47.16 78.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 7.2300000000000004 110.763 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.574 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -77.13 -31.5 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.396 -0.365 . . . . 6.8899999999999997 111.563 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.6 m -69.97 -27.97 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 9.2400000000000002 111.017 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.425 ' HA ' ' HE2' ' A' ' 166' ' ' MET . 41.9 m -72.41 4.5 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.542 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -132.53 9.81 4.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.364 -0.38 . . . . 9.1799999999999997 110.779 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.445 ' HA3' ' HE2' ' A' ' 307' ' ' TYR . . . 160.56 146.32 4.57 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.183 -1.008 . . . . 9.5600000000000005 113.286 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.992 ' HB3' HD22 ' A' ' 187' ' ' LEU . 53.4 Cg_endo -71.04 119.82 6.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.249 2.633 . . . . 10.51 112.534 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' A' ' 305' ' ' CYS . 56.0 mt -100.4 103.23 14.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.199 -0.455 . . . . 8.3000000000000007 110.486 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.497 ' HB3' HG23 ' A' ' 308' ' ' VAL . 53.9 pttt -82.29 -20.7 36.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 8.9399999999999995 110.072 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 306' ' ' GLU . . . -138.99 130.2 26.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.408 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 75.6 t80 -145.21 128.83 17.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.667 0.27 . . . . 6.4900000000000002 110.638 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -140.6 114.19 8.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.357 0.598 . . . . 6.0300000000000002 110.983 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.427 HD12 ' HG ' ' A' ' 299' ' ' SER . 62.4 tp -90.68 131.67 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.458 -0.792 . . . . 6.5300000000000002 109.188 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.45 121.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.916 0.389 . . . . 6.8700000000000001 110.798 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.77 157.95 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.004 -0.544 . . . . 8.2100000000000009 110.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.408 ' HB2' ' CD ' ' A' ' 300' ' ' LYS . 14.5 t70 -91.05 121.64 33.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.216 -0.661 . . . . 10.33 109.216 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 47.2 m -71.61 -29.6 64.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.452 0.538 . . . . 10.93 112.452 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.59 -44.72 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.808 -0.357 . . . . 12.34 110.932 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 10.4 m -73.98 -44.73 53.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.144 -0.48 . . . . 11.460000000000001 111.306 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 90.59 26.32 23.16 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 10.210000000000001 111.889 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 92.3 mt -135.19 168.46 19.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.804 -0.443 . . . . 10.4 109.804 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.427 ' HG ' HD12 ' A' ' 290' ' ' LEU . 42.6 t -70.42 145.92 50.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 7.8700000000000001 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 293' ' ' ASP . 31.5 mmmt -76.32 -20.47 57.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 8.4100000000000001 110.17 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 107.35 -7.84 37.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.621 -0.799 . . . . 6.0899999999999999 112.897 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 52.7 p90 -128.4 147.2 50.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.191 0.52 . . . . 6.7599999999999998 111.534 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -142.3 158.67 43.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 4.6399999999999997 110.435 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 93.0 m-85 -111.59 132.38 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.238 -0.437 . . . . 5.1900000000000004 110.079 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.844 ' HB3' HD23 ' A' ' 285' ' ' LEU . 57.4 m -130.89 115.76 16.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.317 -0.401 . . . . 5.0899999999999999 111.239 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.713 ' HB3' ' HB1' ' A' ' 287' ' ' ALA . 40.5 tt0 -95.4 119.58 34.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.488 -0.56 . . . . 7.0300000000000002 109.488 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.445 ' HE2' ' HA3' ' A' ' 283' ' ' GLY . 30.1 m-85 -90.72 148.36 22.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 7.8899999999999997 111.845 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 286' ' ' LYS . 53.6 t -77.34 -48.26 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 10.42 110.579 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.672 ' HB3' HG23 ' A' ' 312' ' ' VAL . 18.2 t70 -82.37 157.75 23.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 10.81 109.897 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.713 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -110.11 -4.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.489 0.551 . . . . 10.039999999999999 112.489 -173.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -111.02 -30.48 7.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.963 -0.295 . . . . 10.98 111.482 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 309' ' ' ASP . 34.1 m -71.52 -23.71 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.867 0.321 . . . . 9.9100000000000001 111.867 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.862 HG22 ' HB3' ' A' ' 259' ' ' HIS . 13.0 m -57.56 -49.37 76.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.945 0.35 . . . . 8.0600000000000005 111.945 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.39 -27.1 68.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.059 0.457 . . . . 8.9399999999999995 110.748 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.69 -34.74 45.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 10.880000000000001 110.413 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.58 99.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 7.5300000000000002 110.065 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.0 mt -57.38 -47.1 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.719 -0.673 . . . . 6.5800000000000001 110.531 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.87 -33.73 72.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.842 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.92 -44.62 5.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.704 -0.76 . . . . 7.7699999999999996 112.959 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.39 -51.18 15.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 6.5199999999999996 111.402 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.705 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.1 t30 -67.6 120.7 14.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.124 -0.489 . . . . 6.6100000000000003 110.365 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 121.69 -30.17 5.41 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.815 -0.707 . . . . 6.7699999999999996 111.776 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -74.52 141.0 44.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 7.6900000000000004 109.21 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 29.9 tt0 -107.89 120.91 43.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.966 0.412 . . . . 8.2400000000000002 111.541 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.38 103.78 16.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 7.0300000000000002 109.721 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.77 -96.84 0.38 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.011 -0.614 . . . . 8.25 112.265 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.05 2.08 9.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 8.9800000000000004 110.687 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.69 113.51 26.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 7.4299999999999997 110.854 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 87.8 tttt -72.16 131.23 42.52 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.302 -0.629 . . . . 7.4500000000000002 109.302 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.541 HD12 HG21 ' A' ' 263' ' ' ILE . 23.2 tp -77.68 117.16 18.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.961 0.41 . . . . 5.8399999999999999 111.351 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 329' ' ' LYS . 6.3 mp -98.95 123.6 43.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.355 -0.609 . . . . 5.8099999999999996 109.355 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.705 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 57.5 t -125.67 118.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.077 -0.511 . . . . 5.21 110.204 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.75 163.71 34.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.789 -0.819 . . . . 6.1699999999999999 108.789 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.95 141.87 58.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.862 -0.421 . . . . 7.7999999999999998 109.862 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.43 -51.32 47.67 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.418 0.449 . . . . 6.04 111.876 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 120.815 0.341 . . . . 7.7000000000000002 110.274 176.937 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.569 ' H2 ' HG11 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.948 0.404 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.07 -50.59 7.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.381 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 199' ' ' PHE . 99.2 mtt180 -106.99 133.32 51.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 6.9800000000000004 111.034 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 208' ' ' THR . 31.7 mt -92.87 152.92 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.449 . . . . 5.6100000000000003 110.466 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 65.7 t80 -94.14 110.65 22.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.815 -0.63 . . . . 6.2599999999999998 109.736 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 198' ' ' ALA . 5.9 p -111.1 119.92 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.274 0.559 . . . . 4.25 109.88 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.88 15.06 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.652 -0.704 . . . . 5.3099999999999996 111.951 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.12 39.74 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.921 0.867 . . . . 0.0 109.188 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.473 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 27.8 pt -85.76 146.95 44.86 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.004 -0.998 . . . . 5.6100000000000003 110.833 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 6.9 Cg_exo -74.48 120.5 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.896 2.397 . . . . 6.1600000000000001 111.752 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.417 ' CD2' ' HG2' ' A' ' 193' ' ' GLN . 28.5 t80 -62.24 132.8 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.132 -0.486 . . . . 8.8200000000000003 109.929 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 114.31 -17.0 19.46 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.67 -0.776 . . . . 7.3300000000000001 112.597 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.9 tp -78.62 144.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 6.0999999999999996 110.335 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -88.94 152.82 21.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 7.0 110.864 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.619 ' HA ' HD13 ' A' ' 191' ' ' ILE . 40.4 mt-10 -63.09 -39.82 95.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.126 -0.488 . . . . 5.6900000000000004 110.75 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -61.99 -47.29 85.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.599 . . . . 7.29 110.788 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.89 86.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.83 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.4 tpt -63.21 -47.62 81.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 4.5700000000000003 110.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.413 ' HB2' HG12 ' A' ' 189' ' ' VAL . 22.5 ttt -61.15 -46.38 90.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 6.1100000000000003 111.307 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.52 -36.28 82.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 6.5099999999999998 110.854 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.9 -46.9 84.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.967 -0.56 . . . . 5.8700000000000001 110.516 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.651 ' O ' ' HG2' ' A' ' 173' ' ' MET . 54.9 m-85 -64.31 -46.36 83.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 5.0300000000000002 110.83 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.54 -45.68 73.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.719 0.295 . . . . 6.2999999999999998 110.956 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -60.7 -48.76 80.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.896 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.84 -27.0 64.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 6.3200000000000003 111.753 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 32.4 mmt -64.62 -42.69 95.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 7.0300000000000002 110.016 176.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -70.2 -44.61 68.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.842 -0.617 . . . . 9.3100000000000005 110.419 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 79.8 mt -68.21 -34.49 76.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 8.9600000000000009 111.446 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.57 -16.3 73.75 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.601 -0.809 . . . . 8.1099999999999994 112.466 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.78 29.63 34.6 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.685 -0.769 . . . . 8.7200000000000006 112.147 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.601 HD12 ' HE1' ' A' ' 214' ' ' PHE . 4.5 mp -87.89 -22.52 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.36 0.6 . . . . 7.7199999999999998 109.838 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 24.0 m -76.21 122.69 24.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.217 -0.902 . . . . 8.7300000000000004 110.751 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.458 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.1 pt20 -80.6 -30.49 36.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.914 0.387 . . . . 9.8900000000000006 110.932 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.75 124.89 18.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.509 . . . . 9.9700000000000006 110.253 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.79 128.62 2.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.962 3.108 . . . . 11.119999999999999 113.613 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 134.58 -129.63 5.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.915 -0.659 . . . . 9.0600000000000005 112.265 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -123.26 117.95 27.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.724 0.297 . . . . 7.7400000000000002 111.086 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.88 -27.82 9.94 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.599 2.2 . . . . 6.6699999999999999 112.047 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.4 t -90.03 133.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 5.4699999999999998 110.039 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 203' ' ' ARG . 86.9 mt -95.42 -56.3 2.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.6 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.41 157.88 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 200' ' ' LEU . 8.2 p -133.93 137.57 52.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.058 -0.519 . . . . 4.7699999999999996 110.599 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.73 111.12 13.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.632 -0.507 . . . . 6.6500000000000004 109.632 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 162' ' ' GLU . 41.6 mt -104.71 127.23 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 5.8499999999999996 111.555 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -105.36 97.98 7.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.062 -1.088 . . . . 7.7599999999999998 108.062 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.417 ' HG2' ' CD2' ' A' ' 158' ' ' PHE . 16.1 tt0 -85.45 -5.28 59.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.971 -0.559 . . . . 7.6100000000000003 110.307 -172.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.28 -52.64 10.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 9.1199999999999992 110.204 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -91.98 2.67 56.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 9.2799999999999994 110.757 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.86 48.53 3.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.332 -0.849 . . . . 6.9299999999999997 111.712 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 34.8 p90 -148.52 151.32 34.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.301 -0.409 . . . . 7.1100000000000003 110.224 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -141.27 157.51 45.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.522 -0.308 . . . . 4.6600000000000001 110.827 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 150' ' ' ARG . 61.1 m-85 -118.32 119.51 34.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.202 -0.454 . . . . 6.5899999999999999 110.806 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 31.0 mt -95.32 115.0 26.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.678 -0.692 . . . . 4.7699999999999996 109.549 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -96.41 116.87 29.75 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.51 -0.476 . . . . 6.5499999999999998 110.384 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CD1' HG21 ' A' ' 208' ' ' THR . 27.6 m-85 -93.84 163.91 13.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.683 -0.69 . . . . 6.5099999999999998 110.612 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 187' ' ' LEU . 37.0 ptt180 -74.48 -24.19 58.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 8.5399999999999991 110.788 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 71.3 p -125.44 -161.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.19 -0.459 . . . . 8.3000000000000007 110.434 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.569 HG11 ' H2 ' ' A' ' 148' ' ' ALA . 60.2 t -122.12 -34.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.094 0.473 . . . . 9.0099999999999998 110.04 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.11 -52.2 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 8.7799999999999994 111.129 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.2 mt-10 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.748 -0.464 . . . . 7.4800000000000004 109.748 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.573 ' O ' HD12 ' A' ' 151' ' ' LEU . 2.1 m -51.69 -52.43 48.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.465 -0.788 . . . . 6.3899999999999997 110.818 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.3 m -63.41 -33.67 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.766 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.46 ' HG3' HD21 ' A' ' 178' ' ' LEU . 8.9 tp-100 -71.05 -30.0 66.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 7.9400000000000004 110.393 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -16.26 63.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 5.5 111.349 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.9 mtp -69.78 -13.75 62.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 6.46 111.165 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.25 65.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 6.3600000000000003 111.097 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.601 ' HE1' HD12 ' A' ' 178' ' ' LEU . 22.5 m-85 -94.13 12.27 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 5.9299999999999997 111.353 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.84 112.9 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.817 0.341 . . . . 5.9199999999999999 110.28 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.58 30.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.714 -0.755 . . . . 5.7400000000000002 112.499 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.515 HD13 ' HD2' ' A' ' 214' ' ' PHE . 15.4 tt -61.44 138.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.926 0.393 . . . . 5.6299999999999999 110.398 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.11 122.56 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.331 0.586 . . . . 7.2300000000000004 110.883 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -133.68 106.49 7.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.737 -0.665 . . . . 5.79 110.125 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.54 31.27 20.22 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.831 -0.622 . . . . 7.3200000000000003 111.968 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.44 68.36 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.589 -0.815 . . . . 7.5899999999999999 112.851 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 31.1 mm-40 -120.24 136.06 54.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.212 -0.292 . . . . 7.5300000000000002 110.212 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.3 m -87.19 108.8 19.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.401 -0.363 . . . . 6.4500000000000002 110.22 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.73 119.56 11.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.476 . . . . 4.9000000000000004 110.891 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 83.2 tttt -90.94 116.96 29.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.906 -0.588 . . . . 7.5700000000000003 109.804 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.07 105.89 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.04 0.448 . . . . 5.3700000000000001 110.131 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -127.61 170.2 12.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.963 -0.562 . . . . 7.1900000000000004 111.005 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -77.17 144.8 72.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.928 -0.578 . . . . 7.7599999999999998 109.455 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.89 164.47 13.93 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.701 2.267 . . . . 7.9800000000000004 113.026 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.973 177.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.419 ' CE1' ' HB ' ' A' ' 310' ' ' ILE . 64.3 m80 . . . . . 0 CA--C 1.516 -0.361 0 CA-C-O 121.702 0.763 . . . . 9.1300000000000008 109.191 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 33.0 ttmt -60.51 113.37 2.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.086 -1.416 . . . . 6.3600000000000003 109.88 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 307' ' ' TYR . 39.4 mt -90.71 142.29 27.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.081 -0.509 . . . . 5.5899999999999999 110.764 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 88.6 t80 -93.6 105.21 17.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.306 -0.861 . . . . 5.0300000000000002 108.928 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 4.5 mp -96.45 100.41 10.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.648 -0.501 . . . . 4.21 109.648 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.88 108.37 1.74 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.718 -0.753 . . . . 4.5800000000000001 112.102 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 149.68 42.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.708 -0.758 . . . . 5.6299999999999999 112.161 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.503 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.4 mt -119.1 137.97 25.72 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.607 0.242 . . . . 5.9199999999999999 110.462 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 325' ' ' LEU . 24.9 Cg_exo -64.2 154.11 72.66 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.662 2.241 . . . . 7.3099999999999996 111.685 174.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 21.2 p30 -68.18 -23.72 64.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.431 0.53 . . . . 8.8100000000000005 112.431 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -83.62 12.08 6.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.0 0.371 . . . . 9.0700000000000003 112.0 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.08 129.37 36.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.109 0.48 . . . . 7.7199999999999998 110.341 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 275' ' ' VAL . 32.5 p-10 -102.98 179.93 4.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 8.8000000000000007 110.655 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.37 -37.81 81.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 7.8899999999999997 111.528 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.39 -52.88 59.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -61.19 -46.46 90.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 8.7300000000000004 111.817 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 271' ' ' ASN . 61.1 t -63.27 -45.96 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.531 -0.304 . . . . 6.7300000000000004 111.186 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.47 -50.73 72.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.91 -0.316 . . . . 8.1199999999999992 110.516 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.86 -50.2 73.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.035 -0.529 . . . . 9.3800000000000008 111.169 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.81 -50.85 69.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 7.2300000000000004 110.419 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' A' ' 285' ' ' LEU . 84.3 mt -71.36 -37.66 71.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.277 -0.42 . . . . 6.8899999999999997 111.24 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.844 HG21 ' HA ' ' A' ' 284' ' ' PRO . 91.9 m -66.74 -27.81 67.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.51 -0.314 . . . . 9.2400000000000002 111.118 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 49.1 m -60.39 -25.86 66.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.029 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.422 ' CD2' HD22 ' A' ' 320' ' ' LEU . 90.2 m-85 -108.5 -0.21 20.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.989 0.423 . . . . 9.1799999999999997 110.603 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 164.82 122.64 0.61 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.712 -0.676 . . . . 9.5600000000000005 111.634 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.844 ' HA ' HG21 ' A' ' 280' ' ' THR . 37.6 Cg_exo -58.69 131.67 43.62 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.042 2.494 . . . . 10.51 113.0 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 279' ' ' LEU . 81.0 mt -94.67 123.75 38.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 8.3000000000000007 110.981 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -90.24 -22.32 21.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 8.9399999999999995 109.945 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -137.11 134.7 36.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.922 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.476 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 56.2 t80 -146.32 126.9 14.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.326 -0.397 . . . . 6.4900000000000002 111.334 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -140.88 121.9 14.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.558 -0.534 . . . . 6.0300000000000002 109.558 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.581 HD13 ' HB3' ' A' ' 303' ' ' ALA . 59.1 tp -97.92 125.96 43.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 6.5300000000000002 109.814 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.438 HG22 ' CE2' ' A' ' 302' ' ' TYR . 47.5 t -77.55 112.55 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 6.8700000000000001 110.221 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -106.89 161.99 14.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 8.2100000000000009 111.321 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -96.96 135.05 39.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.741 -0.663 . . . . 10.33 109.694 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.0 m -69.86 -40.03 75.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.504 -0.316 . . . . 10.93 111.708 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.31 -48.42 14.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.851 0.357 . . . . 12.34 111.85 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -79.96 -32.23 39.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.238 -0.437 . . . . 11.460000000000001 111.66 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 76.8 24.07 68.04 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.583 -0.818 . . . . 10.210000000000001 111.982 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 89.2 mt -123.24 -178.88 4.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.113 -0.329 . . . . 10.4 110.113 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.415 ' HG ' HD12 ' A' ' 290' ' ' LEU . 46.6 t -77.25 143.73 38.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.728 0.299 . . . . 7.8700000000000001 110.326 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 3.1 mmmp? -74.9 -26.5 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.013 0.435 . . . . 8.4100000000000001 110.044 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 125.39 -7.37 7.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.415 -0.898 . . . . 6.0899999999999999 113.105 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 22.2 p90 -138.79 156.49 47.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 6.7599999999999998 111.154 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.581 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -149.15 165.77 30.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 4.6399999999999997 110.739 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.64 126.13 49.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.436 -0.579 . . . . 5.1900000000000004 109.436 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.476 ' SG ' ' HD1' ' A' ' 288' ' ' PHE . 56.7 m -143.71 138.34 28.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.668 0.27 . . . . 5.0899999999999999 110.915 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -113.48 136.02 53.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.775 -0.454 . . . . 7.0300000000000002 109.775 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.48 ' CE1' HD13 ' A' ' 261' ' ' LEU . 6.0 m-85 -84.19 153.19 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 7.8899999999999997 111.021 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.538 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 90.2 t -64.85 -41.5 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 10.42 110.477 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.11 136.54 40.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 10.81 109.941 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.493 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.82 -1.28 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 111.98 0.363 . . . . 10.039999999999999 111.98 -174.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -93.39 -39.5 10.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.213 0.53 . . . . 10.98 109.673 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.38 -20.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.606 -0.724 . . . . 9.9100000000000001 111.36 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 m -53.72 -47.95 70.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.275 -0.42 . . . . 8.0600000000000005 112.041 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.62 -37.08 85.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 8.9399999999999995 111.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 10.880000000000001 110.809 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.69 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 7.5300000000000002 110.135 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 332' ' ' VAL . 83.8 mt -58.16 -50.92 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.833 -0.621 . . . . 6.5800000000000001 110.77 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.09 71.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.924 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.6 4.06 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.531 -0.842 . . . . 7.7699999999999996 112.965 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 282' ' ' PHE . 96.2 mt -72.54 -40.38 66.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.031 0.382 . . . . 6.5199999999999996 112.031 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.39 113.54 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 6.6100000000000003 110.254 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 119.75 -12.4 10.91 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.963 -0.637 . . . . 6.7699999999999996 112.036 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 62.9 mtt -75.15 -171.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.732 0.301 . . . . 7.6900000000000004 110.474 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -146.35 123.19 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.764 0.316 . . . . 8.2400000000000002 110.686 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.483 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.2 OUTLIER -106.92 112.06 24.84 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.591 -0.892 . . . . 7.0300000000000002 108.591 176.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.56 -104.66 1.42 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.745 -0.741 . . . . 8.25 111.542 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.54 0.5 11.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.721 0.296 . . . . 8.9800000000000004 111.068 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -112.52 138.96 48.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 7.4299999999999997 110.945 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.38 138.66 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 7.4500000000000002 110.4 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.417 ' HG ' HG21 ' A' ' 332' ' ' VAL . 55.0 tp -90.98 108.0 19.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.702 -0.681 . . . . 5.8399999999999999 110.477 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.77 105.53 15.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.212 -0.449 . . . . 5.8099999999999996 109.94 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.437 ' O ' HG21 ' A' ' 317' ' ' ILE . 73.8 t -109.71 123.74 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.126 -0.488 . . . . 5.21 110.676 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . 0.445 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 14.1 pt20 -133.79 -169.45 2.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 6.1699999999999999 109.354 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 74.4 ttt180 -105.65 143.86 33.22 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 7.7999999999999998 109.44 174.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.56 77.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.566 0.222 . . . . 6.04 110.999 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 7.7000000000000002 110.589 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -117.74 -19.81 9.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 70.4 mtt180 -112.07 146.39 38.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.774 0.321 . . . . 6.9800000000000004 110.807 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 208' ' ' THR . 84.7 mt -119.46 150.0 40.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.722 -0.672 . . . . 5.6100000000000003 110.111 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -99.42 109.72 22.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 6.2599999999999998 109.607 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.4 p -109.05 124.76 65.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.329 0.585 . . . . 4.25 110.582 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.27 -178.77 15.47 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.485 -0.779 . . . . 5.3099999999999996 111.687 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 62.03 33.0 17.47 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.409 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.448 HG23 HD23 ' A' ' 224' ' ' LEU . 34.4 pt -80.4 156.65 73.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.481 -0.781 . . . . 5.6100000000000003 110.877 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.51 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 42.2 Cg_endo -69.49 124.62 11.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.47 2.113 . . . . 6.1600000000000001 112.399 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -68.35 112.25 5.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.197 -0.668 . . . . 8.8200000000000003 109.197 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.87 -2.27 8.54 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.628 -0.796 . . . . 7.3300000000000001 112.006 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 10.9 tp -88.31 146.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.92 -0.4 . . . . 6.0999999999999996 109.92 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.9 p -102.76 163.97 11.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.869 0.366 . . . . 7.0 111.314 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.719 ' HA ' HD13 ' A' ' 191' ' ' ILE . 33.2 mt-10 -63.93 -41.02 97.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.655 . . . . 5.6900000000000004 110.69 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -58.39 -47.17 84.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.372 -0.831 . . . . 7.29 110.748 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.43 91.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.5 ttm -71.78 -36.35 70.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 4.5700000000000003 110.652 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.406 ' HB2' HG12 ' A' ' 189' ' ' VAL . 1.6 tmt? -61.0 -50.32 73.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.534 . . . . 6.1100000000000003 109.721 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.42 -41.22 98.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.905 -0.589 . . . . 6.5099999999999998 111.351 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.61 -53.02 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.933 0.346 . . . . 5.8700000000000001 111.933 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.659 0.266 . . . . 5.0300000000000002 111.401 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.14 -37.0 78.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.73 0.3 . . . . 6.2999999999999998 110.865 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.26 83.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.406 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -61.59 -37.17 82.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 6.3200000000000003 111.264 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.542 ' HG3' ' HG2' ' A' ' 185' ' ' PRO . 19.1 mmt -63.9 -45.34 89.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.428 -0.351 . . . . 7.0300000000000002 111.009 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.2 -46.18 61.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 9.3100000000000005 111.221 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.81 -35.27 74.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 8.9600000000000009 111.374 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.01 58.93 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.547 -0.835 . . . . 8.1099999999999994 111.844 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.12 39.14 13.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.881 -0.676 . . . . 8.7200000000000006 112.193 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.85 -0.77 39.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 7.7199999999999998 110.192 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 p -70.24 130.27 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 8.7300000000000004 111.062 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 206' ' ' ASP . 3.9 pt20 -84.69 -14.51 48.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.216 0.531 . . . . 9.8900000000000006 110.236 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.03 29.92 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 9.9700000000000006 109.871 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.45 111.51 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.465 2.11 . . . . 11.119999999999999 111.548 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.92 -148.18 15.85 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.878 -0.677 . . . . 9.0600000000000005 112.059 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -126.39 112.26 23.38 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.689 0.28 . . . . 7.7400000000000002 110.857 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.542 ' HG2' ' HG3' ' A' ' 173' ' ' MET . 50.6 Cg_exo -55.48 -45.8 37.06 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.124 2.549 . . . . 6.6699999999999999 112.433 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.02 107.2 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.562 -0.533 . . . . 5.4699999999999998 109.562 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.5 tp -90.98 -61.63 1.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.354 -175.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 201' ' ' GLU . . . -113.73 137.85 51.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.611 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 166' ' ' MET . 7.3 p -125.81 132.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.108 0.48 . . . . 4.7699999999999996 111.365 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -132.86 114.55 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 6.6500000000000004 109.87 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.719 HD13 ' HA ' ' A' ' 162' ' ' GLU . 46.9 mt -114.43 125.39 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 5.8499999999999996 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -105.2 98.15 7.9 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.061 -0.718 . . . . 7.7599999999999998 109.061 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.19 -19.49 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.697 . . . . 7.6100000000000003 110.338 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -58.4 -60.22 4.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 9.1199999999999992 111.605 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.502 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 41.9 mmtm -98.59 4.7 48.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.571 -0.286 . . . . 9.2799999999999994 111.291 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.34 57.17 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.468 0.651 . . . . 6.9299999999999997 111.36 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 50.8 p90 -149.21 152.69 36.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 7.1100000000000003 109.795 173.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.523 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -141.71 157.34 45.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.967 0.413 . . . . 4.6600000000000001 111.143 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.49 121.68 36.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 6.5899999999999999 110.233 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 82.5 mt -104.18 116.96 33.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.976 -0.556 . . . . 4.7699999999999996 109.769 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 35.0 tt0 -97.49 111.77 23.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 6.5499999999999998 109.756 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -88.5 159.13 18.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.554 . . . . 6.5099999999999998 111.192 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 185' ' ' PRO . 39.0 ptt180 -70.96 -24.14 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.385 -0.825 . . . . 8.5399999999999991 111.278 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 60.1 p -125.84 -165.3 1.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.253 -0.43 . . . . 8.3000000000000007 110.863 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.51 -36.53 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.434 0.635 . . . . 9.0099999999999998 109.423 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.416 ' HB3' ' NE2' ' A' ' 180' ' ' GLN . 17.6 t70 -61.51 -53.07 61.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 8.7799999999999994 111.312 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -64.43 -36.9 85.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 7.4800000000000004 110.282 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.497 ' O ' HD12 ' A' ' 151' ' ' LEU . 9.8 m -54.26 -52.71 60.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.282 0.563 . . . . 6.3899999999999997 110.501 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -28.8 69.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.489 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.58 -29.86 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 7.9400000000000004 109.967 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -68.1 -13.81 62.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 5.5 111.248 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 81.4 mtp -70.37 -14.87 62.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 6.46 110.374 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.14 -5.36 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 6.3600000000000003 110.596 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.412 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 94.3 m-85 -97.11 3.78 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 5.9299999999999997 110.711 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.45 123.15 16.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 5.9199999999999999 110.581 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.35 53.17 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.86 -0.685 . . . . 5.7400000000000002 112.112 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.5 tt -72.75 142.51 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.328 . . . . 5.6299999999999999 110.262 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.7 tp -84.63 113.16 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.356 0.598 . . . . 7.2300000000000004 110.407 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -134.55 114.93 13.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 5.79 110.533 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 61.98 26.6 16.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.796 -0.638 . . . . 7.3200000000000003 111.22 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 86.69 5.38 81.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.88 -0.676 . . . . 7.5899999999999999 112.737 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.51 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.4 mm-40 -115.53 150.69 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.778 0.323 . . . . 7.5300000000000002 110.701 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -97.78 103.51 15.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.488 -0.56 . . . . 6.4500000000000002 109.488 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 156' ' ' ILE . 70.6 mt -69.79 114.42 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 4.9000000000000004 111.503 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 76.6 tttt -83.57 114.51 21.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.588 -0.733 . . . . 7.5700000000000003 109.709 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.14 105.69 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.831 0.348 . . . . 5.3700000000000001 110.442 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -132.7 168.36 18.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.24 -0.436 . . . . 7.1900000000000004 110.684 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.67 129.88 78.06 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.346 -0.388 . . . . 7.7599999999999998 110.4 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 31.9 Cg_exo -58.63 130.76 38.68 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.973 2.448 . . . . 7.9800000000000004 112.052 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 38.5 m80 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.882 179.506 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.0 m80 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 121.013 0.435 . . . . 9.1300000000000008 110.512 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 37.5 ttmt -66.26 138.52 57.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.52 -0.763 . . . . 6.3600000000000003 110.767 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 307' ' ' TYR . 79.7 mt -104.63 141.72 35.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.561 . . . . 5.5899999999999999 111.007 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.656 ' HB2' ' HB3' ' A' ' 335' ' ' ALA . 87.7 t80 -96.91 119.04 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.297 -0.865 . . . . 5.0300000000000002 109.152 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.713 HG21 HD12 ' A' ' 330' ' ' LEU . 3.7 mp -108.46 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 4.21 109.837 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.4 134.79 8.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 4.5800000000000001 112.374 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 123.8 25.69 1.69 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.903 -0.665 . . . . 5.6299999999999999 111.949 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.459 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 84.8 mt -102.46 138.97 19.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.429 -0.211 . . . . 5.9199999999999999 110.429 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.557 ' HB2' HD11 ' A' ' 270' ' ' LEU . 41.8 Cg_exo -58.12 147.95 80.47 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.611 2.207 . . . . 7.3099999999999996 111.483 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 6.4 p30 -73.59 -13.54 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.093 0.405 . . . . 8.8100000000000005 112.093 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -90.05 0.61 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.632 -0.427 . . . . 9.0700000000000003 111.079 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 267' ' ' PRO . 8.0 mp -80.88 117.39 21.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.89 0.376 . . . . 7.7199999999999998 110.196 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -85.65 174.76 9.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 8.8000000000000007 110.904 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.33 -37.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.708 . . . . 7.8899999999999997 112.198 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -53.96 18.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.771 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.12 -39.67 93.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.591 0.234 . . . . 8.7300000000000004 111.14 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' A' ' 279' ' ' LEU . 94.9 t -62.16 -48.98 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 6.7300000000000004 110.443 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -56.39 -53.08 61.59 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.519 -0.309 . . . . 8.1199999999999992 111.047 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.67 -52.5 55.57 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.571 0.544 . . . . 9.3800000000000008 111.809 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 7.2300000000000004 110.526 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.52 HD23 HD11 ' A' ' 320' ' ' LEU . 64.3 mt -75.69 -32.86 60.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.434 -0.348 . . . . 6.8899999999999997 111.433 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 16.2 m -74.18 -16.68 60.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.02 0.438 . . . . 9.2400000000000002 110.816 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 41.2 m -61.53 -14.99 34.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.632 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.12 16.43 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 9.1799999999999997 111.009 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.57 143.94 3.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.55 -0.833 . . . . 9.5600000000000005 112.547 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.512 ' HG2' ' HB ' ' A' ' 308' ' ' VAL . 58.3 Cg_endo -71.9 140.48 35.16 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.693 2.262 . . . . 10.51 112.809 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 305' ' ' CYS . 97.3 mt -98.15 126.45 43.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 8.3000000000000007 111.106 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -94.32 -18.34 21.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.328 0.585 . . . . 8.9399999999999995 109.846 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -147.23 134.23 20.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.083 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.414 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 82.7 t80 -145.56 124.71 12.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.063 -0.517 . . . . 6.4900000000000002 110.625 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.53 108.66 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.541 0.686 . . . . 6.0300000000000002 110.347 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.694 HD13 ' HB3' ' A' ' 303' ' ' ALA . 55.0 tp -79.54 128.35 33.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.242 -0.89 . . . . 6.5300000000000002 109.112 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 303' ' ' ALA . 42.2 t -77.31 111.69 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.059 0.456 . . . . 6.8700000000000001 109.813 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -107.35 148.9 28.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 8.2100000000000009 110.498 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.05 136.94 38.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.495 . . . . 10.33 109.738 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 44.0 m -70.07 -28.46 65.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.794 0.294 . . . . 10.93 111.794 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.56 -48.6 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.734 0.302 . . . . 12.34 111.183 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.7 m -75.34 -49.08 20.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.403 -0.362 . . . . 11.460000000000001 111.353 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 101.51 -26.69 23.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.842 -0.694 . . . . 10.210000000000001 111.965 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.12 173.41 10.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 10.4 111.128 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.567 ' HG ' HD12 ' A' ' 290' ' ' LEU . 46.7 t -69.84 148.46 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 7.8700000000000001 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.79 -1.01 55.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 8.4100000000000001 110.163 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 105.13 -3.42 40.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.851 -0.69 . . . . 6.0899999999999999 112.478 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -147.62 161.16 41.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 6.7599999999999998 111.33 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.694 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -152.38 164.53 37.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 4.6399999999999997 110.459 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -112.46 130.73 55.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.477 -0.564 . . . . 5.1900000000000004 109.477 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.414 ' SG ' ' HD1' ' A' ' 288' ' ' PHE . 47.8 m -138.68 137.88 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.374 -0.375 . . . . 5.0899999999999999 110.572 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.14 134.1 55.34 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.461 -0.57 . . . . 7.0300000000000002 109.461 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.554 ' CE1' HD13 ' A' ' 261' ' ' LEU . 20.0 m-85 -91.78 152.32 20.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.004 0.431 . . . . 7.8899999999999997 111.59 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.512 ' HB ' ' HG2' ' A' ' 284' ' ' PRO . 92.0 t -66.84 -43.49 89.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.563 -0.744 . . . . 10.42 111.284 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.67 157.32 18.19 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.912 -0.403 . . . . 10.81 109.912 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.703 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.85 -19.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.988 0.366 . . . . 10.039999999999999 111.988 -175.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -77.3 -37.88 51.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.354 0.597 . . . . 10.98 109.493 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 24.6 m -65.83 -22.04 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.105 -0.952 . . . . 9.9100000000000001 111.178 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.546 ' O ' HG13 ' A' ' 317' ' ' ILE . 9.5 m -55.25 -50.03 70.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.681 -0.236 . . . . 8.0600000000000005 111.407 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.64 -37.87 76.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.981 0.419 . . . . 8.9399999999999995 110.851 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -64.11 -38.77 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.677 -0.692 . . . . 10.880000000000001 110.249 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.38 86.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.533 -0.758 . . . . 7.5300000000000002 110.811 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 313' ' ' THR . 85.1 mt -58.82 -45.66 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 6.5800000000000001 110.734 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.66 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.32 -53.04 4.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.88 -0.676 . . . . 7.7699999999999996 113.075 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.52 HD11 HD23 ' A' ' 279' ' ' LEU . 75.5 mt -67.9 -52.75 32.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.754 0.312 . . . . 6.5199999999999996 111.702 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 44.2 t30 -63.18 114.96 4.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 6.6100000000000003 110.652 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -26.18 6.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.709 -0.758 . . . . 6.7699999999999996 112.385 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.2 mtt -74.91 168.35 20.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.435 -0.209 . . . . 7.6900000000000004 110.435 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.408 ' HG2' ' HA ' ' A' ' 329' ' ' LYS . 55.1 mt-30 -125.12 131.06 53.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.969 0.414 . . . . 8.2400000000000002 110.588 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -109.8 121.92 46.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.33 -0.619 . . . . 7.0300000000000002 109.33 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 69.36 -96.63 0.49 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.737 -0.744 . . . . 8.25 111.34 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.95 7.81 3.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 8.9800000000000004 110.484 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.47 143.81 45.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.994 0.426 . . . . 7.4299999999999997 111.0 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.408 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 87.9 tttt -84.61 136.67 33.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 7.4500000000000002 110.137 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.713 HD12 HG21 ' A' ' 263' ' ' ILE . 44.3 tp -93.88 124.47 37.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 5.8399999999999999 110.984 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . 0.418 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 6.8 mp -115.07 124.16 50.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.624 . . . . 5.8099999999999996 109.557 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.15 131.14 71.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 5.21 110.363 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -156.74 161.43 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 6.1699999999999999 109.843 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.436 ' HA ' HD21 ' A' ' 261' ' ' LEU . 64.7 mtt85 -64.45 133.19 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.842 0.353 . . . . 7.7999999999999998 110.651 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 262' ' ' PHE . . . -110.3 106.69 16.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 6.04 110.646 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.476 -0.329 . . . . 7.7000000000000002 111.398 -178.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.622 0.249 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -107.94 -6.13 16.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.604 0.24 . . . . 0.0 111.327 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -114.06 138.75 49.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 6.9800000000000004 110.922 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 208' ' ' THR . 51.2 mt -116.02 152.08 34.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.909 -0.587 . . . . 5.6100000000000003 110.43 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -106.08 111.23 23.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 6.2599999999999998 109.698 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.5 p -109.15 131.0 61.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.143 0.497 . . . . 4.25 110.091 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.41 173.26 18.63 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.776 -0.647 . . . . 5.3099999999999996 111.941 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 t30 62.77 68.84 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.459 0.647 . . . . 0.0 110.129 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.676 HG23 HD23 ' A' ' 224' ' ' LEU . 37.6 pt -117.63 160.87 36.54 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.392 -0.822 . . . . 5.6100000000000003 110.29 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.678 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 21.1 Cg_endo -61.92 142.44 93.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.61 2.207 . . . . 6.1600000000000001 112.441 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -79.56 109.81 14.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 8.8200000000000003 110.266 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 96.48 36.88 4.97 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.795 -0.717 . . . . 7.3300000000000001 111.708 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.678 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 5.7 tp -78.71 132.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.125 0.488 . . . . 6.0999999999999996 111.086 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.461 ' HB ' ' HB1' ' A' ' 164' ' ' ALA . 17.2 m -64.51 116.15 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 7.0 109.754 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.5 ' HG2' HD13 ' A' ' 191' ' ' ILE . 41.2 mt-10 -57.38 -47.13 82.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 5.6900000000000004 110.9 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.43 -43.26 93.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.592 -0.731 . . . . 7.29 110.668 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 161' ' ' THR . . . -72.57 -37.63 68.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.204 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.771 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.7 tpt -60.7 -47.37 86.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.957 0.408 . . . . 4.5700000000000003 110.338 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.61 -41.52 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 6.1100000000000003 110.307 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.11 -49.18 78.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.804 -0.635 . . . . 6.5099999999999998 111.104 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.1 -47.33 85.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 5.8700000000000001 111.133 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 211' ' ' ALA . 66.5 t80 -62.49 -49.3 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 5.0300000000000002 110.815 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 78.7 m-20 -61.43 -37.22 82.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.418 -0.355 . . . . 6.2999999999999998 110.838 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.08 -45.4 88.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.94 -30.03 71.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.391 -0.368 . . . . 6.3200000000000003 111.41 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 214' ' ' PHE . 76.1 mtp -69.01 -45.02 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 7.0300000000000002 110.171 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 50.9 mtt180 -65.25 -48.3 73.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 9.3100000000000005 110.76 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.09 -35.33 78.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 8.9600000000000009 110.947 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.89 -27.0 69.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.876 -0.678 . . . . 8.1099999999999994 112.075 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.65 21.58 18.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 8.7200000000000006 112.373 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.7 mp -108.42 82.12 1.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.213 0.53 . . . . 7.7199999999999998 110.359 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.577 HG21 ' HG3' ' A' ' 185' ' ' PRO . 3.2 m -157.13 106.84 2.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.242 -0.651 . . . . 8.7300000000000004 109.242 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.467 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.4 pt20 -73.18 -23.55 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.961 -0.295 . . . . 9.8900000000000006 111.666 -171.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 179' ' ' THR . . . -145.05 158.43 52.18 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.549 -0.296 . . . . 9.9700000000000006 110.583 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 151.65 66.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.419 2.08 . . . . 11.119999999999999 111.704 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.69 -168.88 20.81 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.71 -0.757 . . . . 9.0600000000000005 111.775 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 m-20 -94.98 129.17 36.49 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 110.42 -0.215 . . . . 7.7400000000000002 110.42 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.577 ' HG3' HG21 ' A' ' 179' ' ' THR . 26.7 Cg_exo -63.04 -35.76 63.53 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.594 2.196 . . . . 6.6699999999999999 111.208 176.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.6 131.48 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.4699999999999998 110.121 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.6 tp -87.71 -54.49 4.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.68 153.43 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.404 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.35 138.88 48.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.236 -0.438 . . . . 4.7699999999999996 110.958 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -119.13 105.83 11.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.302 -0.629 . . . . 6.6500000000000004 109.302 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.5 HD13 ' HG2' ' A' ' 162' ' ' GLU . 62.8 mt -109.3 125.62 66.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.129 0.49 . . . . 5.8499999999999996 111.249 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -116.2 120.21 38.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.604 -0.725 . . . . 7.7599999999999998 110.128 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.78 -23.91 23.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.136 -0.484 . . . . 7.6100000000000003 110.731 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' OD2' ' HG2' ' A' ' 195' ' ' LYS . 24.0 t70 -57.63 -56.76 17.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.834 -0.621 . . . . 9.1199999999999992 111.898 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.6 mmtm -105.29 5.24 31.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.793 0.33 . . . . 9.2799999999999994 111.095 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.35 67.46 0.84 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.528 -0.76 . . . . 6.9299999999999997 111.517 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 54.5 p90 -149.65 162.5 40.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.005 -0.543 . . . . 7.1100000000000003 109.821 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -146.68 143.75 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.082 0.468 . . . . 4.6600000000000001 111.148 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -107.52 120.58 42.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.686 -0.688 . . . . 6.5899999999999999 109.734 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.68 115.59 30.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.024 -0.535 . . . . 4.7699999999999996 109.6 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.74 121.68 42.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.071 -0.344 . . . . 6.5499999999999998 110.071 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.552 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 48.1 m-85 -99.14 164.15 12.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.144 0.497 . . . . 6.5099999999999998 110.822 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.67 -22.97 59.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.767 -0.651 . . . . 8.5399999999999991 111.326 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.8 p -142.83 147.22 35.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.632 0.254 . . . . 8.3000000000000007 110.913 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.06 -36.17 72.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.953 0.406 . . . . 9.0099999999999998 110.556 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.37 -58.24 8.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.738 -0.665 . . . . 8.7799999999999994 111.086 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.467 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 49.4 mt-10 -65.4 -34.25 77.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 7.4800000000000004 110.871 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.552 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 81.5 m -53.49 -52.6 59.02 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.22 0.533 . . . . 6.3899999999999997 110.212 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 m -63.87 -30.97 72.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.947 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -29.57 62.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.979 0.419 . . . . 7.9400000000000004 110.361 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 169' ' ' PHE . . . -72.21 -10.11 59.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.529 . . . . 5.5 111.535 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.3 mtp -68.02 -20.32 64.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 6.46 110.455 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.3 -1.82 28.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 6.3600000000000003 111.653 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 173' ' ' MET . 94.9 m-85 -97.41 3.33 50.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.739 0.304 . . . . 5.9299999999999997 110.842 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -57.24 129.66 42.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.055 -0.521 . . . . 5.9199999999999999 110.914 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.31 25.88 27.28 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.936 -0.649 . . . . 5.7400000000000002 112.111 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.8 tt -80.8 132.39 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.813 0.34 . . . . 5.6299999999999999 110.146 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.01 111.23 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.542 0.687 . . . . 7.2300000000000004 111.179 -176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.499 ' HE2' HD11 ' A' ' 160' ' ' ILE . 88.9 t80 -136.07 122.09 20.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.561 -0.745 . . . . 5.79 110.182 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 57.32 33.66 23.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.851 0.358 . . . . 7.3200000000000003 111.836 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.15 6.47 86.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.919 -0.657 . . . . 7.5899999999999999 112.606 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.62 131.85 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.718 0.294 . . . . 7.5300000000000002 110.479 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.6 m -86.08 102.64 14.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.499 -0.556 . . . . 6.4500000000000002 109.499 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.676 HD23 HG23 ' A' ' 156' ' ' ILE . 56.7 mt -66.62 115.52 6.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.9000000000000004 110.344 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.3 tttt -90.18 114.7 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.941 -0.572 . . . . 7.5700000000000003 109.739 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.84 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.421 -0.354 . . . . 5.3700000000000001 110.207 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -128.25 169.46 14.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.205 -0.452 . . . . 7.1900000000000004 110.786 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -79.78 127.14 78.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.311 -0.404 . . . . 7.7599999999999998 109.99 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.04 113.7 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.488 2.125 . . . . 7.9800000000000004 110.863 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m80 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.849 -174.385 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.1 m170 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.128 0.489 . . . . 9.1300000000000008 110.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 40.8 ttmt -77.25 123.62 26.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.671 -0.695 . . . . 6.3600000000000003 109.955 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.534 HD13 ' CE1' ' A' ' 307' ' ' TYR . 41.2 mt -101.64 142.68 32.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.925 -0.579 . . . . 5.5899999999999999 111.014 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -88.42 115.67 26.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.323 -0.853 . . . . 5.0300000000000002 109.221 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.27 107.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.963 -0.384 . . . . 4.21 109.963 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -110.54 171.71 14.87 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.507 -0.637 . . . . 4.5800000000000001 111.507 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.44 26.85 45.68 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 5.6299999999999999 111.694 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.11 125.95 58.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.766 0.317 . . . . 5.9199999999999999 110.587 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.662 ' HB2' HD11 ' A' ' 270' ' ' LEU . 27.1 Cg_exo -63.1 134.78 47.6 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.664 2.242 . . . . 7.3099999999999996 111.681 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -63.4 -20.66 65.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 8.8100000000000005 112.179 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -86.02 1.59 49.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.566 0.222 . . . . 9.0700000000000003 111.59 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.662 HD11 ' HB2' ' A' ' 267' ' ' PRO . 8.4 mp -91.68 144.59 25.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.132 -0.321 . . . . 7.7199999999999998 110.132 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.88 177.19 4.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.271 -0.422 . . . . 8.8000000000000007 110.436 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.496 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 3.8 m-20 -58.36 -38.99 78.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 7.8899999999999997 111.493 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.71 -50.87 65.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.08 -40.47 85.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.511 0.195 . . . . 8.7300000000000004 111.386 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.96 -48.46 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 6.7300000000000004 110.728 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 35.7 mtmm -59.27 -53.25 60.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.576 -0.284 . . . . 8.1199999999999992 111.193 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.27 -43.15 82.83 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.827 0.346 . . . . 9.3800000000000008 111.063 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.04 -53.3 58.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 7.2300000000000004 110.201 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.34 -36.11 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 6.8899999999999997 111.414 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.6 m -63.21 -32.23 73.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 9.2400000000000002 111.291 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 32.2 m -65.62 -14.08 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.8 8.32 13.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 9.1799999999999997 110.388 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.91 125.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.745 -0.661 . . . . 9.5600000000000005 111.91 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.419 ' HA ' HG21 ' A' ' 280' ' ' THR . 35.9 Cg_endo -64.89 139.13 60.75 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.63 2.22 . . . . 10.51 112.712 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 70.6 mt -100.59 133.0 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 8.3000000000000007 110.329 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.658 ' HB3' HG23 ' A' ' 308' ' ' VAL . 19.6 ptpt -95.83 -18.39 20.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.808 -0.442 . . . . 8.9399999999999995 109.808 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -149.18 139.79 22.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.182 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -140.41 130.31 24.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.228 -0.442 . . . . 6.4900000000000002 110.535 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.59 118.57 11.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 6.0300000000000002 110.083 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.666 HD13 ' HB3' ' A' ' 303' ' ' ALA . 60.4 tp -95.66 128.41 42.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 6.5300000000000002 109.797 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.477 HG22 ' CE2' ' A' ' 302' ' ' TYR . 58.9 t -76.21 113.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 6.8700000000000001 109.992 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.496 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 45.2 mttm -114.63 161.69 17.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.787 -0.642 . . . . 8.2100000000000009 111.13 -172.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.993 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 31.2 t70 -126.46 122.82 36.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.023 -0.535 . . . . 10.33 109.872 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.4 m -65.39 -38.7 90.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.151 0.426 . . . . 10.93 112.151 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.57 82.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.985 0.422 . . . . 12.34 111.311 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.9 m -81.12 -35.92 30.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.195 -0.457 . . . . 11.460000000000001 111.12 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.12 10.05 81.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.035 -0.602 . . . . 10.210000000000001 111.983 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.94 175.32 8.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.798 0.332 . . . . 10.4 110.549 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.641 ' HG ' HD12 ' A' ' 290' ' ' LEU . 43.5 t -71.99 156.42 39.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.89 -0.596 . . . . 7.8700000000000001 110.054 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.993 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.3 mmmp? -86.33 1.74 49.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.388 -0.369 . . . . 8.4100000000000001 110.635 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.65 44.64 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.583 -0.817 . . . . 6.0899999999999999 113.439 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.477 ' CE2' HG22 ' A' ' 291' ' ' VAL . 48.6 p90 -157.4 162.12 39.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.194 0.521 . . . . 6.7599999999999998 111.57 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.666 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -148.61 170.09 18.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.438 -0.801 . . . . 4.6399999999999997 110.623 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.566 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.4 m-85 -120.31 127.48 52.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.314 -0.624 . . . . 5.1900000000000004 109.314 175.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 25.9 m -135.04 113.47 11.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.499 -0.319 . . . . 5.0899999999999999 111.125 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 27.2 tt0 -88.3 123.53 32.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.913 0.387 . . . . 7.0300000000000002 110.201 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.534 ' CE1' HD13 ' A' ' 261' ' ' LEU . 13.5 m-85 -80.23 156.76 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.815 -0.629 . . . . 7.8899999999999997 111.426 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 286' ' ' LYS . 96.8 t -81.45 -55.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 10.42 110.684 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.691 ' HB3' HG23 ' A' ' 312' ' ' VAL . 13.1 t70 -82.12 129.46 34.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 10.81 109.971 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.739 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -87.92 0.84 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.252 0.464 . . . . 10.039999999999999 112.252 -173.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -103.51 -35.94 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 10.98 110.227 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 309' ' ' ASP . 27.5 m -72.46 -20.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 9.9100000000000001 111.216 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.497 ' O ' HG13 ' A' ' 317' ' ' ILE . 11.5 m -54.67 -51.55 65.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.394 -0.366 . . . . 8.0600000000000005 111.961 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -71.24 -24.45 62.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 8.9399999999999995 110.795 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.94 -45.16 52.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 10.880000000000001 109.685 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.679 -0.692 . . . . 7.5300000000000002 110.117 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 313' ' ' THR . 75.4 mt -57.61 -52.98 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 6.5800000000000001 110.559 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.36 93.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.647 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -76.6 -43.33 19.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.639 -0.791 . . . . 7.7699999999999996 113.182 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.615 ' HB3' HD21 ' A' ' 330' ' ' LEU . 96.3 mt -82.45 -40.91 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.277 0.473 . . . . 6.5199999999999996 112.277 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -62.84 115.85 4.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.776 0.322 . . . . 6.6100000000000003 110.643 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.71 -23.85 20.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.961 -0.638 . . . . 6.7699999999999996 111.89 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 24.9 ttt -78.78 137.79 37.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 7.6900000000000004 109.741 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -88.04 129.39 35.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.087 0.47 . . . . 8.2400000000000002 111.077 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.85 104.01 15.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.534 -0.913 . . . . 7.0300000000000002 108.534 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.44 -74.72 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.037 -0.825 . . . . 8.25 111.037 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.19 5.99 0.15 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.988 0.423 . . . . 8.9800000000000004 110.088 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.49 ' HD3' ' HG3' ' A' ' 267' ' ' PRO . 12.6 mptt -101.92 129.64 48.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.593 -0.521 . . . . 7.4299999999999997 109.593 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.64 118.02 15.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.802 0.334 . . . . 7.4500000000000002 110.471 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 320' ' ' LEU . 19.0 tp -74.53 115.71 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.914 -0.584 . . . . 5.8399999999999999 109.865 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 4.9 tt -98.47 110.68 23.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.928 -0.768 . . . . 5.8099999999999996 108.928 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.441 HG13 HG12 ' A' ' 317' ' ' ILE . 49.1 t -120.77 127.53 75.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.028 0.442 . . . . 5.21 110.864 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -162.08 -178.29 6.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.6 -0.727 . . . . 6.1699999999999999 109.077 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -73.69 145.03 45.54 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.821 -0.352 . . . . 7.7999999999999998 110.138 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.11 83.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.414 -0.357 . . . . 6.04 111.558 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.491 -0.322 . . . . 7.7000000000000002 110.993 -178.226 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.557 0.218 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.458 ' HB2' ' HG3' ' A' ' 201' ' ' GLU . 68.9 mtm180 -112.61 18.69 18.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.739 0.304 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.554 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 83.4 mtt180 -111.23 146.19 37.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.057 0.456 . . . . 6.9800000000000004 112.113 -173.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.31 154.85 31.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 5.6100000000000003 109.661 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -100.05 109.99 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.206 -0.452 . . . . 6.2599999999999998 109.969 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.492 HG11 ' HB1' ' A' ' 198' ' ' ALA . 7.2 p -109.01 133.31 54.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.131 0.491 . . . . 4.25 110.453 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.31 -179.31 17.38 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.782 -0.645 . . . . 5.3099999999999996 111.803 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.0 t30 58.24 65.65 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.767 0.794 . . . . 0.0 109.985 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.471 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 29.6 pt -115.68 157.69 43.8 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.989 -1.005 . . . . 5.6100000000000003 110.226 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.688 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 36.2 Cg_endo -65.67 131.13 26.71 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.484 2.123 . . . . 6.1600000000000001 112.559 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -72.03 96.22 1.71 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.299 0.571 . . . . 8.8200000000000003 109.888 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 141.59 -10.15 2.65 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.524 -0.762 . . . . 7.3300000000000001 111.517 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.1 tp -66.94 136.18 27.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.911 0.386 . . . . 6.0999999999999996 110.857 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.8 p -89.93 153.26 20.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.099 -0.5 . . . . 7.0 109.703 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.958 ' HA ' HD13 ' A' ' 191' ' ' ILE . 43.4 mt-10 -61.81 -40.67 96.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.782 0.325 . . . . 5.6900000000000004 110.904 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.4 -48.89 73.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.982 -0.554 . . . . 7.29 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.09 86.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.851 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.3 tpt -65.86 -46.68 77.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.234 -0.439 . . . . 4.5700000000000003 110.23 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 23.1 ttt -61.07 -45.75 93.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 6.1100000000000003 110.609 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.38 -41.97 81.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 6.5099999999999998 111.048 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.64 -49.38 76.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 5.8700000000000001 111.009 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.463 ' HE1' HD12 ' A' ' 226' ' ' ILE . 47.8 m-85 -61.19 -45.37 94.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.671 -0.24 . . . . 5.0300000000000002 111.068 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 95.3 m-20 -57.09 -44.92 83.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 6.2999999999999998 110.407 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -48.64 78.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.174 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.57 -43.49 98.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 6.3200000000000003 111.229 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.34 -34.84 78.89 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.939 -0.304 . . . . 7.0300000000000002 110.644 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 95.0 mtt180 -64.31 -52.06 60.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.368 . . . . 9.3100000000000005 110.787 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.93 -36.09 69.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.223 -0.444 . . . . 8.9600000000000009 111.266 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.46 -30.85 68.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.955 -0.64 . . . . 8.1099999999999994 112.043 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.08 36.89 26.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.932 -0.651 . . . . 8.7200000000000006 112.75 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 8.3 mp -101.68 21.42 14.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.185 0.517 . . . . 7.7199999999999998 110.504 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.1 p -102.93 171.46 7.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.848 -0.615 . . . . 8.7300000000000004 110.381 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.451 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -110.79 -1.09 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.935 0.398 . . . . 9.8900000000000006 110.02 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.3 162.71 15.58 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.726 -0.67 . . . . 9.9700000000000006 110.141 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 170.88 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.503 2.135 . . . . 11.119999999999999 111.546 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.73 -153.85 17.87 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.437 -0.887 . . . . 9.0600000000000005 112.764 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -106.93 114.74 61.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.693 0.282 . . . . 7.7400000000000002 110.794 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.407 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 36.6 Cg_exo -60.74 -42.84 35.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.981 2.454 . . . . 6.6699999999999999 112.366 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.06 131.59 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.057 -0.349 . . . . 5.4699999999999998 110.057 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 203' ' ' ARG . 36.1 tp -109.49 -39.01 5.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.723 ' HB2' HG12 ' A' ' 312' ' ' VAL . . . -137.19 131.5 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.57 122.34 64.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.231 0.538 . . . . 4.7699999999999996 111.426 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.38 106.2 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.873 -0.603 . . . . 6.6500000000000004 109.568 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.958 HD13 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -112.53 134.35 55.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.754 0.312 . . . . 5.8499999999999996 111.049 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -114.98 104.38 11.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.634 -0.506 . . . . 7.7599999999999998 109.634 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.4 -17.78 60.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.82 -0.627 . . . . 7.6100000000000003 111.315 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.68 -53.38 22.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.56 -0.291 . . . . 9.1199999999999992 111.09 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.3 mmtm -90.25 -3.64 57.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.822 0.344 . . . . 9.2799999999999994 110.433 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 63.6 56.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.399 -0.819 . . . . 6.9299999999999997 110.841 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 22.2 p90 -148.59 162.97 38.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 7.1100000000000003 109.689 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -151.59 148.95 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.974 0.416 . . . . 4.6600000000000001 111.357 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.4 108.38 17.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.696 -0.684 . . . . 6.5899999999999999 109.563 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 92.5 mt -97.56 116.06 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.975 -0.557 . . . . 4.7699999999999996 110.322 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.628 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 25.4 tt0 -99.22 122.02 41.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.54 -0.541 . . . . 6.5499999999999998 109.54 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.449 ' CD1' HG21 ' A' ' 208' ' ' THR . 90.1 m-85 -93.69 163.97 13.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.944 -0.571 . . . . 6.5099999999999998 110.425 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.495 ' HA ' HD23 ' A' ' 187' ' ' LEU . 38.9 ptt180 -69.16 -17.18 63.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.717 -0.674 . . . . 8.5399999999999991 111.419 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 56.2 p -135.19 -163.64 1.41 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.302 -0.408 . . . . 8.3000000000000007 110.356 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.01 -32.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.261 0.553 . . . . 9.0099999999999998 109.713 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.45 -57.75 11.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 8.7799999999999994 110.573 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 210' ' ' GLN . 38.7 mt-10 -60.13 -37.23 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 7.4800000000000004 109.921 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.449 HG21 ' CD1' ' A' ' 202' ' ' PHE . 12.0 m -54.45 -43.25 71.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 6.3899999999999997 110.806 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.4 m -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.323 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -71.99 -27.77 62.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.382 -0.372 . . . . 7.9400000000000004 110.909 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -63.65 -19.04 64.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 5.5 111.173 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.82 -19.37 62.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 6.46 111.022 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.25 -6.05 51.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 6.3600000000000003 111.306 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.63 2.12 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 5.9299999999999997 110.624 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.11 120.97 10.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 5.9199999999999999 110.441 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.11 42.09 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.682 -0.771 . . . . 5.7400000000000002 112.527 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.7 tt -63.21 136.08 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 5.6299999999999999 110.487 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -87.99 121.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.561 . . . . 7.2300000000000004 110.83 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -134.27 115.01 13.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.807 -0.633 . . . . 5.79 110.571 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 53.08 35.95 20.96 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.952 -0.567 . . . . 7.3200000000000003 112.077 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.7 2.55 75.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.819 -0.705 . . . . 7.5899999999999999 113.221 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -119.37 136.19 54.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.123 0.461 . . . . 7.5300000000000002 110.951 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.6 t -88.75 103.28 15.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.128 -0.693 . . . . 6.4500000000000002 109.128 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 156' ' ' ILE . 84.2 mt -66.34 121.99 16.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 4.9000000000000004 111.04 -174.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.542 ' HE2' ' HG3' ' A' ' 227' ' ' ARG . 87.6 tttt -96.85 115.56 27.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 7.5700000000000003 110.293 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.463 HD12 ' HE1' ' A' ' 169' ' ' PHE . 61.6 mt -115.02 107.14 22.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.921 -0.4 . . . . 5.3700000000000001 109.921 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.542 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 8.0 mmt180 -130.98 172.12 12.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.124 0.488 . . . . 7.1900000000000004 111.51 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 45.1 mtp85 -72.14 131.94 84.84 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.473 -0.785 . . . . 7.7599999999999998 110.248 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 16.9 Cg_exo -66.97 152.59 80.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 7.9800000000000004 111.361 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.47 -0.567 . . . . 9.1300000000000008 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.789 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 39.7 ttmt -58.65 130.73 48.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.076 -0.966 . . . . 6.3600000000000003 111.353 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.61 HD12 HG23 ' A' ' 313' ' ' THR . 83.8 mt -108.38 143.81 36.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.759 -0.655 . . . . 5.5899999999999999 110.661 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -91.49 120.3 32.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.994 -0.548 . . . . 5.0300000000000002 110.06 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.1 106.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.287 -0.415 . . . . 4.21 109.907 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.65 154.74 16.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.845 -0.693 . . . . 4.5800000000000001 112.043 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 103.06 34.29 4.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 5.6299999999999999 112.004 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.534 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.2 mt -102.66 138.86 19.74 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.802 0.334 . . . . 5.9199999999999999 110.85 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 16.8 Cg_exo -68.87 144.53 59.2 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.955 2.437 . . . . 7.3099999999999996 111.946 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.51 -25.95 63.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 8.8100000000000005 110.852 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -87.75 0.63 55.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.22 -0.445 . . . . 9.0700000000000003 111.512 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 40.2 tp -86.79 122.59 30.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.165 -0.309 . . . . 7.7199999999999998 110.165 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.465 ' O ' HG21 ' A' ' 275' ' ' VAL . 29.7 p-10 -78.98 157.11 28.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.123 -0.49 . . . . 8.8000000000000007 111.245 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.469 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 9.0 m-20 -59.67 -32.07 70.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.588 -0.733 . . . . 7.8899999999999997 111.569 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 -53.03 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.66 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.78 -33.54 74.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.391 -0.368 . . . . 8.7300000000000004 111.208 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 271' ' ' ASN . 20.8 t -64.79 -48.74 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.667 0.27 . . . . 6.7300000000000004 110.527 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -58.52 -47.24 84.79 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.322 -0.399 . . . . 8.1199999999999992 110.664 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.67 -47.81 83.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 9.3800000000000008 110.759 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.06 -51.03 70.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 7.2300000000000004 110.255 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.539 ' HB2' HD12 ' A' ' 285' ' ' LEU . 90.7 mt -66.87 -38.22 85.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.258 -0.428 . . . . 6.8899999999999997 111.671 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 28.6 m -69.74 -19.62 63.53 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.154 0.502 . . . . 9.2400000000000002 110.961 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.1 m -73.68 -8.03 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.119 0.485 . . . . 0.0 110.656 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.433 ' CE2' HD22 ' A' ' 320' ' ' LEU . 97.2 m-85 -121.6 14.53 11.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 9.1799999999999997 110.156 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 146.32 136.49 2.91 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.765 -0.652 . . . . 9.5600000000000005 112.058 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.475 ' HD3' ' HG ' ' A' ' 187' ' ' LEU . 24.6 Cg_endo -61.88 135.89 58.38 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.819 2.346 . . . . 10.51 112.316 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 279' ' ' LEU . 99.3 mt -100.11 137.89 37.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 110.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 308' ' ' VAL . 17.3 ptpt -98.06 -32.97 11.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.456 -0.572 . . . . 8.9399999999999995 109.456 175.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -142.56 132.87 24.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.429 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -133.0 117.57 17.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.917 -0.583 . . . . 6.4900000000000002 110.22 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -131.97 113.15 13.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.609 0.719 . . . . 6.0300000000000002 110.379 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.816 HD12 ' HG ' ' A' ' 299' ' ' SER . 62.2 tp -87.38 130.52 34.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 6.5300000000000002 109.199 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 111.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.81 -0.441 . . . . 6.8700000000000001 109.81 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.469 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 61.6 mttm -111.06 156.6 21.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.603 -0.726 . . . . 8.2100000000000009 109.918 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.608 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 33.9 t70 -88.66 136.31 33.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.984 -0.376 . . . . 10.33 109.984 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.3 m -60.12 -38.12 82.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 10.93 112.021 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.17 -48.03 6.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.03 0.443 . . . . 12.34 111.411 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.7 m -67.68 -38.22 83.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.625 . . . . 11.460000000000001 111.001 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.67 4.97 90.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.885 -0.674 . . . . 10.210000000000001 112.321 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 61.8 mt -113.08 169.37 8.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.173 -0.306 . . . . 10.4 110.173 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.816 ' HG ' HD12 ' A' ' 290' ' ' LEU . 46.4 t -65.72 146.21 55.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.221 0.534 . . . . 7.8700000000000001 110.989 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.608 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 30.1 mmmt -87.55 3.24 48.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.813 -0.63 . . . . 8.4100000000000001 110.372 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 102.53 4.88 49.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.574 -0.822 . . . . 6.0899999999999999 113.241 174.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -152.87 156.78 39.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.987 0.422 . . . . 6.7599999999999998 111.148 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.632 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -145.46 167.03 23.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 4.6399999999999997 110.879 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.789 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 90.3 m-85 -122.54 130.02 52.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.793 -0.639 . . . . 5.1900000000000004 109.304 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.1 m -142.25 132.5 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.033 -0.267 . . . . 5.0899999999999999 110.938 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.84 132.18 54.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.853 -0.425 . . . . 7.0300000000000002 109.853 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -88.36 156.5 19.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.725 . . . . 7.8899999999999997 111.34 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 286' ' ' LYS . 79.6 t -82.18 -50.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.633 -0.712 . . . . 10.42 109.552 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.473 ' OD2' HG23 ' A' ' 312' ' ' VAL . 22.0 t70 -77.77 148.96 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 10.81 110.217 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.559 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -124.35 20.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.415 . . . . 10.039999999999999 111.233 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.11 -49.45 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.262 0.553 . . . . 10.98 109.83 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 188' ' ' ALA . 34.0 m -79.21 -20.7 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.298 -0.864 . . . . 9.9100000000000001 111.396 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.61 HG23 HD12 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -53.81 -50.24 66.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.549 0.574 . . . . 8.0600000000000005 112.549 -170.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.29 -35.77 80.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.874 0.369 . . . . 8.9399999999999995 111.188 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.87 -29.15 60.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 10.880000000000001 110.302 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.94 -39.2 76.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.185 -0.461 . . . . 7.5300000000000002 110.033 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 313' ' ' THR . 80.6 mt -57.35 -61.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 6.5800000000000001 110.443 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.64 -15.98 62.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.468 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.67 -47.46 5.63 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.023 -0.608 . . . . 7.7699999999999996 112.471 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 282' ' ' PHE . 92.8 mt -79.95 -40.03 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.589 0.233 . . . . 6.5199999999999996 111.197 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.479 ' OD1' HD13 ' A' ' 331' ' ' LEU . 8.8 t30 -62.01 115.0 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 6.6100000000000003 110.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.33 -23.63 6.04 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.672 -0.775 . . . . 6.7699999999999996 111.856 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 66.7 mtt -78.66 171.99 14.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.733 -0.469 . . . . 7.6900000000000004 109.733 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -117.63 151.75 36.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.723 0.297 . . . . 8.2400000000000002 110.51 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.61 106.73 7.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.998 -0.742 . . . . 7.0300000000000002 108.998 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.5 -94.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.721 -0.752 . . . . 8.25 111.435 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.08 -9.35 5.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 8.9800000000000004 110.404 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.15 159.28 15.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 7.4299999999999997 110.38 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -98.92 129.35 45.25 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.528 -0.545 . . . . 7.4500000000000002 109.528 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.01 115.2 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 5.8399999999999999 110.709 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . 0.479 HD13 ' OD1' ' A' ' 321' ' ' ASN . 51.4 tp -108.6 105.79 15.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.322 -0.854 . . . . 5.8099999999999996 109.832 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.11 115.47 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.724 -0.473 . . . . 5.21 109.724 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -137.76 158.82 43.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.138 0.494 . . . . 6.1699999999999999 111.011 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.78 119.9 16.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 7.7999999999999998 109.215 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.47 -65.32 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.969 0.359 . . . . 6.04 111.969 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.882 0.372 . . . . 7.7000000000000002 110.311 179.664 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 6.5 ptp180 -101.86 -19.04 15.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.041 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.1 mtt180 -114.84 133.28 56.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.867 0.365 . . . . 6.9800000000000004 111.213 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 75.8 mt -98.98 157.8 16.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 5.6100000000000003 110.766 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.496 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 46.7 t80 -115.31 103.46 10.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 6.2599999999999998 110.075 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.7 p -103.06 130.91 52.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.181 0.515 . . . . 4.25 110.12 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.45 16.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.586 -0.734 . . . . 5.3099999999999996 111.595 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.57 55.24 4.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.693 0.759 . . . . 0.0 109.477 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.552 HG23 HD23 ' A' ' 224' ' ' LEU . 35.5 pt -101.09 147.69 34.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 5.6100000000000003 110.156 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.11 114.63 2.4 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.695 2.263 . . . . 6.1600000000000001 112.189 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.4 127.85 34.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.568 . . . . 8.8200000000000003 110.762 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.37 10.67 35.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.845 -0.693 . . . . 7.3300000000000001 111.692 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.1 tp -81.13 137.78 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 6.0999999999999996 109.912 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.3 p -87.2 144.64 26.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.407 -0.361 . . . . 7.0 110.755 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.908 ' HA ' HD13 ' A' ' 191' ' ' ILE . 43.2 mt-10 -57.71 -43.46 85.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.6900000000000004 111.45 -175.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.72 -52.46 64.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 7.29 110.74 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.64 95.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.708 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.836 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.1 tpt -60.54 -46.8 88.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 4.5700000000000003 110.475 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.426 ' HB2' HG12 ' A' ' 189' ' ' VAL . 25.6 ttt -63.28 -47.13 83.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.129 -0.487 . . . . 6.1100000000000003 110.977 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -62.98 -32.04 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 6.5099999999999998 111.387 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.36 -49.1 76.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.565 -0.289 . . . . 5.8700000000000001 110.619 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.519 ' O ' ' HG2' ' A' ' 173' ' ' MET . 56.2 m-85 -63.1 -44.9 94.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 5.0300000000000002 110.798 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.89 -35.94 77.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.35 . . . . 6.2999999999999998 110.941 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.58 68.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.446 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.52 -31.14 71.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 6.3200000000000003 111.281 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.789 ' HA ' ' HE3' ' A' ' 173' ' ' MET . 17.9 mmt -60.95 -51.49 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 7.0300000000000002 110.17 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -69.2 -48.06 63.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.976 -0.557 . . . . 9.3100000000000005 110.972 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -35.56 80.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 8.9600000000000009 111.383 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.53 -29.61 48.09 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.591 -0.814 . . . . 8.1099999999999994 112.165 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.43 0.43 40.46 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.901 -0.666 . . . . 8.7200000000000006 111.823 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 210' ' ' GLN . 5.3 mp -79.25 84.7 5.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.74 -0.467 . . . . 7.7199999999999998 109.74 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 178' ' ' LEU . 34.5 m -159.96 124.38 3.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 8.7300000000000004 110.147 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.436 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -90.04 -27.71 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 9.8900000000000006 111.183 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -141.18 139.83 19.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.455 -0.339 . . . . 9.9700000000000006 110.327 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.14 118.12 4.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.951 2.434 . . . . 11.119999999999999 112.486 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.56 -155.65 22.33 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.122 -0.561 . . . . 9.0600000000000005 111.931 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.7 m-20 -101.57 126.24 34.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.684 0.278 . . . . 7.7400000000000002 111.169 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_exo -68.76 -32.18 23.9 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 123.01 2.474 . . . . 6.6699999999999999 111.83 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.3 124.16 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 5.4699999999999998 110.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.64 -42.07 7.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.035 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.91 159.38 42.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 111.113 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 166' ' ' MET . 9.1 p -140.57 136.63 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.211 -0.449 . . . . 4.7699999999999996 110.84 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.583 ' HB2' ' HB2' ' A' ' 199' ' ' PHE . 41.6 mt-30 -113.86 106.36 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.655 -0.498 . . . . 6.6500000000000004 109.655 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.908 HD13 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -111.43 123.98 67.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.191 0.52 . . . . 5.8499999999999996 111.661 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -127.14 119.24 26.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.569 -0.741 . . . . 7.7599999999999998 109.49 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -93.17 3.42 55.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.757 0.313 . . . . 7.6100000000000003 111.384 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.8 -54.59 5.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.093 0.473 . . . . 9.1199999999999992 109.816 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.607 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 47.3 mmtm -86.52 -7.17 58.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.952 -0.567 . . . . 9.2799999999999994 109.491 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 60.87 70.03 0.64 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.149 -0.932 . . . . 6.9299999999999997 110.812 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 195' ' ' LYS . 41.2 p90 -149.28 163.0 38.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.209 -0.451 . . . . 7.1100000000000003 111.227 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 190' ' ' GLN . . . -144.83 126.87 15.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.646 -0.706 . . . . 4.6600000000000001 110.238 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.583 ' HB2' ' HB2' ' A' ' 190' ' ' GLN . 55.6 m-85 -96.23 126.87 41.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.363 -0.381 . . . . 6.5899999999999999 110.117 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 79.0 mt -105.57 115.21 29.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.052 -0.522 . . . . 4.7699999999999996 109.998 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.03 118.27 31.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.996 -0.372 . . . . 6.5499999999999998 109.996 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -95.64 163.91 13.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.761 -0.654 . . . . 6.5099999999999998 110.814 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.78 -8.32 57.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.311 -0.859 . . . . 8.5399999999999991 111.014 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 p -142.99 -164.72 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 8.3000000000000007 110.294 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.07 -29.96 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 9.0099999999999998 109.227 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.02 -55.62 32.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.124 -0.944 . . . . 8.7799999999999994 111.408 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.436 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 46.9 mt-10 -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 7.4800000000000004 110.026 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.475 ' O ' HD12 ' A' ' 151' ' ' LEU . 1.8 m -53.24 -53.44 50.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.569 -0.741 . . . . 6.3899999999999997 110.807 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 m -60.98 -35.06 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.616 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.66 ' HG3' HD21 ' A' ' 178' ' ' LEU . 9.1 tp-100 -73.28 -30.5 63.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.807 -0.633 . . . . 7.9400000000000004 110.373 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -69.6 -12.81 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 5.5 111.23 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.4 mtp -69.8 -13.52 62.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 6.46 110.85 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.35 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 6.3600000000000003 111.358 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.43 ' HE2' HD23 ' A' ' 178' ' ' LEU . 76.4 m-85 -92.71 15.17 15.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 5.9299999999999997 111.263 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.56 115.48 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.921 -0.4 . . . . 5.9199999999999999 109.921 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.77 30.1 9.31 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.561 -0.828 . . . . 5.7400000000000002 112.006 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 13.1 tt -84.82 136.2 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 5.6299999999999999 110.091 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.46 113.93 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.446 0.641 . . . . 7.2300000000000004 110.811 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -134.68 119.13 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.848 -0.615 . . . . 5.79 110.593 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 61.43 20.85 11.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.947 -0.57 . . . . 7.3200000000000003 112.017 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.55 1.82 63.79 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.619 -0.8 . . . . 7.5899999999999999 112.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -119.84 142.88 48.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.939 0.399 . . . . 7.5300000000000002 111.076 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.0 t -90.24 111.16 22.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.705 -0.679 . . . . 6.4500000000000002 109.885 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.552 HD23 HG23 ' A' ' 156' ' ' ILE . 77.0 mt -76.93 114.13 15.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.026 0.441 . . . . 4.9000000000000004 110.695 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.7 tttt -94.9 114.59 26.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.96 -0.564 . . . . 7.5700000000000003 110.394 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.42 109.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 5.3700000000000001 110.631 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 227' ' ' ARG . 6.8 mmt180 -131.12 171.13 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.506 . . . . 7.1900000000000004 110.621 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 26.8 mtp180 -87.69 127.4 58.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.883 -0.414 . . . . 7.7599999999999998 109.883 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.496 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 14.9 Cg_exo -66.48 104.66 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.954 2.436 . . . . 7.9800000000000004 111.857 -176.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.284 -174.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 57.3 t60 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.681 0.753 . . . . 9.1300000000000008 109.398 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.1 ttmt -78.91 116.91 19.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.15 -0.932 . . . . 6.3600000000000003 111.129 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.757 HD12 HG21 ' A' ' 313' ' ' THR . 68.0 mt -100.89 142.43 32.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.546 -0.752 . . . . 5.5899999999999999 109.872 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -92.93 123.83 36.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.266 -0.424 . . . . 5.0300000000000002 109.988 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.578 HG21 HD12 ' A' ' 330' ' ' LEU . 3.1 mp -114.4 110.55 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.839 -0.618 . . . . 4.21 109.413 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.58 130.64 6.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.717 -0.754 . . . . 4.5800000000000001 112.376 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 124.44 23.47 1.91 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.744 -0.741 . . . . 5.6299999999999999 111.977 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 97.5 mt -95.86 141.53 23.3 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.104 -0.332 . . . . 5.9199999999999999 110.104 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.855 ' HB2' HD11 ' A' ' 270' ' ' LEU . 32.3 Cg_exo -58.47 116.3 3.15 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.535 2.157 . . . . 7.3099999999999996 111.107 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 299' ' ' SER . 29.7 p-10 -70.23 -5.46 27.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.729 0.64 . . . . 8.8100000000000005 112.729 -170.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.59 -0.444 . . . . 9.0700000000000003 111.02 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 267' ' ' PRO . 11.2 mp -86.31 133.39 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 7.7199999999999998 110.202 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.47 ' O ' HG21 ' A' ' 275' ' ' VAL . 30.2 p-10 -79.16 160.04 27.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.984 -0.553 . . . . 8.8000000000000007 110.536 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -54.18 -32.09 54.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.757 -0.656 . . . . 7.8899999999999997 111.501 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.446 ' HB3' ' ND2' ' A' ' 271' ' ' ASN . 17.2 t70 -56.93 -54.81 42.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.602 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -73.93 -33.37 63.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.516 -0.311 . . . . 8.7300000000000004 111.27 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 271' ' ' ASN . 63.0 t -62.92 -48.6 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.537 -0.301 . . . . 6.7300000000000004 110.819 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.0 mtmm -62.88 -45.39 92.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.262 . . . . 8.1199999999999992 111.399 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.96 -40.79 98.78 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.739 0.304 . . . . 9.3800000000000008 110.884 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.63 -49.12 78.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 7.2300000000000004 109.873 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.86 -37.25 78.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.54 . . . . 6.8899999999999997 111.426 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 87.0 m -60.72 -31.27 70.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.483 -0.326 . . . . 9.2400000000000002 110.9 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.3 m -65.62 -15.85 63.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.21 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.58 2.04 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.389 . . . . 9.1799999999999997 110.577 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 157.51 127.13 0.94 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.733 -0.746 . . . . 9.5600000000000005 112.563 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.04 133.28 40.4 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.926 2.417 . . . . 10.51 112.171 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.16 138.45 39.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.08 -0.509 . . . . 8.3000000000000007 111.055 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.529 ' HB3' HG23 ' A' ' 308' ' ' VAL . 12.2 ptpt -104.39 -12.71 16.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 8.9399999999999995 109.707 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 306' ' ' GLU . . . -147.72 136.82 22.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.54 126.45 10.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.26 -0.427 . . . . 6.4900000000000002 110.512 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -140.44 112.08 7.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.362 0.601 . . . . 6.0300000000000002 110.428 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 303' ' ' ALA . 64.7 tp -80.48 121.36 25.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.53 -0.759 . . . . 6.5300000000000002 109.793 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.66 113.47 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.361 0.6 . . . . 6.8700000000000001 110.452 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -113.28 160.27 18.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.369 -0.832 . . . . 8.2100000000000009 109.846 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.767 ' HB2' ' HE3' ' A' ' 300' ' ' LYS . 11.6 t70 -90.03 113.31 24.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.174 -0.676 . . . . 10.33 109.174 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 32.4 m -76.76 -3.2 36.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.538 0.57 . . . . 10.93 112.538 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.37 -23.1 13.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.926 0.393 . . . . 12.34 110.808 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.0 m -106.2 -41.24 5.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.06 -0.518 . . . . 11.460000000000001 111.22 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.0 20.72 25.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.811 -0.709 . . . . 10.210000000000001 112.102 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.97 155.99 29.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.443 -0.206 . . . . 10.4 110.443 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 42.2 t -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.532 -0.304 . . . . 7.8700000000000001 110.336 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.767 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 32.3 mmtp -94.07 -8.21 40.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.298 -0.41 . . . . 8.4100000000000001 111.108 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 90.76 6.74 67.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.656 -0.783 . . . . 6.0899999999999999 113.047 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 300' ' ' LYS . 40.7 p90 -141.55 152.54 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.793 0.33 . . . . 6.7599999999999998 110.533 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -149.27 164.07 35.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.108 -0.496 . . . . 4.6399999999999997 111.185 -176.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.411 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 96.9 m-85 -106.14 123.42 47.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.874 -0.603 . . . . 5.1900000000000004 109.519 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 21.6 m -128.6 121.32 28.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 5.0899999999999999 110.678 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.714 ' HB3' ' HB1' ' A' ' 287' ' ' ALA . 30.8 tt0 -103.24 114.96 29.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 7.0300000000000002 110.129 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.481 ' CE1' HD13 ' A' ' 261' ' ' LEU . 25.8 m-85 -84.05 149.58 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 7.8899999999999997 111.129 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 286' ' ' LYS . 61.3 t -78.89 -55.54 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.9 -0.591 . . . . 10.42 110.684 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 144.94 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 10.81 111.225 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.645 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.88 -19.93 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 10.039999999999999 111.356 -178.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.59 -48.35 64.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.907 0.384 . . . . 10.98 110.039 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.82 -23.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 9.9100000000000001 110.992 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.757 HG21 HD12 ' A' ' 261' ' ' LEU . 98.4 m -55.78 -50.03 71.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.496 -0.32 . . . . 8.0600000000000005 111.728 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.28 -38.11 89.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 8.9399999999999995 110.719 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.45 -40.62 85.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 10.880000000000001 110.479 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -49.61 71.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 7.5300000000000002 110.666 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 313' ' ' THR . 74.8 mt -59.01 -49.17 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.578 -0.283 . . . . 6.5800000000000001 110.798 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.79 69.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.73 -43.42 7.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.699 -0.763 . . . . 7.7699999999999996 112.7 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.428 ' HB3' HD21 ' A' ' 330' ' ' LEU . 96.1 mt -80.92 -42.7 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.544 0.202 . . . . 6.5199999999999996 111.544 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 49.4 t-20 -72.67 113.89 10.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.317 -0.623 . . . . 6.6100000000000003 109.317 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.5 -7.93 47.12 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.283 -0.727 . . . . 6.7699999999999996 111.283 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttt -74.33 135.29 42.53 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 7.6900000000000004 109.864 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 46.0 mt-30 -96.1 117.12 30.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.349 -0.387 . . . . 8.2400000000000002 110.458 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.82 96.83 6.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.355 -0.609 . . . . 7.0300000000000002 109.355 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 85.8 -94.54 1.93 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.166 -0.774 . . . . 8.25 111.166 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.81 -19.12 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.996 0.426 . . . . 8.9800000000000004 110.11 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 158.95 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 7.4299999999999997 110.419 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.503 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 99.4 mttt -110.27 142.42 41.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.041 0.448 . . . . 7.4500000000000002 110.82 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.578 HD12 HG21 ' A' ' 263' ' ' ILE . 55.7 tp -86.29 134.41 33.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.551 -0.75 . . . . 5.8399999999999999 110.14 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.8 mp -121.28 136.27 54.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.899 0.381 . . . . 5.8099999999999996 110.434 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.535 HG23 HG13 ' A' ' 263' ' ' ILE . 62.1 t -129.84 125.06 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.855 -0.612 . . . . 5.21 110.201 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.29 144.68 22.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.046 -0.724 . . . . 6.1699999999999999 109.046 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 68.5 ttt180 -64.07 135.21 56.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.637 -0.425 . . . . 7.7999999999999998 110.518 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -83.17 11.91 5.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 6.04 111.923 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 120.644 0.259 . . . . 7.7000000000000002 110.644 -179.41 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.77 0.319 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.576 ' HG2' HG23 ' A' ' 205' ' ' VAL . 98.6 mtt180 -117.67 9.4 13.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.044 0.45 . . . . 0.0 110.621 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 87.1 mtt180 -106.87 133.23 51.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.91 -0.586 . . . . 6.9800000000000004 110.37 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 52.3 mt -97.2 150.44 20.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.283 -0.417 . . . . 5.6100000000000003 110.546 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -100.66 105.26 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.912 -0.586 . . . . 6.2599999999999998 109.443 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.3 p -107.71 129.33 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.232 0.539 . . . . 4.25 110.446 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -129.74 -177.53 14.93 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.484 -0.78 . . . . 5.3099999999999996 111.78 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 61.78 38.77 14.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.84 0.829 . . . . 0.0 109.375 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.401 HG23 HD23 ' A' ' 224' ' ' LEU . 34.0 pt -84.34 152.34 60.92 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 5.6100000000000003 111.009 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.427 ' O ' HG23 ' A' ' 160' ' ' ILE . 11.6 Cg_exo -71.32 123.08 9.26 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.011 2.474 . . . . 6.1600000000000001 112.165 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -75.89 113.7 13.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 8.8200000000000003 109.828 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 132.21 -33.51 2.68 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.784 -0.722 . . . . 7.3300000000000001 112.283 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 157' ' ' PRO . 11.4 tp -71.26 153.92 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.616 0.246 . . . . 6.0999999999999996 110.634 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 p -88.9 161.09 16.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.85 0.357 . . . . 7.0 111.223 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.803 ' HA ' HD13 ' A' ' 191' ' ' ILE . 41.6 mt-10 -66.05 -37.94 87.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 5.6900000000000004 109.71 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.16 -48.82 80.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.023 -0.99 . . . . 7.29 111.296 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.23 90.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.253 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.2 ttm -65.1 -39.88 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 4.5700000000000003 110.53 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.684 ' HE2' ' HB3' ' A' ' 281' ' ' SER . 23.5 ttt -62.28 -46.22 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.356 . . . . 6.1100000000000003 110.81 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.66 -38.6 88.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 6.5099999999999998 110.472 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -57.62 -48.16 80.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.848 -0.615 . . . . 5.8700000000000001 110.58 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 173' ' ' MET . 33.2 m-85 -64.47 -47.16 80.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 5.0300000000000002 111.14 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -54.89 -46.3 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.165 0.291 . . . . 6.2999999999999998 110.945 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.7 84.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.036 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.3 -37.65 86.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 6.3200000000000003 111.11 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 33.0 mmt -62.6 -42.25 99.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 7.0300000000000002 110.177 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.18 -52.75 17.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 9.3100000000000005 111.007 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.62 -34.05 77.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 8.9600000000000009 111.697 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.85 -16.81 71.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.509 -0.853 . . . . 8.1099999999999994 112.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.06 29.85 30.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 8.7200000000000006 112.137 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.437 HD21 ' HG3' ' A' ' 210' ' ' GLN . 5.9 mp -86.89 -18.8 29.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 7.7199999999999998 110.092 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.68 HG23 ' HG3' ' A' ' 185' ' ' PRO . 13.2 p -69.27 128.2 35.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.501 -0.772 . . . . 8.7300000000000004 111.168 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.454 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.8 pt20 -94.09 -1.04 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 9.8900000000000006 109.322 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -160.07 155.43 21.84 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.082 -0.963 . . . . 9.9700000000000006 109.476 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.7 168.78 15.9 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.503 2.135 . . . . 11.119999999999999 112.136 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.87 -138.61 14.15 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.029 -0.605 . . . . 9.0600000000000005 112.509 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 90.5 m-20 -116.44 118.05 37.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.588 0.232 . . . . 7.7400000000000002 110.574 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.68 ' HG3' HG23 ' A' ' 179' ' ' THR . 18.3 Cg_exo -66.61 -26.52 46.36 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.866 2.377 . . . . 6.6699999999999999 111.864 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.54 127.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.949 -0.568 . . . . 5.4699999999999998 110.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 284' ' ' PRO . 45.0 tp -91.8 -40.4 11.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.232 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -143.34 121.16 11.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.012 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.36 115.4 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.89 -0.595 . . . . 4.7699999999999996 110.144 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -128.67 106.41 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 6.6500000000000004 110.157 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.803 HD13 ' HA ' ' A' ' 162' ' ' GLU . 66.5 mt -113.97 123.06 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.241 -0.436 . . . . 5.8499999999999996 111.655 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -100.54 99.62 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 7.7599999999999998 108.732 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -85.51 -16.93 37.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.69 . . . . 7.6100000000000003 110.167 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.57 -47.55 83.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.616 -0.72 . . . . 9.1199999999999992 110.957 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.484 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 45.1 mmtm -105.57 9.04 33.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.286 -0.415 . . . . 9.2799999999999994 111.207 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.01 48.58 5.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.412 -0.813 . . . . 6.9299999999999997 111.82 171.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 37.1 p90 -148.19 142.83 26.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.818 -0.438 . . . . 7.1100000000000003 109.818 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.549 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -134.28 150.46 50.99 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.921 0.391 . . . . 4.6600000000000001 111.354 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.592 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 74.8 m-85 -117.37 108.47 15.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.63 -0.713 . . . . 6.5899999999999999 109.889 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 87.3 mt -94.85 114.54 26.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.08 -0.509 . . . . 4.7699999999999996 109.63 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 36.1 tt0 -94.06 119.49 33.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.814 -0.439 . . . . 6.5499999999999998 109.814 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.13 164.21 13.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.181 0.515 . . . . 6.5099999999999998 111.213 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -73.31 -11.65 60.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.355 -0.839 . . . . 8.5399999999999991 111.089 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 76.0 p -141.68 -166.75 2.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.198 -0.456 . . . . 8.3000000000000007 110.219 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 149' ' ' ARG . 21.8 t -116.58 -30.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.268 -0.642 . . . . 9.0099999999999998 109.268 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.59 -60.44 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.085 -0.962 . . . . 8.7799999999999994 111.377 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.454 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 42.4 mt-10 -58.88 -40.32 84.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4800000000000004 110.078 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 m -52.45 -52.14 55.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.633 -0.712 . . . . 6.3899999999999997 110.835 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.7 m -63.0 -34.23 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.522 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.437 ' HG3' HD21 ' A' ' 178' ' ' LEU . 9.3 tp-100 -71.17 -30.9 67.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.137 -0.483 . . . . 7.9400000000000004 110.215 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.1 -15.03 62.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.523 . . . . 5.5 111.273 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.31 -16.02 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 6.46 111.117 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.25 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 6.3600000000000003 111.55 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 217' ' ' ILE . 69.7 m-85 -93.04 21.47 5.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.444 -0.344 . . . . 5.9299999999999997 111.577 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.15 109.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 5.9199999999999999 110.369 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.97 13.25 22.11 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.933 -0.651 . . . . 5.7400000000000002 112.233 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 214' ' ' PHE . 17.6 tt -66.41 141.8 17.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 5.6299999999999999 111.2 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.2 tp -82.45 114.1 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.508 0.67 . . . . 7.2300000000000004 111.098 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.27 112.77 10.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.589 -0.732 . . . . 5.79 110.701 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 59.57 31.41 20.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.863 -0.608 . . . . 7.3200000000000003 111.737 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.53 -24.76 29.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.855 -0.688 . . . . 7.5899999999999999 112.585 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.95 167.28 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.879 0.371 . . . . 7.5300000000000002 110.777 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -118.15 99.79 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.385 -0.598 . . . . 6.4500000000000002 109.385 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.401 HD23 HG23 ' A' ' 156' ' ' ILE . 82.6 mt -66.14 112.93 4.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 4.9000000000000004 111.59 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.3 tttt -81.83 124.73 29.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.517 -0.765 . . . . 7.5700000000000003 109.91 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -118.76 106.22 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.029 0.443 . . . . 5.3700000000000001 110.741 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -134.51 171.63 14.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 7.1900000000000004 110.301 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 20.2 mtp180 -83.62 134.97 43.87 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.788 -0.449 . . . . 7.7599999999999998 109.788 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 32.1 Cg_exo -60.28 165.9 10.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.004 2.469 . . . . 7.9800000000000004 112.762 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -79.62 165.84 22.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.884 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.96 102.2 3.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -126.25 131.1 51.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -113.27 124.66 31.0 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.64 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.9 114.43 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.102 1.868 . . . . 0.0 110.855 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.65 114.85 25.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.497 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.51 -172.31 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.824 2.349 . . . . 0.0 111.9 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 240' ' ' GLU . . . -118.18 153.44 17.09 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.039 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 84.9 mtp -92.88 -57.35 2.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 50.3 m -136.78 15.46 3.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.496 ' O ' ' HA3' ' A' ' 237' ' ' GLY . 0.0 OUTLIER -162.08 -169.07 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.565 -174.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.37 141.88 24.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.41 ' HD2' ' HE2' ' A' ' 245' ' ' TYR . 84.8 Cg_exo -49.62 -38.73 45.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.534 2.156 . . . . 0.0 111.42 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 9.0 t -146.2 -75.62 0.21 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.8 -44.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.739 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.41 ' HE2' ' HD2' ' A' ' 242' ' ' PRO . 68.1 m-85 63.39 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.181 0.592 . . . . 0.0 111.294 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.6 p -160.64 128.36 2.77 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.175 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.54 100.83 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.181 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.8 0.42 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.27 142.54 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 250' ' ' VAL . 6.7 t 61.33 19.55 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.701 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 21.3 p -98.14 -25.35 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.305 0.574 . . . . 0.0 109.971 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.6 p -94.8 91.72 6.6 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 31.2 m -92.22 -20.26 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.175 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.83 156.1 40.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.858 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.09 -31.57 90.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.756 2.304 . . . . 0.0 112.242 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.16 117.48 7.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.237 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 30.5 t -155.09 120.98 5.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -75.06 89.39 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.448 ' CE1' ' HA ' ' A' ' 310' ' ' ILE . 13.2 t60 -127.31 1.1 6.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.026 -0.534 . . . . 9.1300000000000008 110.859 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.673 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.2 ttmt -78.09 129.97 35.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.908 -0.587 . . . . 6.3600000000000003 110.541 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 82.8 mt -96.07 140.78 30.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.201 0.524 . . . . 5.5899999999999999 110.792 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -103.45 115.12 29.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.249 -0.887 . . . . 5.0300000000000002 108.627 171.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 263' ' ' ILE . 4.3 mp -105.43 110.05 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.909 -0.587 . . . . 4.21 109.674 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -122.1 171.74 15.37 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.025 -0.607 . . . . 4.5800000000000001 111.814 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.78 27.51 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.664 -0.779 . . . . 5.6299999999999999 111.923 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 96.8 mt -106.36 142.06 24.11 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.646 0.26 . . . . 5.9199999999999999 110.569 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 15.1 Cg_exo -70.36 160.41 49.63 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.771 2.314 . . . . 7.3099999999999996 111.507 173.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -88.42 -9.52 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.033 0.383 . . . . 8.8100000000000005 112.033 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -83.08 -2.14 54.6 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.45 -0.5 . . . . 9.0700000000000003 110.97 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.68 117.4 19.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 7.7199999999999998 110.108 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.38 160.11 22.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.062 -0.517 . . . . 8.8000000000000007 110.817 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.468 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 4.7 m-20 -52.23 -44.45 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 7.8899999999999997 112.584 -173.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.83 -45.26 92.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.816 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.5 -46.49 88.19 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.64 0.257 . . . . 8.7300000000000004 111.012 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.46 -44.57 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 6.7300000000000004 110.646 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -62.94 -48.08 80.46 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.378 -0.374 . . . . 8.1199999999999992 110.82 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.5 -47.82 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 9.3800000000000008 110.653 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.72 -54.74 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 7.2300000000000004 110.584 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.523 HD13 ' HE2' ' A' ' 288' ' ' PHE . 99.3 mt -69.46 -32.15 70.88 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.879 0.325 . . . . 6.8899999999999997 111.879 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 36.1 m -72.2 -19.74 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 9.2400000000000002 110.926 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.684 ' HB3' ' HE2' ' A' ' 166' ' ' MET . 50.5 m -79.63 -0.83 35.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.439 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.68 14.46 11.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 9.1799999999999997 110.917 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 143.7 159.93 8.21 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.567 -0.825 . . . . 9.5600000000000005 112.517 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.453 ' HB3' HD22 ' A' ' 187' ' ' LEU . 55.5 Cg_endo -71.37 122.39 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.658 2.239 . . . . 10.51 112.31 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.96 135.46 33.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 8.3000000000000007 110.436 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.521 ' HB3' HG23 ' A' ' 308' ' ' VAL . 17.9 ptpt -99.33 -26.83 14.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.577 -0.527 . . . . 8.9399999999999995 109.577 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -145.24 136.66 25.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.453 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.523 ' HE2' HD13 ' A' ' 279' ' ' LEU . 16.6 t80 -144.84 110.12 5.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.869 -0.605 . . . . 6.4900000000000002 109.553 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.631 HD22 ' HB2' ' A' ' 304' ' ' PHE . 3.3 p-10 -127.59 116.97 21.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.287 0.565 . . . . 6.0300000000000002 110.44 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 303' ' ' ALA . 64.7 tp -93.23 130.04 39.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.469 -0.787 . . . . 6.5300000000000002 109.973 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.65 112.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.017 0.437 . . . . 6.8700000000000001 110.457 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.468 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 63.0 mttm -106.96 167.83 9.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.605 . . . . 8.2100000000000009 110.124 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.47 128.06 34.92 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.192 -0.67 . . . . 10.33 109.192 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.3 m -63.87 -28.65 69.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.072 0.397 . . . . 10.93 112.072 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -95.47 -51.99 4.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 12.34 111.121 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.8 m -68.6 -51.46 42.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 11.460000000000001 111.227 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 108.77 -25.09 20.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.742 -0.742 . . . . 10.210000000000001 112.172 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.62 164.38 26.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 10.4 110.775 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.502 ' HG ' HD12 ' A' ' 290' ' ' LEU . 42.6 t -68.18 154.24 42.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.971 -0.559 . . . . 7.8700000000000001 110.581 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -86.86 -8.69 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 8.4100000000000001 109.93 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.27 17.16 35.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.791 -0.719 . . . . 6.0899999999999999 113.209 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -156.44 155.94 32.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.682 0.277 . . . . 6.7599999999999998 110.513 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -151.51 166.41 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.193 -0.458 . . . . 4.6399999999999997 111.368 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.673 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.5 m-85 -115.75 127.47 55.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.043 -0.725 . . . . 5.1900000000000004 109.043 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.4 m -144.19 131.18 20.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.66 0.267 . . . . 5.0899999999999999 110.681 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.43 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 32.5 tt0 -116.08 130.16 56.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.899 0.381 . . . . 7.0300000000000002 110.399 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -83.34 158.44 22.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 7.8899999999999997 110.574 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 286' ' ' LYS . 62.9 t -78.63 -55.88 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 10.42 110.464 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.27 147.87 44.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 10.81 110.837 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.776 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -94.03 -4.03 10.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.039999999999999 112.065 -175.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' A' ' 315' ' ' GLN . 37.1 m-80 -93.85 -50.72 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.732 0.301 . . . . 10.98 110.526 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.68 -24.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 9.9100000000000001 112.172 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 317' ' ' ILE . 31.3 m -59.54 -50.68 72.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.931 0.345 . . . . 8.0600000000000005 111.931 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -75.09 -29.04 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 8.9399999999999995 110.63 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 311' ' ' ASN . 84.8 mt-30 -68.64 -39.25 80.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 10.880000000000001 110.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.32 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.769 -0.651 . . . . 7.5300000000000002 110.231 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.476 HG12 HG13 ' A' ' 332' ' ' VAL . 78.8 mt -61.95 -46.06 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 6.5800000000000001 110.4 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.52 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.845 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -91.91 -54.68 1.86 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.536 -0.84 . . . . 7.7699999999999996 113.241 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.26 -50.23 48.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.683 0.253 . . . . 6.5199999999999996 111.683 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.714 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.8 t30 -63.79 114.04 3.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.727 -0.472 . . . . 6.6100000000000003 109.727 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.67 7.08 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.8 -0.714 . . . . 6.7699999999999996 111.815 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.7 mtt -74.16 170.49 15.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.725 -0.472 . . . . 7.6900000000000004 109.725 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -134.56 118.76 17.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.028 0.442 . . . . 8.2400000000000002 110.891 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.71 99.1 10.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.292 -0.633 . . . . 7.0300000000000002 109.292 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.5 2.12 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.732 -0.747 . . . . 8.25 111.516 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -110.52 2.38 18.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.878 0.371 . . . . 8.9800000000000004 110.582 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -105.06 135.51 46.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 7.4299999999999997 110.687 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.48 127.25 35.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.738 -0.468 . . . . 7.4500000000000002 109.738 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.47 115.34 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 5.8399999999999999 110.664 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 54.5 tp -106.72 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.507 -0.77 . . . . 5.8099999999999996 109.887 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 61.9 t -126.42 120.51 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.274 -0.421 . . . . 5.21 110.094 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.33 176.83 11.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.138 -0.69 . . . . 6.1699999999999999 109.138 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -82.29 147.39 28.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.598 -0.441 . . . . 7.7999999999999998 109.875 175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.4 67.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 6.04 112.271 -173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.1 m -86.56 -82.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.096 -0.242 . . . . 7.7000000000000002 111.341 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 93.8 t 63.52 107.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.774 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -61.79 -71.74 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.553 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -169.62 98.89 0.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.412 . . . . 0.0 110.673 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -96.0 -49.52 5.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 64.24 20.95 12.38 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 -179.307 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.746 0.308 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 202' ' ' PHE . 37.3 ptt180 -90.87 -1.4 57.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 68.5 mtt180 -98.12 164.28 12.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.049 0.452 . . . . 6.9800000000000004 111.4 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 64.0 mt -136.86 158.41 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.268 -0.878 . . . . 5.6100000000000003 109.86 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.94 113.47 26.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.831 -0.622 . . . . 6.2599999999999998 109.519 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.8 p -113.19 129.1 69.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.233 0.539 . . . . 4.25 110.763 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.03 177.8 16.46 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.629 -0.714 . . . . 5.3099999999999996 111.759 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.48 63.59 1.67 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.352 0.596 . . . . 0.0 110.4 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.67 155.56 36.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.568 -0.742 . . . . 5.6100000000000003 110.264 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.644 ' HB2' ' HB ' ' A' ' 160' ' ' ILE . 16.1 Cg_exo -69.07 131.03 21.3 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.724 2.282 . . . . 6.1600000000000001 112.013 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -79.47 102.46 8.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 8.8200000000000003 109.674 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.27 20.64 6.18 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.953 -0.642 . . . . 7.3300000000000001 111.895 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 157' ' ' PRO . 11.0 tp -94.03 146.33 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.769 -0.456 . . . . 6.0999999999999996 109.769 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.2 p -86.68 154.05 21.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 7.0 111.5 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.518 -0.765 . . . . 5.6900000000000004 110.288 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.78 -48.1 80.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.719 -0.673 . . . . 7.29 110.408 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.45 -50.8 70.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.225 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 94.5 mmm -63.14 -48.88 76.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.194 -0.457 . . . . 4.5700000000000003 110.958 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.631 ' HE1' ' HA ' ' A' ' 281' ' ' SER . 1.9 tmt? -61.13 -51.6 68.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 6.1100000000000003 110.787 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.46 -36.26 83.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 6.5099999999999998 111.536 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.86 -48.72 80.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.681 0.277 . . . . 5.8700000000000001 111.28 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.452 ' HE1' HD12 ' A' ' 226' ' ' ILE . 60.4 m-85 -64.3 -35.91 82.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.571 -0.286 . . . . 5.0300000000000002 110.728 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 82.5 m-20 -60.22 -50.4 73.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.91 -0.404 . . . . 6.2999999999999998 109.91 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.54 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.473 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -62.99 -39.47 94.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.606 -0.27 . . . . 6.3200000000000003 111.072 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.836 ' HB3' HG21 ' A' ' 179' ' ' THR . 26.4 mmt -62.74 -41.75 99.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 7.0300000000000002 110.54 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 84.8 mtt180 -67.29 -52.2 43.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 9.3100000000000005 111.0 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.38 -33.91 73.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.86 -0.609 . . . . 8.9600000000000009 111.693 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.19 -21.46 45.31 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.334 -0.936 . . . . 8.1099999999999994 112.284 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.03 27.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.983 -0.627 . . . . 8.7200000000000006 111.981 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.747 HD21 ' HB3' ' A' ' 210' ' ' GLN . 4.2 mp -97.93 -5.32 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 7.7199999999999998 110.505 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.836 HG21 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -79.3 156.46 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 8.7300000000000004 111.049 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.429 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -87.79 -14.9 38.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.255 0.55 . . . . 9.8900000000000006 109.94 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -156.2 144.89 14.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 9.9700000000000006 109.84 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.57 113.26 2.22 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.647 2.231 . . . . 11.119999999999999 111.835 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.46 -137.77 5.08 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.655 -0.783 . . . . 9.0600000000000005 112.381 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -112.06 108.34 55.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.539 0.209 . . . . 7.7400000000000002 110.665 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 45.1 Cg_endo -68.69 -34.63 18.5 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.749 2.299 . . . . 6.6699999999999999 111.85 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.76 128.7 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 5.4699999999999998 109.514 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 284' ' ' PRO . 26.6 tp -105.25 -33.24 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.978 0.418 . . . . 0.0 110.361 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 201' ' ' GLU . . . -152.32 155.01 36.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.321 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.02 133.1 22.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.926 0.393 . . . . 4.7699999999999996 110.604 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.33 106.73 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 6.6500000000000004 110.047 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.35 130.56 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.05 -0.523 . . . . 5.8499999999999996 111.428 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -121.59 96.8 5.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.837 -0.801 . . . . 7.7599999999999998 108.837 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -83.48 -6.68 59.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.044 -0.525 . . . . 7.6100000000000003 110.962 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -66.66 -51.91 50.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 9.1199999999999992 110.619 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.507 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.4 mmtm -102.89 -0.24 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.22 -0.445 . . . . 9.2799999999999994 110.406 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 66.76 61.52 0.53 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.345 -0.843 . . . . 6.9299999999999997 111.924 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 48.6 p90 -149.43 163.52 37.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 7.1100000000000003 109.506 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -146.61 153.27 40.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.943 0.402 . . . . 4.6600000000000001 111.095 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.05 122.65 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.852 -0.613 . . . . 6.5899999999999999 110.161 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 75.2 mt -100.69 116.0 31.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 4.7699999999999996 110.279 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.453 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 5.2 tt0 -101.34 113.75 27.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.682 -0.488 . . . . 6.5499999999999998 109.682 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.405 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 69.9 m-85 -90.59 160.11 16.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.077 -0.51 . . . . 6.5099999999999998 110.825 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.74 -25.08 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 8.5399999999999991 110.877 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 93.2 p -132.16 -178.29 4.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.171 -0.468 . . . . 8.3000000000000007 110.053 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.89 -16.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.707 0.765 . . . . 9.0099999999999998 109.032 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.54 -54.65 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.998 -1.001 . . . . 8.7799999999999994 111.078 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.429 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 36.2 mt-10 -66.45 -30.32 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 7.4800000000000004 110.897 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -50.71 -45.31 58.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 6.3899999999999997 112.02 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 m -56.37 -43.46 79.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.688 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.747 ' HB3' HD21 ' A' ' 178' ' ' LEU . 2.2 mp0 -73.64 -28.06 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.51 -0.313 . . . . 7.9400000000000004 110.853 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.5 66.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 5.5 110.617 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.58 -14.83 62.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 6.46 111.22 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.01 -13.56 62.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 6.3600000000000003 110.879 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.704 ' HD2' HD13 ' A' ' 217' ' ' ILE . 68.7 m-85 -100.02 17.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 5.9299999999999997 110.753 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.59 107.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 5.9199999999999999 110.392 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.74 14.23 23.8 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.955 -0.64 . . . . 5.7400000000000002 112.194 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.704 HD13 ' HD2' ' A' ' 214' ' ' PHE . 16.1 tt -68.01 135.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.045 0.45 . . . . 5.6299999999999999 110.689 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.79 114.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.386 0.612 . . . . 7.2300000000000004 111.045 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -134.58 118.65 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.639 -0.709 . . . . 5.79 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 59.63 26.72 15.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.025 -0.534 . . . . 7.3200000000000003 111.516 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 91.87 -5.48 79.26 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.682 -0.77 . . . . 7.5899999999999999 112.881 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.564 0.221 . . . . 7.5300000000000002 110.691 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.1 t -101.0 95.1 6.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.428 -0.582 . . . . 6.4500000000000002 109.428 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.45 106.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 4.9000000000000004 111.459 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 88.4 tttt -82.22 113.92 20.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.709 -0.678 . . . . 7.5700000000000003 109.715 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.452 HD12 ' HE1' ' A' ' 169' ' ' PHE . 67.3 mt -109.1 107.22 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.053 0.454 . . . . 5.3700000000000001 110.625 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -124.9 170.38 11.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.764 -0.653 . . . . 7.1900000000000004 109.74 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -87.73 154.58 53.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 121.043 -0.263 . . . . 7.7599999999999998 110.71 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 230' ' ' HIS . 55.8 Cg_endo -69.76 173.42 11.0 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.744 2.296 . . . . 7.9800000000000004 111.809 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 35.1 m-70 69.41 11.87 8.16 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.38 -44.3 29.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -93.63 -52.85 4.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 63.08 89.73 0.1 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.153 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.5 111.34 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.85 2.366 . . . . 0.0 111.769 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 236' ' ' PRO . 7.3 mp 63.34 92.2 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.769 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 235' ' ' LEU . 15.4 Cg_endo -57.35 -30.91 89.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.321 2.681 . . . . 0.0 113.038 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 175.06 77.14 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.25 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 52.7 ttp -94.66 100.25 12.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.5 m -104.42 104.35 14.21 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.26 -36.59 84.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.291 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.32 151.3 42.7 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.918 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 243' ' ' SER . 59.8 Cg_endo -72.07 -151.48 0.03 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.557 2.172 . . . . 0.0 111.323 175.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' A' ' 242' ' ' PRO . 70.8 m -77.38 60.75 2.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.11 0.481 . . . . 0.0 111.062 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.63 116.11 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.459 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -89.48 129.17 36.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.102 0.477 . . . . 0.0 110.978 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.17 115.1 65.82 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.412 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.99 -179.03 1.53 Allowed 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.655 2.236 . . . . 0.0 112.149 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.98 124.62 36.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.103 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -83.81 122.23 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 0.0 110.286 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.0 p -85.05 153.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.366 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.2 m -59.72 132.98 55.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.597 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 253' ' ' VAL . 0.2 OUTLIER -82.61 175.52 10.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.571 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 252' ' ' THR . 62.3 t -57.83 -58.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 110.229 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 8.0 m -135.19 119.49 13.4 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.538 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 5.7 Cg_exo -79.2 -5.09 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.054 2.502 . . . . 0.0 111.775 177.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.26 109.09 13.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.202 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 m -101.71 122.59 44.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -70.15 118.21 12.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.65 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.572 ' HB3' HG22 ' A' ' 313' ' ' THR . 47.2 m80 -130.97 15.4 5.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.57 -0.741 . . . . 9.1300000000000008 109.077 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.7 ttmt -59.22 125.12 22.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.096 -0.957 . . . . 6.3600000000000003 111.809 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.3 mt -100.29 135.58 41.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.326 -0.852 . . . . 5.5899999999999999 110.001 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -93.09 111.13 22.66 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.145 -0.687 . . . . 5.0300000000000002 109.145 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.734 HG21 HD12 ' A' ' 330' ' ' LEU . 2.3 mp -91.45 109.09 20.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.838 -0.619 . . . . 4.21 109.637 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.86 112.16 2.17 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.623 -0.798 . . . . 4.5800000000000001 112.298 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 137.06 45.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.828 -0.701 . . . . 5.6299999999999999 112.21 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.41 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.9 mt -110.51 144.58 30.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 5.9199999999999999 110.998 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.4 158.28 22.61 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.158 2.572 . . . . 7.3099999999999996 111.694 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -83.95 -13.08 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.572 0.225 . . . . 8.8100000000000005 111.305 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -81.67 -6.78 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 9.0700000000000003 110.21 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.8 120.66 29.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 7.7199999999999998 109.597 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.556 ' O ' HG21 ' A' ' 275' ' ' VAL . 33.4 p30 -91.0 174.21 7.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 8.8000000000000007 111.284 -176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 5.7 m-20 -61.58 -32.1 72.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.691 -0.686 . . . . 7.8899999999999997 111.417 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.18 -54.62 38.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.683 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.75 -34.95 77.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.672 -0.694 . . . . 8.7300000000000004 111.742 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 271' ' ' ASN . 62.9 t -63.0 -48.84 86.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.778 0.323 . . . . 6.7300000000000004 110.465 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.04 -42.7 94.07 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.558 -0.292 . . . . 8.1199999999999992 110.616 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.0 -46.85 84.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.02 -0.536 . . . . 9.3800000000000008 111.249 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -46.94 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 7.2300000000000004 110.116 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.3 mt -69.8 -36.05 75.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.175 -0.466 . . . . 6.8899999999999997 111.236 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.1 m -68.31 -19.71 64.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.03 0.443 . . . . 9.2400000000000002 110.995 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.631 ' HA ' ' HE1' ' A' ' 166' ' ' MET . 38.3 m -68.39 -12.28 60.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.92 11.58 8.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.404 . . . . 9.1799999999999997 111.307 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 145.93 163.95 10.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.442 -0.885 . . . . 9.5600000000000005 113.115 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.66 ' HB3' HD12 ' A' ' 187' ' ' LEU . 86.3 Cg_endo -83.52 134.88 6.76 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.94 2.427 . . . . 10.51 112.642 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.2 mt -90.8 142.14 28.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.381 -0.372 . . . . 8.3000000000000007 110.568 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.451 ' HB3' HG23 ' A' ' 308' ' ' VAL . 7.8 ptpp? -103.18 -22.86 13.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.385 -0.598 . . . . 8.9399999999999995 109.385 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.1 132.49 23.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -145.77 123.52 11.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.224 -0.444 . . . . 6.4900000000000002 110.586 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.91 118.49 12.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.388 0.614 . . . . 6.0300000000000002 109.955 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 303' ' ' ALA . 62.5 tp -91.83 125.43 36.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.658 -0.701 . . . . 6.5300000000000002 109.172 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 112.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.356 -0.538 . . . . 6.8700000000000001 110.137 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 65.9 mttm -101.58 153.17 19.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.475 -0.784 . . . . 8.2100000000000009 109.985 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.652 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 21.2 t70 -64.68 145.53 56.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.349 -0.387 . . . . 10.33 110.237 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.1 m -63.64 -28.33 69.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.033 -0.53 . . . . 10.93 111.738 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -116.62 -40.99 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.99 0.367 . . . . 12.34 111.99 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 30.0 m -69.1 -46.91 66.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.719 0.295 . . . . 11.460000000000001 111.362 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.63 70.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 10.210000000000001 112.962 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.51 170.36 9.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.008 -0.367 . . . . 10.4 110.008 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.7 t -58.08 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.12 0.485 . . . . 7.8700000000000001 111.022 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' ' 293' ' ' ASP . 31.9 mmmt -85.81 -3.45 58.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 8.4100000000000001 109.982 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 103.4 -3.84 47.22 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.805 -0.712 . . . . 6.0899999999999999 112.245 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 18.4 p90 -141.62 157.12 45.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 6.7599999999999998 111.436 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.723 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -156.91 167.06 31.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.824 -0.626 . . . . 4.6399999999999997 110.844 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.487 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.6 m-85 -116.27 125.61 52.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.205 -0.665 . . . . 5.1900000000000004 109.205 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 28.9 m -144.32 136.65 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.646 0.26 . . . . 5.0899999999999999 111.009 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.68 132.29 49.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.758 0.313 . . . . 7.0300000000000002 110.253 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 42.3 m-85 -79.11 166.61 22.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.057 -0.52 . . . . 7.8899999999999997 110.78 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 286' ' ' LYS . 56.9 t -76.32 -51.65 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.197 -0.456 . . . . 10.42 110.23 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 312' ' ' VAL . 16.5 t70 -92.47 156.11 17.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.755 -0.657 . . . . 10.81 110.262 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.686 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -78.86 -30.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.52 -0.309 . . . . 10.039999999999999 111.462 -176.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -67.4 -49.34 64.22 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 110.211 -0.292 . . . . 10.98 110.211 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.602 HG22 ' HD2' ' A' ' 284' ' ' PRO . 19.8 m -65.56 -26.06 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 9.9100000000000001 111.542 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.572 HG22 ' HB3' ' A' ' 259' ' ' HIS . 86.1 m -64.47 -49.81 69.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.324 0.583 . . . . 8.0600000000000005 110.11 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.1 -24.46 58.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 8.9399999999999995 110.991 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 312' ' ' VAL . 45.4 mt-30 -63.42 -40.25 96.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 10.880000000000001 110.17 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 320' ' ' LEU . . . -62.22 -44.91 95.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 7.5300000000000002 110.516 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.36 -36.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 6.5800000000000001 111.297 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -83.82 -52.39 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.778 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.55 -37.19 24.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.035 -0.602 . . . . 7.7699999999999996 113.956 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 330' ' ' LEU . 80.3 mt -83.92 -36.91 22.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.257 0.528 . . . . 6.5199999999999996 111.993 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 6.4 t30 -61.97 119.94 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.732 0.301 . . . . 6.6100000000000003 110.529 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.03 -22.47 20.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.926 -0.654 . . . . 6.7699999999999996 112.297 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 23.9 ttt -71.31 123.26 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.298 -0.26 . . . . 7.6900000000000004 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 328' ' ' LYS . 51.4 mt-30 -82.98 117.5 22.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 8.2400000000000002 111.466 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -91.03 94.86 9.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.559 -0.904 . . . . 7.0300000000000002 108.559 171.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.23 -87.36 1.29 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.547 -0.835 . . . . 8.25 111.181 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -126.51 -25.1 3.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.764 0.316 . . . . 8.9800000000000004 110.865 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 324' ' ' GLN . 94.7 mttt -85.79 134.98 33.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 7.4299999999999997 110.92 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 92.8 mttt -77.47 126.29 30.68 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.454 -0.573 . . . . 7.4500000000000002 109.454 172.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 263' ' ' ILE . 30.8 tp -67.77 102.56 1.24 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.954 0.407 . . . . 5.8399999999999999 110.258 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 53.4 tp -93.57 111.82 23.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.888 -0.596 . . . . 5.8099999999999996 109.674 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.07 108.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 5.21 109.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -124.04 124.32 42.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.104 -0.498 . . . . 6.1699999999999999 110.216 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -72.16 123.03 22.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.966 -0.383 . . . . 7.7999999999999998 109.966 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -111.32 95.48 5.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.532 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 m -147.04 -38.17 0.21 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 7.7000000000000002 110.358 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 29.0 t 55.29 81.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.852 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.67 -145.61 26.38 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.014 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.54 -18.2 21.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.573 0.225 . . . . 0.0 110.736 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 70.55 -72.33 0.11 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.358 0.663 . . . . 0.0 111.877 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -95.49 -51.97 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.819 0.342 . . . . 0.0 110.247 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.475 179.567 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.6 -3.36 16.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.215 0.531 . . . . 0.0 109.638 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 98.7 mtt180 -101.66 146.64 27.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.507 -0.769 . . . . 6.9800000000000004 110.655 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.9 mt -110.14 147.08 34.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.241 -0.436 . . . . 5.6100000000000003 110.05 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -102.62 103.55 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 6.2599999999999998 110.062 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.516 ' CG1' ' HB1' ' A' ' 198' ' ' ALA . 7.6 p -105.33 133.72 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.236 0.541 . . . . 4.25 110.691 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -131.77 -179.66 16.37 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 5.3099999999999996 111.984 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.09 29.77 14.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.367 0.603 . . . . 0.0 109.999 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.1 pt -74.77 151.52 86.78 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 5.6100000000000003 111.02 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 20.9 Cg_endo -62.38 137.18 63.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.8 2.333 . . . . 6.1600000000000001 111.899 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -81.62 114.32 20.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.934 0.397 . . . . 8.8200000000000003 110.043 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.02 21.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 7.3300000000000001 112.153 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.3 tp -76.48 140.87 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.967 -0.383 . . . . 6.0999999999999996 109.967 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -88.56 154.62 20.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.783 0.325 . . . . 7.0 110.608 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.882 ' HA ' HD13 ' A' ' 191' ' ' ILE . 39.8 mt-10 -60.44 -38.49 84.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 5.6900000000000004 110.071 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.1 -55.63 30.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.257 -0.883 . . . . 7.29 111.295 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.38 93.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.406 ' O ' ' HD2' ' A' ' 169' ' ' PHE . 46.5 ttm -67.95 -42.22 81.3 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.998 -0.281 . . . . 4.5700000000000003 110.476 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.563 ' HE2' ' HA ' ' A' ' 281' ' ' SER . 26.8 ttt -62.95 -45.82 90.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 6.1100000000000003 110.422 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.16 -41.4 75.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.559 . . . . 6.5099999999999998 110.985 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 78.0 t80 -57.83 -51.9 67.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 5.8700000000000001 110.95 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.406 ' HD2' ' O ' ' A' ' 165' ' ' MET . 68.1 m-85 -66.38 -39.87 89.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 5.0300000000000002 111.226 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.2 m-20 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 6.2999999999999998 110.384 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.91 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 15.8 mm100 -61.85 -42.19 98.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.558 -0.292 . . . . 6.3200000000000003 110.969 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.504 ' HB3' HG21 ' A' ' 179' ' ' THR . 86.2 mmm -66.04 -36.65 83.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.292 -0.413 . . . . 7.0300000000000002 110.968 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 66.9 mtt180 -72.47 -52.3 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.524 -0.307 . . . . 9.3100000000000005 110.961 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.06 -36.01 77.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 8.9600000000000009 111.51 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.08 -21.01 80.15 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.87 -0.681 . . . . 8.1099999999999994 112.532 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.88 39.33 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 8.7200000000000006 112.5 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.24 9.33 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 7.7199999999999998 110.192 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.504 HG21 ' HB3' ' A' ' 173' ' ' MET . 1.6 p -114.62 105.19 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 8.7300000000000004 111.504 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.74 -22.96 39.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 9.8900000000000006 109.972 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -112.65 137.81 21.84 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.956 -0.566 . . . . 9.9700000000000006 110.238 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 161.1 37.73 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.798 2.332 . . . . 11.119999999999999 112.108 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.09 -152.78 18.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.824 -0.703 . . . . 9.0600000000000005 112.099 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 94.6 m-20 -109.22 122.72 38.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.786 -0.244 . . . . 7.7400000000000002 111.094 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 184' ' ' ASN . 19.7 Cg_endo -60.75 -36.68 83.41 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.946 2.431 . . . . 6.6699999999999999 111.374 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.9 t -81.33 127.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.827 -0.805 . . . . 5.4699999999999998 108.827 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 20.5 tp -90.92 -39.19 12.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.06 153.66 33.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.606 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.433 HG21 HD21 ' A' ' 200' ' ' LEU . 7.4 p -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.27 -0.423 . . . . 4.7699999999999996 110.804 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -130.65 106.87 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 6.6500000000000004 109.699 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.882 HD13 ' HA ' ' A' ' 162' ' ' GLU . 51.5 mt -110.95 126.92 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.162 0.506 . . . . 5.8499999999999996 111.578 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -101.91 101.31 11.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 7.7599999999999998 108.388 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.19 -27.83 53.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 7.6100000000000003 110.648 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.92 -49.03 72.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 9.1199999999999992 111.281 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.17 -6.89 54.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 9.2799999999999994 111.068 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 64.51 56.36 1.24 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.833 -0.621 . . . . 6.9299999999999997 111.321 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -149.04 149.12 30.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.047 -0.524 . . . . 7.1100000000000003 109.879 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.579 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -134.19 140.19 46.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.775 0.321 . . . . 4.6600000000000001 111.087 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.545 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 42.5 m-85 -108.32 109.02 20.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.868 -0.606 . . . . 6.5899999999999999 110.139 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.7 mt -93.27 114.01 26.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 4.7699999999999996 109.32 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.69 114.64 26.3 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.136 -0.32 . . . . 6.5499999999999998 110.136 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.46 ' HB2' ' HG1' ' A' ' 208' ' ' THR . 70.4 m-85 -89.7 155.96 18.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.257 -0.428 . . . . 6.5099999999999998 110.892 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.7 -22.6 60.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.734 -0.666 . . . . 8.5399999999999991 110.972 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 94.6 p -148.18 142.85 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.964 -0.384 . . . . 8.3000000000000007 109.964 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.408 ' HA ' ' OG1' ' A' ' 208' ' ' THR . 94.6 t -63.94 -28.62 45.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.021 0.439 . . . . 9.0099999999999998 110.373 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.68 -40.94 69.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 8.7799999999999994 110.581 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.3 -29.62 26.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 7.4800000000000004 110.965 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.46 ' HG1' ' HB2' ' A' ' 202' ' ' PHE . 32.2 m -54.06 -51.52 63.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.923 0.392 . . . . 6.3899999999999997 110.803 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.72 -24.9 67.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.707 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -68.09 -35.55 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.958 0.408 . . . . 7.9400000000000004 110.196 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.639 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -74.78 -14.28 60.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 5.5 110.91 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.2 mtp -69.43 -20.54 63.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 6.46 110.289 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.37 -15.21 61.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.92 -0.582 . . . . 6.3600000000000003 110.801 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.639 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 90.7 m-85 -92.86 6.5 47.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 5.9299999999999997 110.945 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.48 124.23 20.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.699 0.285 . . . . 5.9199999999999999 110.244 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.68 35.2 11.93 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.686 -0.768 . . . . 5.7400000000000002 111.56 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.87 137.89 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.941 -0.392 . . . . 5.6299999999999999 109.941 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.04 119.15 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.301 0.572 . . . . 7.2300000000000004 110.756 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -133.01 112.28 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.085 -0.507 . . . . 5.79 110.985 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 56.66 35.02 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.769 -0.651 . . . . 7.3200000000000003 111.94 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.86 78.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 7.5899999999999999 113.045 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.7 mm-40 -118.04 124.1 47.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.334 . . . . 7.5300000000000002 110.64 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.6 t -77.3 115.89 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.158 -0.682 . . . . 6.4500000000000002 109.158 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.5 118.69 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 4.9000000000000004 110.98 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.0 tttt -88.36 114.15 24.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 7.5700000000000003 109.642 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.0 mt -109.52 106.56 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.078 0.466 . . . . 5.3700000000000001 110.428 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -114.92 170.09 8.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.892 -0.594 . . . . 7.1900000000000004 110.508 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -83.94 125.13 73.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.268 -0.641 . . . . 7.7599999999999998 109.268 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.545 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 18.1 Cg_endo -58.55 129.63 33.42 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.607 2.205 . . . . 7.9800000000000004 111.379 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.594 ' HB2' ' HD2' ' A' ' 232' ' ' TYR . 8.2 p-80 -62.19 134.85 57.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.88 0.372 . . . . 0.0 110.595 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.34 -4.0 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.379 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . 0.594 ' HD2' ' HB2' ' A' ' 230' ' ' HIS . 17.5 m-85 -79.37 57.9 2.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.74 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -58.81 125.61 77.89 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.574 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.83 134.28 17.61 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.802 3.001 . . . . 0.0 113.003 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.8 mt 61.22 83.48 0.21 Allowed Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.68 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.58 133.78 44.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.439 2.76 . . . . 0.0 112.888 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 242' ' ' PRO . . . 146.65 63.6 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.715 ' HA ' ' HE1' ' A' ' 238' ' ' MET . 3.7 tpt -108.08 -60.1 1.76 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 0.0 110.234 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.7 m -83.32 2.02 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.163 0.506 . . . . 0.0 110.683 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.89 172.68 17.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.143 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -97.81 132.84 24.17 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.378 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.432 ' HG3' ' HA3' ' A' ' 237' ' ' GLY . 43.3 Cg_exo -56.52 112.09 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.845 2.363 . . . . 0.0 111.845 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 p -101.04 97.18 7.77 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.167 0.508 . . . . 0.0 111.182 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.21 -59.96 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.577 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -108.38 -31.97 7.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.208 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.58 126.9 24.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.56 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.41 -46.28 25.52 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.629 2.219 . . . . 0.0 112.255 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 148.31 91.43 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.868 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.678 HG21 HG13 ' A' ' 250' ' ' VAL . 34.5 m -115.05 -26.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 110.928 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.678 HG13 HG21 ' A' ' 249' ' ' VAL . 9.3 p -175.91 -41.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.813 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 50.0 m 56.68 74.77 0.39 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.321 0.581 . . . . 0.0 111.387 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 51.7 m -87.22 93.58 9.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.305 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.44 -46.57 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.31 136.07 28.07 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.51 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.12 161.93 35.07 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.459 2.106 . . . . 0.0 111.739 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.0 104.47 0.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.227 0.537 . . . . 0.0 110.078 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.8 p -147.47 150.51 34.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.121 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.81 104.19 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.377 0.608 . . . . 0.0 111.025 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -96.52 9.98 39.77 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 9.1300000000000008 108.771 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 304' ' ' PHE . 35.2 ttmt -59.1 119.49 7.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.104 -1.407 . . . . 6.3600000000000003 110.113 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.0 141.63 29.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.863 -0.608 . . . . 5.5899999999999999 110.792 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.72 110.0 21.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.489 -0.778 . . . . 5.0300000000000002 109.317 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.76 HG21 HD12 ' A' ' 330' ' ' LEU . 3.9 mp -101.77 103.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.321 -0.622 . . . . 4.21 109.321 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.91 164.13 21.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 4.5800000000000001 112.605 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 102.09 15.71 25.29 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.782 -0.723 . . . . 5.6299999999999999 111.895 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 270' ' ' LEU . 83.4 mt -92.57 148.74 36.83 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.655 0.264 . . . . 5.9199999999999999 110.545 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 270' ' ' LEU . 46.0 Cg_endo -69.23 153.74 70.89 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.687 2.258 . . . . 7.3099999999999996 112.276 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.7 -22.6 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 8.8100000000000005 111.368 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -83.64 1.04 44.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.948 0.404 . . . . 9.0700000000000003 111.187 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 267' ' ' PRO . 11.6 tp -87.11 99.37 11.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.859 -0.793 . . . . 7.7199999999999998 108.859 176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 275' ' ' VAL . 34.2 p-10 -89.68 -179.0 5.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 8.8000000000000007 111.686 -172.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.497 ' CG ' ' HZ3' ' A' ' 292' ' ' LYS . 2.7 m-20 -52.31 -41.02 62.59 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.595 -0.729 . . . . 7.8899999999999997 112.158 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.89 -47.75 81.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.19 -42.92 71.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 8.7300000000000004 111.431 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 271' ' ' ASN . 82.1 t -64.62 -49.38 80.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.555 -0.293 . . . . 6.7300000000000004 111.7 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -65.21 -43.36 91.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.841 -0.344 . . . . 8.1199999999999992 111.228 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.49 -46.97 83.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 9.3800000000000008 110.638 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.66 -52.82 62.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 7.2300000000000004 110.501 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.65 -38.62 80.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.043 0.386 . . . . 6.8899999999999997 112.043 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.4 m -61.58 -34.77 76.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.3 . . . . 9.2400000000000002 111.106 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.563 ' HA ' ' HE2' ' A' ' 166' ' ' MET . 49.0 m -62.74 -23.2 67.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.864 -178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -106.38 12.55 29.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.073 0.397 . . . . 9.1799999999999997 112.073 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 154.58 155.41 7.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.762 -1.209 . . . . 9.5600000000000005 113.462 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.699 ' HD2' HG22 ' A' ' 312' ' ' VAL . 6.9 Cg_exo -72.78 120.69 6.82 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.243 2.629 . . . . 10.51 112.064 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 305' ' ' CYS . 96.1 mt -94.4 141.29 28.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.099 -0.501 . . . . 8.3000000000000007 110.698 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.551 ' HB3' HG23 ' A' ' 308' ' ' VAL . 19.7 ptpt -110.94 -32.73 6.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.019 0.438 . . . . 8.9399999999999995 110.155 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -132.4 111.5 11.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.536 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.3 124.09 41.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 6.4900000000000002 110.183 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -140.34 114.87 9.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.308 0.575 . . . . 6.0300000000000002 110.351 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 303' ' ' ALA . 64.5 tp -90.34 125.49 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 6.5300000000000002 110.247 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.1 116.51 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.127 0.489 . . . . 6.8700000000000001 110.116 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.497 ' HZ3' ' CG ' ' A' ' 272' ' ' ASP . 61.4 mttm -110.73 154.31 24.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.74 -0.664 . . . . 8.2100000000000009 110.86 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.453 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 13.5 t70 -83.29 129.71 35.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.984 -0.747 . . . . 10.33 108.984 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.4 m -85.19 -13.27 50.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.426 -0.352 . . . . 10.93 111.887 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.11 -56.43 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.987 0.422 . . . . 12.34 111.095 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.462 HG23 ' HG ' ' A' ' 298' ' ' LEU . 48.1 m -83.27 -30.42 27.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 11.460000000000001 110.627 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.02 22.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.585 -0.817 . . . . 10.210000000000001 112.59 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 296' ' ' THR . 84.3 mt -110.11 161.54 15.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.73 0.3 . . . . 10.4 110.418 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.9 t -69.52 133.75 48.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.28 -0.637 . . . . 7.8700000000000001 109.28 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.51 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.2 mmmp? -74.82 -15.88 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 8.4100000000000001 110.858 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 97.76 14.78 39.11 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.612 -0.804 . . . . 6.0899999999999999 113.049 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 11.0 p90 -154.89 146.62 23.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 6.7599999999999998 110.779 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.536 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -145.3 168.02 21.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.882 -0.599 . . . . 4.6399999999999997 110.718 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.471 ' HB3' ' HG2' ' A' ' 260' ' ' LYS . 91.8 m-85 -114.54 130.21 56.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 5.1900000000000004 109.557 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 35.5 m -141.98 116.57 9.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 5.0899999999999999 111.608 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 286' ' ' LYS . 39.9 tt0 -100.24 130.62 46.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.821 -0.437 . . . . 7.0300000000000002 109.821 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -88.67 158.51 18.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 7.8899999999999997 111.07 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 286' ' ' LYS . 58.6 t -79.1 -46.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 10.42 111.118 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.553 ' HB3' HG23 ' A' ' 312' ' ' VAL . 12.6 t70 -93.91 132.55 38.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 10.81 110.446 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.506 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -64.79 -28.49 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 112.263 0.468 . . . . 10.039999999999999 112.263 -176.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -71.79 -50.05 33.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.891 -0.411 . . . . 10.98 109.891 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.699 HG22 ' HD2' ' A' ' 284' ' ' PRO . 20.8 m -66.27 -24.68 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 9.9100000000000001 110.856 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 317' ' ' ILE . 47.3 m -61.85 -48.16 81.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.13 0.49 . . . . 8.0600000000000005 110.132 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.81 -35.13 64.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.007 -0.542 . . . . 8.9399999999999995 110.516 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -63.53 -40.22 96.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 10.880000000000001 110.773 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.12 97.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 7.5300000000000002 110.47 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 313' ' ' THR . 71.7 mt -59.08 -45.38 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 6.5800000000000001 110.674 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.51 78.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.749 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.31 -49.36 6.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 7.7699999999999996 113.51 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.504 ' HB3' HD21 ' A' ' 330' ' ' LEU . 98.6 mt -73.57 -49.07 28.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.302 . . . . 6.5199999999999996 111.814 -173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 7.3 t30 -63.05 115.22 4.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 6.6100000000000003 110.44 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.92 -20.55 14.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.853 -0.689 . . . . 6.7699999999999996 112.389 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 20.9 ttt -75.22 141.41 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.146 -0.316 . . . . 7.6900000000000004 110.146 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -88.66 118.87 28.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.785 0.326 . . . . 8.2400000000000002 110.525 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 330' ' ' LEU . 4.6 mm? -101.79 96.52 7.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.124 -0.489 . . . . 7.0300000000000002 109.852 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.2 -85.57 0.81 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.901 -0.666 . . . . 8.25 112.058 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.63 -41.06 2.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.737 0.303 . . . . 8.9800000000000004 111.281 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -91.29 165.64 13.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 7.4299999999999997 110.807 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.66 136.1 37.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 7.4500000000000002 109.536 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.834 ' HB2' HD21 ' A' ' 325' ' ' LEU . 33.0 tp -73.83 125.45 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.173 0.511 . . . . 5.8399999999999999 111.316 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.67 118.63 37.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 5.8099999999999996 109.614 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 91.1 t -127.32 113.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.185 -0.461 . . . . 5.21 109.779 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -138.04 171.87 13.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.122 -0.49 . . . . 6.1699999999999999 110.01 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -86.59 136.83 32.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.402 -0.222 . . . . 7.7999999999999998 110.402 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -62.91 -44.55 95.77 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.115 0.483 . . . . 6.04 110.092 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.8 m -95.03 92.78 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 7.7000000000000002 109.406 172.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.89 -23.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.382 0.611 . . . . 0.0 110.169 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -152.14 -95.81 0.13 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.07 126.62 35.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -107.16 124.6 49.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.411 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 61.76 35.66 16.65 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.641 0.588 . . . . 0.0 111.183 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.88 ' HB2' HG23 ' A' ' 205' ' ' VAL . 56.1 ttp85 75.99 -24.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.773 0.67 . . . . 0.0 111.991 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 148' ' ' ALA . 59.4 mtt180 -97.53 150.91 20.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 6.9800000000000004 111.392 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.532 ' HG ' HG21 ' A' ' 208' ' ' THR . 23.7 mt -113.19 149.43 33.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.861 -0.609 . . . . 5.6100000000000003 111.186 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -107.98 102.9 12.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.125 -0.943 . . . . 6.2599999999999998 108.702 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.543 HG22 ' HZ ' ' A' ' 169' ' ' PHE . 7.4 p -104.11 127.44 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.488 . . . . 4.25 110.301 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.37 -178.75 15.44 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.803 -0.635 . . . . 5.3099999999999996 111.777 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 10.2 m120 62.01 28.85 17.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.085 0.469 . . . . 0.0 110.899 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.512 HG23 HD23 ' A' ' 224' ' ' LEU . 31.8 pt -78.52 153.61 78.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.466 -0.788 . . . . 5.6100000000000003 110.728 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 32.7 Cg_endo -64.35 136.71 52.37 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.556 2.171 . . . . 6.1600000000000001 112.056 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.19 123.34 20.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 8.8200000000000003 109.913 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.29 4.43 53.35 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.576 -0.821 . . . . 7.3300000000000001 112.421 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.3 tp -66.07 130.85 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 6.0999999999999996 110.147 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.8 p -92.24 155.21 18.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.765 0.317 . . . . 7.0 110.751 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -53.69 -46.47 70.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 5.6900000000000004 110.186 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.96 -55.81 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.325 -0.852 . . . . 7.29 111.153 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.94 93.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.288 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.81 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 0.7 OUTLIER -64.94 -47.67 76.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 4.5700000000000003 110.598 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.2 ttt -60.92 -48.83 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 6.1100000000000003 110.769 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.46 -38.78 88.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 6.5099999999999998 111.524 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.49 -49.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.614 -0.267 . . . . 5.8700000000000001 111.068 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.543 ' HZ ' HG22 ' A' ' 153' ' ' VAL . 50.4 m-85 -65.1 -44.22 89.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.593 -0.276 . . . . 5.0300000000000002 111.093 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.03 -33.45 75.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.557 -0.292 . . . . 6.2999999999999998 110.985 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.74 -49.93 68.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.227 175.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.09 -35.36 75.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 6.3200000000000003 111.113 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.847 ' HA ' ' HE3' ' A' ' 173' ' ' MET . 6.0 mmt -60.88 -50.16 74.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 7.0300000000000002 110.529 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -71.06 -44.29 66.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 9.3100000000000005 111.269 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 78.1 mt -65.13 -35.18 80.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.383 . . . . 8.9600000000000009 110.985 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.95 -34.38 38.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.627 -0.796 . . . . 8.1099999999999994 112.104 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.37 47.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.624 . . . . 8.7200000000000006 111.926 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 6.0 mp -96.19 82.83 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 7.7199999999999998 109.672 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.426 HG21 ' HG3' ' A' ' 185' ' ' PRO . 14.2 m -154.93 143.13 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.908 -0.587 . . . . 8.7300000000000004 109.425 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.535 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -93.24 -22.1 19.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.734 -0.387 . . . . 9.8900000000000006 111.442 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.3 145.91 19.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.592 -0.277 . . . . 9.9700000000000006 110.599 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.91 114.17 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.734 2.29 . . . . 11.119999999999999 112.003 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.6 -152.57 24.6 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.825 -0.702 . . . . 9.0600000000000005 111.942 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -114.54 117.73 42.32 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.548 0.213 . . . . 7.7400000000000002 110.865 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.426 ' HG3' HG21 ' A' ' 179' ' ' THR . 28.0 Cg_exo -63.09 -37.83 49.75 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.66 2.24 . . . . 6.6699999999999999 111.53 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 52.8 t -89.72 112.55 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.836 -0.62 . . . . 5.4699999999999998 109.824 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HB3' HG23 ' A' ' 280' ' ' THR . 86.4 mt -89.96 -39.28 13.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.729 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.1 168.94 19.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.46 116.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 4.7699999999999996 110.753 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -98.15 106.96 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 6.6500000000000004 109.614 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.0 mt -91.66 136.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.232 0.539 . . . . 5.8499999999999996 110.958 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -119.55 96.77 5.34 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.732 -0.84 . . . . 7.7599999999999998 108.732 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -70.5 -23.97 62.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.569 -0.741 . . . . 7.6100000000000003 111.697 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.76 -49.92 75.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 9.1199999999999992 111.498 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.506 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 35.2 mmtm -106.19 7.09 31.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 9.2799999999999994 111.028 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.04 61.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.795 . . . . 6.9299999999999997 111.5 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 52.3 p90 -148.99 171.31 16.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.092 -0.504 . . . . 7.1100000000000003 109.676 173.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.94 142.46 28.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.357 . . . . 4.6600000000000001 111.158 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 70.2 m-85 -92.8 113.44 25.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 6.5899999999999999 109.869 175.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 151' ' ' LEU . 97.0 mt -83.35 115.76 22.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.211 -0.449 . . . . 4.7699999999999996 110.253 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.84 108.45 19.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 6.5499999999999998 109.695 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 37.1 m-85 -99.02 157.33 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 6.5099999999999998 111.287 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -82.94 -24.32 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.387 -0.824 . . . . 8.5399999999999991 110.765 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 98.5 p -134.06 163.0 30.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 8.3000000000000007 109.991 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 149' ' ' ARG . 15.7 t -92.1 -15.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.875 0.845 . . . . 9.0099999999999998 108.841 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.99 -56.14 6.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.773 -1.103 . . . . 8.7799999999999994 111.183 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.535 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.5 mt-10 -65.79 -24.28 66.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 7.4800000000000004 111.704 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.532 HG21 ' HG ' ' A' ' 151' ' ' LEU . 13.3 m -48.97 -49.75 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.636 0.585 . . . . 6.3899999999999997 111.508 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.8 m -61.46 -36.23 79.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.012 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 1.9 mp0 -70.11 -28.98 65.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.056 -0.258 . . . . 7.9400000000000004 111.189 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.42 -23.52 62.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.313 0.578 . . . . 5.5 110.337 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.404 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 86.8 mtp -70.8 -14.77 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.704 -0.68 . . . . 6.46 110.794 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.89 2.54 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 6.3600000000000003 111.254 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -113.02 19.69 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 5.9299999999999997 110.436 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.83 117.63 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.927 -0.579 . . . . 5.9199999999999999 111.039 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 97.93 16.62 32.69 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.827 -0.702 . . . . 5.7400000000000002 112.498 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.89 135.61 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 110.036 -0.357 . . . . 5.6299999999999999 110.036 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 tp -84.27 116.43 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 7.2300000000000004 111.004 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -135.18 118.67 16.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.796 -0.638 . . . . 5.79 110.288 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 60.84 32.47 20.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 7.3200000000000003 111.414 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.91 78.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.844 -0.693 . . . . 7.5899999999999999 112.632 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 32.6 mm-40 -110.08 132.35 54.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.258 -0.275 . . . . 7.5300000000000002 110.258 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.5 m -86.37 106.78 17.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.871 -0.418 . . . . 6.4500000000000002 109.871 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 156' ' ' ILE . 75.9 mt -66.1 111.89 3.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 4.9000000000000004 110.896 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 86.5 tttt -87.76 114.61 24.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.742 -0.663 . . . . 7.5700000000000003 109.528 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.6 mt -110.92 105.64 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.937 0.399 . . . . 5.3700000000000001 110.423 -173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -129.25 171.2 12.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.067 -0.515 . . . . 7.1900000000000004 110.324 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.404 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 45.8 mtp180 -104.42 143.68 27.17 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.594 0.235 . . . . 7.7599999999999998 111.109 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.09 160.98 14.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.462 2.108 . . . . 7.9800000000000004 110.769 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -86.58 -4.13 59.13 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.516 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.44 42.97 26.79 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.488 0.492 . . . . 0.0 110.398 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.87 102.61 2.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.936 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.787 ' HB3' HD21 ' A' ' 241' ' ' ASN . 20.3 mt-30 53.34 70.16 1.93 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.508 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.731 ' HD2' ' HE2' ' A' ' 238' ' ' MET . 73.1 Cg_endo -81.02 132.11 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.191 1.927 . . . . 0.0 111.798 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 234' ' ' PRO . 97.0 mt 73.8 136.78 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.851 0.719 . . . . 0.0 111.393 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.14 -14.49 34.95 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.842 2.361 . . . . 0.0 112.948 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -80.71 72.67 2.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.12 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.731 ' HE2' ' HD2' ' A' ' 234' ' ' PRO . 44.3 ttm -151.09 153.32 34.82 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 50.3 m -64.63 -59.8 3.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -95.21 94.03 7.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 109.866 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.787 HD21 ' HB3' ' A' ' 233' ' ' GLN . 21.3 t-20 -165.84 -52.88 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.844 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 10.3 Cg_endo -91.12 99.33 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.578 2.185 . . . . 0.0 111.647 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -75.55 -19.28 59.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.6 m -89.57 178.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.423 ' O ' ' HD3' ' A' ' 247' ' ' PRO . 78.1 t80 -79.72 -40.65 28.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.579 0.228 . . . . 0.0 110.911 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.52 104.07 9.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 245' ' ' TYR . 67.8 Cg_endo -73.31 172.63 15.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.902 2.401 . . . . 0.0 112.643 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.1 154.5 29.05 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.987 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.8 m -122.86 174.98 6.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.679 0.276 . . . . 0.0 110.283 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.46 160.02 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.172 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 52.0 m -73.19 93.62 1.87 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 111.115 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 12.0 p -136.08 5.17 3.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.236 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.9 m -75.34 -11.6 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.759 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.99 115.19 52.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.26 -52.34 2.1 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.997 2.465 . . . . 0.0 112.177 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -84.75 104.36 14.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 109.942 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.1 p -76.31 -3.21 35.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -61.12 101.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.301 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -118.1 13.65 13.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.87 -0.789 . . . . 9.1300000000000008 108.87 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 35.3 ttmt -62.33 125.38 23.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.462 -1.245 . . . . 6.3600000000000003 109.934 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.409 HD13 ' CE1' ' A' ' 307' ' ' TYR . 69.6 mt -98.86 142.31 30.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.113 -0.494 . . . . 5.5899999999999999 110.797 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.663 ' HB2' ' HA ' ' A' ' 335' ' ' ALA . 87.3 t80 -95.99 109.47 21.85 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.294 -0.866 . . . . 5.0300000000000002 108.897 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.34 106.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.863 -0.421 . . . . 4.21 109.863 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.95 171.1 19.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.898 -0.668 . . . . 4.5800000000000001 111.511 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.2 27.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.654 -0.784 . . . . 5.6299999999999999 112.068 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.4 mt -101.42 143.86 27.42 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.259 -0.275 . . . . 5.9199999999999999 110.259 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.663 ' HD2' HD23 ' A' ' 270' ' ' LEU . 30.5 Cg_exo -62.33 143.42 93.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.569 2.179 . . . . 7.3099999999999996 111.98 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.66 -24.43 66.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.615 0.228 . . . . 8.8100000000000005 111.615 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -85.02 -7.17 59.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.754 0.312 . . . . 9.0700000000000003 110.836 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.663 HD23 ' HD2' ' A' ' 267' ' ' PRO . 12.1 tp -71.81 106.5 4.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.617 -0.512 . . . . 7.7199999999999998 109.617 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.528 ' O ' HG21 ' A' ' 275' ' ' VAL . 30.6 p-10 -85.9 172.18 10.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 8.8000000000000007 111.012 -175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.07 -37.69 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 7.8899999999999997 111.94 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.17 -54.39 44.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.758 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.62 -42.59 95.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 8.7300000000000004 111.643 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 271' ' ' ASN . 38.9 t -61.49 -47.03 95.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.561 0.22 . . . . 6.7300000000000004 110.728 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -58.56 -54.0 51.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.586 -0.279 . . . . 8.1199999999999992 110.72 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.75 -51.02 70.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.073 -0.512 . . . . 9.3800000000000008 111.591 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.0 -42.89 81.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 7.2300000000000004 110.693 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 320' ' ' LEU . 62.1 mt -80.32 -29.05 38.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.484 -0.325 . . . . 6.8899999999999997 111.26 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.4 m -71.54 -16.73 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 9.2400000000000002 110.796 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 16.3 m -59.97 -15.03 18.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.917 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.85 9.29 11.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.614 0.245 . . . . 9.1799999999999997 111.23 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.75 146.27 4.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.946 -0.645 . . . . 9.5600000000000005 112.395 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.539 ' HA ' HG21 ' A' ' 280' ' ' THR . 50.4 Cg_endo -69.78 141.75 46.0 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.682 2.254 . . . . 10.51 112.733 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.57 130.76 44.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 8.3000000000000007 110.883 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.65 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.5 ptpt -93.5 -29.24 15.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.131 0.491 . . . . 8.9399999999999995 110.028 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 306' ' ' GLU . . . -136.42 115.07 11.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.541 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -125.82 122.21 35.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 6.4900000000000002 110.759 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -140.87 111.6 6.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.51 0.671 . . . . 6.0300000000000002 110.472 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.645 HD12 ' HG ' ' A' ' 299' ' ' SER . 57.0 tp -85.18 140.11 31.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.386 -0.825 . . . . 6.5300000000000002 109.778 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' A' ' 302' ' ' TYR . 58.4 t -88.81 111.34 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.077 0.465 . . . . 6.8700000000000001 110.123 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -102.35 155.24 18.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 8.2100000000000009 111.099 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.76 135.42 34.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.66 -0.7 . . . . 10.33 109.907 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.6 m -74.45 -12.94 60.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 10.93 112.036 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.03 -68.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 12.34 111.324 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 17.4 m -77.9 -32.35 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 11.460000000000001 111.426 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.04 6.97 62.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.54 -0.838 . . . . 10.210000000000001 112.414 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.32 173.34 11.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.618 0.247 . . . . 10.4 110.339 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.645 ' HG ' HD12 ' A' ' 290' ' ' LEU . 47.4 t -79.38 144.7 33.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.408 -0.36 . . . . 7.8700000000000001 110.1 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 300' ' ' LYS . 30.8 mmtp -79.15 0.34 28.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 8.4100000000000001 110.436 175.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 97.71 17.13 31.62 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 6.0899999999999999 113.069 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.495 ' CE2' HG22 ' A' ' 291' ' ' VAL . 43.6 p90 -162.73 157.03 21.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.329 0.585 . . . . 6.7599999999999998 111.261 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.607 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -147.46 160.17 42.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.314 -0.857 . . . . 4.6399999999999997 110.24 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.523 ' HD2' ' HB2' ' A' ' 335' ' ' ALA . 81.8 m-85 -107.43 122.65 47.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.853 -0.795 . . . . 5.1900000000000004 108.853 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 56.9 m -139.01 115.24 10.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 5.0899999999999999 111.412 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 33.5 tt0 -98.25 135.43 39.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.916 -0.584 . . . . 7.0300000000000002 110.155 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.409 ' CE1' HD13 ' A' ' 261' ' ' LEU . 26.1 m-85 -90.14 147.31 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.213 -0.448 . . . . 7.8899999999999997 111.238 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.65 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 52.5 t -66.32 -53.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 10.42 110.578 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 312' ' ' VAL . 27.0 t70 -88.64 137.16 32.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.997 -0.547 . . . . 10.81 110.374 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.54 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -79.2 -18.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.148 0.425 . . . . 10.039999999999999 112.148 -174.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.61 -40.22 23.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.761 0.315 . . . . 10.98 110.401 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 309' ' ' ASP . 34.5 m -69.49 -22.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 9.9100000000000001 111.439 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 317' ' ' ILE . 21.4 m -55.3 -50.6 69.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.68 0.276 . . . . 8.0600000000000005 111.563 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.92 -32.82 72.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.014 0.435 . . . . 8.9399999999999995 110.789 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -66.12 -41.39 90.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 10.880000000000001 110.443 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.34 94.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 7.5300000000000002 110.734 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 313' ' ' THR . 64.4 mt -57.36 -41.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 6.5800000000000001 110.495 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.54 -43.52 59.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.741 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -75.43 -47.54 12.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.018 -0.611 . . . . 7.7699999999999996 113.469 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.577 HD11 HD23 ' A' ' 279' ' ' LEU . 87.1 mt -70.56 -43.11 70.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.647 0.261 . . . . 6.5199999999999996 111.61 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 8.9 t30 -66.43 115.44 6.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.75 0.31 . . . . 6.6100000000000003 110.272 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.41 -21.55 14.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.925 -0.655 . . . . 6.7699999999999996 111.514 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.5 ttt -73.85 141.86 46.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.039 -0.356 . . . . 7.6900000000000004 110.039 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 26.1 tt0 -105.59 125.18 50.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.833 0.349 . . . . 8.2400000000000002 110.599 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.539 HD13 ' HG2' ' A' ' 267' ' ' PRO . 0.4 OUTLIER -117.14 113.4 22.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.94 -0.763 . . . . 7.0300000000000002 108.94 177.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.86 -88.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.939 -0.648 . . . . 8.25 112.849 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.69 0.26 3.57 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.854 -0.203 . . . . 8.9800000000000004 111.396 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -130.61 152.08 50.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.915 0.388 . . . . 7.4299999999999997 111.147 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 91.3 mttt -103.83 129.7 51.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 7.4500000000000002 109.647 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.72 122.77 18.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.037 0.446 . . . . 5.8399999999999999 112.121 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.53 107.43 19.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.334 -0.987 . . . . 5.8099999999999996 108.334 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 320' ' ' LEU . 59.4 t -110.81 121.87 64.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 5.21 111.643 -173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 13.9 pt20 -139.69 -169.09 2.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 6.1699999999999999 108.77 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -87.14 141.33 28.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.878 -0.416 . . . . 7.7999999999999998 109.878 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.663 ' HA ' ' HB2' ' A' ' 262' ' ' PHE . . . -70.51 -38.18 74.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 6.04 111.272 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.1 m -78.53 -15.19 58.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 7.7000000000000002 110.044 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 93.5 t 71.13 -60.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.925 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.01 56.01 0.67 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -101.95 11.45 38.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.662 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.8 tttt 66.34 101.63 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.149 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.78 -41.67 95.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.902 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.864 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' ' NH2' ' A' ' 228' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.525 ' HB3' HG23 ' A' ' 205' ' ' VAL . 23.4 ptt85 -117.67 20.64 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.883 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.88 139.91 39.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.978 -0.555 . . . . 6.9800000000000004 109.91 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.24 137.21 48.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.847 0.356 . . . . 5.6100000000000003 110.293 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.621 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 74.7 t80 -94.94 104.66 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.847 -0.615 . . . . 6.2599999999999998 109.46 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 5.8 p -107.32 125.08 63.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.315 0.578 . . . . 4.25 110.642 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.69 -178.86 15.48 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.516 -0.765 . . . . 5.3099999999999996 111.632 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.1 t30 59.8 41.31 18.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.029 0.919 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.679 HG23 HD23 ' A' ' 224' ' ' LEU . 32.6 pt -90.42 156.95 45.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.949 . . . . 5.6100000000000003 110.712 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.579 ' HG3' ' HB2' ' A' ' 220' ' ' GLN . 29.6 Cg_endo -63.84 142.32 81.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.669 2.246 . . . . 6.1600000000000001 112.26 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -80.32 126.99 31.85 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.612 -0.514 . . . . 8.8200000000000003 109.612 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.49 21.18 41.65 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.623 -0.798 . . . . 7.3300000000000001 111.999 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.557 HD11 ' HG3' ' A' ' 220' ' ' GLN . 9.3 tp -78.97 139.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.868 0.366 . . . . 6.0999999999999996 110.691 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 164' ' ' ALA . 24.7 m -75.52 128.07 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 7.0 110.293 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.512 ' HA ' HD13 ' A' ' 191' ' ' ILE . 44.1 mt-10 -59.69 -47.9 83.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.506 -0.315 . . . . 5.6900000000000004 110.765 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.96 -42.48 89.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.953 -0.567 . . . . 7.29 110.53 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 161' ' ' THR . . . -63.15 -44.17 96.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.2 ttm -64.94 -45.72 84.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.507 -0.315 . . . . 4.5700000000000003 110.653 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.425 ' HE2' ' HA ' ' A' ' 281' ' ' SER . 27.1 ttt -61.33 -50.95 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.153 -0.476 . . . . 6.1100000000000003 111.004 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.02 -32.78 74.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 6.5099999999999998 110.958 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.488 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 86.3 t80 -59.32 -52.58 65.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 5.8700000000000001 110.579 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -63.67 -41.69 98.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 5.0300000000000002 110.786 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.4 m-20 -55.77 -48.86 74.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 6.2999999999999998 110.43 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.5 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.22 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 17.4 mm100 -64.25 -37.35 87.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.3200000000000003 111.267 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.431 ' HE2' ' HB3' ' A' ' 207' ' ' GLU . 86.7 mtp -69.83 -34.87 74.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.998 -0.281 . . . . 7.0300000000000002 110.583 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 98.6 mtt180 -64.7 -50.9 65.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.013 0.435 . . . . 9.3100000000000005 110.196 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.27 -35.52 81.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 8.9600000000000009 111.911 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.05 -21.37 59.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.603 -0.808 . . . . 8.1099999999999994 112.59 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.91 40.94 7.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.592 -0.813 . . . . 8.7200000000000006 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.66 3.31 34.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.087 0.47 . . . . 7.7199999999999998 110.259 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 p -92.34 140.14 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 8.7300000000000004 110.827 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.423 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.0 pt20 -95.02 -10.71 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.087 0.47 . . . . 9.8900000000000006 110.287 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.11 158.71 33.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 9.9700000000000006 110.227 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 154.06 62.59 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.559 2.172 . . . . 11.119999999999999 111.822 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.37 -145.77 16.1 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.669 -0.777 . . . . 9.0600000000000005 112.599 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.58 122.5 37.2 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 120.462 0.172 . . . . 7.7400000000000002 110.571 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.82 -38.61 47.39 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.737 2.291 . . . . 6.6699999999999999 111.69 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.91 137.26 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.41 -0.589 . . . . 5.4699999999999998 109.41 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 284' ' ' PRO . 50.9 tp -105.1 -41.63 5.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.644 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -142.56 134.25 26.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.76 117.37 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 4.7699999999999996 110.159 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -124.58 105.81 9.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.823 -0.436 . . . . 6.6500000000000004 109.823 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 162' ' ' GLU . 55.4 mt -107.23 134.16 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 5.8499999999999996 111.453 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -109.91 113.85 26.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.542 . . . . 7.7599999999999998 109.538 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -82.97 -10.91 58.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 7.6100000000000003 110.81 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.91 -59.08 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.161 -0.472 . . . . 9.1199999999999992 111.051 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.0 mmtm -91.16 -0.79 57.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.405 -0.361 . . . . 9.2799999999999994 110.686 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 62.2 61.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 6.9299999999999997 110.912 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 42.7 p90 -148.87 158.68 44.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 7.1100000000000003 109.446 175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -139.57 147.63 41.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.942 0.401 . . . . 4.6600000000000001 110.856 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.12 109.55 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.772 -0.649 . . . . 6.5899999999999999 110.008 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.247 -0.649 . . . . 4.7699999999999996 109.247 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 127.36 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.642 . . . . 6.5499999999999998 109.268 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -99.03 162.85 12.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.977 0.417 . . . . 6.5099999999999998 111.203 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -71.93 -25.78 62.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.405 -0.816 . . . . 8.5399999999999991 110.329 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.1 p -124.56 -170.32 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.582 -0.736 . . . . 8.3000000000000007 109.595 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 149' ' ' ARG . 39.2 t -113.78 -28.78 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.644 0.735 . . . . 9.0099999999999998 109.281 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.15 -51.04 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.896 . . . . 8.7799999999999994 111.34 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HB3' ' HE2' ' A' ' 173' ' ' MET . 50.4 mt-10 -65.24 -35.12 80.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.076 -0.511 . . . . 7.4800000000000004 110.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -55.12 -50.14 70.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.316 0.579 . . . . 6.3899999999999997 110.351 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 24.1 m -60.06 -34.13 73.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.698 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -31.59 64.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 7.9400000000000004 110.277 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -76.03 -7.43 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.023 -0.535 . . . . 5.5 111.206 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 85.8 mtp -69.85 -16.65 63.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.411 . . . . 6.46 110.021 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.59 50.38 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.674 -0.694 . . . . 6.3600000000000003 111.049 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.483 ' HD1' HD13 ' A' ' 217' ' ' ILE . 93.3 m-85 -93.75 7.14 45.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 5.9299999999999997 110.812 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.28 114.29 3.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.98 -0.378 . . . . 5.9199999999999999 109.98 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.36 12.51 44.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.859 -0.686 . . . . 5.7400000000000002 112.11 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.483 HD13 ' HD1' ' A' ' 214' ' ' PHE . 16.6 tt -71.53 137.19 24.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 5.6299999999999999 110.044 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -85.55 112.03 21.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.459 0.647 . . . . 7.2300000000000004 110.056 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -133.09 119.4 19.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 5.79 110.579 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 80.9 mm-40 60.82 29.54 19.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.522 -0.763 . . . . 7.3200000000000003 111.273 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.78 7.97 83.36 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.857 -0.687 . . . . 7.5899999999999999 112.857 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -124.76 132.74 53.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.568 -0.372 . . . . 7.5300000000000002 110.824 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 t -78.86 112.33 15.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.147 -0.686 . . . . 6.4500000000000002 109.147 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.679 HD23 HG23 ' A' ' 156' ' ' ILE . 46.4 mt -81.9 120.71 25.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.885 0.374 . . . . 4.9000000000000004 111.352 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.5 tttt -84.78 115.97 23.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 7.5700000000000003 109.543 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.9 mt -121.98 105.89 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.415 . . . . 5.3700000000000001 110.886 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -132.68 167.5 19.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.045 -0.525 . . . . 7.1900000000000004 110.412 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 15.7 mtp180 -79.34 128.17 76.38 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.738 -0.467 . . . . 7.7599999999999998 109.738 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.621 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 3.6 Cg_exo -73.07 153.81 52.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.797 2.331 . . . . 7.9800000000000004 112.241 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -114.21 -7.81 12.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.7 105.89 18.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.479 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -108.62 -58.48 2.0 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -148.31 94.35 4.24 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.276 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.35 102.05 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.819 2.346 . . . . 0.0 111.531 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.742 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 10.0 tt -163.24 -55.79 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.374 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.742 ' HD3' ' HB3' ' A' ' 235' ' ' LEU . 63.3 Cg_exo -54.39 -43.39 59.16 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.13 -81.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.785 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.6 mtp -71.47 -70.61 0.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.813 0.34 . . . . 0.0 110.732 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 33.9 t -128.78 139.28 52.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 39.5 mt-10 -88.04 118.52 27.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -74.26 121.18 84.61 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.11 -34.32 92.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.609 2.206 . . . . 0.0 112.139 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.4 t -84.95 144.64 28.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.388 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 64.8 t -116.72 -47.2 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.401 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -98.43 -80.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.1 t -131.64 114.01 15.47 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.411 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.79 -34.17 5.66 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.661 2.241 . . . . 0.0 113.12 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -132.05 135.81 8.39 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.969 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.9 t 64.91 86.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.51 0.672 . . . . 0.0 110.563 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.2 p -110.55 -16.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.708 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 43.1 m 64.92 -177.05 0.17 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.341 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.6 p -87.68 5.01 41.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.78 125.91 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.697 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.75 132.26 21.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.822 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.2 141.9 57.51 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.826 2.351 . . . . 0.0 111.963 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -88.98 4.49 48.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.3 p -90.19 45.87 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.183 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.58 -18.78 63.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.186 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.862 ' HB3' HG22 ' A' ' 313' ' ' THR . 52.6 m80 63.02 34.93 13.5 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.854 -0.612 . . . . 9.1300000000000008 111.792 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 305' ' ' CYS . 40.3 ttmt -66.44 121.49 15.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.681 -0.488 . . . . 6.3600000000000003 109.681 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.43 142.09 31.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.313 0.577 . . . . 5.5899999999999999 111.476 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.97 107.19 19.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.781 -1.099 . . . . 5.0300000000000002 108.684 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 3.6 mp -100.3 104.58 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.954 -0.566 . . . . 4.21 109.529 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -118.84 120.5 4.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.589 -0.815 . . . . 4.5800000000000001 112.691 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 139.2 9.71 0.9 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.096 -0.573 . . . . 5.6299999999999999 112.296 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.4 144.76 74.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.481 0.182 . . . . 5.9199999999999999 110.65 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 270' ' ' LEU . 41.2 Cg_exo -57.63 135.88 72.21 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.77 2.314 . . . . 7.3099999999999996 112.292 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 9.1 p30 -62.39 -23.55 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.918 -0.583 . . . . 8.8100000000000005 111.137 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -100.59 12.58 37.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.551 . . . . 9.0700000000000003 111.34 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 267' ' ' PRO . 26.8 tp -89.32 125.2 35.02 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.779 -0.452 . . . . 7.7199999999999998 109.779 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.532 ' O ' HG21 ' A' ' 275' ' ' VAL . 29.8 p-10 -85.09 157.01 20.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 8.8000000000000007 111.186 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 2.8 m-20 -52.5 -36.16 54.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.663 -0.699 . . . . 7.8899999999999997 112.055 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.25 -53.06 58.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.431 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -72.62 -40.09 66.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 8.7300000000000004 111.081 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 271' ' ' ASN . 59.9 t -56.83 -47.81 82.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.428 -0.351 . . . . 6.7300000000000004 110.716 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.4 mtmm -59.96 -47.53 85.44 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.477 -0.328 . . . . 8.1199999999999992 110.815 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -49.74 76.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.106 -0.237 . . . . 9.3800000000000008 110.965 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.23 -47.16 78.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 7.2300000000000004 110.763 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.574 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -77.13 -31.5 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.396 -0.365 . . . . 6.8899999999999997 111.563 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.6 m -69.97 -27.97 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 9.2400000000000002 111.017 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.425 ' HA ' ' HE2' ' A' ' 166' ' ' MET . 41.9 m -72.41 4.5 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.542 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -132.53 9.81 4.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.364 -0.38 . . . . 9.1799999999999997 110.779 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.445 ' HA3' ' HE2' ' A' ' 307' ' ' TYR . . . 160.56 146.32 4.57 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.183 -1.008 . . . . 9.5600000000000005 113.286 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.992 ' HB3' HD22 ' A' ' 187' ' ' LEU . 53.4 Cg_endo -71.04 119.82 6.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.249 2.633 . . . . 10.51 112.534 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' A' ' 305' ' ' CYS . 56.0 mt -100.4 103.23 14.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.199 -0.455 . . . . 8.3000000000000007 110.486 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.497 ' HB3' HG23 ' A' ' 308' ' ' VAL . 53.9 pttt -82.29 -20.7 36.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 8.9399999999999995 110.072 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 306' ' ' GLU . . . -138.99 130.2 26.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.408 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 75.6 t80 -145.21 128.83 17.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.667 0.27 . . . . 6.4900000000000002 110.638 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -140.6 114.19 8.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.357 0.598 . . . . 6.0300000000000002 110.983 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.427 HD12 ' HG ' ' A' ' 299' ' ' SER . 62.4 tp -90.68 131.67 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.458 -0.792 . . . . 6.5300000000000002 109.188 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.45 121.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.916 0.389 . . . . 6.8700000000000001 110.798 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.77 157.95 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.004 -0.544 . . . . 8.2100000000000009 110.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.408 ' HB2' ' CD ' ' A' ' 300' ' ' LYS . 14.5 t70 -91.05 121.64 33.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.216 -0.661 . . . . 10.33 109.216 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 47.2 m -71.61 -29.6 64.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.452 0.538 . . . . 10.93 112.452 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.59 -44.72 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.808 -0.357 . . . . 12.34 110.932 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 10.4 m -73.98 -44.73 53.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.144 -0.48 . . . . 11.460000000000001 111.306 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 90.59 26.32 23.16 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 10.210000000000001 111.889 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 92.3 mt -135.19 168.46 19.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.804 -0.443 . . . . 10.4 109.804 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.427 ' HG ' HD12 ' A' ' 290' ' ' LEU . 42.6 t -70.42 145.92 50.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 7.8700000000000001 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 293' ' ' ASP . 31.5 mmmt -76.32 -20.47 57.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 8.4100000000000001 110.17 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 107.35 -7.84 37.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.621 -0.799 . . . . 6.0899999999999999 112.897 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 52.7 p90 -128.4 147.2 50.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.191 0.52 . . . . 6.7599999999999998 111.534 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -142.3 158.67 43.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 4.6399999999999997 110.435 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 93.0 m-85 -111.59 132.38 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.238 -0.437 . . . . 5.1900000000000004 110.079 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.844 ' HB3' HD23 ' A' ' 285' ' ' LEU . 57.4 m -130.89 115.76 16.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.317 -0.401 . . . . 5.0899999999999999 111.239 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.713 ' HB3' ' HB1' ' A' ' 287' ' ' ALA . 40.5 tt0 -95.4 119.58 34.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.488 -0.56 . . . . 7.0300000000000002 109.488 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.445 ' HE2' ' HA3' ' A' ' 283' ' ' GLY . 30.1 m-85 -90.72 148.36 22.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 7.8899999999999997 111.845 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 286' ' ' LYS . 53.6 t -77.34 -48.26 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 10.42 110.579 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.672 ' HB3' HG23 ' A' ' 312' ' ' VAL . 18.2 t70 -82.37 157.75 23.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 10.81 109.897 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.713 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -110.11 -4.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.489 0.551 . . . . 10.039999999999999 112.489 -173.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -111.02 -30.48 7.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.963 -0.295 . . . . 10.98 111.482 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 309' ' ' ASP . 34.1 m -71.52 -23.71 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.867 0.321 . . . . 9.9100000000000001 111.867 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.862 HG22 ' HB3' ' A' ' 259' ' ' HIS . 13.0 m -57.56 -49.37 76.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.945 0.35 . . . . 8.0600000000000005 111.945 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.39 -27.1 68.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.059 0.457 . . . . 8.9399999999999995 110.748 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.69 -34.74 45.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 10.880000000000001 110.413 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.58 99.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 7.5300000000000002 110.065 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.0 mt -57.38 -47.1 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.719 -0.673 . . . . 6.5800000000000001 110.531 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.87 -33.73 72.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.842 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.92 -44.62 5.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.704 -0.76 . . . . 7.7699999999999996 112.959 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.39 -51.18 15.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 6.5199999999999996 111.402 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.705 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.1 t30 -67.6 120.7 14.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.124 -0.489 . . . . 6.6100000000000003 110.365 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 121.69 -30.17 5.41 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.815 -0.707 . . . . 6.7699999999999996 111.776 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -74.52 141.0 44.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 7.6900000000000004 109.21 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 29.9 tt0 -107.89 120.91 43.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.966 0.412 . . . . 8.2400000000000002 111.541 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.38 103.78 16.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 7.0300000000000002 109.721 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.77 -96.84 0.38 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.011 -0.614 . . . . 8.25 112.265 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.05 2.08 9.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 8.9800000000000004 110.687 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.69 113.51 26.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 7.4299999999999997 110.854 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 87.8 tttt -72.16 131.23 42.52 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.302 -0.629 . . . . 7.4500000000000002 109.302 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.541 HD12 HG21 ' A' ' 263' ' ' ILE . 23.2 tp -77.68 117.16 18.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.961 0.41 . . . . 5.8399999999999999 111.351 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 329' ' ' LYS . 6.3 mp -98.95 123.6 43.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.355 -0.609 . . . . 5.8099999999999996 109.355 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.705 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 57.5 t -125.67 118.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.077 -0.511 . . . . 5.21 110.204 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.75 163.71 34.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.789 -0.819 . . . . 6.1699999999999999 108.789 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.715 ' HB2' ' HA ' ' A' ' 337' ' ' VAL . 93.9 mtt180 -64.95 141.87 58.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.862 -0.421 . . . . 7.7999999999999998 109.862 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.43 -51.32 47.67 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.418 0.449 . . . . 6.04 111.876 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 37.0 m -110.52 -20.01 12.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.815 0.341 . . . . 7.7000000000000002 110.274 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.715 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 94.5 t 71.64 -65.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.113 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 64.25 55.27 24.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.572 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -59.73 -57.15 14.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.934 0.397 . . . . 0.0 110.686 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.05 -40.91 2.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.934 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -107.98 115.9 30.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.689 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.569 ' H2 ' HG11 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.948 0.404 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.07 -50.59 7.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.381 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 199' ' ' PHE . 99.2 mtt180 -106.99 133.32 51.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 6.9800000000000004 111.034 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 208' ' ' THR . 31.7 mt -92.87 152.92 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.449 . . . . 5.6100000000000003 110.466 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 65.7 t80 -94.14 110.65 22.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.815 -0.63 . . . . 6.2599999999999998 109.736 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 198' ' ' ALA . 5.9 p -111.1 119.92 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.274 0.559 . . . . 4.25 109.88 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.88 15.06 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.652 -0.704 . . . . 5.3099999999999996 111.951 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.12 39.74 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.921 0.867 . . . . 0.0 109.188 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.473 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 27.8 pt -85.76 146.95 44.86 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.004 -0.998 . . . . 5.6100000000000003 110.833 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 6.9 Cg_exo -74.48 120.5 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.896 2.397 . . . . 6.1600000000000001 111.752 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.417 ' CD2' ' HG2' ' A' ' 193' ' ' GLN . 28.5 t80 -62.24 132.8 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.132 -0.486 . . . . 8.8200000000000003 109.929 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 114.31 -17.0 19.46 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.67 -0.776 . . . . 7.3300000000000001 112.597 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.9 tp -78.62 144.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 6.0999999999999996 110.335 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -88.94 152.82 21.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 7.0 110.864 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.619 ' HA ' HD13 ' A' ' 191' ' ' ILE . 40.4 mt-10 -63.09 -39.82 95.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.126 -0.488 . . . . 5.6900000000000004 110.75 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -61.99 -47.29 85.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.599 . . . . 7.29 110.788 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.89 86.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.83 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.4 tpt -63.21 -47.62 81.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 4.5700000000000003 110.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.413 ' HB2' HG12 ' A' ' 189' ' ' VAL . 22.5 ttt -61.15 -46.38 90.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 6.1100000000000003 111.307 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.52 -36.28 82.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 6.5099999999999998 110.854 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.9 -46.9 84.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.967 -0.56 . . . . 5.8700000000000001 110.516 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.651 ' O ' ' HG2' ' A' ' 173' ' ' MET . 54.9 m-85 -64.31 -46.36 83.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 5.0300000000000002 110.83 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.54 -45.68 73.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.719 0.295 . . . . 6.2999999999999998 110.956 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -60.7 -48.76 80.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.896 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.84 -27.0 64.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 6.3200000000000003 111.753 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 32.4 mmt -64.62 -42.69 95.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 7.0300000000000002 110.016 176.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -70.2 -44.61 68.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.842 -0.617 . . . . 9.3100000000000005 110.419 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 79.8 mt -68.21 -34.49 76.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 8.9600000000000009 111.446 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.57 -16.3 73.75 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.601 -0.809 . . . . 8.1099999999999994 112.466 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.78 29.63 34.6 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.685 -0.769 . . . . 8.7200000000000006 112.147 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.601 HD12 ' HE1' ' A' ' 214' ' ' PHE . 4.5 mp -87.89 -22.52 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.36 0.6 . . . . 7.7199999999999998 109.838 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 24.0 m -76.21 122.69 24.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.217 -0.902 . . . . 8.7300000000000004 110.751 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.458 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.1 pt20 -80.6 -30.49 36.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.914 0.387 . . . . 9.8900000000000006 110.932 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.75 124.89 18.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.509 . . . . 9.9700000000000006 110.253 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.79 128.62 2.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.962 3.108 . . . . 11.119999999999999 113.613 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 134.58 -129.63 5.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.915 -0.659 . . . . 9.0600000000000005 112.265 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -123.26 117.95 27.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.724 0.297 . . . . 7.7400000000000002 111.086 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.88 -27.82 9.94 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.599 2.2 . . . . 6.6699999999999999 112.047 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.4 t -90.03 133.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 5.4699999999999998 110.039 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 203' ' ' ARG . 86.9 mt -95.42 -56.3 2.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.6 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.41 157.88 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 200' ' ' LEU . 8.2 p -133.93 137.57 52.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.058 -0.519 . . . . 4.7699999999999996 110.599 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.73 111.12 13.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.632 -0.507 . . . . 6.6500000000000004 109.632 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 162' ' ' GLU . 41.6 mt -104.71 127.23 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 5.8499999999999996 111.555 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -105.36 97.98 7.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.062 -1.088 . . . . 7.7599999999999998 108.062 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.417 ' HG2' ' CD2' ' A' ' 158' ' ' PHE . 16.1 tt0 -85.45 -5.28 59.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.971 -0.559 . . . . 7.6100000000000003 110.307 -172.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.28 -52.64 10.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 9.1199999999999992 110.204 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -91.98 2.67 56.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 9.2799999999999994 110.757 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.86 48.53 3.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.332 -0.849 . . . . 6.9299999999999997 111.712 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 34.8 p90 -148.52 151.32 34.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.301 -0.409 . . . . 7.1100000000000003 110.224 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -141.27 157.51 45.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.522 -0.308 . . . . 4.6600000000000001 110.827 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 150' ' ' ARG . 61.1 m-85 -118.32 119.51 34.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.202 -0.454 . . . . 6.5899999999999999 110.806 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 31.0 mt -95.32 115.0 26.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.678 -0.692 . . . . 4.7699999999999996 109.549 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -96.41 116.87 29.75 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.51 -0.476 . . . . 6.5499999999999998 110.384 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CD1' HG21 ' A' ' 208' ' ' THR . 27.6 m-85 -93.84 163.91 13.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.683 -0.69 . . . . 6.5099999999999998 110.612 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.481 ' HA ' HD12 ' A' ' 187' ' ' LEU . 37.0 ptt180 -74.48 -24.19 58.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 8.5399999999999991 110.788 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 71.3 p -125.44 -161.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.19 -0.459 . . . . 8.3000000000000007 110.434 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.569 HG11 ' H2 ' ' A' ' 148' ' ' ALA . 60.2 t -122.12 -34.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.094 0.473 . . . . 9.0099999999999998 110.04 176.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.11 -52.2 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 8.7799999999999994 111.129 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.2 mt-10 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.748 -0.464 . . . . 7.4800000000000004 109.748 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.573 ' O ' HD12 ' A' ' 151' ' ' LEU . 2.1 m -51.69 -52.43 48.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.465 -0.788 . . . . 6.3899999999999997 110.818 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.3 m -63.41 -33.67 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.766 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.46 ' HG3' HD21 ' A' ' 178' ' ' LEU . 8.9 tp-100 -71.05 -30.0 66.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 7.9400000000000004 110.393 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -16.26 63.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 5.5 111.349 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.9 mtp -69.78 -13.75 62.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 6.46 111.165 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.25 65.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 6.3600000000000003 111.097 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.601 ' HE1' HD12 ' A' ' 178' ' ' LEU . 22.5 m-85 -94.13 12.27 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 5.9299999999999997 111.353 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.84 112.9 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.817 0.341 . . . . 5.9199999999999999 110.28 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.58 30.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.714 -0.755 . . . . 5.7400000000000002 112.499 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.515 HD13 ' HD2' ' A' ' 214' ' ' PHE . 15.4 tt -61.44 138.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.926 0.393 . . . . 5.6299999999999999 110.398 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.11 122.56 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.331 0.586 . . . . 7.2300000000000004 110.883 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -133.68 106.49 7.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.737 -0.665 . . . . 5.79 110.125 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.54 31.27 20.22 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.831 -0.622 . . . . 7.3200000000000003 111.968 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.44 68.36 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.589 -0.815 . . . . 7.5899999999999999 112.851 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 31.1 mm-40 -120.24 136.06 54.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.212 -0.292 . . . . 7.5300000000000002 110.212 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.3 m -87.19 108.8 19.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.401 -0.363 . . . . 6.4500000000000002 110.22 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.73 119.56 11.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.476 . . . . 4.9000000000000004 110.891 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 83.2 tttt -90.94 116.96 29.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.906 -0.588 . . . . 7.5700000000000003 109.804 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.07 105.89 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.04 0.448 . . . . 5.3700000000000001 110.131 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -127.61 170.2 12.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.963 -0.562 . . . . 7.1900000000000004 111.005 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -77.17 144.8 72.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.928 -0.578 . . . . 7.7599999999999998 109.455 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.89 164.47 13.93 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.701 2.267 . . . . 7.9800000000000004 113.026 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 73.39 15.69 4.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.973 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.3 -32.33 18.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -86.51 142.01 28.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.863 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -79.98 120.79 80.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -57.09 116.53 3.28 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.54 2.16 . . . . 0.0 111.201 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 236' ' ' PRO . 4.0 pp -71.36 141.11 85.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -176.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 12.4 Cg_exo -70.37 -28.67 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.938 2.426 . . . . 0.0 112.217 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 104.22 82.93 1.65 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.795 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 20.7 mmt -76.17 -28.0 57.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 43.4 m -144.18 129.65 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.466 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.25 79.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.735 0.647 . . . . 0.0 110.332 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -84.8 116.94 67.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.279 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.46 -27.2 39.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.927 2.418 . . . . 0.0 112.513 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -82.47 89.14 6.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.29 147.13 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -118.03 139.92 50.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.344 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 29.7 m -78.39 140.06 60.18 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 12.4 Cg_exo -71.0 -176.42 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.944 2.429 . . . . 0.0 112.181 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.23 -96.5 0.64 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.22 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.2 t 51.69 74.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.182 0.515 . . . . 0.0 110.208 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.7 t 65.02 90.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.197 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.2 m -58.54 135.29 57.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.1 t -87.35 144.79 26.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.183 0.516 . . . . 0.0 110.65 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.56 140.26 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.321 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 7.4 p -144.86 122.57 6.47 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.006 0.431 . . . . 0.0 111.061 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 6.6 Cg_exo -73.71 110.11 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.706 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.44 98.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.796 0.685 . . . . 0.0 110.75 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.7 p -75.66 128.18 34.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.143 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -122.95 123.3 40.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.929 0.395 . . . . 0.0 111.299 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.419 ' CE1' ' HB ' ' A' ' 310' ' ' ILE . 64.3 m80 -94.41 23.0 5.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.702 0.763 . . . . 9.1300000000000008 109.191 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 33.0 ttmt -60.51 113.37 2.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.086 -1.416 . . . . 6.3600000000000003 109.88 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 307' ' ' TYR . 39.4 mt -90.71 142.29 27.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.081 -0.509 . . . . 5.5899999999999999 110.764 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 88.6 t80 -93.6 105.21 17.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.306 -0.861 . . . . 5.0300000000000002 108.928 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 4.5 mp -96.45 100.41 10.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.648 -0.501 . . . . 4.21 109.648 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.88 108.37 1.74 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.718 -0.753 . . . . 4.5800000000000001 112.102 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 149.68 42.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.708 -0.758 . . . . 5.6299999999999999 112.161 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.503 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.4 mt -119.1 137.97 25.72 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.607 0.242 . . . . 5.9199999999999999 110.462 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 325' ' ' LEU . 24.9 Cg_exo -64.2 154.11 72.66 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.662 2.241 . . . . 7.3099999999999996 111.685 174.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 21.2 p30 -68.18 -23.72 64.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.431 0.53 . . . . 8.8100000000000005 112.431 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -83.62 12.08 6.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.0 0.371 . . . . 9.0700000000000003 112.0 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.08 129.37 36.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.109 0.48 . . . . 7.7199999999999998 110.341 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 275' ' ' VAL . 32.5 p-10 -102.98 179.93 4.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 8.8000000000000007 110.655 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.37 -37.81 81.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 7.8899999999999997 111.528 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.39 -52.88 59.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -61.19 -46.46 90.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 8.7300000000000004 111.817 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 271' ' ' ASN . 61.1 t -63.27 -45.96 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.531 -0.304 . . . . 6.7300000000000004 111.186 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.47 -50.73 72.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.91 -0.316 . . . . 8.1199999999999992 110.516 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.86 -50.2 73.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.035 -0.529 . . . . 9.3800000000000008 111.169 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.81 -50.85 69.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 7.2300000000000004 110.419 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' A' ' 285' ' ' LEU . 84.3 mt -71.36 -37.66 71.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.277 -0.42 . . . . 6.8899999999999997 111.24 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.844 HG21 ' HA ' ' A' ' 284' ' ' PRO . 91.9 m -66.74 -27.81 67.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.51 -0.314 . . . . 9.2400000000000002 111.118 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 49.1 m -60.39 -25.86 66.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.029 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.422 ' CD2' HD22 ' A' ' 320' ' ' LEU . 90.2 m-85 -108.5 -0.21 20.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.989 0.423 . . . . 9.1799999999999997 110.603 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 164.82 122.64 0.61 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.712 -0.676 . . . . 9.5600000000000005 111.634 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.844 ' HA ' HG21 ' A' ' 280' ' ' THR . 37.6 Cg_exo -58.69 131.67 43.62 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.042 2.494 . . . . 10.51 113.0 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 279' ' ' LEU . 81.0 mt -94.67 123.75 38.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 8.3000000000000007 110.981 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -90.24 -22.32 21.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 8.9399999999999995 109.945 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -137.11 134.7 36.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.922 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.476 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 56.2 t80 -146.32 126.9 14.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.326 -0.397 . . . . 6.4900000000000002 111.334 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -140.88 121.9 14.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.558 -0.534 . . . . 6.0300000000000002 109.558 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.581 HD13 ' HB3' ' A' ' 303' ' ' ALA . 59.1 tp -97.92 125.96 43.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 6.5300000000000002 109.814 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.438 HG22 ' CE2' ' A' ' 302' ' ' TYR . 47.5 t -77.55 112.55 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 6.8700000000000001 110.221 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -106.89 161.99 14.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 8.2100000000000009 111.321 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -96.96 135.05 39.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.741 -0.663 . . . . 10.33 109.694 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.0 m -69.86 -40.03 75.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.504 -0.316 . . . . 10.93 111.708 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.31 -48.42 14.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.851 0.357 . . . . 12.34 111.85 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -79.96 -32.23 39.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.238 -0.437 . . . . 11.460000000000001 111.66 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 76.8 24.07 68.04 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.583 -0.818 . . . . 10.210000000000001 111.982 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 89.2 mt -123.24 -178.88 4.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.113 -0.329 . . . . 10.4 110.113 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.415 ' HG ' HD12 ' A' ' 290' ' ' LEU . 46.6 t -77.25 143.73 38.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.728 0.299 . . . . 7.8700000000000001 110.326 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 3.1 mmmp? -74.9 -26.5 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.013 0.435 . . . . 8.4100000000000001 110.044 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 125.39 -7.37 7.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.415 -0.898 . . . . 6.0899999999999999 113.105 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 22.2 p90 -138.79 156.49 47.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 6.7599999999999998 111.154 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.581 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -149.15 165.77 30.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 4.6399999999999997 110.739 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.64 126.13 49.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.436 -0.579 . . . . 5.1900000000000004 109.436 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.476 ' SG ' ' HD1' ' A' ' 288' ' ' PHE . 56.7 m -143.71 138.34 28.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.668 0.27 . . . . 5.0899999999999999 110.915 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -113.48 136.02 53.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.775 -0.454 . . . . 7.0300000000000002 109.775 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.48 ' CE1' HD13 ' A' ' 261' ' ' LEU . 6.0 m-85 -84.19 153.19 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 7.8899999999999997 111.021 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.538 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 90.2 t -64.85 -41.5 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 10.42 110.477 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.11 136.54 40.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 10.81 109.941 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.493 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.82 -1.28 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 111.98 0.363 . . . . 10.039999999999999 111.98 -174.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -93.39 -39.5 10.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.213 0.53 . . . . 10.98 109.673 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.38 -20.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.606 -0.724 . . . . 9.9100000000000001 111.36 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 m -53.72 -47.95 70.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.275 -0.42 . . . . 8.0600000000000005 112.041 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.62 -37.08 85.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 8.9399999999999995 111.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 10.880000000000001 110.809 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.69 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 7.5300000000000002 110.135 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 332' ' ' VAL . 83.8 mt -58.16 -50.92 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.833 -0.621 . . . . 6.5800000000000001 110.77 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.09 71.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.924 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.6 4.06 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.531 -0.842 . . . . 7.7699999999999996 112.965 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 282' ' ' PHE . 96.2 mt -72.54 -40.38 66.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.031 0.382 . . . . 6.5199999999999996 112.031 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.39 113.54 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 6.6100000000000003 110.254 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 119.75 -12.4 10.91 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.963 -0.637 . . . . 6.7699999999999996 112.036 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 62.9 mtt -75.15 -171.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.732 0.301 . . . . 7.6900000000000004 110.474 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -146.35 123.19 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.764 0.316 . . . . 8.2400000000000002 110.686 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.483 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.2 OUTLIER -106.92 112.06 24.84 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.591 -0.892 . . . . 7.0300000000000002 108.591 176.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.56 -104.66 1.42 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.745 -0.741 . . . . 8.25 111.542 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.54 0.5 11.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.721 0.296 . . . . 8.9800000000000004 111.068 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -112.52 138.96 48.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 7.4299999999999997 110.945 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.38 138.66 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 7.4500000000000002 110.4 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.417 ' HG ' HG21 ' A' ' 332' ' ' VAL . 55.0 tp -90.98 108.0 19.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.702 -0.681 . . . . 5.8399999999999999 110.477 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.77 105.53 15.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.212 -0.449 . . . . 5.8099999999999996 109.94 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.437 ' O ' HG21 ' A' ' 317' ' ' ILE . 73.8 t -109.71 123.74 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.126 -0.488 . . . . 5.21 110.676 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.445 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 14.1 pt20 -133.79 -169.45 2.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 6.1699999999999999 109.354 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 337' ' ' VAL . 74.4 ttt180 -105.65 143.86 33.22 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 7.7999999999999998 109.44 174.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.56 77.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.566 0.222 . . . . 6.04 110.999 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -71.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 7.7000000000000002 110.589 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 334' ' ' ARG . 9.3 m -131.17 114.6 26.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.348 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -156.62 46.08 0.5 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.123 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -120.82 90.55 3.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.981 0.42 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -89.51 103.58 16.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.955 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -131.05 125.8 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.091 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.289 0 O-C-N 123.638 0.586 . . . . 0.0 111.226 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -117.74 -19.81 9.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 70.4 mtt180 -112.07 146.39 38.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.774 0.321 . . . . 6.9800000000000004 110.807 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 208' ' ' THR . 84.7 mt -119.46 150.0 40.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.722 -0.672 . . . . 5.6100000000000003 110.111 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -99.42 109.72 22.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 6.2599999999999998 109.607 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.4 p -109.05 124.76 65.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.329 0.585 . . . . 4.25 110.582 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.27 -178.77 15.47 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.485 -0.779 . . . . 5.3099999999999996 111.687 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 62.03 33.0 17.47 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.409 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.448 HG23 HD23 ' A' ' 224' ' ' LEU . 34.4 pt -80.4 156.65 73.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.481 -0.781 . . . . 5.6100000000000003 110.877 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.51 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 42.2 Cg_endo -69.49 124.62 11.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.47 2.113 . . . . 6.1600000000000001 112.399 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -68.35 112.25 5.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.197 -0.668 . . . . 8.8200000000000003 109.197 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.87 -2.27 8.54 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.628 -0.796 . . . . 7.3300000000000001 112.006 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 10.9 tp -88.31 146.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.92 -0.4 . . . . 6.0999999999999996 109.92 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.9 p -102.76 163.97 11.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.869 0.366 . . . . 7.0 111.314 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.719 ' HA ' HD13 ' A' ' 191' ' ' ILE . 33.2 mt-10 -63.93 -41.02 97.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.655 . . . . 5.6900000000000004 110.69 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -58.39 -47.17 84.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.372 -0.831 . . . . 7.29 110.748 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.43 91.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.5 ttm -71.78 -36.35 70.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 4.5700000000000003 110.652 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.406 ' HB2' HG12 ' A' ' 189' ' ' VAL . 1.6 tmt? -61.0 -50.32 73.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.534 . . . . 6.1100000000000003 109.721 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.42 -41.22 98.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.905 -0.589 . . . . 6.5099999999999998 111.351 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.61 -53.02 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.933 0.346 . . . . 5.8700000000000001 111.933 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.659 0.266 . . . . 5.0300000000000002 111.401 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.14 -37.0 78.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.73 0.3 . . . . 6.2999999999999998 110.865 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.26 83.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.406 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -61.59 -37.17 82.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 6.3200000000000003 111.264 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.542 ' HG3' ' HG2' ' A' ' 185' ' ' PRO . 19.1 mmt -63.9 -45.34 89.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.428 -0.351 . . . . 7.0300000000000002 111.009 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.2 -46.18 61.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 9.3100000000000005 111.221 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.81 -35.27 74.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 8.9600000000000009 111.374 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.01 58.93 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.547 -0.835 . . . . 8.1099999999999994 111.844 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.12 39.14 13.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.881 -0.676 . . . . 8.7200000000000006 112.193 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.85 -0.77 39.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 7.7199999999999998 110.192 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 p -70.24 130.27 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 8.7300000000000004 111.062 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 206' ' ' ASP . 3.9 pt20 -84.69 -14.51 48.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.216 0.531 . . . . 9.8900000000000006 110.236 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.03 29.92 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 9.9700000000000006 109.871 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.45 111.51 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.465 2.11 . . . . 11.119999999999999 111.548 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.92 -148.18 15.85 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.878 -0.677 . . . . 9.0600000000000005 112.059 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -126.39 112.26 23.38 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.689 0.28 . . . . 7.7400000000000002 110.857 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.542 ' HG2' ' HG3' ' A' ' 173' ' ' MET . 50.6 Cg_exo -55.48 -45.8 37.06 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.124 2.549 . . . . 6.6699999999999999 112.433 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.02 107.2 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.562 -0.533 . . . . 5.4699999999999998 109.562 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.5 tp -90.98 -61.63 1.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.354 -175.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 201' ' ' GLU . . . -113.73 137.85 51.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.611 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 166' ' ' MET . 7.3 p -125.81 132.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.108 0.48 . . . . 4.7699999999999996 111.365 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -132.86 114.55 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 6.6500000000000004 109.87 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.719 HD13 ' HA ' ' A' ' 162' ' ' GLU . 46.9 mt -114.43 125.39 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 5.8499999999999996 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -105.2 98.15 7.9 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.061 -0.718 . . . . 7.7599999999999998 109.061 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.19 -19.49 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.697 . . . . 7.6100000000000003 110.338 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -58.4 -60.22 4.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 9.1199999999999992 111.605 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.502 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 41.9 mmtm -98.59 4.7 48.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.571 -0.286 . . . . 9.2799999999999994 111.291 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.34 57.17 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.468 0.651 . . . . 6.9299999999999997 111.36 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 50.8 p90 -149.21 152.69 36.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 7.1100000000000003 109.795 173.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.523 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -141.71 157.34 45.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.967 0.413 . . . . 4.6600000000000001 111.143 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.49 121.68 36.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 6.5899999999999999 110.233 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 82.5 mt -104.18 116.96 33.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.976 -0.556 . . . . 4.7699999999999996 109.769 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 35.0 tt0 -97.49 111.77 23.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 6.5499999999999998 109.756 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -88.5 159.13 18.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.554 . . . . 6.5099999999999998 111.192 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 185' ' ' PRO . 39.0 ptt180 -70.96 -24.14 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.385 -0.825 . . . . 8.5399999999999991 111.278 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 60.1 p -125.84 -165.3 1.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.253 -0.43 . . . . 8.3000000000000007 110.863 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.51 -36.53 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.434 0.635 . . . . 9.0099999999999998 109.423 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.416 ' HB3' ' NE2' ' A' ' 180' ' ' GLN . 17.6 t70 -61.51 -53.07 61.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 8.7799999999999994 111.312 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -64.43 -36.9 85.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 7.4800000000000004 110.282 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.497 ' O ' HD12 ' A' ' 151' ' ' LEU . 9.8 m -54.26 -52.71 60.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.282 0.563 . . . . 6.3899999999999997 110.501 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -28.8 69.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.489 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.58 -29.86 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 7.9400000000000004 109.967 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -68.1 -13.81 62.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 5.5 111.248 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 81.4 mtp -70.37 -14.87 62.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 6.46 110.374 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.14 -5.36 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 6.3600000000000003 110.596 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.412 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 94.3 m-85 -97.11 3.78 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 5.9299999999999997 110.711 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.45 123.15 16.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 5.9199999999999999 110.581 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.35 53.17 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.86 -0.685 . . . . 5.7400000000000002 112.112 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.5 tt -72.75 142.51 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.328 . . . . 5.6299999999999999 110.262 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.7 tp -84.63 113.16 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.356 0.598 . . . . 7.2300000000000004 110.407 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -134.55 114.93 13.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 5.79 110.533 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 61.98 26.6 16.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.796 -0.638 . . . . 7.3200000000000003 111.22 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 86.69 5.38 81.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.88 -0.676 . . . . 7.5899999999999999 112.737 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.51 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.4 mm-40 -115.53 150.69 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.778 0.323 . . . . 7.5300000000000002 110.701 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -97.78 103.51 15.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.488 -0.56 . . . . 6.4500000000000002 109.488 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 156' ' ' ILE . 70.6 mt -69.79 114.42 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 4.9000000000000004 111.503 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 76.6 tttt -83.57 114.51 21.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.588 -0.733 . . . . 7.5700000000000003 109.709 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.14 105.69 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.831 0.348 . . . . 5.3700000000000001 110.442 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -132.7 168.36 18.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.24 -0.436 . . . . 7.1900000000000004 110.684 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.67 129.88 78.06 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.346 -0.388 . . . . 7.7599999999999998 110.4 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 31.9 Cg_exo -58.63 130.76 38.68 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.973 2.448 . . . . 7.9800000000000004 112.052 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.55 -74.45 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.882 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -159.36 111.09 2.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.918 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -123.64 91.41 3.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.432 0.634 . . . . 0.0 110.047 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -109.95 138.63 20.8 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.773 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.5 112.38 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.996 2.464 . . . . 0.0 112.1 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.2 tp -130.29 94.27 30.67 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.029 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.03 99.58 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.775 2.317 . . . . 0.0 111.674 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -100.89 139.28 14.32 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.779 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 51.1 mtt -87.77 91.85 8.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.048 0.451 . . . . 0.0 110.512 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 26.4 t -77.21 -35.43 55.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -95.1 100.76 12.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.203 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.482 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 13.2 m120 -89.93 -48.24 0.39 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.834 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 24.1 Cg_exo -64.63 119.57 6.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.89 1.727 . . . . 0.0 111.979 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.5 t 61.31 78.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.309 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.05 115.21 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -126.78 150.83 48.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.923 0.392 . . . . 0.0 110.782 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.85 113.7 16.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.865 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.85 -44.58 43.57 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.709 2.273 . . . . 0.0 111.781 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.31 116.93 4.0 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.609 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.78 115.02 16.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.463 0.649 . . . . 0.0 110.736 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.0 105.62 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.55 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 43.1 t -115.19 100.92 8.5 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.6 p -85.2 5.7 29.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.698 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.829 HG12 ' HB2' ' A' ' 334' ' ' ARG . 86.9 t -65.58 -57.94 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.355 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 55.6 t 63.18 86.77 0.14 Allowed Pre-proline 0 C--N 1.331 -0.221 0 O-C-N 123.761 0.663 . . . . 0.0 110.343 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.501 ' HA ' ' CB ' ' A' ' 336' ' ' SER . 73.7 Cg_endo -93.15 143.96 2.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.072 2.514 . . . . 0.0 112.783 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.41 -171.14 2.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.2 t -77.52 79.28 4.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 109.753 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -169.17 -45.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.61 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.0 m80 66.33 28.81 9.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.445 -0.798 . . . . 9.1300000000000008 110.512 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 37.5 ttmt -66.26 138.52 57.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.52 -0.763 . . . . 6.3600000000000003 110.767 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 307' ' ' TYR . 79.7 mt -104.63 141.72 35.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.561 . . . . 5.5899999999999999 111.007 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.656 ' HB2' ' HB3' ' A' ' 335' ' ' ALA . 87.7 t80 -96.91 119.04 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.297 -0.865 . . . . 5.0300000000000002 109.152 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.713 HG21 HD12 ' A' ' 330' ' ' LEU . 3.7 mp -108.46 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 4.21 109.837 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.4 134.79 8.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 4.5800000000000001 112.374 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 123.8 25.69 1.69 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.903 -0.665 . . . . 5.6299999999999999 111.949 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.459 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 84.8 mt -102.46 138.97 19.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.429 -0.211 . . . . 5.9199999999999999 110.429 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.557 ' HB2' HD11 ' A' ' 270' ' ' LEU . 41.8 Cg_exo -58.12 147.95 80.47 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.611 2.207 . . . . 7.3099999999999996 111.483 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 6.4 p30 -73.59 -13.54 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.093 0.405 . . . . 8.8100000000000005 112.093 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -90.05 0.61 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.632 -0.427 . . . . 9.0700000000000003 111.079 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 267' ' ' PRO . 8.0 mp -80.88 117.39 21.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.89 0.376 . . . . 7.7199999999999998 110.196 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -85.65 174.76 9.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 8.8000000000000007 110.904 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.33 -37.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.708 . . . . 7.8899999999999997 112.198 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -53.96 18.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.771 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.12 -39.67 93.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.591 0.234 . . . . 8.7300000000000004 111.14 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' A' ' 279' ' ' LEU . 94.9 t -62.16 -48.98 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 6.7300000000000004 110.443 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -56.39 -53.08 61.59 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.519 -0.309 . . . . 8.1199999999999992 111.047 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.67 -52.5 55.57 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.571 0.544 . . . . 9.3800000000000008 111.809 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 7.2300000000000004 110.526 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.52 HD23 HD11 ' A' ' 320' ' ' LEU . 64.3 mt -75.69 -32.86 60.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.434 -0.348 . . . . 6.8899999999999997 111.433 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 16.2 m -74.18 -16.68 60.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.02 0.438 . . . . 9.2400000000000002 110.816 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 41.2 m -61.53 -14.99 34.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.632 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.12 16.43 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 9.1799999999999997 111.009 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.57 143.94 3.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.55 -0.833 . . . . 9.5600000000000005 112.547 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.512 ' HG2' ' HB ' ' A' ' 308' ' ' VAL . 58.3 Cg_endo -71.9 140.48 35.16 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.693 2.262 . . . . 10.51 112.809 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 305' ' ' CYS . 97.3 mt -98.15 126.45 43.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 8.3000000000000007 111.106 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -94.32 -18.34 21.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.328 0.585 . . . . 8.9399999999999995 109.846 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -147.23 134.23 20.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.083 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.414 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 82.7 t80 -145.56 124.71 12.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.063 -0.517 . . . . 6.4900000000000002 110.625 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.53 108.66 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.541 0.686 . . . . 6.0300000000000002 110.347 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.694 HD13 ' HB3' ' A' ' 303' ' ' ALA . 55.0 tp -79.54 128.35 33.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.242 -0.89 . . . . 6.5300000000000002 109.112 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 303' ' ' ALA . 42.2 t -77.31 111.69 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.059 0.456 . . . . 6.8700000000000001 109.813 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -107.35 148.9 28.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 8.2100000000000009 110.498 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.05 136.94 38.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.495 . . . . 10.33 109.738 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 44.0 m -70.07 -28.46 65.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.794 0.294 . . . . 10.93 111.794 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.56 -48.6 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.734 0.302 . . . . 12.34 111.183 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.7 m -75.34 -49.08 20.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.403 -0.362 . . . . 11.460000000000001 111.353 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 101.51 -26.69 23.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.842 -0.694 . . . . 10.210000000000001 111.965 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.12 173.41 10.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 10.4 111.128 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.567 ' HG ' HD12 ' A' ' 290' ' ' LEU . 46.7 t -69.84 148.46 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 7.8700000000000001 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.79 -1.01 55.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 8.4100000000000001 110.163 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 105.13 -3.42 40.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.851 -0.69 . . . . 6.0899999999999999 112.478 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -147.62 161.16 41.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 6.7599999999999998 111.33 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.694 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -152.38 164.53 37.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 4.6399999999999997 110.459 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -112.46 130.73 55.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.477 -0.564 . . . . 5.1900000000000004 109.477 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.414 ' SG ' ' HD1' ' A' ' 288' ' ' PHE . 47.8 m -138.68 137.88 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.374 -0.375 . . . . 5.0899999999999999 110.572 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.14 134.1 55.34 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.461 -0.57 . . . . 7.0300000000000002 109.461 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.554 ' CE1' HD13 ' A' ' 261' ' ' LEU . 20.0 m-85 -91.78 152.32 20.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.004 0.431 . . . . 7.8899999999999997 111.59 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.512 ' HB ' ' HG2' ' A' ' 284' ' ' PRO . 92.0 t -66.84 -43.49 89.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.563 -0.744 . . . . 10.42 111.284 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.67 157.32 18.19 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.912 -0.403 . . . . 10.81 109.912 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.703 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.85 -19.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.988 0.366 . . . . 10.039999999999999 111.988 -175.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -77.3 -37.88 51.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.354 0.597 . . . . 10.98 109.493 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 24.6 m -65.83 -22.04 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.105 -0.952 . . . . 9.9100000000000001 111.178 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.546 ' O ' HG13 ' A' ' 317' ' ' ILE . 9.5 m -55.25 -50.03 70.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.681 -0.236 . . . . 8.0600000000000005 111.407 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.64 -37.87 76.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.981 0.419 . . . . 8.9399999999999995 110.851 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -64.11 -38.77 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.677 -0.692 . . . . 10.880000000000001 110.249 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.38 86.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.533 -0.758 . . . . 7.5300000000000002 110.811 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 313' ' ' THR . 85.1 mt -58.82 -45.66 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 6.5800000000000001 110.734 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.66 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.32 -53.04 4.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.88 -0.676 . . . . 7.7699999999999996 113.075 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.52 HD11 HD23 ' A' ' 279' ' ' LEU . 75.5 mt -67.9 -52.75 32.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.754 0.312 . . . . 6.5199999999999996 111.702 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 44.2 t30 -63.18 114.96 4.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 6.6100000000000003 110.652 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -26.18 6.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.709 -0.758 . . . . 6.7699999999999996 112.385 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.2 mtt -74.91 168.35 20.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.435 -0.209 . . . . 7.6900000000000004 110.435 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.408 ' HG2' ' HA ' ' A' ' 329' ' ' LYS . 55.1 mt-30 -125.12 131.06 53.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.969 0.414 . . . . 8.2400000000000002 110.588 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -109.8 121.92 46.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.33 -0.619 . . . . 7.0300000000000002 109.33 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 69.36 -96.63 0.49 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.737 -0.744 . . . . 8.25 111.34 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.95 7.81 3.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 8.9800000000000004 110.484 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.47 143.81 45.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.994 0.426 . . . . 7.4299999999999997 111.0 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.408 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 87.9 tttt -84.61 136.67 33.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 7.4500000000000002 110.137 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.713 HD12 HG21 ' A' ' 263' ' ' ILE . 44.3 tp -93.88 124.47 37.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 5.8399999999999999 110.984 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.418 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 6.8 mp -115.07 124.16 50.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.624 . . . . 5.8099999999999996 109.557 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.15 131.14 71.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 5.21 110.363 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -156.74 161.43 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 6.1699999999999999 109.843 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.829 ' HB2' HG12 ' A' ' 253' ' ' VAL . 64.7 mtt85 -64.45 133.19 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.842 0.353 . . . . 7.7999999999999998 110.651 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 262' ' ' PHE . . . -110.3 106.69 16.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 6.04 110.646 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 255' ' ' PRO . 53.0 m -154.73 -56.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.476 -0.329 . . . . 7.7000000000000002 111.398 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 95.5 t 72.47 -60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.929 0.492 . . . . 0.0 111.15 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 120.35 -174.97 15.84 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.805 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -70.27 -27.32 64.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.611 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.54 162.34 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.242 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -116.64 127.32 54.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.667 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.622 0.249 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -107.94 -6.13 16.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.604 0.24 . . . . 0.0 111.327 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -114.06 138.75 49.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 6.9800000000000004 110.922 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 208' ' ' THR . 51.2 mt -116.02 152.08 34.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.909 -0.587 . . . . 5.6100000000000003 110.43 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -106.08 111.23 23.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 6.2599999999999998 109.698 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.5 p -109.15 131.0 61.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.143 0.497 . . . . 4.25 110.091 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.41 173.26 18.63 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.776 -0.647 . . . . 5.3099999999999996 111.941 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 t30 62.77 68.84 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.459 0.647 . . . . 0.0 110.129 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.676 HG23 HD23 ' A' ' 224' ' ' LEU . 37.6 pt -117.63 160.87 36.54 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.392 -0.822 . . . . 5.6100000000000003 110.29 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.678 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 21.1 Cg_endo -61.92 142.44 93.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.61 2.207 . . . . 6.1600000000000001 112.441 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -79.56 109.81 14.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 8.8200000000000003 110.266 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 96.48 36.88 4.97 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.795 -0.717 . . . . 7.3300000000000001 111.708 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.678 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 5.7 tp -78.71 132.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.125 0.488 . . . . 6.0999999999999996 111.086 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.461 ' HB ' ' HB1' ' A' ' 164' ' ' ALA . 17.2 m -64.51 116.15 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 7.0 109.754 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.5 ' HG2' HD13 ' A' ' 191' ' ' ILE . 41.2 mt-10 -57.38 -47.13 82.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 5.6900000000000004 110.9 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.43 -43.26 93.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.592 -0.731 . . . . 7.29 110.668 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 161' ' ' THR . . . -72.57 -37.63 68.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.204 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.771 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.7 tpt -60.7 -47.37 86.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.957 0.408 . . . . 4.5700000000000003 110.338 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.61 -41.52 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 6.1100000000000003 110.307 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.11 -49.18 78.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.804 -0.635 . . . . 6.5099999999999998 111.104 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.1 -47.33 85.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 5.8700000000000001 111.133 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 211' ' ' ALA . 66.5 t80 -62.49 -49.3 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 5.0300000000000002 110.815 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 78.7 m-20 -61.43 -37.22 82.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.418 -0.355 . . . . 6.2999999999999998 110.838 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.08 -45.4 88.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.94 -30.03 71.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.391 -0.368 . . . . 6.3200000000000003 111.41 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 214' ' ' PHE . 76.1 mtp -69.01 -45.02 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 7.0300000000000002 110.171 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 50.9 mtt180 -65.25 -48.3 73.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 9.3100000000000005 110.76 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.09 -35.33 78.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 8.9600000000000009 110.947 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.89 -27.0 69.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.876 -0.678 . . . . 8.1099999999999994 112.075 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.65 21.58 18.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 8.7200000000000006 112.373 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.7 mp -108.42 82.12 1.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.213 0.53 . . . . 7.7199999999999998 110.359 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.577 HG21 ' HG3' ' A' ' 185' ' ' PRO . 3.2 m -157.13 106.84 2.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.242 -0.651 . . . . 8.7300000000000004 109.242 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.467 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.4 pt20 -73.18 -23.55 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.961 -0.295 . . . . 9.8900000000000006 111.666 -171.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 179' ' ' THR . . . -145.05 158.43 52.18 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.549 -0.296 . . . . 9.9700000000000006 110.583 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 151.65 66.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.419 2.08 . . . . 11.119999999999999 111.704 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.69 -168.88 20.81 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.71 -0.757 . . . . 9.0600000000000005 111.775 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 m-20 -94.98 129.17 36.49 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 110.42 -0.215 . . . . 7.7400000000000002 110.42 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.577 ' HG3' HG21 ' A' ' 179' ' ' THR . 26.7 Cg_exo -63.04 -35.76 63.53 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.594 2.196 . . . . 6.6699999999999999 111.208 176.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.6 131.48 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.4699999999999998 110.121 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.6 tp -87.71 -54.49 4.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.68 153.43 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.404 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.35 138.88 48.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.236 -0.438 . . . . 4.7699999999999996 110.958 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -119.13 105.83 11.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.302 -0.629 . . . . 6.6500000000000004 109.302 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.5 HD13 ' HG2' ' A' ' 162' ' ' GLU . 62.8 mt -109.3 125.62 66.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.129 0.49 . . . . 5.8499999999999996 111.249 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -116.2 120.21 38.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.604 -0.725 . . . . 7.7599999999999998 110.128 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.78 -23.91 23.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.136 -0.484 . . . . 7.6100000000000003 110.731 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' OD2' ' HG2' ' A' ' 195' ' ' LYS . 24.0 t70 -57.63 -56.76 17.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.834 -0.621 . . . . 9.1199999999999992 111.898 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.6 mmtm -105.29 5.24 31.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.793 0.33 . . . . 9.2799999999999994 111.095 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.35 67.46 0.84 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.528 -0.76 . . . . 6.9299999999999997 111.517 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 54.5 p90 -149.65 162.5 40.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.005 -0.543 . . . . 7.1100000000000003 109.821 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -146.68 143.75 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.082 0.468 . . . . 4.6600000000000001 111.148 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -107.52 120.58 42.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.686 -0.688 . . . . 6.5899999999999999 109.734 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.68 115.59 30.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.024 -0.535 . . . . 4.7699999999999996 109.6 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.74 121.68 42.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.071 -0.344 . . . . 6.5499999999999998 110.071 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.552 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 48.1 m-85 -99.14 164.15 12.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.144 0.497 . . . . 6.5099999999999998 110.822 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.67 -22.97 59.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.767 -0.651 . . . . 8.5399999999999991 111.326 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.8 p -142.83 147.22 35.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.632 0.254 . . . . 8.3000000000000007 110.913 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.06 -36.17 72.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.953 0.406 . . . . 9.0099999999999998 110.556 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.37 -58.24 8.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.738 -0.665 . . . . 8.7799999999999994 111.086 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.467 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 49.4 mt-10 -65.4 -34.25 77.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 7.4800000000000004 110.871 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.552 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 81.5 m -53.49 -52.6 59.02 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.22 0.533 . . . . 6.3899999999999997 110.212 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 m -63.87 -30.97 72.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.947 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -29.57 62.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.979 0.419 . . . . 7.9400000000000004 110.361 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 169' ' ' PHE . . . -72.21 -10.11 59.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.529 . . . . 5.5 111.535 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.3 mtp -68.02 -20.32 64.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 6.46 110.455 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.3 -1.82 28.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 6.3600000000000003 111.653 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 173' ' ' MET . 94.9 m-85 -97.41 3.33 50.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.739 0.304 . . . . 5.9299999999999997 110.842 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -57.24 129.66 42.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.055 -0.521 . . . . 5.9199999999999999 110.914 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.31 25.88 27.28 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.936 -0.649 . . . . 5.7400000000000002 112.111 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.8 tt -80.8 132.39 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.813 0.34 . . . . 5.6299999999999999 110.146 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.01 111.23 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.542 0.687 . . . . 7.2300000000000004 111.179 -176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.499 ' HE2' HD11 ' A' ' 160' ' ' ILE . 88.9 t80 -136.07 122.09 20.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.561 -0.745 . . . . 5.79 110.182 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 57.32 33.66 23.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.851 0.358 . . . . 7.3200000000000003 111.836 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.15 6.47 86.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.919 -0.657 . . . . 7.5899999999999999 112.606 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.62 131.85 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.718 0.294 . . . . 7.5300000000000002 110.479 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.6 m -86.08 102.64 14.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.499 -0.556 . . . . 6.4500000000000002 109.499 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.676 HD23 HG23 ' A' ' 156' ' ' ILE . 56.7 mt -66.62 115.52 6.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.9000000000000004 110.344 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.3 tttt -90.18 114.7 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.941 -0.572 . . . . 7.5700000000000003 109.739 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.84 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.421 -0.354 . . . . 5.3700000000000001 110.207 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -128.25 169.46 14.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.205 -0.452 . . . . 7.1900000000000004 110.786 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -79.78 127.14 78.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.311 -0.404 . . . . 7.7599999999999998 109.99 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.04 113.7 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.488 2.125 . . . . 7.9800000000000004 110.863 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -73.65 165.99 24.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.849 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -83.56 76.73 9.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.392 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -84.5 131.01 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.733 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 60.97 77.44 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 123.775 0.672 . . . . 0.0 110.095 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.19 124.36 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.254 2.636 . . . . 0.0 112.567 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.89 140.35 15.56 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.798 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.65 135.73 54.32 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.35 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -100.13 -116.58 3.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.419 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 55.9 mtt 61.59 38.99 15.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.768 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 34.1 m -81.97 31.54 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.508 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -129.18 116.0 18.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.859 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -111.22 141.93 25.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.94 17.43 1.31 Allowed 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.709 2.272 . . . . 0.0 113.493 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 9.2 t -115.9 20.53 14.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.406 0.622 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.7 m -72.23 132.27 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.225 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -109.07 121.59 45.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.746 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.31 117.49 53.02 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 249' ' ' VAL . 24.4 Cg_exo -65.22 -24.65 58.29 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.615 2.21 . . . . 0.0 111.45 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 77.71 26.08 61.48 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.265 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.649 HG23 ' HB2' ' A' ' 247' ' ' PRO . 22.4 m -126.42 125.02 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -97.93 -34.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.0 109.497 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.0 m -146.04 -170.33 3.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.717 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 4.5 p -59.48 -36.97 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.724 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.3 158.03 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 62.6 t -77.38 118.69 73.67 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 5.2 Cg_exo -74.42 164.78 33.23 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.844 2.362 . . . . 0.0 111.635 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.9 -64.3 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.472 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.2 m 55.46 28.85 12.24 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.193 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.82 127.43 32.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -83.17 -2.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.521 . . . . 9.1300000000000008 110.37 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 40.8 ttmt -77.25 123.62 26.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.671 -0.695 . . . . 6.3600000000000003 109.955 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.534 HD13 ' CE1' ' A' ' 307' ' ' TYR . 41.2 mt -101.64 142.68 32.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.925 -0.579 . . . . 5.5899999999999999 111.014 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -88.42 115.67 26.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.323 -0.853 . . . . 5.0300000000000002 109.221 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.27 107.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.963 -0.384 . . . . 4.21 109.963 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -110.54 171.71 14.87 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.507 -0.637 . . . . 4.5800000000000001 111.507 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.44 26.85 45.68 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 5.6299999999999999 111.694 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.11 125.95 58.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.766 0.317 . . . . 5.9199999999999999 110.587 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.662 ' HB2' HD11 ' A' ' 270' ' ' LEU . 27.1 Cg_exo -63.1 134.78 47.6 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.664 2.242 . . . . 7.3099999999999996 111.681 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -63.4 -20.66 65.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 8.8100000000000005 112.179 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -86.02 1.59 49.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.566 0.222 . . . . 9.0700000000000003 111.59 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.662 HD11 ' HB2' ' A' ' 267' ' ' PRO . 8.4 mp -91.68 144.59 25.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.132 -0.321 . . . . 7.7199999999999998 110.132 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -106.88 177.19 4.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.271 -0.422 . . . . 8.8000000000000007 110.436 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.496 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 3.8 m-20 -58.36 -38.99 78.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 7.8899999999999997 111.493 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.71 -50.87 65.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.08 -40.47 85.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.511 0.195 . . . . 8.7300000000000004 111.386 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.96 -48.46 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 6.7300000000000004 110.728 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 35.7 mtmm -59.27 -53.25 60.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.576 -0.284 . . . . 8.1199999999999992 111.193 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.27 -43.15 82.83 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.827 0.346 . . . . 9.3800000000000008 111.063 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.04 -53.3 58.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 7.2300000000000004 110.201 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.34 -36.11 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 6.8899999999999997 111.414 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.6 m -63.21 -32.23 73.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 9.2400000000000002 111.291 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 32.2 m -65.62 -14.08 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.8 8.32 13.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 9.1799999999999997 110.388 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.91 125.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.745 -0.661 . . . . 9.5600000000000005 111.91 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.419 ' HA ' HG21 ' A' ' 280' ' ' THR . 35.9 Cg_endo -64.89 139.13 60.75 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.63 2.22 . . . . 10.51 112.712 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 70.6 mt -100.59 133.0 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 8.3000000000000007 110.329 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.658 ' HB3' HG23 ' A' ' 308' ' ' VAL . 19.6 ptpt -95.83 -18.39 20.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.808 -0.442 . . . . 8.9399999999999995 109.808 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -149.18 139.79 22.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.182 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -140.41 130.31 24.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.228 -0.442 . . . . 6.4900000000000002 110.535 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.59 118.57 11.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 6.0300000000000002 110.083 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.666 HD13 ' HB3' ' A' ' 303' ' ' ALA . 60.4 tp -95.66 128.41 42.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 6.5300000000000002 109.797 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.477 HG22 ' CE2' ' A' ' 302' ' ' TYR . 58.9 t -76.21 113.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 6.8700000000000001 109.992 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.496 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 45.2 mttm -114.63 161.69 17.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.787 -0.642 . . . . 8.2100000000000009 111.13 -172.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.993 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 31.2 t70 -126.46 122.82 36.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.023 -0.535 . . . . 10.33 109.872 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.4 m -65.39 -38.7 90.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.151 0.426 . . . . 10.93 112.151 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.57 82.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.985 0.422 . . . . 12.34 111.311 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.9 m -81.12 -35.92 30.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.195 -0.457 . . . . 11.460000000000001 111.12 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.12 10.05 81.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.035 -0.602 . . . . 10.210000000000001 111.983 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.94 175.32 8.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.798 0.332 . . . . 10.4 110.549 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.641 ' HG ' HD12 ' A' ' 290' ' ' LEU . 43.5 t -71.99 156.42 39.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.89 -0.596 . . . . 7.8700000000000001 110.054 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.993 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.3 mmmp? -86.33 1.74 49.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.388 -0.369 . . . . 8.4100000000000001 110.635 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.65 44.64 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.583 -0.817 . . . . 6.0899999999999999 113.439 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.477 ' CE2' HG22 ' A' ' 291' ' ' VAL . 48.6 p90 -157.4 162.12 39.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.194 0.521 . . . . 6.7599999999999998 111.57 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.666 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -148.61 170.09 18.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.438 -0.801 . . . . 4.6399999999999997 110.623 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.566 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.4 m-85 -120.31 127.48 52.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.314 -0.624 . . . . 5.1900000000000004 109.314 175.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 25.9 m -135.04 113.47 11.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.499 -0.319 . . . . 5.0899999999999999 111.125 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 27.2 tt0 -88.3 123.53 32.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.913 0.387 . . . . 7.0300000000000002 110.201 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.534 ' CE1' HD13 ' A' ' 261' ' ' LEU . 13.5 m-85 -80.23 156.76 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.815 -0.629 . . . . 7.8899999999999997 111.426 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 286' ' ' LYS . 96.8 t -81.45 -55.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 10.42 110.684 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.691 ' HB3' HG23 ' A' ' 312' ' ' VAL . 13.1 t70 -82.12 129.46 34.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 10.81 109.971 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.739 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -87.92 0.84 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.252 0.464 . . . . 10.039999999999999 112.252 -173.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -103.51 -35.94 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 10.98 110.227 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 309' ' ' ASP . 27.5 m -72.46 -20.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 9.9100000000000001 111.216 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.497 ' O ' HG13 ' A' ' 317' ' ' ILE . 11.5 m -54.67 -51.55 65.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.394 -0.366 . . . . 8.0600000000000005 111.961 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -71.24 -24.45 62.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 8.9399999999999995 110.795 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.94 -45.16 52.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 10.880000000000001 109.685 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.679 -0.692 . . . . 7.5300000000000002 110.117 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 313' ' ' THR . 75.4 mt -57.61 -52.98 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 6.5800000000000001 110.559 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.36 93.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.647 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -76.6 -43.33 19.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.639 -0.791 . . . . 7.7699999999999996 113.182 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.615 ' HB3' HD21 ' A' ' 330' ' ' LEU . 96.3 mt -82.45 -40.91 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.277 0.473 . . . . 6.5199999999999996 112.277 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -62.84 115.85 4.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.776 0.322 . . . . 6.6100000000000003 110.643 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.71 -23.85 20.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.961 -0.638 . . . . 6.7699999999999996 111.89 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 24.9 ttt -78.78 137.79 37.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 7.6900000000000004 109.741 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -88.04 129.39 35.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.087 0.47 . . . . 8.2400000000000002 111.077 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.85 104.01 15.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.534 -0.913 . . . . 7.0300000000000002 108.534 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.44 -74.72 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.037 -0.825 . . . . 8.25 111.037 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.19 5.99 0.15 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.988 0.423 . . . . 8.9800000000000004 110.088 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.49 ' HD3' ' HG3' ' A' ' 267' ' ' PRO . 12.6 mptt -101.92 129.64 48.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.593 -0.521 . . . . 7.4299999999999997 109.593 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.64 118.02 15.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.802 0.334 . . . . 7.4500000000000002 110.471 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 320' ' ' LEU . 19.0 tp -74.53 115.71 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.914 -0.584 . . . . 5.8399999999999999 109.865 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 4.9 tt -98.47 110.68 23.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.928 -0.768 . . . . 5.8099999999999996 108.928 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.441 HG13 HG12 ' A' ' 317' ' ' ILE . 49.1 t -120.77 127.53 75.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.028 0.442 . . . . 5.21 110.864 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -162.08 -178.29 6.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.6 -0.727 . . . . 6.1699999999999999 109.077 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -73.69 145.03 45.54 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.821 -0.352 . . . . 7.7999999999999998 110.138 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.11 83.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.414 -0.357 . . . . 6.04 111.558 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 33.1 m -106.27 -36.47 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.491 -0.322 . . . . 7.7000000000000002 110.993 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.5 t 72.24 -57.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.289 0.636 . . . . 0.0 111.571 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.27 26.47 1.2 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.385 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -111.58 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -110.03 119.21 38.59 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -109.3 121.57 45.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 178.296 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.557 0.218 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.458 ' HB2' ' HG3' ' A' ' 201' ' ' GLU . 68.9 mtm180 -112.61 18.69 18.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.739 0.304 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.554 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 83.4 mtt180 -111.23 146.19 37.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.057 0.456 . . . . 6.9800000000000004 112.113 -173.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.31 154.85 31.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 5.6100000000000003 109.661 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -100.05 109.99 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.206 -0.452 . . . . 6.2599999999999998 109.969 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG11 ' HB1' ' A' ' 198' ' ' ALA . 7.2 p -109.01 133.31 54.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.131 0.491 . . . . 4.25 110.453 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.31 -179.31 17.38 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.782 -0.645 . . . . 5.3099999999999996 111.803 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.0 t30 58.24 65.65 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.767 0.794 . . . . 0.0 109.985 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.471 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 29.6 pt -115.68 157.69 43.8 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.989 -1.005 . . . . 5.6100000000000003 110.226 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.688 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 36.2 Cg_endo -65.67 131.13 26.71 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.484 2.123 . . . . 6.1600000000000001 112.559 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -72.03 96.22 1.71 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.299 0.571 . . . . 8.8200000000000003 109.888 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 141.59 -10.15 2.65 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.524 -0.762 . . . . 7.3300000000000001 111.517 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.688 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.1 tp -66.94 136.18 27.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.911 0.386 . . . . 6.0999999999999996 110.857 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.8 p -89.93 153.26 20.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.099 -0.5 . . . . 7.0 109.703 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.958 ' HA ' HD13 ' A' ' 191' ' ' ILE . 43.4 mt-10 -61.81 -40.67 96.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.782 0.325 . . . . 5.6900000000000004 110.904 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.4 -48.89 73.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.982 -0.554 . . . . 7.29 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.09 86.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.851 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.3 tpt -65.86 -46.68 77.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.234 -0.439 . . . . 4.5700000000000003 110.23 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 23.1 ttt -61.07 -45.75 93.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 6.1100000000000003 110.609 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.38 -41.97 81.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 6.5099999999999998 111.048 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.64 -49.38 76.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 5.8700000000000001 111.009 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.463 ' HE1' HD12 ' A' ' 226' ' ' ILE . 47.8 m-85 -61.19 -45.37 94.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.671 -0.24 . . . . 5.0300000000000002 111.068 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 95.3 m-20 -57.09 -44.92 83.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 6.2999999999999998 110.407 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -48.64 78.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.174 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.57 -43.49 98.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 6.3200000000000003 111.229 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.34 -34.84 78.89 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.939 -0.304 . . . . 7.0300000000000002 110.644 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 95.0 mtt180 -64.31 -52.06 60.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.368 . . . . 9.3100000000000005 110.787 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.93 -36.09 69.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.223 -0.444 . . . . 8.9600000000000009 111.266 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.46 -30.85 68.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.955 -0.64 . . . . 8.1099999999999994 112.043 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.08 36.89 26.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.932 -0.651 . . . . 8.7200000000000006 112.75 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 8.3 mp -101.68 21.42 14.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.185 0.517 . . . . 7.7199999999999998 110.504 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.1 p -102.93 171.46 7.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.848 -0.615 . . . . 8.7300000000000004 110.381 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.451 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -110.79 -1.09 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.935 0.398 . . . . 9.8900000000000006 110.02 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.3 162.71 15.58 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.726 -0.67 . . . . 9.9700000000000006 110.141 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 170.88 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.503 2.135 . . . . 11.119999999999999 111.546 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.73 -153.85 17.87 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.437 -0.887 . . . . 9.0600000000000005 112.764 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -106.93 114.74 61.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.693 0.282 . . . . 7.7400000000000002 110.794 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.407 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 36.6 Cg_exo -60.74 -42.84 35.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.981 2.454 . . . . 6.6699999999999999 112.366 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.06 131.59 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.057 -0.349 . . . . 5.4699999999999998 110.057 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 203' ' ' ARG . 36.1 tp -109.49 -39.01 5.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.723 ' HB2' HG12 ' A' ' 312' ' ' VAL . . . -137.19 131.5 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.57 122.34 64.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.231 0.538 . . . . 4.7699999999999996 111.426 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.38 106.2 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.873 -0.603 . . . . 6.6500000000000004 109.568 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.958 HD13 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -112.53 134.35 55.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.754 0.312 . . . . 5.8499999999999996 111.049 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -114.98 104.38 11.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.634 -0.506 . . . . 7.7599999999999998 109.634 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.4 -17.78 60.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.82 -0.627 . . . . 7.6100000000000003 111.315 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.68 -53.38 22.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.56 -0.291 . . . . 9.1199999999999992 111.09 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.3 mmtm -90.25 -3.64 57.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.822 0.344 . . . . 9.2799999999999994 110.433 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 63.6 56.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.399 -0.819 . . . . 6.9299999999999997 110.841 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 22.2 p90 -148.59 162.97 38.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 7.1100000000000003 109.689 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 153' ' ' VAL . . . -151.59 148.95 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.974 0.416 . . . . 4.6600000000000001 111.357 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.4 108.38 17.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.696 -0.684 . . . . 6.5899999999999999 109.563 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 92.5 mt -97.56 116.06 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.975 -0.557 . . . . 4.7699999999999996 110.322 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.628 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 25.4 tt0 -99.22 122.02 41.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.54 -0.541 . . . . 6.5499999999999998 109.54 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.449 ' CD1' HG21 ' A' ' 208' ' ' THR . 90.1 m-85 -93.69 163.97 13.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.944 -0.571 . . . . 6.5099999999999998 110.425 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.495 ' HA ' HD23 ' A' ' 187' ' ' LEU . 38.9 ptt180 -69.16 -17.18 63.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.717 -0.674 . . . . 8.5399999999999991 111.419 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 56.2 p -135.19 -163.64 1.41 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.302 -0.408 . . . . 8.3000000000000007 110.356 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 1.043 HG12 ' HA2' ' A' ' 248' ' ' GLY . 46.5 t -123.01 -32.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.261 0.553 . . . . 9.0099999999999998 109.713 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.45 -57.75 11.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 8.7799999999999994 110.573 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 210' ' ' GLN . 38.7 mt-10 -60.13 -37.23 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 7.4800000000000004 109.921 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.449 HG21 ' CD1' ' A' ' 202' ' ' PHE . 12.0 m -54.45 -43.25 71.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 6.3899999999999997 110.806 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.4 m -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.323 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -71.99 -27.77 62.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.382 -0.372 . . . . 7.9400000000000004 110.909 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -63.65 -19.04 64.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 5.5 111.173 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.82 -19.37 62.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 6.46 111.022 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.25 -6.05 51.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 6.3600000000000003 111.306 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.63 2.12 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 5.9299999999999997 110.624 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.11 120.97 10.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 5.9199999999999999 110.441 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.11 42.09 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.682 -0.771 . . . . 5.7400000000000002 112.527 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.7 tt -63.21 136.08 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 5.6299999999999999 110.487 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -87.99 121.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.561 . . . . 7.2300000000000004 110.83 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -134.27 115.01 13.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.807 -0.633 . . . . 5.79 110.571 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 53.08 35.95 20.96 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.952 -0.567 . . . . 7.3200000000000003 112.077 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.7 2.55 75.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.819 -0.705 . . . . 7.5899999999999999 113.221 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -119.37 136.19 54.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.123 0.461 . . . . 7.5300000000000002 110.951 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.6 t -88.75 103.28 15.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.128 -0.693 . . . . 6.4500000000000002 109.128 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 156' ' ' ILE . 84.2 mt -66.34 121.99 16.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 4.9000000000000004 111.04 -174.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.542 ' HE2' ' HG3' ' A' ' 227' ' ' ARG . 87.6 tttt -96.85 115.56 27.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 7.5700000000000003 110.293 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.463 HD12 ' HE1' ' A' ' 169' ' ' PHE . 61.6 mt -115.02 107.14 22.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.921 -0.4 . . . . 5.3700000000000001 109.921 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.542 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 8.0 mmt180 -130.98 172.12 12.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.124 0.488 . . . . 7.1900000000000004 111.51 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 45.1 mtp85 -72.14 131.94 84.84 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.473 -0.785 . . . . 7.7599999999999998 110.248 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 16.9 Cg_exo -66.97 152.59 80.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 7.9800000000000004 111.361 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.17 135.22 50.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.29 135.82 25.86 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.668 0.605 . . . . 0.0 110.755 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -87.81 -56.11 3.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.961 -171.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -100.4 125.66 38.61 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.09 124.51 12.7 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.877 2.385 . . . . 0.0 112.08 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 238' ' ' MET . 80.8 mt -103.54 128.55 27.18 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 17.2 Cg_exo -67.17 107.51 1.37 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.784 2.323 . . . . 0.0 111.219 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 58.07 3.63 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.226 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.923 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -95.04 177.83 5.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.99 0.424 . . . . 0.0 111.107 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.459 ' HB2' ' HG3' ' A' ' 242' ' ' PRO . 28.9 m -150.66 141.91 23.24 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.98 -57.33 6.35 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.56 87.29 36.36 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.459 ' HG3' ' HB2' ' A' ' 239' ' ' SER . 14.3 Cg_exo -69.57 -43.22 2.95 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.843 2.362 . . . . 0.0 112.149 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.5 t -155.52 -55.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.8 m -96.61 161.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.489 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.97 -63.98 1.26 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 36.7 t -106.89 111.18 63.85 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.43 -33.7 92.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.135 2.557 . . . . 0.0 112.695 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 1.043 ' HA2' HG12 ' A' ' 205' ' ' VAL . . . 99.91 -143.01 16.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.771 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.62 76.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.152 0.501 . . . . 0.0 110.015 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.49 -6.51 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.676 0.751 . . . . 0.0 109.563 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 44.5 t -156.37 140.08 16.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.448 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.1 t -134.19 139.85 46.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.04 0.448 . . . . 0.0 110.621 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.5 t -85.41 114.68 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.661 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 23.9 m -76.37 136.76 68.17 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.528 ' HB3' HG11 ' A' ' 308' ' ' VAL . 41.8 Cg_endo -68.28 138.77 43.92 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.846 2.364 . . . . 0.0 112.954 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.412 ' CB ' HG22 ' A' ' 310' ' ' ILE . 27.8 t70 -91.39 129.92 37.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.183 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.0 p -86.09 162.54 18.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.795 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 66.05 22.12 11.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.446 0.641 . . . . 0.0 110.348 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -103.7 16.14 27.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.46 -0.791 . . . . 9.1300000000000008 109.47 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.789 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 39.7 ttmt -58.65 130.73 48.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.076 -0.966 . . . . 6.3600000000000003 111.353 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.61 HD12 HG23 ' A' ' 313' ' ' THR . 83.8 mt -108.38 143.81 36.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.759 -0.655 . . . . 5.5899999999999999 110.661 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -91.49 120.3 32.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.994 -0.548 . . . . 5.0300000000000002 110.06 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.1 106.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.287 -0.415 . . . . 4.21 109.907 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.65 154.74 16.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.845 -0.693 . . . . 4.5800000000000001 112.043 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 103.06 34.29 4.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 5.6299999999999999 112.004 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.534 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.2 mt -102.66 138.86 19.74 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.802 0.334 . . . . 5.9199999999999999 110.85 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 16.8 Cg_exo -68.87 144.53 59.2 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.955 2.437 . . . . 7.3099999999999996 111.946 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.51 -25.95 63.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 8.8100000000000005 110.852 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -87.75 0.63 55.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.22 -0.445 . . . . 9.0700000000000003 111.512 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 40.2 tp -86.79 122.59 30.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.165 -0.309 . . . . 7.7199999999999998 110.165 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.465 ' O ' HG21 ' A' ' 275' ' ' VAL . 29.7 p-10 -78.98 157.11 28.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.123 -0.49 . . . . 8.8000000000000007 111.245 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.469 ' CG ' ' HZ2' ' A' ' 292' ' ' LYS . 9.0 m-20 -59.67 -32.07 70.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.588 -0.733 . . . . 7.8899999999999997 111.569 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 -53.03 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.66 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.78 -33.54 74.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.391 -0.368 . . . . 8.7300000000000004 111.208 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 271' ' ' ASN . 20.8 t -64.79 -48.74 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.667 0.27 . . . . 6.7300000000000004 110.527 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -58.52 -47.24 84.79 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.322 -0.399 . . . . 8.1199999999999992 110.664 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.67 -47.81 83.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 9.3800000000000008 110.759 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.06 -51.03 70.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 7.2300000000000004 110.255 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.539 ' HB2' HD12 ' A' ' 285' ' ' LEU . 90.7 mt -66.87 -38.22 85.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.258 -0.428 . . . . 6.8899999999999997 111.671 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 28.6 m -69.74 -19.62 63.53 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.154 0.502 . . . . 9.2400000000000002 110.961 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.1 m -73.68 -8.03 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.119 0.485 . . . . 0.0 110.656 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.433 ' CE2' HD22 ' A' ' 320' ' ' LEU . 97.2 m-85 -121.6 14.53 11.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 9.1799999999999997 110.156 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 146.32 136.49 2.91 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.765 -0.652 . . . . 9.5600000000000005 112.058 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.475 ' HD3' ' HG ' ' A' ' 187' ' ' LEU . 24.6 Cg_endo -61.88 135.89 58.38 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.819 2.346 . . . . 10.51 112.316 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 279' ' ' LEU . 99.3 mt -100.11 137.89 37.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 110.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 308' ' ' VAL . 17.3 ptpt -98.06 -32.97 11.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.456 -0.572 . . . . 8.9399999999999995 109.456 175.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -142.56 132.87 24.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.429 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -133.0 117.57 17.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.917 -0.583 . . . . 6.4900000000000002 110.22 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -131.97 113.15 13.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.609 0.719 . . . . 6.0300000000000002 110.379 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.816 HD12 ' HG ' ' A' ' 299' ' ' SER . 62.2 tp -87.38 130.52 34.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 6.5300000000000002 109.199 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 111.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.81 -0.441 . . . . 6.8700000000000001 109.81 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.469 ' HZ2' ' CG ' ' A' ' 272' ' ' ASP . 61.6 mttm -111.06 156.6 21.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.603 -0.726 . . . . 8.2100000000000009 109.918 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.608 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 33.9 t70 -88.66 136.31 33.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.984 -0.376 . . . . 10.33 109.984 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.3 m -60.12 -38.12 82.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 10.93 112.021 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.17 -48.03 6.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.03 0.443 . . . . 12.34 111.411 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.7 m -67.68 -38.22 83.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.625 . . . . 11.460000000000001 111.001 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.67 4.97 90.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.885 -0.674 . . . . 10.210000000000001 112.321 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 61.8 mt -113.08 169.37 8.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.173 -0.306 . . . . 10.4 110.173 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.816 ' HG ' HD12 ' A' ' 290' ' ' LEU . 46.4 t -65.72 146.21 55.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.221 0.534 . . . . 7.8700000000000001 110.989 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.608 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 30.1 mmmt -87.55 3.24 48.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.813 -0.63 . . . . 8.4100000000000001 110.372 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 102.53 4.88 49.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.574 -0.822 . . . . 6.0899999999999999 113.241 174.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -152.87 156.78 39.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.987 0.422 . . . . 6.7599999999999998 111.148 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.632 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -145.46 167.03 23.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 4.6399999999999997 110.879 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.789 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 90.3 m-85 -122.54 130.02 52.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.793 -0.639 . . . . 5.1900000000000004 109.304 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.1 m -142.25 132.5 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.033 -0.267 . . . . 5.0899999999999999 110.938 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.84 132.18 54.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.853 -0.425 . . . . 7.0300000000000002 109.853 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -88.36 156.5 19.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.725 . . . . 7.8899999999999997 111.34 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 255' ' ' PRO . 79.6 t -82.18 -50.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.633 -0.712 . . . . 10.42 109.552 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.473 ' OD2' HG23 ' A' ' 312' ' ' VAL . 22.0 t70 -77.77 148.96 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 10.81 110.217 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.559 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -124.35 20.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.415 . . . . 10.039999999999999 111.233 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.11 -49.45 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.262 0.553 . . . . 10.98 109.83 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 188' ' ' ALA . 34.0 m -79.21 -20.7 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.298 -0.864 . . . . 9.9100000000000001 111.396 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.61 HG23 HD12 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -53.81 -50.24 66.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.549 0.574 . . . . 8.0600000000000005 112.549 -170.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.29 -35.77 80.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.874 0.369 . . . . 8.9399999999999995 111.188 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.87 -29.15 60.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 10.880000000000001 110.302 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.94 -39.2 76.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.185 -0.461 . . . . 7.5300000000000002 110.033 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 313' ' ' THR . 80.6 mt -57.35 -61.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 6.5800000000000001 110.443 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.64 -15.98 62.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.468 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.67 -47.46 5.63 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.023 -0.608 . . . . 7.7699999999999996 112.471 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 282' ' ' PHE . 92.8 mt -79.95 -40.03 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.589 0.233 . . . . 6.5199999999999996 111.197 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.479 ' OD1' HD13 ' A' ' 331' ' ' LEU . 8.8 t30 -62.01 115.0 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 6.6100000000000003 110.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.33 -23.63 6.04 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.672 -0.775 . . . . 6.7699999999999996 111.856 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 66.7 mtt -78.66 171.99 14.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.733 -0.469 . . . . 7.6900000000000004 109.733 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -117.63 151.75 36.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.723 0.297 . . . . 8.2400000000000002 110.51 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.61 106.73 7.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.998 -0.742 . . . . 7.0300000000000002 108.998 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.5 -94.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.721 -0.752 . . . . 8.25 111.435 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.08 -9.35 5.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 8.9800000000000004 110.404 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.15 159.28 15.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 7.4299999999999997 110.38 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -98.92 129.35 45.25 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.528 -0.545 . . . . 7.4500000000000002 109.528 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.01 115.2 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 5.8399999999999999 110.709 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.479 HD13 ' OD1' ' A' ' 321' ' ' ASN . 51.4 tp -108.6 105.79 15.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.322 -0.854 . . . . 5.8099999999999996 109.832 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.11 115.47 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.724 -0.473 . . . . 5.21 109.724 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -137.76 158.82 43.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.138 0.494 . . . . 6.1699999999999999 111.011 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.682 ' HG2' ' HA ' ' A' ' 337' ' ' VAL . 21.0 ttt180 -71.78 119.9 16.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 7.7999999999999998 109.215 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.47 -65.32 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.969 0.359 . . . . 6.04 111.969 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 39.6 m -70.56 -32.46 69.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.882 0.372 . . . . 7.7000000000000002 110.311 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.682 ' HA ' ' HG2' ' A' ' 334' ' ' ARG . 46.3 t 66.88 -78.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.773 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 76.79 -88.34 0.95 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.577 -174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -152.29 98.47 2.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.637 0.256 . . . . 0.0 110.311 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -79.45 98.63 6.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -139.5 -37.33 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.878 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.722 -179.612 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 6.5 ptp180 -101.86 -19.04 15.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.041 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.1 mtt180 -114.84 133.28 56.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.867 0.365 . . . . 6.9800000000000004 111.213 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 75.8 mt -98.98 157.8 16.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 5.6100000000000003 110.766 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.496 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 46.7 t80 -115.31 103.46 10.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 6.2599999999999998 110.075 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.7 p -103.06 130.91 52.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.181 0.515 . . . . 4.25 110.12 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.45 16.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.586 -0.734 . . . . 5.3099999999999996 111.595 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.57 55.24 4.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.693 0.759 . . . . 0.0 109.477 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.552 HG23 HD23 ' A' ' 224' ' ' LEU . 35.5 pt -101.09 147.69 34.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 5.6100000000000003 110.156 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.11 114.63 2.4 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.695 2.263 . . . . 6.1600000000000001 112.189 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.4 127.85 34.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.568 . . . . 8.8200000000000003 110.762 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.37 10.67 35.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.845 -0.693 . . . . 7.3300000000000001 111.692 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.1 tp -81.13 137.78 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 6.0999999999999996 109.912 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.3 p -87.2 144.64 26.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.407 -0.361 . . . . 7.0 110.755 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.908 ' HA ' HD13 ' A' ' 191' ' ' ILE . 43.2 mt-10 -57.71 -43.46 85.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.6900000000000004 111.45 -175.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.72 -52.46 64.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 7.29 110.74 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.64 95.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.708 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.836 ' HA ' ' HE1' ' A' ' 165' ' ' MET . 2.1 tpt -60.54 -46.8 88.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 4.5700000000000003 110.475 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.426 ' HB2' HG12 ' A' ' 189' ' ' VAL . 25.6 ttt -63.28 -47.13 83.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.129 -0.487 . . . . 6.1100000000000003 110.977 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -62.98 -32.04 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 6.5099999999999998 111.387 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.36 -49.1 76.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.565 -0.289 . . . . 5.8700000000000001 110.619 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.519 ' O ' ' HG2' ' A' ' 173' ' ' MET . 56.2 m-85 -63.1 -44.9 94.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 5.0300000000000002 110.798 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.89 -35.94 77.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.35 . . . . 6.2999999999999998 110.941 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.58 68.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.446 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.52 -31.14 71.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 6.3200000000000003 111.281 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.789 ' HA ' ' HE3' ' A' ' 173' ' ' MET . 17.9 mmt -60.95 -51.49 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 7.0300000000000002 110.17 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -69.2 -48.06 63.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.976 -0.557 . . . . 9.3100000000000005 110.972 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -35.56 80.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 8.9600000000000009 111.383 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.53 -29.61 48.09 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.591 -0.814 . . . . 8.1099999999999994 112.165 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.43 0.43 40.46 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.901 -0.666 . . . . 8.7200000000000006 111.823 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 210' ' ' GLN . 5.3 mp -79.25 84.7 5.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.74 -0.467 . . . . 7.7199999999999998 109.74 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 178' ' ' LEU . 34.5 m -159.96 124.38 3.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 8.7300000000000004 110.147 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.436 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -90.04 -27.71 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 9.8900000000000006 111.183 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -141.18 139.83 19.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.455 -0.339 . . . . 9.9700000000000006 110.327 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.14 118.12 4.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.951 2.434 . . . . 11.119999999999999 112.486 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.56 -155.65 22.33 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.122 -0.561 . . . . 9.0600000000000005 111.931 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.7 m-20 -101.57 126.24 34.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.684 0.278 . . . . 7.7400000000000002 111.169 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_exo -68.76 -32.18 23.9 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 123.01 2.474 . . . . 6.6699999999999999 111.83 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.3 124.16 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 5.4699999999999998 110.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.64 -42.07 7.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.035 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.91 159.38 42.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 111.113 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 166' ' ' MET . 9.1 p -140.57 136.63 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.211 -0.449 . . . . 4.7699999999999996 110.84 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.583 ' HB2' ' HB2' ' A' ' 199' ' ' PHE . 41.6 mt-30 -113.86 106.36 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.655 -0.498 . . . . 6.6500000000000004 109.655 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.908 HD13 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -111.43 123.98 67.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.191 0.52 . . . . 5.8499999999999996 111.661 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -127.14 119.24 26.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.569 -0.741 . . . . 7.7599999999999998 109.49 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -93.17 3.42 55.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.757 0.313 . . . . 7.6100000000000003 111.384 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.8 -54.59 5.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.093 0.473 . . . . 9.1199999999999992 109.816 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.607 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 47.3 mmtm -86.52 -7.17 58.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.952 -0.567 . . . . 9.2799999999999994 109.491 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 60.87 70.03 0.64 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.149 -0.932 . . . . 6.9299999999999997 110.812 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 195' ' ' LYS . 41.2 p90 -149.28 163.0 38.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.209 -0.451 . . . . 7.1100000000000003 111.227 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 190' ' ' GLN . . . -144.83 126.87 15.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.646 -0.706 . . . . 4.6600000000000001 110.238 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.583 ' HB2' ' HB2' ' A' ' 190' ' ' GLN . 55.6 m-85 -96.23 126.87 41.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.363 -0.381 . . . . 6.5899999999999999 110.117 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 79.0 mt -105.57 115.21 29.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.052 -0.522 . . . . 4.7699999999999996 109.998 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.03 118.27 31.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.996 -0.372 . . . . 6.5499999999999998 109.996 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -95.64 163.91 13.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.761 -0.654 . . . . 6.5099999999999998 110.814 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.78 -8.32 57.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.311 -0.859 . . . . 8.5399999999999991 111.014 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 p -142.99 -164.72 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 8.3000000000000007 110.294 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.07 -29.96 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 9.0099999999999998 109.227 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.02 -55.62 32.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.124 -0.944 . . . . 8.7799999999999994 111.408 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.436 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 46.9 mt-10 -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 7.4800000000000004 110.026 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.475 ' O ' HD12 ' A' ' 151' ' ' LEU . 1.8 m -53.24 -53.44 50.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.569 -0.741 . . . . 6.3899999999999997 110.807 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 m -60.98 -35.06 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.616 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.66 ' HG3' HD21 ' A' ' 178' ' ' LEU . 9.1 tp-100 -73.28 -30.5 63.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.807 -0.633 . . . . 7.9400000000000004 110.373 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -69.6 -12.81 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 5.5 111.23 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.4 mtp -69.8 -13.52 62.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 6.46 110.85 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.35 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 6.3600000000000003 111.358 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.43 ' HE2' HD23 ' A' ' 178' ' ' LEU . 76.4 m-85 -92.71 15.17 15.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 5.9299999999999997 111.263 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.56 115.48 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.921 -0.4 . . . . 5.9199999999999999 109.921 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.77 30.1 9.31 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.561 -0.828 . . . . 5.7400000000000002 112.006 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 13.1 tt -84.82 136.2 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 5.6299999999999999 110.091 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.46 113.93 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.446 0.641 . . . . 7.2300000000000004 110.811 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -134.68 119.13 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.848 -0.615 . . . . 5.79 110.593 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 61.43 20.85 11.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.947 -0.57 . . . . 7.3200000000000003 112.017 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.55 1.82 63.79 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.619 -0.8 . . . . 7.5899999999999999 112.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -119.84 142.88 48.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.939 0.399 . . . . 7.5300000000000002 111.076 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.0 t -90.24 111.16 22.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.705 -0.679 . . . . 6.4500000000000002 109.885 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.552 HD23 HG23 ' A' ' 156' ' ' ILE . 77.0 mt -76.93 114.13 15.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.026 0.441 . . . . 4.9000000000000004 110.695 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.7 tttt -94.9 114.59 26.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.96 -0.564 . . . . 7.5700000000000003 110.394 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.42 109.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 5.3700000000000001 110.631 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 227' ' ' ARG . 6.8 mmt180 -131.12 171.13 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.506 . . . . 7.1900000000000004 110.621 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 26.8 mtp180 -87.69 127.4 58.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.883 -0.414 . . . . 7.7599999999999998 109.883 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.656 ' HB2' ' HB3' ' A' ' 232' ' ' TYR . 14.9 Cg_exo -66.48 104.66 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.954 2.436 . . . . 7.9800000000000004 111.857 -176.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.571 ' HA ' ' NE2' ' A' ' 233' ' ' GLN . 51.2 t-80 -71.98 -37.67 69.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.284 -174.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -79.64 -13.18 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.374 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . 0.656 ' HB3' ' HB2' ' A' ' 229' ' ' PRO . 72.3 t80 -90.88 -11.11 40.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.315 0.579 . . . . 0.0 110.482 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.571 ' NE2' ' HA ' ' A' ' 230' ' ' HIS . 66.7 mt-30 -79.27 138.06 56.08 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.113 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.58 168.62 16.11 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 111.307 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.3 mt 62.74 88.38 0.12 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 121.126 0.488 . . . . 0.0 110.607 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.455 ' HG2' ' H ' ' A' ' 241' ' ' ASN . 6.2 Cg_exo -80.54 47.82 2.68 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.73 2.954 . . . . 0.0 112.965 -176.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.69 -105.9 2.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.902 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 94.7 mmm -88.48 99.12 12.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.677 0.275 . . . . 0.0 110.889 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 19.3 m 66.8 176.9 0.24 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.638 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -73.56 148.0 43.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.455 ' H ' ' HG2' ' A' ' 236' ' ' PRO . 30.5 m-80 -133.65 98.0 15.27 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.173 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 243' ' ' SER . 65.5 Cg_endo -72.48 -7.89 21.65 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.993 2.462 . . . . 0.0 113.371 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 242' ' ' PRO . 45.7 t 74.14 -46.14 0.61 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.716 0.635 . . . . 0.0 110.092 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.57 113.63 36.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 109.849 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.44 -31.05 12.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.006 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.8 m -63.27 150.78 88.51 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.49 132.13 49.37 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.932 2.421 . . . . 0.0 112.451 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.24 -171.44 44.58 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.7 172.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.86 0.362 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 9.7 p -121.92 149.91 25.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.654 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.7 t -116.61 83.09 1.9 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.912 0.387 . . . . 0.0 110.204 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 35.1 m -154.56 85.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.69 158.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.485 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.9 m -133.88 114.62 13.02 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.07 -37.2 65.87 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.385 2.057 . . . . 0.0 111.234 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 17.9 t70 70.44 -57.04 0.59 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.734 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 63.1 m -85.35 -4.63 59.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.72 0.295 . . . . 0.0 111.426 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -145.5 93.53 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.962 0.411 . . . . 0.0 110.685 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -154.4 33.78 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.681 0.753 . . . . 9.1300000000000008 109.398 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.1 ttmt -78.91 116.91 19.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.15 -0.932 . . . . 6.3600000000000003 111.129 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.757 HD12 HG21 ' A' ' 313' ' ' THR . 68.0 mt -100.89 142.43 32.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.546 -0.752 . . . . 5.5899999999999999 109.872 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -92.93 123.83 36.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.266 -0.424 . . . . 5.0300000000000002 109.988 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.578 HG21 HD12 ' A' ' 330' ' ' LEU . 3.1 mp -114.4 110.55 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.839 -0.618 . . . . 4.21 109.413 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.58 130.64 6.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.717 -0.754 . . . . 4.5800000000000001 112.376 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 124.44 23.47 1.91 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.744 -0.741 . . . . 5.6299999999999999 111.977 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 97.5 mt -95.86 141.53 23.3 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.104 -0.332 . . . . 5.9199999999999999 110.104 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.855 ' HB2' HD11 ' A' ' 270' ' ' LEU . 32.3 Cg_exo -58.47 116.3 3.15 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.535 2.157 . . . . 7.3099999999999996 111.107 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 299' ' ' SER . 29.7 p-10 -70.23 -5.46 27.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.729 0.64 . . . . 8.8100000000000005 112.729 -170.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.59 -0.444 . . . . 9.0700000000000003 111.02 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 267' ' ' PRO . 11.2 mp -86.31 133.39 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 7.7199999999999998 110.202 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.47 ' O ' HG21 ' A' ' 275' ' ' VAL . 30.2 p-10 -79.16 160.04 27.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.984 -0.553 . . . . 8.8000000000000007 110.536 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -54.18 -32.09 54.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.757 -0.656 . . . . 7.8899999999999997 111.501 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.446 ' HB3' ' ND2' ' A' ' 271' ' ' ASN . 17.2 t70 -56.93 -54.81 42.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.602 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -73.93 -33.37 63.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.516 -0.311 . . . . 8.7300000000000004 111.27 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 271' ' ' ASN . 63.0 t -62.92 -48.6 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.537 -0.301 . . . . 6.7300000000000004 110.819 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.0 mtmm -62.88 -45.39 92.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.262 . . . . 8.1199999999999992 111.399 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.96 -40.79 98.78 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.739 0.304 . . . . 9.3800000000000008 110.884 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.63 -49.12 78.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 7.2300000000000004 109.873 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.86 -37.25 78.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.54 . . . . 6.8899999999999997 111.426 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 87.0 m -60.72 -31.27 70.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.483 -0.326 . . . . 9.2400000000000002 110.9 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.3 m -65.62 -15.85 63.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.21 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.58 2.04 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.389 . . . . 9.1799999999999997 110.577 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 157.51 127.13 0.94 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.733 -0.746 . . . . 9.5600000000000005 112.563 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.04 133.28 40.4 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.926 2.417 . . . . 10.51 112.171 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.16 138.45 39.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.08 -0.509 . . . . 8.3000000000000007 111.055 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.529 ' HB3' HG23 ' A' ' 308' ' ' VAL . 12.2 ptpt -104.39 -12.71 16.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 8.9399999999999995 109.707 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 306' ' ' GLU . . . -147.72 136.82 22.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.54 126.45 10.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.26 -0.427 . . . . 6.4900000000000002 110.512 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -140.44 112.08 7.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.362 0.601 . . . . 6.0300000000000002 110.428 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 303' ' ' ALA . 64.7 tp -80.48 121.36 25.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.53 -0.759 . . . . 6.5300000000000002 109.793 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.66 113.47 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.361 0.6 . . . . 6.8700000000000001 110.452 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -113.28 160.27 18.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.369 -0.832 . . . . 8.2100000000000009 109.846 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.767 ' HB2' ' HE3' ' A' ' 300' ' ' LYS . 11.6 t70 -90.03 113.31 24.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.174 -0.676 . . . . 10.33 109.174 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 32.4 m -76.76 -3.2 36.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.538 0.57 . . . . 10.93 112.538 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.37 -23.1 13.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.926 0.393 . . . . 12.34 110.808 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.0 m -106.2 -41.24 5.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.06 -0.518 . . . . 11.460000000000001 111.22 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.0 20.72 25.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.811 -0.709 . . . . 10.210000000000001 112.102 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.97 155.99 29.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.443 -0.206 . . . . 10.4 110.443 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 42.2 t -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.532 -0.304 . . . . 7.8700000000000001 110.336 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.767 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 32.3 mmtp -94.07 -8.21 40.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.298 -0.41 . . . . 8.4100000000000001 111.108 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 90.76 6.74 67.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.656 -0.783 . . . . 6.0899999999999999 113.047 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 300' ' ' LYS . 40.7 p90 -141.55 152.54 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.793 0.33 . . . . 6.7599999999999998 110.533 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 290' ' ' LEU . . . -149.27 164.07 35.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.108 -0.496 . . . . 4.6399999999999997 111.185 -176.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.411 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 96.9 m-85 -106.14 123.42 47.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.874 -0.603 . . . . 5.1900000000000004 109.519 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 21.6 m -128.6 121.32 28.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 5.0899999999999999 110.678 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.714 ' HB3' ' HB1' ' A' ' 287' ' ' ALA . 30.8 tt0 -103.24 114.96 29.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 7.0300000000000002 110.129 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.481 ' CE1' HD13 ' A' ' 261' ' ' LEU . 25.8 m-85 -84.05 149.58 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 7.8899999999999997 111.129 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 286' ' ' LYS . 61.3 t -78.89 -55.54 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.9 -0.591 . . . . 10.42 110.684 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 144.94 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 10.81 111.225 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.645 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.88 -19.93 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 10.039999999999999 111.356 -178.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.59 -48.35 64.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.907 0.384 . . . . 10.98 110.039 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.82 -23.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 9.9100000000000001 110.992 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.757 HG21 HD12 ' A' ' 261' ' ' LEU . 98.4 m -55.78 -50.03 71.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.496 -0.32 . . . . 8.0600000000000005 111.728 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.28 -38.11 89.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 8.9399999999999995 110.719 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.45 -40.62 85.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 10.880000000000001 110.479 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -49.61 71.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 7.5300000000000002 110.666 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 313' ' ' THR . 74.8 mt -59.01 -49.17 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.578 -0.283 . . . . 6.5800000000000001 110.798 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.79 69.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.73 -43.42 7.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.699 -0.763 . . . . 7.7699999999999996 112.7 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.428 ' HB3' HD21 ' A' ' 330' ' ' LEU . 96.1 mt -80.92 -42.7 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.544 0.202 . . . . 6.5199999999999996 111.544 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 49.4 t-20 -72.67 113.89 10.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.317 -0.623 . . . . 6.6100000000000003 109.317 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.5 -7.93 47.12 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.283 -0.727 . . . . 6.7699999999999996 111.283 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttt -74.33 135.29 42.53 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 7.6900000000000004 109.864 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 46.0 mt-30 -96.1 117.12 30.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.349 -0.387 . . . . 8.2400000000000002 110.458 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.82 96.83 6.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.355 -0.609 . . . . 7.0300000000000002 109.355 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 85.8 -94.54 1.93 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.166 -0.774 . . . . 8.25 111.166 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.81 -19.12 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.996 0.426 . . . . 8.9800000000000004 110.11 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 158.95 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 7.4299999999999997 110.419 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.503 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 99.4 mttt -110.27 142.42 41.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.041 0.448 . . . . 7.4500000000000002 110.82 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.578 HD12 HG21 ' A' ' 263' ' ' ILE . 55.7 tp -86.29 134.41 33.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.551 -0.75 . . . . 5.8399999999999999 110.14 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.8 mp -121.28 136.27 54.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.899 0.381 . . . . 5.8099999999999996 110.434 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.535 HG23 HG13 ' A' ' 263' ' ' ILE . 62.1 t -129.84 125.06 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.855 -0.612 . . . . 5.21 110.201 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.29 144.68 22.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.046 -0.724 . . . . 6.1699999999999999 109.046 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 337' ' ' VAL . 68.5 ttt180 -64.07 135.21 56.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.637 -0.425 . . . . 7.7999999999999998 110.518 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -83.17 11.91 5.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 6.04 111.923 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 337' ' ' VAL . 9.5 m -126.71 -94.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.644 0.259 . . . . 7.7000000000000002 110.644 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 18.5 m -125.06 136.87 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.54 76.63 0.95 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.13 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.92 173.39 11.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -90.16 86.98 6.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -165.28 -55.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.732 179.703 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.77 0.319 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 205' ' ' VAL . 98.6 mtt180 -117.67 9.4 13.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.044 0.45 . . . . 0.0 110.621 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 87.1 mtt180 -106.87 133.23 51.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.91 -0.586 . . . . 6.52 110.37 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 52.3 mt -97.2 150.44 20.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.283 -0.417 . . . . 5.24 110.546 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -100.66 105.26 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.912 -0.586 . . . . 6.15 109.443 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.3 p -107.71 129.33 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.232 0.539 . . . . 4.24 110.446 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -129.74 -177.53 14.93 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.484 -0.78 . . . . 4.95 111.78 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 61.78 38.77 14.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.84 0.829 . . . . 0.0 109.375 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.42 HG22 HD22 ' A' ' 224' ' ' LEU . 34.0 pt -84.34 152.34 60.92 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 5.61 111.009 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 160' ' ' ILE . 11.6 Cg_exo -71.32 123.08 9.26 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.011 2.474 . . . . 5.97 112.165 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -75.89 113.7 13.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 8.47 109.828 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 132.21 -33.51 2.68 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.784 -0.722 . . . . 6.96 112.283 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 157' ' ' PRO . 11.4 tp -71.26 153.92 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.616 0.246 . . . . 6.1 110.634 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 p -88.9 161.09 16.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.85 0.357 . . . . 6.62 111.223 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 191' ' ' ILE . 41.6 mt-10 -66.05 -37.94 87.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 5.69 109.71 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.16 -48.82 80.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.023 -0.99 . . . . 7.29 111.296 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.23 90.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.253 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.2 ttm -65.1 -39.88 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 4.49 110.53 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.669 ' HE3' ' HB ' ' A' ' 186' ' ' VAL . 23.5 ttt -62.28 -46.22 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.356 . . . . 5.76 110.81 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.66 -38.6 88.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 6.51 110.472 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -57.62 -48.16 80.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.848 -0.615 . . . . 5.44 110.58 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HG2' ' A' ' 173' ' ' MET . 33.2 m-85 -64.47 -47.16 80.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 5.03 111.14 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -54.89 -46.3 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.165 0.291 . . . . 6.3 110.945 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.7 84.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.036 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.3 -37.65 86.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 6.25 111.11 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 33.0 mmt -62.6 -42.25 99.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 7.03 110.177 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.18 -52.75 17.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 8.94 111.007 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.62 -34.05 77.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 8.7 111.697 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.85 -16.81 71.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.509 -0.853 . . . . 8.11 112.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.06 29.85 30.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 8.49 112.137 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.442 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.9 mp -86.89 -18.8 29.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 7.59 110.092 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.717 HG22 ' HG3' ' A' ' 185' ' ' PRO . 13.2 p -69.27 128.2 35.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.501 -0.772 . . . . 8.73 111.168 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 12.7 pt20 -94.09 -1.04 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 9.89 109.322 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -160.07 155.43 21.84 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.082 -0.963 . . . . 9.69 109.476 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.7 168.78 15.9 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.503 2.135 . . . . 10.74 112.136 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.87 -138.61 14.15 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.029 -0.605 . . . . 8.97 112.509 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 90.5 m-20 -116.44 118.05 37.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.588 0.232 . . . . 7.58 110.574 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.717 ' HG3' HG22 ' A' ' 179' ' ' THR . 18.3 Cg_exo -66.61 -26.52 46.36 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.866 2.377 . . . . 6.4 111.864 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.669 ' HB ' ' HE3' ' A' ' 166' ' ' MET . 40.3 t -82.54 127.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.949 -0.568 . . . . 5.47 110.112 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 284' ' ' PRO . 45.0 tp -91.8 -40.4 11.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.232 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -143.34 121.16 11.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.012 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.36 115.4 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.89 -0.595 . . . . 4.68 110.144 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -128.67 106.41 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 6.34 110.157 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 162' ' ' GLU . 66.5 mt -113.97 123.06 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.241 -0.436 . . . . 5.85 111.655 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -100.54 99.62 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -85.51 -16.93 37.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.69 . . . . 7.61 110.167 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.57 -47.55 83.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.616 -0.72 . . . . 9.12 110.957 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 45.1 mmtm -105.57 9.04 33.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.286 -0.415 . . . . 9.1 111.207 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.01 48.58 5.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.412 -0.813 . . . . 6.6 111.82 171.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 37.1 p90 -148.19 142.83 26.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.818 -0.438 . . . . 6.67 109.818 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -134.28 150.46 50.99 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.921 0.391 . . . . 4.58 111.354 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.597 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 74.8 m-85 -117.37 108.47 15.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.63 -0.713 . . . . 6.22 109.889 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 87.3 mt -94.85 114.54 26.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.08 -0.509 . . . . 4.77 109.63 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 36.1 tt0 -94.06 119.49 33.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.814 -0.439 . . . . 6.55 109.814 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.13 164.21 13.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.181 0.515 . . . . 6.51 111.213 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -73.31 -11.65 60.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.355 -0.839 . . . . 8.27 111.089 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 76.0 p -141.68 -166.75 2.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.198 -0.456 . . . . 7.96 110.219 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.592 HG22 ' HG2' ' A' ' 149' ' ' ARG . 21.8 t -116.58 -30.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.268 -0.642 . . . . 8.73 109.268 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.59 -60.44 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.085 -0.962 . . . . 8.5 111.377 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 42.4 mt-10 -58.88 -40.32 84.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4 110.078 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 m -52.45 -52.14 55.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.633 -0.712 . . . . 6.13 110.835 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.7 m -63.0 -34.23 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.522 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.442 ' HG3' HD23 ' A' ' 178' ' ' LEU . 61.8 tp60 -71.17 -30.9 67.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.137 -0.483 . . . . 7.75 110.215 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.1 -15.03 62.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.523 . . . . 5.43 111.273 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.31 -16.02 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 6.29 111.117 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.25 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 6.14 111.55 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 217' ' ' ILE . 69.7 m-85 -93.04 21.47 5.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.444 -0.344 . . . . 5.57 111.577 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.15 109.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 5.92 110.369 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.97 13.25 22.11 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.933 -0.651 . . . . 5.74 112.233 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 214' ' ' PHE . 17.6 tt -66.41 141.8 17.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 5.3 111.2 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.2 tp -82.45 114.1 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.508 0.67 . . . . 6.8 111.098 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.27 112.77 10.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.589 -0.732 . . . . 5.79 110.701 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 59.57 31.41 20.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.863 -0.608 . . . . 7.32 111.737 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.53 -24.76 29.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.855 -0.688 . . . . 7.28 112.585 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.95 167.28 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.879 0.371 . . . . 7.21 110.777 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -118.15 99.79 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.385 -0.598 . . . . 6.14 109.385 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 156' ' ' ILE . 82.6 mt -66.14 112.93 4.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 4.9 111.59 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.3 tttt -81.83 124.73 29.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.517 -0.765 . . . . 7.3 109.91 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -118.76 106.22 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.029 0.443 . . . . 5.37 110.741 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -134.51 171.63 14.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 6.97 110.301 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 20.2 mtp180 -83.62 134.97 43.87 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.788 -0.449 . . . . 7.37 109.788 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.597 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 32.1 Cg_exo -60.28 165.9 10.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.004 2.469 . . . . 7.98 112.762 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.884 -179.673 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.444 ' CE1' ' HA ' ' A' ' 310' ' ' ILE . 13.2 t60 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.95 0.405 . . . . 8.75 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.685 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.2 ttmt -78.09 129.97 35.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.908 -0.587 . . . . 6.04 110.541 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.41 HD23 ' HG2' ' A' ' 334' ' ' ARG . 82.8 mt -96.07 140.78 30.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.201 0.524 . . . . 5.29 110.792 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -103.45 115.12 29.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.249 -0.887 . . . . 4.77 108.627 171.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 263' ' ' ILE . 4.3 mp -105.43 110.05 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.909 -0.587 . . . . 3.94 109.674 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -122.1 171.74 15.37 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.025 -0.607 . . . . 4.58 111.814 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.78 27.51 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.664 -0.779 . . . . 5.58 111.923 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 96.8 mt -106.36 142.06 24.11 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.646 0.26 . . . . 5.92 110.569 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 15.1 Cg_exo -70.36 160.41 49.63 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.771 2.314 . . . . 6.94 111.507 173.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -88.42 -9.52 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.033 0.383 . . . . 8.81 112.033 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -83.08 -2.14 54.6 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.45 -0.5 . . . . 8.73 110.97 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.68 117.4 19.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 7.52 110.108 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.38 160.11 22.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.062 -0.517 . . . . 8.79 110.817 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.23 -44.45 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 7.62 112.584 -173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.83 -45.26 92.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.816 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.5 -46.49 88.19 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.64 0.257 . . . . 8.69 111.012 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.46 -44.57 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 6.64 110.646 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -62.94 -48.08 80.46 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.378 -0.374 . . . . 7.74 110.82 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.5 -47.82 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 9.38 110.653 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.72 -54.74 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 7.06 110.584 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 288' ' ' PHE . 99.3 mt -69.46 -32.15 70.88 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.879 0.325 . . . . 6.89 111.879 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 36.1 m -72.2 -19.74 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 8.85 110.926 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 50.5 m -79.63 -0.83 35.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.439 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 320' ' ' LEU . 94.7 m-85 -120.68 14.46 11.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 9.18 110.917 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 143.7 159.93 8.21 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.567 -0.825 . . . . 9.06 112.517 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' A' ' 187' ' ' LEU . 55.5 Cg_endo -71.37 122.39 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.658 2.239 . . . . 10.14 112.31 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.96 135.46 33.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 8.3 110.436 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.9 ptpt -99.33 -26.83 14.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.577 -0.527 . . . . 8.65 109.577 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -145.24 136.66 25.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.453 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.531 ' HE2' HD12 ' A' ' 279' ' ' LEU . 16.6 t80 -144.84 110.12 5.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.869 -0.605 . . . . 6.27 109.553 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.59 116.97 21.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.287 0.565 . . . . 5.79 110.44 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -93.23 130.04 39.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.469 -0.787 . . . . 6.35 109.973 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.65 112.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.017 0.437 . . . . 6.61 110.457 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 63.0 mttm -106.96 167.83 9.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.605 . . . . 8.17 110.124 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.47 128.06 34.92 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.192 -0.67 . . . . 10.33 109.192 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.3 m -63.87 -28.65 69.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.072 0.397 . . . . 10.8 112.072 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -95.47 -51.99 4.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 12.13 111.121 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.8 m -68.6 -51.46 42.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 11.16 111.227 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 108.77 -25.09 20.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.742 -0.742 . . . . 10.11 112.172 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.62 164.38 26.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 10.12 110.775 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 42.6 t -68.18 154.24 42.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.971 -0.559 . . . . 7.73 110.581 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -86.86 -8.69 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 8.01 109.93 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.27 17.16 35.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.791 -0.719 . . . . 6.09 113.209 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -156.44 155.94 32.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.682 0.277 . . . . 6.54 110.513 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -151.51 166.41 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.193 -0.458 . . . . 4.38 111.368 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.5 m-85 -115.75 127.47 55.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.043 -0.725 . . . . 4.93 109.043 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.4 m -144.19 131.18 20.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.66 0.267 . . . . 5.09 110.681 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 32.5 tt0 -116.08 130.16 56.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.899 0.381 . . . . 7.03 110.399 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -83.34 158.44 22.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 7.81 110.574 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 286' ' ' LYS . 62.9 t -78.63 -55.88 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 10.03 110.464 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.27 147.87 44.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 10.81 110.837 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.865 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -94.03 -4.03 10.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 9.77 112.065 -175.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -93.85 -50.72 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.732 0.301 . . . . 10.89 110.526 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.68 -24.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 9.5 112.172 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 317' ' ' ILE . 31.3 m -59.54 -50.68 72.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.931 0.345 . . . . 7.83 111.931 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -75.09 -29.04 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 8.79 110.63 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -68.64 -39.25 80.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 10.51 110.157 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.32 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.769 -0.651 . . . . 7.31 110.231 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 332' ' ' VAL . 78.8 mt -61.95 -46.06 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 6.44 110.4 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.52 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.845 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -91.91 -54.68 1.86 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.536 -0.84 . . . . 7.46 113.241 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.402 HD21 ' CE2' ' A' ' 282' ' ' PHE . 96.4 mt -69.26 -50.23 48.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.683 0.253 . . . . 6.42 111.683 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.738 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.8 t30 -63.79 114.04 3.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.727 -0.472 . . . . 6.53 109.727 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.67 7.08 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.8 -0.714 . . . . 6.77 111.815 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.7 mtt -74.16 170.49 15.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.725 -0.472 . . . . 7.29 109.725 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -134.56 118.76 17.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.028 0.442 . . . . 7.83 110.891 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.71 99.1 10.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.292 -0.633 . . . . 7.01 109.292 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.5 2.12 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.732 -0.747 . . . . 8.18 111.516 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -110.52 2.38 18.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.878 0.371 . . . . 8.94 110.582 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -105.06 135.51 46.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 7.29 110.687 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.48 127.25 35.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.738 -0.468 . . . . 7.13 109.738 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.47 115.34 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 5.63 110.664 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 54.5 tp -106.72 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.507 -0.77 . . . . 5.53 109.887 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 61.9 t -126.42 120.51 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.274 -0.421 . . . . 5.21 110.094 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.33 176.83 11.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.138 -0.69 . . . . 6.05 109.138 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' HD23 ' A' ' 261' ' ' LEU . 59.8 mtm180 -82.29 147.39 28.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.598 -0.441 . . . . 7.58 109.875 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.4 67.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 6.04 112.271 -173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--N 1.324 -0.5 0 C-N-CA 121.096 -0.242 . . . . 7.57 111.341 -177.806 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.746 0.308 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 202' ' ' PHE . 37.3 ptt180 -90.87 -1.4 57.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 68.5 mtt180 -98.12 164.28 12.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.049 0.452 . . . . 6.52 111.4 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 64.0 mt -136.86 158.41 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.268 -0.878 . . . . 5.24 109.86 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.94 113.47 26.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.831 -0.622 . . . . 6.15 109.519 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.8 p -113.19 129.1 69.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.233 0.539 . . . . 4.24 110.763 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.03 177.8 16.46 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.629 -0.714 . . . . 4.95 111.759 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.48 63.59 1.67 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.352 0.596 . . . . 0.0 110.4 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.67 155.56 36.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.568 -0.742 . . . . 5.61 110.264 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.659 ' HB2' ' HB ' ' A' ' 160' ' ' ILE . 16.1 Cg_exo -69.07 131.03 21.3 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.724 2.282 . . . . 5.97 112.013 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -79.47 102.46 8.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 8.47 109.674 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.27 20.64 6.18 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.953 -0.642 . . . . 6.96 111.895 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB2' ' A' ' 157' ' ' PRO . 11.0 tp -94.03 146.33 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.769 -0.456 . . . . 6.1 109.769 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.2 p -86.68 154.05 21.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 6.62 111.5 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.518 -0.765 . . . . 5.69 110.288 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.78 -48.1 80.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.719 -0.673 . . . . 7.29 110.408 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.45 -50.8 70.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.225 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 94.5 mmm -63.14 -48.88 76.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.194 -0.457 . . . . 4.49 110.958 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 281' ' ' SER . 1.9 tmt? -61.13 -51.6 68.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 5.76 110.787 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.46 -36.26 83.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 6.51 111.536 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.86 -48.72 80.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.681 0.277 . . . . 5.44 111.28 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.458 ' HE1' HD11 ' A' ' 226' ' ' ILE . 60.4 m-85 -64.3 -35.91 82.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.571 -0.286 . . . . 5.03 110.728 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 82.5 m-20 -60.22 -50.4 73.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.91 -0.404 . . . . 6.3 109.91 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -56.8 -47.54 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.473 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.99 -39.47 94.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.606 -0.27 . . . . 6.25 111.072 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 179' ' ' THR . 26.4 mmt -62.74 -41.75 99.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 7.03 110.54 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 84.8 mtt180 -67.29 -52.2 43.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 8.94 111.0 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 89.3 mt -60.38 -33.91 73.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.86 -0.609 . . . . 8.7 111.693 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.19 -21.46 45.31 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.334 -0.936 . . . . 8.11 112.284 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.03 27.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.983 -0.627 . . . . 8.49 111.981 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 210' ' ' GLN . 4.2 mp -97.93 -5.32 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 7.59 110.505 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -79.3 156.46 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 8.73 111.049 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.43 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 13.8 pt20 -87.79 -14.9 38.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.255 0.55 . . . . 9.89 109.94 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -156.2 144.89 14.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 9.69 109.84 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.57 113.26 2.22 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.647 2.231 . . . . 10.74 111.835 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.46 -137.77 5.08 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.655 -0.783 . . . . 8.97 112.381 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -112.06 108.34 55.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.539 0.209 . . . . 7.58 110.665 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.594 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 45.1 Cg_endo -68.69 -34.63 18.5 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.749 2.299 . . . . 6.4 111.85 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.76 128.7 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 5.47 109.514 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 284' ' ' PRO . 26.6 tp -105.25 -33.24 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.978 0.418 . . . . 0.0 110.361 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -152.32 155.01 36.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.321 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 200' ' ' LEU . 7.2 p -143.02 133.1 22.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.926 0.393 . . . . 4.68 110.604 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.33 106.73 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 6.34 110.047 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.35 130.56 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.05 -0.523 . . . . 5.85 111.428 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -121.59 96.8 5.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.837 -0.801 . . . . 7.34 108.837 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -83.48 -6.68 59.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.044 -0.525 . . . . 7.61 110.962 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -66.66 -51.91 50.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 9.12 110.619 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.522 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.4 mmtm -102.89 -0.24 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.22 -0.445 . . . . 9.1 110.406 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 66.76 61.52 0.53 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.345 -0.843 . . . . 6.6 111.924 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 48.6 p90 -149.43 163.52 37.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 6.67 109.506 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.61 153.27 40.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.943 0.402 . . . . 4.58 111.095 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.05 122.65 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.852 -0.613 . . . . 6.22 110.161 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 75.2 mt -100.69 116.0 31.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 4.77 110.279 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 5.2 tt0 -101.34 113.75 27.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.682 -0.488 . . . . 6.55 109.682 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.404 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 69.9 m-85 -90.59 160.11 16.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.077 -0.51 . . . . 6.51 110.825 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.74 -25.08 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 8.27 110.877 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 93.2 p -132.16 -178.29 4.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.171 -0.468 . . . . 7.96 110.053 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.89 -16.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.707 0.765 . . . . 8.73 109.032 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.54 -54.65 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.998 -1.001 . . . . 8.5 111.078 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.43 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 36.2 mt-10 -66.45 -30.32 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 7.4 110.897 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -50.71 -45.31 58.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 6.13 112.02 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 m -56.37 -43.46 79.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.688 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.759 ' HB3' HD23 ' A' ' 178' ' ' LEU . 29.0 mp0 -73.64 -28.06 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.51 -0.313 . . . . 7.75 110.853 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.402 ' HA ' ' HE3' ' A' ' 173' ' ' MET . . . -63.27 -21.5 66.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 5.43 110.617 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.58 -14.83 62.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 6.29 111.22 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.01 -13.56 62.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 6.14 110.879 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.716 ' HD2' HD12 ' A' ' 217' ' ' ILE . 68.7 m-85 -100.02 17.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 5.57 110.753 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.59 107.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 5.92 110.392 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.74 14.23 23.8 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.955 -0.64 . . . . 5.74 112.194 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.716 HD12 ' HD2' ' A' ' 214' ' ' PHE . 16.1 tt -68.01 135.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.045 0.45 . . . . 5.3 110.689 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.79 114.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.386 0.612 . . . . 6.8 111.045 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -134.58 118.65 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.639 -0.709 . . . . 5.79 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 59.63 26.72 15.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.025 -0.534 . . . . 7.32 111.516 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 91.87 -5.48 79.26 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.682 -0.77 . . . . 7.28 112.881 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.564 0.221 . . . . 7.21 110.691 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.1 t -101.0 95.1 6.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.428 -0.582 . . . . 6.14 109.428 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.45 106.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 4.9 111.459 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 88.4 tttt -82.22 113.92 20.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.709 -0.678 . . . . 7.3 109.715 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.458 HD11 ' HE1' ' A' ' 169' ' ' PHE . 67.3 mt -109.1 107.22 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.053 0.454 . . . . 5.37 110.625 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -124.9 170.38 11.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.764 -0.653 . . . . 6.97 109.74 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -87.73 154.58 53.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 121.043 -0.263 . . . . 7.37 110.71 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 55.8 Cg_endo -69.76 173.42 11.0 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.744 2.296 . . . . 7.98 111.809 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 35.1 m-70 . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.588 ' HB3' HG21 ' A' ' 313' ' ' THR . 47.2 m80 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.077 -0.712 . . . . 8.75 109.077 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.479 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.7 ttmt -59.22 125.12 22.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.096 -0.957 . . . . 6.04 111.809 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.3 mt -100.29 135.58 41.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.326 -0.852 . . . . 5.29 110.001 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.425 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 93.6 t80 -93.09 111.13 22.66 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.145 -0.687 . . . . 4.77 109.145 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.749 HG23 HD11 ' A' ' 330' ' ' LEU . 2.3 mp -91.45 109.09 20.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.838 -0.619 . . . . 3.94 109.637 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.86 112.16 2.17 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.623 -0.798 . . . . 4.58 112.298 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 137.06 45.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.828 -0.701 . . . . 5.58 112.21 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.9 mt -110.51 144.58 30.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 5.92 110.998 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.4 158.28 22.61 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.158 2.572 . . . . 6.94 111.694 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -83.95 -13.08 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.572 0.225 . . . . 8.81 111.305 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -81.67 -6.78 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 8.73 110.21 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 275' ' ' VAL . 13.8 tp -87.8 120.66 29.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 7.52 109.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 275' ' ' VAL . 33.4 p30 -91.0 174.21 7.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 8.79 111.284 -176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.58 -32.1 72.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.691 -0.686 . . . . 7.62 111.417 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.18 -54.62 38.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.683 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.75 -34.95 77.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.672 -0.694 . . . . 8.69 111.742 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 271' ' ' ASN . 62.9 t -63.0 -48.84 86.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.778 0.323 . . . . 6.64 110.465 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.04 -42.7 94.07 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.558 -0.292 . . . . 7.74 110.616 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.0 -46.85 84.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.02 -0.536 . . . . 9.38 111.249 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -46.94 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 7.06 110.116 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.3 mt -69.8 -36.05 75.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.175 -0.466 . . . . 6.89 111.236 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.1 m -68.31 -19.71 64.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.03 0.443 . . . . 8.85 110.995 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.472 ' HA ' ' CE ' ' A' ' 166' ' ' MET . 38.3 m -68.39 -12.28 60.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.92 11.58 8.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.404 . . . . 9.18 111.307 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 145.93 163.95 10.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.442 -0.885 . . . . 9.06 113.115 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HB3' HD11 ' A' ' 187' ' ' LEU . 86.3 Cg_endo -83.52 134.88 6.76 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.94 2.427 . . . . 10.14 112.642 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.2 mt -90.8 142.14 28.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.381 -0.372 . . . . 8.3 110.568 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.466 ' HB3' HG22 ' A' ' 308' ' ' VAL . 7.8 ptpp? -103.18 -22.86 13.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.385 -0.598 . . . . 8.65 109.385 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.1 132.49 23.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -145.77 123.52 11.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.224 -0.444 . . . . 6.27 110.586 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.91 118.49 12.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.388 0.614 . . . . 5.79 109.955 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.745 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.5 tp -91.83 125.43 36.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.658 -0.701 . . . . 6.35 109.172 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 303' ' ' ALA . 46.4 t -76.75 112.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.356 -0.538 . . . . 6.61 110.137 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.58 153.17 19.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.475 -0.784 . . . . 8.17 109.985 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.668 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 21.2 t70 -64.68 145.53 56.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.349 -0.387 . . . . 10.33 110.237 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.1 m -63.64 -28.33 69.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.033 -0.53 . . . . 10.8 111.738 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -116.62 -40.99 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.99 0.367 . . . . 12.13 111.99 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 30.0 m -69.1 -46.91 66.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.719 0.295 . . . . 11.16 111.362 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.63 70.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 10.11 112.962 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.51 170.36 9.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.008 -0.367 . . . . 10.12 110.008 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.7 t -58.08 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.12 0.485 . . . . 7.73 111.022 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.668 ' HD3' ' HA ' ' A' ' 293' ' ' ASP . 31.9 mmmt -85.81 -3.45 58.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 8.01 109.982 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 103.4 -3.84 47.22 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.805 -0.712 . . . . 6.09 112.245 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 18.4 p90 -141.62 157.12 45.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 6.54 111.436 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -156.91 167.06 31.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.824 -0.626 . . . . 4.38 110.844 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.479 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.6 m-85 -116.27 125.61 52.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.205 -0.665 . . . . 4.93 109.205 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 28.9 m -144.32 136.65 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.646 0.26 . . . . 5.09 111.009 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.68 132.29 49.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.758 0.313 . . . . 7.03 110.253 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 42.3 m-85 -79.11 166.61 22.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.057 -0.52 . . . . 7.81 110.78 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 286' ' ' LYS . 56.9 t -76.32 -51.65 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.197 -0.456 . . . . 10.03 110.23 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.546 ' HB3' HG22 ' A' ' 312' ' ' VAL . 16.5 t70 -92.47 156.11 17.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.755 -0.657 . . . . 10.81 110.262 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.766 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -78.86 -30.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.52 -0.309 . . . . 9.77 111.462 -176.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -67.4 -49.34 64.22 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 110.211 -0.292 . . . . 10.89 110.211 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.618 HG21 ' HD2' ' A' ' 284' ' ' PRO . 19.8 m -65.56 -26.06 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 9.5 111.542 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.588 HG21 ' HB3' ' A' ' 259' ' ' HIS . 86.1 m -64.47 -49.81 69.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.324 0.583 . . . . 7.83 110.11 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.1 -24.46 58.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 8.79 110.991 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLN . . . . . 0.47 ' HB2' ' HA ' ' A' ' 312' ' ' VAL . 45.4 mt-30 -63.42 -40.25 96.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 10.51 110.17 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 320' ' ' LEU . . . -62.22 -44.91 95.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 7.31 110.516 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.36 -36.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 6.44 111.297 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -83.82 -52.39 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.778 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.55 -37.19 24.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.035 -0.602 . . . . 7.46 113.956 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' A' ' 330' ' ' LEU . 80.3 mt -83.92 -36.91 22.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.257 0.528 . . . . 6.42 111.993 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 6.4 t30 -61.97 119.94 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.732 0.301 . . . . 6.53 110.529 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.03 -22.47 20.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.926 -0.654 . . . . 6.77 112.297 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 23.9 ttt -71.31 123.26 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.298 -0.26 . . . . 7.29 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.474 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 51.4 mt-30 -82.98 117.5 22.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 7.83 111.466 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -91.03 94.86 9.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.559 -0.904 . . . . 7.01 108.559 171.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.23 -87.36 1.29 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.547 -0.835 . . . . 8.18 111.181 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -126.51 -25.1 3.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.764 0.316 . . . . 8.94 110.865 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 324' ' ' GLN . 94.7 mttt -85.79 134.98 33.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 7.29 110.92 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 92.8 mttt -77.47 126.29 30.68 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.454 -0.573 . . . . 7.13 109.454 172.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 263' ' ' ILE . 30.8 tp -67.77 102.56 1.24 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.954 0.407 . . . . 5.63 110.258 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 53.4 tp -93.57 111.82 23.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.888 -0.596 . . . . 5.53 109.674 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.07 108.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 5.21 109.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 17.6 pt20 -124.04 124.32 42.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.104 -0.498 . . . . 6.05 110.216 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -72.16 123.03 22.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.966 -0.383 . . . . 7.58 109.966 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -111.32 95.48 5.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.532 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 7.57 110.358 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.6 -3.36 16.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.215 0.531 . . . . 0.0 109.638 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 98.7 mtt180 -101.66 146.64 27.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.507 -0.769 . . . . 6.52 110.655 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.9 mt -110.14 147.08 34.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.241 -0.436 . . . . 5.24 110.05 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 85.1 t80 -102.62 103.55 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 6.15 110.062 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 198' ' ' ALA . 7.6 p -105.33 133.72 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.236 0.541 . . . . 4.24 110.691 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -131.77 -179.66 16.37 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 4.95 111.984 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.09 29.77 14.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.367 0.603 . . . . 0.0 109.999 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.1 pt -74.77 151.52 86.78 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 5.61 111.02 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.38 137.18 63.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.8 2.333 . . . . 5.97 111.899 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -81.62 114.32 20.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.934 0.397 . . . . 8.47 110.043 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.02 21.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 6.96 112.153 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.3 tp -76.48 140.87 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.967 -0.383 . . . . 6.1 109.967 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -88.56 154.62 20.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.783 0.325 . . . . 6.62 110.608 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.902 ' HA ' HD12 ' A' ' 191' ' ' ILE . 39.8 mt-10 -60.44 -38.49 84.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 5.69 110.071 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.1 -55.63 30.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.257 -0.883 . . . . 7.29 111.295 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.38 93.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 169' ' ' PHE . 46.5 ttm -67.95 -42.22 81.3 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.998 -0.281 . . . . 4.49 110.476 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 281' ' ' SER . 26.8 ttt -62.95 -45.82 90.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 5.76 110.422 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.16 -41.4 75.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.559 . . . . 6.51 110.985 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.455 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 78.0 t80 -57.83 -51.9 67.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 5.44 110.95 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.408 ' HD2' ' O ' ' A' ' 165' ' ' MET . 68.1 m-85 -66.38 -39.87 89.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 5.03 111.226 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.2 m-20 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 6.3 110.384 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.91 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 87.5 mm-40 -61.85 -42.19 98.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.558 -0.292 . . . . 6.25 110.969 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.521 ' HB3' HG23 ' A' ' 179' ' ' THR . 86.2 mmm -66.04 -36.65 83.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.292 -0.413 . . . . 7.03 110.968 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 66.9 mtt180 -72.47 -52.3 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.524 -0.307 . . . . 8.94 110.961 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.06 -36.01 77.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 8.7 111.51 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.08 -21.01 80.15 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.87 -0.681 . . . . 8.11 112.532 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.88 39.33 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 8.49 112.5 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.24 9.33 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 7.59 110.192 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.6 p -114.62 105.19 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 8.73 111.504 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -80.74 -22.96 39.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 9.89 109.972 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -112.65 137.81 21.84 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.956 -0.566 . . . . 9.69 110.238 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 161.1 37.73 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.798 2.332 . . . . 10.74 112.108 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.09 -152.78 18.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.824 -0.703 . . . . 8.97 112.099 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 94.6 m-20 -109.22 122.72 38.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.786 -0.244 . . . . 7.58 111.094 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HG3' ' CB ' ' A' ' 173' ' ' MET . 19.7 Cg_endo -60.75 -36.68 83.41 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.946 2.431 . . . . 6.4 111.374 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.9 t -81.33 127.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.827 -0.805 . . . . 5.47 108.827 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 20.5 tp -90.92 -39.19 12.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.06 153.66 33.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.606 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.448 HG23 HD23 ' A' ' 200' ' ' LEU . 7.4 p -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.27 -0.423 . . . . 4.68 110.804 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -130.65 106.87 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 6.34 109.699 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 162' ' ' GLU . 51.5 mt -110.95 126.92 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.162 0.506 . . . . 5.85 111.578 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -101.91 101.31 11.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 7.34 108.388 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.19 -27.83 53.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 7.61 110.648 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.92 -49.03 72.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 9.12 111.281 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.17 -6.89 54.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 9.1 111.068 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 64.51 56.36 1.24 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.833 -0.621 . . . . 6.6 111.321 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 40.3 p90 -149.04 149.12 30.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.047 -0.524 . . . . 6.67 109.879 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -134.19 140.19 46.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.775 0.321 . . . . 4.58 111.087 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 42.5 m-85 -108.32 109.02 20.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.868 -0.606 . . . . 6.22 110.139 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.7 mt -93.27 114.01 26.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 4.77 109.32 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.69 114.64 26.3 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.136 -0.32 . . . . 6.55 110.136 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -89.7 155.96 18.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.257 -0.428 . . . . 6.51 110.892 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.7 -22.6 60.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.734 -0.666 . . . . 8.27 110.972 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 94.6 p -148.18 142.85 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.964 -0.384 . . . . 7.96 109.964 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.415 ' HA ' ' OG1' ' A' ' 208' ' ' THR . 94.6 t -63.94 -28.62 45.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.021 0.439 . . . . 8.73 110.373 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.68 -40.94 69.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 8.5 110.581 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.3 -29.62 26.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 7.4 110.965 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 205' ' ' VAL . 32.2 m -54.06 -51.52 63.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.923 0.392 . . . . 6.13 110.803 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.72 -24.9 67.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.707 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -68.09 -35.55 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.958 0.408 . . . . 7.75 110.196 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -74.78 -14.28 60.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 5.43 110.91 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.2 mtp -69.43 -20.54 63.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 6.29 110.289 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.37 -15.21 61.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.92 -0.582 . . . . 6.14 110.801 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.659 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 90.7 m-85 -92.86 6.5 47.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 5.57 110.945 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.48 124.23 20.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.699 0.285 . . . . 5.92 110.244 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.68 35.2 11.93 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.686 -0.768 . . . . 5.74 111.56 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.87 137.89 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.941 -0.392 . . . . 5.3 109.941 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.04 119.15 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.301 0.572 . . . . 6.8 110.756 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -133.01 112.28 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.085 -0.507 . . . . 5.79 110.985 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 56.66 35.02 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.769 -0.651 . . . . 7.32 111.94 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.86 78.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 7.28 113.045 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -118.04 124.1 47.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.334 . . . . 7.21 110.64 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.6 t -77.3 115.89 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.158 -0.682 . . . . 6.14 109.158 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.5 118.69 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 4.9 110.98 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.0 tttt -88.36 114.15 24.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 7.3 109.642 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.0 mt -109.52 106.56 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.078 0.466 . . . . 5.37 110.428 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 4.5 mmp_? -114.92 170.09 8.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.892 -0.594 . . . . 6.97 110.508 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -83.94 125.13 73.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.268 -0.641 . . . . 7.37 109.268 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.561 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 18.1 Cg_endo -58.55 129.63 33.42 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.607 2.205 . . . . 7.98 111.379 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.88 0.372 . . . . 0.0 110.595 -177.07 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 43.0 m80 . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.771 -0.825 . . . . 8.75 108.771 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 304' ' ' PHE . 35.2 ttmt -59.1 119.49 7.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.104 -1.407 . . . . 6.04 110.113 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.0 141.63 29.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.863 -0.608 . . . . 5.29 110.792 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.72 110.0 21.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.489 -0.778 . . . . 4.77 109.317 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.776 HG23 HD11 ' A' ' 330' ' ' LEU . 3.9 mp -101.77 103.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.321 -0.622 . . . . 3.94 109.321 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.91 164.13 21.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 4.58 112.605 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 102.09 15.71 25.29 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.782 -0.723 . . . . 5.58 111.895 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 270' ' ' LEU . 83.4 mt -92.57 148.74 36.83 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.655 0.264 . . . . 5.92 110.545 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 270' ' ' LEU . 46.0 Cg_endo -69.23 153.74 70.89 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.687 2.258 . . . . 6.94 112.276 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.7 -22.6 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 8.81 111.368 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -83.64 1.04 44.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.948 0.404 . . . . 8.73 111.187 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 267' ' ' PRO . 11.6 tp -87.11 99.37 11.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.859 -0.793 . . . . 7.52 108.859 176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 34.2 p-10 -89.68 -179.0 5.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 8.79 111.686 -172.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.485 ' CG ' ' HZ1' ' A' ' 292' ' ' LYS . 2.7 m-20 -52.31 -41.02 62.59 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.595 -0.729 . . . . 7.62 112.158 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.89 -47.75 81.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.19 -42.92 71.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 8.69 111.431 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 82.1 t -64.62 -49.38 80.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.555 -0.293 . . . . 6.64 111.7 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -65.21 -43.36 91.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.841 -0.344 . . . . 7.74 111.228 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.49 -46.97 83.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 9.38 110.638 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.66 -52.82 62.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 7.06 110.501 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.65 -38.62 80.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.043 0.386 . . . . 6.89 112.043 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.4 m -61.58 -34.77 76.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.3 . . . . 8.85 111.106 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.432 ' HB3' ' SD ' ' A' ' 166' ' ' MET . 49.0 m -62.74 -23.2 67.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.864 -178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -106.38 12.55 29.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.073 0.397 . . . . 9.18 112.073 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 154.58 155.41 7.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.762 -1.209 . . . . 9.06 113.462 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.734 ' HD2' HG21 ' A' ' 312' ' ' VAL . 6.9 Cg_exo -72.78 120.69 6.82 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.243 2.629 . . . . 10.14 112.064 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 305' ' ' CYS . 96.1 mt -94.4 141.29 28.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.099 -0.501 . . . . 8.3 110.698 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.7 ptpt -110.94 -32.73 6.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.019 0.438 . . . . 8.65 110.155 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -132.4 111.5 11.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.536 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.3 124.09 41.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 6.27 110.183 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -140.34 114.87 9.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.308 0.575 . . . . 5.79 110.351 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.5 tp -90.34 125.49 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 6.35 110.247 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.1 116.51 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.127 0.489 . . . . 6.61 110.116 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.485 ' HZ1' ' CG ' ' A' ' 272' ' ' ASP . 61.4 mttm -110.73 154.31 24.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.74 -0.664 . . . . 8.17 110.86 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 13.5 t70 -83.29 129.71 35.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.984 -0.747 . . . . 10.33 108.984 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.4 m -85.19 -13.27 50.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.426 -0.352 . . . . 10.8 111.887 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.11 -56.43 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.987 0.422 . . . . 12.13 111.095 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.467 HG22 ' HG ' ' A' ' 298' ' ' LEU . 48.1 m -83.27 -30.42 27.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 11.16 110.627 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.02 22.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.585 -0.817 . . . . 10.11 112.59 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' A' ' 296' ' ' THR . 84.3 mt -110.11 161.54 15.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.73 0.3 . . . . 10.12 110.418 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.9 t -69.52 133.75 48.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.28 -0.637 . . . . 7.73 109.28 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.467 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.2 mmmp? -74.82 -15.88 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 8.01 110.858 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 97.76 14.78 39.11 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.612 -0.804 . . . . 6.09 113.049 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 11.0 p90 -154.89 146.62 23.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 6.54 110.779 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.3 168.02 21.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.882 -0.599 . . . . 4.38 110.718 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.475 ' HB3' ' HG2' ' A' ' 260' ' ' LYS . 91.8 m-85 -114.54 130.21 56.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 4.93 109.557 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 35.5 m -141.98 116.57 9.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 5.09 111.608 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.479 ' OE1' ' HD2' ' A' ' 286' ' ' LYS . 39.9 tt0 -100.24 130.62 46.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.821 -0.437 . . . . 7.03 109.821 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' ' OG1' ' A' ' 313' ' ' THR . 47.5 m-85 -88.67 158.51 18.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 7.81 111.07 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 286' ' ' LYS . 58.6 t -79.1 -46.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 10.03 111.118 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.561 ' HB3' HG22 ' A' ' 312' ' ' VAL . 12.6 t70 -93.91 132.55 38.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 10.81 110.446 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -64.79 -28.49 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 112.263 0.468 . . . . 9.77 112.263 -176.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -71.79 -50.05 33.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.891 -0.411 . . . . 10.89 109.891 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.734 HG21 ' HD2' ' A' ' 284' ' ' PRO . 20.8 m -66.27 -24.68 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 9.5 110.856 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 317' ' ' ILE . 47.3 m -61.85 -48.16 81.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.13 0.49 . . . . 7.83 110.132 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.81 -35.13 64.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.007 -0.542 . . . . 8.79 110.516 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -63.53 -40.22 96.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 10.51 110.773 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.12 97.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 7.31 110.47 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 313' ' ' THR . 71.7 mt -59.08 -45.38 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 6.44 110.674 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.51 78.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.749 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.31 -49.36 6.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 7.46 113.51 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.509 ' HB3' HD23 ' A' ' 330' ' ' LEU . 98.6 mt -73.57 -49.07 28.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.302 . . . . 6.42 111.814 -173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 7.3 t30 -63.05 115.22 4.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 6.53 110.44 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.92 -20.55 14.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.853 -0.689 . . . . 6.77 112.389 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 20.9 ttt -75.22 141.41 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.146 -0.316 . . . . 7.29 110.146 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -88.66 118.87 28.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.785 0.326 . . . . 7.83 110.525 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.6 mm? -101.79 96.52 7.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.124 -0.489 . . . . 7.01 109.852 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.2 -85.57 0.81 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.901 -0.666 . . . . 8.18 112.058 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.63 -41.06 2.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.737 0.303 . . . . 8.94 111.281 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -91.29 165.64 13.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 7.29 110.807 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.66 136.1 37.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 7.13 109.536 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.856 ' HB2' HD23 ' A' ' 325' ' ' LEU . 33.0 tp -73.83 125.45 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.173 0.511 . . . . 5.63 111.316 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.67 118.63 37.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 5.53 109.614 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 91.1 t -127.32 113.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.185 -0.461 . . . . 5.21 109.779 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -138.04 171.87 13.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.122 -0.49 . . . . 6.05 110.01 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 334' ' ' ARG . 47.7 mtm180 -86.59 136.83 32.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.402 -0.222 . . . . 7.58 110.402 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -62.91 -44.55 95.77 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.115 0.483 . . . . 6.04 110.092 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 7.57 109.406 172.177 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.889 ' HB2' HG22 ' A' ' 205' ' ' VAL . 56.1 ttp85 75.99 -24.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.773 0.67 . . . . 0.0 111.991 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -97.53 150.91 20.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 6.52 111.392 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 208' ' ' THR . 23.7 mt -113.19 149.43 33.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.861 -0.609 . . . . 5.24 111.186 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -107.98 102.9 12.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.125 -0.943 . . . . 6.15 108.702 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 169' ' ' PHE . 7.4 p -104.11 127.44 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.488 . . . . 4.24 110.301 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.37 -178.75 15.44 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.803 -0.635 . . . . 4.95 111.777 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 10.2 m120 62.01 28.85 17.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.085 0.469 . . . . 0.0 110.899 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.528 HG22 HD22 ' A' ' 224' ' ' LEU . 31.8 pt -78.52 153.61 78.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.466 -0.788 . . . . 5.61 110.728 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.498 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 32.7 Cg_endo -64.35 136.71 52.37 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.556 2.171 . . . . 5.97 112.056 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.19 123.34 20.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 8.47 109.913 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.29 4.43 53.35 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.576 -0.821 . . . . 6.96 112.421 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.3 tp -66.07 130.85 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 6.1 110.147 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.8 p -92.24 155.21 18.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.765 0.317 . . . . 6.62 110.751 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 162' ' ' GLU . 25.6 mp0 -53.69 -46.47 70.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 5.69 110.186 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.96 -55.81 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.325 -0.852 . . . . 7.29 111.153 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.94 93.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.288 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 0.7 OUTLIER -64.94 -47.67 76.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 4.49 110.598 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.2 ttt -60.92 -48.83 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 5.76 110.769 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.46 -38.78 88.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 6.51 111.524 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.49 -49.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.614 -0.267 . . . . 5.44 111.068 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 153' ' ' VAL . 50.4 m-85 -65.1 -44.22 89.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.593 -0.276 . . . . 5.03 111.093 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.03 -33.45 75.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.557 -0.292 . . . . 6.3 110.985 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.74 -49.93 68.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.227 175.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -60.09 -35.36 75.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 6.25 111.113 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.703 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 6.0 mmt -60.88 -50.16 74.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 7.03 110.529 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -71.06 -44.29 66.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 8.94 111.269 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 78.1 mt -65.13 -35.18 80.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.383 . . . . 8.7 110.985 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.95 -34.38 38.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.627 -0.796 . . . . 8.11 112.104 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.37 47.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.624 . . . . 8.49 111.926 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 6.0 mp -96.19 82.83 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 7.59 109.672 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 185' ' ' PRO . 14.2 m -154.93 143.13 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.908 -0.587 . . . . 8.73 109.425 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.537 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 11.1 pt20 -93.24 -22.1 19.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.734 -0.387 . . . . 9.89 111.442 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.3 145.91 19.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.592 -0.277 . . . . 9.69 110.599 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.91 114.17 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.734 2.29 . . . . 10.74 112.003 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.6 -152.57 24.6 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.825 -0.702 . . . . 8.97 111.942 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -114.54 117.73 42.32 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.548 0.213 . . . . 7.58 110.865 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HG3' HG23 ' A' ' 179' ' ' THR . 28.0 Cg_exo -63.09 -37.83 49.75 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.66 2.24 . . . . 6.4 111.53 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 52.8 t -89.72 112.55 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.836 -0.62 . . . . 5.47 109.824 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 280' ' ' THR . 86.4 mt -89.96 -39.28 13.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.729 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.1 168.94 19.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.46 116.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 4.68 110.753 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -98.15 106.96 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 6.34 109.614 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.0 mt -91.66 136.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.232 0.539 . . . . 5.85 110.958 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -119.55 96.77 5.34 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -70.5 -23.97 62.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.569 -0.741 . . . . 7.61 111.697 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.76 -49.92 75.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 9.12 111.498 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 35.2 mmtm -106.19 7.09 31.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 9.1 111.028 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.04 61.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.795 . . . . 6.6 111.5 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 52.3 p90 -148.99 171.31 16.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.092 -0.504 . . . . 6.67 109.676 173.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.94 142.46 28.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.357 . . . . 4.58 111.158 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 70.2 m-85 -92.8 113.44 25.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 6.22 109.869 175.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 151' ' ' LEU . 97.0 mt -83.35 115.76 22.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.211 -0.449 . . . . 4.77 110.253 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.84 108.45 19.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 6.55 109.695 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 37.1 m-85 -99.02 157.33 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 6.51 111.287 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -82.94 -24.32 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.387 -0.824 . . . . 8.27 110.765 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 98.5 p -134.06 163.0 30.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 7.96 109.991 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 149' ' ' ARG . 15.7 t -92.1 -15.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.875 0.845 . . . . 8.73 108.841 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.99 -56.14 6.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.773 -1.103 . . . . 8.5 111.183 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.537 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.5 mt-10 -65.79 -24.28 66.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 7.4 111.704 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 151' ' ' LEU . 13.3 m -48.97 -49.75 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.636 0.585 . . . . 6.13 111.508 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.8 m -61.46 -36.23 79.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.012 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.692 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 24.2 mp0 -70.11 -28.98 65.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.056 -0.258 . . . . 7.75 111.189 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.42 -23.52 62.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.313 0.578 . . . . 5.43 110.337 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 86.8 mtp -70.8 -14.77 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.704 -0.68 . . . . 6.29 110.794 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.89 2.54 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 6.14 111.254 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -113.02 19.69 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 5.57 110.436 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.83 117.63 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.927 -0.579 . . . . 5.92 111.039 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 97.93 16.62 32.69 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.827 -0.702 . . . . 5.74 112.498 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.89 135.61 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 110.036 -0.357 . . . . 5.3 110.036 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 tp -84.27 116.43 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 6.8 111.004 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -135.18 118.67 16.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.796 -0.638 . . . . 5.79 110.288 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 60.84 32.47 20.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 7.32 111.414 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.91 78.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.844 -0.693 . . . . 7.28 112.632 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 32.6 mm-40 -110.08 132.35 54.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.258 -0.275 . . . . 7.21 110.258 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.5 m -86.37 106.78 17.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.871 -0.418 . . . . 6.14 109.871 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 156' ' ' ILE . 75.9 mt -66.1 111.89 3.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 4.9 110.896 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 86.5 tttt -87.76 114.61 24.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.742 -0.663 . . . . 7.3 109.528 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.6 mt -110.92 105.64 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.937 0.399 . . . . 5.37 110.423 -173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 15.1 mmt85 -129.25 171.2 12.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.067 -0.515 . . . . 6.97 110.324 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 45.8 mtp180 -104.42 143.68 27.17 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.594 0.235 . . . . 7.37 111.109 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.09 160.98 14.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.462 2.108 . . . . 7.98 110.769 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.516 -175.101 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 108.87 -0.789 . . . . 8.75 108.87 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 35.3 ttmt -62.33 125.38 23.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.462 -1.245 . . . . 6.04 109.934 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 307' ' ' TYR . 69.6 mt -98.86 142.31 30.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.113 -0.494 . . . . 5.29 110.797 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.676 ' HB2' ' HA ' ' A' ' 335' ' ' ALA . 87.3 t80 -95.99 109.47 21.85 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.294 -0.866 . . . . 4.77 108.897 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.34 106.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.863 -0.421 . . . . 3.94 109.863 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.95 171.1 19.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.898 -0.668 . . . . 4.58 111.511 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.2 27.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.654 -0.784 . . . . 5.58 112.068 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.4 mt -101.42 143.86 27.42 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.259 -0.275 . . . . 5.92 110.259 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.689 ' HD2' HD22 ' A' ' 270' ' ' LEU . 30.5 Cg_exo -62.33 143.42 93.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.569 2.179 . . . . 6.94 111.98 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.66 -24.43 66.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.615 0.228 . . . . 8.81 111.615 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -85.02 -7.17 59.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.754 0.312 . . . . 8.73 110.836 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.689 HD22 ' HD2' ' A' ' 267' ' ' PRO . 12.1 tp -71.81 106.5 4.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.617 -0.512 . . . . 7.52 109.617 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.6 p-10 -85.9 172.18 10.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 8.79 111.012 -175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.07 -37.69 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 7.62 111.94 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.17 -54.39 44.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.758 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.62 -42.59 95.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 8.69 111.643 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 271' ' ' ASN . 38.9 t -61.49 -47.03 95.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.561 0.22 . . . . 6.64 110.728 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -58.56 -54.0 51.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.586 -0.279 . . . . 7.74 110.72 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.75 -51.02 70.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.073 -0.512 . . . . 9.38 111.591 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.0 -42.89 81.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 7.06 110.693 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 320' ' ' LEU . 62.1 mt -80.32 -29.05 38.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.484 -0.325 . . . . 6.89 111.26 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.4 m -71.54 -16.73 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 8.85 110.796 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 16.3 m -59.97 -15.03 18.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.917 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.85 9.29 11.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.614 0.245 . . . . 9.18 111.23 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.75 146.27 4.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.946 -0.645 . . . . 9.06 112.395 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HA ' HG23 ' A' ' 280' ' ' THR . 50.4 Cg_endo -69.78 141.75 46.0 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.682 2.254 . . . . 10.14 112.733 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 305' ' ' CYS . 86.6 mt -97.57 130.76 44.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 8.3 110.883 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.5 ptpt -93.5 -29.24 15.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.131 0.491 . . . . 8.65 110.028 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -136.42 115.07 11.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.541 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.576 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 76.8 t80 -125.82 122.21 35.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 6.27 110.759 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.87 111.6 6.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.51 0.671 . . . . 5.79 110.472 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 303' ' ' ALA . 57.0 tp -85.18 140.11 31.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.386 -0.825 . . . . 6.35 109.778 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.4 t -88.81 111.34 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.077 0.465 . . . . 6.61 110.123 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -102.35 155.24 18.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 8.17 111.099 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.76 135.42 34.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.66 -0.7 . . . . 10.33 109.907 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.6 m -74.45 -12.94 60.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 10.8 112.036 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.03 -68.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 12.13 111.324 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 17.4 m -77.9 -32.35 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 11.16 111.426 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.04 6.97 62.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.54 -0.838 . . . . 10.11 112.414 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.32 173.34 11.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.618 0.247 . . . . 10.12 110.339 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -79.38 144.7 33.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.408 -0.36 . . . . 7.73 110.1 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 300' ' ' LYS . 30.8 mmtp -79.15 0.34 28.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 8.01 110.436 175.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 97.71 17.13 31.62 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 6.09 113.069 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 291' ' ' VAL . 43.6 p90 -162.73 157.03 21.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.329 0.585 . . . . 6.54 111.261 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -147.46 160.17 42.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.314 -0.857 . . . . 4.38 110.24 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.473 ' HD2' ' HB1' ' A' ' 335' ' ' ALA . 81.8 m-85 -107.43 122.65 47.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.853 -0.795 . . . . 4.93 108.853 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.576 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.9 m -139.01 115.24 10.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 5.09 111.412 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 33.5 tt0 -98.25 135.43 39.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.916 -0.584 . . . . 7.03 110.155 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.414 ' CE1' HD12 ' A' ' 261' ' ' LEU . 26.1 m-85 -90.14 147.31 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.213 -0.448 . . . . 7.81 111.238 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.681 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 52.5 t -66.32 -53.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 10.03 110.578 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.466 ' HB3' HG22 ' A' ' 312' ' ' VAL . 27.0 t70 -88.64 137.16 32.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.997 -0.547 . . . . 10.81 110.374 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -79.2 -18.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.148 0.425 . . . . 9.77 112.148 -174.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.61 -40.22 23.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.761 0.315 . . . . 10.89 110.401 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.5 m -69.49 -22.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 9.5 111.439 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 317' ' ' ILE . 21.4 m -55.3 -50.6 69.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.68 0.276 . . . . 7.83 111.563 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.92 -32.82 72.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.014 0.435 . . . . 8.79 110.789 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -66.12 -41.39 90.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 10.51 110.443 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.34 94.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 7.31 110.734 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 313' ' ' THR . 64.4 mt -57.36 -41.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 6.44 110.495 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.54 -43.52 59.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.741 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -75.43 -47.54 12.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.018 -0.611 . . . . 7.46 113.469 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HB2' HG21 ' A' ' 332' ' ' VAL . 87.1 mt -70.56 -43.11 70.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.647 0.261 . . . . 6.42 111.61 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 8.9 t30 -66.43 115.44 6.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.75 0.31 . . . . 6.53 110.272 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.41 -21.55 14.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.925 -0.655 . . . . 6.77 111.514 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.5 ttt -73.85 141.86 46.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.039 -0.356 . . . . 7.29 110.039 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 26.1 tt0 -105.59 125.18 50.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.833 0.349 . . . . 7.83 110.599 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 267' ' ' PRO . 0.4 OUTLIER -117.14 113.4 22.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.94 -0.763 . . . . 7.01 108.94 177.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.86 -88.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.939 -0.648 . . . . 8.18 112.849 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.69 0.26 3.57 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.854 -0.203 . . . . 8.94 111.396 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -130.61 152.08 50.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.915 0.388 . . . . 7.29 111.147 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 91.3 mttt -103.83 129.7 51.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 7.13 109.647 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.72 122.77 18.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.037 0.446 . . . . 5.63 112.121 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.53 107.43 19.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.334 -0.987 . . . . 5.53 108.334 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 320' ' ' LEU . 59.4 t -110.81 121.87 64.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 5.21 111.643 -173.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 13.9 pt20 -139.69 -169.09 2.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 6.05 108.77 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -87.14 141.33 28.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.878 -0.416 . . . . 7.58 109.878 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 262' ' ' PHE . . . -70.51 -38.18 74.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 6.04 111.272 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 7.57 110.044 177.705 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.47 ' HB3' ' NH2' ' A' ' 228' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 205' ' ' VAL . 23.4 ptt85 -117.67 20.64 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.883 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.88 139.91 39.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.978 -0.555 . . . . 6.52 109.91 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.24 137.21 48.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.847 0.356 . . . . 5.24 110.293 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.633 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 74.7 t80 -94.94 104.66 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.847 -0.615 . . . . 6.15 109.46 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 5.8 p -107.32 125.08 63.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.315 0.578 . . . . 4.24 110.642 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.69 -178.86 15.48 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.516 -0.765 . . . . 4.95 111.632 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.1 t30 59.8 41.31 18.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.029 0.919 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.694 HG22 HD22 ' A' ' 224' ' ' LEU . 32.6 pt -90.42 156.95 45.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.949 . . . . 5.61 110.712 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.588 ' HG3' ' HB2' ' A' ' 220' ' ' GLN . 29.6 Cg_endo -63.84 142.32 81.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.669 2.246 . . . . 5.97 112.26 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -80.32 126.99 31.85 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.612 -0.514 . . . . 8.47 109.612 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.49 21.18 41.65 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.623 -0.798 . . . . 6.96 111.999 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.576 HD13 ' HG3' ' A' ' 220' ' ' GLN . 9.3 tp -78.97 139.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.868 0.366 . . . . 6.1 110.691 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 24.7 m -75.52 128.07 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 6.62 110.293 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.523 ' HA ' HD12 ' A' ' 191' ' ' ILE . 44.1 mt-10 -59.69 -47.9 83.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.506 -0.315 . . . . 5.69 110.765 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.96 -42.48 89.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.953 -0.567 . . . . 7.29 110.53 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -63.15 -44.17 96.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.2 ttm -64.94 -45.72 84.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.507 -0.315 . . . . 4.49 110.653 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.1 ttt -61.33 -50.95 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.153 -0.476 . . . . 5.76 111.004 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.02 -32.78 74.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 6.51 110.958 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.499 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 86.3 t80 -59.32 -52.58 65.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 5.44 110.579 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -63.67 -41.69 98.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 5.03 110.786 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.4 m-20 -55.77 -48.86 74.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 6.3 110.43 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.5 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.22 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 87.3 mm-40 -64.25 -37.35 87.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.25 111.267 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 86.7 mtp -69.83 -34.87 74.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.998 -0.281 . . . . 7.03 110.583 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 98.6 mtt180 -64.7 -50.9 65.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.013 0.435 . . . . 8.94 110.196 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.27 -35.52 81.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 8.7 111.911 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.05 -21.37 59.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.603 -0.808 . . . . 8.11 112.59 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.91 40.94 7.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.592 -0.813 . . . . 8.49 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.66 3.31 34.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.087 0.47 . . . . 7.59 110.259 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 p -92.34 140.14 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 8.73 110.827 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 12.6 pt20 -95.02 -10.71 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.087 0.47 . . . . 9.89 110.287 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.11 158.71 33.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 9.69 110.227 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 154.06 62.59 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.559 2.172 . . . . 10.74 111.822 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.37 -145.77 16.1 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.669 -0.777 . . . . 8.97 112.599 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.58 122.5 37.2 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 120.462 0.172 . . . . 7.58 110.571 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.82 -38.61 47.39 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.737 2.291 . . . . 6.4 111.69 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.91 137.26 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.41 -0.589 . . . . 5.47 109.41 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 284' ' ' PRO . 50.9 tp -105.1 -41.63 5.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.644 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -142.56 134.25 26.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.76 117.37 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 4.68 110.159 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -124.58 105.81 9.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.823 -0.436 . . . . 6.34 109.823 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 162' ' ' GLU . 55.4 mt -107.23 134.16 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 5.85 111.453 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -109.91 113.85 26.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.542 . . . . 7.34 109.538 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -82.97 -10.91 58.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 7.61 110.81 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.91 -59.08 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.161 -0.472 . . . . 9.12 111.051 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.0 mmtm -91.16 -0.79 57.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.405 -0.361 . . . . 9.1 110.686 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 62.2 61.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 6.6 110.912 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 42.7 p90 -148.87 158.68 44.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 6.67 109.446 175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -139.57 147.63 41.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.942 0.401 . . . . 4.58 110.856 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.12 109.55 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.772 -0.649 . . . . 6.22 110.008 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.247 -0.649 . . . . 4.77 109.247 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 127.36 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.642 . . . . 6.55 109.268 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -99.03 162.85 12.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.977 0.417 . . . . 6.51 111.203 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -71.93 -25.78 62.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.405 -0.816 . . . . 8.27 110.329 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.1 p -124.56 -170.32 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.582 -0.736 . . . . 7.96 109.595 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 149' ' ' ARG . 39.2 t -113.78 -28.78 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.644 0.735 . . . . 8.73 109.281 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.15 -51.04 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.896 . . . . 8.5 111.34 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 50.4 mt-10 -65.24 -35.12 80.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.076 -0.511 . . . . 7.4 110.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -55.12 -50.14 70.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.316 0.579 . . . . 6.13 110.351 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 24.1 m -60.06 -34.13 73.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.698 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -31.59 64.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 7.75 110.277 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -76.03 -7.43 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.023 -0.535 . . . . 5.43 111.206 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 85.8 mtp -69.85 -16.65 63.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.411 . . . . 6.29 110.021 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.59 50.38 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.674 -0.694 . . . . 6.14 111.049 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.493 ' HD1' HD12 ' A' ' 217' ' ' ILE . 93.3 m-85 -93.75 7.14 45.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 5.57 110.812 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.28 114.29 3.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.98 -0.378 . . . . 5.92 109.98 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.36 12.51 44.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.859 -0.686 . . . . 5.74 112.11 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.493 HD12 ' HD1' ' A' ' 214' ' ' PHE . 16.6 tt -71.53 137.19 24.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 5.3 110.044 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -85.55 112.03 21.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.459 0.647 . . . . 6.8 110.056 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -133.09 119.4 19.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 5.79 110.579 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.588 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 80.9 mm-40 60.82 29.54 19.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.522 -0.763 . . . . 7.32 111.273 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.78 7.97 83.36 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.857 -0.687 . . . . 7.28 112.857 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -124.76 132.74 53.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.568 -0.372 . . . . 7.21 110.824 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 t -78.86 112.33 15.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.147 -0.686 . . . . 6.14 109.147 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.694 HD22 HG22 ' A' ' 156' ' ' ILE . 46.4 mt -81.9 120.71 25.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.885 0.374 . . . . 4.9 111.352 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.5 tttt -84.78 115.97 23.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 7.3 109.543 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.9 mt -121.98 105.89 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.415 . . . . 5.37 110.886 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.7 mmt180 -132.68 167.5 19.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.045 -0.525 . . . . 6.97 110.412 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 15.7 mtp180 -79.34 128.17 76.38 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.738 -0.467 . . . . 7.37 109.738 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.633 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 3.6 Cg_exo -73.07 153.81 52.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.797 2.331 . . . . 7.98 112.241 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.015 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.879 ' HB3' HG21 ' A' ' 313' ' ' THR . 52.6 m80 . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 111.792 0.293 . . . . 8.75 111.792 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 305' ' ' CYS . 40.3 ttmt -66.44 121.49 15.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.681 -0.488 . . . . 6.04 109.681 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.43 142.09 31.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.313 0.577 . . . . 5.29 111.476 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.97 107.19 19.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.781 -1.099 . . . . 4.77 108.684 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 3.6 mp -100.3 104.58 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.954 -0.566 . . . . 3.94 109.529 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -118.84 120.5 4.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.589 -0.815 . . . . 4.58 112.691 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 139.2 9.71 0.9 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.096 -0.573 . . . . 5.58 112.296 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.4 144.76 74.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.481 0.182 . . . . 5.92 110.65 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD2' HD22 ' A' ' 270' ' ' LEU . 41.2 Cg_exo -57.63 135.88 72.21 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.77 2.314 . . . . 6.94 112.292 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 9.1 p30 -62.39 -23.55 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.918 -0.583 . . . . 8.81 111.137 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -100.59 12.58 37.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.551 . . . . 8.73 111.34 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.444 HD22 ' HD2' ' A' ' 267' ' ' PRO . 26.8 tp -89.32 125.2 35.02 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.779 -0.452 . . . . 7.52 109.779 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.8 p-10 -85.09 157.01 20.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 8.79 111.186 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 2.8 m-20 -52.5 -36.16 54.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.663 -0.699 . . . . 7.62 112.055 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.25 -53.06 58.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.431 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -72.62 -40.09 66.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 8.69 111.081 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.9 t -56.83 -47.81 82.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.428 -0.351 . . . . 6.64 110.716 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.4 mtmm -59.96 -47.53 85.44 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.477 -0.328 . . . . 7.74 110.815 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -49.74 76.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.106 -0.237 . . . . 9.38 110.965 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.23 -47.16 78.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 7.06 110.763 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.568 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -77.13 -31.5 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.396 -0.365 . . . . 6.89 111.563 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.6 m -69.97 -27.97 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 8.85 111.017 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 41.9 m -72.41 4.5 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.542 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -132.53 9.81 4.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.364 -0.38 . . . . 9.18 110.779 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.439 ' HA3' ' HE2' ' A' ' 307' ' ' TYR . . . 160.56 146.32 4.57 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.183 -1.008 . . . . 9.06 113.286 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 1.01 ' HB3' HD21 ' A' ' 187' ' ' LEU . 53.4 Cg_endo -71.04 119.82 6.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.249 2.633 . . . . 10.14 112.534 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.855 HD22 ' HB3' ' A' ' 305' ' ' CYS . 56.0 mt -100.4 103.23 14.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.199 -0.455 . . . . 8.3 110.486 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 308' ' ' VAL . 53.9 pttt -82.29 -20.7 36.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 8.65 110.072 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -138.99 130.2 26.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.411 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 75.6 t80 -145.21 128.83 17.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.667 0.27 . . . . 6.27 110.638 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -140.6 114.19 8.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.357 0.598 . . . . 5.79 110.983 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 62.4 tp -90.68 131.67 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.458 -0.792 . . . . 6.35 109.188 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.45 121.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.916 0.389 . . . . 6.61 110.798 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.77 157.95 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.004 -0.544 . . . . 8.17 110.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.404 ' HB2' ' CD ' ' A' ' 300' ' ' LYS . 14.5 t70 -91.05 121.64 33.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.216 -0.661 . . . . 10.33 109.216 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 47.2 m -71.61 -29.6 64.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.452 0.538 . . . . 10.8 112.452 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.59 -44.72 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.808 -0.357 . . . . 12.13 110.932 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 10.4 m -73.98 -44.73 53.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.144 -0.48 . . . . 11.16 111.306 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 90.59 26.32 23.16 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 10.11 111.889 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 92.3 mt -135.19 168.46 19.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.804 -0.443 . . . . 10.12 109.804 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 42.6 t -70.42 145.92 50.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 7.73 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.404 ' CD ' ' HB2' ' A' ' 293' ' ' ASP . 31.5 mmmt -76.32 -20.47 57.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 8.01 110.17 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 107.35 -7.84 37.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.621 -0.799 . . . . 6.09 112.897 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 52.7 p90 -128.4 147.2 50.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.191 0.52 . . . . 6.54 111.534 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -142.3 158.67 43.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 4.38 110.435 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.409 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 93.0 m-85 -111.59 132.38 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.238 -0.437 . . . . 4.93 110.079 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.855 ' HB3' HD22 ' A' ' 285' ' ' LEU . 57.4 m -130.89 115.76 16.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.317 -0.401 . . . . 5.09 111.239 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 40.5 tt0 -95.4 119.58 34.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.488 -0.56 . . . . 7.03 109.488 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.439 ' HE2' ' HA3' ' A' ' 283' ' ' GLY . 30.1 m-85 -90.72 148.36 22.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 7.81 111.845 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 286' ' ' LYS . 53.6 t -77.34 -48.26 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 10.03 110.579 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.659 ' HB3' HG22 ' A' ' 312' ' ' VAL . 18.2 t70 -82.37 157.75 23.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 10.81 109.897 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -110.11 -4.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.489 0.551 . . . . 9.77 112.489 -173.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -111.02 -30.48 7.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.963 -0.295 . . . . 10.89 111.482 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.1 m -71.52 -23.71 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.867 0.321 . . . . 9.5 111.867 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.879 HG21 ' HB3' ' A' ' 259' ' ' HIS . 13.0 m -57.56 -49.37 76.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.945 0.35 . . . . 7.83 111.945 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.39 -27.1 68.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.059 0.457 . . . . 8.79 110.748 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.69 -34.74 45.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 10.51 110.413 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.58 99.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 7.31 110.065 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.0 mt -57.38 -47.1 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.719 -0.673 . . . . 6.44 110.531 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.87 -33.73 72.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.842 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.92 -44.62 5.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.704 -0.76 . . . . 7.46 112.959 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.39 -51.18 15.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 6.42 111.402 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.735 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.1 t30 -67.6 120.7 14.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.124 -0.489 . . . . 6.53 110.365 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 121.69 -30.17 5.41 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.815 -0.707 . . . . 6.77 111.776 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -74.52 141.0 44.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 7.29 109.21 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 29.9 tt0 -107.89 120.91 43.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.966 0.412 . . . . 7.83 111.541 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.38 103.78 16.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 7.01 109.721 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.77 -96.84 0.38 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.011 -0.614 . . . . 8.18 112.265 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.05 2.08 9.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 8.94 110.687 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.69 113.51 26.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 7.29 110.854 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 87.8 tttt -72.16 131.23 42.52 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.302 -0.629 . . . . 7.13 109.302 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 263' ' ' ILE . 23.2 tp -77.68 117.16 18.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.961 0.41 . . . . 5.63 111.351 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 329' ' ' LYS . 6.3 mp -98.95 123.6 43.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.355 -0.609 . . . . 5.53 109.355 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.735 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 57.5 t -125.67 118.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.077 -0.511 . . . . 5.21 110.204 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.75 163.71 34.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.789 -0.819 . . . . 6.05 108.789 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.95 141.87 58.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.862 -0.421 . . . . 7.58 109.862 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.43 -51.32 47.67 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.418 0.449 . . . . 6.04 111.876 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 120.815 0.341 . . . . 7.57 110.274 176.937 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.948 0.404 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.07 -50.59 7.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.381 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 199' ' ' PHE . 99.2 mtt180 -106.99 133.32 51.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 6.52 111.034 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 208' ' ' THR . 31.7 mt -92.87 152.92 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.449 . . . . 5.24 110.466 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 65.7 t80 -94.14 110.65 22.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.815 -0.63 . . . . 6.15 109.736 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 198' ' ' ALA . 5.9 p -111.1 119.92 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.274 0.559 . . . . 4.24 109.88 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.88 15.06 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.652 -0.704 . . . . 4.95 111.951 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.12 39.74 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.921 0.867 . . . . 0.0 109.188 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 27.8 pt -85.76 146.95 44.86 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.004 -0.998 . . . . 5.61 110.833 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 6.9 Cg_exo -74.48 120.5 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.896 2.397 . . . . 5.97 111.752 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 193' ' ' GLN . 28.5 t80 -62.24 132.8 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.132 -0.486 . . . . 8.47 109.929 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 114.31 -17.0 19.46 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.67 -0.776 . . . . 6.96 112.597 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.9 tp -78.62 144.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 6.1 110.335 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -88.94 152.82 21.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 6.62 110.864 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.617 ' HA ' HD12 ' A' ' 191' ' ' ILE . 40.4 mt-10 -63.09 -39.82 95.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.126 -0.488 . . . . 5.69 110.75 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -61.99 -47.29 85.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.599 . . . . 7.29 110.788 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.89 86.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.4 tpt -63.21 -47.62 81.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 4.49 110.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.426 ' HB2' HG11 ' A' ' 189' ' ' VAL . 22.5 ttt -61.15 -46.38 90.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 5.76 111.307 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.52 -36.28 82.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 6.51 110.854 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.9 -46.9 84.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.967 -0.56 . . . . 5.44 110.516 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 173' ' ' MET . 54.9 m-85 -64.31 -46.36 83.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 5.03 110.83 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.54 -45.68 73.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.719 0.295 . . . . 6.3 110.956 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -60.7 -48.76 80.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.896 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -69.84 -27.0 64.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 6.25 111.753 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.663 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 32.4 mmt -64.62 -42.69 95.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 7.03 110.016 176.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -70.2 -44.61 68.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.842 -0.617 . . . . 8.94 110.419 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 79.8 mt -68.21 -34.49 76.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 8.7 111.446 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.57 -16.3 73.75 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.601 -0.809 . . . . 8.11 112.466 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.78 29.63 34.6 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.685 -0.769 . . . . 8.49 112.147 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.613 HD11 ' HE1' ' A' ' 214' ' ' PHE . 4.5 mp -87.89 -22.52 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.36 0.6 . . . . 7.59 109.838 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 24.0 m -76.21 122.69 24.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.217 -0.902 . . . . 8.73 110.751 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.465 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 11.7 pt20 -80.6 -30.49 36.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.914 0.387 . . . . 9.89 110.932 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.75 124.89 18.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.509 . . . . 9.69 110.253 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.79 128.62 2.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.962 3.108 . . . . 10.74 113.613 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 134.58 -129.63 5.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.915 -0.659 . . . . 8.97 112.265 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -123.26 117.95 27.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.724 0.297 . . . . 7.58 111.086 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.88 -27.82 9.94 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.599 2.2 . . . . 6.4 112.047 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.4 t -90.03 133.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 5.47 110.039 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 203' ' ' ARG . 86.9 mt -95.42 -56.3 2.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.6 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.41 157.88 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.528 HG23 HD23 ' A' ' 200' ' ' LEU . 8.2 p -133.93 137.57 52.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.058 -0.519 . . . . 4.68 110.599 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.73 111.12 13.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.632 -0.507 . . . . 6.34 109.632 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 162' ' ' GLU . 41.6 mt -104.71 127.23 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 5.85 111.555 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -105.36 97.98 7.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.062 -1.088 . . . . 7.34 108.062 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 158' ' ' PHE . 16.1 tt0 -85.45 -5.28 59.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.971 -0.559 . . . . 7.61 110.307 -172.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.28 -52.64 10.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 9.12 110.204 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 26.1 mmtm -91.98 2.67 56.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 9.1 110.757 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.86 48.53 3.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.332 -0.849 . . . . 6.6 111.712 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.457 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 34.8 p90 -148.52 151.32 34.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.301 -0.409 . . . . 6.67 110.224 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.27 157.51 45.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.522 -0.308 . . . . 4.58 110.827 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 150' ' ' ARG . 61.1 m-85 -118.32 119.51 34.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.202 -0.454 . . . . 6.22 110.806 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 31.0 mt -95.32 115.0 26.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.678 -0.692 . . . . 4.77 109.549 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -96.41 116.87 29.75 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.51 -0.476 . . . . 6.55 110.384 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 208' ' ' THR . 27.6 m-85 -93.84 163.91 13.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.683 -0.69 . . . . 6.51 110.612 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.495 ' HA ' HD11 ' A' ' 187' ' ' LEU . 37.0 ptt180 -74.48 -24.19 58.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 8.27 110.788 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 71.3 p -125.44 -161.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.19 -0.459 . . . . 7.96 110.434 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.12 -34.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.094 0.473 . . . . 8.73 110.04 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.11 -52.2 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 8.5 111.129 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.465 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.2 mt-10 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.748 -0.464 . . . . 7.4 109.748 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 151' ' ' LEU . 2.1 m -51.69 -52.43 48.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.465 -0.788 . . . . 6.13 110.818 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.3 m -63.41 -33.67 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.766 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.455 ' HG3' HD23 ' A' ' 178' ' ' LEU . 64.8 tp60 -71.05 -30.0 66.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 7.75 110.393 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -16.26 63.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 5.43 111.349 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.9 mtp -69.78 -13.75 62.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 6.29 111.165 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.25 65.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 6.14 111.097 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.613 ' HE1' HD11 ' A' ' 178' ' ' LEU . 22.5 m-85 -94.13 12.27 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 5.57 111.353 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.84 112.9 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.817 0.341 . . . . 5.92 110.28 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.58 30.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.714 -0.755 . . . . 5.74 112.499 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ILE . . . . . 0.533 HD12 ' HD2' ' A' ' 214' ' ' PHE . 15.4 tt -61.44 138.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.926 0.393 . . . . 5.3 110.398 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.11 122.56 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.331 0.586 . . . . 6.8 110.883 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -133.68 106.49 7.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.737 -0.665 . . . . 5.79 110.125 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.54 31.27 20.22 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.831 -0.622 . . . . 7.32 111.968 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.44 68.36 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.589 -0.815 . . . . 7.28 112.851 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 31.1 mm-40 -120.24 136.06 54.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.212 -0.292 . . . . 7.21 110.212 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.3 m -87.19 108.8 19.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.401 -0.363 . . . . 6.14 110.22 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.73 119.56 11.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.476 . . . . 4.9 110.891 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 83.2 tttt -90.94 116.96 29.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.906 -0.588 . . . . 7.3 109.804 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.07 105.89 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.04 0.448 . . . . 5.37 110.131 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.6 mmt85 -127.61 170.2 12.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.963 -0.562 . . . . 6.97 111.005 -174.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -77.17 144.8 72.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.928 -0.578 . . . . 7.37 109.455 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.89 164.47 13.93 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.701 2.267 . . . . 7.98 113.026 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.973 177.918 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.416 ' NE2' ' HB ' ' A' ' 310' ' ' ILE . 64.3 m80 . . . . . 0 CA--C 1.516 -0.361 0 CA-C-O 121.702 0.763 . . . . 8.75 109.191 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 33.0 ttmt -60.51 113.37 2.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.086 -1.416 . . . . 6.04 109.88 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 307' ' ' TYR . 39.4 mt -90.71 142.29 27.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.081 -0.509 . . . . 5.29 110.764 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.476 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 88.6 t80 -93.6 105.21 17.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.306 -0.861 . . . . 4.77 108.928 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 4.5 mp -96.45 100.41 10.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.648 -0.501 . . . . 3.94 109.648 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.88 108.37 1.74 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.718 -0.753 . . . . 4.58 112.102 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 149.68 42.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.708 -0.758 . . . . 5.58 112.161 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.522 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.4 mt -119.1 137.97 25.72 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.607 0.242 . . . . 5.92 110.462 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 325' ' ' LEU . 24.9 Cg_exo -64.2 154.11 72.66 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.662 2.241 . . . . 6.94 111.685 174.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 21.2 p30 -68.18 -23.72 64.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.431 0.53 . . . . 8.81 112.431 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -83.62 12.08 6.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.0 0.371 . . . . 8.73 112.0 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.08 129.37 36.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.109 0.48 . . . . 7.52 110.341 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.5 p-10 -102.98 179.93 4.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 8.79 110.655 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.37 -37.81 81.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 7.62 111.528 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.39 -52.88 59.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -61.19 -46.46 90.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 8.69 111.817 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 271' ' ' ASN . 61.1 t -63.27 -45.96 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.531 -0.304 . . . . 6.64 111.186 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.47 -50.73 72.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.91 -0.316 . . . . 7.74 110.516 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.86 -50.2 73.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.035 -0.529 . . . . 9.38 111.169 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 278' ' ' LEU . 1.5 tm? -55.81 -50.85 69.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 7.06 110.419 -175.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.794 ' HB2' HD11 ' A' ' 285' ' ' LEU . 84.3 mt -71.36 -37.66 71.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.277 -0.42 . . . . 6.89 111.24 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 284' ' ' PRO . 91.9 m -66.74 -27.81 67.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.51 -0.314 . . . . 8.85 111.118 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 49.1 m -60.39 -25.86 66.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.029 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.43 ' CD2' HD21 ' A' ' 320' ' ' LEU . 90.2 m-85 -108.5 -0.21 20.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.989 0.423 . . . . 9.18 110.603 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 164.82 122.64 0.61 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.712 -0.676 . . . . 9.06 111.634 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 280' ' ' THR . 37.6 Cg_exo -58.69 131.67 43.62 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.042 2.494 . . . . 10.14 113.0 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 279' ' ' LEU . 81.0 mt -94.67 123.75 38.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 8.3 110.981 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -90.24 -22.32 21.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 8.65 109.945 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -137.11 134.7 36.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.922 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.734 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 56.2 t80 -146.32 126.9 14.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.326 -0.397 . . . . 6.27 111.334 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 3.6 p-10 -140.88 121.9 14.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.558 -0.534 . . . . 5.79 109.558 168.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 303' ' ' ALA . 59.1 tp -97.92 125.96 43.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 6.35 109.814 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 302' ' ' TYR . 47.5 t -77.55 112.55 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 6.61 110.221 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -106.89 161.99 14.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 8.17 111.321 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -96.96 135.05 39.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.741 -0.663 . . . . 10.33 109.694 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.0 m -69.86 -40.03 75.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.504 -0.316 . . . . 10.8 111.708 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.31 -48.42 14.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.851 0.357 . . . . 12.13 111.85 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -79.96 -32.23 39.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.238 -0.437 . . . . 11.16 111.66 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 76.8 24.07 68.04 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.583 -0.818 . . . . 10.11 111.982 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 89.2 mt -123.24 -178.88 4.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.113 -0.329 . . . . 10.12 110.113 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -77.25 143.73 38.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.728 0.299 . . . . 7.73 110.326 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -74.9 -26.5 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.013 0.435 . . . . 8.01 110.044 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 125.39 -7.37 7.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.415 -0.898 . . . . 6.09 113.105 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 22.2 p90 -138.79 156.49 47.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 6.54 111.154 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.15 165.77 30.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 4.38 110.739 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.413 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 98.7 m-85 -120.64 126.13 49.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.436 -0.579 . . . . 4.93 109.436 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.734 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.7 m -143.71 138.34 28.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.668 0.27 . . . . 5.09 110.915 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -113.48 136.02 53.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.775 -0.454 . . . . 7.03 109.775 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 261' ' ' LEU . 6.0 m-85 -84.19 153.19 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 7.81 111.021 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.568 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 90.2 t -64.85 -41.5 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 10.03 110.477 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.11 136.54 40.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 10.81 109.941 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.82 -1.28 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 111.98 0.363 . . . . 9.77 111.98 -174.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -93.39 -39.5 10.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.213 0.53 . . . . 10.89 109.673 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.38 -20.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.606 -0.724 . . . . 9.5 111.36 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 m -53.72 -47.95 70.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.275 -0.42 . . . . 7.83 112.041 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.62 -37.08 85.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 8.79 111.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 10.51 110.809 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.69 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 7.31 110.135 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 332' ' ' VAL . 83.8 mt -58.16 -50.92 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.833 -0.621 . . . . 6.44 110.77 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.09 71.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.924 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.6 4.06 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.531 -0.842 . . . . 7.46 112.965 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.43 HD21 ' CD2' ' A' ' 282' ' ' PHE . 96.2 mt -72.54 -40.38 66.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.031 0.382 . . . . 6.42 112.031 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 51.1 t30 -66.39 113.54 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 6.53 110.254 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 119.75 -12.4 10.91 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.963 -0.637 . . . . 6.77 112.036 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 62.9 mtt -75.15 -171.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.732 0.301 . . . . 7.29 110.474 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -146.35 123.19 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.764 0.316 . . . . 7.83 110.686 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.2 OUTLIER -106.92 112.06 24.84 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.591 -0.892 . . . . 7.01 108.591 176.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.56 -104.66 1.42 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.745 -0.741 . . . . 8.18 111.542 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.54 0.5 11.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.721 0.296 . . . . 8.94 111.068 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -112.52 138.96 48.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 7.29 110.945 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.38 138.66 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 7.13 110.4 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.439 HD11 HG23 ' A' ' 263' ' ' ILE . 55.0 tp -90.98 108.0 19.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.702 -0.681 . . . . 5.63 110.477 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.412 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 9.3 mp -105.77 105.53 15.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.212 -0.449 . . . . 5.53 109.94 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 317' ' ' ILE . 73.8 t -109.71 123.74 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.126 -0.488 . . . . 5.21 110.676 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 14.1 pt20 -133.79 -169.45 2.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 6.05 109.354 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 74.4 ttt180 -105.65 143.86 33.22 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 7.58 109.44 174.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.56 77.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.566 0.222 . . . . 6.04 110.999 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 7.57 110.589 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -117.74 -19.81 9.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 70.4 mtt180 -112.07 146.39 38.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.774 0.321 . . . . 6.52 110.807 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 208' ' ' THR . 84.7 mt -119.46 150.0 40.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.722 -0.672 . . . . 5.24 110.111 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -99.42 109.72 22.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 6.15 109.607 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.4 p -109.05 124.76 65.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.329 0.585 . . . . 4.24 110.582 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.27 -178.77 15.47 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.485 -0.779 . . . . 4.95 111.687 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 62.03 33.0 17.47 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.409 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.463 HG22 HD22 ' A' ' 224' ' ' LEU . 34.4 pt -80.4 156.65 73.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.481 -0.781 . . . . 5.61 110.877 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.469 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 42.2 Cg_endo -69.49 124.62 11.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.47 2.113 . . . . 5.97 112.399 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -68.35 112.25 5.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.197 -0.668 . . . . 8.47 109.197 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.87 -2.27 8.54 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.628 -0.796 . . . . 6.96 112.006 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 10.9 tp -88.31 146.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.92 -0.4 . . . . 6.1 109.92 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.9 p -102.76 163.97 11.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.869 0.366 . . . . 6.62 111.314 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.738 ' HG2' ' HB ' ' A' ' 191' ' ' ILE . 33.2 mt-10 -63.93 -41.02 97.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.655 . . . . 5.69 110.69 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -58.39 -47.17 84.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.372 -0.831 . . . . 7.29 110.748 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.43 91.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.5 ttm -71.78 -36.35 70.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 4.49 110.652 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.412 ' HB2' HG11 ' A' ' 189' ' ' VAL . 1.6 tmt? -61.0 -50.32 73.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.534 . . . . 5.76 109.721 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.42 -41.22 98.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.905 -0.589 . . . . 6.51 111.351 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.61 -53.02 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.933 0.346 . . . . 5.44 111.933 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.659 0.266 . . . . 5.03 111.401 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.14 -37.0 78.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.73 0.3 . . . . 6.3 110.865 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.26 83.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.406 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -61.59 -37.17 82.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 6.25 111.264 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.526 ' HG3' ' HG2' ' A' ' 185' ' ' PRO . 19.1 mmt -63.9 -45.34 89.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.428 -0.351 . . . . 7.03 111.009 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.2 -46.18 61.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 8.94 111.221 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.81 -35.27 74.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 8.7 111.374 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.01 58.93 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.547 -0.835 . . . . 8.11 111.844 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.12 39.14 13.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.881 -0.676 . . . . 8.49 112.193 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.85 -0.77 39.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 7.59 110.192 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 p -70.24 130.27 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 8.73 111.062 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -84.69 -14.51 48.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.216 0.531 . . . . 9.89 110.236 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.03 29.92 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 9.69 109.871 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.45 111.51 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.465 2.11 . . . . 10.74 111.548 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.92 -148.18 15.85 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.878 -0.677 . . . . 8.97 112.059 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -126.39 112.26 23.38 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.689 0.28 . . . . 7.58 110.857 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 203' ' ' ARG . 50.6 Cg_exo -55.48 -45.8 37.06 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.124 2.549 . . . . 6.4 112.433 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.02 107.2 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.562 -0.533 . . . . 5.47 109.562 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.5 tp -90.98 -61.63 1.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.354 -175.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -113.73 137.85 51.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.611 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 166' ' ' MET . 7.3 p -125.81 132.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.108 0.48 . . . . 4.68 111.365 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -132.86 114.55 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 6.34 109.87 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.738 ' HB ' ' HG2' ' A' ' 162' ' ' GLU . 46.9 mt -114.43 125.39 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 5.85 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -105.2 98.15 7.9 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.061 -0.718 . . . . 7.34 109.061 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.19 -19.49 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.697 . . . . 7.61 110.338 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -58.4 -60.22 4.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 9.12 111.605 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 41.9 mmtm -98.59 4.7 48.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.571 -0.286 . . . . 9.1 111.291 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.34 57.17 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.468 0.651 . . . . 6.6 111.36 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 50.8 p90 -149.21 152.69 36.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 6.67 109.795 173.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.71 157.34 45.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.967 0.413 . . . . 4.58 111.143 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.49 121.68 36.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 6.22 110.233 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 82.5 mt -104.18 116.96 33.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.976 -0.556 . . . . 4.77 109.769 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 35.0 tt0 -97.49 111.77 23.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 6.55 109.756 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -88.5 159.13 18.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.554 . . . . 6.51 111.192 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 185' ' ' PRO . 39.0 ptt180 -70.96 -24.14 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.385 -0.825 . . . . 8.27 111.278 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 60.1 p -125.84 -165.3 1.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.253 -0.43 . . . . 7.96 110.863 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.51 -36.53 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.434 0.635 . . . . 8.73 109.423 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.51 -53.07 61.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 8.5 111.312 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -64.43 -36.9 85.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 7.4 110.282 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 151' ' ' LEU . 9.8 m -54.26 -52.71 60.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.282 0.563 . . . . 6.13 110.501 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -28.8 69.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.489 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.58 -29.86 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 7.75 109.967 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -68.1 -13.81 62.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 5.43 111.248 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 81.4 mtp -70.37 -14.87 62.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 6.29 110.374 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.14 -5.36 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 6.14 110.596 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 94.3 m-85 -97.11 3.78 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 5.57 110.711 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.45 123.15 16.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 5.92 110.581 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.35 53.17 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.86 -0.685 . . . . 5.74 112.112 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.5 tt -72.75 142.51 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.328 . . . . 5.3 110.262 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.7 tp -84.63 113.16 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.356 0.598 . . . . 6.8 110.407 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -134.55 114.93 13.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 5.79 110.533 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 61.98 26.6 16.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.796 -0.638 . . . . 7.32 111.22 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 86.69 5.38 81.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.88 -0.676 . . . . 7.28 112.737 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.4 mm-40 -115.53 150.69 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.778 0.323 . . . . 7.21 110.701 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -97.78 103.51 15.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.488 -0.56 . . . . 6.14 109.488 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.463 HD22 HG22 ' A' ' 156' ' ' ILE . 70.6 mt -69.79 114.42 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 4.9 111.503 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 76.6 tttt -83.57 114.51 21.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.588 -0.733 . . . . 7.3 109.709 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.14 105.69 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.831 0.348 . . . . 5.37 110.442 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -132.7 168.36 18.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.24 -0.436 . . . . 6.97 110.684 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.67 129.88 78.06 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.346 -0.388 . . . . 7.37 110.4 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 31.9 Cg_exo -58.63 130.76 38.68 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.973 2.448 . . . . 7.98 112.052 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 38.5 m80 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.882 179.506 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.0 m80 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 121.013 0.435 . . . . 8.75 110.512 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 37.5 ttmt -66.26 138.52 57.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.52 -0.763 . . . . 6.04 110.767 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 307' ' ' TYR . 79.7 mt -104.63 141.72 35.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.561 . . . . 5.29 111.007 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 335' ' ' ALA . 87.7 t80 -96.91 119.04 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.297 -0.865 . . . . 4.77 109.152 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.73 HG23 HD11 ' A' ' 330' ' ' LEU . 3.7 mp -108.46 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 3.94 109.837 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.4 134.79 8.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 4.58 112.374 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 123.8 25.69 1.69 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.903 -0.665 . . . . 5.58 111.949 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 84.8 mt -102.46 138.97 19.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.429 -0.211 . . . . 5.92 110.429 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.561 ' HB2' HD13 ' A' ' 270' ' ' LEU . 41.8 Cg_exo -58.12 147.95 80.47 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.611 2.207 . . . . 6.94 111.483 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 6.4 p30 -73.59 -13.54 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.093 0.405 . . . . 8.81 112.093 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -90.05 0.61 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.632 -0.427 . . . . 8.73 111.079 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.0 mp -80.88 117.39 21.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.89 0.376 . . . . 7.52 110.196 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -85.65 174.76 9.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 8.79 110.904 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.33 -37.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.708 . . . . 7.62 112.198 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -53.96 18.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.771 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.12 -39.67 93.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.591 0.234 . . . . 8.69 111.14 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 279' ' ' LEU . 94.9 t -62.16 -48.98 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 6.64 110.443 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -56.39 -53.08 61.59 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.519 -0.309 . . . . 7.74 111.047 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.67 -52.5 55.57 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.571 0.544 . . . . 9.38 111.809 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 7.06 110.526 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.531 HD22 HD13 ' A' ' 320' ' ' LEU . 64.3 mt -75.69 -32.86 60.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.434 -0.348 . . . . 6.89 111.433 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 16.2 m -74.18 -16.68 60.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.02 0.438 . . . . 8.85 110.816 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 41.2 m -61.53 -14.99 34.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.632 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.12 16.43 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 9.18 111.009 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.57 143.94 3.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.55 -0.833 . . . . 9.06 112.547 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 280' ' ' THR . 58.3 Cg_endo -71.9 140.48 35.16 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.693 2.262 . . . . 10.14 112.809 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 305' ' ' CYS . 97.3 mt -98.15 126.45 43.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 8.3 111.106 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -94.32 -18.34 21.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.328 0.585 . . . . 8.65 109.846 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.23 134.23 20.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.083 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.577 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 82.7 t80 -145.56 124.71 12.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.063 -0.517 . . . . 6.27 110.625 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -139.53 108.66 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.541 0.686 . . . . 5.79 110.347 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 303' ' ' ALA . 55.0 tp -79.54 128.35 33.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.242 -0.89 . . . . 6.35 109.112 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 303' ' ' ALA . 42.2 t -77.31 111.69 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.059 0.456 . . . . 6.61 109.813 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -107.35 148.9 28.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 8.17 110.498 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.05 136.94 38.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.495 . . . . 10.33 109.738 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 44.0 m -70.07 -28.46 65.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.794 0.294 . . . . 10.8 111.794 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.56 -48.6 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.734 0.302 . . . . 12.13 111.183 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.7 m -75.34 -49.08 20.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.403 -0.362 . . . . 11.16 111.353 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 101.51 -26.69 23.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.842 -0.694 . . . . 10.11 111.965 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.12 173.41 10.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 10.12 111.128 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 46.7 t -69.84 148.46 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 7.73 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.79 -1.01 55.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 8.01 110.163 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 105.13 -3.42 40.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.851 -0.69 . . . . 6.09 112.478 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -147.62 161.16 41.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 6.54 111.33 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -152.38 164.53 37.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 4.38 110.459 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -112.46 130.73 55.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.477 -0.564 . . . . 4.93 109.477 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.577 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 47.8 m -138.68 137.88 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.374 -0.375 . . . . 5.09 110.572 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 29.1 tt0 -120.14 134.1 55.34 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.461 -0.57 . . . . 7.03 109.461 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CE1' HD12 ' A' ' 261' ' ' LEU . 20.0 m-85 -91.78 152.32 20.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.004 0.431 . . . . 7.81 111.59 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.528 ' HB ' ' HG2' ' A' ' 284' ' ' PRO . 92.0 t -66.84 -43.49 89.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.563 -0.744 . . . . 10.03 111.284 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.67 157.32 18.19 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.912 -0.403 . . . . 10.81 109.912 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.85 -19.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.988 0.366 . . . . 9.77 111.988 -175.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -77.3 -37.88 51.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.354 0.597 . . . . 10.89 109.493 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 24.6 m -65.83 -22.04 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.105 -0.952 . . . . 9.5 111.178 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.544 ' O ' HG13 ' A' ' 317' ' ' ILE . 9.5 m -55.25 -50.03 70.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.681 -0.236 . . . . 7.83 111.407 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.64 -37.87 76.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.981 0.419 . . . . 8.79 110.851 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -64.11 -38.77 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.677 -0.692 . . . . 10.51 110.249 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.38 86.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.533 -0.758 . . . . 7.31 110.811 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 313' ' ' THR . 85.1 mt -58.82 -45.66 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 6.44 110.734 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.66 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.32 -53.04 4.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.88 -0.676 . . . . 7.46 113.075 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.531 HD13 HD22 ' A' ' 279' ' ' LEU . 75.5 mt -67.9 -52.75 32.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.754 0.312 . . . . 6.42 111.702 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 44.2 t30 -63.18 114.96 4.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 6.53 110.652 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -26.18 6.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.709 -0.758 . . . . 6.77 112.385 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.2 mtt -74.91 168.35 20.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.435 -0.209 . . . . 7.29 110.435 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 329' ' ' LYS . 55.1 mt-30 -125.12 131.06 53.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.969 0.414 . . . . 7.83 110.588 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -109.8 121.92 46.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.33 -0.619 . . . . 7.01 109.33 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 69.36 -96.63 0.49 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.737 -0.744 . . . . 8.18 111.34 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.95 7.81 3.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 8.94 110.484 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.47 143.81 45.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.994 0.426 . . . . 7.29 111.0 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 87.9 tttt -84.61 136.67 33.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 7.13 110.137 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 263' ' ' ILE . 44.3 tp -93.88 124.47 37.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 5.63 110.984 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.433 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 6.8 mp -115.07 124.16 50.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.624 . . . . 5.53 109.557 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.15 131.14 71.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 5.21 110.363 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -156.74 161.43 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 6.05 109.843 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.461 ' HA ' HD23 ' A' ' 261' ' ' LEU . 64.7 mtt85 -64.45 133.19 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.842 0.353 . . . . 7.58 110.651 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 262' ' ' PHE . . . -110.3 106.69 16.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 6.04 110.646 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.476 -0.329 . . . . 7.57 111.398 -178.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.622 0.249 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -107.94 -6.13 16.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.604 0.24 . . . . 0.0 111.327 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.7 mtt180 -114.06 138.75 49.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 6.52 110.922 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 208' ' ' THR . 51.2 mt -116.02 152.08 34.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.909 -0.587 . . . . 5.24 110.43 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -106.08 111.23 23.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 6.15 109.698 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.5 p -109.15 131.0 61.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.143 0.497 . . . . 4.24 110.091 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.41 173.26 18.63 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.776 -0.647 . . . . 4.95 111.941 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 t30 62.77 68.84 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.459 0.647 . . . . 0.0 110.129 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.689 HG22 HD22 ' A' ' 224' ' ' LEU . 37.6 pt -117.63 160.87 36.54 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.392 -0.822 . . . . 5.61 110.29 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.698 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 21.1 Cg_endo -61.92 142.44 93.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.61 2.207 . . . . 5.97 112.441 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -79.56 109.81 14.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 8.47 110.266 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 96.48 36.88 4.97 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.795 -0.717 . . . . 6.96 111.708 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.698 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 5.7 tp -78.71 132.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.125 0.488 . . . . 6.1 111.086 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 17.2 m -64.51 116.15 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 6.62 109.754 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.509 ' HG2' HD12 ' A' ' 191' ' ' ILE . 41.2 mt-10 -57.38 -47.13 82.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 5.69 110.9 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.43 -43.26 93.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.592 -0.731 . . . . 7.29 110.668 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -72.57 -37.63 68.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.204 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.7 tpt -60.7 -47.37 86.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.957 0.408 . . . . 4.49 110.338 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.61 -41.52 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 5.76 110.307 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.11 -49.18 78.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.804 -0.635 . . . . 6.51 111.104 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.1 -47.33 85.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 5.44 111.133 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.488 ' HZ ' ' HB1' ' A' ' 211' ' ' ALA . 66.5 t80 -62.49 -49.3 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 5.03 110.815 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.433 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 78.7 m-20 -61.43 -37.22 82.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.418 -0.355 . . . . 6.3 110.838 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.08 -45.4 88.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -64.94 -30.03 71.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.391 -0.368 . . . . 6.25 111.41 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 214' ' ' PHE . 76.1 mtp -69.01 -45.02 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 7.03 110.171 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 50.9 mtt180 -65.25 -48.3 73.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 8.94 110.76 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.09 -35.33 78.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 8.7 110.947 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.89 -27.0 69.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.876 -0.678 . . . . 8.11 112.075 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.65 21.58 18.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 8.49 112.373 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.7 mp -108.42 82.12 1.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.213 0.53 . . . . 7.59 110.359 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.601 HG23 ' HG3' ' A' ' 185' ' ' PRO . 3.2 m -157.13 106.84 2.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.242 -0.651 . . . . 8.73 109.242 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.472 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 11.2 pt20 -73.18 -23.55 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.961 -0.295 . . . . 9.89 111.666 -171.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' THR . . . -145.05 158.43 52.18 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.549 -0.296 . . . . 9.69 110.583 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 151.65 66.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.419 2.08 . . . . 10.74 111.704 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.69 -168.88 20.81 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.71 -0.757 . . . . 8.97 111.775 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 m-20 -94.98 129.17 36.49 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 110.42 -0.215 . . . . 7.58 110.42 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 179' ' ' THR . 26.7 Cg_exo -63.04 -35.76 63.53 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.594 2.196 . . . . 6.4 111.208 176.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.6 131.48 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.47 110.121 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 281' ' ' SER . 43.6 tp -87.71 -54.49 4.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.728 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.68 153.43 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.404 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.35 138.88 48.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.236 -0.438 . . . . 4.68 110.958 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -119.13 105.83 11.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.302 -0.629 . . . . 6.34 109.302 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.509 HD12 ' HG2' ' A' ' 162' ' ' GLU . 62.8 mt -109.3 125.62 66.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.129 0.49 . . . . 5.85 111.249 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -116.2 120.21 38.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.604 -0.725 . . . . 7.34 110.128 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.78 -23.91 23.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.136 -0.484 . . . . 7.61 110.731 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 195' ' ' LYS . 24.0 t70 -57.63 -56.76 17.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.834 -0.621 . . . . 9.12 111.898 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.6 mmtm -105.29 5.24 31.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.793 0.33 . . . . 9.1 111.095 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.35 67.46 0.84 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.528 -0.76 . . . . 6.6 111.517 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 54.5 p90 -149.65 162.5 40.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.005 -0.543 . . . . 6.67 109.821 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.68 143.75 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.082 0.468 . . . . 4.58 111.148 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -107.52 120.58 42.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.686 -0.688 . . . . 6.22 109.734 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 76.8 mt -101.68 115.59 30.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.024 -0.535 . . . . 4.77 109.6 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.74 121.68 42.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.071 -0.344 . . . . 6.55 110.071 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.553 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 48.1 m-85 -99.14 164.15 12.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.144 0.497 . . . . 6.51 110.822 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.67 -22.97 59.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.767 -0.651 . . . . 8.27 111.326 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.8 p -142.83 147.22 35.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.632 0.254 . . . . 7.96 110.913 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.06 -36.17 72.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.953 0.406 . . . . 8.73 110.556 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.37 -58.24 8.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.738 -0.665 . . . . 8.5 111.086 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.472 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 49.4 mt-10 -65.4 -34.25 77.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 7.4 110.871 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 81.5 m -53.49 -52.6 59.02 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.22 0.533 . . . . 6.13 110.212 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 m -63.87 -30.97 72.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.947 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -29.57 62.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.979 0.419 . . . . 7.75 110.361 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.488 ' HB1' ' HZ ' ' A' ' 169' ' ' PHE . . . -72.21 -10.11 59.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.529 . . . . 5.43 111.535 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.3 mtp -68.02 -20.32 64.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 6.29 110.455 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.3 -1.82 28.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 6.14 111.653 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 173' ' ' MET . 94.9 m-85 -97.41 3.33 50.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.739 0.304 . . . . 5.57 110.842 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -57.24 129.66 42.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.055 -0.521 . . . . 5.92 110.914 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.31 25.88 27.28 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.936 -0.649 . . . . 5.74 112.111 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.8 tt -80.8 132.39 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.813 0.34 . . . . 5.3 110.146 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.01 111.23 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.542 0.687 . . . . 6.8 111.179 -176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.497 ' HE2' HD13 ' A' ' 160' ' ' ILE . 88.9 t80 -136.07 122.09 20.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.561 -0.745 . . . . 5.79 110.182 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 57.32 33.66 23.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.851 0.358 . . . . 7.32 111.836 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.15 6.47 86.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.919 -0.657 . . . . 7.28 112.606 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.62 131.85 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.718 0.294 . . . . 7.21 110.479 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.6 m -86.08 102.64 14.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.499 -0.556 . . . . 6.14 109.499 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 156' ' ' ILE . 56.7 mt -66.62 115.52 6.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.9 110.344 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.3 tttt -90.18 114.7 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.941 -0.572 . . . . 7.3 109.739 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.84 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.421 -0.354 . . . . 5.37 110.207 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.424 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 7.8 mmt85 -128.25 169.46 14.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.205 -0.452 . . . . 6.97 110.786 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -79.78 127.14 78.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.311 -0.404 . . . . 7.37 109.99 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.04 113.7 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.488 2.125 . . . . 7.98 110.863 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m80 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.849 -174.385 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 306' ' ' GLU . 23.1 m170 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.128 0.489 . . . . 8.75 110.37 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 40.8 ttmt -77.25 123.62 26.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.671 -0.695 . . . . 6.04 109.955 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.526 HD12 ' CE1' ' A' ' 307' ' ' TYR . 41.2 mt -101.64 142.68 32.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.925 -0.579 . . . . 5.29 111.014 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -88.42 115.67 26.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.323 -0.853 . . . . 4.77 109.221 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.27 107.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.963 -0.384 . . . . 3.94 109.963 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -110.54 171.71 14.87 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.507 -0.637 . . . . 4.58 111.507 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.44 26.85 45.68 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 5.58 111.694 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.41 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 91.2 mt -90.11 125.95 58.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.766 0.317 . . . . 5.92 110.587 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.673 ' HB2' HD13 ' A' ' 270' ' ' LEU . 27.1 Cg_exo -63.1 134.78 47.6 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.664 2.242 . . . . 6.94 111.681 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -63.4 -20.66 65.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 8.81 112.179 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -86.02 1.59 49.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.566 0.222 . . . . 8.73 111.59 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.4 mp -91.68 144.59 25.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.132 -0.321 . . . . 7.52 110.132 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.8 p-10 -106.88 177.19 4.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.271 -0.422 . . . . 8.79 110.436 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 3.8 m-20 -58.36 -38.99 78.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 7.62 111.493 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.71 -50.87 65.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.08 -40.47 85.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.511 0.195 . . . . 8.69 111.386 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.1 t -65.96 -48.46 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 6.64 110.728 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 35.7 mtmm -59.27 -53.25 60.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.576 -0.284 . . . . 7.74 111.193 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.27 -43.15 82.83 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.827 0.346 . . . . 9.38 111.063 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.04 -53.3 58.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 7.06 110.201 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.34 -36.11 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 6.89 111.414 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.6 m -63.21 -32.23 73.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 8.85 111.291 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 32.2 m -65.62 -14.08 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.8 8.32 13.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 9.18 110.388 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.91 125.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.745 -0.661 . . . . 9.06 111.91 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 280' ' ' THR . 35.9 Cg_endo -64.89 139.13 60.75 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.63 2.22 . . . . 10.14 112.712 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 70.6 mt -100.59 133.0 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 8.3 110.329 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.687 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.6 ptpt -95.83 -18.39 20.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.808 -0.442 . . . . 8.65 109.808 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -149.18 139.79 22.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.182 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.552 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 84.9 t80 -140.41 130.31 24.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.228 -0.442 . . . . 6.27 110.535 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.59 118.57 11.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 5.79 110.083 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 303' ' ' ALA . 60.4 tp -95.66 128.41 42.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 6.35 109.797 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.9 t -76.21 113.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 6.61 109.992 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.492 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 45.2 mttm -114.63 161.69 17.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.787 -0.642 . . . . 8.17 111.13 -172.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 1.025 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 31.2 t70 -126.46 122.82 36.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.023 -0.535 . . . . 10.33 109.872 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.4 m -65.39 -38.7 90.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.151 0.426 . . . . 10.8 112.151 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.57 82.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.985 0.422 . . . . 12.13 111.311 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.9 m -81.12 -35.92 30.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.195 -0.457 . . . . 11.16 111.12 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.12 10.05 81.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.035 -0.602 . . . . 10.11 111.983 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.94 175.32 8.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.798 0.332 . . . . 10.12 110.549 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.5 t -71.99 156.42 39.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.89 -0.596 . . . . 7.73 110.054 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 1.025 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.3 mmmp? -86.33 1.74 49.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.388 -0.369 . . . . 8.01 110.635 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 104.05 4.65 44.64 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.583 -0.817 . . . . 6.09 113.439 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.489 ' CE2' HG21 ' A' ' 291' ' ' VAL . 48.6 p90 -157.4 162.12 39.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.194 0.521 . . . . 6.54 111.57 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -148.61 170.09 18.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.438 -0.801 . . . . 4.38 110.623 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.582 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.4 m-85 -120.31 127.48 52.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.314 -0.624 . . . . 4.93 109.314 175.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.552 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 25.9 m -135.04 113.47 11.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.499 -0.319 . . . . 5.09 111.125 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 27.2 tt0 -88.3 123.53 32.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.913 0.387 . . . . 7.03 110.201 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.526 ' CE1' HD12 ' A' ' 261' ' ' LEU . 13.5 m-85 -80.23 156.76 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.815 -0.629 . . . . 7.81 111.426 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 286' ' ' LYS . 96.8 t -81.45 -55.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 10.03 110.684 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.695 ' HB3' HG22 ' A' ' 312' ' ' VAL . 13.1 t70 -82.12 129.46 34.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 10.81 109.971 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -87.92 0.84 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.252 0.464 . . . . 9.77 112.252 -173.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -103.51 -35.94 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 10.89 110.227 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 309' ' ' ASP . 27.5 m -72.46 -20.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 9.5 111.216 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.495 ' O ' HG13 ' A' ' 317' ' ' ILE . 11.5 m -54.67 -51.55 65.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.394 -0.366 . . . . 7.83 111.961 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -71.24 -24.45 62.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 8.79 110.795 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.94 -45.16 52.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 10.51 109.685 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.679 -0.692 . . . . 7.31 110.117 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 313' ' ' THR . 75.4 mt -57.61 -52.98 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 6.44 110.559 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.36 93.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.647 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -76.6 -43.33 19.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.639 -0.791 . . . . 7.46 113.182 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.64 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.3 mt -82.45 -40.91 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.277 0.473 . . . . 6.42 112.277 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -62.84 115.85 4.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.776 0.322 . . . . 6.53 110.643 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.71 -23.85 20.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.961 -0.638 . . . . 6.77 111.89 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 24.9 ttt -78.78 137.79 37.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 7.29 109.741 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -88.04 129.39 35.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.087 0.47 . . . . 7.83 111.077 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.85 104.01 15.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.534 -0.913 . . . . 7.01 108.534 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.44 -74.72 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.037 -0.825 . . . . 8.18 111.037 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.19 5.99 0.15 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.988 0.423 . . . . 8.94 110.088 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HD3' ' HG3' ' A' ' 267' ' ' PRO . 12.6 mptt -101.92 129.64 48.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.593 -0.521 . . . . 7.29 109.593 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.64 118.02 15.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.802 0.334 . . . . 7.13 110.471 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 320' ' ' LEU . 19.0 tp -74.53 115.71 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.914 -0.584 . . . . 5.63 109.865 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 4.9 tt -98.47 110.68 23.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.928 -0.768 . . . . 5.53 108.928 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 317' ' ' ILE . 49.1 t -120.77 127.53 75.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.028 0.442 . . . . 5.21 110.864 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -162.08 -178.29 6.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.6 -0.727 . . . . 6.05 109.077 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -73.69 145.03 45.54 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.821 -0.352 . . . . 7.58 110.138 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.11 83.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.414 -0.357 . . . . 6.04 111.558 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.491 -0.322 . . . . 7.57 110.993 -178.226 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.557 0.218 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.493 ' HB2' ' HG3' ' A' ' 201' ' ' GLU . 68.9 mtm180 -112.61 18.69 18.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.739 0.304 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 83.4 mtt180 -111.23 146.19 37.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.057 0.456 . . . . 6.52 112.113 -173.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.31 154.85 31.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 5.24 109.661 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -100.05 109.99 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.206 -0.452 . . . . 6.15 109.969 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 198' ' ' ALA . 7.2 p -109.01 133.31 54.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.131 0.491 . . . . 4.24 110.453 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.31 -179.31 17.38 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.782 -0.645 . . . . 4.95 111.803 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.0 t30 58.24 65.65 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.767 0.794 . . . . 0.0 109.985 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 29.6 pt -115.68 157.69 43.8 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.989 -1.005 . . . . 5.61 110.226 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 36.2 Cg_endo -65.67 131.13 26.71 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.484 2.123 . . . . 5.97 112.559 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -72.03 96.22 1.71 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.299 0.571 . . . . 8.47 109.888 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 141.59 -10.15 2.65 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.524 -0.762 . . . . 6.96 111.517 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.708 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.1 tp -66.94 136.18 27.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.911 0.386 . . . . 6.1 110.857 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.8 p -89.93 153.26 20.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.099 -0.5 . . . . 6.62 109.703 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.97 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.4 mt-10 -61.81 -40.67 96.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.782 0.325 . . . . 5.69 110.904 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.4 -48.89 73.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.982 -0.554 . . . . 7.29 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.09 86.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.3 tpt -65.86 -46.68 77.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.234 -0.439 . . . . 4.49 110.23 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 23.1 ttt -61.07 -45.75 93.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 5.76 110.609 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.38 -41.97 81.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 6.51 111.048 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.64 -49.38 76.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 5.44 111.009 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.469 ' HE1' HD11 ' A' ' 226' ' ' ILE . 47.8 m-85 -61.19 -45.37 94.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.671 -0.24 . . . . 5.03 111.068 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 95.3 m-20 -57.09 -44.92 83.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 6.3 110.407 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -48.64 78.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.174 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -61.57 -43.49 98.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 6.25 111.229 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.34 -34.84 78.89 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.939 -0.304 . . . . 7.03 110.644 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 95.0 mtt180 -64.31 -52.06 60.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.368 . . . . 8.94 110.787 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.93 -36.09 69.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.223 -0.444 . . . . 8.7 111.266 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.46 -30.85 68.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.955 -0.64 . . . . 8.11 112.043 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.08 36.89 26.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.932 -0.651 . . . . 8.49 112.75 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 8.3 mp -101.68 21.42 14.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.185 0.517 . . . . 7.59 110.504 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.1 p -102.93 171.46 7.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.848 -0.615 . . . . 8.73 110.381 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 13.7 pt20 -110.79 -1.09 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.935 0.398 . . . . 9.89 110.02 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.3 162.71 15.58 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.726 -0.67 . . . . 9.69 110.141 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 170.88 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.503 2.135 . . . . 10.74 111.546 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.73 -153.85 17.87 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.437 -0.887 . . . . 8.97 112.764 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -106.93 114.74 61.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.693 0.282 . . . . 7.58 110.794 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 36.6 Cg_exo -60.74 -42.84 35.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.981 2.454 . . . . 6.4 112.366 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.06 131.59 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.057 -0.349 . . . . 5.47 110.057 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 203' ' ' ARG . 36.1 tp -109.49 -39.01 5.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.733 ' HB1' HG11 ' A' ' 312' ' ' VAL . . . -137.19 131.5 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.57 122.34 64.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.231 0.538 . . . . 4.68 111.426 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.38 106.2 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.873 -0.603 . . . . 6.34 109.568 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -112.53 134.35 55.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.754 0.312 . . . . 5.85 111.049 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -114.98 104.38 11.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.634 -0.506 . . . . 7.34 109.634 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.4 -17.78 60.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.82 -0.627 . . . . 7.61 111.315 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.68 -53.38 22.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.56 -0.291 . . . . 9.12 111.09 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.3 mmtm -90.25 -3.64 57.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.822 0.344 . . . . 9.1 110.433 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 63.6 56.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.399 -0.819 . . . . 6.6 110.841 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 22.2 p90 -148.59 162.97 38.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 6.67 109.689 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.516 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -151.59 148.95 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.974 0.416 . . . . 4.58 111.357 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 55.5 m-85 -111.4 108.38 17.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.696 -0.684 . . . . 6.22 109.563 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 92.5 mt -97.56 116.06 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.975 -0.557 . . . . 4.77 110.322 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 25.4 tt0 -99.22 122.02 41.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.54 -0.541 . . . . 6.55 109.54 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' A' ' 208' ' ' THR . 90.1 m-85 -93.69 163.97 13.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.944 -0.571 . . . . 6.51 110.425 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.505 ' HA ' HD22 ' A' ' 187' ' ' LEU . 38.9 ptt180 -69.16 -17.18 63.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.717 -0.674 . . . . 8.27 111.419 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 56.2 p -135.19 -163.64 1.41 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.302 -0.408 . . . . 7.96 110.356 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.01 -32.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.261 0.553 . . . . 8.73 109.713 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.45 -57.75 11.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 8.5 110.573 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 38.7 mt-10 -60.13 -37.23 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 7.4 109.921 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.461 HG23 ' CD1' ' A' ' 202' ' ' PHE . 12.0 m -54.45 -43.25 71.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 6.13 110.806 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.4 m -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.323 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 8.5 mp0 -71.99 -27.77 62.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.382 -0.372 . . . . 7.75 110.909 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 214' ' ' PHE . . . -63.65 -19.04 64.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 5.43 111.173 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.82 -19.37 62.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 6.29 111.022 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.25 -6.05 51.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 6.14 111.306 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 211' ' ' ALA . 97.5 m-85 -89.63 2.12 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 5.57 110.624 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.11 120.97 10.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 5.92 110.441 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.11 42.09 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.682 -0.771 . . . . 5.74 112.527 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.7 tt -63.21 136.08 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 5.3 110.487 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -87.99 121.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.561 . . . . 6.8 110.83 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -134.27 115.01 13.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.807 -0.633 . . . . 5.79 110.571 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 53.08 35.95 20.96 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.952 -0.567 . . . . 7.32 112.077 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.7 2.55 75.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.819 -0.705 . . . . 7.28 113.221 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -119.37 136.19 54.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.123 0.461 . . . . 7.21 110.951 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.6 t -88.75 103.28 15.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.128 -0.693 . . . . 6.14 109.128 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 156' ' ' ILE . 84.2 mt -66.34 121.99 16.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 4.9 111.04 -174.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.59 ' HE2' ' HG3' ' A' ' 227' ' ' ARG . 87.6 tttt -96.85 115.56 27.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 7.3 110.293 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.469 HD11 ' HE1' ' A' ' 169' ' ' PHE . 61.6 mt -115.02 107.14 22.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.921 -0.4 . . . . 5.37 109.921 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.59 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 8.0 mmt180 -130.98 172.12 12.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.124 0.488 . . . . 6.97 111.51 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 45.1 mtp85 -72.14 131.94 84.84 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.473 -0.785 . . . . 7.37 110.248 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 16.9 Cg_exo -66.97 152.59 80.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 7.98 111.361 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.47 -0.567 . . . . 8.75 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.776 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 39.7 ttmt -58.65 130.73 48.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.076 -0.966 . . . . 6.04 111.353 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 313' ' ' THR . 83.8 mt -108.38 143.81 36.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.759 -0.655 . . . . 5.29 110.661 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -91.49 120.3 32.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.994 -0.548 . . . . 4.77 110.06 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.1 106.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.287 -0.415 . . . . 3.94 109.907 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.65 154.74 16.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.845 -0.693 . . . . 4.58 112.043 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 103.06 34.29 4.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 5.58 112.004 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.2 mt -102.66 138.86 19.74 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.802 0.334 . . . . 5.92 110.85 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 16.8 Cg_exo -68.87 144.53 59.2 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.955 2.437 . . . . 6.94 111.946 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.51 -25.95 63.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 8.81 110.852 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -87.75 0.63 55.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.22 -0.445 . . . . 8.73 111.512 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 40.2 tp -86.79 122.59 30.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.165 -0.309 . . . . 7.52 110.165 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.7 p-10 -78.98 157.11 28.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.123 -0.49 . . . . 8.79 111.245 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.67 -32.07 70.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.588 -0.733 . . . . 7.62 111.569 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 -53.03 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.66 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.78 -33.54 74.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.391 -0.368 . . . . 8.69 111.208 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 271' ' ' ASN . 20.8 t -64.79 -48.74 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.667 0.27 . . . . 6.64 110.527 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -58.52 -47.24 84.79 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.322 -0.399 . . . . 7.74 110.664 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.67 -47.81 83.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 9.38 110.759 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.06 -51.03 70.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 7.06 110.255 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 285' ' ' LEU . 90.7 mt -66.87 -38.22 85.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.258 -0.428 . . . . 6.89 111.671 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 28.6 m -69.74 -19.62 63.53 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.154 0.502 . . . . 8.85 110.961 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.1 m -73.68 -8.03 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.119 0.485 . . . . 0.0 110.656 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 320' ' ' LEU . 97.2 m-85 -121.6 14.53 11.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 9.18 110.156 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 146.32 136.49 2.91 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.765 -0.652 . . . . 9.06 112.058 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.468 ' HD3' ' HG ' ' A' ' 187' ' ' LEU . 24.6 Cg_endo -61.88 135.89 58.38 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.819 2.346 . . . . 10.14 112.316 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 279' ' ' LEU . 99.3 mt -100.11 137.89 37.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.24 -0.436 . . . . 8.3 110.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.433 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.3 ptpt -98.06 -32.97 11.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.456 -0.572 . . . . 8.65 109.456 175.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 286' ' ' LYS . . . -142.56 132.87 24.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.429 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -133.0 117.57 17.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.917 -0.583 . . . . 6.27 110.22 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -131.97 113.15 13.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.609 0.719 . . . . 5.79 110.379 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.2 tp -87.38 130.52 34.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 6.35 109.199 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 111.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.81 -0.441 . . . . 6.61 109.81 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.414 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 61.6 mttm -111.06 156.6 21.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.603 -0.726 . . . . 8.17 109.918 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.63 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 33.9 t70 -88.66 136.31 33.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.984 -0.376 . . . . 10.33 109.984 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.3 m -60.12 -38.12 82.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 10.8 112.021 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.17 -48.03 6.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.03 0.443 . . . . 12.13 111.411 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.7 m -67.68 -38.22 83.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.625 . . . . 11.16 111.001 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.67 4.97 90.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.885 -0.674 . . . . 10.11 112.321 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 61.8 mt -113.08 169.37 8.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.173 -0.306 . . . . 10.12 110.173 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.518 ' HB2' HD21 ' A' ' 290' ' ' LEU . 46.4 t -65.72 146.21 55.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.221 0.534 . . . . 7.73 110.989 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.63 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 30.1 mmmt -87.55 3.24 48.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.813 -0.63 . . . . 8.01 110.372 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 102.53 4.88 49.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.574 -0.822 . . . . 6.09 113.241 174.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -152.87 156.78 39.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.987 0.422 . . . . 6.54 111.148 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.669 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.46 167.03 23.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 4.38 110.879 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.776 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 90.3 m-85 -122.54 130.02 52.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.793 -0.639 . . . . 4.93 109.304 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.1 m -142.25 132.5 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.033 -0.267 . . . . 5.09 110.938 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.84 132.18 54.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.853 -0.425 . . . . 7.03 109.853 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -88.36 156.5 19.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.725 . . . . 7.81 111.34 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 286' ' ' LYS . 79.6 t -82.18 -50.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.633 -0.712 . . . . 10.03 109.552 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.482 ' OD2' HG22 ' A' ' 312' ' ' VAL . 22.0 t70 -77.77 148.96 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 10.81 110.217 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.592 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -124.35 20.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.415 . . . . 9.77 111.233 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.11 -49.45 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.262 0.553 . . . . 10.89 109.83 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.733 HG11 ' HB1' ' A' ' 188' ' ' ALA . 34.0 m -79.21 -20.7 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.298 -0.864 . . . . 9.5 111.396 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.621 HG22 HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -53.81 -50.24 66.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.549 0.574 . . . . 7.83 112.549 -170.268 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.29 -35.77 80.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.874 0.369 . . . . 8.79 111.188 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.87 -29.15 60.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 10.51 110.302 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.94 -39.2 76.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.185 -0.461 . . . . 7.31 110.033 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 313' ' ' THR . 80.6 mt -57.35 -61.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 6.44 110.443 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.64 -15.98 62.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.468 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.67 -47.46 5.63 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.023 -0.608 . . . . 7.46 112.471 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 282' ' ' PHE . 92.8 mt -79.95 -40.03 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.589 0.233 . . . . 6.42 111.197 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.489 ' OD1' HD12 ' A' ' 331' ' ' LEU . 8.8 t30 -62.01 115.0 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 6.53 110.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.33 -23.63 6.04 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.672 -0.775 . . . . 6.77 111.856 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 66.7 mtt -78.66 171.99 14.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.733 -0.469 . . . . 7.29 109.733 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -117.63 151.75 36.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.723 0.297 . . . . 7.83 110.51 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.61 106.73 7.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.998 -0.742 . . . . 7.01 108.998 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.5 -94.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.721 -0.752 . . . . 8.18 111.435 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.08 -9.35 5.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 8.94 110.404 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.15 159.28 15.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 7.29 110.38 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -98.92 129.35 45.25 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.528 -0.545 . . . . 7.13 109.528 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.01 115.2 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 5.63 110.709 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.489 HD12 ' OD1' ' A' ' 321' ' ' ASN . 51.4 tp -108.6 105.79 15.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.322 -0.854 . . . . 5.53 109.832 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.11 115.47 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.724 -0.473 . . . . 5.21 109.724 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -137.76 158.82 43.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.138 0.494 . . . . 6.05 111.011 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.78 119.9 16.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 7.58 109.215 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.47 -65.32 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.969 0.359 . . . . 6.04 111.969 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.882 0.372 . . . . 7.57 110.311 179.664 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 6.5 ptp180 -101.86 -19.04 15.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.041 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.1 mtt180 -114.84 133.28 56.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.867 0.365 . . . . 6.52 111.213 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 75.8 mt -98.98 157.8 16.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 5.24 110.766 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.503 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 46.7 t80 -115.31 103.46 10.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 6.15 110.075 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.7 p -103.06 130.91 52.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.181 0.515 . . . . 4.24 110.12 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.45 16.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.586 -0.734 . . . . 4.95 111.595 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.57 55.24 4.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.693 0.759 . . . . 0.0 109.477 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.566 HG22 HD22 ' A' ' 224' ' ' LEU . 35.5 pt -101.09 147.69 34.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 5.61 110.156 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.11 114.63 2.4 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.695 2.263 . . . . 5.97 112.189 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.4 127.85 34.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.568 . . . . 8.47 110.762 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.37 10.67 35.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.845 -0.693 . . . . 6.96 111.692 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.1 tp -81.13 137.78 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 6.1 109.912 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.3 p -87.2 144.64 26.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.407 -0.361 . . . . 6.62 110.755 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.928 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.2 mt-10 -57.71 -43.46 85.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.69 111.45 -175.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.72 -52.46 64.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 7.29 110.74 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.64 95.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.708 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.457 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.1 tpt -60.54 -46.8 88.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 4.49 110.475 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.443 ' HB2' HG11 ' A' ' 189' ' ' VAL . 25.6 ttt -63.28 -47.13 83.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.129 -0.487 . . . . 5.76 110.977 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -62.98 -32.04 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 6.51 111.387 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.36 -49.1 76.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.565 -0.289 . . . . 5.44 110.619 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 173' ' ' MET . 56.2 m-85 -63.1 -44.9 94.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 5.03 110.798 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.89 -35.94 77.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.35 . . . . 6.3 110.941 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.58 68.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.446 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.52 -31.14 71.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 6.25 111.281 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 17.9 mmt -60.95 -51.49 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 7.03 110.17 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -69.2 -48.06 63.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.976 -0.557 . . . . 8.94 110.972 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -35.56 80.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 8.7 111.383 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.53 -29.61 48.09 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.591 -0.814 . . . . 8.11 112.165 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.43 0.43 40.46 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.901 -0.666 . . . . 8.49 111.823 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.3 mp -79.25 84.7 5.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.74 -0.467 . . . . 7.59 109.74 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.5 m -159.96 124.38 3.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 8.73 110.147 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 12.0 pt20 -90.04 -27.71 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 9.89 111.183 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -141.18 139.83 19.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.455 -0.339 . . . . 9.69 110.327 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.14 118.12 4.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.951 2.434 . . . . 10.74 112.486 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.56 -155.65 22.33 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.122 -0.561 . . . . 8.97 111.931 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.7 m-20 -101.57 126.24 34.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.684 0.278 . . . . 7.58 111.169 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_exo -68.76 -32.18 23.9 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 123.01 2.474 . . . . 6.4 111.83 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.3 124.16 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 5.47 110.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.64 -42.07 7.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.035 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.91 159.38 42.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 111.113 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 166' ' ' MET . 9.1 p -140.57 136.63 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.211 -0.449 . . . . 4.68 110.84 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 199' ' ' PHE . 41.6 mt-30 -113.86 106.36 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.655 -0.498 . . . . 6.34 109.655 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -111.43 123.98 67.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.191 0.52 . . . . 5.85 111.661 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -127.14 119.24 26.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.569 -0.741 . . . . 7.34 109.49 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -93.17 3.42 55.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.757 0.313 . . . . 7.61 111.384 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.8 -54.59 5.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.093 0.473 . . . . 9.12 109.816 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.624 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 47.3 mmtm -86.52 -7.17 58.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.952 -0.567 . . . . 9.1 109.491 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 60.87 70.03 0.64 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.149 -0.932 . . . . 6.6 110.812 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 195' ' ' LYS . 41.2 p90 -149.28 163.0 38.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.209 -0.451 . . . . 6.67 111.227 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 190' ' ' GLN . . . -144.83 126.87 15.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.646 -0.706 . . . . 4.58 110.238 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 190' ' ' GLN . 55.6 m-85 -96.23 126.87 41.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.363 -0.381 . . . . 6.22 110.117 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 79.0 mt -105.57 115.21 29.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.052 -0.522 . . . . 4.77 109.998 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.03 118.27 31.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.996 -0.372 . . . . 6.55 109.996 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -95.64 163.91 13.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.761 -0.654 . . . . 6.51 110.814 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.78 -8.32 57.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.311 -0.859 . . . . 8.27 111.014 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 p -142.99 -164.72 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 7.96 110.294 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.07 -29.96 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 8.73 109.227 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.02 -55.62 32.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.124 -0.944 . . . . 8.5 111.408 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 46.9 mt-10 -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 7.4 110.026 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.487 ' O ' HD11 ' A' ' 151' ' ' LEU . 1.8 m -53.24 -53.44 50.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.569 -0.741 . . . . 6.13 110.807 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 m -60.98 -35.06 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.616 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.674 ' HG3' HD23 ' A' ' 178' ' ' LEU . 61.0 tp60 -73.28 -30.5 63.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.807 -0.633 . . . . 7.75 110.373 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -69.6 -12.81 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 5.43 111.23 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.4 mtp -69.8 -13.52 62.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 6.29 110.85 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.35 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 6.14 111.358 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.439 ' HE2' HD22 ' A' ' 178' ' ' LEU . 76.4 m-85 -92.71 15.17 15.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 5.57 111.263 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.56 115.48 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.921 -0.4 . . . . 5.92 109.921 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.77 30.1 9.31 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.561 -0.828 . . . . 5.74 112.006 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 13.1 tt -84.82 136.2 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 5.3 110.091 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.46 113.93 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.446 0.641 . . . . 6.8 110.811 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -134.68 119.13 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.848 -0.615 . . . . 5.79 110.593 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 61.43 20.85 11.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.947 -0.57 . . . . 7.32 112.017 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.55 1.82 63.79 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.619 -0.8 . . . . 7.28 112.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -119.84 142.88 48.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.939 0.399 . . . . 7.21 111.076 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.0 t -90.24 111.16 22.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.705 -0.679 . . . . 6.14 109.885 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 156' ' ' ILE . 77.0 mt -76.93 114.13 15.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.026 0.441 . . . . 4.9 110.695 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.7 tttt -94.9 114.59 26.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.96 -0.564 . . . . 7.3 110.394 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.42 109.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 5.37 110.631 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 227' ' ' ARG . 6.8 mmt180 -131.12 171.13 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.506 . . . . 6.97 110.621 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 26.8 mtp180 -87.69 127.4 58.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.883 -0.414 . . . . 7.37 109.883 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.503 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 14.9 Cg_exo -66.48 104.66 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.954 2.436 . . . . 7.98 111.857 -176.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.284 -174.935 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 57.3 t60 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.681 0.753 . . . . 8.75 109.398 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.1 ttmt -78.91 116.91 19.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.15 -0.932 . . . . 6.04 111.129 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.777 HD11 HG23 ' A' ' 313' ' ' THR . 68.0 mt -100.89 142.43 32.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.546 -0.752 . . . . 5.29 109.872 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -92.93 123.83 36.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.266 -0.424 . . . . 4.77 109.988 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 330' ' ' LEU . 3.1 mp -114.4 110.55 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.839 -0.618 . . . . 3.94 109.413 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.58 130.64 6.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.717 -0.754 . . . . 4.58 112.376 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 124.44 23.47 1.91 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.744 -0.741 . . . . 5.58 111.977 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.5 mt -95.86 141.53 23.3 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.104 -0.332 . . . . 5.92 110.104 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.875 ' HB2' HD13 ' A' ' 270' ' ' LEU . 32.3 Cg_exo -58.47 116.3 3.15 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.535 2.157 . . . . 6.94 111.107 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 299' ' ' SER . 29.7 p-10 -70.23 -5.46 27.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.729 0.64 . . . . 8.81 112.729 -170.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.59 -0.444 . . . . 8.73 111.02 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.875 HD13 ' HB2' ' A' ' 267' ' ' PRO . 11.2 mp -86.31 133.39 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 7.52 110.202 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.2 p-10 -79.16 160.04 27.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.984 -0.553 . . . . 8.79 110.536 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.18 -32.09 54.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.757 -0.656 . . . . 7.62 111.501 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.464 ' HB3' ' ND2' ' A' ' 271' ' ' ASN . 17.2 t70 -56.93 -54.81 42.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.602 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -73.93 -33.37 63.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.516 -0.311 . . . . 8.69 111.27 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 271' ' ' ASN . 63.0 t -62.92 -48.6 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.537 -0.301 . . . . 6.64 110.819 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -62.88 -45.39 92.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.262 . . . . 7.74 111.399 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.96 -40.79 98.78 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.739 0.304 . . . . 9.38 110.884 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.63 -49.12 78.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 7.06 109.873 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.86 -37.25 78.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.54 . . . . 6.89 111.426 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 87.0 m -60.72 -31.27 70.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.483 -0.326 . . . . 8.85 110.9 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.3 m -65.62 -15.85 63.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.21 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.58 2.04 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.389 . . . . 9.18 110.577 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 157.51 127.13 0.94 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.733 -0.746 . . . . 9.06 112.563 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.408 ' HD3' ' HA2' ' A' ' 283' ' ' GLY . 27.4 Cg_exo -63.04 133.28 40.4 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.926 2.417 . . . . 10.14 112.171 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.16 138.45 39.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.08 -0.509 . . . . 8.3 111.055 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 308' ' ' VAL . 12.2 ptpt -104.39 -12.71 16.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 8.65 109.707 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.72 136.82 22.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.593 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 72.4 t80 -150.54 126.45 10.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.26 -0.427 . . . . 6.27 110.512 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -140.44 112.08 7.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.362 0.601 . . . . 5.79 110.428 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -80.48 121.36 25.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.53 -0.759 . . . . 6.35 109.793 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.66 113.47 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.361 0.6 . . . . 6.61 110.452 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -113.28 160.27 18.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.369 -0.832 . . . . 8.17 109.846 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.777 ' HB2' ' HE3' ' A' ' 300' ' ' LYS . 11.6 t70 -90.03 113.31 24.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.174 -0.676 . . . . 10.33 109.174 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 32.4 m -76.76 -3.2 36.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.538 0.57 . . . . 10.8 112.538 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.37 -23.1 13.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.926 0.393 . . . . 12.13 110.808 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.0 m -106.2 -41.24 5.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.06 -0.518 . . . . 11.16 111.22 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.0 20.72 25.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.811 -0.709 . . . . 10.11 112.102 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.97 155.99 29.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.443 -0.206 . . . . 10.12 110.443 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 42.2 t -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.532 -0.304 . . . . 7.73 110.336 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.777 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 32.3 mmtp -94.07 -8.21 40.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.298 -0.41 . . . . 8.01 111.108 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 90.76 6.74 67.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.656 -0.783 . . . . 6.09 113.047 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 300' ' ' LYS . 40.7 p90 -141.55 152.54 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.793 0.33 . . . . 6.54 110.533 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.27 164.07 35.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.108 -0.496 . . . . 4.38 111.185 -176.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 96.9 m-85 -106.14 123.42 47.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.874 -0.603 . . . . 4.93 109.519 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.593 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 21.6 m -128.6 121.32 28.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 5.09 110.678 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 30.8 tt0 -103.24 114.96 29.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 7.03 110.129 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.49 ' CE1' HD12 ' A' ' 261' ' ' LEU . 25.8 m-85 -84.05 149.58 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 7.81 111.129 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 286' ' ' LYS . 61.3 t -78.89 -55.54 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.9 -0.591 . . . . 10.03 110.684 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 144.94 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 10.81 111.225 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.88 -19.93 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 9.77 111.356 -178.172 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.59 -48.35 64.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.907 0.384 . . . . 10.89 110.039 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.82 -23.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 9.5 110.992 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.777 HG23 HD11 ' A' ' 261' ' ' LEU . 98.4 m -55.78 -50.03 71.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.496 -0.32 . . . . 7.83 111.728 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.28 -38.11 89.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 8.79 110.719 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.45 -40.62 85.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 10.51 110.479 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -49.61 71.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 7.31 110.666 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 313' ' ' THR . 74.8 mt -59.01 -49.17 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.578 -0.283 . . . . 6.44 110.798 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.79 69.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.73 -43.42 7.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.699 -0.763 . . . . 7.46 112.7 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.427 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.1 mt -80.92 -42.7 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.544 0.202 . . . . 6.42 111.544 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 49.4 t-20 -72.67 113.89 10.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.317 -0.623 . . . . 6.53 109.317 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.5 -7.93 47.12 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.283 -0.727 . . . . 6.77 111.283 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttt -74.33 135.29 42.53 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 7.29 109.864 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.54 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 46.0 mt-30 -96.1 117.12 30.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.349 -0.387 . . . . 7.83 110.458 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.82 96.83 6.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.355 -0.609 . . . . 7.01 109.355 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 85.8 -94.54 1.93 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.166 -0.774 . . . . 8.18 111.166 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.81 -19.12 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.996 0.426 . . . . 8.94 110.11 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 158.95 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 7.29 110.419 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.54 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 99.4 mttt -110.27 142.42 41.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.041 0.448 . . . . 7.13 110.82 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.587 HD11 HG23 ' A' ' 263' ' ' ILE . 55.7 tp -86.29 134.41 33.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.551 -0.75 . . . . 5.63 110.14 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.8 mp -121.28 136.27 54.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.899 0.381 . . . . 5.53 110.434 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.543 HG22 HG13 ' A' ' 263' ' ' ILE . 62.1 t -129.84 125.06 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.855 -0.612 . . . . 5.21 110.201 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.29 144.68 22.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.046 -0.724 . . . . 6.05 109.046 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 68.5 ttt180 -64.07 135.21 56.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.637 -0.425 . . . . 7.58 110.518 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -83.17 11.91 5.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 6.04 111.923 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.476 ' H ' ' HG2' ' A' ' 334' ' ' ARG . 9.5 m . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 120.644 0.259 . . . . 7.57 110.644 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.77 0.319 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 205' ' ' VAL . 98.6 mtt180 -117.67 9.4 13.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.044 0.45 . . . . 0.0 110.621 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 87.1 mtt180 -106.87 133.23 51.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.91 -0.586 . . . . 6.52 110.37 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 52.3 mt -97.2 150.44 20.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.283 -0.417 . . . . 5.24 110.546 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -100.66 105.26 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.912 -0.586 . . . . 6.15 109.443 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.3 p -107.71 129.33 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.232 0.539 . . . . 4.24 110.446 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -129.74 -177.53 14.93 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.484 -0.78 . . . . 4.95 111.78 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 61.78 38.77 14.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.84 0.829 . . . . 0.0 109.375 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.42 HG22 HD22 ' A' ' 224' ' ' LEU . 34.0 pt -84.34 152.34 60.92 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 5.61 111.009 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 160' ' ' ILE . 11.6 Cg_exo -71.32 123.08 9.26 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.011 2.474 . . . . 5.97 112.165 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -75.89 113.7 13.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 8.47 109.828 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 132.21 -33.51 2.68 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.784 -0.722 . . . . 6.96 112.283 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 157' ' ' PRO . 11.4 tp -71.26 153.92 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.616 0.246 . . . . 6.1 110.634 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 p -88.9 161.09 16.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.85 0.357 . . . . 6.62 111.223 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 191' ' ' ILE . 41.6 mt-10 -66.05 -37.94 87.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 5.69 109.71 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.16 -48.82 80.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.023 -0.99 . . . . 7.29 111.296 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.23 90.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.253 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.2 ttm -65.1 -39.88 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 4.49 110.53 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.669 ' HE3' ' HB ' ' A' ' 186' ' ' VAL . 23.5 ttt -62.28 -46.22 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.356 . . . . 5.76 110.81 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.66 -38.6 88.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 6.51 110.472 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -57.62 -48.16 80.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.848 -0.615 . . . . 5.44 110.58 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HG2' ' A' ' 173' ' ' MET . 33.2 m-85 -64.47 -47.16 80.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 5.03 111.14 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -54.89 -46.3 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.165 0.291 . . . . 6.3 110.945 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.7 84.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.036 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.3 -37.65 86.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 6.25 111.11 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 33.0 mmt -62.6 -42.25 99.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 7.03 110.177 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.18 -52.75 17.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 8.94 111.007 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.62 -34.05 77.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 8.7 111.697 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.85 -16.81 71.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.509 -0.853 . . . . 8.11 112.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.06 29.85 30.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 8.49 112.137 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.442 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.9 mp -86.89 -18.8 29.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 7.59 110.092 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.717 HG22 ' HG3' ' A' ' 185' ' ' PRO . 13.2 p -69.27 128.2 35.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.501 -0.772 . . . . 8.73 111.168 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 12.7 pt20 -94.09 -1.04 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 9.89 109.322 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -160.07 155.43 21.84 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.082 -0.963 . . . . 9.69 109.476 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.7 168.78 15.9 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.503 2.135 . . . . 10.74 112.136 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.87 -138.61 14.15 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.029 -0.605 . . . . 8.97 112.509 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 90.5 m-20 -116.44 118.05 37.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.588 0.232 . . . . 7.58 110.574 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.717 ' HG3' HG22 ' A' ' 179' ' ' THR . 18.3 Cg_exo -66.61 -26.52 46.36 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.866 2.377 . . . . 6.4 111.864 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.669 ' HB ' ' HE3' ' A' ' 166' ' ' MET . 40.3 t -82.54 127.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.949 -0.568 . . . . 5.47 110.112 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 284' ' ' PRO . 45.0 tp -91.8 -40.4 11.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.232 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -143.34 121.16 11.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.012 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.36 115.4 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.89 -0.595 . . . . 4.68 110.144 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -128.67 106.41 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 6.34 110.157 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 162' ' ' GLU . 66.5 mt -113.97 123.06 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.241 -0.436 . . . . 5.85 111.655 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -100.54 99.62 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -85.51 -16.93 37.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.69 . . . . 7.61 110.167 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.57 -47.55 83.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.616 -0.72 . . . . 9.12 110.957 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 45.1 mmtm -105.57 9.04 33.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.286 -0.415 . . . . 9.1 111.207 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.01 48.58 5.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.412 -0.813 . . . . 6.6 111.82 171.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 37.1 p90 -148.19 142.83 26.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.818 -0.438 . . . . 6.67 109.818 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -134.28 150.46 50.99 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.921 0.391 . . . . 4.58 111.354 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.597 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 74.8 m-85 -117.37 108.47 15.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.63 -0.713 . . . . 6.22 109.889 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 87.3 mt -94.85 114.54 26.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.08 -0.509 . . . . 4.77 109.63 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 36.1 tt0 -94.06 119.49 33.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.814 -0.439 . . . . 6.55 109.814 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.13 164.21 13.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.181 0.515 . . . . 6.51 111.213 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -73.31 -11.65 60.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.355 -0.839 . . . . 8.27 111.089 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 76.0 p -141.68 -166.75 2.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.198 -0.456 . . . . 7.96 110.219 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.592 HG22 ' HG2' ' A' ' 149' ' ' ARG . 21.8 t -116.58 -30.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.268 -0.642 . . . . 8.73 109.268 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.59 -60.44 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.085 -0.962 . . . . 8.5 111.377 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 42.4 mt-10 -58.88 -40.32 84.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4 110.078 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 m -52.45 -52.14 55.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.633 -0.712 . . . . 6.13 110.835 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.7 m -63.0 -34.23 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.522 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.442 ' HG3' HD23 ' A' ' 178' ' ' LEU . 61.8 tp60 -71.17 -30.9 67.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.137 -0.483 . . . . 7.75 110.215 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.1 -15.03 62.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.523 . . . . 5.43 111.273 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.31 -16.02 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 6.29 111.117 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.25 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 6.14 111.55 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 217' ' ' ILE . 69.7 m-85 -93.04 21.47 5.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.444 -0.344 . . . . 5.57 111.577 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.15 109.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 5.92 110.369 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.97 13.25 22.11 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.933 -0.651 . . . . 5.74 112.233 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 214' ' ' PHE . 17.6 tt -66.41 141.8 17.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 5.3 111.2 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.2 tp -82.45 114.1 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.508 0.67 . . . . 6.8 111.098 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.27 112.77 10.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.589 -0.732 . . . . 5.79 110.701 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 59.57 31.41 20.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.863 -0.608 . . . . 7.32 111.737 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.53 -24.76 29.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.855 -0.688 . . . . 7.28 112.585 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.95 167.28 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.879 0.371 . . . . 7.21 110.777 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -118.15 99.79 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.385 -0.598 . . . . 6.14 109.385 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 156' ' ' ILE . 82.6 mt -66.14 112.93 4.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 4.9 111.59 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.3 tttt -81.83 124.73 29.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.517 -0.765 . . . . 7.3 109.91 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -118.76 106.22 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.029 0.443 . . . . 5.37 110.741 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -134.51 171.63 14.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 6.97 110.301 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 20.2 mtp180 -83.62 134.97 43.87 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.788 -0.449 . . . . 7.37 109.788 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.597 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 32.1 Cg_exo -60.28 165.9 10.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.004 2.469 . . . . 7.98 112.762 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -79.62 165.84 22.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.884 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.96 102.2 3.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -126.25 131.1 51.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -113.27 124.66 31.0 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.64 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.9 114.43 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.102 1.868 . . . . 0.0 110.855 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.65 114.85 25.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.497 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.51 -172.31 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.824 2.349 . . . . 0.0 111.9 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 240' ' ' GLU . . . -118.18 153.44 17.09 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.039 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 84.9 mtp -92.88 -57.35 2.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 50.3 m -136.78 15.46 3.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.515 ' O ' ' HA3' ' A' ' 237' ' ' GLY . 0.0 OUTLIER -162.08 -169.07 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.565 -174.289 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.37 141.88 24.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.407 ' HD2' ' HE2' ' A' ' 245' ' ' TYR . 84.8 Cg_exo -49.62 -38.73 45.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.534 2.156 . . . . 0.0 111.42 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 9.0 t -146.2 -75.62 0.21 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.8 -44.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.739 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.407 ' HE2' ' HD2' ' A' ' 242' ' ' PRO . 68.1 m-85 63.39 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.181 0.592 . . . . 0.0 111.294 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 4.6 p -160.64 128.36 2.77 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.175 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 26.9 Cg_exo -62.54 100.83 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.181 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.8 0.42 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.27 142.54 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 250' ' ' VAL . 6.7 t 61.33 19.55 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.701 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 21.3 p -98.14 -25.35 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.305 0.574 . . . . 0.0 109.971 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.6 p -94.8 91.72 6.6 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 254' ' ' VAL . 31.2 m -92.22 -20.26 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.175 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 253' ' ' VAL . 27.1 m -109.83 156.1 40.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.858 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.09 -31.57 90.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.756 2.304 . . . . 0.0 112.242 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.16 117.48 7.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.237 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 30.5 t -155.09 120.98 5.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -75.06 89.39 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.444 ' CE1' ' HA ' ' A' ' 310' ' ' ILE . 13.2 t60 -127.31 1.1 6.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.026 -0.534 . . . . 8.75 110.859 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.685 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.2 ttmt -78.09 129.97 35.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.908 -0.587 . . . . 6.04 110.541 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.41 HD23 ' HG2' ' A' ' 334' ' ' ARG . 82.8 mt -96.07 140.78 30.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.201 0.524 . . . . 5.29 110.792 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -103.45 115.12 29.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.249 -0.887 . . . . 4.77 108.627 171.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 263' ' ' ILE . 4.3 mp -105.43 110.05 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.909 -0.587 . . . . 3.94 109.674 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -122.1 171.74 15.37 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.025 -0.607 . . . . 4.58 111.814 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.78 27.51 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.664 -0.779 . . . . 5.58 111.923 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 96.8 mt -106.36 142.06 24.11 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.646 0.26 . . . . 5.92 110.569 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 15.1 Cg_exo -70.36 160.41 49.63 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.771 2.314 . . . . 6.94 111.507 173.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -88.42 -9.52 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.033 0.383 . . . . 8.81 112.033 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -83.08 -2.14 54.6 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.45 -0.5 . . . . 8.73 110.97 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.68 117.4 19.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 7.52 110.108 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.38 160.11 22.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.062 -0.517 . . . . 8.79 110.817 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.23 -44.45 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 7.62 112.584 -173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.83 -45.26 92.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.816 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.5 -46.49 88.19 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.64 0.257 . . . . 8.69 111.012 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.46 -44.57 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 6.64 110.646 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -62.94 -48.08 80.46 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.378 -0.374 . . . . 7.74 110.82 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.5 -47.82 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 9.38 110.653 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.72 -54.74 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 7.06 110.584 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 288' ' ' PHE . 99.3 mt -69.46 -32.15 70.88 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.879 0.325 . . . . 6.89 111.879 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 36.1 m -72.2 -19.74 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 8.85 110.926 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 50.5 m -79.63 -0.83 35.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.439 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 320' ' ' LEU . 94.7 m-85 -120.68 14.46 11.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 9.18 110.917 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 143.7 159.93 8.21 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.567 -0.825 . . . . 9.06 112.517 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' A' ' 187' ' ' LEU . 55.5 Cg_endo -71.37 122.39 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.658 2.239 . . . . 10.14 112.31 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.96 135.46 33.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 8.3 110.436 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.9 ptpt -99.33 -26.83 14.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.577 -0.527 . . . . 8.65 109.577 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -145.24 136.66 25.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.453 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.531 ' HE2' HD12 ' A' ' 279' ' ' LEU . 16.6 t80 -144.84 110.12 5.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.869 -0.605 . . . . 6.27 109.553 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.59 116.97 21.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.287 0.565 . . . . 5.79 110.44 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -93.23 130.04 39.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.469 -0.787 . . . . 6.35 109.973 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.65 112.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.017 0.437 . . . . 6.61 110.457 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 63.0 mttm -106.96 167.83 9.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.605 . . . . 8.17 110.124 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.47 128.06 34.92 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.192 -0.67 . . . . 10.33 109.192 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.3 m -63.87 -28.65 69.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.072 0.397 . . . . 10.8 112.072 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -95.47 -51.99 4.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 12.13 111.121 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.8 m -68.6 -51.46 42.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 11.16 111.227 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 108.77 -25.09 20.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.742 -0.742 . . . . 10.11 112.172 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.62 164.38 26.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 10.12 110.775 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 42.6 t -68.18 154.24 42.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.971 -0.559 . . . . 7.73 110.581 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -86.86 -8.69 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 8.01 109.93 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.27 17.16 35.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.791 -0.719 . . . . 6.09 113.209 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -156.44 155.94 32.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.682 0.277 . . . . 6.54 110.513 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -151.51 166.41 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.193 -0.458 . . . . 4.38 111.368 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.5 m-85 -115.75 127.47 55.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.043 -0.725 . . . . 4.93 109.043 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.4 m -144.19 131.18 20.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.66 0.267 . . . . 5.09 110.681 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 32.5 tt0 -116.08 130.16 56.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.899 0.381 . . . . 7.03 110.399 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -83.34 158.44 22.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 7.81 110.574 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 286' ' ' LYS . 62.9 t -78.63 -55.88 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 10.03 110.464 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.27 147.87 44.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 10.81 110.837 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.865 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -94.03 -4.03 10.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 9.77 112.065 -175.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -93.85 -50.72 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.732 0.301 . . . . 10.89 110.526 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.68 -24.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 9.5 112.172 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 317' ' ' ILE . 31.3 m -59.54 -50.68 72.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.931 0.345 . . . . 7.83 111.931 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -75.09 -29.04 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 8.79 110.63 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -68.64 -39.25 80.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 10.51 110.157 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.32 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.769 -0.651 . . . . 7.31 110.231 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 332' ' ' VAL . 78.8 mt -61.95 -46.06 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 6.44 110.4 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.52 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.845 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -91.91 -54.68 1.86 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.536 -0.84 . . . . 7.46 113.241 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.402 HD21 ' CE2' ' A' ' 282' ' ' PHE . 96.4 mt -69.26 -50.23 48.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.683 0.253 . . . . 6.42 111.683 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.738 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.8 t30 -63.79 114.04 3.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.727 -0.472 . . . . 6.53 109.727 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.67 7.08 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.8 -0.714 . . . . 6.77 111.815 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.7 mtt -74.16 170.49 15.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.725 -0.472 . . . . 7.29 109.725 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -134.56 118.76 17.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.028 0.442 . . . . 7.83 110.891 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.71 99.1 10.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.292 -0.633 . . . . 7.01 109.292 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.5 2.12 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.732 -0.747 . . . . 8.18 111.516 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -110.52 2.38 18.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.878 0.371 . . . . 8.94 110.582 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -105.06 135.51 46.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 7.29 110.687 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.48 127.25 35.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.738 -0.468 . . . . 7.13 109.738 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.47 115.34 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 5.63 110.664 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 54.5 tp -106.72 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.507 -0.77 . . . . 5.53 109.887 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 61.9 t -126.42 120.51 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.274 -0.421 . . . . 5.21 110.094 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.33 176.83 11.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.138 -0.69 . . . . 6.05 109.138 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' HD23 ' A' ' 261' ' ' LEU . 59.8 mtm180 -82.29 147.39 28.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.598 -0.441 . . . . 7.58 109.875 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.4 67.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 6.04 112.271 -173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.1 m -86.56 -82.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.096 -0.242 . . . . 7.57 111.341 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 93.8 t 63.52 107.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.774 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -61.79 -71.74 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.553 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -169.62 98.89 0.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.412 . . . . 0.0 110.673 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -96.0 -49.52 5.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 64.24 20.95 12.38 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 -179.307 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.746 0.308 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 202' ' ' PHE . 37.3 ptt180 -90.87 -1.4 57.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 68.5 mtt180 -98.12 164.28 12.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.049 0.452 . . . . 6.52 111.4 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 64.0 mt -136.86 158.41 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.268 -0.878 . . . . 5.24 109.86 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.94 113.47 26.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.831 -0.622 . . . . 6.15 109.519 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.8 p -113.19 129.1 69.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.233 0.539 . . . . 4.24 110.763 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.03 177.8 16.46 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.629 -0.714 . . . . 4.95 111.759 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.48 63.59 1.67 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.352 0.596 . . . . 0.0 110.4 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.67 155.56 36.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.568 -0.742 . . . . 5.61 110.264 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.659 ' HB2' ' HB ' ' A' ' 160' ' ' ILE . 16.1 Cg_exo -69.07 131.03 21.3 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.724 2.282 . . . . 5.97 112.013 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -79.47 102.46 8.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 8.47 109.674 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.27 20.64 6.18 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.953 -0.642 . . . . 6.96 111.895 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB2' ' A' ' 157' ' ' PRO . 11.0 tp -94.03 146.33 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.769 -0.456 . . . . 6.1 109.769 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.2 p -86.68 154.05 21.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 6.62 111.5 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.518 -0.765 . . . . 5.69 110.288 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.78 -48.1 80.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.719 -0.673 . . . . 7.29 110.408 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.45 -50.8 70.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.225 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 94.5 mmm -63.14 -48.88 76.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.194 -0.457 . . . . 4.49 110.958 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 281' ' ' SER . 1.9 tmt? -61.13 -51.6 68.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 5.76 110.787 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.46 -36.26 83.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 6.51 111.536 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.86 -48.72 80.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.681 0.277 . . . . 5.44 111.28 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.458 ' HE1' HD11 ' A' ' 226' ' ' ILE . 60.4 m-85 -64.3 -35.91 82.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.571 -0.286 . . . . 5.03 110.728 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 82.5 m-20 -60.22 -50.4 73.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.91 -0.404 . . . . 6.3 109.91 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -56.8 -47.54 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.473 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.99 -39.47 94.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.606 -0.27 . . . . 6.25 111.072 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 179' ' ' THR . 26.4 mmt -62.74 -41.75 99.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 7.03 110.54 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 84.8 mtt180 -67.29 -52.2 43.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 8.94 111.0 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 89.3 mt -60.38 -33.91 73.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.86 -0.609 . . . . 8.7 111.693 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.19 -21.46 45.31 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.334 -0.936 . . . . 8.11 112.284 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.03 27.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.983 -0.627 . . . . 8.49 111.981 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 210' ' ' GLN . 4.2 mp -97.93 -5.32 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 7.59 110.505 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -79.3 156.46 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 8.73 111.049 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.43 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 13.8 pt20 -87.79 -14.9 38.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.255 0.55 . . . . 9.89 109.94 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -156.2 144.89 14.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 9.69 109.84 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.57 113.26 2.22 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.647 2.231 . . . . 10.74 111.835 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.46 -137.77 5.08 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.655 -0.783 . . . . 8.97 112.381 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -112.06 108.34 55.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.539 0.209 . . . . 7.58 110.665 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.594 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 45.1 Cg_endo -68.69 -34.63 18.5 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.749 2.299 . . . . 6.4 111.85 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.76 128.7 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 5.47 109.514 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 284' ' ' PRO . 26.6 tp -105.25 -33.24 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.978 0.418 . . . . 0.0 110.361 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -152.32 155.01 36.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.321 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 200' ' ' LEU . 7.2 p -143.02 133.1 22.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.926 0.393 . . . . 4.68 110.604 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.33 106.73 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 6.34 110.047 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.35 130.56 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.05 -0.523 . . . . 5.85 111.428 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -121.59 96.8 5.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.837 -0.801 . . . . 7.34 108.837 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -83.48 -6.68 59.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.044 -0.525 . . . . 7.61 110.962 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -66.66 -51.91 50.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 9.12 110.619 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.522 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.4 mmtm -102.89 -0.24 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.22 -0.445 . . . . 9.1 110.406 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 66.76 61.52 0.53 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.345 -0.843 . . . . 6.6 111.924 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 48.6 p90 -149.43 163.52 37.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 6.67 109.506 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.61 153.27 40.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.943 0.402 . . . . 4.58 111.095 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.05 122.65 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.852 -0.613 . . . . 6.22 110.161 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 75.2 mt -100.69 116.0 31.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 4.77 110.279 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 5.2 tt0 -101.34 113.75 27.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.682 -0.488 . . . . 6.55 109.682 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.404 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 69.9 m-85 -90.59 160.11 16.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.077 -0.51 . . . . 6.51 110.825 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.74 -25.08 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 8.27 110.877 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 93.2 p -132.16 -178.29 4.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.171 -0.468 . . . . 7.96 110.053 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.89 -16.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.707 0.765 . . . . 8.73 109.032 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.54 -54.65 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.998 -1.001 . . . . 8.5 111.078 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.43 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 36.2 mt-10 -66.45 -30.32 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 7.4 110.897 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -50.71 -45.31 58.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 6.13 112.02 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 m -56.37 -43.46 79.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.688 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.759 ' HB3' HD23 ' A' ' 178' ' ' LEU . 29.0 mp0 -73.64 -28.06 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.51 -0.313 . . . . 7.75 110.853 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.402 ' HA ' ' HE3' ' A' ' 173' ' ' MET . . . -63.27 -21.5 66.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 5.43 110.617 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.58 -14.83 62.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 6.29 111.22 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.01 -13.56 62.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 6.14 110.879 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.716 ' HD2' HD12 ' A' ' 217' ' ' ILE . 68.7 m-85 -100.02 17.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 5.57 110.753 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.59 107.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 5.92 110.392 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.74 14.23 23.8 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.955 -0.64 . . . . 5.74 112.194 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.716 HD12 ' HD2' ' A' ' 214' ' ' PHE . 16.1 tt -68.01 135.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.045 0.45 . . . . 5.3 110.689 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.79 114.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.386 0.612 . . . . 6.8 111.045 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -134.58 118.65 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.639 -0.709 . . . . 5.79 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 59.63 26.72 15.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.025 -0.534 . . . . 7.32 111.516 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 91.87 -5.48 79.26 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.682 -0.77 . . . . 7.28 112.881 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.564 0.221 . . . . 7.21 110.691 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.1 t -101.0 95.1 6.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.428 -0.582 . . . . 6.14 109.428 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.45 106.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 4.9 111.459 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 88.4 tttt -82.22 113.92 20.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.709 -0.678 . . . . 7.3 109.715 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.458 HD11 ' HE1' ' A' ' 169' ' ' PHE . 67.3 mt -109.1 107.22 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.053 0.454 . . . . 5.37 110.625 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -124.9 170.38 11.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.764 -0.653 . . . . 6.97 109.74 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -87.73 154.58 53.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 121.043 -0.263 . . . . 7.37 110.71 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 55.8 Cg_endo -69.76 173.42 11.0 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.744 2.296 . . . . 7.98 111.809 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 35.1 m-70 69.41 11.87 8.16 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.38 -44.3 29.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -93.63 -52.85 4.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 63.08 89.73 0.1 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.153 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.5 111.34 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.85 2.366 . . . . 0.0 111.769 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 236' ' ' PRO . 7.3 mp 63.34 92.2 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.769 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 235' ' ' LEU . 15.4 Cg_endo -57.35 -30.91 89.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.321 2.681 . . . . 0.0 113.038 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 175.06 77.14 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.25 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 52.7 ttp -94.66 100.25 12.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.5 m -104.42 104.35 14.21 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.26 -36.59 84.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.291 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -91.32 151.3 42.7 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.918 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.07 -151.48 0.03 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.557 2.172 . . . . 0.0 111.323 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.8 m -77.38 60.75 2.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.11 0.481 . . . . 0.0 111.062 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.63 116.11 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.459 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -89.48 129.17 36.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.102 0.477 . . . . 0.0 110.978 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.17 115.1 65.82 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.412 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.99 -179.03 1.53 Allowed 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.655 2.236 . . . . 0.0 112.149 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.98 124.62 36.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.103 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -83.81 122.23 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 0.0 110.286 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.0 p -85.05 153.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.366 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.2 m -59.72 132.98 55.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.597 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 253' ' ' VAL . 0.2 OUTLIER -82.61 175.52 10.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.571 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 252' ' ' THR . 62.3 t -57.83 -58.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 110.229 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 8.0 m -135.19 119.49 13.4 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.538 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 5.7 Cg_exo -79.2 -5.09 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.054 2.502 . . . . 0.0 111.775 177.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.26 109.09 13.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.202 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 m -101.71 122.59 44.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -70.15 118.21 12.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.65 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.588 ' HB3' HG21 ' A' ' 313' ' ' THR . 47.2 m80 -130.97 15.4 5.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.57 -0.741 . . . . 8.75 109.077 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.479 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.7 ttmt -59.22 125.12 22.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.096 -0.957 . . . . 6.04 111.809 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.3 mt -100.29 135.58 41.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.326 -0.852 . . . . 5.29 110.001 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.425 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 93.6 t80 -93.09 111.13 22.66 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.145 -0.687 . . . . 4.77 109.145 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.749 HG23 HD11 ' A' ' 330' ' ' LEU . 2.3 mp -91.45 109.09 20.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.838 -0.619 . . . . 3.94 109.637 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.86 112.16 2.17 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.623 -0.798 . . . . 4.58 112.298 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 137.06 45.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.828 -0.701 . . . . 5.58 112.21 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.9 mt -110.51 144.58 30.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 5.92 110.998 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.4 158.28 22.61 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.158 2.572 . . . . 6.94 111.694 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -83.95 -13.08 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.572 0.225 . . . . 8.81 111.305 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -81.67 -6.78 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 8.73 110.21 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 275' ' ' VAL . 13.8 tp -87.8 120.66 29.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 7.52 109.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 275' ' ' VAL . 33.4 p30 -91.0 174.21 7.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 8.79 111.284 -176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.58 -32.1 72.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.691 -0.686 . . . . 7.62 111.417 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.18 -54.62 38.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.683 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.75 -34.95 77.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.672 -0.694 . . . . 8.69 111.742 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 271' ' ' ASN . 62.9 t -63.0 -48.84 86.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.778 0.323 . . . . 6.64 110.465 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.04 -42.7 94.07 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.558 -0.292 . . . . 7.74 110.616 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.0 -46.85 84.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.02 -0.536 . . . . 9.38 111.249 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -46.94 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 7.06 110.116 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.3 mt -69.8 -36.05 75.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.175 -0.466 . . . . 6.89 111.236 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.1 m -68.31 -19.71 64.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.03 0.443 . . . . 8.85 110.995 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.472 ' HA ' ' CE ' ' A' ' 166' ' ' MET . 38.3 m -68.39 -12.28 60.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.92 11.58 8.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.404 . . . . 9.18 111.307 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 145.93 163.95 10.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.442 -0.885 . . . . 9.06 113.115 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HB3' HD11 ' A' ' 187' ' ' LEU . 86.3 Cg_endo -83.52 134.88 6.76 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.94 2.427 . . . . 10.14 112.642 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.2 mt -90.8 142.14 28.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.381 -0.372 . . . . 8.3 110.568 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.466 ' HB3' HG22 ' A' ' 308' ' ' VAL . 7.8 ptpp? -103.18 -22.86 13.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.385 -0.598 . . . . 8.65 109.385 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.1 132.49 23.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -145.77 123.52 11.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.224 -0.444 . . . . 6.27 110.586 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.91 118.49 12.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.388 0.614 . . . . 5.79 109.955 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.745 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.5 tp -91.83 125.43 36.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.658 -0.701 . . . . 6.35 109.172 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 303' ' ' ALA . 46.4 t -76.75 112.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.356 -0.538 . . . . 6.61 110.137 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.58 153.17 19.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.475 -0.784 . . . . 8.17 109.985 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.668 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 21.2 t70 -64.68 145.53 56.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.349 -0.387 . . . . 10.33 110.237 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.1 m -63.64 -28.33 69.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.033 -0.53 . . . . 10.8 111.738 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -116.62 -40.99 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.99 0.367 . . . . 12.13 111.99 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 30.0 m -69.1 -46.91 66.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.719 0.295 . . . . 11.16 111.362 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.63 70.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 10.11 112.962 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.51 170.36 9.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.008 -0.367 . . . . 10.12 110.008 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.7 t -58.08 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.12 0.485 . . . . 7.73 111.022 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.668 ' HD3' ' HA ' ' A' ' 293' ' ' ASP . 31.9 mmmt -85.81 -3.45 58.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 8.01 109.982 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 103.4 -3.84 47.22 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.805 -0.712 . . . . 6.09 112.245 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 18.4 p90 -141.62 157.12 45.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 6.54 111.436 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -156.91 167.06 31.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.824 -0.626 . . . . 4.38 110.844 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.479 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.6 m-85 -116.27 125.61 52.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.205 -0.665 . . . . 4.93 109.205 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 28.9 m -144.32 136.65 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.646 0.26 . . . . 5.09 111.009 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.68 132.29 49.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.758 0.313 . . . . 7.03 110.253 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 42.3 m-85 -79.11 166.61 22.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.057 -0.52 . . . . 7.81 110.78 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 286' ' ' LYS . 56.9 t -76.32 -51.65 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.197 -0.456 . . . . 10.03 110.23 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.546 ' HB3' HG22 ' A' ' 312' ' ' VAL . 16.5 t70 -92.47 156.11 17.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.755 -0.657 . . . . 10.81 110.262 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.766 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -78.86 -30.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.52 -0.309 . . . . 9.77 111.462 -176.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -67.4 -49.34 64.22 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 110.211 -0.292 . . . . 10.89 110.211 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.618 HG21 ' HD2' ' A' ' 284' ' ' PRO . 19.8 m -65.56 -26.06 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 9.5 111.542 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.588 HG21 ' HB3' ' A' ' 259' ' ' HIS . 86.1 m -64.47 -49.81 69.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.324 0.583 . . . . 7.83 110.11 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.1 -24.46 58.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 8.79 110.991 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLN . . . . . 0.47 ' HB2' ' HA ' ' A' ' 312' ' ' VAL . 45.4 mt-30 -63.42 -40.25 96.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 10.51 110.17 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 320' ' ' LEU . . . -62.22 -44.91 95.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 7.31 110.516 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.36 -36.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 6.44 111.297 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -83.82 -52.39 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.778 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.55 -37.19 24.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.035 -0.602 . . . . 7.46 113.956 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' A' ' 330' ' ' LEU . 80.3 mt -83.92 -36.91 22.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.257 0.528 . . . . 6.42 111.993 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 6.4 t30 -61.97 119.94 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.732 0.301 . . . . 6.53 110.529 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.03 -22.47 20.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.926 -0.654 . . . . 6.77 112.297 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 23.9 ttt -71.31 123.26 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.298 -0.26 . . . . 7.29 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.474 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 51.4 mt-30 -82.98 117.5 22.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 7.83 111.466 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -91.03 94.86 9.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.559 -0.904 . . . . 7.01 108.559 171.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.23 -87.36 1.29 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.547 -0.835 . . . . 8.18 111.181 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -126.51 -25.1 3.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.764 0.316 . . . . 8.94 110.865 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 324' ' ' GLN . 94.7 mttt -85.79 134.98 33.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 7.29 110.92 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 92.8 mttt -77.47 126.29 30.68 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.454 -0.573 . . . . 7.13 109.454 172.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 263' ' ' ILE . 30.8 tp -67.77 102.56 1.24 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.954 0.407 . . . . 5.63 110.258 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 53.4 tp -93.57 111.82 23.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.888 -0.596 . . . . 5.53 109.674 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.07 108.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 5.21 109.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 17.6 pt20 -124.04 124.32 42.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.104 -0.498 . . . . 6.05 110.216 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -72.16 123.03 22.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.966 -0.383 . . . . 7.58 109.966 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -111.32 95.48 5.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.532 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 m -147.04 -38.17 0.21 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 7.57 110.358 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 29.0 t 55.29 81.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.852 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.67 -145.61 26.38 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.014 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.54 -18.2 21.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.573 0.225 . . . . 0.0 110.736 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 70.55 -72.33 0.11 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.358 0.663 . . . . 0.0 111.877 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -95.49 -51.97 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.819 0.342 . . . . 0.0 110.247 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.475 179.567 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.6 -3.36 16.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.215 0.531 . . . . 0.0 109.638 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 98.7 mtt180 -101.66 146.64 27.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.507 -0.769 . . . . 6.52 110.655 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.9 mt -110.14 147.08 34.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.241 -0.436 . . . . 5.24 110.05 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 85.1 t80 -102.62 103.55 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 6.15 110.062 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 198' ' ' ALA . 7.6 p -105.33 133.72 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.236 0.541 . . . . 4.24 110.691 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -131.77 -179.66 16.37 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 4.95 111.984 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.09 29.77 14.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.367 0.603 . . . . 0.0 109.999 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.1 pt -74.77 151.52 86.78 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 5.61 111.02 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.38 137.18 63.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.8 2.333 . . . . 5.97 111.899 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -81.62 114.32 20.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.934 0.397 . . . . 8.47 110.043 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.02 21.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 6.96 112.153 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.3 tp -76.48 140.87 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.967 -0.383 . . . . 6.1 109.967 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -88.56 154.62 20.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.783 0.325 . . . . 6.62 110.608 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.902 ' HA ' HD12 ' A' ' 191' ' ' ILE . 39.8 mt-10 -60.44 -38.49 84.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 5.69 110.071 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.1 -55.63 30.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.257 -0.883 . . . . 7.29 111.295 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.38 93.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 169' ' ' PHE . 46.5 ttm -67.95 -42.22 81.3 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.998 -0.281 . . . . 4.49 110.476 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 281' ' ' SER . 26.8 ttt -62.95 -45.82 90.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 5.76 110.422 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.16 -41.4 75.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.559 . . . . 6.51 110.985 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.455 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 78.0 t80 -57.83 -51.9 67.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 5.44 110.95 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.408 ' HD2' ' O ' ' A' ' 165' ' ' MET . 68.1 m-85 -66.38 -39.87 89.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 5.03 111.226 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.2 m-20 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 6.3 110.384 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.91 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 87.5 mm-40 -61.85 -42.19 98.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.558 -0.292 . . . . 6.25 110.969 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.521 ' HB3' HG23 ' A' ' 179' ' ' THR . 86.2 mmm -66.04 -36.65 83.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.292 -0.413 . . . . 7.03 110.968 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 66.9 mtt180 -72.47 -52.3 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.524 -0.307 . . . . 8.94 110.961 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.06 -36.01 77.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 8.7 111.51 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.08 -21.01 80.15 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.87 -0.681 . . . . 8.11 112.532 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.88 39.33 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 8.49 112.5 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.24 9.33 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 7.59 110.192 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.6 p -114.62 105.19 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 8.73 111.504 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -80.74 -22.96 39.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 9.89 109.972 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -112.65 137.81 21.84 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.956 -0.566 . . . . 9.69 110.238 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 161.1 37.73 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.798 2.332 . . . . 10.74 112.108 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.09 -152.78 18.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.824 -0.703 . . . . 8.97 112.099 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 94.6 m-20 -109.22 122.72 38.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.786 -0.244 . . . . 7.58 111.094 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HG3' ' CB ' ' A' ' 173' ' ' MET . 19.7 Cg_endo -60.75 -36.68 83.41 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.946 2.431 . . . . 6.4 111.374 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.9 t -81.33 127.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.827 -0.805 . . . . 5.47 108.827 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 20.5 tp -90.92 -39.19 12.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.06 153.66 33.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.606 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.448 HG23 HD23 ' A' ' 200' ' ' LEU . 7.4 p -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.27 -0.423 . . . . 4.68 110.804 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -130.65 106.87 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 6.34 109.699 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 162' ' ' GLU . 51.5 mt -110.95 126.92 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.162 0.506 . . . . 5.85 111.578 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -101.91 101.31 11.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 7.34 108.388 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.19 -27.83 53.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 7.61 110.648 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.92 -49.03 72.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 9.12 111.281 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.17 -6.89 54.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 9.1 111.068 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 64.51 56.36 1.24 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.833 -0.621 . . . . 6.6 111.321 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 40.3 p90 -149.04 149.12 30.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.047 -0.524 . . . . 6.67 109.879 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -134.19 140.19 46.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.775 0.321 . . . . 4.58 111.087 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 42.5 m-85 -108.32 109.02 20.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.868 -0.606 . . . . 6.22 110.139 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.7 mt -93.27 114.01 26.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 4.77 109.32 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.69 114.64 26.3 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.136 -0.32 . . . . 6.55 110.136 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -89.7 155.96 18.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.257 -0.428 . . . . 6.51 110.892 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.7 -22.6 60.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.734 -0.666 . . . . 8.27 110.972 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 94.6 p -148.18 142.85 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.964 -0.384 . . . . 7.96 109.964 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.415 ' HA ' ' OG1' ' A' ' 208' ' ' THR . 94.6 t -63.94 -28.62 45.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.021 0.439 . . . . 8.73 110.373 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.68 -40.94 69.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 8.5 110.581 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.3 -29.62 26.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 7.4 110.965 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 205' ' ' VAL . 32.2 m -54.06 -51.52 63.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.923 0.392 . . . . 6.13 110.803 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.72 -24.9 67.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.707 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -68.09 -35.55 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.958 0.408 . . . . 7.75 110.196 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -74.78 -14.28 60.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 5.43 110.91 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.2 mtp -69.43 -20.54 63.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 6.29 110.289 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.37 -15.21 61.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.92 -0.582 . . . . 6.14 110.801 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.659 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 90.7 m-85 -92.86 6.5 47.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 5.57 110.945 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.48 124.23 20.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.699 0.285 . . . . 5.92 110.244 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.68 35.2 11.93 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.686 -0.768 . . . . 5.74 111.56 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.87 137.89 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.941 -0.392 . . . . 5.3 109.941 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.04 119.15 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.301 0.572 . . . . 6.8 110.756 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -133.01 112.28 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.085 -0.507 . . . . 5.79 110.985 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 56.66 35.02 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.769 -0.651 . . . . 7.32 111.94 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.86 78.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 7.28 113.045 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -118.04 124.1 47.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.334 . . . . 7.21 110.64 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.6 t -77.3 115.89 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.158 -0.682 . . . . 6.14 109.158 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.5 118.69 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 4.9 110.98 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.0 tttt -88.36 114.15 24.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 7.3 109.642 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.0 mt -109.52 106.56 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.078 0.466 . . . . 5.37 110.428 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 4.5 mmp_? -114.92 170.09 8.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.892 -0.594 . . . . 6.97 110.508 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -83.94 125.13 73.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.268 -0.641 . . . . 7.37 109.268 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.561 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 18.1 Cg_endo -58.55 129.63 33.42 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.607 2.205 . . . . 7.98 111.379 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.592 ' HB2' ' HD2' ' A' ' 232' ' ' TYR . 8.2 p-80 -62.19 134.85 57.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.88 0.372 . . . . 0.0 110.595 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.34 -4.0 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.379 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 230' ' ' HIS . 17.5 m-85 -79.37 57.9 2.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.74 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 28.9 tt0 -58.81 125.61 77.89 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.574 -177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 233' ' ' GLN . 3.3 Cg_endo -46.83 134.28 17.61 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.802 3.001 . . . . 0.0 113.003 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.8 mt 61.22 83.48 0.21 Allowed Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.68 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.58 133.78 44.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.439 2.76 . . . . 0.0 112.888 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.447 ' HA3' ' HG3' ' A' ' 242' ' ' PRO . . . 146.65 63.6 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.08 -60.1 1.76 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 0.0 110.234 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.7 m -83.32 2.02 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.163 0.506 . . . . 0.0 110.683 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.89 172.68 17.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.143 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -97.81 132.84 24.17 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.378 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.447 ' HG3' ' HA3' ' A' ' 237' ' ' GLY . 43.3 Cg_exo -56.52 112.09 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.845 2.363 . . . . 0.0 111.845 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 p -101.04 97.18 7.77 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.167 0.508 . . . . 0.0 111.182 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.21 -59.96 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.577 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -108.38 -31.97 7.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.208 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.58 126.9 24.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.56 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.41 -46.28 25.52 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.629 2.219 . . . . 0.0 112.255 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 148.31 91.43 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.868 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.699 HG23 HG12 ' A' ' 250' ' ' VAL . 34.5 m -115.05 -26.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 110.928 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.699 HG12 HG23 ' A' ' 249' ' ' VAL . 9.3 p -175.91 -41.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.813 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 50.0 m 56.68 74.77 0.39 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.321 0.581 . . . . 0.0 111.387 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 51.7 m -87.22 93.58 9.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.305 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.44 -46.57 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.31 136.07 28.07 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.51 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.12 161.93 35.07 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.459 2.106 . . . . 0.0 111.739 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.0 104.47 0.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.227 0.537 . . . . 0.0 110.078 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.8 p -147.47 150.51 34.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.121 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.81 104.19 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.377 0.608 . . . . 0.0 111.025 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -96.52 9.98 39.77 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 8.75 108.771 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 304' ' ' PHE . 35.2 ttmt -59.1 119.49 7.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.104 -1.407 . . . . 6.04 110.113 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.0 141.63 29.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.863 -0.608 . . . . 5.29 110.792 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.72 110.0 21.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.489 -0.778 . . . . 4.77 109.317 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.776 HG23 HD11 ' A' ' 330' ' ' LEU . 3.9 mp -101.77 103.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.321 -0.622 . . . . 3.94 109.321 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.91 164.13 21.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 4.58 112.605 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 102.09 15.71 25.29 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.782 -0.723 . . . . 5.58 111.895 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 270' ' ' LEU . 83.4 mt -92.57 148.74 36.83 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.655 0.264 . . . . 5.92 110.545 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 270' ' ' LEU . 46.0 Cg_endo -69.23 153.74 70.89 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.687 2.258 . . . . 6.94 112.276 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.7 -22.6 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 8.81 111.368 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -83.64 1.04 44.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.948 0.404 . . . . 8.73 111.187 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 267' ' ' PRO . 11.6 tp -87.11 99.37 11.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.859 -0.793 . . . . 7.52 108.859 176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 34.2 p-10 -89.68 -179.0 5.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 8.79 111.686 -172.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.485 ' CG ' ' HZ1' ' A' ' 292' ' ' LYS . 2.7 m-20 -52.31 -41.02 62.59 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.595 -0.729 . . . . 7.62 112.158 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.89 -47.75 81.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.19 -42.92 71.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 8.69 111.431 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 82.1 t -64.62 -49.38 80.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.555 -0.293 . . . . 6.64 111.7 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -65.21 -43.36 91.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.841 -0.344 . . . . 7.74 111.228 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.49 -46.97 83.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 9.38 110.638 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.66 -52.82 62.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 7.06 110.501 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.65 -38.62 80.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.043 0.386 . . . . 6.89 112.043 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.4 m -61.58 -34.77 76.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.3 . . . . 8.85 111.106 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.432 ' HB3' ' SD ' ' A' ' 166' ' ' MET . 49.0 m -62.74 -23.2 67.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.864 -178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -106.38 12.55 29.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.073 0.397 . . . . 9.18 112.073 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 154.58 155.41 7.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.762 -1.209 . . . . 9.06 113.462 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.734 ' HD2' HG21 ' A' ' 312' ' ' VAL . 6.9 Cg_exo -72.78 120.69 6.82 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.243 2.629 . . . . 10.14 112.064 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 305' ' ' CYS . 96.1 mt -94.4 141.29 28.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.099 -0.501 . . . . 8.3 110.698 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.7 ptpt -110.94 -32.73 6.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.019 0.438 . . . . 8.65 110.155 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -132.4 111.5 11.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.536 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.3 124.09 41.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 6.27 110.183 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -140.34 114.87 9.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.308 0.575 . . . . 5.79 110.351 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.5 tp -90.34 125.49 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 6.35 110.247 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.1 116.51 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.127 0.489 . . . . 6.61 110.116 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.485 ' HZ1' ' CG ' ' A' ' 272' ' ' ASP . 61.4 mttm -110.73 154.31 24.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.74 -0.664 . . . . 8.17 110.86 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 13.5 t70 -83.29 129.71 35.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.984 -0.747 . . . . 10.33 108.984 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.4 m -85.19 -13.27 50.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.426 -0.352 . . . . 10.8 111.887 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.11 -56.43 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.987 0.422 . . . . 12.13 111.095 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.467 HG22 ' HG ' ' A' ' 298' ' ' LEU . 48.1 m -83.27 -30.42 27.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 11.16 110.627 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.02 22.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.585 -0.817 . . . . 10.11 112.59 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' A' ' 296' ' ' THR . 84.3 mt -110.11 161.54 15.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.73 0.3 . . . . 10.12 110.418 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.9 t -69.52 133.75 48.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.28 -0.637 . . . . 7.73 109.28 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.467 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.2 mmmp? -74.82 -15.88 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 8.01 110.858 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 97.76 14.78 39.11 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.612 -0.804 . . . . 6.09 113.049 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 11.0 p90 -154.89 146.62 23.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 6.54 110.779 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.3 168.02 21.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.882 -0.599 . . . . 4.38 110.718 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.475 ' HB3' ' HG2' ' A' ' 260' ' ' LYS . 91.8 m-85 -114.54 130.21 56.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 4.93 109.557 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 35.5 m -141.98 116.57 9.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 5.09 111.608 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.479 ' OE1' ' HD2' ' A' ' 286' ' ' LYS . 39.9 tt0 -100.24 130.62 46.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.821 -0.437 . . . . 7.03 109.821 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' ' OG1' ' A' ' 313' ' ' THR . 47.5 m-85 -88.67 158.51 18.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 7.81 111.07 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 286' ' ' LYS . 58.6 t -79.1 -46.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 10.03 111.118 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.561 ' HB3' HG22 ' A' ' 312' ' ' VAL . 12.6 t70 -93.91 132.55 38.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 10.81 110.446 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -64.79 -28.49 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 112.263 0.468 . . . . 9.77 112.263 -176.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -71.79 -50.05 33.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.891 -0.411 . . . . 10.89 109.891 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.734 HG21 ' HD2' ' A' ' 284' ' ' PRO . 20.8 m -66.27 -24.68 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 9.5 110.856 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 317' ' ' ILE . 47.3 m -61.85 -48.16 81.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.13 0.49 . . . . 7.83 110.132 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.81 -35.13 64.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.007 -0.542 . . . . 8.79 110.516 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -63.53 -40.22 96.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 10.51 110.773 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.12 97.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 7.31 110.47 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 313' ' ' THR . 71.7 mt -59.08 -45.38 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 6.44 110.674 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.51 78.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.749 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.31 -49.36 6.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 7.46 113.51 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.509 ' HB3' HD23 ' A' ' 330' ' ' LEU . 98.6 mt -73.57 -49.07 28.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.302 . . . . 6.42 111.814 -173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 7.3 t30 -63.05 115.22 4.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 6.53 110.44 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.92 -20.55 14.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.853 -0.689 . . . . 6.77 112.389 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 20.9 ttt -75.22 141.41 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.146 -0.316 . . . . 7.29 110.146 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -88.66 118.87 28.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.785 0.326 . . . . 7.83 110.525 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.6 mm? -101.79 96.52 7.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.124 -0.489 . . . . 7.01 109.852 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.2 -85.57 0.81 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.901 -0.666 . . . . 8.18 112.058 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.63 -41.06 2.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.737 0.303 . . . . 8.94 111.281 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -91.29 165.64 13.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 7.29 110.807 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.66 136.1 37.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 7.13 109.536 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.856 ' HB2' HD23 ' A' ' 325' ' ' LEU . 33.0 tp -73.83 125.45 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.173 0.511 . . . . 5.63 111.316 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.67 118.63 37.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 5.53 109.614 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 91.1 t -127.32 113.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.185 -0.461 . . . . 5.21 109.779 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -138.04 171.87 13.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.122 -0.49 . . . . 6.05 110.01 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 334' ' ' ARG . 47.7 mtm180 -86.59 136.83 32.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.402 -0.222 . . . . 7.58 110.402 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -62.91 -44.55 95.77 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.115 0.483 . . . . 6.04 110.092 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.8 m -95.03 92.78 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 7.57 109.406 172.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.89 -23.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.382 0.611 . . . . 0.0 110.169 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -152.14 -95.81 0.13 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.07 126.62 35.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -107.16 124.6 49.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.411 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 61.76 35.66 16.65 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.641 0.588 . . . . 0.0 111.183 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.889 ' HB2' HG22 ' A' ' 205' ' ' VAL . 56.1 ttp85 75.99 -24.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.773 0.67 . . . . 0.0 111.991 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -97.53 150.91 20.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 6.52 111.392 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 208' ' ' THR . 23.7 mt -113.19 149.43 33.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.861 -0.609 . . . . 5.24 111.186 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -107.98 102.9 12.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.125 -0.943 . . . . 6.15 108.702 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 169' ' ' PHE . 7.4 p -104.11 127.44 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.488 . . . . 4.24 110.301 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.37 -178.75 15.44 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.803 -0.635 . . . . 4.95 111.777 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 10.2 m120 62.01 28.85 17.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.085 0.469 . . . . 0.0 110.899 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.528 HG22 HD22 ' A' ' 224' ' ' LEU . 31.8 pt -78.52 153.61 78.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.466 -0.788 . . . . 5.61 110.728 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.498 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 32.7 Cg_endo -64.35 136.71 52.37 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.556 2.171 . . . . 5.97 112.056 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.19 123.34 20.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 8.47 109.913 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.29 4.43 53.35 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.576 -0.821 . . . . 6.96 112.421 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.3 tp -66.07 130.85 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 6.1 110.147 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.8 p -92.24 155.21 18.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.765 0.317 . . . . 6.62 110.751 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 162' ' ' GLU . 25.6 mp0 -53.69 -46.47 70.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 5.69 110.186 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.96 -55.81 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.325 -0.852 . . . . 7.29 111.153 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.94 93.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.288 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 0.7 OUTLIER -64.94 -47.67 76.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 4.49 110.598 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.2 ttt -60.92 -48.83 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 5.76 110.769 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.46 -38.78 88.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 6.51 111.524 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.49 -49.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.614 -0.267 . . . . 5.44 111.068 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 153' ' ' VAL . 50.4 m-85 -65.1 -44.22 89.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.593 -0.276 . . . . 5.03 111.093 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.03 -33.45 75.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.557 -0.292 . . . . 6.3 110.985 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.74 -49.93 68.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.227 175.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -60.09 -35.36 75.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 6.25 111.113 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.703 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 6.0 mmt -60.88 -50.16 74.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 7.03 110.529 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -71.06 -44.29 66.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 8.94 111.269 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 78.1 mt -65.13 -35.18 80.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.383 . . . . 8.7 110.985 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.95 -34.38 38.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.627 -0.796 . . . . 8.11 112.104 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.37 47.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.624 . . . . 8.49 111.926 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 6.0 mp -96.19 82.83 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 7.59 109.672 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 185' ' ' PRO . 14.2 m -154.93 143.13 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.908 -0.587 . . . . 8.73 109.425 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.537 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 11.1 pt20 -93.24 -22.1 19.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.734 -0.387 . . . . 9.89 111.442 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.3 145.91 19.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.592 -0.277 . . . . 9.69 110.599 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.91 114.17 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.734 2.29 . . . . 10.74 112.003 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.6 -152.57 24.6 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.825 -0.702 . . . . 8.97 111.942 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -114.54 117.73 42.32 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.548 0.213 . . . . 7.58 110.865 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HG3' HG23 ' A' ' 179' ' ' THR . 28.0 Cg_exo -63.09 -37.83 49.75 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.66 2.24 . . . . 6.4 111.53 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 52.8 t -89.72 112.55 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.836 -0.62 . . . . 5.47 109.824 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 280' ' ' THR . 86.4 mt -89.96 -39.28 13.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.729 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.1 168.94 19.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.46 116.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 4.68 110.753 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -98.15 106.96 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 6.34 109.614 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.0 mt -91.66 136.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.232 0.539 . . . . 5.85 110.958 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -119.55 96.77 5.34 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -70.5 -23.97 62.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.569 -0.741 . . . . 7.61 111.697 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.76 -49.92 75.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 9.12 111.498 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 35.2 mmtm -106.19 7.09 31.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 9.1 111.028 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.04 61.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.795 . . . . 6.6 111.5 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 52.3 p90 -148.99 171.31 16.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.092 -0.504 . . . . 6.67 109.676 173.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.94 142.46 28.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.357 . . . . 4.58 111.158 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 70.2 m-85 -92.8 113.44 25.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 6.22 109.869 175.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 151' ' ' LEU . 97.0 mt -83.35 115.76 22.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.211 -0.449 . . . . 4.77 110.253 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.84 108.45 19.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 6.55 109.695 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 37.1 m-85 -99.02 157.33 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 6.51 111.287 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -82.94 -24.32 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.387 -0.824 . . . . 8.27 110.765 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 98.5 p -134.06 163.0 30.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 7.96 109.991 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 149' ' ' ARG . 15.7 t -92.1 -15.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.875 0.845 . . . . 8.73 108.841 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.99 -56.14 6.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.773 -1.103 . . . . 8.5 111.183 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.537 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.5 mt-10 -65.79 -24.28 66.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 7.4 111.704 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 151' ' ' LEU . 13.3 m -48.97 -49.75 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.636 0.585 . . . . 6.13 111.508 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.8 m -61.46 -36.23 79.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.012 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.692 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 24.2 mp0 -70.11 -28.98 65.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.056 -0.258 . . . . 7.75 111.189 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.42 -23.52 62.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.313 0.578 . . . . 5.43 110.337 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 86.8 mtp -70.8 -14.77 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.704 -0.68 . . . . 6.29 110.794 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.89 2.54 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 6.14 111.254 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -113.02 19.69 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 5.57 110.436 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.83 117.63 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.927 -0.579 . . . . 5.92 111.039 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 97.93 16.62 32.69 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.827 -0.702 . . . . 5.74 112.498 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.89 135.61 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 110.036 -0.357 . . . . 5.3 110.036 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 tp -84.27 116.43 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 6.8 111.004 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -135.18 118.67 16.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.796 -0.638 . . . . 5.79 110.288 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 60.84 32.47 20.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 7.32 111.414 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.91 78.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.844 -0.693 . . . . 7.28 112.632 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 32.6 mm-40 -110.08 132.35 54.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.258 -0.275 . . . . 7.21 110.258 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.5 m -86.37 106.78 17.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.871 -0.418 . . . . 6.14 109.871 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 156' ' ' ILE . 75.9 mt -66.1 111.89 3.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 4.9 110.896 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 86.5 tttt -87.76 114.61 24.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.742 -0.663 . . . . 7.3 109.528 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.6 mt -110.92 105.64 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.937 0.399 . . . . 5.37 110.423 -173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 15.1 mmt85 -129.25 171.2 12.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.067 -0.515 . . . . 6.97 110.324 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 45.8 mtp180 -104.42 143.68 27.17 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.594 0.235 . . . . 7.37 111.109 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.09 160.98 14.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.462 2.108 . . . . 7.98 110.769 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -86.58 -4.13 59.13 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.516 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.44 42.97 26.79 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.488 0.492 . . . . 0.0 110.398 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.87 102.61 2.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.936 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 53.34 70.16 1.93 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.508 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.422 ' HD2' ' HE1' ' A' ' 238' ' ' MET . 73.1 Cg_endo -81.02 132.11 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.191 1.927 . . . . 0.0 111.798 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.0 mt 73.8 136.78 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.851 0.719 . . . . 0.0 111.393 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.14 -14.49 34.95 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.842 2.361 . . . . 0.0 112.948 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -80.71 72.67 2.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.12 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.422 ' HE1' ' HD2' ' A' ' 234' ' ' PRO . 44.3 ttm -151.09 153.32 34.82 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 50.3 m -64.63 -59.8 3.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -95.21 94.03 7.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 109.866 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.744 ' HB3' ' HD3' ' A' ' 242' ' ' PRO . 4.8 t30 -165.84 -52.88 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.844 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 10.3 Cg_endo -91.12 99.33 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.578 2.185 . . . . 0.0 111.647 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -75.55 -19.28 59.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.6 m -89.57 178.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.442 ' O ' ' HD3' ' A' ' 247' ' ' PRO . 78.1 t80 -79.72 -40.65 28.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.579 0.228 . . . . 0.0 110.911 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.52 104.07 9.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 245' ' ' TYR . 67.8 Cg_endo -73.31 172.63 15.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.902 2.401 . . . . 0.0 112.643 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.1 154.5 29.05 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.987 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.8 m -122.86 174.98 6.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.679 0.276 . . . . 0.0 110.283 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.46 160.02 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.172 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 52.0 m -73.19 93.62 1.87 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 111.115 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 12.0 p -136.08 5.17 3.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.236 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.9 m -75.34 -11.6 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.759 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.99 115.19 52.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.26 -52.34 2.1 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.997 2.465 . . . . 0.0 112.177 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -84.75 104.36 14.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 109.942 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.1 p -76.31 -3.21 35.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -61.12 101.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.301 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -118.1 13.65 13.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.87 -0.789 . . . . 8.75 108.87 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 35.3 ttmt -62.33 125.38 23.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.462 -1.245 . . . . 6.04 109.934 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 307' ' ' TYR . 69.6 mt -98.86 142.31 30.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.113 -0.494 . . . . 5.29 110.797 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.676 ' HB2' ' HA ' ' A' ' 335' ' ' ALA . 87.3 t80 -95.99 109.47 21.85 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.294 -0.866 . . . . 4.77 108.897 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.34 106.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.863 -0.421 . . . . 3.94 109.863 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.95 171.1 19.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.898 -0.668 . . . . 4.58 111.511 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.2 27.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.654 -0.784 . . . . 5.58 112.068 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.4 mt -101.42 143.86 27.42 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.259 -0.275 . . . . 5.92 110.259 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.689 ' HD2' HD22 ' A' ' 270' ' ' LEU . 30.5 Cg_exo -62.33 143.42 93.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.569 2.179 . . . . 6.94 111.98 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.66 -24.43 66.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.615 0.228 . . . . 8.81 111.615 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -85.02 -7.17 59.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.754 0.312 . . . . 8.73 110.836 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.689 HD22 ' HD2' ' A' ' 267' ' ' PRO . 12.1 tp -71.81 106.5 4.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.617 -0.512 . . . . 7.52 109.617 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.6 p-10 -85.9 172.18 10.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 8.79 111.012 -175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.07 -37.69 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 7.62 111.94 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.17 -54.39 44.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.758 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.62 -42.59 95.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 8.69 111.643 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 271' ' ' ASN . 38.9 t -61.49 -47.03 95.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.561 0.22 . . . . 6.64 110.728 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -58.56 -54.0 51.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.586 -0.279 . . . . 7.74 110.72 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.75 -51.02 70.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.073 -0.512 . . . . 9.38 111.591 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.0 -42.89 81.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 7.06 110.693 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 320' ' ' LEU . 62.1 mt -80.32 -29.05 38.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.484 -0.325 . . . . 6.89 111.26 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.4 m -71.54 -16.73 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 8.85 110.796 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 16.3 m -59.97 -15.03 18.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.917 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.85 9.29 11.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.614 0.245 . . . . 9.18 111.23 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.75 146.27 4.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.946 -0.645 . . . . 9.06 112.395 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HA ' HG23 ' A' ' 280' ' ' THR . 50.4 Cg_endo -69.78 141.75 46.0 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.682 2.254 . . . . 10.14 112.733 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 305' ' ' CYS . 86.6 mt -97.57 130.76 44.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 8.3 110.883 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.5 ptpt -93.5 -29.24 15.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.131 0.491 . . . . 8.65 110.028 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -136.42 115.07 11.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.541 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.576 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 76.8 t80 -125.82 122.21 35.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 6.27 110.759 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.87 111.6 6.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.51 0.671 . . . . 5.79 110.472 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 303' ' ' ALA . 57.0 tp -85.18 140.11 31.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.386 -0.825 . . . . 6.35 109.778 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.4 t -88.81 111.34 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.077 0.465 . . . . 6.61 110.123 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -102.35 155.24 18.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 8.17 111.099 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.76 135.42 34.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.66 -0.7 . . . . 10.33 109.907 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.6 m -74.45 -12.94 60.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 10.8 112.036 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.03 -68.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 12.13 111.324 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 17.4 m -77.9 -32.35 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 11.16 111.426 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.04 6.97 62.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.54 -0.838 . . . . 10.11 112.414 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.32 173.34 11.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.618 0.247 . . . . 10.12 110.339 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -79.38 144.7 33.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.408 -0.36 . . . . 7.73 110.1 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 300' ' ' LYS . 30.8 mmtp -79.15 0.34 28.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 8.01 110.436 175.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 97.71 17.13 31.62 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 6.09 113.069 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 291' ' ' VAL . 43.6 p90 -162.73 157.03 21.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.329 0.585 . . . . 6.54 111.261 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -147.46 160.17 42.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.314 -0.857 . . . . 4.38 110.24 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.473 ' HD2' ' HB1' ' A' ' 335' ' ' ALA . 81.8 m-85 -107.43 122.65 47.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.853 -0.795 . . . . 4.93 108.853 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.576 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.9 m -139.01 115.24 10.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 5.09 111.412 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 33.5 tt0 -98.25 135.43 39.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.916 -0.584 . . . . 7.03 110.155 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.414 ' CE1' HD12 ' A' ' 261' ' ' LEU . 26.1 m-85 -90.14 147.31 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.213 -0.448 . . . . 7.81 111.238 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.681 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 52.5 t -66.32 -53.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 10.03 110.578 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.466 ' HB3' HG22 ' A' ' 312' ' ' VAL . 27.0 t70 -88.64 137.16 32.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.997 -0.547 . . . . 10.81 110.374 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -79.2 -18.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.148 0.425 . . . . 9.77 112.148 -174.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.61 -40.22 23.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.761 0.315 . . . . 10.89 110.401 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.5 m -69.49 -22.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 9.5 111.439 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 317' ' ' ILE . 21.4 m -55.3 -50.6 69.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.68 0.276 . . . . 7.83 111.563 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.92 -32.82 72.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.014 0.435 . . . . 8.79 110.789 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -66.12 -41.39 90.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 10.51 110.443 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.34 94.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 7.31 110.734 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 313' ' ' THR . 64.4 mt -57.36 -41.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 6.44 110.495 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.54 -43.52 59.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.741 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -75.43 -47.54 12.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.018 -0.611 . . . . 7.46 113.469 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HB2' HG21 ' A' ' 332' ' ' VAL . 87.1 mt -70.56 -43.11 70.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.647 0.261 . . . . 6.42 111.61 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 8.9 t30 -66.43 115.44 6.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.75 0.31 . . . . 6.53 110.272 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.41 -21.55 14.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.925 -0.655 . . . . 6.77 111.514 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.5 ttt -73.85 141.86 46.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.039 -0.356 . . . . 7.29 110.039 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 26.1 tt0 -105.59 125.18 50.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.833 0.349 . . . . 7.83 110.599 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 267' ' ' PRO . 0.4 OUTLIER -117.14 113.4 22.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.94 -0.763 . . . . 7.01 108.94 177.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.86 -88.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.939 -0.648 . . . . 8.18 112.849 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.69 0.26 3.57 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.854 -0.203 . . . . 8.94 111.396 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -130.61 152.08 50.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.915 0.388 . . . . 7.29 111.147 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 91.3 mttt -103.83 129.7 51.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 7.13 109.647 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.72 122.77 18.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.037 0.446 . . . . 5.63 112.121 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.53 107.43 19.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.334 -0.987 . . . . 5.53 108.334 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 320' ' ' LEU . 59.4 t -110.81 121.87 64.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 5.21 111.643 -173.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 13.9 pt20 -139.69 -169.09 2.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 6.05 108.77 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -87.14 141.33 28.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.878 -0.416 . . . . 7.58 109.878 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 262' ' ' PHE . . . -70.51 -38.18 74.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 6.04 111.272 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.1 m -78.53 -15.19 58.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 7.57 110.044 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 93.5 t 71.13 -60.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.925 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.01 56.01 0.67 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -101.95 11.45 38.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.662 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.8 tttt 66.34 101.63 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.149 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.78 -41.67 95.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.902 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.864 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.47 ' HB3' ' NH2' ' A' ' 228' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 205' ' ' VAL . 23.4 ptt85 -117.67 20.64 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.883 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.88 139.91 39.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.978 -0.555 . . . . 6.52 109.91 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.24 137.21 48.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.847 0.356 . . . . 5.24 110.293 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.633 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 74.7 t80 -94.94 104.66 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.847 -0.615 . . . . 6.15 109.46 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 5.8 p -107.32 125.08 63.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.315 0.578 . . . . 4.24 110.642 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.69 -178.86 15.48 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.516 -0.765 . . . . 4.95 111.632 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.1 t30 59.8 41.31 18.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.029 0.919 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.694 HG22 HD22 ' A' ' 224' ' ' LEU . 32.6 pt -90.42 156.95 45.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.949 . . . . 5.61 110.712 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.588 ' HG3' ' HB2' ' A' ' 220' ' ' GLN . 29.6 Cg_endo -63.84 142.32 81.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.669 2.246 . . . . 5.97 112.26 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -80.32 126.99 31.85 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.612 -0.514 . . . . 8.47 109.612 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.49 21.18 41.65 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.623 -0.798 . . . . 6.96 111.999 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.576 HD13 ' HG3' ' A' ' 220' ' ' GLN . 9.3 tp -78.97 139.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.868 0.366 . . . . 6.1 110.691 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 24.7 m -75.52 128.07 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 6.62 110.293 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.523 ' HA ' HD12 ' A' ' 191' ' ' ILE . 44.1 mt-10 -59.69 -47.9 83.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.506 -0.315 . . . . 5.69 110.765 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.96 -42.48 89.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.953 -0.567 . . . . 7.29 110.53 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -63.15 -44.17 96.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.2 ttm -64.94 -45.72 84.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.507 -0.315 . . . . 4.49 110.653 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.1 ttt -61.33 -50.95 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.153 -0.476 . . . . 5.76 111.004 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.02 -32.78 74.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 6.51 110.958 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.499 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 86.3 t80 -59.32 -52.58 65.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 5.44 110.579 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -63.67 -41.69 98.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 5.03 110.786 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.4 m-20 -55.77 -48.86 74.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 6.3 110.43 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.5 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.22 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 87.3 mm-40 -64.25 -37.35 87.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.25 111.267 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 86.7 mtp -69.83 -34.87 74.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.998 -0.281 . . . . 7.03 110.583 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 98.6 mtt180 -64.7 -50.9 65.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.013 0.435 . . . . 8.94 110.196 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.27 -35.52 81.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 8.7 111.911 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.05 -21.37 59.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.603 -0.808 . . . . 8.11 112.59 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.91 40.94 7.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.592 -0.813 . . . . 8.49 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.66 3.31 34.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.087 0.47 . . . . 7.59 110.259 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 p -92.34 140.14 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 8.73 110.827 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 12.6 pt20 -95.02 -10.71 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.087 0.47 . . . . 9.89 110.287 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.11 158.71 33.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 9.69 110.227 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 154.06 62.59 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.559 2.172 . . . . 10.74 111.822 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.37 -145.77 16.1 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.669 -0.777 . . . . 8.97 112.599 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.58 122.5 37.2 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 120.462 0.172 . . . . 7.58 110.571 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.82 -38.61 47.39 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.737 2.291 . . . . 6.4 111.69 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.91 137.26 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.41 -0.589 . . . . 5.47 109.41 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 284' ' ' PRO . 50.9 tp -105.1 -41.63 5.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.644 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -142.56 134.25 26.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.76 117.37 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 4.68 110.159 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -124.58 105.81 9.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.823 -0.436 . . . . 6.34 109.823 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 162' ' ' GLU . 55.4 mt -107.23 134.16 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 5.85 111.453 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -109.91 113.85 26.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.542 . . . . 7.34 109.538 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -82.97 -10.91 58.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 7.61 110.81 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.91 -59.08 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.161 -0.472 . . . . 9.12 111.051 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.0 mmtm -91.16 -0.79 57.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.405 -0.361 . . . . 9.1 110.686 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 62.2 61.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 6.6 110.912 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 42.7 p90 -148.87 158.68 44.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 6.67 109.446 175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -139.57 147.63 41.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.942 0.401 . . . . 4.58 110.856 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.12 109.55 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.772 -0.649 . . . . 6.22 110.008 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.247 -0.649 . . . . 4.77 109.247 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 127.36 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.642 . . . . 6.55 109.268 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -99.03 162.85 12.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.977 0.417 . . . . 6.51 111.203 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -71.93 -25.78 62.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.405 -0.816 . . . . 8.27 110.329 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.1 p -124.56 -170.32 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.582 -0.736 . . . . 7.96 109.595 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 149' ' ' ARG . 39.2 t -113.78 -28.78 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.644 0.735 . . . . 8.73 109.281 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.15 -51.04 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.896 . . . . 8.5 111.34 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 50.4 mt-10 -65.24 -35.12 80.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.076 -0.511 . . . . 7.4 110.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -55.12 -50.14 70.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.316 0.579 . . . . 6.13 110.351 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 24.1 m -60.06 -34.13 73.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.698 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -31.59 64.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 7.75 110.277 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -76.03 -7.43 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.023 -0.535 . . . . 5.43 111.206 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 85.8 mtp -69.85 -16.65 63.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.411 . . . . 6.29 110.021 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.59 50.38 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.674 -0.694 . . . . 6.14 111.049 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.493 ' HD1' HD12 ' A' ' 217' ' ' ILE . 93.3 m-85 -93.75 7.14 45.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 5.57 110.812 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.28 114.29 3.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.98 -0.378 . . . . 5.92 109.98 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.36 12.51 44.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.859 -0.686 . . . . 5.74 112.11 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.493 HD12 ' HD1' ' A' ' 214' ' ' PHE . 16.6 tt -71.53 137.19 24.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 5.3 110.044 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -85.55 112.03 21.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.459 0.647 . . . . 6.8 110.056 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -133.09 119.4 19.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 5.79 110.579 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.588 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 80.9 mm-40 60.82 29.54 19.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.522 -0.763 . . . . 7.32 111.273 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.78 7.97 83.36 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.857 -0.687 . . . . 7.28 112.857 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -124.76 132.74 53.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.568 -0.372 . . . . 7.21 110.824 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 t -78.86 112.33 15.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.147 -0.686 . . . . 6.14 109.147 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.694 HD22 HG22 ' A' ' 156' ' ' ILE . 46.4 mt -81.9 120.71 25.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.885 0.374 . . . . 4.9 111.352 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.5 tttt -84.78 115.97 23.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 7.3 109.543 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.9 mt -121.98 105.89 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.415 . . . . 5.37 110.886 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.7 mmt180 -132.68 167.5 19.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.045 -0.525 . . . . 6.97 110.412 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 15.7 mtp180 -79.34 128.17 76.38 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.738 -0.467 . . . . 7.37 109.738 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.633 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 3.6 Cg_exo -73.07 153.81 52.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.797 2.331 . . . . 7.98 112.241 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -114.21 -7.81 12.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.7 105.89 18.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.479 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -108.62 -58.48 2.0 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -148.31 94.35 4.24 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.276 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.35 102.05 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.819 2.346 . . . . 0.0 111.531 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.754 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 10.0 tt -163.24 -55.79 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.374 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 235' ' ' LEU . 63.3 Cg_exo -54.39 -43.39 59.16 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.13 -81.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.785 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.6 mtp -71.47 -70.61 0.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.813 0.34 . . . . 0.0 110.732 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 33.9 t -128.78 139.28 52.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 39.5 mt-10 -88.04 118.52 27.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -74.26 121.18 84.61 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.11 -34.32 92.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.609 2.206 . . . . 0.0 112.139 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.4 t -84.95 144.64 28.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.388 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 64.8 t -116.72 -47.2 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.401 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -98.43 -80.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.1 t -131.64 114.01 15.47 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.411 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.79 -34.17 5.66 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.661 2.241 . . . . 0.0 113.12 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -132.05 135.81 8.39 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.969 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.9 t 64.91 86.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.51 0.672 . . . . 0.0 110.563 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.2 p -110.55 -16.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.708 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 43.1 m 64.92 -177.05 0.17 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.341 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.6 p -87.68 5.01 41.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.78 125.91 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.697 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.75 132.26 21.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.822 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.2 141.9 57.51 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.826 2.351 . . . . 0.0 111.963 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -88.98 4.49 48.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.3 p -90.19 45.87 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.183 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.58 -18.78 63.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.186 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.879 ' HB3' HG21 ' A' ' 313' ' ' THR . 52.6 m80 63.02 34.93 13.5 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.854 -0.612 . . . . 8.75 111.792 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 305' ' ' CYS . 40.3 ttmt -66.44 121.49 15.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.681 -0.488 . . . . 6.04 109.681 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.43 142.09 31.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.313 0.577 . . . . 5.29 111.476 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.97 107.19 19.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.781 -1.099 . . . . 4.77 108.684 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 3.6 mp -100.3 104.58 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.954 -0.566 . . . . 3.94 109.529 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -118.84 120.5 4.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.589 -0.815 . . . . 4.58 112.691 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 139.2 9.71 0.9 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.096 -0.573 . . . . 5.58 112.296 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.4 144.76 74.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.481 0.182 . . . . 5.92 110.65 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD2' HD22 ' A' ' 270' ' ' LEU . 41.2 Cg_exo -57.63 135.88 72.21 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.77 2.314 . . . . 6.94 112.292 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 9.1 p30 -62.39 -23.55 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.918 -0.583 . . . . 8.81 111.137 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -100.59 12.58 37.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.551 . . . . 8.73 111.34 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.444 HD22 ' HD2' ' A' ' 267' ' ' PRO . 26.8 tp -89.32 125.2 35.02 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.779 -0.452 . . . . 7.52 109.779 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.8 p-10 -85.09 157.01 20.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 8.79 111.186 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 2.8 m-20 -52.5 -36.16 54.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.663 -0.699 . . . . 7.62 112.055 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.25 -53.06 58.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.431 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -72.62 -40.09 66.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 8.69 111.081 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.9 t -56.83 -47.81 82.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.428 -0.351 . . . . 6.64 110.716 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.4 mtmm -59.96 -47.53 85.44 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.477 -0.328 . . . . 7.74 110.815 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -49.74 76.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.106 -0.237 . . . . 9.38 110.965 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.23 -47.16 78.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 7.06 110.763 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.568 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -77.13 -31.5 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.396 -0.365 . . . . 6.89 111.563 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.6 m -69.97 -27.97 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 8.85 111.017 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 41.9 m -72.41 4.5 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.542 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -132.53 9.81 4.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.364 -0.38 . . . . 9.18 110.779 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.439 ' HA3' ' HE2' ' A' ' 307' ' ' TYR . . . 160.56 146.32 4.57 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.183 -1.008 . . . . 9.06 113.286 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 1.01 ' HB3' HD21 ' A' ' 187' ' ' LEU . 53.4 Cg_endo -71.04 119.82 6.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.249 2.633 . . . . 10.14 112.534 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.855 HD22 ' HB3' ' A' ' 305' ' ' CYS . 56.0 mt -100.4 103.23 14.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.199 -0.455 . . . . 8.3 110.486 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 308' ' ' VAL . 53.9 pttt -82.29 -20.7 36.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 8.65 110.072 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -138.99 130.2 26.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.411 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 75.6 t80 -145.21 128.83 17.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.667 0.27 . . . . 6.27 110.638 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -140.6 114.19 8.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.357 0.598 . . . . 5.79 110.983 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 62.4 tp -90.68 131.67 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.458 -0.792 . . . . 6.35 109.188 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.45 121.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.916 0.389 . . . . 6.61 110.798 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.77 157.95 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.004 -0.544 . . . . 8.17 110.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.404 ' HB2' ' CD ' ' A' ' 300' ' ' LYS . 14.5 t70 -91.05 121.64 33.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.216 -0.661 . . . . 10.33 109.216 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 47.2 m -71.61 -29.6 64.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.452 0.538 . . . . 10.8 112.452 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.59 -44.72 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.808 -0.357 . . . . 12.13 110.932 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 10.4 m -73.98 -44.73 53.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.144 -0.48 . . . . 11.16 111.306 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 90.59 26.32 23.16 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 10.11 111.889 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 92.3 mt -135.19 168.46 19.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.804 -0.443 . . . . 10.12 109.804 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 42.6 t -70.42 145.92 50.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 7.73 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.404 ' CD ' ' HB2' ' A' ' 293' ' ' ASP . 31.5 mmmt -76.32 -20.47 57.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 8.01 110.17 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 107.35 -7.84 37.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.621 -0.799 . . . . 6.09 112.897 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 52.7 p90 -128.4 147.2 50.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.191 0.52 . . . . 6.54 111.534 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -142.3 158.67 43.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 4.38 110.435 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.409 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 93.0 m-85 -111.59 132.38 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.238 -0.437 . . . . 4.93 110.079 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.855 ' HB3' HD22 ' A' ' 285' ' ' LEU . 57.4 m -130.89 115.76 16.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.317 -0.401 . . . . 5.09 111.239 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 40.5 tt0 -95.4 119.58 34.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.488 -0.56 . . . . 7.03 109.488 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.439 ' HE2' ' HA3' ' A' ' 283' ' ' GLY . 30.1 m-85 -90.72 148.36 22.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 7.81 111.845 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 286' ' ' LYS . 53.6 t -77.34 -48.26 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 10.03 110.579 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.659 ' HB3' HG22 ' A' ' 312' ' ' VAL . 18.2 t70 -82.37 157.75 23.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 10.81 109.897 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -110.11 -4.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.489 0.551 . . . . 9.77 112.489 -173.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -111.02 -30.48 7.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.963 -0.295 . . . . 10.89 111.482 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.1 m -71.52 -23.71 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.867 0.321 . . . . 9.5 111.867 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.879 HG21 ' HB3' ' A' ' 259' ' ' HIS . 13.0 m -57.56 -49.37 76.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.945 0.35 . . . . 7.83 111.945 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.39 -27.1 68.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.059 0.457 . . . . 8.79 110.748 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.69 -34.74 45.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 10.51 110.413 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.58 99.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 7.31 110.065 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.0 mt -57.38 -47.1 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.719 -0.673 . . . . 6.44 110.531 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.87 -33.73 72.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.842 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.92 -44.62 5.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.704 -0.76 . . . . 7.46 112.959 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.39 -51.18 15.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 6.42 111.402 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.735 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.1 t30 -67.6 120.7 14.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.124 -0.489 . . . . 6.53 110.365 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 121.69 -30.17 5.41 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.815 -0.707 . . . . 6.77 111.776 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -74.52 141.0 44.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 7.29 109.21 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 29.9 tt0 -107.89 120.91 43.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.966 0.412 . . . . 7.83 111.541 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.38 103.78 16.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 7.01 109.721 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.77 -96.84 0.38 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.011 -0.614 . . . . 8.18 112.265 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.05 2.08 9.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 8.94 110.687 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.69 113.51 26.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 7.29 110.854 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 87.8 tttt -72.16 131.23 42.52 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.302 -0.629 . . . . 7.13 109.302 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 263' ' ' ILE . 23.2 tp -77.68 117.16 18.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.961 0.41 . . . . 5.63 111.351 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 329' ' ' LYS . 6.3 mp -98.95 123.6 43.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.355 -0.609 . . . . 5.53 109.355 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.735 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 57.5 t -125.67 118.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.077 -0.511 . . . . 5.21 110.204 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.75 163.71 34.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.789 -0.819 . . . . 6.05 108.789 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 337' ' ' VAL . 93.9 mtt180 -64.95 141.87 58.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.862 -0.421 . . . . 7.58 109.862 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.43 -51.32 47.67 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.418 0.449 . . . . 6.04 111.876 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 37.0 m -110.52 -20.01 12.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.815 0.341 . . . . 7.57 110.274 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 94.5 t 71.64 -65.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.113 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 64.25 55.27 24.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.572 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -59.73 -57.15 14.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.934 0.397 . . . . 0.0 110.686 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.05 -40.91 2.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.934 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -107.98 115.9 30.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.689 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.948 0.404 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.07 -50.59 7.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.381 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 199' ' ' PHE . 99.2 mtt180 -106.99 133.32 51.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 6.52 111.034 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 208' ' ' THR . 31.7 mt -92.87 152.92 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.449 . . . . 5.24 110.466 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 65.7 t80 -94.14 110.65 22.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.815 -0.63 . . . . 6.15 109.736 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 198' ' ' ALA . 5.9 p -111.1 119.92 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.274 0.559 . . . . 4.24 109.88 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.88 15.06 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.652 -0.704 . . . . 4.95 111.951 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.12 39.74 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.921 0.867 . . . . 0.0 109.188 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 27.8 pt -85.76 146.95 44.86 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.004 -0.998 . . . . 5.61 110.833 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 6.9 Cg_exo -74.48 120.5 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.896 2.397 . . . . 5.97 111.752 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 193' ' ' GLN . 28.5 t80 -62.24 132.8 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.132 -0.486 . . . . 8.47 109.929 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 114.31 -17.0 19.46 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.67 -0.776 . . . . 6.96 112.597 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.9 tp -78.62 144.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 6.1 110.335 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -88.94 152.82 21.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 6.62 110.864 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.617 ' HA ' HD12 ' A' ' 191' ' ' ILE . 40.4 mt-10 -63.09 -39.82 95.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.126 -0.488 . . . . 5.69 110.75 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -61.99 -47.29 85.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.599 . . . . 7.29 110.788 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.89 86.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.4 tpt -63.21 -47.62 81.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 4.49 110.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.426 ' HB2' HG11 ' A' ' 189' ' ' VAL . 22.5 ttt -61.15 -46.38 90.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 5.76 111.307 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.52 -36.28 82.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 6.51 110.854 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.9 -46.9 84.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.967 -0.56 . . . . 5.44 110.516 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 173' ' ' MET . 54.9 m-85 -64.31 -46.36 83.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 5.03 110.83 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.54 -45.68 73.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.719 0.295 . . . . 6.3 110.956 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -60.7 -48.76 80.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.896 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -69.84 -27.0 64.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 6.25 111.753 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.663 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 32.4 mmt -64.62 -42.69 95.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 7.03 110.016 176.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -70.2 -44.61 68.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.842 -0.617 . . . . 8.94 110.419 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 79.8 mt -68.21 -34.49 76.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 8.7 111.446 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.57 -16.3 73.75 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.601 -0.809 . . . . 8.11 112.466 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.78 29.63 34.6 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.685 -0.769 . . . . 8.49 112.147 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.613 HD11 ' HE1' ' A' ' 214' ' ' PHE . 4.5 mp -87.89 -22.52 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.36 0.6 . . . . 7.59 109.838 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 24.0 m -76.21 122.69 24.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.217 -0.902 . . . . 8.73 110.751 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.465 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 11.7 pt20 -80.6 -30.49 36.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.914 0.387 . . . . 9.89 110.932 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.75 124.89 18.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.509 . . . . 9.69 110.253 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.79 128.62 2.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.962 3.108 . . . . 10.74 113.613 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 134.58 -129.63 5.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.915 -0.659 . . . . 8.97 112.265 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -123.26 117.95 27.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.724 0.297 . . . . 7.58 111.086 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.88 -27.82 9.94 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.599 2.2 . . . . 6.4 112.047 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.4 t -90.03 133.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 5.47 110.039 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 203' ' ' ARG . 86.9 mt -95.42 -56.3 2.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.6 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.41 157.88 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.528 HG23 HD23 ' A' ' 200' ' ' LEU . 8.2 p -133.93 137.57 52.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.058 -0.519 . . . . 4.68 110.599 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.73 111.12 13.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.632 -0.507 . . . . 6.34 109.632 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 162' ' ' GLU . 41.6 mt -104.71 127.23 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 5.85 111.555 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -105.36 97.98 7.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.062 -1.088 . . . . 7.34 108.062 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 158' ' ' PHE . 16.1 tt0 -85.45 -5.28 59.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.971 -0.559 . . . . 7.61 110.307 -172.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.28 -52.64 10.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 9.12 110.204 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 26.1 mmtm -91.98 2.67 56.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 9.1 110.757 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.86 48.53 3.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.332 -0.849 . . . . 6.6 111.712 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.457 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 34.8 p90 -148.52 151.32 34.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.301 -0.409 . . . . 6.67 110.224 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.27 157.51 45.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.522 -0.308 . . . . 4.58 110.827 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 150' ' ' ARG . 61.1 m-85 -118.32 119.51 34.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.202 -0.454 . . . . 6.22 110.806 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 31.0 mt -95.32 115.0 26.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.678 -0.692 . . . . 4.77 109.549 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -96.41 116.87 29.75 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.51 -0.476 . . . . 6.55 110.384 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 208' ' ' THR . 27.6 m-85 -93.84 163.91 13.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.683 -0.69 . . . . 6.51 110.612 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.495 ' HA ' HD11 ' A' ' 187' ' ' LEU . 37.0 ptt180 -74.48 -24.19 58.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 8.27 110.788 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 71.3 p -125.44 -161.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.19 -0.459 . . . . 7.96 110.434 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.12 -34.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.094 0.473 . . . . 8.73 110.04 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.11 -52.2 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 8.5 111.129 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.465 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.2 mt-10 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.748 -0.464 . . . . 7.4 109.748 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 151' ' ' LEU . 2.1 m -51.69 -52.43 48.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.465 -0.788 . . . . 6.13 110.818 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.3 m -63.41 -33.67 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.766 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.455 ' HG3' HD23 ' A' ' 178' ' ' LEU . 64.8 tp60 -71.05 -30.0 66.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 7.75 110.393 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -16.26 63.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 5.43 111.349 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.9 mtp -69.78 -13.75 62.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 6.29 111.165 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.25 65.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 6.14 111.097 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.613 ' HE1' HD11 ' A' ' 178' ' ' LEU . 22.5 m-85 -94.13 12.27 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 5.57 111.353 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.84 112.9 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.817 0.341 . . . . 5.92 110.28 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.58 30.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.714 -0.755 . . . . 5.74 112.499 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.533 HD12 ' HD2' ' A' ' 214' ' ' PHE . 15.4 tt -61.44 138.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.926 0.393 . . . . 5.3 110.398 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.11 122.56 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.331 0.586 . . . . 6.8 110.883 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -133.68 106.49 7.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.737 -0.665 . . . . 5.79 110.125 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.54 31.27 20.22 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.831 -0.622 . . . . 7.32 111.968 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.44 68.36 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.589 -0.815 . . . . 7.28 112.851 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 31.1 mm-40 -120.24 136.06 54.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.212 -0.292 . . . . 7.21 110.212 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.3 m -87.19 108.8 19.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.401 -0.363 . . . . 6.14 110.22 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.73 119.56 11.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.476 . . . . 4.9 110.891 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 83.2 tttt -90.94 116.96 29.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.906 -0.588 . . . . 7.3 109.804 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.07 105.89 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.04 0.448 . . . . 5.37 110.131 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.6 mmt85 -127.61 170.2 12.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.963 -0.562 . . . . 6.97 111.005 -174.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -77.17 144.8 72.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.928 -0.578 . . . . 7.37 109.455 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.89 164.47 13.93 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.701 2.267 . . . . 7.98 113.026 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 73.39 15.69 4.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.973 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.3 -32.33 18.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -86.51 142.01 28.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.863 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -79.98 120.79 80.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -57.09 116.53 3.28 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.54 2.16 . . . . 0.0 111.201 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 236' ' ' PRO . 4.0 pp -71.36 141.11 85.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 12.4 Cg_exo -70.37 -28.67 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.938 2.426 . . . . 0.0 112.217 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 104.22 82.93 1.65 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.795 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 20.7 mmt -76.17 -28.0 57.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 43.4 m -144.18 129.65 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.466 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.25 79.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.735 0.647 . . . . 0.0 110.332 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -84.8 116.94 67.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.279 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.46 -27.2 39.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.927 2.418 . . . . 0.0 112.513 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -82.47 89.14 6.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.29 147.13 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -118.03 139.92 50.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.344 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 29.7 m -78.39 140.06 60.18 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 12.4 Cg_exo -71.0 -176.42 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.944 2.429 . . . . 0.0 112.181 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.23 -96.5 0.64 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.22 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.2 t 51.69 74.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.182 0.515 . . . . 0.0 110.208 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.7 t 65.02 90.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.197 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.2 m -58.54 135.29 57.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.1 t -87.35 144.79 26.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.183 0.516 . . . . 0.0 110.65 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.56 140.26 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.321 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 7.4 p -144.86 122.57 6.47 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.006 0.431 . . . . 0.0 111.061 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 6.6 Cg_exo -73.71 110.11 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.706 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.44 98.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.796 0.685 . . . . 0.0 110.75 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.7 p -75.66 128.18 34.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.143 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -122.95 123.3 40.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.929 0.395 . . . . 0.0 111.299 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.416 ' NE2' ' HB ' ' A' ' 310' ' ' ILE . 64.3 m80 -94.41 23.0 5.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.702 0.763 . . . . 8.75 109.191 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 33.0 ttmt -60.51 113.37 2.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.086 -1.416 . . . . 6.04 109.88 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 307' ' ' TYR . 39.4 mt -90.71 142.29 27.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.081 -0.509 . . . . 5.29 110.764 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.476 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 88.6 t80 -93.6 105.21 17.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.306 -0.861 . . . . 4.77 108.928 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 4.5 mp -96.45 100.41 10.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.648 -0.501 . . . . 3.94 109.648 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.88 108.37 1.74 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.718 -0.753 . . . . 4.58 112.102 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 149.68 42.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.708 -0.758 . . . . 5.58 112.161 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.522 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.4 mt -119.1 137.97 25.72 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.607 0.242 . . . . 5.92 110.462 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 325' ' ' LEU . 24.9 Cg_exo -64.2 154.11 72.66 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.662 2.241 . . . . 6.94 111.685 174.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 21.2 p30 -68.18 -23.72 64.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.431 0.53 . . . . 8.81 112.431 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -83.62 12.08 6.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.0 0.371 . . . . 8.73 112.0 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.08 129.37 36.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.109 0.48 . . . . 7.52 110.341 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.5 p-10 -102.98 179.93 4.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 8.79 110.655 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.37 -37.81 81.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 7.62 111.528 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.39 -52.88 59.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -61.19 -46.46 90.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 8.69 111.817 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 271' ' ' ASN . 61.1 t -63.27 -45.96 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.531 -0.304 . . . . 6.64 111.186 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.47 -50.73 72.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.91 -0.316 . . . . 7.74 110.516 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.86 -50.2 73.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.035 -0.529 . . . . 9.38 111.169 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 278' ' ' LEU . 1.5 tm? -55.81 -50.85 69.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 7.06 110.419 -175.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.794 ' HB2' HD11 ' A' ' 285' ' ' LEU . 84.3 mt -71.36 -37.66 71.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.277 -0.42 . . . . 6.89 111.24 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 284' ' ' PRO . 91.9 m -66.74 -27.81 67.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.51 -0.314 . . . . 8.85 111.118 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 49.1 m -60.39 -25.86 66.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.029 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.43 ' CD2' HD21 ' A' ' 320' ' ' LEU . 90.2 m-85 -108.5 -0.21 20.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.989 0.423 . . . . 9.18 110.603 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 164.82 122.64 0.61 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.712 -0.676 . . . . 9.06 111.634 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 280' ' ' THR . 37.6 Cg_exo -58.69 131.67 43.62 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.042 2.494 . . . . 10.14 113.0 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 279' ' ' LEU . 81.0 mt -94.67 123.75 38.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 8.3 110.981 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -90.24 -22.32 21.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 8.65 109.945 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -137.11 134.7 36.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.922 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.734 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 56.2 t80 -146.32 126.9 14.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.326 -0.397 . . . . 6.27 111.334 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 3.6 p-10 -140.88 121.9 14.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.558 -0.534 . . . . 5.79 109.558 168.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 303' ' ' ALA . 59.1 tp -97.92 125.96 43.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 6.35 109.814 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 302' ' ' TYR . 47.5 t -77.55 112.55 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 6.61 110.221 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -106.89 161.99 14.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 8.17 111.321 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -96.96 135.05 39.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.741 -0.663 . . . . 10.33 109.694 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.0 m -69.86 -40.03 75.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.504 -0.316 . . . . 10.8 111.708 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.31 -48.42 14.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.851 0.357 . . . . 12.13 111.85 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -79.96 -32.23 39.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.238 -0.437 . . . . 11.16 111.66 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 76.8 24.07 68.04 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.583 -0.818 . . . . 10.11 111.982 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 89.2 mt -123.24 -178.88 4.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.113 -0.329 . . . . 10.12 110.113 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -77.25 143.73 38.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.728 0.299 . . . . 7.73 110.326 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -74.9 -26.5 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.013 0.435 . . . . 8.01 110.044 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 125.39 -7.37 7.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.415 -0.898 . . . . 6.09 113.105 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 22.2 p90 -138.79 156.49 47.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 6.54 111.154 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.15 165.77 30.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 4.38 110.739 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.413 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 98.7 m-85 -120.64 126.13 49.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.436 -0.579 . . . . 4.93 109.436 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.734 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.7 m -143.71 138.34 28.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.668 0.27 . . . . 5.09 110.915 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -113.48 136.02 53.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.775 -0.454 . . . . 7.03 109.775 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 261' ' ' LEU . 6.0 m-85 -84.19 153.19 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 7.81 111.021 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.568 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 90.2 t -64.85 -41.5 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 10.03 110.477 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.11 136.54 40.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 10.81 109.941 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.82 -1.28 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 111.98 0.363 . . . . 9.77 111.98 -174.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -93.39 -39.5 10.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.213 0.53 . . . . 10.89 109.673 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.38 -20.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.606 -0.724 . . . . 9.5 111.36 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 m -53.72 -47.95 70.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.275 -0.42 . . . . 7.83 112.041 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.62 -37.08 85.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 8.79 111.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 10.51 110.809 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.69 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 7.31 110.135 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 332' ' ' VAL . 83.8 mt -58.16 -50.92 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.833 -0.621 . . . . 6.44 110.77 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.09 71.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.924 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.6 4.06 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.531 -0.842 . . . . 7.46 112.965 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.43 HD21 ' CD2' ' A' ' 282' ' ' PHE . 96.2 mt -72.54 -40.38 66.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.031 0.382 . . . . 6.42 112.031 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 51.1 t30 -66.39 113.54 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 6.53 110.254 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 119.75 -12.4 10.91 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.963 -0.637 . . . . 6.77 112.036 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 62.9 mtt -75.15 -171.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.732 0.301 . . . . 7.29 110.474 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -146.35 123.19 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.764 0.316 . . . . 7.83 110.686 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.2 OUTLIER -106.92 112.06 24.84 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.591 -0.892 . . . . 7.01 108.591 176.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.56 -104.66 1.42 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.745 -0.741 . . . . 8.18 111.542 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.54 0.5 11.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.721 0.296 . . . . 8.94 111.068 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -112.52 138.96 48.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 7.29 110.945 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.38 138.66 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 7.13 110.4 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.439 HD11 HG23 ' A' ' 263' ' ' ILE . 55.0 tp -90.98 108.0 19.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.702 -0.681 . . . . 5.63 110.477 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.412 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 9.3 mp -105.77 105.53 15.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.212 -0.449 . . . . 5.53 109.94 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 317' ' ' ILE . 73.8 t -109.71 123.74 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.126 -0.488 . . . . 5.21 110.676 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 14.1 pt20 -133.79 -169.45 2.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 6.05 109.354 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 337' ' ' VAL . 74.4 ttt180 -105.65 143.86 33.22 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 7.58 109.44 174.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.56 77.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.566 0.222 . . . . 6.04 110.999 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -71.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 7.57 110.589 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 334' ' ' ARG . 9.3 m -131.17 114.6 26.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.348 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -156.62 46.08 0.5 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.123 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -120.82 90.55 3.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.981 0.42 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -89.51 103.58 16.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.955 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -131.05 125.8 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.091 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.289 0 O-C-N 123.638 0.586 . . . . 0.0 111.226 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -117.74 -19.81 9.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 70.4 mtt180 -112.07 146.39 38.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.774 0.321 . . . . 6.52 110.807 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 208' ' ' THR . 84.7 mt -119.46 150.0 40.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.722 -0.672 . . . . 5.24 110.111 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -99.42 109.72 22.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 6.15 109.607 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.4 p -109.05 124.76 65.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.329 0.585 . . . . 4.24 110.582 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.27 -178.77 15.47 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.485 -0.779 . . . . 4.95 111.687 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 62.03 33.0 17.47 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.409 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.463 HG22 HD22 ' A' ' 224' ' ' LEU . 34.4 pt -80.4 156.65 73.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.481 -0.781 . . . . 5.61 110.877 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.469 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 42.2 Cg_endo -69.49 124.62 11.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.47 2.113 . . . . 5.97 112.399 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -68.35 112.25 5.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.197 -0.668 . . . . 8.47 109.197 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.87 -2.27 8.54 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.628 -0.796 . . . . 6.96 112.006 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 10.9 tp -88.31 146.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.92 -0.4 . . . . 6.1 109.92 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.9 p -102.76 163.97 11.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.869 0.366 . . . . 6.62 111.314 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.738 ' HG2' ' HB ' ' A' ' 191' ' ' ILE . 33.2 mt-10 -63.93 -41.02 97.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.655 . . . . 5.69 110.69 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -58.39 -47.17 84.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.372 -0.831 . . . . 7.29 110.748 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.43 91.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.5 ttm -71.78 -36.35 70.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 4.49 110.652 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.412 ' HB2' HG11 ' A' ' 189' ' ' VAL . 1.6 tmt? -61.0 -50.32 73.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.534 . . . . 5.76 109.721 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.42 -41.22 98.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.905 -0.589 . . . . 6.51 111.351 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.61 -53.02 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.933 0.346 . . . . 5.44 111.933 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.659 0.266 . . . . 5.03 111.401 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.14 -37.0 78.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.73 0.3 . . . . 6.3 110.865 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.26 83.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.406 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -61.59 -37.17 82.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 6.25 111.264 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.526 ' HG3' ' HG2' ' A' ' 185' ' ' PRO . 19.1 mmt -63.9 -45.34 89.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.428 -0.351 . . . . 7.03 111.009 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.2 -46.18 61.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 8.94 111.221 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.81 -35.27 74.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 8.7 111.374 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.01 58.93 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.547 -0.835 . . . . 8.11 111.844 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.12 39.14 13.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.881 -0.676 . . . . 8.49 112.193 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.85 -0.77 39.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 7.59 110.192 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 p -70.24 130.27 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 8.73 111.062 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -84.69 -14.51 48.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.216 0.531 . . . . 9.89 110.236 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.03 29.92 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 9.69 109.871 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.45 111.51 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.465 2.11 . . . . 10.74 111.548 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.92 -148.18 15.85 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.878 -0.677 . . . . 8.97 112.059 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -126.39 112.26 23.38 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.689 0.28 . . . . 7.58 110.857 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 203' ' ' ARG . 50.6 Cg_exo -55.48 -45.8 37.06 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.124 2.549 . . . . 6.4 112.433 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.02 107.2 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.562 -0.533 . . . . 5.47 109.562 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.5 tp -90.98 -61.63 1.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.354 -175.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -113.73 137.85 51.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.611 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 166' ' ' MET . 7.3 p -125.81 132.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.108 0.48 . . . . 4.68 111.365 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -132.86 114.55 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 6.34 109.87 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.738 ' HB ' ' HG2' ' A' ' 162' ' ' GLU . 46.9 mt -114.43 125.39 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 5.85 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -105.2 98.15 7.9 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.061 -0.718 . . . . 7.34 109.061 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.19 -19.49 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.697 . . . . 7.61 110.338 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -58.4 -60.22 4.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 9.12 111.605 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 41.9 mmtm -98.59 4.7 48.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.571 -0.286 . . . . 9.1 111.291 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.34 57.17 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.468 0.651 . . . . 6.6 111.36 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 50.8 p90 -149.21 152.69 36.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 6.67 109.795 173.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.71 157.34 45.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.967 0.413 . . . . 4.58 111.143 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.49 121.68 36.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 6.22 110.233 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 82.5 mt -104.18 116.96 33.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.976 -0.556 . . . . 4.77 109.769 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 35.0 tt0 -97.49 111.77 23.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 6.55 109.756 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -88.5 159.13 18.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.554 . . . . 6.51 111.192 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 185' ' ' PRO . 39.0 ptt180 -70.96 -24.14 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.385 -0.825 . . . . 8.27 111.278 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 60.1 p -125.84 -165.3 1.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.253 -0.43 . . . . 7.96 110.863 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.51 -36.53 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.434 0.635 . . . . 8.73 109.423 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.51 -53.07 61.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 8.5 111.312 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -64.43 -36.9 85.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 7.4 110.282 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 151' ' ' LEU . 9.8 m -54.26 -52.71 60.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.282 0.563 . . . . 6.13 110.501 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -28.8 69.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.489 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.58 -29.86 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 7.75 109.967 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -68.1 -13.81 62.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 5.43 111.248 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 81.4 mtp -70.37 -14.87 62.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 6.29 110.374 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.14 -5.36 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 6.14 110.596 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 94.3 m-85 -97.11 3.78 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 5.57 110.711 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.45 123.15 16.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 5.92 110.581 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.35 53.17 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.86 -0.685 . . . . 5.74 112.112 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.5 tt -72.75 142.51 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.328 . . . . 5.3 110.262 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.7 tp -84.63 113.16 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.356 0.598 . . . . 6.8 110.407 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -134.55 114.93 13.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 5.79 110.533 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 61.98 26.6 16.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.796 -0.638 . . . . 7.32 111.22 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 86.69 5.38 81.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.88 -0.676 . . . . 7.28 112.737 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.4 mm-40 -115.53 150.69 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.778 0.323 . . . . 7.21 110.701 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -97.78 103.51 15.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.488 -0.56 . . . . 6.14 109.488 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.463 HD22 HG22 ' A' ' 156' ' ' ILE . 70.6 mt -69.79 114.42 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 4.9 111.503 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 76.6 tttt -83.57 114.51 21.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.588 -0.733 . . . . 7.3 109.709 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.14 105.69 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.831 0.348 . . . . 5.37 110.442 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -132.7 168.36 18.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.24 -0.436 . . . . 6.97 110.684 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.67 129.88 78.06 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.346 -0.388 . . . . 7.37 110.4 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 31.9 Cg_exo -58.63 130.76 38.68 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.973 2.448 . . . . 7.98 112.052 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.55 -74.45 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.882 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -159.36 111.09 2.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.918 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -123.64 91.41 3.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.432 0.634 . . . . 0.0 110.047 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -109.95 138.63 20.8 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.773 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.5 112.38 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.996 2.464 . . . . 0.0 112.1 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.2 tp -130.29 94.27 30.67 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.029 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.03 99.58 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.775 2.317 . . . . 0.0 111.674 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -100.89 139.28 14.32 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.779 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 51.1 mtt -87.77 91.85 8.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.048 0.451 . . . . 0.0 110.512 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 26.4 t -77.21 -35.43 55.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -95.1 100.76 12.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.203 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.495 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 13.2 m120 -89.93 -48.24 0.39 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.834 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 24.1 Cg_exo -64.63 119.57 6.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.89 1.727 . . . . 0.0 111.979 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.5 t 61.31 78.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.309 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.05 115.21 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -126.78 150.83 48.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.923 0.392 . . . . 0.0 110.782 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.85 113.7 16.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.865 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.85 -44.58 43.57 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.709 2.273 . . . . 0.0 111.781 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.31 116.93 4.0 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.609 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.78 115.02 16.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.463 0.649 . . . . 0.0 110.736 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.0 105.62 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.55 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 43.1 t -115.19 100.92 8.5 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.6 p -85.2 5.7 29.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.698 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.862 HG11 ' HB2' ' A' ' 334' ' ' ARG . 86.9 t -65.58 -57.94 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.355 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 55.6 t 63.18 86.77 0.14 Allowed Pre-proline 0 C--N 1.331 -0.221 0 O-C-N 123.761 0.663 . . . . 0.0 110.343 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 336' ' ' SER . 73.7 Cg_endo -93.15 143.96 2.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.072 2.514 . . . . 0.0 112.783 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.41 -171.14 2.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.2 t -77.52 79.28 4.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 109.753 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -169.17 -45.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.61 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.0 m80 66.33 28.81 9.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.445 -0.798 . . . . 8.75 110.512 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 37.5 ttmt -66.26 138.52 57.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.52 -0.763 . . . . 6.04 110.767 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 307' ' ' TYR . 79.7 mt -104.63 141.72 35.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.561 . . . . 5.29 111.007 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 335' ' ' ALA . 87.7 t80 -96.91 119.04 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.297 -0.865 . . . . 4.77 109.152 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.73 HG23 HD11 ' A' ' 330' ' ' LEU . 3.7 mp -108.46 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 3.94 109.837 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.4 134.79 8.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 4.58 112.374 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 123.8 25.69 1.69 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.903 -0.665 . . . . 5.58 111.949 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 84.8 mt -102.46 138.97 19.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.429 -0.211 . . . . 5.92 110.429 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.561 ' HB2' HD13 ' A' ' 270' ' ' LEU . 41.8 Cg_exo -58.12 147.95 80.47 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.611 2.207 . . . . 6.94 111.483 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 6.4 p30 -73.59 -13.54 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.093 0.405 . . . . 8.81 112.093 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -90.05 0.61 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.632 -0.427 . . . . 8.73 111.079 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.0 mp -80.88 117.39 21.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.89 0.376 . . . . 7.52 110.196 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -85.65 174.76 9.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 8.79 110.904 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.33 -37.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.708 . . . . 7.62 112.198 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -53.96 18.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.771 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.12 -39.67 93.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.591 0.234 . . . . 8.69 111.14 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 279' ' ' LEU . 94.9 t -62.16 -48.98 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 6.64 110.443 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -56.39 -53.08 61.59 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.519 -0.309 . . . . 7.74 111.047 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.67 -52.5 55.57 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.571 0.544 . . . . 9.38 111.809 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 7.06 110.526 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.531 HD22 HD13 ' A' ' 320' ' ' LEU . 64.3 mt -75.69 -32.86 60.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.434 -0.348 . . . . 6.89 111.433 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 16.2 m -74.18 -16.68 60.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.02 0.438 . . . . 8.85 110.816 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 41.2 m -61.53 -14.99 34.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.632 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.12 16.43 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 9.18 111.009 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.57 143.94 3.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.55 -0.833 . . . . 9.06 112.547 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 280' ' ' THR . 58.3 Cg_endo -71.9 140.48 35.16 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.693 2.262 . . . . 10.14 112.809 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 305' ' ' CYS . 97.3 mt -98.15 126.45 43.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 8.3 111.106 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -94.32 -18.34 21.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.328 0.585 . . . . 8.65 109.846 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.23 134.23 20.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.083 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.577 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 82.7 t80 -145.56 124.71 12.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.063 -0.517 . . . . 6.27 110.625 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -139.53 108.66 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.541 0.686 . . . . 5.79 110.347 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 303' ' ' ALA . 55.0 tp -79.54 128.35 33.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.242 -0.89 . . . . 6.35 109.112 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 303' ' ' ALA . 42.2 t -77.31 111.69 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.059 0.456 . . . . 6.61 109.813 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -107.35 148.9 28.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 8.17 110.498 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.05 136.94 38.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.495 . . . . 10.33 109.738 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 44.0 m -70.07 -28.46 65.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.794 0.294 . . . . 10.8 111.794 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.56 -48.6 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.734 0.302 . . . . 12.13 111.183 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.7 m -75.34 -49.08 20.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.403 -0.362 . . . . 11.16 111.353 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 101.51 -26.69 23.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.842 -0.694 . . . . 10.11 111.965 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.12 173.41 10.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 10.12 111.128 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 46.7 t -69.84 148.46 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 7.73 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.79 -1.01 55.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 8.01 110.163 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 105.13 -3.42 40.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.851 -0.69 . . . . 6.09 112.478 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -147.62 161.16 41.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 6.54 111.33 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -152.38 164.53 37.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 4.38 110.459 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -112.46 130.73 55.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.477 -0.564 . . . . 4.93 109.477 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.577 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 47.8 m -138.68 137.88 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.374 -0.375 . . . . 5.09 110.572 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 29.1 tt0 -120.14 134.1 55.34 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.461 -0.57 . . . . 7.03 109.461 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CE1' HD12 ' A' ' 261' ' ' LEU . 20.0 m-85 -91.78 152.32 20.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.004 0.431 . . . . 7.81 111.59 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.528 ' HB ' ' HG2' ' A' ' 284' ' ' PRO . 92.0 t -66.84 -43.49 89.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.563 -0.744 . . . . 10.03 111.284 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.67 157.32 18.19 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.912 -0.403 . . . . 10.81 109.912 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.85 -19.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.988 0.366 . . . . 9.77 111.988 -175.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -77.3 -37.88 51.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.354 0.597 . . . . 10.89 109.493 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 24.6 m -65.83 -22.04 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.105 -0.952 . . . . 9.5 111.178 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.544 ' O ' HG13 ' A' ' 317' ' ' ILE . 9.5 m -55.25 -50.03 70.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.681 -0.236 . . . . 7.83 111.407 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.64 -37.87 76.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.981 0.419 . . . . 8.79 110.851 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -64.11 -38.77 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.677 -0.692 . . . . 10.51 110.249 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.38 86.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.533 -0.758 . . . . 7.31 110.811 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 313' ' ' THR . 85.1 mt -58.82 -45.66 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 6.44 110.734 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.66 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.32 -53.04 4.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.88 -0.676 . . . . 7.46 113.075 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.531 HD13 HD22 ' A' ' 279' ' ' LEU . 75.5 mt -67.9 -52.75 32.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.754 0.312 . . . . 6.42 111.702 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 44.2 t30 -63.18 114.96 4.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 6.53 110.652 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -26.18 6.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.709 -0.758 . . . . 6.77 112.385 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.2 mtt -74.91 168.35 20.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.435 -0.209 . . . . 7.29 110.435 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 329' ' ' LYS . 55.1 mt-30 -125.12 131.06 53.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.969 0.414 . . . . 7.83 110.588 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -109.8 121.92 46.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.33 -0.619 . . . . 7.01 109.33 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 69.36 -96.63 0.49 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.737 -0.744 . . . . 8.18 111.34 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.95 7.81 3.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 8.94 110.484 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.47 143.81 45.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.994 0.426 . . . . 7.29 111.0 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 87.9 tttt -84.61 136.67 33.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 7.13 110.137 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 263' ' ' ILE . 44.3 tp -93.88 124.47 37.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 5.63 110.984 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.433 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 6.8 mp -115.07 124.16 50.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.624 . . . . 5.53 109.557 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.15 131.14 71.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 5.21 110.363 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -156.74 161.43 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 6.05 109.843 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.862 ' HB2' HG11 ' A' ' 253' ' ' VAL . 64.7 mtt85 -64.45 133.19 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.842 0.353 . . . . 7.58 110.651 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 262' ' ' PHE . . . -110.3 106.69 16.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 6.04 110.646 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 255' ' ' PRO . 53.0 m -154.73 -56.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.476 -0.329 . . . . 7.57 111.398 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 336' ' ' SER . 95.5 t 72.47 -60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.929 0.492 . . . . 0.0 111.15 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 120.35 -174.97 15.84 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.805 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -70.27 -27.32 64.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.611 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.54 162.34 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.242 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -116.64 127.32 54.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.667 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.622 0.249 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -107.94 -6.13 16.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.604 0.24 . . . . 0.0 111.327 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.7 mtt180 -114.06 138.75 49.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 6.52 110.922 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 208' ' ' THR . 51.2 mt -116.02 152.08 34.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.909 -0.587 . . . . 5.24 110.43 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -106.08 111.23 23.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 6.15 109.698 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.5 p -109.15 131.0 61.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.143 0.497 . . . . 4.24 110.091 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.41 173.26 18.63 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.776 -0.647 . . . . 4.95 111.941 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 t30 62.77 68.84 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.459 0.647 . . . . 0.0 110.129 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.689 HG22 HD22 ' A' ' 224' ' ' LEU . 37.6 pt -117.63 160.87 36.54 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.392 -0.822 . . . . 5.61 110.29 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.698 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 21.1 Cg_endo -61.92 142.44 93.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.61 2.207 . . . . 5.97 112.441 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -79.56 109.81 14.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 8.47 110.266 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 96.48 36.88 4.97 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.795 -0.717 . . . . 6.96 111.708 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.698 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 5.7 tp -78.71 132.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.125 0.488 . . . . 6.1 111.086 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 17.2 m -64.51 116.15 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 6.62 109.754 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.509 ' HG2' HD12 ' A' ' 191' ' ' ILE . 41.2 mt-10 -57.38 -47.13 82.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 5.69 110.9 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.43 -43.26 93.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.592 -0.731 . . . . 7.29 110.668 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -72.57 -37.63 68.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.204 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.7 tpt -60.7 -47.37 86.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.957 0.408 . . . . 4.49 110.338 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.61 -41.52 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 5.76 110.307 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.11 -49.18 78.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.804 -0.635 . . . . 6.51 111.104 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.1 -47.33 85.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 5.44 111.133 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.488 ' HZ ' ' HB1' ' A' ' 211' ' ' ALA . 66.5 t80 -62.49 -49.3 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 5.03 110.815 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.433 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 78.7 m-20 -61.43 -37.22 82.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.418 -0.355 . . . . 6.3 110.838 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.08 -45.4 88.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -64.94 -30.03 71.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.391 -0.368 . . . . 6.25 111.41 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 214' ' ' PHE . 76.1 mtp -69.01 -45.02 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 7.03 110.171 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 50.9 mtt180 -65.25 -48.3 73.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 8.94 110.76 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.09 -35.33 78.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 8.7 110.947 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.89 -27.0 69.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.876 -0.678 . . . . 8.11 112.075 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.65 21.58 18.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 8.49 112.373 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.7 mp -108.42 82.12 1.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.213 0.53 . . . . 7.59 110.359 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.601 HG23 ' HG3' ' A' ' 185' ' ' PRO . 3.2 m -157.13 106.84 2.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.242 -0.651 . . . . 8.73 109.242 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.472 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 11.2 pt20 -73.18 -23.55 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.961 -0.295 . . . . 9.89 111.666 -171.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' THR . . . -145.05 158.43 52.18 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.549 -0.296 . . . . 9.69 110.583 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 151.65 66.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.419 2.08 . . . . 10.74 111.704 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.69 -168.88 20.81 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.71 -0.757 . . . . 8.97 111.775 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 m-20 -94.98 129.17 36.49 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 110.42 -0.215 . . . . 7.58 110.42 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 179' ' ' THR . 26.7 Cg_exo -63.04 -35.76 63.53 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.594 2.196 . . . . 6.4 111.208 176.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.6 131.48 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.47 110.121 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 281' ' ' SER . 43.6 tp -87.71 -54.49 4.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.728 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.68 153.43 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.404 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.35 138.88 48.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.236 -0.438 . . . . 4.68 110.958 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -119.13 105.83 11.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.302 -0.629 . . . . 6.34 109.302 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.509 HD12 ' HG2' ' A' ' 162' ' ' GLU . 62.8 mt -109.3 125.62 66.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.129 0.49 . . . . 5.85 111.249 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -116.2 120.21 38.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.604 -0.725 . . . . 7.34 110.128 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.78 -23.91 23.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.136 -0.484 . . . . 7.61 110.731 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 195' ' ' LYS . 24.0 t70 -57.63 -56.76 17.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.834 -0.621 . . . . 9.12 111.898 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.6 mmtm -105.29 5.24 31.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.793 0.33 . . . . 9.1 111.095 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.35 67.46 0.84 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.528 -0.76 . . . . 6.6 111.517 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 54.5 p90 -149.65 162.5 40.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.005 -0.543 . . . . 6.67 109.821 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.68 143.75 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.082 0.468 . . . . 4.58 111.148 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -107.52 120.58 42.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.686 -0.688 . . . . 6.22 109.734 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 76.8 mt -101.68 115.59 30.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.024 -0.535 . . . . 4.77 109.6 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.74 121.68 42.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.071 -0.344 . . . . 6.55 110.071 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.553 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 48.1 m-85 -99.14 164.15 12.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.144 0.497 . . . . 6.51 110.822 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.67 -22.97 59.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.767 -0.651 . . . . 8.27 111.326 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.8 p -142.83 147.22 35.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.632 0.254 . . . . 7.96 110.913 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.06 -36.17 72.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.953 0.406 . . . . 8.73 110.556 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.37 -58.24 8.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.738 -0.665 . . . . 8.5 111.086 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.472 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 49.4 mt-10 -65.4 -34.25 77.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 7.4 110.871 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 81.5 m -53.49 -52.6 59.02 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.22 0.533 . . . . 6.13 110.212 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 m -63.87 -30.97 72.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.947 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -29.57 62.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.979 0.419 . . . . 7.75 110.361 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.488 ' HB1' ' HZ ' ' A' ' 169' ' ' PHE . . . -72.21 -10.11 59.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.529 . . . . 5.43 111.535 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.3 mtp -68.02 -20.32 64.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 6.29 110.455 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.3 -1.82 28.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 6.14 111.653 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 173' ' ' MET . 94.9 m-85 -97.41 3.33 50.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.739 0.304 . . . . 5.57 110.842 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -57.24 129.66 42.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.055 -0.521 . . . . 5.92 110.914 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.31 25.88 27.28 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.936 -0.649 . . . . 5.74 112.111 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.8 tt -80.8 132.39 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.813 0.34 . . . . 5.3 110.146 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.01 111.23 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.542 0.687 . . . . 6.8 111.179 -176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.497 ' HE2' HD13 ' A' ' 160' ' ' ILE . 88.9 t80 -136.07 122.09 20.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.561 -0.745 . . . . 5.79 110.182 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 57.32 33.66 23.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.851 0.358 . . . . 7.32 111.836 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.15 6.47 86.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.919 -0.657 . . . . 7.28 112.606 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.62 131.85 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.718 0.294 . . . . 7.21 110.479 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.6 m -86.08 102.64 14.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.499 -0.556 . . . . 6.14 109.499 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 156' ' ' ILE . 56.7 mt -66.62 115.52 6.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.9 110.344 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.3 tttt -90.18 114.7 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.941 -0.572 . . . . 7.3 109.739 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.84 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.421 -0.354 . . . . 5.37 110.207 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.424 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 7.8 mmt85 -128.25 169.46 14.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.205 -0.452 . . . . 6.97 110.786 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -79.78 127.14 78.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.311 -0.404 . . . . 7.37 109.99 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.04 113.7 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.488 2.125 . . . . 7.98 110.863 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -73.65 165.99 24.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.849 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -83.56 76.73 9.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.392 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -84.5 131.01 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.733 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 60.97 77.44 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 123.775 0.672 . . . . 0.0 110.095 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.19 124.36 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.254 2.636 . . . . 0.0 112.567 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.89 140.35 15.56 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.798 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.65 135.73 54.32 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.35 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -100.13 -116.58 3.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.419 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 55.9 mtt 61.59 38.99 15.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.768 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 34.1 m -81.97 31.54 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.508 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -129.18 116.0 18.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.859 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -111.22 141.93 25.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.94 17.43 1.31 Allowed 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.709 2.272 . . . . 0.0 113.493 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 9.2 t -115.9 20.53 14.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.406 0.622 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.7 m -72.23 132.27 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.225 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -109.07 121.59 45.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.746 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.31 117.49 53.02 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.674 ' HB2' HG22 ' A' ' 249' ' ' VAL . 24.4 Cg_exo -65.22 -24.65 58.29 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.615 2.21 . . . . 0.0 111.45 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 77.71 26.08 61.48 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.265 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.674 HG22 ' HB2' ' A' ' 247' ' ' PRO . 22.4 m -126.42 125.02 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -97.93 -34.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.0 109.497 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.0 m -146.04 -170.33 3.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.717 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 4.5 p -59.48 -36.97 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.724 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.3 158.03 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 62.6 t -77.38 118.69 73.67 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 5.2 Cg_exo -74.42 164.78 33.23 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.844 2.362 . . . . 0.0 111.635 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.9 -64.3 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.472 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.2 m 55.46 28.85 12.24 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.193 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.82 127.43 32.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 306' ' ' GLU . 23.1 m170 -83.17 -2.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.521 . . . . 8.75 110.37 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 40.8 ttmt -77.25 123.62 26.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.671 -0.695 . . . . 6.04 109.955 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.526 HD12 ' CE1' ' A' ' 307' ' ' TYR . 41.2 mt -101.64 142.68 32.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.925 -0.579 . . . . 5.29 111.014 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -88.42 115.67 26.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.323 -0.853 . . . . 4.77 109.221 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.27 107.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.963 -0.384 . . . . 3.94 109.963 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -110.54 171.71 14.87 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.507 -0.637 . . . . 4.58 111.507 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.44 26.85 45.68 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 5.58 111.694 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.41 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 91.2 mt -90.11 125.95 58.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.766 0.317 . . . . 5.92 110.587 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.673 ' HB2' HD13 ' A' ' 270' ' ' LEU . 27.1 Cg_exo -63.1 134.78 47.6 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.664 2.242 . . . . 6.94 111.681 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -63.4 -20.66 65.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 8.81 112.179 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -86.02 1.59 49.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.566 0.222 . . . . 8.73 111.59 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.4 mp -91.68 144.59 25.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.132 -0.321 . . . . 7.52 110.132 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.8 p-10 -106.88 177.19 4.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.271 -0.422 . . . . 8.79 110.436 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 3.8 m-20 -58.36 -38.99 78.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 7.62 111.493 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.71 -50.87 65.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.08 -40.47 85.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.511 0.195 . . . . 8.69 111.386 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.1 t -65.96 -48.46 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 6.64 110.728 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 35.7 mtmm -59.27 -53.25 60.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.576 -0.284 . . . . 7.74 111.193 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.27 -43.15 82.83 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.827 0.346 . . . . 9.38 111.063 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.04 -53.3 58.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 7.06 110.201 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.34 -36.11 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 6.89 111.414 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.6 m -63.21 -32.23 73.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 8.85 111.291 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 32.2 m -65.62 -14.08 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.8 8.32 13.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 9.18 110.388 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.91 125.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.745 -0.661 . . . . 9.06 111.91 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 280' ' ' THR . 35.9 Cg_endo -64.89 139.13 60.75 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.63 2.22 . . . . 10.14 112.712 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 70.6 mt -100.59 133.0 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 8.3 110.329 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.687 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.6 ptpt -95.83 -18.39 20.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.808 -0.442 . . . . 8.65 109.808 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -149.18 139.79 22.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.182 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.552 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 84.9 t80 -140.41 130.31 24.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.228 -0.442 . . . . 6.27 110.535 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.59 118.57 11.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 5.79 110.083 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 303' ' ' ALA . 60.4 tp -95.66 128.41 42.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 6.35 109.797 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.9 t -76.21 113.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 6.61 109.992 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.492 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 45.2 mttm -114.63 161.69 17.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.787 -0.642 . . . . 8.17 111.13 -172.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 1.025 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 31.2 t70 -126.46 122.82 36.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.023 -0.535 . . . . 10.33 109.872 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.4 m -65.39 -38.7 90.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.151 0.426 . . . . 10.8 112.151 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.57 82.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.985 0.422 . . . . 12.13 111.311 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.9 m -81.12 -35.92 30.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.195 -0.457 . . . . 11.16 111.12 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.12 10.05 81.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.035 -0.602 . . . . 10.11 111.983 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.94 175.32 8.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.798 0.332 . . . . 10.12 110.549 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.5 t -71.99 156.42 39.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.89 -0.596 . . . . 7.73 110.054 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 1.025 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.3 mmmp? -86.33 1.74 49.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.388 -0.369 . . . . 8.01 110.635 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 104.05 4.65 44.64 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.583 -0.817 . . . . 6.09 113.439 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.489 ' CE2' HG21 ' A' ' 291' ' ' VAL . 48.6 p90 -157.4 162.12 39.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.194 0.521 . . . . 6.54 111.57 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -148.61 170.09 18.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.438 -0.801 . . . . 4.38 110.623 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.582 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.4 m-85 -120.31 127.48 52.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.314 -0.624 . . . . 4.93 109.314 175.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.552 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 25.9 m -135.04 113.47 11.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.499 -0.319 . . . . 5.09 111.125 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 27.2 tt0 -88.3 123.53 32.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.913 0.387 . . . . 7.03 110.201 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.526 ' CE1' HD12 ' A' ' 261' ' ' LEU . 13.5 m-85 -80.23 156.76 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.815 -0.629 . . . . 7.81 111.426 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 286' ' ' LYS . 96.8 t -81.45 -55.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 10.03 110.684 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.695 ' HB3' HG22 ' A' ' 312' ' ' VAL . 13.1 t70 -82.12 129.46 34.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 10.81 109.971 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -87.92 0.84 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.252 0.464 . . . . 9.77 112.252 -173.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -103.51 -35.94 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 10.89 110.227 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 309' ' ' ASP . 27.5 m -72.46 -20.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 9.5 111.216 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.495 ' O ' HG13 ' A' ' 317' ' ' ILE . 11.5 m -54.67 -51.55 65.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.394 -0.366 . . . . 7.83 111.961 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -71.24 -24.45 62.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 8.79 110.795 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.94 -45.16 52.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 10.51 109.685 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.679 -0.692 . . . . 7.31 110.117 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 313' ' ' THR . 75.4 mt -57.61 -52.98 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 6.44 110.559 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.36 93.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.647 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -76.6 -43.33 19.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.639 -0.791 . . . . 7.46 113.182 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.64 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.3 mt -82.45 -40.91 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.277 0.473 . . . . 6.42 112.277 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -62.84 115.85 4.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.776 0.322 . . . . 6.53 110.643 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.71 -23.85 20.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.961 -0.638 . . . . 6.77 111.89 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 24.9 ttt -78.78 137.79 37.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 7.29 109.741 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -88.04 129.39 35.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.087 0.47 . . . . 7.83 111.077 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.85 104.01 15.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.534 -0.913 . . . . 7.01 108.534 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.44 -74.72 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.037 -0.825 . . . . 8.18 111.037 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.19 5.99 0.15 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.988 0.423 . . . . 8.94 110.088 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HD3' ' HG3' ' A' ' 267' ' ' PRO . 12.6 mptt -101.92 129.64 48.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.593 -0.521 . . . . 7.29 109.593 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.64 118.02 15.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.802 0.334 . . . . 7.13 110.471 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 320' ' ' LEU . 19.0 tp -74.53 115.71 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.914 -0.584 . . . . 5.63 109.865 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 4.9 tt -98.47 110.68 23.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.928 -0.768 . . . . 5.53 108.928 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 317' ' ' ILE . 49.1 t -120.77 127.53 75.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.028 0.442 . . . . 5.21 110.864 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -162.08 -178.29 6.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.6 -0.727 . . . . 6.05 109.077 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -73.69 145.03 45.54 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.821 -0.352 . . . . 7.58 110.138 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.11 83.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.414 -0.357 . . . . 6.04 111.558 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 33.1 m -106.27 -36.47 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.491 -0.322 . . . . 7.57 110.993 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.5 t 72.24 -57.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.289 0.636 . . . . 0.0 111.571 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.27 26.47 1.2 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.385 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -111.58 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -110.03 119.21 38.59 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -109.3 121.57 45.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 178.296 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.557 0.218 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.493 ' HB2' ' HG3' ' A' ' 201' ' ' GLU . 68.9 mtm180 -112.61 18.69 18.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.739 0.304 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 83.4 mtt180 -111.23 146.19 37.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.057 0.456 . . . . 6.52 112.113 -173.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.31 154.85 31.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 5.24 109.661 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -100.05 109.99 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.206 -0.452 . . . . 6.15 109.969 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 198' ' ' ALA . 7.2 p -109.01 133.31 54.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.131 0.491 . . . . 4.24 110.453 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.31 -179.31 17.38 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.782 -0.645 . . . . 4.95 111.803 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.0 t30 58.24 65.65 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.767 0.794 . . . . 0.0 109.985 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 29.6 pt -115.68 157.69 43.8 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.989 -1.005 . . . . 5.61 110.226 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 36.2 Cg_endo -65.67 131.13 26.71 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.484 2.123 . . . . 5.97 112.559 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -72.03 96.22 1.71 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.299 0.571 . . . . 8.47 109.888 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 141.59 -10.15 2.65 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.524 -0.762 . . . . 6.96 111.517 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.708 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.1 tp -66.94 136.18 27.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.911 0.386 . . . . 6.1 110.857 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.8 p -89.93 153.26 20.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.099 -0.5 . . . . 6.62 109.703 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.97 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.4 mt-10 -61.81 -40.67 96.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.782 0.325 . . . . 5.69 110.904 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.4 -48.89 73.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.982 -0.554 . . . . 7.29 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.09 86.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.3 tpt -65.86 -46.68 77.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.234 -0.439 . . . . 4.49 110.23 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 23.1 ttt -61.07 -45.75 93.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 5.76 110.609 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.38 -41.97 81.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 6.51 111.048 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.64 -49.38 76.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 5.44 111.009 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.469 ' HE1' HD11 ' A' ' 226' ' ' ILE . 47.8 m-85 -61.19 -45.37 94.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.671 -0.24 . . . . 5.03 111.068 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 95.3 m-20 -57.09 -44.92 83.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 6.3 110.407 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -48.64 78.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.174 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -61.57 -43.49 98.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 6.25 111.229 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.34 -34.84 78.89 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.939 -0.304 . . . . 7.03 110.644 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 95.0 mtt180 -64.31 -52.06 60.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.368 . . . . 8.94 110.787 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.93 -36.09 69.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.223 -0.444 . . . . 8.7 111.266 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.46 -30.85 68.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.955 -0.64 . . . . 8.11 112.043 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.08 36.89 26.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.932 -0.651 . . . . 8.49 112.75 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 8.3 mp -101.68 21.42 14.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.185 0.517 . . . . 7.59 110.504 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.1 p -102.93 171.46 7.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.848 -0.615 . . . . 8.73 110.381 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 13.7 pt20 -110.79 -1.09 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.935 0.398 . . . . 9.89 110.02 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.3 162.71 15.58 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.726 -0.67 . . . . 9.69 110.141 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 170.88 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.503 2.135 . . . . 10.74 111.546 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.73 -153.85 17.87 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.437 -0.887 . . . . 8.97 112.764 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -106.93 114.74 61.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.693 0.282 . . . . 7.58 110.794 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 36.6 Cg_exo -60.74 -42.84 35.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.981 2.454 . . . . 6.4 112.366 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.06 131.59 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.057 -0.349 . . . . 5.47 110.057 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 203' ' ' ARG . 36.1 tp -109.49 -39.01 5.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.733 ' HB1' HG11 ' A' ' 312' ' ' VAL . . . -137.19 131.5 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.57 122.34 64.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.231 0.538 . . . . 4.68 111.426 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.38 106.2 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.873 -0.603 . . . . 6.34 109.568 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -112.53 134.35 55.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.754 0.312 . . . . 5.85 111.049 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -114.98 104.38 11.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.634 -0.506 . . . . 7.34 109.634 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.4 -17.78 60.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.82 -0.627 . . . . 7.61 111.315 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.68 -53.38 22.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.56 -0.291 . . . . 9.12 111.09 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.3 mmtm -90.25 -3.64 57.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.822 0.344 . . . . 9.1 110.433 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 63.6 56.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.399 -0.819 . . . . 6.6 110.841 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 22.2 p90 -148.59 162.97 38.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 6.67 109.689 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.516 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -151.59 148.95 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.974 0.416 . . . . 4.58 111.357 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 55.5 m-85 -111.4 108.38 17.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.696 -0.684 . . . . 6.22 109.563 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 92.5 mt -97.56 116.06 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.975 -0.557 . . . . 4.77 110.322 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 25.4 tt0 -99.22 122.02 41.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.54 -0.541 . . . . 6.55 109.54 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' A' ' 208' ' ' THR . 90.1 m-85 -93.69 163.97 13.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.944 -0.571 . . . . 6.51 110.425 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.505 ' HA ' HD22 ' A' ' 187' ' ' LEU . 38.9 ptt180 -69.16 -17.18 63.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.717 -0.674 . . . . 8.27 111.419 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 56.2 p -135.19 -163.64 1.41 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.302 -0.408 . . . . 7.96 110.356 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 1.052 HG11 ' HA2' ' A' ' 248' ' ' GLY . 46.5 t -123.01 -32.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.261 0.553 . . . . 8.73 109.713 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.45 -57.75 11.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 8.5 110.573 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 38.7 mt-10 -60.13 -37.23 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 7.4 109.921 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.461 HG23 ' CD1' ' A' ' 202' ' ' PHE . 12.0 m -54.45 -43.25 71.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 6.13 110.806 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.4 m -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.323 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 8.5 mp0 -71.99 -27.77 62.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.382 -0.372 . . . . 7.75 110.909 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 214' ' ' PHE . . . -63.65 -19.04 64.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 5.43 111.173 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.82 -19.37 62.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 6.29 111.022 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.25 -6.05 51.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 6.14 111.306 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 211' ' ' ALA . 97.5 m-85 -89.63 2.12 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 5.57 110.624 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.11 120.97 10.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 5.92 110.441 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.11 42.09 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.682 -0.771 . . . . 5.74 112.527 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.7 tt -63.21 136.08 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 5.3 110.487 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -87.99 121.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.561 . . . . 6.8 110.83 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -134.27 115.01 13.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.807 -0.633 . . . . 5.79 110.571 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 53.08 35.95 20.96 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.952 -0.567 . . . . 7.32 112.077 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.7 2.55 75.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.819 -0.705 . . . . 7.28 113.221 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -119.37 136.19 54.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.123 0.461 . . . . 7.21 110.951 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.6 t -88.75 103.28 15.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.128 -0.693 . . . . 6.14 109.128 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 156' ' ' ILE . 84.2 mt -66.34 121.99 16.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 4.9 111.04 -174.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.59 ' HE2' ' HG3' ' A' ' 227' ' ' ARG . 87.6 tttt -96.85 115.56 27.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 7.3 110.293 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.469 HD11 ' HE1' ' A' ' 169' ' ' PHE . 61.6 mt -115.02 107.14 22.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.921 -0.4 . . . . 5.37 109.921 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.59 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 8.0 mmt180 -130.98 172.12 12.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.124 0.488 . . . . 6.97 111.51 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 45.1 mtp85 -72.14 131.94 84.84 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.473 -0.785 . . . . 7.37 110.248 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 16.9 Cg_exo -66.97 152.59 80.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 7.98 111.361 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.17 135.22 50.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.29 135.82 25.86 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.668 0.605 . . . . 0.0 110.755 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -87.81 -56.11 3.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.961 -171.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -100.4 125.66 38.61 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.09 124.51 12.7 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.877 2.385 . . . . 0.0 112.08 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.945 ' HB2' ' HB3' ' A' ' 238' ' ' MET . 80.8 mt -103.54 128.55 27.18 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 17.2 Cg_exo -67.17 107.51 1.37 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.784 2.323 . . . . 0.0 111.219 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 58.07 3.63 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.226 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.945 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -95.04 177.83 5.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.99 0.424 . . . . 0.0 111.107 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.451 ' HB2' ' HG3' ' A' ' 242' ' ' PRO . 28.9 m -150.66 141.91 23.24 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.98 -57.33 6.35 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -119.56 87.29 36.36 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 239' ' ' SER . 14.3 Cg_exo -69.57 -43.22 2.95 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.843 2.362 . . . . 0.0 112.149 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.5 t -155.52 -55.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.8 m -96.61 161.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.489 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.97 -63.98 1.26 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 36.7 t -106.89 111.18 63.85 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.43 -33.7 92.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.135 2.557 . . . . 0.0 112.695 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 1.052 ' HA2' HG11 ' A' ' 205' ' ' VAL . . . 99.91 -143.01 16.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.771 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.62 76.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.152 0.501 . . . . 0.0 110.015 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.49 -6.51 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.676 0.751 . . . . 0.0 109.563 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 44.5 t -156.37 140.08 16.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.448 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.1 t -134.19 139.85 46.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.04 0.448 . . . . 0.0 110.621 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.5 t -85.41 114.68 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.661 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 23.9 m -76.37 136.76 68.17 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.539 ' HB3' HG13 ' A' ' 308' ' ' VAL . 41.8 Cg_endo -68.28 138.77 43.92 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.846 2.364 . . . . 0.0 112.954 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 310' ' ' ILE . 27.8 t70 -91.39 129.92 37.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.183 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.0 p -86.09 162.54 18.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.795 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 66.05 22.12 11.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.446 0.641 . . . . 0.0 110.348 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -103.7 16.14 27.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.46 -0.791 . . . . 8.75 109.47 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.776 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 39.7 ttmt -58.65 130.73 48.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.076 -0.966 . . . . 6.04 111.353 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 313' ' ' THR . 83.8 mt -108.38 143.81 36.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.759 -0.655 . . . . 5.29 110.661 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -91.49 120.3 32.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.994 -0.548 . . . . 4.77 110.06 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.1 106.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.287 -0.415 . . . . 3.94 109.907 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.65 154.74 16.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.845 -0.693 . . . . 4.58 112.043 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 103.06 34.29 4.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 5.58 112.004 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.2 mt -102.66 138.86 19.74 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.802 0.334 . . . . 5.92 110.85 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 16.8 Cg_exo -68.87 144.53 59.2 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.955 2.437 . . . . 6.94 111.946 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.51 -25.95 63.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 8.81 110.852 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -87.75 0.63 55.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.22 -0.445 . . . . 8.73 111.512 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 40.2 tp -86.79 122.59 30.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.165 -0.309 . . . . 7.52 110.165 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.7 p-10 -78.98 157.11 28.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.123 -0.49 . . . . 8.79 111.245 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.67 -32.07 70.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.588 -0.733 . . . . 7.62 111.569 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 -53.03 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.66 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.78 -33.54 74.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.391 -0.368 . . . . 8.69 111.208 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 271' ' ' ASN . 20.8 t -64.79 -48.74 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.667 0.27 . . . . 6.64 110.527 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -58.52 -47.24 84.79 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.322 -0.399 . . . . 7.74 110.664 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.67 -47.81 83.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 9.38 110.759 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.06 -51.03 70.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 7.06 110.255 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 285' ' ' LEU . 90.7 mt -66.87 -38.22 85.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.258 -0.428 . . . . 6.89 111.671 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 28.6 m -69.74 -19.62 63.53 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.154 0.502 . . . . 8.85 110.961 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.1 m -73.68 -8.03 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.119 0.485 . . . . 0.0 110.656 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 320' ' ' LEU . 97.2 m-85 -121.6 14.53 11.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 9.18 110.156 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 146.32 136.49 2.91 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.765 -0.652 . . . . 9.06 112.058 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.468 ' HD3' ' HG ' ' A' ' 187' ' ' LEU . 24.6 Cg_endo -61.88 135.89 58.38 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.819 2.346 . . . . 10.14 112.316 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 279' ' ' LEU . 99.3 mt -100.11 137.89 37.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.24 -0.436 . . . . 8.3 110.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.433 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.3 ptpt -98.06 -32.97 11.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.456 -0.572 . . . . 8.65 109.456 175.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 286' ' ' LYS . . . -142.56 132.87 24.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.429 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -133.0 117.57 17.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.917 -0.583 . . . . 6.27 110.22 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -131.97 113.15 13.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.609 0.719 . . . . 5.79 110.379 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.2 tp -87.38 130.52 34.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 6.35 109.199 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 111.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.81 -0.441 . . . . 6.61 109.81 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.414 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 61.6 mttm -111.06 156.6 21.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.603 -0.726 . . . . 8.17 109.918 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.63 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 33.9 t70 -88.66 136.31 33.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.984 -0.376 . . . . 10.33 109.984 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.3 m -60.12 -38.12 82.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 10.8 112.021 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.17 -48.03 6.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.03 0.443 . . . . 12.13 111.411 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.7 m -67.68 -38.22 83.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.625 . . . . 11.16 111.001 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.67 4.97 90.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.885 -0.674 . . . . 10.11 112.321 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 61.8 mt -113.08 169.37 8.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.173 -0.306 . . . . 10.12 110.173 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.518 ' HB2' HD21 ' A' ' 290' ' ' LEU . 46.4 t -65.72 146.21 55.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.221 0.534 . . . . 7.73 110.989 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.63 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 30.1 mmmt -87.55 3.24 48.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.813 -0.63 . . . . 8.01 110.372 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 102.53 4.88 49.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.574 -0.822 . . . . 6.09 113.241 174.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -152.87 156.78 39.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.987 0.422 . . . . 6.54 111.148 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.669 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.46 167.03 23.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 4.38 110.879 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.776 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 90.3 m-85 -122.54 130.02 52.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.793 -0.639 . . . . 4.93 109.304 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.1 m -142.25 132.5 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.033 -0.267 . . . . 5.09 110.938 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.84 132.18 54.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.853 -0.425 . . . . 7.03 109.853 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -88.36 156.5 19.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.725 . . . . 7.81 111.34 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 255' ' ' PRO . 79.6 t -82.18 -50.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.633 -0.712 . . . . 10.03 109.552 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.482 ' OD2' HG22 ' A' ' 312' ' ' VAL . 22.0 t70 -77.77 148.96 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 10.81 110.217 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.592 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -124.35 20.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.415 . . . . 9.77 111.233 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.11 -49.45 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.262 0.553 . . . . 10.89 109.83 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.733 HG11 ' HB1' ' A' ' 188' ' ' ALA . 34.0 m -79.21 -20.7 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.298 -0.864 . . . . 9.5 111.396 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.621 HG22 HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -53.81 -50.24 66.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.549 0.574 . . . . 7.83 112.549 -170.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.29 -35.77 80.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.874 0.369 . . . . 8.79 111.188 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.87 -29.15 60.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 10.51 110.302 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.94 -39.2 76.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.185 -0.461 . . . . 7.31 110.033 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 313' ' ' THR . 80.6 mt -57.35 -61.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 6.44 110.443 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.64 -15.98 62.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.468 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.67 -47.46 5.63 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.023 -0.608 . . . . 7.46 112.471 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 282' ' ' PHE . 92.8 mt -79.95 -40.03 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.589 0.233 . . . . 6.42 111.197 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.489 ' OD1' HD12 ' A' ' 331' ' ' LEU . 8.8 t30 -62.01 115.0 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 6.53 110.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.33 -23.63 6.04 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.672 -0.775 . . . . 6.77 111.856 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 66.7 mtt -78.66 171.99 14.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.733 -0.469 . . . . 7.29 109.733 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -117.63 151.75 36.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.723 0.297 . . . . 7.83 110.51 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.61 106.73 7.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.998 -0.742 . . . . 7.01 108.998 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.5 -94.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.721 -0.752 . . . . 8.18 111.435 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.08 -9.35 5.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 8.94 110.404 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.15 159.28 15.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 7.29 110.38 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -98.92 129.35 45.25 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.528 -0.545 . . . . 7.13 109.528 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.01 115.2 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 5.63 110.709 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.489 HD12 ' OD1' ' A' ' 321' ' ' ASN . 51.4 tp -108.6 105.79 15.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.322 -0.854 . . . . 5.53 109.832 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.11 115.47 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.724 -0.473 . . . . 5.21 109.724 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -137.76 158.82 43.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.138 0.494 . . . . 6.05 111.011 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 337' ' ' VAL . 21.0 ttt180 -71.78 119.9 16.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 7.58 109.215 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.47 -65.32 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.969 0.359 . . . . 6.04 111.969 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 39.6 m -70.56 -32.46 69.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.882 0.372 . . . . 7.57 110.311 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.709 ' HA ' ' HG2' ' A' ' 334' ' ' ARG . 46.3 t 66.88 -78.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.773 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 76.79 -88.34 0.95 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.577 -174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -152.29 98.47 2.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.637 0.256 . . . . 0.0 110.311 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -79.45 98.63 6.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -139.5 -37.33 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.878 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.722 -179.612 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 6.5 ptp180 -101.86 -19.04 15.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.041 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.1 mtt180 -114.84 133.28 56.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.867 0.365 . . . . 6.52 111.213 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 75.8 mt -98.98 157.8 16.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 5.24 110.766 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.503 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 46.7 t80 -115.31 103.46 10.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 6.15 110.075 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.7 p -103.06 130.91 52.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.181 0.515 . . . . 4.24 110.12 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.45 16.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.586 -0.734 . . . . 4.95 111.595 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.57 55.24 4.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.693 0.759 . . . . 0.0 109.477 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.566 HG22 HD22 ' A' ' 224' ' ' LEU . 35.5 pt -101.09 147.69 34.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 5.61 110.156 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.11 114.63 2.4 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.695 2.263 . . . . 5.97 112.189 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.4 127.85 34.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.568 . . . . 8.47 110.762 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.37 10.67 35.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.845 -0.693 . . . . 6.96 111.692 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.1 tp -81.13 137.78 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 6.1 109.912 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.3 p -87.2 144.64 26.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.407 -0.361 . . . . 6.62 110.755 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.928 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.2 mt-10 -57.71 -43.46 85.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.69 111.45 -175.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.72 -52.46 64.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 7.29 110.74 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.64 95.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.708 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.457 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.1 tpt -60.54 -46.8 88.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 4.49 110.475 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.443 ' HB2' HG11 ' A' ' 189' ' ' VAL . 25.6 ttt -63.28 -47.13 83.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.129 -0.487 . . . . 5.76 110.977 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -62.98 -32.04 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 6.51 111.387 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.36 -49.1 76.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.565 -0.289 . . . . 5.44 110.619 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 173' ' ' MET . 56.2 m-85 -63.1 -44.9 94.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 5.03 110.798 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.89 -35.94 77.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.35 . . . . 6.3 110.941 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.58 68.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.446 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -61.52 -31.14 71.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 6.25 111.281 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 17.9 mmt -60.95 -51.49 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 7.03 110.17 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -69.2 -48.06 63.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.976 -0.557 . . . . 8.94 110.972 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -35.56 80.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 8.7 111.383 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.53 -29.61 48.09 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.591 -0.814 . . . . 8.11 112.165 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.43 0.43 40.46 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.901 -0.666 . . . . 8.49 111.823 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.3 mp -79.25 84.7 5.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.74 -0.467 . . . . 7.59 109.74 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.5 m -159.96 124.38 3.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 8.73 110.147 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 12.0 pt20 -90.04 -27.71 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 9.89 111.183 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -141.18 139.83 19.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.455 -0.339 . . . . 9.69 110.327 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.14 118.12 4.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.951 2.434 . . . . 10.74 112.486 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.56 -155.65 22.33 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.122 -0.561 . . . . 8.97 111.931 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.7 m-20 -101.57 126.24 34.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.684 0.278 . . . . 7.58 111.169 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_exo -68.76 -32.18 23.9 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 123.01 2.474 . . . . 6.4 111.83 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.3 124.16 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 5.47 110.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.64 -42.07 7.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.035 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.91 159.38 42.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 111.113 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 166' ' ' MET . 9.1 p -140.57 136.63 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.211 -0.449 . . . . 4.68 110.84 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 199' ' ' PHE . 41.6 mt-30 -113.86 106.36 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.655 -0.498 . . . . 6.34 109.655 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -111.43 123.98 67.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.191 0.52 . . . . 5.85 111.661 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -127.14 119.24 26.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.569 -0.741 . . . . 7.34 109.49 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -93.17 3.42 55.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.757 0.313 . . . . 7.61 111.384 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.8 -54.59 5.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.093 0.473 . . . . 9.12 109.816 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.624 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 47.3 mmtm -86.52 -7.17 58.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.952 -0.567 . . . . 9.1 109.491 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 60.87 70.03 0.64 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.149 -0.932 . . . . 6.6 110.812 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 195' ' ' LYS . 41.2 p90 -149.28 163.0 38.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.209 -0.451 . . . . 6.67 111.227 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 190' ' ' GLN . . . -144.83 126.87 15.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.646 -0.706 . . . . 4.58 110.238 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 190' ' ' GLN . 55.6 m-85 -96.23 126.87 41.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.363 -0.381 . . . . 6.22 110.117 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 79.0 mt -105.57 115.21 29.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.052 -0.522 . . . . 4.77 109.998 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.03 118.27 31.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.996 -0.372 . . . . 6.55 109.996 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -95.64 163.91 13.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.761 -0.654 . . . . 6.51 110.814 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.78 -8.32 57.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.311 -0.859 . . . . 8.27 111.014 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 p -142.99 -164.72 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 7.96 110.294 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.07 -29.96 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 8.73 109.227 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.02 -55.62 32.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.124 -0.944 . . . . 8.5 111.408 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 46.9 mt-10 -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 7.4 110.026 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.487 ' O ' HD11 ' A' ' 151' ' ' LEU . 1.8 m -53.24 -53.44 50.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.569 -0.741 . . . . 6.13 110.807 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 m -60.98 -35.06 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.616 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.674 ' HG3' HD23 ' A' ' 178' ' ' LEU . 61.0 tp60 -73.28 -30.5 63.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.807 -0.633 . . . . 7.75 110.373 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -69.6 -12.81 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 5.43 111.23 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.4 mtp -69.8 -13.52 62.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 6.29 110.85 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.35 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 6.14 111.358 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.439 ' HE2' HD22 ' A' ' 178' ' ' LEU . 76.4 m-85 -92.71 15.17 15.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 5.57 111.263 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.56 115.48 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.921 -0.4 . . . . 5.92 109.921 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.77 30.1 9.31 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.561 -0.828 . . . . 5.74 112.006 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 13.1 tt -84.82 136.2 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 5.3 110.091 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.46 113.93 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.446 0.641 . . . . 6.8 110.811 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -134.68 119.13 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.848 -0.615 . . . . 5.79 110.593 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 61.43 20.85 11.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.947 -0.57 . . . . 7.32 112.017 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.55 1.82 63.79 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.619 -0.8 . . . . 7.28 112.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -119.84 142.88 48.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.939 0.399 . . . . 7.21 111.076 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.0 t -90.24 111.16 22.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.705 -0.679 . . . . 6.14 109.885 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 156' ' ' ILE . 77.0 mt -76.93 114.13 15.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.026 0.441 . . . . 4.9 110.695 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.7 tttt -94.9 114.59 26.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.96 -0.564 . . . . 7.3 110.394 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.42 109.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 5.37 110.631 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 227' ' ' ARG . 6.8 mmt180 -131.12 171.13 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.506 . . . . 6.97 110.621 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 26.8 mtp180 -87.69 127.4 58.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.883 -0.414 . . . . 7.37 109.883 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.689 ' HB2' ' HB3' ' A' ' 232' ' ' TYR . 14.9 Cg_exo -66.48 104.66 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.954 2.436 . . . . 7.98 111.857 -176.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.43 ' HA ' ' OE1' ' A' ' 233' ' ' GLN . 51.2 t-80 -71.98 -37.67 69.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.284 -174.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -79.64 -13.18 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.374 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TYR . . . . . 0.689 ' HB3' ' HB2' ' A' ' 229' ' ' PRO . 72.3 t80 -90.88 -11.11 40.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.315 0.579 . . . . 0.0 110.482 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 229' ' ' PRO . 24.4 mt-30 -79.27 138.06 56.08 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.113 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.58 168.62 16.11 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 111.307 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.3 mt 62.74 88.38 0.12 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 121.126 0.488 . . . . 0.0 110.607 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.503 ' HG2' ' H ' ' A' ' 241' ' ' ASN . 6.2 Cg_exo -80.54 47.82 2.68 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.73 2.954 . . . . 0.0 112.965 -176.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.69 -105.9 2.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.902 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 94.7 mmm -88.48 99.12 12.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.677 0.275 . . . . 0.0 110.889 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 19.3 m 66.8 176.9 0.24 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.638 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -73.56 148.0 43.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.503 ' H ' ' HG2' ' A' ' 236' ' ' PRO . 10.4 m120 -133.65 98.0 15.27 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.173 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 243' ' ' SER . 65.5 Cg_endo -72.48 -7.89 21.65 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.993 2.462 . . . . 0.0 113.371 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 242' ' ' PRO . 45.7 t 74.14 -46.14 0.61 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.716 0.635 . . . . 0.0 110.092 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.57 113.63 36.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 109.849 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.44 -31.05 12.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.006 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.8 m -63.27 150.78 88.51 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.49 132.13 49.37 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.932 2.421 . . . . 0.0 112.451 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.24 -171.44 44.58 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.7 172.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.86 0.362 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 9.7 p -121.92 149.91 25.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.654 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.7 t -116.61 83.09 1.9 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.912 0.387 . . . . 0.0 110.204 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 35.1 m -154.56 85.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.69 158.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.485 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.9 m -133.88 114.62 13.02 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.07 -37.2 65.87 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.385 2.057 . . . . 0.0 111.234 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 17.9 t70 70.44 -57.04 0.59 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.734 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 63.1 m -85.35 -4.63 59.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.72 0.295 . . . . 0.0 111.426 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -145.5 93.53 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.962 0.411 . . . . 0.0 110.685 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -154.4 33.78 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.681 0.753 . . . . 8.75 109.398 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.1 ttmt -78.91 116.91 19.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.15 -0.932 . . . . 6.04 111.129 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.777 HD11 HG23 ' A' ' 313' ' ' THR . 68.0 mt -100.89 142.43 32.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.546 -0.752 . . . . 5.29 109.872 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -92.93 123.83 36.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.266 -0.424 . . . . 4.77 109.988 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 330' ' ' LEU . 3.1 mp -114.4 110.55 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.839 -0.618 . . . . 3.94 109.413 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.58 130.64 6.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.717 -0.754 . . . . 4.58 112.376 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 124.44 23.47 1.91 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.744 -0.741 . . . . 5.58 111.977 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.5 mt -95.86 141.53 23.3 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.104 -0.332 . . . . 5.92 110.104 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.875 ' HB2' HD13 ' A' ' 270' ' ' LEU . 32.3 Cg_exo -58.47 116.3 3.15 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.535 2.157 . . . . 6.94 111.107 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 299' ' ' SER . 29.7 p-10 -70.23 -5.46 27.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.729 0.64 . . . . 8.81 112.729 -170.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.59 -0.444 . . . . 8.73 111.02 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.875 HD13 ' HB2' ' A' ' 267' ' ' PRO . 11.2 mp -86.31 133.39 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 7.52 110.202 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.2 p-10 -79.16 160.04 27.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.984 -0.553 . . . . 8.79 110.536 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.18 -32.09 54.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.757 -0.656 . . . . 7.62 111.501 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.464 ' HB3' ' ND2' ' A' ' 271' ' ' ASN . 17.2 t70 -56.93 -54.81 42.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.602 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -73.93 -33.37 63.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.516 -0.311 . . . . 8.69 111.27 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 271' ' ' ASN . 63.0 t -62.92 -48.6 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.537 -0.301 . . . . 6.64 110.819 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -62.88 -45.39 92.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.262 . . . . 7.74 111.399 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.96 -40.79 98.78 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.739 0.304 . . . . 9.38 110.884 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.63 -49.12 78.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 7.06 109.873 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.86 -37.25 78.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.54 . . . . 6.89 111.426 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 87.0 m -60.72 -31.27 70.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.483 -0.326 . . . . 8.85 110.9 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.3 m -65.62 -15.85 63.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.21 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.58 2.04 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.389 . . . . 9.18 110.577 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 157.51 127.13 0.94 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.733 -0.746 . . . . 9.06 112.563 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.408 ' HD3' ' HA2' ' A' ' 283' ' ' GLY . 27.4 Cg_exo -63.04 133.28 40.4 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.926 2.417 . . . . 10.14 112.171 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.16 138.45 39.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.08 -0.509 . . . . 8.3 111.055 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 308' ' ' VAL . 12.2 ptpt -104.39 -12.71 16.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 8.65 109.707 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.72 136.82 22.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.593 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 72.4 t80 -150.54 126.45 10.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.26 -0.427 . . . . 6.27 110.512 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -140.44 112.08 7.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.362 0.601 . . . . 5.79 110.428 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -80.48 121.36 25.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.53 -0.759 . . . . 6.35 109.793 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.66 113.47 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.361 0.6 . . . . 6.61 110.452 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -113.28 160.27 18.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.369 -0.832 . . . . 8.17 109.846 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.777 ' HB2' ' HE3' ' A' ' 300' ' ' LYS . 11.6 t70 -90.03 113.31 24.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.174 -0.676 . . . . 10.33 109.174 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 32.4 m -76.76 -3.2 36.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.538 0.57 . . . . 10.8 112.538 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.37 -23.1 13.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.926 0.393 . . . . 12.13 110.808 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.0 m -106.2 -41.24 5.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.06 -0.518 . . . . 11.16 111.22 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.0 20.72 25.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.811 -0.709 . . . . 10.11 112.102 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.97 155.99 29.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.443 -0.206 . . . . 10.12 110.443 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 42.2 t -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.532 -0.304 . . . . 7.73 110.336 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.777 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 32.3 mmtp -94.07 -8.21 40.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.298 -0.41 . . . . 8.01 111.108 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 90.76 6.74 67.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.656 -0.783 . . . . 6.09 113.047 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 300' ' ' LYS . 40.7 p90 -141.55 152.54 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.793 0.33 . . . . 6.54 110.533 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.27 164.07 35.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.108 -0.496 . . . . 4.38 111.185 -176.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 96.9 m-85 -106.14 123.42 47.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.874 -0.603 . . . . 4.93 109.519 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.593 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 21.6 m -128.6 121.32 28.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 5.09 110.678 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 30.8 tt0 -103.24 114.96 29.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 7.03 110.129 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.49 ' CE1' HD12 ' A' ' 261' ' ' LEU . 25.8 m-85 -84.05 149.58 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 7.81 111.129 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 286' ' ' LYS . 61.3 t -78.89 -55.54 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.9 -0.591 . . . . 10.03 110.684 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 144.94 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 10.81 111.225 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.88 -19.93 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 9.77 111.356 -178.172 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.59 -48.35 64.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.907 0.384 . . . . 10.89 110.039 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.82 -23.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 9.5 110.992 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.777 HG23 HD11 ' A' ' 261' ' ' LEU . 98.4 m -55.78 -50.03 71.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.496 -0.32 . . . . 7.83 111.728 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.28 -38.11 89.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 8.79 110.719 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.45 -40.62 85.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 10.51 110.479 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -49.61 71.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 7.31 110.666 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 313' ' ' THR . 74.8 mt -59.01 -49.17 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.578 -0.283 . . . . 6.44 110.798 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.79 69.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.73 -43.42 7.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.699 -0.763 . . . . 7.46 112.7 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.427 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.1 mt -80.92 -42.7 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.544 0.202 . . . . 6.42 111.544 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 49.4 t-20 -72.67 113.89 10.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.317 -0.623 . . . . 6.53 109.317 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.5 -7.93 47.12 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.283 -0.727 . . . . 6.77 111.283 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttt -74.33 135.29 42.53 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 7.29 109.864 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.54 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 46.0 mt-30 -96.1 117.12 30.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.349 -0.387 . . . . 7.83 110.458 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.82 96.83 6.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.355 -0.609 . . . . 7.01 109.355 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 85.8 -94.54 1.93 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.166 -0.774 . . . . 8.18 111.166 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.81 -19.12 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.996 0.426 . . . . 8.94 110.11 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 158.95 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 7.29 110.419 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.54 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 99.4 mttt -110.27 142.42 41.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.041 0.448 . . . . 7.13 110.82 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.587 HD11 HG23 ' A' ' 263' ' ' ILE . 55.7 tp -86.29 134.41 33.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.551 -0.75 . . . . 5.63 110.14 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.8 mp -121.28 136.27 54.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.899 0.381 . . . . 5.53 110.434 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.543 HG22 HG13 ' A' ' 263' ' ' ILE . 62.1 t -129.84 125.06 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.855 -0.612 . . . . 5.21 110.201 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.29 144.68 22.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.046 -0.724 . . . . 6.05 109.046 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 337' ' ' VAL . 68.5 ttt180 -64.07 135.21 56.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.637 -0.425 . . . . 7.58 110.518 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -83.17 11.91 5.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 6.04 111.923 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.476 ' H ' ' HG2' ' A' ' 334' ' ' ARG . 9.5 m -126.71 -94.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.644 0.259 . . . . 7.57 110.644 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.61 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 18.5 m -125.06 136.87 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.54 76.63 0.95 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.13 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.92 173.39 11.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -90.16 86.98 6.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -165.28 -55.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.732 179.703 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.77 0.319 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 205' ' ' VAL . 98.6 mtt180 -117.67 9.4 13.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.044 0.45 . . . . 0.0 110.621 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 87.1 mtt180 -106.87 133.23 51.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.91 -0.586 . . . . 6.52 110.37 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 52.3 mt -97.2 150.44 20.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.283 -0.417 . . . . 5.24 110.546 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -100.66 105.26 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.912 -0.586 . . . . 6.15 109.443 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.3 p -107.71 129.33 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.232 0.539 . . . . 4.24 110.446 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -129.74 -177.53 14.93 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.484 -0.78 . . . . 4.95 111.78 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 61.78 38.77 14.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.84 0.829 . . . . 0.0 109.375 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.42 HG22 HD22 ' A' ' 224' ' ' LEU . 34.0 pt -84.34 152.34 60.92 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 5.61 111.009 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 160' ' ' ILE . 11.6 Cg_exo -71.32 123.08 9.26 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.011 2.474 . . . . 5.97 112.165 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -75.89 113.7 13.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 8.47 109.828 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 132.21 -33.51 2.68 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.784 -0.722 . . . . 6.96 112.283 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 157' ' ' PRO . 11.4 tp -71.26 153.92 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.616 0.246 . . . . 6.1 110.634 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 p -88.9 161.09 16.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.85 0.357 . . . . 6.62 111.223 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 191' ' ' ILE . 41.6 mt-10 -66.05 -37.94 87.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 5.69 109.71 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.16 -48.82 80.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.023 -0.99 . . . . 7.29 111.296 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.23 90.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.253 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.2 ttm -65.1 -39.88 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 4.49 110.53 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.669 ' HE3' ' HB ' ' A' ' 186' ' ' VAL . 23.5 ttt -62.28 -46.22 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.356 . . . . 5.76 110.81 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.66 -38.6 88.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 6.51 110.472 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -57.62 -48.16 80.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.848 -0.615 . . . . 5.44 110.58 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HG2' ' A' ' 173' ' ' MET . 33.2 m-85 -64.47 -47.16 80.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 5.03 111.14 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -54.89 -46.3 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.165 0.291 . . . . 6.3 110.945 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.7 84.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.036 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.3 -37.65 86.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 6.25 111.11 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 33.0 mmt -62.6 -42.25 99.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 7.03 110.177 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.18 -52.75 17.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 8.94 111.007 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.62 -34.05 77.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 8.7 111.697 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.85 -16.81 71.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.509 -0.853 . . . . 8.11 112.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.06 29.85 30.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 8.49 112.137 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.442 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.9 mp -86.89 -18.8 29.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 7.59 110.092 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.717 HG22 ' HG3' ' A' ' 185' ' ' PRO . 13.2 p -69.27 128.2 35.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.501 -0.772 . . . . 8.73 111.168 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.8 pt20 -94.09 -1.04 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 9.89 109.322 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -160.07 155.43 21.84 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.082 -0.963 . . . . 9.69 109.476 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.7 168.78 15.9 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.503 2.135 . . . . 10.74 112.136 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.87 -138.61 14.15 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.029 -0.605 . . . . 8.97 112.509 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 90.5 m-20 -116.44 118.05 37.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.588 0.232 . . . . 7.58 110.574 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.717 ' HG3' HG22 ' A' ' 179' ' ' THR . 18.3 Cg_exo -66.61 -26.52 46.36 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.866 2.377 . . . . 6.4 111.864 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.669 ' HB ' ' HE3' ' A' ' 166' ' ' MET . 40.3 t -82.54 127.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.949 -0.568 . . . . 5.47 110.112 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 284' ' ' PRO . 45.0 tp -91.8 -40.4 11.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.232 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -143.34 121.16 11.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.012 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.36 115.4 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.89 -0.595 . . . . 4.68 110.144 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -128.67 106.41 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 6.34 110.157 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 162' ' ' GLU . 66.5 mt -113.97 123.06 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.241 -0.436 . . . . 5.85 111.655 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -100.54 99.62 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -85.51 -16.93 37.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.69 . . . . 7.61 110.167 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.57 -47.55 83.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.616 -0.72 . . . . 9.12 110.957 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 45.1 mmtm -105.57 9.04 33.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.286 -0.415 . . . . 9.1 111.207 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.01 48.58 5.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.412 -0.813 . . . . 6.6 111.82 171.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 37.1 p90 -148.19 142.83 26.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.818 -0.438 . . . . 6.67 109.818 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -134.28 150.46 50.99 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.921 0.391 . . . . 4.58 111.354 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.597 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 74.8 m-85 -117.37 108.47 15.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.63 -0.713 . . . . 6.22 109.889 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 87.3 mt -94.85 114.54 26.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.08 -0.509 . . . . 4.77 109.63 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 36.1 tt0 -94.06 119.49 33.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.814 -0.439 . . . . 6.55 109.814 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.13 164.21 13.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.181 0.515 . . . . 6.51 111.213 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -73.31 -11.65 60.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.355 -0.839 . . . . 8.27 111.089 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 76.0 p -141.68 -166.75 2.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.198 -0.456 . . . . 7.96 110.219 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.592 HG22 ' HG2' ' A' ' 149' ' ' ARG . 21.8 t -116.58 -30.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.268 -0.642 . . . . 8.73 109.268 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.59 -60.44 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.085 -0.962 . . . . 8.5 111.377 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 42.4 mt-10 -58.88 -40.32 84.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4 110.078 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 m -52.45 -52.14 55.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.633 -0.712 . . . . 6.13 110.835 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.7 m -63.0 -34.23 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.522 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.442 ' HG3' HD23 ' A' ' 178' ' ' LEU . 9.3 tp-100 -71.17 -30.9 67.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.137 -0.483 . . . . 7.75 110.215 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.1 -15.03 62.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.523 . . . . 5.43 111.273 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.31 -16.02 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 6.29 111.117 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.25 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 6.14 111.55 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 217' ' ' ILE . 69.7 m-85 -93.04 21.47 5.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.444 -0.344 . . . . 5.57 111.577 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.15 109.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 5.92 110.369 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.97 13.25 22.11 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.933 -0.651 . . . . 5.74 112.233 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 214' ' ' PHE . 17.6 tt -66.41 141.8 17.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 5.3 111.2 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.2 tp -82.45 114.1 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.508 0.67 . . . . 6.8 111.098 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.27 112.77 10.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.589 -0.732 . . . . 5.79 110.701 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 59.57 31.41 20.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.863 -0.608 . . . . 7.32 111.737 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.53 -24.76 29.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.855 -0.688 . . . . 7.28 112.585 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.95 167.28 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.879 0.371 . . . . 7.21 110.777 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -118.15 99.79 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.385 -0.598 . . . . 6.14 109.385 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 156' ' ' ILE . 82.6 mt -66.14 112.93 4.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 4.9 111.59 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.3 tttt -81.83 124.73 29.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.517 -0.765 . . . . 7.3 109.91 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -118.76 106.22 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.029 0.443 . . . . 5.37 110.741 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -134.51 171.63 14.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 6.97 110.301 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 20.2 mtp180 -83.62 134.97 43.87 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.788 -0.449 . . . . 7.37 109.788 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.597 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 32.1 Cg_exo -60.28 165.9 10.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.004 2.469 . . . . 7.98 112.762 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.884 -179.673 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.444 ' CE1' ' HA ' ' A' ' 310' ' ' ILE . 13.2 t60 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.95 0.405 . . . . 8.75 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.685 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.2 ttmt -78.09 129.97 35.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.908 -0.587 . . . . 6.04 110.541 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.41 HD23 ' HG2' ' A' ' 334' ' ' ARG . 82.8 mt -96.07 140.78 30.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.201 0.524 . . . . 5.29 110.792 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -103.45 115.12 29.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.249 -0.887 . . . . 4.77 108.627 171.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 263' ' ' ILE . 4.3 mp -105.43 110.05 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.909 -0.587 . . . . 3.94 109.674 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -122.1 171.74 15.37 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.025 -0.607 . . . . 4.58 111.814 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.78 27.51 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.664 -0.779 . . . . 5.58 111.923 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 96.8 mt -106.36 142.06 24.11 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.646 0.26 . . . . 5.92 110.569 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 15.1 Cg_exo -70.36 160.41 49.63 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.771 2.314 . . . . 6.94 111.507 173.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -88.42 -9.52 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.033 0.383 . . . . 8.81 112.033 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -83.08 -2.14 54.6 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.45 -0.5 . . . . 8.73 110.97 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.68 117.4 19.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 7.52 110.108 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.38 160.11 22.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.062 -0.517 . . . . 8.79 110.817 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.23 -44.45 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 7.62 112.584 -173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.83 -45.26 92.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.816 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.5 -46.49 88.19 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.64 0.257 . . . . 8.69 111.012 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.46 -44.57 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 6.64 110.646 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -62.94 -48.08 80.46 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.378 -0.374 . . . . 7.74 110.82 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.5 -47.82 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 9.38 110.653 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.72 -54.74 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 7.06 110.584 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 288' ' ' PHE . 99.3 mt -69.46 -32.15 70.88 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.879 0.325 . . . . 6.89 111.879 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 36.1 m -72.2 -19.74 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 8.85 110.926 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 50.5 m -79.63 -0.83 35.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.439 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 320' ' ' LEU . 94.7 m-85 -120.68 14.46 11.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 9.18 110.917 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 143.7 159.93 8.21 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.567 -0.825 . . . . 9.06 112.517 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' A' ' 187' ' ' LEU . 55.5 Cg_endo -71.37 122.39 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.658 2.239 . . . . 10.14 112.31 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.96 135.46 33.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 8.3 110.436 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.9 ptpt -99.33 -26.83 14.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.577 -0.527 . . . . 8.65 109.577 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -145.24 136.66 25.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.453 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.531 ' HE2' HD12 ' A' ' 279' ' ' LEU . 16.6 t80 -144.84 110.12 5.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.869 -0.605 . . . . 6.27 109.553 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.627 HD21 ' HB2' ' A' ' 304' ' ' PHE . 3.3 p-10 -127.59 116.97 21.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.287 0.565 . . . . 5.79 110.44 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -93.23 130.04 39.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.469 -0.787 . . . . 6.35 109.973 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.65 112.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.017 0.437 . . . . 6.61 110.457 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 63.0 mttm -106.96 167.83 9.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.605 . . . . 8.17 110.124 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.47 128.06 34.92 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.192 -0.67 . . . . 10.33 109.192 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.3 m -63.87 -28.65 69.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.072 0.397 . . . . 10.8 112.072 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -95.47 -51.99 4.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 12.13 111.121 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.8 m -68.6 -51.46 42.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 11.16 111.227 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 108.77 -25.09 20.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.742 -0.742 . . . . 10.11 112.172 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.62 164.38 26.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 10.12 110.775 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 42.6 t -68.18 154.24 42.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.971 -0.559 . . . . 7.73 110.581 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -86.86 -8.69 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 8.01 109.93 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.27 17.16 35.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.791 -0.719 . . . . 6.09 113.209 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -156.44 155.94 32.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.682 0.277 . . . . 6.54 110.513 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -151.51 166.41 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.193 -0.458 . . . . 4.38 111.368 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.5 m-85 -115.75 127.47 55.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.043 -0.725 . . . . 4.93 109.043 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.4 m -144.19 131.18 20.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.66 0.267 . . . . 5.09 110.681 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 32.5 tt0 -116.08 130.16 56.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.899 0.381 . . . . 7.03 110.399 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -83.34 158.44 22.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 7.81 110.574 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 286' ' ' LYS . 62.9 t -78.63 -55.88 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 10.03 110.464 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.27 147.87 44.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 10.81 110.837 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.865 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -94.03 -4.03 10.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 9.77 112.065 -175.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -93.85 -50.72 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.732 0.301 . . . . 10.89 110.526 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.68 -24.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 9.5 112.172 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 317' ' ' ILE . 31.3 m -59.54 -50.68 72.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.931 0.345 . . . . 7.83 111.931 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -75.09 -29.04 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 8.79 110.63 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -68.64 -39.25 80.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 10.51 110.157 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.32 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.769 -0.651 . . . . 7.31 110.231 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 332' ' ' VAL . 78.8 mt -61.95 -46.06 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 6.44 110.4 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.52 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.845 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -91.91 -54.68 1.86 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.536 -0.84 . . . . 7.46 113.241 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.402 HD21 ' CE2' ' A' ' 282' ' ' PHE . 96.4 mt -69.26 -50.23 48.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.683 0.253 . . . . 6.42 111.683 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.738 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.8 t30 -63.79 114.04 3.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.727 -0.472 . . . . 6.53 109.727 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.67 7.08 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.8 -0.714 . . . . 6.77 111.815 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.7 mtt -74.16 170.49 15.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.725 -0.472 . . . . 7.29 109.725 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -134.56 118.76 17.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.028 0.442 . . . . 7.83 110.891 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.71 99.1 10.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.292 -0.633 . . . . 7.01 109.292 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.5 2.12 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.732 -0.747 . . . . 8.18 111.516 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -110.52 2.38 18.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.878 0.371 . . . . 8.94 110.582 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -105.06 135.51 46.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 7.29 110.687 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.48 127.25 35.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.738 -0.468 . . . . 7.13 109.738 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.47 115.34 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 5.63 110.664 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 54.5 tp -106.72 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.507 -0.77 . . . . 5.53 109.887 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 61.9 t -126.42 120.51 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.274 -0.421 . . . . 5.21 110.094 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.33 176.83 11.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.138 -0.69 . . . . 6.05 109.138 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' HD23 ' A' ' 261' ' ' LEU . 59.8 mtm180 -82.29 147.39 28.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.598 -0.441 . . . . 7.58 109.875 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.4 67.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 6.04 112.271 -173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--N 1.324 -0.5 0 C-N-CA 121.096 -0.242 . . . . 7.57 111.341 -177.806 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.746 0.308 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 202' ' ' PHE . 37.3 ptt180 -90.87 -1.4 57.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 68.5 mtt180 -98.12 164.28 12.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.049 0.452 . . . . 6.52 111.4 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 64.0 mt -136.86 158.41 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.268 -0.878 . . . . 5.24 109.86 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.94 113.47 26.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.831 -0.622 . . . . 6.15 109.519 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.8 p -113.19 129.1 69.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.233 0.539 . . . . 4.24 110.763 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.03 177.8 16.46 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.629 -0.714 . . . . 4.95 111.759 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.48 63.59 1.67 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.352 0.596 . . . . 0.0 110.4 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.67 155.56 36.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.568 -0.742 . . . . 5.61 110.264 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.659 ' HB2' ' HB ' ' A' ' 160' ' ' ILE . 16.1 Cg_exo -69.07 131.03 21.3 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.724 2.282 . . . . 5.97 112.013 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -79.47 102.46 8.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 8.47 109.674 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.27 20.64 6.18 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.953 -0.642 . . . . 6.96 111.895 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB2' ' A' ' 157' ' ' PRO . 11.0 tp -94.03 146.33 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.769 -0.456 . . . . 6.1 109.769 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.2 p -86.68 154.05 21.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 6.62 111.5 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.518 -0.765 . . . . 5.69 110.288 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.78 -48.1 80.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.719 -0.673 . . . . 7.29 110.408 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.45 -50.8 70.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.225 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 94.5 mmm -63.14 -48.88 76.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.194 -0.457 . . . . 4.49 110.958 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 281' ' ' SER . 1.9 tmt? -61.13 -51.6 68.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 5.76 110.787 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.46 -36.26 83.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 6.51 111.536 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.86 -48.72 80.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.681 0.277 . . . . 5.44 111.28 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.458 ' HE1' HD11 ' A' ' 226' ' ' ILE . 60.4 m-85 -64.3 -35.91 82.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.571 -0.286 . . . . 5.03 110.728 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 82.5 m-20 -60.22 -50.4 73.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.91 -0.404 . . . . 6.3 109.91 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -56.8 -47.54 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.473 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -62.99 -39.47 94.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.606 -0.27 . . . . 6.25 111.072 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 179' ' ' THR . 26.4 mmt -62.74 -41.75 99.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 7.03 110.54 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 84.8 mtt180 -67.29 -52.2 43.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 8.94 111.0 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 89.3 mt -60.38 -33.91 73.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.86 -0.609 . . . . 8.7 111.693 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.19 -21.46 45.31 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.334 -0.936 . . . . 8.11 112.284 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.03 27.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.983 -0.627 . . . . 8.49 111.981 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 210' ' ' GLN . 4.2 mp -97.93 -5.32 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 7.59 110.505 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -79.3 156.46 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 8.73 111.049 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.43 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -87.79 -14.9 38.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.255 0.55 . . . . 9.89 109.94 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -156.2 144.89 14.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 9.69 109.84 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.57 113.26 2.22 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.647 2.231 . . . . 10.74 111.835 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.46 -137.77 5.08 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.655 -0.783 . . . . 8.97 112.381 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -112.06 108.34 55.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.539 0.209 . . . . 7.58 110.665 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.594 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 45.1 Cg_endo -68.69 -34.63 18.5 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.749 2.299 . . . . 6.4 111.85 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.76 128.7 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 5.47 109.514 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 284' ' ' PRO . 26.6 tp -105.25 -33.24 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.978 0.418 . . . . 0.0 110.361 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -152.32 155.01 36.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.321 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 200' ' ' LEU . 7.2 p -143.02 133.1 22.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.926 0.393 . . . . 4.68 110.604 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.33 106.73 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 6.34 110.047 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.35 130.56 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.05 -0.523 . . . . 5.85 111.428 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -121.59 96.8 5.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.837 -0.801 . . . . 7.34 108.837 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -83.48 -6.68 59.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.044 -0.525 . . . . 7.61 110.962 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -66.66 -51.91 50.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 9.12 110.619 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.522 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.4 mmtm -102.89 -0.24 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.22 -0.445 . . . . 9.1 110.406 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 66.76 61.52 0.53 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.345 -0.843 . . . . 6.6 111.924 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 48.6 p90 -149.43 163.52 37.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 6.67 109.506 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.61 153.27 40.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.943 0.402 . . . . 4.58 111.095 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.05 122.65 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.852 -0.613 . . . . 6.22 110.161 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 75.2 mt -100.69 116.0 31.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 4.77 110.279 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 5.2 tt0 -101.34 113.75 27.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.682 -0.488 . . . . 6.55 109.682 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.404 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 69.9 m-85 -90.59 160.11 16.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.077 -0.51 . . . . 6.51 110.825 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.74 -25.08 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 8.27 110.877 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 93.2 p -132.16 -178.29 4.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.171 -0.468 . . . . 7.96 110.053 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.89 -16.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.707 0.765 . . . . 8.73 109.032 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.54 -54.65 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.998 -1.001 . . . . 8.5 111.078 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.43 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 36.2 mt-10 -66.45 -30.32 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 7.4 110.897 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -50.71 -45.31 58.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 6.13 112.02 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 m -56.37 -43.46 79.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.688 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.759 ' HB3' HD23 ' A' ' 178' ' ' LEU . 2.2 mp0 -73.64 -28.06 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.51 -0.313 . . . . 7.75 110.853 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.402 ' HA ' ' HE3' ' A' ' 173' ' ' MET . . . -63.27 -21.5 66.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 5.43 110.617 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.58 -14.83 62.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 6.29 111.22 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.01 -13.56 62.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 6.14 110.879 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.716 ' HD2' HD12 ' A' ' 217' ' ' ILE . 68.7 m-85 -100.02 17.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 5.57 110.753 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.59 107.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 5.92 110.392 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.74 14.23 23.8 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.955 -0.64 . . . . 5.74 112.194 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.716 HD12 ' HD2' ' A' ' 214' ' ' PHE . 16.1 tt -68.01 135.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.045 0.45 . . . . 5.3 110.689 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.79 114.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.386 0.612 . . . . 6.8 111.045 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -134.58 118.65 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.639 -0.709 . . . . 5.79 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 59.63 26.72 15.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.025 -0.534 . . . . 7.32 111.516 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 91.87 -5.48 79.26 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.682 -0.77 . . . . 7.28 112.881 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.564 0.221 . . . . 7.21 110.691 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.1 t -101.0 95.1 6.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.428 -0.582 . . . . 6.14 109.428 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.45 106.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 4.9 111.459 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 88.4 tttt -82.22 113.92 20.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.709 -0.678 . . . . 7.3 109.715 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.458 HD11 ' HE1' ' A' ' 169' ' ' PHE . 67.3 mt -109.1 107.22 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.053 0.454 . . . . 5.37 110.625 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -124.9 170.38 11.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.764 -0.653 . . . . 6.97 109.74 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -87.73 154.58 53.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 121.043 -0.263 . . . . 7.37 110.71 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 55.8 Cg_endo -69.76 173.42 11.0 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.744 2.296 . . . . 7.98 111.809 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 35.1 m-70 . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.588 ' HB3' HG21 ' A' ' 313' ' ' THR . 47.2 m80 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.077 -0.712 . . . . 8.75 109.077 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.479 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.7 ttmt -59.22 125.12 22.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.096 -0.957 . . . . 6.04 111.809 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.3 mt -100.29 135.58 41.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.326 -0.852 . . . . 5.29 110.001 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.425 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 93.6 t80 -93.09 111.13 22.66 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.145 -0.687 . . . . 4.77 109.145 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.749 HG23 HD11 ' A' ' 330' ' ' LEU . 2.3 mp -91.45 109.09 20.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.838 -0.619 . . . . 3.94 109.637 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.86 112.16 2.17 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.623 -0.798 . . . . 4.58 112.298 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 137.06 45.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.828 -0.701 . . . . 5.58 112.21 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.9 mt -110.51 144.58 30.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 5.92 110.998 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.4 158.28 22.61 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.158 2.572 . . . . 6.94 111.694 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -83.95 -13.08 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.572 0.225 . . . . 8.81 111.305 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -81.67 -6.78 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 8.73 110.21 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 275' ' ' VAL . 13.8 tp -87.8 120.66 29.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 7.52 109.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 275' ' ' VAL . 33.4 p30 -91.0 174.21 7.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 8.79 111.284 -176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.58 -32.1 72.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.691 -0.686 . . . . 7.62 111.417 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.18 -54.62 38.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.683 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.75 -34.95 77.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.672 -0.694 . . . . 8.69 111.742 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 271' ' ' ASN . 62.9 t -63.0 -48.84 86.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.778 0.323 . . . . 6.64 110.465 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.04 -42.7 94.07 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.558 -0.292 . . . . 7.74 110.616 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.0 -46.85 84.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.02 -0.536 . . . . 9.38 111.249 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -46.94 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 7.06 110.116 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.3 mt -69.8 -36.05 75.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.175 -0.466 . . . . 6.89 111.236 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.1 m -68.31 -19.71 64.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.03 0.443 . . . . 8.85 110.995 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.472 ' HA ' ' CE ' ' A' ' 166' ' ' MET . 38.3 m -68.39 -12.28 60.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.92 11.58 8.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.404 . . . . 9.18 111.307 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 145.93 163.95 10.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.442 -0.885 . . . . 9.06 113.115 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HB3' HD11 ' A' ' 187' ' ' LEU . 86.3 Cg_endo -83.52 134.88 6.76 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.94 2.427 . . . . 10.14 112.642 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.2 mt -90.8 142.14 28.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.381 -0.372 . . . . 8.3 110.568 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.466 ' HB3' HG22 ' A' ' 308' ' ' VAL . 7.8 ptpp? -103.18 -22.86 13.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.385 -0.598 . . . . 8.65 109.385 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.1 132.49 23.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -145.77 123.52 11.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.224 -0.444 . . . . 6.27 110.586 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.91 118.49 12.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.388 0.614 . . . . 5.79 109.955 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.745 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.5 tp -91.83 125.43 36.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.658 -0.701 . . . . 6.35 109.172 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 303' ' ' ALA . 46.4 t -76.75 112.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.356 -0.538 . . . . 6.61 110.137 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.58 153.17 19.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.475 -0.784 . . . . 8.17 109.985 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.668 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 21.2 t70 -64.68 145.53 56.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.349 -0.387 . . . . 10.33 110.237 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.1 m -63.64 -28.33 69.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.033 -0.53 . . . . 10.8 111.738 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -116.62 -40.99 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.99 0.367 . . . . 12.13 111.99 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 30.0 m -69.1 -46.91 66.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.719 0.295 . . . . 11.16 111.362 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.63 70.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 10.11 112.962 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.51 170.36 9.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.008 -0.367 . . . . 10.12 110.008 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.7 t -58.08 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.12 0.485 . . . . 7.73 111.022 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.668 ' HD3' ' HA ' ' A' ' 293' ' ' ASP . 31.9 mmmt -85.81 -3.45 58.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 8.01 109.982 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 103.4 -3.84 47.22 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.805 -0.712 . . . . 6.09 112.245 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 18.4 p90 -141.62 157.12 45.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 6.54 111.436 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -156.91 167.06 31.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.824 -0.626 . . . . 4.38 110.844 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.479 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.6 m-85 -116.27 125.61 52.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.205 -0.665 . . . . 4.93 109.205 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 28.9 m -144.32 136.65 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.646 0.26 . . . . 5.09 111.009 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.68 132.29 49.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.758 0.313 . . . . 7.03 110.253 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 42.3 m-85 -79.11 166.61 22.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.057 -0.52 . . . . 7.81 110.78 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 286' ' ' LYS . 56.9 t -76.32 -51.65 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.197 -0.456 . . . . 10.03 110.23 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.546 ' HB3' HG22 ' A' ' 312' ' ' VAL . 16.5 t70 -92.47 156.11 17.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.755 -0.657 . . . . 10.81 110.262 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.766 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -78.86 -30.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.52 -0.309 . . . . 9.77 111.462 -176.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -67.4 -49.34 64.22 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 110.211 -0.292 . . . . 10.89 110.211 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.618 HG21 ' HD2' ' A' ' 284' ' ' PRO . 19.8 m -65.56 -26.06 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 9.5 111.542 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.588 HG21 ' HB3' ' A' ' 259' ' ' HIS . 86.1 m -64.47 -49.81 69.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.324 0.583 . . . . 7.83 110.11 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.1 -24.46 58.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 8.79 110.991 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . 0.47 ' HB2' ' HA ' ' A' ' 312' ' ' VAL . 45.4 mt-30 -63.42 -40.25 96.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 10.51 110.17 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 320' ' ' LEU . . . -62.22 -44.91 95.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 7.31 110.516 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.36 -36.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 6.44 111.297 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -83.82 -52.39 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.778 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.55 -37.19 24.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.035 -0.602 . . . . 7.46 113.956 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' A' ' 330' ' ' LEU . 80.3 mt -83.92 -36.91 22.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.257 0.528 . . . . 6.42 111.993 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 6.4 t30 -61.97 119.94 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.732 0.301 . . . . 6.53 110.529 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.03 -22.47 20.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.926 -0.654 . . . . 6.77 112.297 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 23.9 ttt -71.31 123.26 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.298 -0.26 . . . . 7.29 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.474 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 51.4 mt-30 -82.98 117.5 22.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 7.83 111.466 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -91.03 94.86 9.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.559 -0.904 . . . . 7.01 108.559 171.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.23 -87.36 1.29 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.547 -0.835 . . . . 8.18 111.181 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -126.51 -25.1 3.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.764 0.316 . . . . 8.94 110.865 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 324' ' ' GLN . 94.7 mttt -85.79 134.98 33.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 7.29 110.92 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 92.8 mttt -77.47 126.29 30.68 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.454 -0.573 . . . . 7.13 109.454 172.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 263' ' ' ILE . 30.8 tp -67.77 102.56 1.24 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.954 0.407 . . . . 5.63 110.258 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 53.4 tp -93.57 111.82 23.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.888 -0.596 . . . . 5.53 109.674 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.07 108.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 5.21 109.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 17.6 pt20 -124.04 124.32 42.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.104 -0.498 . . . . 6.05 110.216 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -72.16 123.03 22.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.966 -0.383 . . . . 7.58 109.966 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -111.32 95.48 5.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.532 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 7.57 110.358 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.6 -3.36 16.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.215 0.531 . . . . 0.0 109.638 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 98.7 mtt180 -101.66 146.64 27.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.507 -0.769 . . . . 6.52 110.655 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.9 mt -110.14 147.08 34.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.241 -0.436 . . . . 5.24 110.05 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 85.1 t80 -102.62 103.55 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 6.15 110.062 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 198' ' ' ALA . 7.6 p -105.33 133.72 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.236 0.541 . . . . 4.24 110.691 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -131.77 -179.66 16.37 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 4.95 111.984 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.09 29.77 14.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.367 0.603 . . . . 0.0 109.999 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.1 pt -74.77 151.52 86.78 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 5.61 111.02 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.38 137.18 63.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.8 2.333 . . . . 5.97 111.899 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -81.62 114.32 20.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.934 0.397 . . . . 8.47 110.043 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.02 21.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 6.96 112.153 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.3 tp -76.48 140.87 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.967 -0.383 . . . . 6.1 109.967 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -88.56 154.62 20.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.783 0.325 . . . . 6.62 110.608 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.902 ' HA ' HD12 ' A' ' 191' ' ' ILE . 39.8 mt-10 -60.44 -38.49 84.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 5.69 110.071 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.1 -55.63 30.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.257 -0.883 . . . . 7.29 111.295 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.38 93.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 169' ' ' PHE . 46.5 ttm -67.95 -42.22 81.3 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.998 -0.281 . . . . 4.49 110.476 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 281' ' ' SER . 26.8 ttt -62.95 -45.82 90.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 5.76 110.422 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.16 -41.4 75.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.559 . . . . 6.51 110.985 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.455 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 78.0 t80 -57.83 -51.9 67.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 5.44 110.95 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.408 ' HD2' ' O ' ' A' ' 165' ' ' MET . 68.1 m-85 -66.38 -39.87 89.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 5.03 111.226 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.2 m-20 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 6.3 110.384 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.91 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 15.8 mm100 -61.85 -42.19 98.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.558 -0.292 . . . . 6.25 110.969 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.521 ' HB3' HG23 ' A' ' 179' ' ' THR . 86.2 mmm -66.04 -36.65 83.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.292 -0.413 . . . . 7.03 110.968 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 66.9 mtt180 -72.47 -52.3 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.524 -0.307 . . . . 8.94 110.961 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.06 -36.01 77.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 8.7 111.51 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.08 -21.01 80.15 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.87 -0.681 . . . . 8.11 112.532 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.88 39.33 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 8.49 112.5 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.24 9.33 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 7.59 110.192 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.6 p -114.62 105.19 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 8.73 111.504 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.74 -22.96 39.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 9.89 109.972 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -112.65 137.81 21.84 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.956 -0.566 . . . . 9.69 110.238 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 161.1 37.73 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.798 2.332 . . . . 10.74 112.108 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.09 -152.78 18.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.824 -0.703 . . . . 8.97 112.099 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 94.6 m-20 -109.22 122.72 38.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.786 -0.244 . . . . 7.58 111.094 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HG3' ' CB ' ' A' ' 173' ' ' MET . 19.7 Cg_endo -60.75 -36.68 83.41 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.946 2.431 . . . . 6.4 111.374 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.9 t -81.33 127.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.827 -0.805 . . . . 5.47 108.827 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 20.5 tp -90.92 -39.19 12.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.06 153.66 33.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.606 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.448 HG23 HD23 ' A' ' 200' ' ' LEU . 7.4 p -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.27 -0.423 . . . . 4.68 110.804 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -130.65 106.87 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 6.34 109.699 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 162' ' ' GLU . 51.5 mt -110.95 126.92 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.162 0.506 . . . . 5.85 111.578 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -101.91 101.31 11.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 7.34 108.388 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.19 -27.83 53.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 7.61 110.648 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.92 -49.03 72.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 9.12 111.281 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.17 -6.89 54.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 9.1 111.068 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 64.51 56.36 1.24 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.833 -0.621 . . . . 6.6 111.321 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 40.3 p90 -149.04 149.12 30.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.047 -0.524 . . . . 6.67 109.879 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -134.19 140.19 46.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.775 0.321 . . . . 4.58 111.087 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 42.5 m-85 -108.32 109.02 20.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.868 -0.606 . . . . 6.22 110.139 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.7 mt -93.27 114.01 26.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 4.77 109.32 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.69 114.64 26.3 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.136 -0.32 . . . . 6.55 110.136 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -89.7 155.96 18.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.257 -0.428 . . . . 6.51 110.892 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.7 -22.6 60.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.734 -0.666 . . . . 8.27 110.972 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 94.6 p -148.18 142.85 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.964 -0.384 . . . . 7.96 109.964 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.415 ' HA ' ' OG1' ' A' ' 208' ' ' THR . 94.6 t -63.94 -28.62 45.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.021 0.439 . . . . 8.73 110.373 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.68 -40.94 69.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 8.5 110.581 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.3 -29.62 26.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 7.4 110.965 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 205' ' ' VAL . 32.2 m -54.06 -51.52 63.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.923 0.392 . . . . 6.13 110.803 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.72 -24.9 67.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.707 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -68.09 -35.55 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.958 0.408 . . . . 7.75 110.196 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -74.78 -14.28 60.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 5.43 110.91 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.2 mtp -69.43 -20.54 63.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 6.29 110.289 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.37 -15.21 61.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.92 -0.582 . . . . 6.14 110.801 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.659 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 90.7 m-85 -92.86 6.5 47.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 5.57 110.945 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.48 124.23 20.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.699 0.285 . . . . 5.92 110.244 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.68 35.2 11.93 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.686 -0.768 . . . . 5.74 111.56 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.87 137.89 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.941 -0.392 . . . . 5.3 109.941 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.04 119.15 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.301 0.572 . . . . 6.8 110.756 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -133.01 112.28 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.085 -0.507 . . . . 5.79 110.985 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 56.66 35.02 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.769 -0.651 . . . . 7.32 111.94 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.86 78.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 7.28 113.045 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -118.04 124.1 47.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.334 . . . . 7.21 110.64 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.6 t -77.3 115.89 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.158 -0.682 . . . . 6.14 109.158 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.5 118.69 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 4.9 110.98 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.0 tttt -88.36 114.15 24.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 7.3 109.642 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.0 mt -109.52 106.56 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.078 0.466 . . . . 5.37 110.428 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 4.5 mmp_? -114.92 170.09 8.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.892 -0.594 . . . . 6.97 110.508 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -83.94 125.13 73.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.268 -0.641 . . . . 7.37 109.268 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.561 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 18.1 Cg_endo -58.55 129.63 33.42 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.607 2.205 . . . . 7.98 111.379 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.88 0.372 . . . . 0.0 110.595 -177.07 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 43.0 m80 . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.771 -0.825 . . . . 8.75 108.771 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 304' ' ' PHE . 35.2 ttmt -59.1 119.49 7.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.104 -1.407 . . . . 6.04 110.113 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.0 141.63 29.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.863 -0.608 . . . . 5.29 110.792 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.72 110.0 21.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.489 -0.778 . . . . 4.77 109.317 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.776 HG23 HD11 ' A' ' 330' ' ' LEU . 3.9 mp -101.77 103.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.321 -0.622 . . . . 3.94 109.321 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.91 164.13 21.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 4.58 112.605 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 102.09 15.71 25.29 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.782 -0.723 . . . . 5.58 111.895 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 270' ' ' LEU . 83.4 mt -92.57 148.74 36.83 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.655 0.264 . . . . 5.92 110.545 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 270' ' ' LEU . 46.0 Cg_endo -69.23 153.74 70.89 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.687 2.258 . . . . 6.94 112.276 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.7 -22.6 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 8.81 111.368 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -83.64 1.04 44.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.948 0.404 . . . . 8.73 111.187 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 267' ' ' PRO . 11.6 tp -87.11 99.37 11.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.859 -0.793 . . . . 7.52 108.859 176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 34.2 p-10 -89.68 -179.0 5.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 8.79 111.686 -172.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.485 ' CG ' ' HZ1' ' A' ' 292' ' ' LYS . 2.7 m-20 -52.31 -41.02 62.59 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.595 -0.729 . . . . 7.62 112.158 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.89 -47.75 81.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.19 -42.92 71.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 8.69 111.431 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 82.1 t -64.62 -49.38 80.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.555 -0.293 . . . . 6.64 111.7 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -65.21 -43.36 91.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.841 -0.344 . . . . 7.74 111.228 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.49 -46.97 83.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 9.38 110.638 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.66 -52.82 62.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 7.06 110.501 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.65 -38.62 80.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.043 0.386 . . . . 6.89 112.043 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.4 m -61.58 -34.77 76.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.3 . . . . 8.85 111.106 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.432 ' HB3' ' SD ' ' A' ' 166' ' ' MET . 49.0 m -62.74 -23.2 67.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.864 -178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -106.38 12.55 29.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.073 0.397 . . . . 9.18 112.073 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 154.58 155.41 7.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.762 -1.209 . . . . 9.06 113.462 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.734 ' HD2' HG21 ' A' ' 312' ' ' VAL . 6.9 Cg_exo -72.78 120.69 6.82 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.243 2.629 . . . . 10.14 112.064 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 305' ' ' CYS . 96.1 mt -94.4 141.29 28.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.099 -0.501 . . . . 8.3 110.698 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.7 ptpt -110.94 -32.73 6.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.019 0.438 . . . . 8.65 110.155 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -132.4 111.5 11.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.536 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.3 124.09 41.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 6.27 110.183 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -140.34 114.87 9.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.308 0.575 . . . . 5.79 110.351 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.5 tp -90.34 125.49 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 6.35 110.247 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.1 116.51 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.127 0.489 . . . . 6.61 110.116 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.485 ' HZ1' ' CG ' ' A' ' 272' ' ' ASP . 61.4 mttm -110.73 154.31 24.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.74 -0.664 . . . . 8.17 110.86 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 13.5 t70 -83.29 129.71 35.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.984 -0.747 . . . . 10.33 108.984 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.4 m -85.19 -13.27 50.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.426 -0.352 . . . . 10.8 111.887 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.11 -56.43 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.987 0.422 . . . . 12.13 111.095 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.467 HG22 ' HG ' ' A' ' 298' ' ' LEU . 48.1 m -83.27 -30.42 27.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 11.16 110.627 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.02 22.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.585 -0.817 . . . . 10.11 112.59 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' A' ' 296' ' ' THR . 84.3 mt -110.11 161.54 15.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.73 0.3 . . . . 10.12 110.418 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.9 t -69.52 133.75 48.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.28 -0.637 . . . . 7.73 109.28 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.467 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.2 mmmp? -74.82 -15.88 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 8.01 110.858 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 97.76 14.78 39.11 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.612 -0.804 . . . . 6.09 113.049 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 11.0 p90 -154.89 146.62 23.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 6.54 110.779 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.3 168.02 21.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.882 -0.599 . . . . 4.38 110.718 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.475 ' HB3' ' HG2' ' A' ' 260' ' ' LYS . 91.8 m-85 -114.54 130.21 56.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 4.93 109.557 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 35.5 m -141.98 116.57 9.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 5.09 111.608 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.479 ' OE1' ' HD2' ' A' ' 286' ' ' LYS . 39.9 tt0 -100.24 130.62 46.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.821 -0.437 . . . . 7.03 109.821 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' ' OG1' ' A' ' 313' ' ' THR . 47.5 m-85 -88.67 158.51 18.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 7.81 111.07 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 286' ' ' LYS . 58.6 t -79.1 -46.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 10.03 111.118 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.561 ' HB3' HG22 ' A' ' 312' ' ' VAL . 12.6 t70 -93.91 132.55 38.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 10.81 110.446 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -64.79 -28.49 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 112.263 0.468 . . . . 9.77 112.263 -176.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -71.79 -50.05 33.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.891 -0.411 . . . . 10.89 109.891 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.734 HG21 ' HD2' ' A' ' 284' ' ' PRO . 20.8 m -66.27 -24.68 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 9.5 110.856 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 317' ' ' ILE . 47.3 m -61.85 -48.16 81.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.13 0.49 . . . . 7.83 110.132 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.81 -35.13 64.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.007 -0.542 . . . . 8.79 110.516 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -63.53 -40.22 96.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 10.51 110.773 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.12 97.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 7.31 110.47 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 313' ' ' THR . 71.7 mt -59.08 -45.38 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 6.44 110.674 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.51 78.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.749 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.31 -49.36 6.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 7.46 113.51 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.509 ' HB3' HD23 ' A' ' 330' ' ' LEU . 98.6 mt -73.57 -49.07 28.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.302 . . . . 6.42 111.814 -173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 7.3 t30 -63.05 115.22 4.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 6.53 110.44 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.92 -20.55 14.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.853 -0.689 . . . . 6.77 112.389 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 20.9 ttt -75.22 141.41 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.146 -0.316 . . . . 7.29 110.146 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -88.66 118.87 28.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.785 0.326 . . . . 7.83 110.525 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.6 mm? -101.79 96.52 7.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.124 -0.489 . . . . 7.01 109.852 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.2 -85.57 0.81 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.901 -0.666 . . . . 8.18 112.058 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.63 -41.06 2.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.737 0.303 . . . . 8.94 111.281 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -91.29 165.64 13.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 7.29 110.807 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.66 136.1 37.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 7.13 109.536 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.856 ' HB2' HD23 ' A' ' 325' ' ' LEU . 33.0 tp -73.83 125.45 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.173 0.511 . . . . 5.63 111.316 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.67 118.63 37.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 5.53 109.614 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 91.1 t -127.32 113.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.185 -0.461 . . . . 5.21 109.779 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -138.04 171.87 13.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.122 -0.49 . . . . 6.05 110.01 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 334' ' ' ARG . 47.7 mtm180 -86.59 136.83 32.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.402 -0.222 . . . . 7.58 110.402 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -62.91 -44.55 95.77 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.115 0.483 . . . . 6.04 110.092 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 7.57 109.406 172.177 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.889 ' HB2' HG22 ' A' ' 205' ' ' VAL . 56.1 ttp85 75.99 -24.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.773 0.67 . . . . 0.0 111.991 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -97.53 150.91 20.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 6.52 111.392 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 208' ' ' THR . 23.7 mt -113.19 149.43 33.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.861 -0.609 . . . . 5.24 111.186 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -107.98 102.9 12.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.125 -0.943 . . . . 6.15 108.702 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 169' ' ' PHE . 7.4 p -104.11 127.44 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.488 . . . . 4.24 110.301 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.37 -178.75 15.44 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.803 -0.635 . . . . 4.95 111.777 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 10.2 m120 62.01 28.85 17.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.085 0.469 . . . . 0.0 110.899 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.528 HG22 HD22 ' A' ' 224' ' ' LEU . 31.8 pt -78.52 153.61 78.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.466 -0.788 . . . . 5.61 110.728 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.498 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 32.7 Cg_endo -64.35 136.71 52.37 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.556 2.171 . . . . 5.97 112.056 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.19 123.34 20.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 8.47 109.913 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.29 4.43 53.35 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.576 -0.821 . . . . 6.96 112.421 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.3 tp -66.07 130.85 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 6.1 110.147 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.8 p -92.24 155.21 18.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.765 0.317 . . . . 6.62 110.751 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 162' ' ' GLU . 25.6 mp0 -53.69 -46.47 70.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 5.69 110.186 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.96 -55.81 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.325 -0.852 . . . . 7.29 111.153 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.94 93.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.288 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 0.7 OUTLIER -64.94 -47.67 76.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 4.49 110.598 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.2 ttt -60.92 -48.83 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 5.76 110.769 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.46 -38.78 88.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 6.51 111.524 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.49 -49.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.614 -0.267 . . . . 5.44 111.068 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 153' ' ' VAL . 50.4 m-85 -65.1 -44.22 89.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.593 -0.276 . . . . 5.03 111.093 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.03 -33.45 75.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.557 -0.292 . . . . 6.3 110.985 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.74 -49.93 68.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.227 175.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.09 -35.36 75.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 6.25 111.113 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.703 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 6.0 mmt -60.88 -50.16 74.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 7.03 110.529 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -71.06 -44.29 66.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 8.94 111.269 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 78.1 mt -65.13 -35.18 80.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.383 . . . . 8.7 110.985 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.95 -34.38 38.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.627 -0.796 . . . . 8.11 112.104 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.37 47.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.624 . . . . 8.49 111.926 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 6.0 mp -96.19 82.83 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 7.59 109.672 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 185' ' ' PRO . 14.2 m -154.93 143.13 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.908 -0.587 . . . . 8.73 109.425 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.537 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -93.24 -22.1 19.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.734 -0.387 . . . . 9.89 111.442 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.3 145.91 19.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.592 -0.277 . . . . 9.69 110.599 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.91 114.17 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.734 2.29 . . . . 10.74 112.003 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.6 -152.57 24.6 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.825 -0.702 . . . . 8.97 111.942 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -114.54 117.73 42.32 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.548 0.213 . . . . 7.58 110.865 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HG3' HG23 ' A' ' 179' ' ' THR . 28.0 Cg_exo -63.09 -37.83 49.75 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.66 2.24 . . . . 6.4 111.53 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 52.8 t -89.72 112.55 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.836 -0.62 . . . . 5.47 109.824 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 280' ' ' THR . 86.4 mt -89.96 -39.28 13.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.729 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.1 168.94 19.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.46 116.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 4.68 110.753 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -98.15 106.96 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 6.34 109.614 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.0 mt -91.66 136.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.232 0.539 . . . . 5.85 110.958 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -119.55 96.77 5.34 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -70.5 -23.97 62.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.569 -0.741 . . . . 7.61 111.697 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.76 -49.92 75.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 9.12 111.498 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 35.2 mmtm -106.19 7.09 31.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 9.1 111.028 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.04 61.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.795 . . . . 6.6 111.5 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 52.3 p90 -148.99 171.31 16.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.092 -0.504 . . . . 6.67 109.676 173.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.94 142.46 28.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.357 . . . . 4.58 111.158 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 70.2 m-85 -92.8 113.44 25.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 6.22 109.869 175.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 151' ' ' LEU . 97.0 mt -83.35 115.76 22.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.211 -0.449 . . . . 4.77 110.253 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.84 108.45 19.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 6.55 109.695 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 37.1 m-85 -99.02 157.33 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 6.51 111.287 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -82.94 -24.32 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.387 -0.824 . . . . 8.27 110.765 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 98.5 p -134.06 163.0 30.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 7.96 109.991 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 149' ' ' ARG . 15.7 t -92.1 -15.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.875 0.845 . . . . 8.73 108.841 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.99 -56.14 6.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.773 -1.103 . . . . 8.5 111.183 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.537 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.5 mt-10 -65.79 -24.28 66.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 7.4 111.704 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 151' ' ' LEU . 13.3 m -48.97 -49.75 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.636 0.585 . . . . 6.13 111.508 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.8 m -61.46 -36.23 79.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.012 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.692 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 1.9 mp0 -70.11 -28.98 65.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.056 -0.258 . . . . 7.75 111.189 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.42 -23.52 62.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.313 0.578 . . . . 5.43 110.337 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 86.8 mtp -70.8 -14.77 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.704 -0.68 . . . . 6.29 110.794 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.89 2.54 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 6.14 111.254 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -113.02 19.69 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 5.57 110.436 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.83 117.63 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.927 -0.579 . . . . 5.92 111.039 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 97.93 16.62 32.69 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.827 -0.702 . . . . 5.74 112.498 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.89 135.61 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 110.036 -0.357 . . . . 5.3 110.036 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 tp -84.27 116.43 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 6.8 111.004 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -135.18 118.67 16.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.796 -0.638 . . . . 5.79 110.288 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 60.84 32.47 20.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 7.32 111.414 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.91 78.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.844 -0.693 . . . . 7.28 112.632 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 32.6 mm-40 -110.08 132.35 54.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.258 -0.275 . . . . 7.21 110.258 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.5 m -86.37 106.78 17.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.871 -0.418 . . . . 6.14 109.871 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 156' ' ' ILE . 75.9 mt -66.1 111.89 3.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 4.9 110.896 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 86.5 tttt -87.76 114.61 24.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.742 -0.663 . . . . 7.3 109.528 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.6 mt -110.92 105.64 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.937 0.399 . . . . 5.37 110.423 -173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 15.1 mmt85 -129.25 171.2 12.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.067 -0.515 . . . . 6.97 110.324 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 45.8 mtp180 -104.42 143.68 27.17 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.594 0.235 . . . . 7.37 111.109 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.09 160.98 14.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.462 2.108 . . . . 7.98 110.769 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.516 -175.101 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 108.87 -0.789 . . . . 8.75 108.87 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 35.3 ttmt -62.33 125.38 23.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.462 -1.245 . . . . 6.04 109.934 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 307' ' ' TYR . 69.6 mt -98.86 142.31 30.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.113 -0.494 . . . . 5.29 110.797 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.676 ' HB2' ' HA ' ' A' ' 335' ' ' ALA . 87.3 t80 -95.99 109.47 21.85 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.294 -0.866 . . . . 4.77 108.897 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.34 106.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.863 -0.421 . . . . 3.94 109.863 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.95 171.1 19.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.898 -0.668 . . . . 4.58 111.511 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.2 27.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.654 -0.784 . . . . 5.58 112.068 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.4 mt -101.42 143.86 27.42 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.259 -0.275 . . . . 5.92 110.259 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.689 ' HD2' HD22 ' A' ' 270' ' ' LEU . 30.5 Cg_exo -62.33 143.42 93.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.569 2.179 . . . . 6.94 111.98 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.66 -24.43 66.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.615 0.228 . . . . 8.81 111.615 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -85.02 -7.17 59.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.754 0.312 . . . . 8.73 110.836 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.689 HD22 ' HD2' ' A' ' 267' ' ' PRO . 12.1 tp -71.81 106.5 4.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.617 -0.512 . . . . 7.52 109.617 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.6 p-10 -85.9 172.18 10.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 8.79 111.012 -175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.07 -37.69 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 7.62 111.94 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.17 -54.39 44.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.758 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.62 -42.59 95.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 8.69 111.643 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 271' ' ' ASN . 38.9 t -61.49 -47.03 95.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.561 0.22 . . . . 6.64 110.728 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -58.56 -54.0 51.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.586 -0.279 . . . . 7.74 110.72 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.75 -51.02 70.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.073 -0.512 . . . . 9.38 111.591 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.0 -42.89 81.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 7.06 110.693 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 320' ' ' LEU . 62.1 mt -80.32 -29.05 38.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.484 -0.325 . . . . 6.89 111.26 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.4 m -71.54 -16.73 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 8.85 110.796 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 16.3 m -59.97 -15.03 18.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.917 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.85 9.29 11.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.614 0.245 . . . . 9.18 111.23 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.75 146.27 4.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.946 -0.645 . . . . 9.06 112.395 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HA ' HG23 ' A' ' 280' ' ' THR . 50.4 Cg_endo -69.78 141.75 46.0 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.682 2.254 . . . . 10.14 112.733 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 305' ' ' CYS . 86.6 mt -97.57 130.76 44.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 8.3 110.883 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.5 ptpt -93.5 -29.24 15.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.131 0.491 . . . . 8.65 110.028 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -136.42 115.07 11.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.541 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.576 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 76.8 t80 -125.82 122.21 35.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 6.27 110.759 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -140.87 111.6 6.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.51 0.671 . . . . 5.79 110.472 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 303' ' ' ALA . 57.0 tp -85.18 140.11 31.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.386 -0.825 . . . . 6.35 109.778 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.4 t -88.81 111.34 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.077 0.465 . . . . 6.61 110.123 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -102.35 155.24 18.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 8.17 111.099 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.76 135.42 34.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.66 -0.7 . . . . 10.33 109.907 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.6 m -74.45 -12.94 60.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 10.8 112.036 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.03 -68.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 12.13 111.324 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 17.4 m -77.9 -32.35 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 11.16 111.426 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.04 6.97 62.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.54 -0.838 . . . . 10.11 112.414 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.32 173.34 11.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.618 0.247 . . . . 10.12 110.339 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -79.38 144.7 33.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.408 -0.36 . . . . 7.73 110.1 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 300' ' ' LYS . 30.8 mmtp -79.15 0.34 28.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 8.01 110.436 175.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 97.71 17.13 31.62 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 6.09 113.069 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 291' ' ' VAL . 43.6 p90 -162.73 157.03 21.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.329 0.585 . . . . 6.54 111.261 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -147.46 160.17 42.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.314 -0.857 . . . . 4.38 110.24 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.473 ' HD2' ' HB1' ' A' ' 335' ' ' ALA . 81.8 m-85 -107.43 122.65 47.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.853 -0.795 . . . . 4.93 108.853 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.576 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.9 m -139.01 115.24 10.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 5.09 111.412 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 33.5 tt0 -98.25 135.43 39.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.916 -0.584 . . . . 7.03 110.155 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.414 ' CE1' HD12 ' A' ' 261' ' ' LEU . 26.1 m-85 -90.14 147.31 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.213 -0.448 . . . . 7.81 111.238 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.681 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 52.5 t -66.32 -53.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 10.03 110.578 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.466 ' HB3' HG22 ' A' ' 312' ' ' VAL . 27.0 t70 -88.64 137.16 32.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.997 -0.547 . . . . 10.81 110.374 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -79.2 -18.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.148 0.425 . . . . 9.77 112.148 -174.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.61 -40.22 23.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.761 0.315 . . . . 10.89 110.401 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.5 m -69.49 -22.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 9.5 111.439 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 317' ' ' ILE . 21.4 m -55.3 -50.6 69.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.68 0.276 . . . . 7.83 111.563 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.92 -32.82 72.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.014 0.435 . . . . 8.79 110.789 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -66.12 -41.39 90.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 10.51 110.443 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.34 94.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 7.31 110.734 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 313' ' ' THR . 64.4 mt -57.36 -41.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 6.44 110.495 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.54 -43.52 59.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.741 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -75.43 -47.54 12.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.018 -0.611 . . . . 7.46 113.469 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HB2' HG21 ' A' ' 332' ' ' VAL . 87.1 mt -70.56 -43.11 70.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.647 0.261 . . . . 6.42 111.61 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 8.9 t30 -66.43 115.44 6.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.75 0.31 . . . . 6.53 110.272 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.41 -21.55 14.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.925 -0.655 . . . . 6.77 111.514 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.5 ttt -73.85 141.86 46.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.039 -0.356 . . . . 7.29 110.039 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 26.1 tt0 -105.59 125.18 50.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.833 0.349 . . . . 7.83 110.599 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 267' ' ' PRO . 0.4 OUTLIER -117.14 113.4 22.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.94 -0.763 . . . . 7.01 108.94 177.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.86 -88.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.939 -0.648 . . . . 8.18 112.849 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.69 0.26 3.57 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.854 -0.203 . . . . 8.94 111.396 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -130.61 152.08 50.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.915 0.388 . . . . 7.29 111.147 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 91.3 mttt -103.83 129.7 51.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 7.13 109.647 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.72 122.77 18.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.037 0.446 . . . . 5.63 112.121 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.53 107.43 19.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.334 -0.987 . . . . 5.53 108.334 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 320' ' ' LEU . 59.4 t -110.81 121.87 64.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 5.21 111.643 -173.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 13.9 pt20 -139.69 -169.09 2.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 6.05 108.77 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -87.14 141.33 28.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.878 -0.416 . . . . 7.58 109.878 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 262' ' ' PHE . . . -70.51 -38.18 74.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 6.04 111.272 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 7.57 110.044 177.705 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.47 ' HB3' ' NH2' ' A' ' 228' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 205' ' ' VAL . 23.4 ptt85 -117.67 20.64 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.883 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.88 139.91 39.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.978 -0.555 . . . . 6.52 109.91 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.24 137.21 48.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.847 0.356 . . . . 5.24 110.293 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.633 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 74.7 t80 -94.94 104.66 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.847 -0.615 . . . . 6.15 109.46 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 5.8 p -107.32 125.08 63.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.315 0.578 . . . . 4.24 110.642 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.69 -178.86 15.48 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.516 -0.765 . . . . 4.95 111.632 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.1 t30 59.8 41.31 18.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.029 0.919 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.694 HG22 HD22 ' A' ' 224' ' ' LEU . 32.6 pt -90.42 156.95 45.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.949 . . . . 5.61 110.712 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.588 ' HG3' ' HB2' ' A' ' 220' ' ' GLN . 29.6 Cg_endo -63.84 142.32 81.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.669 2.246 . . . . 5.97 112.26 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -80.32 126.99 31.85 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.612 -0.514 . . . . 8.47 109.612 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.49 21.18 41.65 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.623 -0.798 . . . . 6.96 111.999 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.576 HD13 ' HG3' ' A' ' 220' ' ' GLN . 9.3 tp -78.97 139.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.868 0.366 . . . . 6.1 110.691 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 24.7 m -75.52 128.07 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 6.62 110.293 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.523 ' HA ' HD12 ' A' ' 191' ' ' ILE . 44.1 mt-10 -59.69 -47.9 83.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.506 -0.315 . . . . 5.69 110.765 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.96 -42.48 89.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.953 -0.567 . . . . 7.29 110.53 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -63.15 -44.17 96.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.2 ttm -64.94 -45.72 84.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.507 -0.315 . . . . 4.49 110.653 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.1 ttt -61.33 -50.95 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.153 -0.476 . . . . 5.76 111.004 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.02 -32.78 74.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 6.51 110.958 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.499 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 86.3 t80 -59.32 -52.58 65.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 5.44 110.579 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -63.67 -41.69 98.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 5.03 110.786 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.4 m-20 -55.77 -48.86 74.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 6.3 110.43 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.5 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.22 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 17.4 mm100 -64.25 -37.35 87.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.25 111.267 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 86.7 mtp -69.83 -34.87 74.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.998 -0.281 . . . . 7.03 110.583 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 98.6 mtt180 -64.7 -50.9 65.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.013 0.435 . . . . 8.94 110.196 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.27 -35.52 81.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 8.7 111.911 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.05 -21.37 59.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.603 -0.808 . . . . 8.11 112.59 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.91 40.94 7.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.592 -0.813 . . . . 8.49 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.66 3.31 34.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.087 0.47 . . . . 7.59 110.259 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 p -92.34 140.14 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 8.73 110.827 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.0 pt20 -95.02 -10.71 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.087 0.47 . . . . 9.89 110.287 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.11 158.71 33.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 9.69 110.227 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 154.06 62.59 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.559 2.172 . . . . 10.74 111.822 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.37 -145.77 16.1 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.669 -0.777 . . . . 8.97 112.599 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.58 122.5 37.2 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 120.462 0.172 . . . . 7.58 110.571 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.82 -38.61 47.39 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.737 2.291 . . . . 6.4 111.69 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.91 137.26 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.41 -0.589 . . . . 5.47 109.41 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 284' ' ' PRO . 50.9 tp -105.1 -41.63 5.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.644 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -142.56 134.25 26.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.76 117.37 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 4.68 110.159 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -124.58 105.81 9.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.823 -0.436 . . . . 6.34 109.823 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 162' ' ' GLU . 55.4 mt -107.23 134.16 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 5.85 111.453 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -109.91 113.85 26.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.542 . . . . 7.34 109.538 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -82.97 -10.91 58.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 7.61 110.81 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.91 -59.08 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.161 -0.472 . . . . 9.12 111.051 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.0 mmtm -91.16 -0.79 57.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.405 -0.361 . . . . 9.1 110.686 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 62.2 61.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 6.6 110.912 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 42.7 p90 -148.87 158.68 44.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 6.67 109.446 175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -139.57 147.63 41.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.942 0.401 . . . . 4.58 110.856 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.12 109.55 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.772 -0.649 . . . . 6.22 110.008 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.247 -0.649 . . . . 4.77 109.247 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 127.36 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.642 . . . . 6.55 109.268 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -99.03 162.85 12.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.977 0.417 . . . . 6.51 111.203 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -71.93 -25.78 62.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.405 -0.816 . . . . 8.27 110.329 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.1 p -124.56 -170.32 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.582 -0.736 . . . . 7.96 109.595 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 149' ' ' ARG . 39.2 t -113.78 -28.78 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.644 0.735 . . . . 8.73 109.281 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.15 -51.04 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.896 . . . . 8.5 111.34 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 50.4 mt-10 -65.24 -35.12 80.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.076 -0.511 . . . . 7.4 110.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -55.12 -50.14 70.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.316 0.579 . . . . 6.13 110.351 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 24.1 m -60.06 -34.13 73.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.698 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -31.59 64.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 7.75 110.277 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -76.03 -7.43 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.023 -0.535 . . . . 5.43 111.206 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 85.8 mtp -69.85 -16.65 63.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.411 . . . . 6.29 110.021 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.59 50.38 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.674 -0.694 . . . . 6.14 111.049 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.493 ' HD1' HD12 ' A' ' 217' ' ' ILE . 93.3 m-85 -93.75 7.14 45.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 5.57 110.812 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.28 114.29 3.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.98 -0.378 . . . . 5.92 109.98 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.36 12.51 44.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.859 -0.686 . . . . 5.74 112.11 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.493 HD12 ' HD1' ' A' ' 214' ' ' PHE . 16.6 tt -71.53 137.19 24.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 5.3 110.044 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -85.55 112.03 21.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.459 0.647 . . . . 6.8 110.056 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -133.09 119.4 19.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 5.79 110.579 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.588 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 80.9 mm-40 60.82 29.54 19.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.522 -0.763 . . . . 7.32 111.273 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.78 7.97 83.36 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.857 -0.687 . . . . 7.28 112.857 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -124.76 132.74 53.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.568 -0.372 . . . . 7.21 110.824 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 t -78.86 112.33 15.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.147 -0.686 . . . . 6.14 109.147 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.694 HD22 HG22 ' A' ' 156' ' ' ILE . 46.4 mt -81.9 120.71 25.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.885 0.374 . . . . 4.9 111.352 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.5 tttt -84.78 115.97 23.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 7.3 109.543 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.9 mt -121.98 105.89 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.415 . . . . 5.37 110.886 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.7 mmt180 -132.68 167.5 19.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.045 -0.525 . . . . 6.97 110.412 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 15.7 mtp180 -79.34 128.17 76.38 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.738 -0.467 . . . . 7.37 109.738 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.633 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 3.6 Cg_exo -73.07 153.81 52.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.797 2.331 . . . . 7.98 112.241 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.015 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.879 ' HB3' HG21 ' A' ' 313' ' ' THR . 52.6 m80 . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 111.792 0.293 . . . . 8.75 111.792 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 305' ' ' CYS . 40.3 ttmt -66.44 121.49 15.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.681 -0.488 . . . . 6.04 109.681 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.43 142.09 31.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.313 0.577 . . . . 5.29 111.476 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.97 107.19 19.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.781 -1.099 . . . . 4.77 108.684 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 3.6 mp -100.3 104.58 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.954 -0.566 . . . . 3.94 109.529 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -118.84 120.5 4.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.589 -0.815 . . . . 4.58 112.691 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 139.2 9.71 0.9 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.096 -0.573 . . . . 5.58 112.296 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.4 144.76 74.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.481 0.182 . . . . 5.92 110.65 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD2' HD22 ' A' ' 270' ' ' LEU . 41.2 Cg_exo -57.63 135.88 72.21 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.77 2.314 . . . . 6.94 112.292 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 9.1 p30 -62.39 -23.55 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.918 -0.583 . . . . 8.81 111.137 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -100.59 12.58 37.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.551 . . . . 8.73 111.34 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.444 HD22 ' HD2' ' A' ' 267' ' ' PRO . 26.8 tp -89.32 125.2 35.02 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.779 -0.452 . . . . 7.52 109.779 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.8 p-10 -85.09 157.01 20.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 8.79 111.186 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 2.8 m-20 -52.5 -36.16 54.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.663 -0.699 . . . . 7.62 112.055 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.25 -53.06 58.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.431 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -72.62 -40.09 66.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 8.69 111.081 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.9 t -56.83 -47.81 82.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.428 -0.351 . . . . 6.64 110.716 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.4 mtmm -59.96 -47.53 85.44 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.477 -0.328 . . . . 7.74 110.815 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -49.74 76.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.106 -0.237 . . . . 9.38 110.965 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.23 -47.16 78.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 7.06 110.763 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.568 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -77.13 -31.5 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.396 -0.365 . . . . 6.89 111.563 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.6 m -69.97 -27.97 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 8.85 111.017 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 41.9 m -72.41 4.5 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.542 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -132.53 9.81 4.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.364 -0.38 . . . . 9.18 110.779 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.439 ' HA3' ' HE2' ' A' ' 307' ' ' TYR . . . 160.56 146.32 4.57 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.183 -1.008 . . . . 9.06 113.286 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 1.01 ' HB3' HD21 ' A' ' 187' ' ' LEU . 53.4 Cg_endo -71.04 119.82 6.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.249 2.633 . . . . 10.14 112.534 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.855 HD22 ' HB3' ' A' ' 305' ' ' CYS . 56.0 mt -100.4 103.23 14.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.199 -0.455 . . . . 8.3 110.486 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 308' ' ' VAL . 53.9 pttt -82.29 -20.7 36.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 8.65 110.072 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -138.99 130.2 26.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.411 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 75.6 t80 -145.21 128.83 17.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.667 0.27 . . . . 6.27 110.638 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -140.6 114.19 8.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.357 0.598 . . . . 5.79 110.983 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 62.4 tp -90.68 131.67 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.458 -0.792 . . . . 6.35 109.188 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.45 121.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.916 0.389 . . . . 6.61 110.798 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.77 157.95 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.004 -0.544 . . . . 8.17 110.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.404 ' HB2' ' CD ' ' A' ' 300' ' ' LYS . 14.5 t70 -91.05 121.64 33.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.216 -0.661 . . . . 10.33 109.216 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 47.2 m -71.61 -29.6 64.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.452 0.538 . . . . 10.8 112.452 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.59 -44.72 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.808 -0.357 . . . . 12.13 110.932 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 10.4 m -73.98 -44.73 53.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.144 -0.48 . . . . 11.16 111.306 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 90.59 26.32 23.16 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 10.11 111.889 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 92.3 mt -135.19 168.46 19.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.804 -0.443 . . . . 10.12 109.804 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 42.6 t -70.42 145.92 50.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 7.73 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.404 ' CD ' ' HB2' ' A' ' 293' ' ' ASP . 31.5 mmmt -76.32 -20.47 57.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 8.01 110.17 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 107.35 -7.84 37.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.621 -0.799 . . . . 6.09 112.897 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 52.7 p90 -128.4 147.2 50.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.191 0.52 . . . . 6.54 111.534 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -142.3 158.67 43.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 4.38 110.435 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.409 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 93.0 m-85 -111.59 132.38 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.238 -0.437 . . . . 4.93 110.079 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.855 ' HB3' HD22 ' A' ' 285' ' ' LEU . 57.4 m -130.89 115.76 16.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.317 -0.401 . . . . 5.09 111.239 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 40.5 tt0 -95.4 119.58 34.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.488 -0.56 . . . . 7.03 109.488 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.439 ' HE2' ' HA3' ' A' ' 283' ' ' GLY . 30.1 m-85 -90.72 148.36 22.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 7.81 111.845 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 286' ' ' LYS . 53.6 t -77.34 -48.26 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 10.03 110.579 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.659 ' HB3' HG22 ' A' ' 312' ' ' VAL . 18.2 t70 -82.37 157.75 23.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 10.81 109.897 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -110.11 -4.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.489 0.551 . . . . 9.77 112.489 -173.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -111.02 -30.48 7.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.963 -0.295 . . . . 10.89 111.482 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.1 m -71.52 -23.71 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.867 0.321 . . . . 9.5 111.867 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.879 HG21 ' HB3' ' A' ' 259' ' ' HIS . 13.0 m -57.56 -49.37 76.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.945 0.35 . . . . 7.83 111.945 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.39 -27.1 68.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.059 0.457 . . . . 8.79 110.748 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.69 -34.74 45.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 10.51 110.413 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.58 99.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 7.31 110.065 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.0 mt -57.38 -47.1 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.719 -0.673 . . . . 6.44 110.531 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.87 -33.73 72.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.842 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.92 -44.62 5.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.704 -0.76 . . . . 7.46 112.959 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.39 -51.18 15.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 6.42 111.402 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.735 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.1 t30 -67.6 120.7 14.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.124 -0.489 . . . . 6.53 110.365 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 121.69 -30.17 5.41 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.815 -0.707 . . . . 6.77 111.776 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -74.52 141.0 44.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 7.29 109.21 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 29.9 tt0 -107.89 120.91 43.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.966 0.412 . . . . 7.83 111.541 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.38 103.78 16.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 7.01 109.721 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.77 -96.84 0.38 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.011 -0.614 . . . . 8.18 112.265 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.05 2.08 9.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 8.94 110.687 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.69 113.51 26.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 7.29 110.854 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 87.8 tttt -72.16 131.23 42.52 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.302 -0.629 . . . . 7.13 109.302 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 263' ' ' ILE . 23.2 tp -77.68 117.16 18.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.961 0.41 . . . . 5.63 111.351 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 329' ' ' LYS . 6.3 mp -98.95 123.6 43.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.355 -0.609 . . . . 5.53 109.355 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.735 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 57.5 t -125.67 118.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.077 -0.511 . . . . 5.21 110.204 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.75 163.71 34.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.789 -0.819 . . . . 6.05 108.789 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.95 141.87 58.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.862 -0.421 . . . . 7.58 109.862 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.43 -51.32 47.67 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.418 0.449 . . . . 6.04 111.876 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 120.815 0.341 . . . . 7.57 110.274 176.937 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.948 0.404 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.07 -50.59 7.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.381 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 199' ' ' PHE . 99.2 mtt180 -106.99 133.32 51.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 6.52 111.034 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 208' ' ' THR . 31.7 mt -92.87 152.92 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.449 . . . . 5.24 110.466 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 65.7 t80 -94.14 110.65 22.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.815 -0.63 . . . . 6.15 109.736 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 198' ' ' ALA . 5.9 p -111.1 119.92 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.274 0.559 . . . . 4.24 109.88 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.88 15.06 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.652 -0.704 . . . . 4.95 111.951 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.12 39.74 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.921 0.867 . . . . 0.0 109.188 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 27.8 pt -85.76 146.95 44.86 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.004 -0.998 . . . . 5.61 110.833 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 6.9 Cg_exo -74.48 120.5 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.896 2.397 . . . . 5.97 111.752 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 193' ' ' GLN . 28.5 t80 -62.24 132.8 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.132 -0.486 . . . . 8.47 109.929 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 114.31 -17.0 19.46 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.67 -0.776 . . . . 6.96 112.597 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.9 tp -78.62 144.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 6.1 110.335 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -88.94 152.82 21.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 6.62 110.864 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.617 ' HA ' HD12 ' A' ' 191' ' ' ILE . 40.4 mt-10 -63.09 -39.82 95.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.126 -0.488 . . . . 5.69 110.75 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -61.99 -47.29 85.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.599 . . . . 7.29 110.788 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.89 86.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.4 tpt -63.21 -47.62 81.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 4.49 110.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.426 ' HB2' HG11 ' A' ' 189' ' ' VAL . 22.5 ttt -61.15 -46.38 90.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 5.76 111.307 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.52 -36.28 82.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 6.51 110.854 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.9 -46.9 84.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.967 -0.56 . . . . 5.44 110.516 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 173' ' ' MET . 54.9 m-85 -64.31 -46.36 83.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 5.03 110.83 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.54 -45.68 73.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.719 0.295 . . . . 6.3 110.956 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -60.7 -48.76 80.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.896 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.84 -27.0 64.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 6.25 111.753 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.663 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 32.4 mmt -64.62 -42.69 95.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 7.03 110.016 176.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -70.2 -44.61 68.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.842 -0.617 . . . . 8.94 110.419 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 79.8 mt -68.21 -34.49 76.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 8.7 111.446 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.57 -16.3 73.75 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.601 -0.809 . . . . 8.11 112.466 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.78 29.63 34.6 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.685 -0.769 . . . . 8.49 112.147 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.613 HD11 ' HE1' ' A' ' 214' ' ' PHE . 4.5 mp -87.89 -22.52 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.36 0.6 . . . . 7.59 109.838 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 24.0 m -76.21 122.69 24.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.217 -0.902 . . . . 8.73 110.751 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.465 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.1 pt20 -80.6 -30.49 36.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.914 0.387 . . . . 9.89 110.932 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.75 124.89 18.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.509 . . . . 9.69 110.253 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.79 128.62 2.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.962 3.108 . . . . 10.74 113.613 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 134.58 -129.63 5.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.915 -0.659 . . . . 8.97 112.265 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -123.26 117.95 27.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.724 0.297 . . . . 7.58 111.086 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.88 -27.82 9.94 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.599 2.2 . . . . 6.4 112.047 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.4 t -90.03 133.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 5.47 110.039 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 203' ' ' ARG . 86.9 mt -95.42 -56.3 2.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.6 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.41 157.88 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.528 HG23 HD23 ' A' ' 200' ' ' LEU . 8.2 p -133.93 137.57 52.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.058 -0.519 . . . . 4.68 110.599 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.73 111.12 13.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.632 -0.507 . . . . 6.34 109.632 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 162' ' ' GLU . 41.6 mt -104.71 127.23 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 5.85 111.555 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -105.36 97.98 7.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.062 -1.088 . . . . 7.34 108.062 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 158' ' ' PHE . 16.1 tt0 -85.45 -5.28 59.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.971 -0.559 . . . . 7.61 110.307 -172.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.28 -52.64 10.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 9.12 110.204 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 26.1 mmtm -91.98 2.67 56.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 9.1 110.757 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.86 48.53 3.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.332 -0.849 . . . . 6.6 111.712 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.457 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 34.8 p90 -148.52 151.32 34.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.301 -0.409 . . . . 6.67 110.224 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.27 157.51 45.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.522 -0.308 . . . . 4.58 110.827 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 150' ' ' ARG . 61.1 m-85 -118.32 119.51 34.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.202 -0.454 . . . . 6.22 110.806 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 31.0 mt -95.32 115.0 26.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.678 -0.692 . . . . 4.77 109.549 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -96.41 116.87 29.75 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.51 -0.476 . . . . 6.55 110.384 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 208' ' ' THR . 27.6 m-85 -93.84 163.91 13.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.683 -0.69 . . . . 6.51 110.612 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.495 ' HA ' HD11 ' A' ' 187' ' ' LEU . 37.0 ptt180 -74.48 -24.19 58.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 8.27 110.788 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 71.3 p -125.44 -161.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.19 -0.459 . . . . 7.96 110.434 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.12 -34.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.094 0.473 . . . . 8.73 110.04 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.11 -52.2 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 8.5 111.129 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.465 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.2 mt-10 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.748 -0.464 . . . . 7.4 109.748 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 151' ' ' LEU . 2.1 m -51.69 -52.43 48.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.465 -0.788 . . . . 6.13 110.818 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.3 m -63.41 -33.67 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.766 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.455 ' HG3' HD23 ' A' ' 178' ' ' LEU . 8.9 tp-100 -71.05 -30.0 66.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 7.75 110.393 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -16.26 63.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 5.43 111.349 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.9 mtp -69.78 -13.75 62.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 6.29 111.165 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.25 65.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 6.14 111.097 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.613 ' HE1' HD11 ' A' ' 178' ' ' LEU . 22.5 m-85 -94.13 12.27 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 5.57 111.353 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.84 112.9 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.817 0.341 . . . . 5.92 110.28 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.58 30.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.714 -0.755 . . . . 5.74 112.499 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . 0.533 HD12 ' HD2' ' A' ' 214' ' ' PHE . 15.4 tt -61.44 138.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.926 0.393 . . . . 5.3 110.398 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.11 122.56 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.331 0.586 . . . . 6.8 110.883 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -133.68 106.49 7.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.737 -0.665 . . . . 5.79 110.125 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.54 31.27 20.22 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.831 -0.622 . . . . 7.32 111.968 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.44 68.36 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.589 -0.815 . . . . 7.28 112.851 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 31.1 mm-40 -120.24 136.06 54.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.212 -0.292 . . . . 7.21 110.212 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.3 m -87.19 108.8 19.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.401 -0.363 . . . . 6.14 110.22 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.73 119.56 11.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.476 . . . . 4.9 110.891 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 83.2 tttt -90.94 116.96 29.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.906 -0.588 . . . . 7.3 109.804 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.07 105.89 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.04 0.448 . . . . 5.37 110.131 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.6 mmt85 -127.61 170.2 12.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.963 -0.562 . . . . 6.97 111.005 -174.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -77.17 144.8 72.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.928 -0.578 . . . . 7.37 109.455 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.89 164.47 13.93 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.701 2.267 . . . . 7.98 113.026 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.973 177.918 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.416 ' NE2' ' HB ' ' A' ' 310' ' ' ILE . 64.3 m80 . . . . . 0 CA--C 1.516 -0.361 0 CA-C-O 121.702 0.763 . . . . 8.75 109.191 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 33.0 ttmt -60.51 113.37 2.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.086 -1.416 . . . . 6.04 109.88 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 307' ' ' TYR . 39.4 mt -90.71 142.29 27.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.081 -0.509 . . . . 5.29 110.764 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.476 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 88.6 t80 -93.6 105.21 17.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.306 -0.861 . . . . 4.77 108.928 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 4.5 mp -96.45 100.41 10.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.648 -0.501 . . . . 3.94 109.648 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.88 108.37 1.74 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.718 -0.753 . . . . 4.58 112.102 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 149.68 42.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.708 -0.758 . . . . 5.58 112.161 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.522 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.4 mt -119.1 137.97 25.72 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.607 0.242 . . . . 5.92 110.462 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 325' ' ' LEU . 24.9 Cg_exo -64.2 154.11 72.66 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.662 2.241 . . . . 6.94 111.685 174.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 21.2 p30 -68.18 -23.72 64.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.431 0.53 . . . . 8.81 112.431 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -83.62 12.08 6.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.0 0.371 . . . . 8.73 112.0 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.08 129.37 36.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.109 0.48 . . . . 7.52 110.341 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.5 p-10 -102.98 179.93 4.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 8.79 110.655 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.37 -37.81 81.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 7.62 111.528 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.39 -52.88 59.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -61.19 -46.46 90.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 8.69 111.817 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 271' ' ' ASN . 61.1 t -63.27 -45.96 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.531 -0.304 . . . . 6.64 111.186 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.47 -50.73 72.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.91 -0.316 . . . . 7.74 110.516 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.86 -50.2 73.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.035 -0.529 . . . . 9.38 111.169 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 278' ' ' LEU . 1.5 tm? -55.81 -50.85 69.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 7.06 110.419 -175.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.794 ' HB2' HD11 ' A' ' 285' ' ' LEU . 84.3 mt -71.36 -37.66 71.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.277 -0.42 . . . . 6.89 111.24 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 284' ' ' PRO . 91.9 m -66.74 -27.81 67.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.51 -0.314 . . . . 8.85 111.118 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 49.1 m -60.39 -25.86 66.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.029 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.43 ' CD2' HD21 ' A' ' 320' ' ' LEU . 90.2 m-85 -108.5 -0.21 20.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.989 0.423 . . . . 9.18 110.603 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 164.82 122.64 0.61 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.712 -0.676 . . . . 9.06 111.634 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 280' ' ' THR . 37.6 Cg_exo -58.69 131.67 43.62 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.042 2.494 . . . . 10.14 113.0 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 279' ' ' LEU . 81.0 mt -94.67 123.75 38.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 8.3 110.981 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -90.24 -22.32 21.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 8.65 109.945 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -137.11 134.7 36.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.922 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.734 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 56.2 t80 -146.32 126.9 14.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.326 -0.397 . . . . 6.27 111.334 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 3.6 p-10 -140.88 121.9 14.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.558 -0.534 . . . . 5.79 109.558 168.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 303' ' ' ALA . 59.1 tp -97.92 125.96 43.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 6.35 109.814 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 302' ' ' TYR . 47.5 t -77.55 112.55 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 6.61 110.221 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -106.89 161.99 14.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 8.17 111.321 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -96.96 135.05 39.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.741 -0.663 . . . . 10.33 109.694 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.0 m -69.86 -40.03 75.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.504 -0.316 . . . . 10.8 111.708 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.31 -48.42 14.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.851 0.357 . . . . 12.13 111.85 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -79.96 -32.23 39.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.238 -0.437 . . . . 11.16 111.66 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 76.8 24.07 68.04 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.583 -0.818 . . . . 10.11 111.982 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 89.2 mt -123.24 -178.88 4.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.113 -0.329 . . . . 10.12 110.113 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -77.25 143.73 38.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.728 0.299 . . . . 7.73 110.326 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -74.9 -26.5 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.013 0.435 . . . . 8.01 110.044 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 125.39 -7.37 7.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.415 -0.898 . . . . 6.09 113.105 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 22.2 p90 -138.79 156.49 47.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 6.54 111.154 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.15 165.77 30.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 4.38 110.739 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.413 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 98.7 m-85 -120.64 126.13 49.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.436 -0.579 . . . . 4.93 109.436 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.734 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.7 m -143.71 138.34 28.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.668 0.27 . . . . 5.09 110.915 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -113.48 136.02 53.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.775 -0.454 . . . . 7.03 109.775 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 261' ' ' LEU . 6.0 m-85 -84.19 153.19 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 7.81 111.021 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.568 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 90.2 t -64.85 -41.5 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 10.03 110.477 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.11 136.54 40.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 10.81 109.941 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.82 -1.28 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 111.98 0.363 . . . . 9.77 111.98 -174.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -93.39 -39.5 10.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.213 0.53 . . . . 10.89 109.673 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.38 -20.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.606 -0.724 . . . . 9.5 111.36 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 m -53.72 -47.95 70.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.275 -0.42 . . . . 7.83 112.041 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.62 -37.08 85.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 8.79 111.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 10.51 110.809 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.69 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 7.31 110.135 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 332' ' ' VAL . 83.8 mt -58.16 -50.92 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.833 -0.621 . . . . 6.44 110.77 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.09 71.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.924 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.6 4.06 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.531 -0.842 . . . . 7.46 112.965 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.43 HD21 ' CD2' ' A' ' 282' ' ' PHE . 96.2 mt -72.54 -40.38 66.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.031 0.382 . . . . 6.42 112.031 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 51.1 t30 -66.39 113.54 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 6.53 110.254 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 119.75 -12.4 10.91 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.963 -0.637 . . . . 6.77 112.036 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 62.9 mtt -75.15 -171.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.732 0.301 . . . . 7.29 110.474 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -146.35 123.19 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.764 0.316 . . . . 7.83 110.686 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.2 OUTLIER -106.92 112.06 24.84 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.591 -0.892 . . . . 7.01 108.591 176.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.56 -104.66 1.42 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.745 -0.741 . . . . 8.18 111.542 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.54 0.5 11.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.721 0.296 . . . . 8.94 111.068 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -112.52 138.96 48.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 7.29 110.945 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.38 138.66 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 7.13 110.4 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.439 HD11 HG23 ' A' ' 263' ' ' ILE . 55.0 tp -90.98 108.0 19.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.702 -0.681 . . . . 5.63 110.477 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.412 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 9.3 mp -105.77 105.53 15.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.212 -0.449 . . . . 5.53 109.94 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 317' ' ' ILE . 73.8 t -109.71 123.74 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.126 -0.488 . . . . 5.21 110.676 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 14.1 pt20 -133.79 -169.45 2.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 6.05 109.354 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 74.4 ttt180 -105.65 143.86 33.22 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 7.58 109.44 174.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.56 77.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.566 0.222 . . . . 6.04 110.999 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 7.57 110.589 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -117.74 -19.81 9.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 70.4 mtt180 -112.07 146.39 38.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.774 0.321 . . . . 6.52 110.807 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 208' ' ' THR . 84.7 mt -119.46 150.0 40.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.722 -0.672 . . . . 5.24 110.111 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -99.42 109.72 22.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 6.15 109.607 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.4 p -109.05 124.76 65.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.329 0.585 . . . . 4.24 110.582 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.27 -178.77 15.47 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.485 -0.779 . . . . 4.95 111.687 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 62.03 33.0 17.47 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.409 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.463 HG22 HD22 ' A' ' 224' ' ' LEU . 34.4 pt -80.4 156.65 73.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.481 -0.781 . . . . 5.61 110.877 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.469 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 42.2 Cg_endo -69.49 124.62 11.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.47 2.113 . . . . 5.97 112.399 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -68.35 112.25 5.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.197 -0.668 . . . . 8.47 109.197 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.87 -2.27 8.54 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.628 -0.796 . . . . 6.96 112.006 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 10.9 tp -88.31 146.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.92 -0.4 . . . . 6.1 109.92 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.9 p -102.76 163.97 11.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.869 0.366 . . . . 6.62 111.314 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.738 ' HG2' ' HB ' ' A' ' 191' ' ' ILE . 33.2 mt-10 -63.93 -41.02 97.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.655 . . . . 5.69 110.69 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -58.39 -47.17 84.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.372 -0.831 . . . . 7.29 110.748 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.43 91.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.5 ttm -71.78 -36.35 70.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 4.49 110.652 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.412 ' HB2' HG11 ' A' ' 189' ' ' VAL . 1.6 tmt? -61.0 -50.32 73.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.534 . . . . 5.76 109.721 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.42 -41.22 98.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.905 -0.589 . . . . 6.51 111.351 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.61 -53.02 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.933 0.346 . . . . 5.44 111.933 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.659 0.266 . . . . 5.03 111.401 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.14 -37.0 78.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.73 0.3 . . . . 6.3 110.865 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.26 83.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.406 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -61.59 -37.17 82.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 6.25 111.264 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.526 ' HG3' ' HG2' ' A' ' 185' ' ' PRO . 19.1 mmt -63.9 -45.34 89.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.428 -0.351 . . . . 7.03 111.009 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.2 -46.18 61.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 8.94 111.221 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.81 -35.27 74.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 8.7 111.374 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.01 58.93 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.547 -0.835 . . . . 8.11 111.844 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.12 39.14 13.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.881 -0.676 . . . . 8.49 112.193 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.85 -0.77 39.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 7.59 110.192 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 p -70.24 130.27 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 8.73 111.062 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.451 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.9 pt20 -84.69 -14.51 48.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.216 0.531 . . . . 9.89 110.236 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.03 29.92 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 9.69 109.871 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.45 111.51 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.465 2.11 . . . . 10.74 111.548 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.92 -148.18 15.85 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.878 -0.677 . . . . 8.97 112.059 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -126.39 112.26 23.38 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.689 0.28 . . . . 7.58 110.857 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 203' ' ' ARG . 50.6 Cg_exo -55.48 -45.8 37.06 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.124 2.549 . . . . 6.4 112.433 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.02 107.2 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.562 -0.533 . . . . 5.47 109.562 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.5 tp -90.98 -61.63 1.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.354 -175.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -113.73 137.85 51.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.611 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 166' ' ' MET . 7.3 p -125.81 132.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.108 0.48 . . . . 4.68 111.365 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -132.86 114.55 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 6.34 109.87 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.738 ' HB ' ' HG2' ' A' ' 162' ' ' GLU . 46.9 mt -114.43 125.39 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 5.85 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -105.2 98.15 7.9 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.061 -0.718 . . . . 7.34 109.061 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.19 -19.49 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.697 . . . . 7.61 110.338 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -58.4 -60.22 4.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 9.12 111.605 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 41.9 mmtm -98.59 4.7 48.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.571 -0.286 . . . . 9.1 111.291 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.34 57.17 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.468 0.651 . . . . 6.6 111.36 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 50.8 p90 -149.21 152.69 36.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 6.67 109.795 173.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.71 157.34 45.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.967 0.413 . . . . 4.58 111.143 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.49 121.68 36.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 6.22 110.233 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 82.5 mt -104.18 116.96 33.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.976 -0.556 . . . . 4.77 109.769 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 35.0 tt0 -97.49 111.77 23.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 6.55 109.756 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -88.5 159.13 18.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.554 . . . . 6.51 111.192 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 185' ' ' PRO . 39.0 ptt180 -70.96 -24.14 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.385 -0.825 . . . . 8.27 111.278 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 60.1 p -125.84 -165.3 1.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.253 -0.43 . . . . 7.96 110.863 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.51 -36.53 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.434 0.635 . . . . 8.73 109.423 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.451 ' HB3' HE22 ' A' ' 180' ' ' GLN . 17.6 t70 -61.51 -53.07 61.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 8.5 111.312 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -64.43 -36.9 85.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 7.4 110.282 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 151' ' ' LEU . 9.8 m -54.26 -52.71 60.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.282 0.563 . . . . 6.13 110.501 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -28.8 69.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.489 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.58 -29.86 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 7.75 109.967 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -68.1 -13.81 62.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 5.43 111.248 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 81.4 mtp -70.37 -14.87 62.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 6.29 110.374 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.14 -5.36 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 6.14 110.596 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 94.3 m-85 -97.11 3.78 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 5.57 110.711 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.45 123.15 16.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 5.92 110.581 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.35 53.17 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.86 -0.685 . . . . 5.74 112.112 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.5 tt -72.75 142.51 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.328 . . . . 5.3 110.262 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.7 tp -84.63 113.16 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.356 0.598 . . . . 6.8 110.407 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -134.55 114.93 13.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 5.79 110.533 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 61.98 26.6 16.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.796 -0.638 . . . . 7.32 111.22 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 86.69 5.38 81.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.88 -0.676 . . . . 7.28 112.737 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.4 mm-40 -115.53 150.69 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.778 0.323 . . . . 7.21 110.701 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -97.78 103.51 15.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.488 -0.56 . . . . 6.14 109.488 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.463 HD22 HG22 ' A' ' 156' ' ' ILE . 70.6 mt -69.79 114.42 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 4.9 111.503 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 76.6 tttt -83.57 114.51 21.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.588 -0.733 . . . . 7.3 109.709 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.14 105.69 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.831 0.348 . . . . 5.37 110.442 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -132.7 168.36 18.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.24 -0.436 . . . . 6.97 110.684 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.67 129.88 78.06 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.346 -0.388 . . . . 7.37 110.4 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 31.9 Cg_exo -58.63 130.76 38.68 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.973 2.448 . . . . 7.98 112.052 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 38.5 m80 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.882 179.506 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.0 m80 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 121.013 0.435 . . . . 8.75 110.512 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 37.5 ttmt -66.26 138.52 57.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.52 -0.763 . . . . 6.04 110.767 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 307' ' ' TYR . 79.7 mt -104.63 141.72 35.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.561 . . . . 5.29 111.007 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 335' ' ' ALA . 87.7 t80 -96.91 119.04 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.297 -0.865 . . . . 4.77 109.152 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.73 HG23 HD11 ' A' ' 330' ' ' LEU . 3.7 mp -108.46 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 3.94 109.837 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.4 134.79 8.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 4.58 112.374 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 123.8 25.69 1.69 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.903 -0.665 . . . . 5.58 111.949 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 84.8 mt -102.46 138.97 19.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.429 -0.211 . . . . 5.92 110.429 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.561 ' HB2' HD13 ' A' ' 270' ' ' LEU . 41.8 Cg_exo -58.12 147.95 80.47 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.611 2.207 . . . . 6.94 111.483 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 6.4 p30 -73.59 -13.54 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.093 0.405 . . . . 8.81 112.093 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -90.05 0.61 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.632 -0.427 . . . . 8.73 111.079 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.0 mp -80.88 117.39 21.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.89 0.376 . . . . 7.52 110.196 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -85.65 174.76 9.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 8.79 110.904 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.33 -37.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.708 . . . . 7.62 112.198 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -53.96 18.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.771 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.12 -39.67 93.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.591 0.234 . . . . 8.69 111.14 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 279' ' ' LEU . 94.9 t -62.16 -48.98 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 6.64 110.443 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -56.39 -53.08 61.59 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.519 -0.309 . . . . 7.74 111.047 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.67 -52.5 55.57 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.571 0.544 . . . . 9.38 111.809 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 7.06 110.526 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.531 HD22 HD13 ' A' ' 320' ' ' LEU . 64.3 mt -75.69 -32.86 60.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.434 -0.348 . . . . 6.89 111.433 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 16.2 m -74.18 -16.68 60.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.02 0.438 . . . . 8.85 110.816 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 41.2 m -61.53 -14.99 34.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.632 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.12 16.43 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 9.18 111.009 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.57 143.94 3.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.55 -0.833 . . . . 9.06 112.547 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 280' ' ' THR . 58.3 Cg_endo -71.9 140.48 35.16 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.693 2.262 . . . . 10.14 112.809 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 305' ' ' CYS . 97.3 mt -98.15 126.45 43.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 8.3 111.106 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -94.32 -18.34 21.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.328 0.585 . . . . 8.65 109.846 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.23 134.23 20.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.083 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.577 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 82.7 t80 -145.56 124.71 12.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.063 -0.517 . . . . 6.27 110.625 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.53 108.66 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.541 0.686 . . . . 5.79 110.347 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 303' ' ' ALA . 55.0 tp -79.54 128.35 33.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.242 -0.89 . . . . 6.35 109.112 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 303' ' ' ALA . 42.2 t -77.31 111.69 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.059 0.456 . . . . 6.61 109.813 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -107.35 148.9 28.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 8.17 110.498 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.05 136.94 38.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.495 . . . . 10.33 109.738 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 44.0 m -70.07 -28.46 65.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.794 0.294 . . . . 10.8 111.794 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.56 -48.6 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.734 0.302 . . . . 12.13 111.183 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.7 m -75.34 -49.08 20.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.403 -0.362 . . . . 11.16 111.353 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 101.51 -26.69 23.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.842 -0.694 . . . . 10.11 111.965 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.12 173.41 10.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 10.12 111.128 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 46.7 t -69.84 148.46 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 7.73 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.79 -1.01 55.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 8.01 110.163 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 105.13 -3.42 40.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.851 -0.69 . . . . 6.09 112.478 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -147.62 161.16 41.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 6.54 111.33 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -152.38 164.53 37.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 4.38 110.459 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -112.46 130.73 55.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.477 -0.564 . . . . 4.93 109.477 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.577 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 47.8 m -138.68 137.88 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.374 -0.375 . . . . 5.09 110.572 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 29.1 tt0 -120.14 134.1 55.34 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.461 -0.57 . . . . 7.03 109.461 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CE1' HD12 ' A' ' 261' ' ' LEU . 20.0 m-85 -91.78 152.32 20.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.004 0.431 . . . . 7.81 111.59 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.528 ' HB ' ' HG2' ' A' ' 284' ' ' PRO . 92.0 t -66.84 -43.49 89.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.563 -0.744 . . . . 10.03 111.284 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.67 157.32 18.19 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.912 -0.403 . . . . 10.81 109.912 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.85 -19.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.988 0.366 . . . . 9.77 111.988 -175.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -77.3 -37.88 51.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.354 0.597 . . . . 10.89 109.493 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 24.6 m -65.83 -22.04 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.105 -0.952 . . . . 9.5 111.178 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.544 ' O ' HG13 ' A' ' 317' ' ' ILE . 9.5 m -55.25 -50.03 70.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.681 -0.236 . . . . 7.83 111.407 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.64 -37.87 76.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.981 0.419 . . . . 8.79 110.851 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -64.11 -38.77 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.677 -0.692 . . . . 10.51 110.249 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.38 86.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.533 -0.758 . . . . 7.31 110.811 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 313' ' ' THR . 85.1 mt -58.82 -45.66 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 6.44 110.734 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.66 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.32 -53.04 4.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.88 -0.676 . . . . 7.46 113.075 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.531 HD13 HD22 ' A' ' 279' ' ' LEU . 75.5 mt -67.9 -52.75 32.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.754 0.312 . . . . 6.42 111.702 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 44.2 t30 -63.18 114.96 4.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 6.53 110.652 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -26.18 6.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.709 -0.758 . . . . 6.77 112.385 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.2 mtt -74.91 168.35 20.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.435 -0.209 . . . . 7.29 110.435 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 329' ' ' LYS . 55.1 mt-30 -125.12 131.06 53.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.969 0.414 . . . . 7.83 110.588 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -109.8 121.92 46.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.33 -0.619 . . . . 7.01 109.33 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 69.36 -96.63 0.49 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.737 -0.744 . . . . 8.18 111.34 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.95 7.81 3.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 8.94 110.484 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.47 143.81 45.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.994 0.426 . . . . 7.29 111.0 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 87.9 tttt -84.61 136.67 33.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 7.13 110.137 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 263' ' ' ILE . 44.3 tp -93.88 124.47 37.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 5.63 110.984 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.433 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 6.8 mp -115.07 124.16 50.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.624 . . . . 5.53 109.557 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.15 131.14 71.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 5.21 110.363 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -156.74 161.43 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 6.05 109.843 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.461 ' HA ' HD23 ' A' ' 261' ' ' LEU . 64.7 mtt85 -64.45 133.19 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.842 0.353 . . . . 7.58 110.651 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 262' ' ' PHE . . . -110.3 106.69 16.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 6.04 110.646 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.476 -0.329 . . . . 7.57 111.398 -178.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.622 0.249 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -107.94 -6.13 16.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.604 0.24 . . . . 0.0 111.327 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.7 mtt180 -114.06 138.75 49.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 6.52 110.922 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 208' ' ' THR . 51.2 mt -116.02 152.08 34.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.909 -0.587 . . . . 5.24 110.43 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -106.08 111.23 23.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 6.15 109.698 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.5 p -109.15 131.0 61.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.143 0.497 . . . . 4.24 110.091 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.41 173.26 18.63 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.776 -0.647 . . . . 4.95 111.941 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 t30 62.77 68.84 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.459 0.647 . . . . 0.0 110.129 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.689 HG22 HD22 ' A' ' 224' ' ' LEU . 37.6 pt -117.63 160.87 36.54 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.392 -0.822 . . . . 5.61 110.29 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.698 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 21.1 Cg_endo -61.92 142.44 93.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.61 2.207 . . . . 5.97 112.441 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -79.56 109.81 14.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 8.47 110.266 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 96.48 36.88 4.97 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.795 -0.717 . . . . 6.96 111.708 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.698 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 5.7 tp -78.71 132.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.125 0.488 . . . . 6.1 111.086 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 17.2 m -64.51 116.15 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 6.62 109.754 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.509 ' HG2' HD12 ' A' ' 191' ' ' ILE . 41.2 mt-10 -57.38 -47.13 82.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 5.69 110.9 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.43 -43.26 93.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.592 -0.731 . . . . 7.29 110.668 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -72.57 -37.63 68.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.204 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.7 tpt -60.7 -47.37 86.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.957 0.408 . . . . 4.49 110.338 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.61 -41.52 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 5.76 110.307 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.11 -49.18 78.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.804 -0.635 . . . . 6.51 111.104 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.1 -47.33 85.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 5.44 111.133 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.488 ' HZ ' ' HB1' ' A' ' 211' ' ' ALA . 66.5 t80 -62.49 -49.3 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 5.03 110.815 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.433 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 78.7 m-20 -61.43 -37.22 82.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.418 -0.355 . . . . 6.3 110.838 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.08 -45.4 88.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.94 -30.03 71.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.391 -0.368 . . . . 6.25 111.41 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 214' ' ' PHE . 76.1 mtp -69.01 -45.02 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 7.03 110.171 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 50.9 mtt180 -65.25 -48.3 73.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 8.94 110.76 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.09 -35.33 78.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 8.7 110.947 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.89 -27.0 69.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.876 -0.678 . . . . 8.11 112.075 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.65 21.58 18.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 8.49 112.373 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.7 mp -108.42 82.12 1.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.213 0.53 . . . . 7.59 110.359 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.601 HG23 ' HG3' ' A' ' 185' ' ' PRO . 3.2 m -157.13 106.84 2.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.242 -0.651 . . . . 8.73 109.242 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.472 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.4 pt20 -73.18 -23.55 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.961 -0.295 . . . . 9.89 111.666 -171.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' THR . . . -145.05 158.43 52.18 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.549 -0.296 . . . . 9.69 110.583 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 151.65 66.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.419 2.08 . . . . 10.74 111.704 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.69 -168.88 20.81 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.71 -0.757 . . . . 8.97 111.775 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 m-20 -94.98 129.17 36.49 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 110.42 -0.215 . . . . 7.58 110.42 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 179' ' ' THR . 26.7 Cg_exo -63.04 -35.76 63.53 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.594 2.196 . . . . 6.4 111.208 176.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.6 131.48 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.47 110.121 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 281' ' ' SER . 43.6 tp -87.71 -54.49 4.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.728 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.68 153.43 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.404 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.35 138.88 48.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.236 -0.438 . . . . 4.68 110.958 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -119.13 105.83 11.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.302 -0.629 . . . . 6.34 109.302 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.509 HD12 ' HG2' ' A' ' 162' ' ' GLU . 62.8 mt -109.3 125.62 66.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.129 0.49 . . . . 5.85 111.249 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -116.2 120.21 38.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.604 -0.725 . . . . 7.34 110.128 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.78 -23.91 23.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.136 -0.484 . . . . 7.61 110.731 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 195' ' ' LYS . 24.0 t70 -57.63 -56.76 17.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.834 -0.621 . . . . 9.12 111.898 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.6 mmtm -105.29 5.24 31.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.793 0.33 . . . . 9.1 111.095 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.35 67.46 0.84 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.528 -0.76 . . . . 6.6 111.517 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 54.5 p90 -149.65 162.5 40.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.005 -0.543 . . . . 6.67 109.821 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.68 143.75 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.082 0.468 . . . . 4.58 111.148 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -107.52 120.58 42.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.686 -0.688 . . . . 6.22 109.734 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 76.8 mt -101.68 115.59 30.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.024 -0.535 . . . . 4.77 109.6 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.74 121.68 42.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.071 -0.344 . . . . 6.55 110.071 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.553 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 48.1 m-85 -99.14 164.15 12.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.144 0.497 . . . . 6.51 110.822 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.67 -22.97 59.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.767 -0.651 . . . . 8.27 111.326 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.8 p -142.83 147.22 35.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.632 0.254 . . . . 7.96 110.913 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.06 -36.17 72.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.953 0.406 . . . . 8.73 110.556 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.37 -58.24 8.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.738 -0.665 . . . . 8.5 111.086 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.472 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 49.4 mt-10 -65.4 -34.25 77.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 7.4 110.871 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 81.5 m -53.49 -52.6 59.02 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.22 0.533 . . . . 6.13 110.212 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 m -63.87 -30.97 72.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.947 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -29.57 62.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.979 0.419 . . . . 7.75 110.361 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.488 ' HB1' ' HZ ' ' A' ' 169' ' ' PHE . . . -72.21 -10.11 59.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.529 . . . . 5.43 111.535 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.3 mtp -68.02 -20.32 64.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 6.29 110.455 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.3 -1.82 28.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 6.14 111.653 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 173' ' ' MET . 94.9 m-85 -97.41 3.33 50.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.739 0.304 . . . . 5.57 110.842 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -57.24 129.66 42.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.055 -0.521 . . . . 5.92 110.914 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.31 25.88 27.28 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.936 -0.649 . . . . 5.74 112.111 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.8 tt -80.8 132.39 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.813 0.34 . . . . 5.3 110.146 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.01 111.23 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.542 0.687 . . . . 6.8 111.179 -176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.497 ' HE2' HD13 ' A' ' 160' ' ' ILE . 88.9 t80 -136.07 122.09 20.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.561 -0.745 . . . . 5.79 110.182 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 57.32 33.66 23.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.851 0.358 . . . . 7.32 111.836 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.15 6.47 86.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.919 -0.657 . . . . 7.28 112.606 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.62 131.85 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.718 0.294 . . . . 7.21 110.479 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.6 m -86.08 102.64 14.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.499 -0.556 . . . . 6.14 109.499 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 156' ' ' ILE . 56.7 mt -66.62 115.52 6.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.9 110.344 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.3 tttt -90.18 114.7 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.941 -0.572 . . . . 7.3 109.739 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.84 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.421 -0.354 . . . . 5.37 110.207 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.424 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 7.8 mmt85 -128.25 169.46 14.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.205 -0.452 . . . . 6.97 110.786 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -79.78 127.14 78.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.311 -0.404 . . . . 7.37 109.99 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.04 113.7 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.488 2.125 . . . . 7.98 110.863 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m80 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.849 -174.385 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 306' ' ' GLU . 23.1 m170 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.128 0.489 . . . . 8.75 110.37 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 40.8 ttmt -77.25 123.62 26.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.671 -0.695 . . . . 6.04 109.955 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.526 HD12 ' CE1' ' A' ' 307' ' ' TYR . 41.2 mt -101.64 142.68 32.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.925 -0.579 . . . . 5.29 111.014 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -88.42 115.67 26.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.323 -0.853 . . . . 4.77 109.221 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.27 107.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.963 -0.384 . . . . 3.94 109.963 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -110.54 171.71 14.87 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.507 -0.637 . . . . 4.58 111.507 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.44 26.85 45.68 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 5.58 111.694 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.41 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 91.2 mt -90.11 125.95 58.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.766 0.317 . . . . 5.92 110.587 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.673 ' HB2' HD13 ' A' ' 270' ' ' LEU . 27.1 Cg_exo -63.1 134.78 47.6 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.664 2.242 . . . . 6.94 111.681 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -63.4 -20.66 65.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 8.81 112.179 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -86.02 1.59 49.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.566 0.222 . . . . 8.73 111.59 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.4 mp -91.68 144.59 25.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.132 -0.321 . . . . 7.52 110.132 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.8 p-10 -106.88 177.19 4.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.271 -0.422 . . . . 8.79 110.436 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 3.8 m-20 -58.36 -38.99 78.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 7.62 111.493 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.71 -50.87 65.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.08 -40.47 85.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.511 0.195 . . . . 8.69 111.386 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.1 t -65.96 -48.46 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 6.64 110.728 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 35.7 mtmm -59.27 -53.25 60.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.576 -0.284 . . . . 7.74 111.193 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.27 -43.15 82.83 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.827 0.346 . . . . 9.38 111.063 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.04 -53.3 58.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 7.06 110.201 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.34 -36.11 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 6.89 111.414 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.6 m -63.21 -32.23 73.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 8.85 111.291 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 32.2 m -65.62 -14.08 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.8 8.32 13.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 9.18 110.388 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.91 125.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.745 -0.661 . . . . 9.06 111.91 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 280' ' ' THR . 35.9 Cg_endo -64.89 139.13 60.75 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.63 2.22 . . . . 10.14 112.712 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 70.6 mt -100.59 133.0 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 8.3 110.329 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.687 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.6 ptpt -95.83 -18.39 20.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.808 -0.442 . . . . 8.65 109.808 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -149.18 139.79 22.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.182 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.552 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 84.9 t80 -140.41 130.31 24.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.228 -0.442 . . . . 6.27 110.535 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.59 118.57 11.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 5.79 110.083 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 303' ' ' ALA . 60.4 tp -95.66 128.41 42.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 6.35 109.797 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.9 t -76.21 113.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 6.61 109.992 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.492 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 45.2 mttm -114.63 161.69 17.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.787 -0.642 . . . . 8.17 111.13 -172.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 1.025 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 31.2 t70 -126.46 122.82 36.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.023 -0.535 . . . . 10.33 109.872 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.4 m -65.39 -38.7 90.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.151 0.426 . . . . 10.8 112.151 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.57 82.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.985 0.422 . . . . 12.13 111.311 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.9 m -81.12 -35.92 30.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.195 -0.457 . . . . 11.16 111.12 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.12 10.05 81.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.035 -0.602 . . . . 10.11 111.983 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.94 175.32 8.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.798 0.332 . . . . 10.12 110.549 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.5 t -71.99 156.42 39.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.89 -0.596 . . . . 7.73 110.054 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 1.025 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.3 mmmp? -86.33 1.74 49.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.388 -0.369 . . . . 8.01 110.635 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 104.05 4.65 44.64 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.583 -0.817 . . . . 6.09 113.439 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.489 ' CE2' HG21 ' A' ' 291' ' ' VAL . 48.6 p90 -157.4 162.12 39.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.194 0.521 . . . . 6.54 111.57 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -148.61 170.09 18.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.438 -0.801 . . . . 4.38 110.623 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.582 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.4 m-85 -120.31 127.48 52.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.314 -0.624 . . . . 4.93 109.314 175.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.552 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 25.9 m -135.04 113.47 11.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.499 -0.319 . . . . 5.09 111.125 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 27.2 tt0 -88.3 123.53 32.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.913 0.387 . . . . 7.03 110.201 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.526 ' CE1' HD12 ' A' ' 261' ' ' LEU . 13.5 m-85 -80.23 156.76 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.815 -0.629 . . . . 7.81 111.426 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 286' ' ' LYS . 96.8 t -81.45 -55.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 10.03 110.684 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.695 ' HB3' HG22 ' A' ' 312' ' ' VAL . 13.1 t70 -82.12 129.46 34.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 10.81 109.971 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -87.92 0.84 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.252 0.464 . . . . 9.77 112.252 -173.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -103.51 -35.94 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 10.89 110.227 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 309' ' ' ASP . 27.5 m -72.46 -20.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 9.5 111.216 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.495 ' O ' HG13 ' A' ' 317' ' ' ILE . 11.5 m -54.67 -51.55 65.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.394 -0.366 . . . . 7.83 111.961 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -71.24 -24.45 62.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 8.79 110.795 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.94 -45.16 52.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 10.51 109.685 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.679 -0.692 . . . . 7.31 110.117 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 313' ' ' THR . 75.4 mt -57.61 -52.98 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 6.44 110.559 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.36 93.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.647 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -76.6 -43.33 19.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.639 -0.791 . . . . 7.46 113.182 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.64 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.3 mt -82.45 -40.91 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.277 0.473 . . . . 6.42 112.277 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -62.84 115.85 4.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.776 0.322 . . . . 6.53 110.643 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.71 -23.85 20.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.961 -0.638 . . . . 6.77 111.89 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 24.9 ttt -78.78 137.79 37.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 7.29 109.741 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -88.04 129.39 35.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.087 0.47 . . . . 7.83 111.077 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.85 104.01 15.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.534 -0.913 . . . . 7.01 108.534 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.44 -74.72 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.037 -0.825 . . . . 8.18 111.037 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.19 5.99 0.15 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.988 0.423 . . . . 8.94 110.088 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HD3' ' HG3' ' A' ' 267' ' ' PRO . 12.6 mptt -101.92 129.64 48.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.593 -0.521 . . . . 7.29 109.593 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.64 118.02 15.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.802 0.334 . . . . 7.13 110.471 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 320' ' ' LEU . 19.0 tp -74.53 115.71 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.914 -0.584 . . . . 5.63 109.865 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 4.9 tt -98.47 110.68 23.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.928 -0.768 . . . . 5.53 108.928 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 317' ' ' ILE . 49.1 t -120.77 127.53 75.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.028 0.442 . . . . 5.21 110.864 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -162.08 -178.29 6.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.6 -0.727 . . . . 6.05 109.077 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -73.69 145.03 45.54 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.821 -0.352 . . . . 7.58 110.138 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.11 83.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.414 -0.357 . . . . 6.04 111.558 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 116.491 -0.322 . . . . 7.57 110.993 -178.226 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.557 0.218 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.493 ' HB2' ' HG3' ' A' ' 201' ' ' GLU . 68.9 mtm180 -112.61 18.69 18.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.739 0.304 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 83.4 mtt180 -111.23 146.19 37.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.057 0.456 . . . . 6.52 112.113 -173.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.31 154.85 31.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 5.24 109.661 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -100.05 109.99 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.206 -0.452 . . . . 6.15 109.969 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 198' ' ' ALA . 7.2 p -109.01 133.31 54.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.131 0.491 . . . . 4.24 110.453 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.31 -179.31 17.38 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.782 -0.645 . . . . 4.95 111.803 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.0 t30 58.24 65.65 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.767 0.794 . . . . 0.0 109.985 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 29.6 pt -115.68 157.69 43.8 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.989 -1.005 . . . . 5.61 110.226 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 36.2 Cg_endo -65.67 131.13 26.71 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.484 2.123 . . . . 5.97 112.559 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -72.03 96.22 1.71 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.299 0.571 . . . . 8.47 109.888 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 141.59 -10.15 2.65 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.524 -0.762 . . . . 6.96 111.517 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.708 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.1 tp -66.94 136.18 27.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.911 0.386 . . . . 6.1 110.857 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.8 p -89.93 153.26 20.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.099 -0.5 . . . . 6.62 109.703 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.97 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.4 mt-10 -61.81 -40.67 96.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.782 0.325 . . . . 5.69 110.904 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.4 -48.89 73.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.982 -0.554 . . . . 7.29 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.09 86.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.3 tpt -65.86 -46.68 77.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.234 -0.439 . . . . 4.49 110.23 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 23.1 ttt -61.07 -45.75 93.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 5.76 110.609 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.38 -41.97 81.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 6.51 111.048 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.64 -49.38 76.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 5.44 111.009 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.469 ' HE1' HD11 ' A' ' 226' ' ' ILE . 47.8 m-85 -61.19 -45.37 94.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.671 -0.24 . . . . 5.03 111.068 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 95.3 m-20 -57.09 -44.92 83.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 6.3 110.407 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -48.64 78.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.174 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.57 -43.49 98.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 6.25 111.229 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.34 -34.84 78.89 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.939 -0.304 . . . . 7.03 110.644 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 95.0 mtt180 -64.31 -52.06 60.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.368 . . . . 8.94 110.787 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.93 -36.09 69.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.223 -0.444 . . . . 8.7 111.266 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.46 -30.85 68.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.955 -0.64 . . . . 8.11 112.043 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.08 36.89 26.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.932 -0.651 . . . . 8.49 112.75 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 8.3 mp -101.68 21.42 14.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.185 0.517 . . . . 7.59 110.504 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.1 p -102.93 171.46 7.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.848 -0.615 . . . . 8.73 110.381 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -110.79 -1.09 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.935 0.398 . . . . 9.89 110.02 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.3 162.71 15.58 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.726 -0.67 . . . . 9.69 110.141 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 170.88 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.503 2.135 . . . . 10.74 111.546 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.73 -153.85 17.87 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.437 -0.887 . . . . 8.97 112.764 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -106.93 114.74 61.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.693 0.282 . . . . 7.58 110.794 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 36.6 Cg_exo -60.74 -42.84 35.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.981 2.454 . . . . 6.4 112.366 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.06 131.59 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.057 -0.349 . . . . 5.47 110.057 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 203' ' ' ARG . 36.1 tp -109.49 -39.01 5.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.733 ' HB1' HG11 ' A' ' 312' ' ' VAL . . . -137.19 131.5 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.57 122.34 64.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.231 0.538 . . . . 4.68 111.426 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.38 106.2 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.873 -0.603 . . . . 6.34 109.568 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -112.53 134.35 55.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.754 0.312 . . . . 5.85 111.049 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -114.98 104.38 11.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.634 -0.506 . . . . 7.34 109.634 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.4 -17.78 60.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.82 -0.627 . . . . 7.61 111.315 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.68 -53.38 22.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.56 -0.291 . . . . 9.12 111.09 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.3 mmtm -90.25 -3.64 57.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.822 0.344 . . . . 9.1 110.433 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 63.6 56.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.399 -0.819 . . . . 6.6 110.841 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 22.2 p90 -148.59 162.97 38.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 6.67 109.689 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.516 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -151.59 148.95 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.974 0.416 . . . . 4.58 111.357 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 55.5 m-85 -111.4 108.38 17.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.696 -0.684 . . . . 6.22 109.563 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 92.5 mt -97.56 116.06 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.975 -0.557 . . . . 4.77 110.322 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 25.4 tt0 -99.22 122.02 41.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.54 -0.541 . . . . 6.55 109.54 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' A' ' 208' ' ' THR . 90.1 m-85 -93.69 163.97 13.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.944 -0.571 . . . . 6.51 110.425 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.505 ' HA ' HD22 ' A' ' 187' ' ' LEU . 38.9 ptt180 -69.16 -17.18 63.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.717 -0.674 . . . . 8.27 111.419 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 56.2 p -135.19 -163.64 1.41 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.302 -0.408 . . . . 7.96 110.356 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.01 -32.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.261 0.553 . . . . 8.73 109.713 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.45 -57.75 11.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 8.5 110.573 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 38.7 mt-10 -60.13 -37.23 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 7.4 109.921 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.461 HG23 ' CD1' ' A' ' 202' ' ' PHE . 12.0 m -54.45 -43.25 71.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 6.13 110.806 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.4 m -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.323 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -71.99 -27.77 62.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.382 -0.372 . . . . 7.75 110.909 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 214' ' ' PHE . . . -63.65 -19.04 64.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 5.43 111.173 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.82 -19.37 62.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 6.29 111.022 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.25 -6.05 51.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 6.14 111.306 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 211' ' ' ALA . 97.5 m-85 -89.63 2.12 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 5.57 110.624 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.11 120.97 10.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 5.92 110.441 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.11 42.09 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.682 -0.771 . . . . 5.74 112.527 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.7 tt -63.21 136.08 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 5.3 110.487 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -87.99 121.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.561 . . . . 6.8 110.83 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -134.27 115.01 13.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.807 -0.633 . . . . 5.79 110.571 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 53.08 35.95 20.96 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.952 -0.567 . . . . 7.32 112.077 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.7 2.55 75.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.819 -0.705 . . . . 7.28 113.221 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -119.37 136.19 54.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.123 0.461 . . . . 7.21 110.951 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.6 t -88.75 103.28 15.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.128 -0.693 . . . . 6.14 109.128 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 156' ' ' ILE . 84.2 mt -66.34 121.99 16.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 4.9 111.04 -174.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.59 ' HE2' ' HG3' ' A' ' 227' ' ' ARG . 87.6 tttt -96.85 115.56 27.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 7.3 110.293 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.469 HD11 ' HE1' ' A' ' 169' ' ' PHE . 61.6 mt -115.02 107.14 22.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.921 -0.4 . . . . 5.37 109.921 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.59 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 8.0 mmt180 -130.98 172.12 12.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.124 0.488 . . . . 6.97 111.51 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 45.1 mtp85 -72.14 131.94 84.84 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.473 -0.785 . . . . 7.37 110.248 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 16.9 Cg_exo -66.97 152.59 80.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 7.98 111.361 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.47 -0.567 . . . . 8.75 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.776 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 39.7 ttmt -58.65 130.73 48.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.076 -0.966 . . . . 6.04 111.353 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 313' ' ' THR . 83.8 mt -108.38 143.81 36.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.759 -0.655 . . . . 5.29 110.661 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -91.49 120.3 32.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.994 -0.548 . . . . 4.77 110.06 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.1 106.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.287 -0.415 . . . . 3.94 109.907 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.65 154.74 16.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.845 -0.693 . . . . 4.58 112.043 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 103.06 34.29 4.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 5.58 112.004 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.2 mt -102.66 138.86 19.74 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.802 0.334 . . . . 5.92 110.85 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 16.8 Cg_exo -68.87 144.53 59.2 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.955 2.437 . . . . 6.94 111.946 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.51 -25.95 63.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 8.81 110.852 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -87.75 0.63 55.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.22 -0.445 . . . . 8.73 111.512 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 40.2 tp -86.79 122.59 30.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.165 -0.309 . . . . 7.52 110.165 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.7 p-10 -78.98 157.11 28.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.123 -0.49 . . . . 8.79 111.245 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.67 -32.07 70.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.588 -0.733 . . . . 7.62 111.569 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 -53.03 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.66 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.78 -33.54 74.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.391 -0.368 . . . . 8.69 111.208 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 271' ' ' ASN . 20.8 t -64.79 -48.74 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.667 0.27 . . . . 6.64 110.527 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -58.52 -47.24 84.79 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.322 -0.399 . . . . 7.74 110.664 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.67 -47.81 83.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 9.38 110.759 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.06 -51.03 70.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 7.06 110.255 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 285' ' ' LEU . 90.7 mt -66.87 -38.22 85.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.258 -0.428 . . . . 6.89 111.671 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 28.6 m -69.74 -19.62 63.53 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.154 0.502 . . . . 8.85 110.961 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.1 m -73.68 -8.03 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.119 0.485 . . . . 0.0 110.656 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 320' ' ' LEU . 97.2 m-85 -121.6 14.53 11.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 9.18 110.156 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 146.32 136.49 2.91 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.765 -0.652 . . . . 9.06 112.058 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.468 ' HD3' ' HG ' ' A' ' 187' ' ' LEU . 24.6 Cg_endo -61.88 135.89 58.38 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.819 2.346 . . . . 10.14 112.316 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 279' ' ' LEU . 99.3 mt -100.11 137.89 37.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.24 -0.436 . . . . 8.3 110.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.433 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.3 ptpt -98.06 -32.97 11.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.456 -0.572 . . . . 8.65 109.456 175.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 286' ' ' LYS . . . -142.56 132.87 24.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.429 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -133.0 117.57 17.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.917 -0.583 . . . . 6.27 110.22 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -131.97 113.15 13.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.609 0.719 . . . . 5.79 110.379 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.2 tp -87.38 130.52 34.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 6.35 109.199 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 111.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.81 -0.441 . . . . 6.61 109.81 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.414 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 61.6 mttm -111.06 156.6 21.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.603 -0.726 . . . . 8.17 109.918 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.63 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 33.9 t70 -88.66 136.31 33.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.984 -0.376 . . . . 10.33 109.984 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.3 m -60.12 -38.12 82.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 10.8 112.021 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.17 -48.03 6.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.03 0.443 . . . . 12.13 111.411 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.7 m -67.68 -38.22 83.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.625 . . . . 11.16 111.001 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.67 4.97 90.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.885 -0.674 . . . . 10.11 112.321 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 61.8 mt -113.08 169.37 8.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.173 -0.306 . . . . 10.12 110.173 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.518 ' HB2' HD21 ' A' ' 290' ' ' LEU . 46.4 t -65.72 146.21 55.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.221 0.534 . . . . 7.73 110.989 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.63 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 30.1 mmmt -87.55 3.24 48.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.813 -0.63 . . . . 8.01 110.372 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 102.53 4.88 49.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.574 -0.822 . . . . 6.09 113.241 174.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -152.87 156.78 39.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.987 0.422 . . . . 6.54 111.148 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.669 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.46 167.03 23.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 4.38 110.879 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.776 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 90.3 m-85 -122.54 130.02 52.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.793 -0.639 . . . . 4.93 109.304 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.1 m -142.25 132.5 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.033 -0.267 . . . . 5.09 110.938 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.84 132.18 54.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.853 -0.425 . . . . 7.03 109.853 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -88.36 156.5 19.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.725 . . . . 7.81 111.34 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 286' ' ' LYS . 79.6 t -82.18 -50.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.633 -0.712 . . . . 10.03 109.552 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.482 ' OD2' HG22 ' A' ' 312' ' ' VAL . 22.0 t70 -77.77 148.96 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 10.81 110.217 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.592 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -124.35 20.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.415 . . . . 9.77 111.233 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.11 -49.45 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.262 0.553 . . . . 10.89 109.83 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.733 HG11 ' HB1' ' A' ' 188' ' ' ALA . 34.0 m -79.21 -20.7 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.298 -0.864 . . . . 9.5 111.396 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.621 HG22 HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -53.81 -50.24 66.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.549 0.574 . . . . 7.83 112.549 -170.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.29 -35.77 80.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.874 0.369 . . . . 8.79 111.188 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.87 -29.15 60.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 10.51 110.302 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.94 -39.2 76.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.185 -0.461 . . . . 7.31 110.033 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 313' ' ' THR . 80.6 mt -57.35 -61.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 6.44 110.443 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.64 -15.98 62.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.468 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.67 -47.46 5.63 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.023 -0.608 . . . . 7.46 112.471 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 282' ' ' PHE . 92.8 mt -79.95 -40.03 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.589 0.233 . . . . 6.42 111.197 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.489 ' OD1' HD12 ' A' ' 331' ' ' LEU . 8.8 t30 -62.01 115.0 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 6.53 110.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.33 -23.63 6.04 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.672 -0.775 . . . . 6.77 111.856 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 66.7 mtt -78.66 171.99 14.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.733 -0.469 . . . . 7.29 109.733 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -117.63 151.75 36.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.723 0.297 . . . . 7.83 110.51 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.61 106.73 7.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.998 -0.742 . . . . 7.01 108.998 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.5 -94.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.721 -0.752 . . . . 8.18 111.435 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.08 -9.35 5.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 8.94 110.404 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.15 159.28 15.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 7.29 110.38 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -98.92 129.35 45.25 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.528 -0.545 . . . . 7.13 109.528 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.01 115.2 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 5.63 110.709 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.489 HD12 ' OD1' ' A' ' 321' ' ' ASN . 51.4 tp -108.6 105.79 15.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.322 -0.854 . . . . 5.53 109.832 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.11 115.47 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.724 -0.473 . . . . 5.21 109.724 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -137.76 158.82 43.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.138 0.494 . . . . 6.05 111.011 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.78 119.9 16.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 7.58 109.215 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.47 -65.32 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.969 0.359 . . . . 6.04 111.969 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.882 0.372 . . . . 7.57 110.311 179.664 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 6.5 ptp180 -101.86 -19.04 15.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.041 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.1 mtt180 -114.84 133.28 56.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.867 0.365 . . . . 6.52 111.213 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 75.8 mt -98.98 157.8 16.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 5.24 110.766 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.503 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 46.7 t80 -115.31 103.46 10.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 6.15 110.075 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.7 p -103.06 130.91 52.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.181 0.515 . . . . 4.24 110.12 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.45 16.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.586 -0.734 . . . . 4.95 111.595 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.57 55.24 4.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.693 0.759 . . . . 0.0 109.477 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.566 HG22 HD22 ' A' ' 224' ' ' LEU . 35.5 pt -101.09 147.69 34.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 5.61 110.156 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.11 114.63 2.4 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.695 2.263 . . . . 5.97 112.189 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.4 127.85 34.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.568 . . . . 8.47 110.762 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.37 10.67 35.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.845 -0.693 . . . . 6.96 111.692 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.1 tp -81.13 137.78 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 6.1 109.912 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.3 p -87.2 144.64 26.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.407 -0.361 . . . . 6.62 110.755 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.928 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.2 mt-10 -57.71 -43.46 85.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.69 111.45 -175.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.72 -52.46 64.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 7.29 110.74 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.64 95.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.708 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.457 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.1 tpt -60.54 -46.8 88.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 4.49 110.475 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.443 ' HB2' HG11 ' A' ' 189' ' ' VAL . 25.6 ttt -63.28 -47.13 83.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.129 -0.487 . . . . 5.76 110.977 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -62.98 -32.04 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 6.51 111.387 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.36 -49.1 76.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.565 -0.289 . . . . 5.44 110.619 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 173' ' ' MET . 56.2 m-85 -63.1 -44.9 94.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 5.03 110.798 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.89 -35.94 77.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.35 . . . . 6.3 110.941 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.58 68.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.446 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.52 -31.14 71.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 6.25 111.281 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 17.9 mmt -60.95 -51.49 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 7.03 110.17 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -69.2 -48.06 63.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.976 -0.557 . . . . 8.94 110.972 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -35.56 80.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 8.7 111.383 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.53 -29.61 48.09 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.591 -0.814 . . . . 8.11 112.165 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.43 0.43 40.46 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.901 -0.666 . . . . 8.49 111.823 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.3 mp -79.25 84.7 5.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.74 -0.467 . . . . 7.59 109.74 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.5 m -159.96 124.38 3.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 8.73 110.147 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -90.04 -27.71 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 9.89 111.183 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -141.18 139.83 19.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.455 -0.339 . . . . 9.69 110.327 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.14 118.12 4.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.951 2.434 . . . . 10.74 112.486 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.56 -155.65 22.33 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.122 -0.561 . . . . 8.97 111.931 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.7 m-20 -101.57 126.24 34.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.684 0.278 . . . . 7.58 111.169 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_exo -68.76 -32.18 23.9 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 123.01 2.474 . . . . 6.4 111.83 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.3 124.16 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 5.47 110.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.64 -42.07 7.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.035 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.91 159.38 42.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 111.113 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 166' ' ' MET . 9.1 p -140.57 136.63 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.211 -0.449 . . . . 4.68 110.84 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 199' ' ' PHE . 41.6 mt-30 -113.86 106.36 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.655 -0.498 . . . . 6.34 109.655 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -111.43 123.98 67.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.191 0.52 . . . . 5.85 111.661 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -127.14 119.24 26.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.569 -0.741 . . . . 7.34 109.49 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -93.17 3.42 55.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.757 0.313 . . . . 7.61 111.384 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.8 -54.59 5.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.093 0.473 . . . . 9.12 109.816 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.624 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 47.3 mmtm -86.52 -7.17 58.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.952 -0.567 . . . . 9.1 109.491 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 60.87 70.03 0.64 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.149 -0.932 . . . . 6.6 110.812 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 195' ' ' LYS . 41.2 p90 -149.28 163.0 38.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.209 -0.451 . . . . 6.67 111.227 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 190' ' ' GLN . . . -144.83 126.87 15.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.646 -0.706 . . . . 4.58 110.238 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 190' ' ' GLN . 55.6 m-85 -96.23 126.87 41.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.363 -0.381 . . . . 6.22 110.117 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 79.0 mt -105.57 115.21 29.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.052 -0.522 . . . . 4.77 109.998 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.03 118.27 31.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.996 -0.372 . . . . 6.55 109.996 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -95.64 163.91 13.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.761 -0.654 . . . . 6.51 110.814 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.78 -8.32 57.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.311 -0.859 . . . . 8.27 111.014 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 p -142.99 -164.72 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 7.96 110.294 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.07 -29.96 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 8.73 109.227 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.02 -55.62 32.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.124 -0.944 . . . . 8.5 111.408 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 46.9 mt-10 -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 7.4 110.026 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.487 ' O ' HD11 ' A' ' 151' ' ' LEU . 1.8 m -53.24 -53.44 50.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.569 -0.741 . . . . 6.13 110.807 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 m -60.98 -35.06 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.616 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.674 ' HG3' HD23 ' A' ' 178' ' ' LEU . 9.1 tp-100 -73.28 -30.5 63.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.807 -0.633 . . . . 7.75 110.373 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -69.6 -12.81 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 5.43 111.23 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.4 mtp -69.8 -13.52 62.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 6.29 110.85 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.35 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 6.14 111.358 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.439 ' HE2' HD22 ' A' ' 178' ' ' LEU . 76.4 m-85 -92.71 15.17 15.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 5.57 111.263 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.56 115.48 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.921 -0.4 . . . . 5.92 109.921 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.77 30.1 9.31 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.561 -0.828 . . . . 5.74 112.006 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 13.1 tt -84.82 136.2 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 5.3 110.091 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.46 113.93 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.446 0.641 . . . . 6.8 110.811 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -134.68 119.13 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.848 -0.615 . . . . 5.79 110.593 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 61.43 20.85 11.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.947 -0.57 . . . . 7.32 112.017 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.55 1.82 63.79 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.619 -0.8 . . . . 7.28 112.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -119.84 142.88 48.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.939 0.399 . . . . 7.21 111.076 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.0 t -90.24 111.16 22.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.705 -0.679 . . . . 6.14 109.885 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 156' ' ' ILE . 77.0 mt -76.93 114.13 15.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.026 0.441 . . . . 4.9 110.695 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.7 tttt -94.9 114.59 26.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.96 -0.564 . . . . 7.3 110.394 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.42 109.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 5.37 110.631 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 227' ' ' ARG . 6.8 mmt180 -131.12 171.13 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.506 . . . . 6.97 110.621 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 26.8 mtp180 -87.69 127.4 58.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.883 -0.414 . . . . 7.37 109.883 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.503 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 14.9 Cg_exo -66.48 104.66 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.954 2.436 . . . . 7.98 111.857 -176.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.284 -174.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 57.3 t60 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.681 0.753 . . . . 8.75 109.398 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.1 ttmt -78.91 116.91 19.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.15 -0.932 . . . . 6.04 111.129 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.777 HD11 HG23 ' A' ' 313' ' ' THR . 68.0 mt -100.89 142.43 32.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.546 -0.752 . . . . 5.29 109.872 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -92.93 123.83 36.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.266 -0.424 . . . . 4.77 109.988 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 330' ' ' LEU . 3.1 mp -114.4 110.55 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.839 -0.618 . . . . 3.94 109.413 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.58 130.64 6.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.717 -0.754 . . . . 4.58 112.376 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 124.44 23.47 1.91 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.744 -0.741 . . . . 5.58 111.977 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.5 mt -95.86 141.53 23.3 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.104 -0.332 . . . . 5.92 110.104 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.875 ' HB2' HD13 ' A' ' 270' ' ' LEU . 32.3 Cg_exo -58.47 116.3 3.15 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.535 2.157 . . . . 6.94 111.107 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 299' ' ' SER . 29.7 p-10 -70.23 -5.46 27.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.729 0.64 . . . . 8.81 112.729 -170.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.59 -0.444 . . . . 8.73 111.02 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.875 HD13 ' HB2' ' A' ' 267' ' ' PRO . 11.2 mp -86.31 133.39 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 7.52 110.202 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.2 p-10 -79.16 160.04 27.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.984 -0.553 . . . . 8.79 110.536 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.18 -32.09 54.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.757 -0.656 . . . . 7.62 111.501 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.464 ' HB3' ' ND2' ' A' ' 271' ' ' ASN . 17.2 t70 -56.93 -54.81 42.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.602 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -73.93 -33.37 63.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.516 -0.311 . . . . 8.69 111.27 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 271' ' ' ASN . 63.0 t -62.92 -48.6 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.537 -0.301 . . . . 6.64 110.819 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -62.88 -45.39 92.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.262 . . . . 7.74 111.399 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.96 -40.79 98.78 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.739 0.304 . . . . 9.38 110.884 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.63 -49.12 78.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 7.06 109.873 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.86 -37.25 78.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.54 . . . . 6.89 111.426 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 87.0 m -60.72 -31.27 70.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.483 -0.326 . . . . 8.85 110.9 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.3 m -65.62 -15.85 63.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.21 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.58 2.04 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.389 . . . . 9.18 110.577 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 157.51 127.13 0.94 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.733 -0.746 . . . . 9.06 112.563 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.408 ' HD3' ' HA2' ' A' ' 283' ' ' GLY . 27.4 Cg_exo -63.04 133.28 40.4 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.926 2.417 . . . . 10.14 112.171 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.16 138.45 39.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.08 -0.509 . . . . 8.3 111.055 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 308' ' ' VAL . 12.2 ptpt -104.39 -12.71 16.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 8.65 109.707 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.72 136.82 22.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.593 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 72.4 t80 -150.54 126.45 10.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.26 -0.427 . . . . 6.27 110.512 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -140.44 112.08 7.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.362 0.601 . . . . 5.79 110.428 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -80.48 121.36 25.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.53 -0.759 . . . . 6.35 109.793 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.66 113.47 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.361 0.6 . . . . 6.61 110.452 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -113.28 160.27 18.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.369 -0.832 . . . . 8.17 109.846 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.777 ' HB2' ' HE3' ' A' ' 300' ' ' LYS . 11.6 t70 -90.03 113.31 24.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.174 -0.676 . . . . 10.33 109.174 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 32.4 m -76.76 -3.2 36.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.538 0.57 . . . . 10.8 112.538 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.37 -23.1 13.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.926 0.393 . . . . 12.13 110.808 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.0 m -106.2 -41.24 5.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.06 -0.518 . . . . 11.16 111.22 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.0 20.72 25.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.811 -0.709 . . . . 10.11 112.102 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.97 155.99 29.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.443 -0.206 . . . . 10.12 110.443 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 42.2 t -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.532 -0.304 . . . . 7.73 110.336 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.777 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 32.3 mmtp -94.07 -8.21 40.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.298 -0.41 . . . . 8.01 111.108 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 90.76 6.74 67.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.656 -0.783 . . . . 6.09 113.047 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 300' ' ' LYS . 40.7 p90 -141.55 152.54 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.793 0.33 . . . . 6.54 110.533 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.27 164.07 35.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.108 -0.496 . . . . 4.38 111.185 -176.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 96.9 m-85 -106.14 123.42 47.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.874 -0.603 . . . . 4.93 109.519 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.593 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 21.6 m -128.6 121.32 28.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 5.09 110.678 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 30.8 tt0 -103.24 114.96 29.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 7.03 110.129 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.49 ' CE1' HD12 ' A' ' 261' ' ' LEU . 25.8 m-85 -84.05 149.58 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 7.81 111.129 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 286' ' ' LYS . 61.3 t -78.89 -55.54 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.9 -0.591 . . . . 10.03 110.684 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 144.94 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 10.81 111.225 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.88 -19.93 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 9.77 111.356 -178.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.59 -48.35 64.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.907 0.384 . . . . 10.89 110.039 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.82 -23.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 9.5 110.992 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.777 HG23 HD11 ' A' ' 261' ' ' LEU . 98.4 m -55.78 -50.03 71.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.496 -0.32 . . . . 7.83 111.728 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.28 -38.11 89.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 8.79 110.719 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.45 -40.62 85.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 10.51 110.479 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -49.61 71.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 7.31 110.666 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 313' ' ' THR . 74.8 mt -59.01 -49.17 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.578 -0.283 . . . . 6.44 110.798 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.79 69.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.73 -43.42 7.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.699 -0.763 . . . . 7.46 112.7 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.427 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.1 mt -80.92 -42.7 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.544 0.202 . . . . 6.42 111.544 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 49.4 t-20 -72.67 113.89 10.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.317 -0.623 . . . . 6.53 109.317 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.5 -7.93 47.12 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.283 -0.727 . . . . 6.77 111.283 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttt -74.33 135.29 42.53 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 7.29 109.864 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.54 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 46.0 mt-30 -96.1 117.12 30.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.349 -0.387 . . . . 7.83 110.458 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.82 96.83 6.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.355 -0.609 . . . . 7.01 109.355 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 85.8 -94.54 1.93 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.166 -0.774 . . . . 8.18 111.166 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.81 -19.12 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.996 0.426 . . . . 8.94 110.11 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 158.95 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 7.29 110.419 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.54 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 99.4 mttt -110.27 142.42 41.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.041 0.448 . . . . 7.13 110.82 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.587 HD11 HG23 ' A' ' 263' ' ' ILE . 55.7 tp -86.29 134.41 33.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.551 -0.75 . . . . 5.63 110.14 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.8 mp -121.28 136.27 54.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.899 0.381 . . . . 5.53 110.434 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.543 HG22 HG13 ' A' ' 263' ' ' ILE . 62.1 t -129.84 125.06 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.855 -0.612 . . . . 5.21 110.201 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.29 144.68 22.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.046 -0.724 . . . . 6.05 109.046 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 261' ' ' LEU . 68.5 ttt180 -64.07 135.21 56.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.637 -0.425 . . . . 7.58 110.518 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -83.17 11.91 5.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 6.04 111.923 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.476 ' H ' ' HG2' ' A' ' 334' ' ' ARG . 9.5 m . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 120.644 0.259 . . . . 7.57 110.644 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.77 0.319 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 205' ' ' VAL . 98.6 mtt180 -117.67 9.4 13.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.044 0.45 . . . . 0.0 110.621 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.597 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 87.1 mtt180 -106.87 133.23 51.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.91 -0.586 . . . . 6.52 110.37 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 52.3 mt -97.2 150.44 20.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.283 -0.417 . . . . 5.24 110.546 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -100.66 105.26 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.912 -0.586 . . . . 6.15 109.443 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.3 p -107.71 129.33 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.232 0.539 . . . . 4.24 110.446 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -129.74 -177.53 14.93 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.484 -0.78 . . . . 4.95 111.78 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 61.78 38.77 14.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.84 0.829 . . . . 0.0 109.375 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.42 HG22 HD22 ' A' ' 224' ' ' LEU . 34.0 pt -84.34 152.34 60.92 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.985 -1.007 . . . . 5.61 111.009 -176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 160' ' ' ILE . 11.6 Cg_exo -71.32 123.08 9.26 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.011 2.474 . . . . 5.97 112.165 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -75.89 113.7 13.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 8.47 109.828 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 132.21 -33.51 2.68 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.784 -0.722 . . . . 6.96 112.283 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 157' ' ' PRO . 11.4 tp -71.26 153.92 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.616 0.246 . . . . 6.1 110.634 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 p -88.9 161.09 16.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.85 0.357 . . . . 6.62 111.223 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.818 ' HA ' HD12 ' A' ' 191' ' ' ILE . 41.6 mt-10 -66.05 -37.94 87.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 5.69 109.71 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.16 -48.82 80.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.023 -0.99 . . . . 7.29 111.296 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.23 90.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.253 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.2 ttm -65.1 -39.88 93.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 4.49 110.53 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.669 ' HE3' ' HB ' ' A' ' 186' ' ' VAL . 23.5 ttt -62.28 -46.22 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.356 . . . . 5.76 110.81 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.66 -38.6 88.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 6.51 110.472 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -57.62 -48.16 80.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.848 -0.615 . . . . 5.44 110.58 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HG2' ' A' ' 173' ' ' MET . 33.2 m-85 -64.47 -47.16 80.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 5.03 111.14 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -54.89 -46.3 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.165 0.291 . . . . 6.3 110.945 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.7 84.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.036 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.3 -37.65 86.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 6.25 111.11 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 33.0 mmt -62.6 -42.25 99.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.928 0.394 . . . . 7.03 110.177 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.18 -52.75 17.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 8.94 111.007 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.62 -34.05 77.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 8.7 111.697 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.85 -16.81 71.75 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.509 -0.853 . . . . 8.11 112.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.06 29.85 30.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 8.49 112.137 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.442 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.9 mp -86.89 -18.8 29.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 7.59 110.092 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.717 HG22 ' HG3' ' A' ' 185' ' ' PRO . 13.2 p -69.27 128.2 35.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.501 -0.772 . . . . 8.73 111.168 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.8 pt20 -94.09 -1.04 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.477 0.656 . . . . 9.89 109.322 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -160.07 155.43 21.84 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.082 -0.963 . . . . 9.69 109.476 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.7 168.78 15.9 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.503 2.135 . . . . 10.74 112.136 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.87 -138.61 14.15 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.029 -0.605 . . . . 8.97 112.509 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 90.5 m-20 -116.44 118.05 37.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.588 0.232 . . . . 7.58 110.574 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.717 ' HG3' HG22 ' A' ' 179' ' ' THR . 18.3 Cg_exo -66.61 -26.52 46.36 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.866 2.377 . . . . 6.4 111.864 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.669 ' HB ' ' HE3' ' A' ' 166' ' ' MET . 40.3 t -82.54 127.26 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.949 -0.568 . . . . 5.47 110.112 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 284' ' ' PRO . 45.0 tp -91.8 -40.4 11.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.232 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -143.34 121.16 11.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.012 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.36 115.4 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.89 -0.595 . . . . 4.68 110.144 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -128.67 106.41 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 6.34 110.157 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 162' ' ' GLU . 66.5 mt -113.97 123.06 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.241 -0.436 . . . . 5.85 111.655 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -100.54 99.62 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -85.51 -16.93 37.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.69 . . . . 7.61 110.167 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -62.57 -47.55 83.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.616 -0.72 . . . . 9.12 110.957 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 45.1 mmtm -105.57 9.04 33.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.286 -0.415 . . . . 9.1 111.207 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.01 48.58 5.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.412 -0.813 . . . . 6.6 111.82 171.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 37.1 p90 -148.19 142.83 26.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.818 -0.438 . . . . 6.67 109.818 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -134.28 150.46 50.99 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.921 0.391 . . . . 4.58 111.354 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.597 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 74.8 m-85 -117.37 108.47 15.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.63 -0.713 . . . . 6.22 109.889 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 87.3 mt -94.85 114.54 26.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.08 -0.509 . . . . 4.77 109.63 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.597 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 36.1 tt0 -94.06 119.49 33.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.814 -0.439 . . . . 6.55 109.814 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.13 164.21 13.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.181 0.515 . . . . 6.51 111.213 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -73.31 -11.65 60.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.355 -0.839 . . . . 8.27 111.089 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 76.0 p -141.68 -166.75 2.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.198 -0.456 . . . . 7.96 110.219 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.592 HG22 ' HG2' ' A' ' 149' ' ' ARG . 21.8 t -116.58 -30.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.268 -0.642 . . . . 8.73 109.268 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.59 -60.44 3.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.085 -0.962 . . . . 8.5 111.377 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 42.4 mt-10 -58.88 -40.32 84.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4 110.078 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 m -52.45 -52.14 55.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.633 -0.712 . . . . 6.13 110.835 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.7 m -63.0 -34.23 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.522 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.442 ' HG3' HD23 ' A' ' 178' ' ' LEU . 9.3 tp-100 -71.17 -30.9 67.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.137 -0.483 . . . . 7.75 110.215 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -72.1 -15.03 62.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.523 . . . . 5.43 111.273 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.31 -16.02 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 6.29 111.117 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.25 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 6.14 111.55 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 217' ' ' ILE . 69.7 m-85 -93.04 21.47 5.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.444 -0.344 . . . . 5.57 111.577 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.15 109.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 5.92 110.369 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.97 13.25 22.11 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.933 -0.651 . . . . 5.74 112.233 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 214' ' ' PHE . 17.6 tt -66.41 141.8 17.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 5.3 111.2 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.2 tp -82.45 114.1 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.508 0.67 . . . . 6.8 111.098 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.27 112.77 10.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.589 -0.732 . . . . 5.79 110.701 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 59.57 31.41 20.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.863 -0.608 . . . . 7.32 111.737 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.53 -24.76 29.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.855 -0.688 . . . . 7.28 112.585 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.95 167.28 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.879 0.371 . . . . 7.21 110.777 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -118.15 99.79 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.385 -0.598 . . . . 6.14 109.385 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 156' ' ' ILE . 82.6 mt -66.14 112.93 4.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 4.9 111.59 -172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.3 tttt -81.83 124.73 29.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.517 -0.765 . . . . 7.3 109.91 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -118.76 106.22 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.029 0.443 . . . . 5.37 110.741 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -134.51 171.63 14.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 6.97 110.301 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 20.2 mtp180 -83.62 134.97 43.87 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.788 -0.449 . . . . 7.37 109.788 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.597 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 32.1 Cg_exo -60.28 165.9 10.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.004 2.469 . . . . 7.98 112.762 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -79.62 165.84 22.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.884 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.96 102.2 3.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -126.25 131.1 51.99 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -113.27 124.66 31.0 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.64 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.9 114.43 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.102 1.868 . . . . 0.0 110.855 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.65 114.85 25.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.497 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.51 -172.31 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.824 2.349 . . . . 0.0 111.9 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 240' ' ' GLU . . . -118.18 153.44 17.09 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.039 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 84.9 mtp -92.88 -57.35 2.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 50.3 m -136.78 15.46 3.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.515 ' O ' ' HA3' ' A' ' 237' ' ' GLY . 0.0 OUTLIER -162.08 -169.07 2.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.565 -174.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.37 141.88 24.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.407 ' HD2' ' HE2' ' A' ' 245' ' ' TYR . 84.8 Cg_exo -49.62 -38.73 45.99 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.534 2.156 . . . . 0.0 111.42 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 9.0 t -146.2 -75.62 0.21 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.8 -44.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.739 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.407 ' HE2' ' HD2' ' A' ' 242' ' ' PRO . 68.1 m-85 63.39 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.181 0.592 . . . . 0.0 111.294 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 4.6 p -160.64 128.36 2.77 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.175 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 26.9 Cg_exo -62.54 100.83 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.181 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.8 0.42 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.27 142.54 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 250' ' ' VAL . 6.7 t 61.33 19.55 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.701 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 21.3 p -98.14 -25.35 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.305 0.574 . . . . 0.0 109.971 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.6 p -94.8 91.72 6.6 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 254' ' ' VAL . 31.2 m -92.22 -20.26 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.175 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 253' ' ' VAL . 27.1 m -109.83 156.1 40.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.858 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.09 -31.57 90.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.756 2.304 . . . . 0.0 112.242 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.16 117.48 7.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.237 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 30.5 t -155.09 120.98 5.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -75.06 89.39 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.444 ' CE1' ' HA ' ' A' ' 310' ' ' ILE . 13.2 t60 -127.31 1.1 6.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.026 -0.534 . . . . 8.75 110.859 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.685 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.2 ttmt -78.09 129.97 35.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.908 -0.587 . . . . 6.04 110.541 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.41 HD23 ' HG2' ' A' ' 334' ' ' ARG . 82.8 mt -96.07 140.78 30.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.201 0.524 . . . . 5.29 110.792 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -103.45 115.12 29.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.249 -0.887 . . . . 4.77 108.627 171.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 263' ' ' ILE . 4.3 mp -105.43 110.05 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.909 -0.587 . . . . 3.94 109.674 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -122.1 171.74 15.37 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.025 -0.607 . . . . 4.58 111.814 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.78 27.51 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.664 -0.779 . . . . 5.58 111.923 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 96.8 mt -106.36 142.06 24.11 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.646 0.26 . . . . 5.92 110.569 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 15.1 Cg_exo -70.36 160.41 49.63 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.771 2.314 . . . . 6.94 111.507 173.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -88.42 -9.52 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.033 0.383 . . . . 8.81 112.033 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -83.08 -2.14 54.6 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.45 -0.5 . . . . 8.73 110.97 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.2 mp -78.68 117.4 19.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 7.52 110.108 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.38 160.11 22.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.062 -0.517 . . . . 8.79 110.817 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.23 -44.45 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.356 -0.838 . . . . 7.62 112.584 -173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.83 -45.26 92.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.816 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.5 -46.49 88.19 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.64 0.257 . . . . 8.69 111.012 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.46 -44.57 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 6.64 110.646 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -62.94 -48.08 80.46 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.378 -0.374 . . . . 7.74 110.82 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -56.5 -47.82 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 9.38 110.653 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.72 -54.74 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 7.06 110.584 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 288' ' ' PHE . 99.3 mt -69.46 -32.15 70.88 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.879 0.325 . . . . 6.89 111.879 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 36.1 m -72.2 -19.74 61.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.024 0.44 . . . . 8.85 110.926 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 50.5 m -79.63 -0.83 35.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.439 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 320' ' ' LEU . 94.7 m-85 -120.68 14.46 11.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 9.18 110.917 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 143.7 159.93 8.21 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.567 -0.825 . . . . 9.06 112.517 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' A' ' 187' ' ' LEU . 55.5 Cg_endo -71.37 122.39 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.658 2.239 . . . . 10.14 112.31 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.96 135.46 33.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 8.3 110.436 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.9 ptpt -99.33 -26.83 14.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.577 -0.527 . . . . 8.65 109.577 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -145.24 136.66 25.14 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.453 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.531 ' HE2' HD12 ' A' ' 279' ' ' LEU . 16.6 t80 -144.84 110.12 5.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.869 -0.605 . . . . 6.27 109.553 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.627 HD21 ' HB2' ' A' ' 304' ' ' PHE . 3.3 p-10 -127.59 116.97 21.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.287 0.565 . . . . 5.79 110.44 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -93.23 130.04 39.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.469 -0.787 . . . . 6.35 109.973 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.65 112.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.017 0.437 . . . . 6.61 110.457 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 299' ' ' SER . 63.0 mttm -106.96 167.83 9.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.605 . . . . 8.17 110.124 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.47 128.06 34.92 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.192 -0.67 . . . . 10.33 109.192 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.3 m -63.87 -28.65 69.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.072 0.397 . . . . 10.8 112.072 -174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -95.47 -51.99 4.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 12.13 111.121 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 23.8 m -68.6 -51.46 42.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 11.16 111.227 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 108.77 -25.09 20.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.742 -0.742 . . . . 10.11 112.172 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.62 164.38 26.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 10.12 110.775 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 292' ' ' LYS . 42.6 t -68.18 154.24 42.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.971 -0.559 . . . . 7.73 110.581 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -86.86 -8.69 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.948 -0.569 . . . . 8.01 109.93 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.27 17.16 35.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.791 -0.719 . . . . 6.09 113.209 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -156.44 155.94 32.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.682 0.277 . . . . 6.54 110.513 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -151.51 166.41 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.193 -0.458 . . . . 4.38 111.368 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.5 m-85 -115.75 127.47 55.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.043 -0.725 . . . . 4.93 109.043 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.4 m -144.19 131.18 20.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.66 0.267 . . . . 5.09 110.681 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 32.5 tt0 -116.08 130.16 56.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.899 0.381 . . . . 7.03 110.399 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -83.34 158.44 22.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 7.81 110.574 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 286' ' ' LYS . 62.9 t -78.63 -55.88 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 10.03 110.464 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.27 147.87 44.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 10.81 110.837 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.865 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -94.03 -4.03 10.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 9.77 112.065 -175.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -93.85 -50.72 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.732 0.301 . . . . 10.89 110.526 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.68 -24.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 9.5 112.172 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 317' ' ' ILE . 31.3 m -59.54 -50.68 72.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.931 0.345 . . . . 7.83 111.931 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -75.09 -29.04 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 8.79 110.63 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -68.64 -39.25 80.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.973 -0.558 . . . . 10.51 110.157 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.32 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.769 -0.651 . . . . 7.31 110.231 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 332' ' ' VAL . 78.8 mt -61.95 -46.06 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 6.44 110.4 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.52 69.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.845 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -91.91 -54.68 1.86 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.536 -0.84 . . . . 7.46 113.241 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.402 HD21 ' CE2' ' A' ' 282' ' ' PHE . 96.4 mt -69.26 -50.23 48.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.683 0.253 . . . . 6.42 111.683 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.738 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.8 t30 -63.79 114.04 3.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.727 -0.472 . . . . 6.53 109.727 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.67 7.08 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.8 -0.714 . . . . 6.77 111.815 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.7 mtt -74.16 170.49 15.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.725 -0.472 . . . . 7.29 109.725 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -134.56 118.76 17.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.028 0.442 . . . . 7.83 110.891 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.71 99.1 10.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.292 -0.633 . . . . 7.01 109.292 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.5 2.12 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.732 -0.747 . . . . 8.18 111.516 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -110.52 2.38 18.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.878 0.371 . . . . 8.94 110.582 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -105.06 135.51 46.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 7.29 110.687 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.48 127.25 35.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.738 -0.468 . . . . 7.13 109.738 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.47 115.34 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 5.63 110.664 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 54.5 tp -106.72 115.99 31.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.507 -0.77 . . . . 5.53 109.887 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 61.9 t -126.42 120.51 56.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.274 -0.421 . . . . 5.21 110.094 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -154.33 176.83 11.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.138 -0.69 . . . . 6.05 109.138 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' HD23 ' A' ' 261' ' ' LEU . 59.8 mtm180 -82.29 147.39 28.92 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.598 -0.441 . . . . 7.58 109.875 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.4 67.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 6.04 112.271 -173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.1 m -86.56 -82.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.096 -0.242 . . . . 7.57 111.341 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 93.8 t 63.52 107.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.774 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -61.79 -71.74 0.76 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.553 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -169.62 98.89 0.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.964 0.412 . . . . 0.0 110.673 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -96.0 -49.52 5.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 64.24 20.95 12.38 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.796 -179.307 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.746 0.308 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 202' ' ' PHE . 37.3 ptt180 -90.87 -1.4 57.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 68.5 mtt180 -98.12 164.28 12.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.049 0.452 . . . . 6.52 111.4 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 64.0 mt -136.86 158.41 44.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.268 -0.878 . . . . 5.24 109.86 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -107.94 113.47 26.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.831 -0.622 . . . . 6.15 109.519 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.8 p -113.19 129.1 69.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.233 0.539 . . . . 4.24 110.763 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -119.03 177.8 16.46 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.629 -0.714 . . . . 4.95 111.759 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.48 63.59 1.67 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.352 0.596 . . . . 0.0 110.4 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.0 pt -101.67 155.56 36.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.568 -0.742 . . . . 5.61 110.264 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.659 ' HB2' ' HB ' ' A' ' 160' ' ' ILE . 16.1 Cg_exo -69.07 131.03 21.3 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.724 2.282 . . . . 5.97 112.013 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -79.47 102.46 8.78 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 8.47 109.674 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.27 20.64 6.18 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.953 -0.642 . . . . 6.96 111.895 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.659 ' HB ' ' HB2' ' A' ' 157' ' ' PRO . 11.0 tp -94.03 146.33 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.769 -0.456 . . . . 6.1 109.769 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.2 p -86.68 154.05 21.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 6.62 111.5 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.518 -0.765 . . . . 5.69 110.288 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.78 -48.1 80.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.719 -0.673 . . . . 7.29 110.408 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.45 -50.8 70.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.225 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 94.5 mmm -63.14 -48.88 76.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.194 -0.457 . . . . 4.49 110.958 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 281' ' ' SER . 1.9 tmt? -61.13 -51.6 68.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 5.76 110.787 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.46 -36.26 83.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 6.51 111.536 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -59.86 -48.72 80.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.681 0.277 . . . . 5.44 111.28 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.458 ' HE1' HD11 ' A' ' 226' ' ' ILE . 60.4 m-85 -64.3 -35.91 82.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.571 -0.286 . . . . 5.03 110.728 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 82.5 m-20 -60.22 -50.4 73.83 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.91 -0.404 . . . . 6.3 109.91 175.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -56.8 -47.54 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.473 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -62.99 -39.47 94.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.606 -0.27 . . . . 6.25 111.072 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.854 ' HB3' HG23 ' A' ' 179' ' ' THR . 26.4 mmt -62.74 -41.75 99.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 7.03 110.54 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 84.8 mtt180 -67.29 -52.2 43.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 8.94 111.0 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 89.3 mt -60.38 -33.91 73.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.86 -0.609 . . . . 8.7 111.693 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -88.19 -21.46 45.31 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.334 -0.936 . . . . 8.11 112.284 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.03 27.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.983 -0.627 . . . . 8.49 111.981 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' A' ' 210' ' ' GLN . 4.2 mp -97.93 -5.32 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.158 0.504 . . . . 7.59 110.505 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.854 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.0 OUTLIER -79.3 156.46 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 8.73 111.049 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.43 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -87.79 -14.9 38.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.255 0.55 . . . . 9.89 109.94 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -156.2 144.89 14.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 9.69 109.84 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.57 113.26 2.22 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.647 2.231 . . . . 10.74 111.835 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.46 -137.77 5.08 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.655 -0.783 . . . . 8.97 112.381 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -112.06 108.34 55.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.539 0.209 . . . . 7.58 110.665 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.594 ' HG3' ' HG3' ' A' ' 173' ' ' MET . 45.1 Cg_endo -68.69 -34.63 18.5 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.749 2.299 . . . . 6.4 111.85 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.76 128.7 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 5.47 109.514 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 284' ' ' PRO . 26.6 tp -105.25 -33.24 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.978 0.418 . . . . 0.0 110.361 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -152.32 155.01 36.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.321 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 200' ' ' LEU . 7.2 p -143.02 133.1 22.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.926 0.393 . . . . 4.68 110.604 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.33 106.73 12.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 6.34 110.047 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.35 130.56 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.05 -0.523 . . . . 5.85 111.428 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -121.59 96.8 5.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.837 -0.801 . . . . 7.34 108.837 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -83.48 -6.68 59.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.044 -0.525 . . . . 7.61 110.962 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -66.66 -51.91 50.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 9.12 110.619 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.522 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.4 mmtm -102.89 -0.24 31.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.22 -0.445 . . . . 9.1 110.406 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 66.76 61.52 0.53 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.345 -0.843 . . . . 6.6 111.924 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 48.6 p90 -149.43 163.52 37.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 6.67 109.506 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.61 153.27 40.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.943 0.402 . . . . 4.58 111.095 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.05 122.65 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.852 -0.613 . . . . 6.22 110.161 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 75.2 mt -100.69 116.0 31.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 4.77 110.279 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 5.2 tt0 -101.34 113.75 27.11 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.682 -0.488 . . . . 6.55 109.682 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.404 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 69.9 m-85 -90.59 160.11 16.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.077 -0.51 . . . . 6.51 110.825 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.74 -25.08 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 8.27 110.877 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 93.2 p -132.16 -178.29 4.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.171 -0.468 . . . . 7.96 110.053 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.89 -16.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.707 0.765 . . . . 8.73 109.032 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.54 -54.65 21.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.998 -1.001 . . . . 8.5 111.078 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.43 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 36.2 mt-10 -66.45 -30.32 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.01 -0.541 . . . . 7.4 110.897 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -50.71 -45.31 58.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.467 -0.788 . . . . 6.13 112.02 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 m -56.37 -43.46 79.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.688 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.759 ' HB3' HD23 ' A' ' 178' ' ' LEU . 2.2 mp0 -73.64 -28.06 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.51 -0.313 . . . . 7.75 110.853 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.402 ' HA ' ' HE3' ' A' ' 173' ' ' MET . . . -63.27 -21.5 66.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 5.43 110.617 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.3 mtp -71.58 -14.83 62.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 6.29 111.22 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.01 -13.56 62.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.03 0.443 . . . . 6.14 110.879 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.716 ' HD2' HD12 ' A' ' 217' ' ' ILE . 68.7 m-85 -100.02 17.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.055 -0.52 . . . . 5.57 110.753 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.59 107.07 1.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 5.92 110.392 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.74 14.23 23.8 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.955 -0.64 . . . . 5.74 112.194 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.716 HD12 ' HD2' ' A' ' 214' ' ' PHE . 16.1 tt -68.01 135.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.045 0.45 . . . . 5.3 110.689 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.79 114.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.386 0.612 . . . . 6.8 111.045 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -134.58 118.65 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.639 -0.709 . . . . 5.79 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 59.63 26.72 15.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.025 -0.534 . . . . 7.32 111.516 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 91.87 -5.48 79.26 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.682 -0.77 . . . . 7.28 112.881 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.564 0.221 . . . . 7.21 110.691 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.1 t -101.0 95.1 6.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.428 -0.582 . . . . 6.14 109.428 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.45 106.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.845 -0.616 . . . . 4.9 111.459 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 88.4 tttt -82.22 113.92 20.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.709 -0.678 . . . . 7.3 109.715 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.458 HD11 ' HE1' ' A' ' 169' ' ' PHE . 67.3 mt -109.1 107.22 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.053 0.454 . . . . 5.37 110.625 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -124.9 170.38 11.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.764 -0.653 . . . . 6.97 109.74 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -87.73 154.58 53.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 121.043 -0.263 . . . . 7.37 110.71 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 55.8 Cg_endo -69.76 173.42 11.0 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.744 2.296 . . . . 7.98 111.809 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 229' ' ' PRO . 35.1 m-70 69.41 11.87 8.16 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.38 -44.3 29.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -93.63 -52.85 4.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.675 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 63.08 89.73 0.1 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.153 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.5 111.34 2.93 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.85 2.366 . . . . 0.0 111.769 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 236' ' ' PRO . 7.3 mp 63.34 92.2 0.07 OUTLIER Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.769 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 235' ' ' LEU . 15.4 Cg_endo -57.35 -30.91 89.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.321 2.681 . . . . 0.0 113.038 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 175.06 77.14 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.25 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 52.7 ttp -94.66 100.25 12.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.5 m -104.42 104.35 14.21 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.26 -36.59 84.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.291 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.32 151.3 42.7 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.918 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.07 -151.48 0.03 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.557 2.172 . . . . 0.0 111.323 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.8 m -77.38 60.75 2.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.11 0.481 . . . . 0.0 111.062 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.63 116.11 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.459 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -89.48 129.17 36.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.102 0.477 . . . . 0.0 110.978 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.17 115.1 65.82 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.412 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.99 -179.03 1.53 Allowed 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.655 2.236 . . . . 0.0 112.149 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.98 124.62 36.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.103 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 33.3 t -83.81 122.23 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.905 0.383 . . . . 0.0 110.286 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.0 p -85.05 153.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.366 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.2 m -59.72 132.98 55.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.597 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 253' ' ' VAL . 0.2 OUTLIER -82.61 175.52 10.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.571 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 252' ' ' THR . 62.3 t -57.83 -58.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 110.229 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 8.0 m -135.19 119.49 13.4 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.538 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 5.7 Cg_exo -79.2 -5.09 14.23 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.054 2.502 . . . . 0.0 111.775 177.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.26 109.09 13.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.202 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 m -101.71 122.59 44.21 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -70.15 118.21 12.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.65 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.588 ' HB3' HG21 ' A' ' 313' ' ' THR . 47.2 m80 -130.97 15.4 5.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.57 -0.741 . . . . 8.75 109.077 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.479 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.7 ttmt -59.22 125.12 22.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.096 -0.957 . . . . 6.04 111.809 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.3 mt -100.29 135.58 41.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.326 -0.852 . . . . 5.29 110.001 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.425 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 93.6 t80 -93.09 111.13 22.66 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.145 -0.687 . . . . 4.77 109.145 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.749 HG23 HD11 ' A' ' 330' ' ' LEU . 2.3 mp -91.45 109.09 20.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.838 -0.619 . . . . 3.94 109.637 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.86 112.16 2.17 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.623 -0.798 . . . . 4.58 112.298 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 137.06 45.81 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.828 -0.701 . . . . 5.58 112.21 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.9 mt -110.51 144.58 30.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 5.92 110.998 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.4 158.28 22.61 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.158 2.572 . . . . 6.94 111.694 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -83.95 -13.08 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.572 0.225 . . . . 8.81 111.305 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -81.67 -6.78 59.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 8.73 110.21 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 275' ' ' VAL . 13.8 tp -87.8 120.66 29.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 7.52 109.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 275' ' ' VAL . 33.4 p30 -91.0 174.21 7.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 8.79 111.284 -176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.58 -32.1 72.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.691 -0.686 . . . . 7.62 111.417 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.18 -54.62 38.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.683 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.75 -34.95 77.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.672 -0.694 . . . . 8.69 111.742 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 271' ' ' ASN . 62.9 t -63.0 -48.84 86.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.778 0.323 . . . . 6.64 110.465 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.04 -42.7 94.07 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.558 -0.292 . . . . 7.74 110.616 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.0 -46.85 84.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.02 -0.536 . . . . 9.38 111.249 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -46.94 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.604 . . . . 7.06 110.116 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.3 mt -69.8 -36.05 75.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.175 -0.466 . . . . 6.89 111.236 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 39.1 m -68.31 -19.71 64.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.03 0.443 . . . . 8.85 110.995 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.472 ' HA ' ' CE ' ' A' ' 166' ' ' MET . 38.3 m -68.39 -12.28 60.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -123.92 11.58 8.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.404 . . . . 9.18 111.307 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 145.93 163.95 10.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.442 -0.885 . . . . 9.06 113.115 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HB3' HD11 ' A' ' 187' ' ' LEU . 86.3 Cg_endo -83.52 134.88 6.76 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.94 2.427 . . . . 10.14 112.642 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.2 mt -90.8 142.14 28.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.381 -0.372 . . . . 8.3 110.568 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.466 ' HB3' HG22 ' A' ' 308' ' ' VAL . 7.8 ptpp? -103.18 -22.86 13.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.385 -0.598 . . . . 8.65 109.385 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.1 132.49 23.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -145.77 123.52 11.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.224 -0.444 . . . . 6.27 110.586 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.91 118.49 12.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.388 0.614 . . . . 5.79 109.955 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.745 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.5 tp -91.83 125.43 36.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.658 -0.701 . . . . 6.35 109.172 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 303' ' ' ALA . 46.4 t -76.75 112.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.356 -0.538 . . . . 6.61 110.137 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.58 153.17 19.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.475 -0.784 . . . . 8.17 109.985 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.668 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 21.2 t70 -64.68 145.53 56.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.349 -0.387 . . . . 10.33 110.237 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.1 m -63.64 -28.33 69.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.033 -0.53 . . . . 10.8 111.738 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -116.62 -40.99 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.99 0.367 . . . . 12.13 111.99 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 30.0 m -69.1 -46.91 66.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.719 0.295 . . . . 11.16 111.362 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.0 -1.63 70.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 10.11 112.962 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.51 170.36 9.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.008 -0.367 . . . . 10.12 110.008 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.7 t -58.08 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.12 0.485 . . . . 7.73 111.022 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.668 ' HD3' ' HA ' ' A' ' 293' ' ' ASP . 31.9 mmmt -85.81 -3.45 58.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 8.01 109.982 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 103.4 -3.84 47.22 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.805 -0.712 . . . . 6.09 112.245 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 18.4 p90 -141.62 157.12 45.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 6.54 111.436 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -156.91 167.06 31.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.824 -0.626 . . . . 4.38 110.844 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.479 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.6 m-85 -116.27 125.61 52.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.205 -0.665 . . . . 4.93 109.205 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 28.9 m -144.32 136.65 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.646 0.26 . . . . 5.09 111.009 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.68 132.29 49.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.758 0.313 . . . . 7.03 110.253 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 42.3 m-85 -79.11 166.61 22.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.057 -0.52 . . . . 7.81 110.78 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 286' ' ' LYS . 56.9 t -76.32 -51.65 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.197 -0.456 . . . . 10.03 110.23 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.546 ' HB3' HG22 ' A' ' 312' ' ' VAL . 16.5 t70 -92.47 156.11 17.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.755 -0.657 . . . . 10.81 110.262 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.766 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -78.86 -30.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.52 -0.309 . . . . 9.77 111.462 -176.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -67.4 -49.34 64.22 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 110.211 -0.292 . . . . 10.89 110.211 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.618 HG21 ' HD2' ' A' ' 284' ' ' PRO . 19.8 m -65.56 -26.06 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 9.5 111.542 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.588 HG21 ' HB3' ' A' ' 259' ' ' HIS . 86.1 m -64.47 -49.81 69.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.324 0.583 . . . . 7.83 110.11 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.1 -24.46 58.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 8.79 110.991 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . 0.47 ' HB2' ' HA ' ' A' ' 312' ' ' VAL . 45.4 mt-30 -63.42 -40.25 96.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 10.51 110.17 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 320' ' ' LEU . . . -62.22 -44.91 95.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.235 -0.439 . . . . 7.31 110.516 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.36 -36.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 6.44 111.297 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -83.82 -52.39 6.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.778 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.55 -37.19 24.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.035 -0.602 . . . . 7.46 113.956 -172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' A' ' 330' ' ' LEU . 80.3 mt -83.92 -36.91 22.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.257 0.528 . . . . 6.42 111.993 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 6.4 t30 -61.97 119.94 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.732 0.301 . . . . 6.53 110.529 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.03 -22.47 20.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.926 -0.654 . . . . 6.77 112.297 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 23.9 ttt -71.31 123.26 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.298 -0.26 . . . . 7.29 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.474 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 51.4 mt-30 -82.98 117.5 22.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 7.83 111.466 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -91.03 94.86 9.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.559 -0.904 . . . . 7.01 108.559 171.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 80.23 -87.36 1.29 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.547 -0.835 . . . . 8.18 111.181 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -126.51 -25.1 3.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.764 0.316 . . . . 8.94 110.865 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 324' ' ' GLN . 94.7 mttt -85.79 134.98 33.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 7.29 110.92 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 92.8 mttt -77.47 126.29 30.68 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.454 -0.573 . . . . 7.13 109.454 172.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 263' ' ' ILE . 30.8 tp -67.77 102.56 1.24 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.954 0.407 . . . . 5.63 110.258 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 53.4 tp -93.57 111.82 23.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.888 -0.596 . . . . 5.53 109.674 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.07 108.8 26.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 5.21 109.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 17.6 pt20 -124.04 124.32 42.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.104 -0.498 . . . . 6.05 110.216 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -72.16 123.03 22.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.966 -0.383 . . . . 7.58 109.966 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -111.32 95.48 5.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 6.04 110.532 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 m -147.04 -38.17 0.21 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 7.57 110.358 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 29.0 t 55.29 81.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.852 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.67 -145.61 26.38 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.014 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.54 -18.2 21.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.573 0.225 . . . . 0.0 110.736 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 70.55 -72.33 0.11 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.358 0.663 . . . . 0.0 111.877 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -95.49 -51.97 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.819 0.342 . . . . 0.0 110.247 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.475 179.567 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.6 -3.36 16.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.215 0.531 . . . . 0.0 109.638 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 98.7 mtt180 -101.66 146.64 27.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.507 -0.769 . . . . 6.52 110.655 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.9 mt -110.14 147.08 34.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.241 -0.436 . . . . 5.24 110.05 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 85.1 t80 -102.62 103.55 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.004 -0.544 . . . . 6.15 110.062 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 198' ' ' ALA . 7.6 p -105.33 133.72 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.236 0.541 . . . . 4.24 110.691 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -131.77 -179.66 16.37 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 4.95 111.984 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.09 29.77 14.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.367 0.603 . . . . 0.0 109.999 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.1 pt -74.77 151.52 86.78 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.26 -0.882 . . . . 5.61 111.02 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.38 137.18 63.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.8 2.333 . . . . 5.97 111.899 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -81.62 114.32 20.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.934 0.397 . . . . 8.47 110.043 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 115.87 -2.02 21.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.713 -0.756 . . . . 6.96 112.153 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.3 tp -76.48 140.87 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.967 -0.383 . . . . 6.1 109.967 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -88.56 154.62 20.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.783 0.325 . . . . 6.62 110.608 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.902 ' HA ' HD12 ' A' ' 191' ' ' ILE . 39.8 mt-10 -60.44 -38.49 84.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 5.69 110.071 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -56.1 -55.63 30.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.257 -0.883 . . . . 7.29 111.295 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.38 93.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 169' ' ' PHE . 46.5 ttm -67.95 -42.22 81.3 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.998 -0.281 . . . . 4.49 110.476 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 281' ' ' SER . 26.8 ttt -62.95 -45.82 90.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 5.76 110.422 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.16 -41.4 75.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.559 . . . . 6.51 110.985 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.455 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 78.0 t80 -57.83 -51.9 67.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 5.44 110.95 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.408 ' HD2' ' O ' ' A' ' 165' ' ' MET . 68.1 m-85 -66.38 -39.87 89.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 5.03 111.226 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.2 m-20 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 6.3 110.384 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.91 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 15.8 mm100 -61.85 -42.19 98.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.558 -0.292 . . . . 6.25 110.969 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.521 ' HB3' HG23 ' A' ' 179' ' ' THR . 86.2 mmm -66.04 -36.65 83.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.292 -0.413 . . . . 7.03 110.968 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 66.9 mtt180 -72.47 -52.3 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.524 -0.307 . . . . 8.94 110.961 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.06 -36.01 77.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 8.7 111.51 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -73.08 -21.01 80.15 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.87 -0.681 . . . . 8.11 112.532 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.88 39.33 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 8.49 112.5 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.24 9.33 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 7.59 110.192 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 173' ' ' MET . 1.6 p -114.62 105.19 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 8.73 111.504 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -80.74 -22.96 39.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 9.89 109.972 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -112.65 137.81 21.84 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.956 -0.566 . . . . 9.69 110.238 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 161.1 37.73 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.798 2.332 . . . . 10.74 112.108 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.09 -152.78 18.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.824 -0.703 . . . . 8.97 112.099 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 185' ' ' PRO . 94.6 m-20 -109.22 122.72 38.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.786 -0.244 . . . . 7.58 111.094 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.416 ' HG3' ' CB ' ' A' ' 173' ' ' MET . 19.7 Cg_endo -60.75 -36.68 83.41 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.946 2.431 . . . . 6.4 111.374 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.9 t -81.33 127.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.827 -0.805 . . . . 5.47 108.827 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 20.5 tp -90.92 -39.19 12.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.06 153.66 33.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.606 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.448 HG23 HD23 ' A' ' 200' ' ' LEU . 7.4 p -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.27 -0.423 . . . . 4.68 110.804 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -130.65 106.87 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 6.34 109.699 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 162' ' ' GLU . 51.5 mt -110.95 126.92 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.162 0.506 . . . . 5.85 111.578 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -101.91 101.31 11.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 7.34 108.388 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.19 -27.83 53.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.829 -0.623 . . . . 7.61 110.648 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.92 -49.03 72.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.024 -0.535 . . . . 9.12 111.281 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.17 -6.89 54.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 9.1 111.068 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 64.51 56.36 1.24 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.833 -0.621 . . . . 6.6 111.321 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 40.3 p90 -149.04 149.12 30.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.047 -0.524 . . . . 6.67 109.879 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -134.19 140.19 46.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.775 0.321 . . . . 4.58 111.087 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 42.5 m-85 -108.32 109.02 20.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.868 -0.606 . . . . 6.22 110.139 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 44.7 mt -93.27 114.01 26.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.32 -0.622 . . . . 4.77 109.32 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.69 114.64 26.3 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.136 -0.32 . . . . 6.55 110.136 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -89.7 155.96 18.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.257 -0.428 . . . . 6.51 110.892 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.7 -22.6 60.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.734 -0.666 . . . . 8.27 110.972 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 94.6 p -148.18 142.85 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.964 -0.384 . . . . 7.96 109.964 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.415 ' HA ' ' OG1' ' A' ' 208' ' ' THR . 94.6 t -63.94 -28.62 45.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.021 0.439 . . . . 8.73 110.373 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.68 -40.94 69.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.643 -0.708 . . . . 8.5 110.581 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.3 -29.62 26.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.8 -0.637 . . . . 7.4 110.965 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 205' ' ' VAL . 32.2 m -54.06 -51.52 63.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.923 0.392 . . . . 6.13 110.803 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.72 -24.9 67.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.707 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -68.09 -35.55 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.958 0.408 . . . . 7.75 110.196 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -74.78 -14.28 60.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 5.43 110.91 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.2 mtp -69.43 -20.54 63.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.951 0.405 . . . . 6.29 110.289 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.37 -15.21 61.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.92 -0.582 . . . . 6.14 110.801 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.659 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 90.7 m-85 -92.86 6.5 47.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 5.57 110.945 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -61.48 124.23 20.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.699 0.285 . . . . 5.92 110.244 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.68 35.2 11.93 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.686 -0.768 . . . . 5.74 111.56 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.87 137.89 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.941 -0.392 . . . . 5.3 109.941 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.04 119.15 31.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.301 0.572 . . . . 6.8 110.756 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -133.01 112.28 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.085 -0.507 . . . . 5.79 110.985 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 56.66 35.02 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.769 -0.651 . . . . 7.32 111.94 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.86 78.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.649 -0.786 . . . . 7.28 113.045 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -118.04 124.1 47.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.334 . . . . 7.21 110.64 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.6 t -77.3 115.89 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.158 -0.682 . . . . 6.14 109.158 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.5 118.69 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 4.9 110.98 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.0 tttt -88.36 114.15 24.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 7.3 109.642 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.0 mt -109.52 106.56 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.078 0.466 . . . . 5.37 110.428 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 4.5 mmp_? -114.92 170.09 8.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.892 -0.594 . . . . 6.97 110.508 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -83.94 125.13 73.68 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.268 -0.641 . . . . 7.37 109.268 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.561 ' HB3' ' HE1' ' A' ' 199' ' ' PHE . 18.1 Cg_endo -58.55 129.63 33.42 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.607 2.205 . . . . 7.98 111.379 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.592 ' HB2' ' HD2' ' A' ' 232' ' ' TYR . 8.2 p-80 -62.19 134.85 57.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.88 0.372 . . . . 0.0 110.595 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.34 -4.0 16.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.379 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 230' ' ' HIS . 17.5 m-85 -79.37 57.9 2.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.74 176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 28.9 tt0 -58.81 125.61 77.89 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.574 -177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 233' ' ' GLN . 3.3 Cg_endo -46.83 134.28 17.61 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.802 3.001 . . . . 0.0 113.003 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.8 mt 61.22 83.48 0.21 Allowed Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.68 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.58 133.78 44.73 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.439 2.76 . . . . 0.0 112.888 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.447 ' HA3' ' HG3' ' A' ' 242' ' ' PRO . . . 146.65 63.6 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.08 -60.1 1.76 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 0.0 110.234 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 27.7 m -83.32 2.02 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.163 0.506 . . . . 0.0 110.683 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.89 172.68 17.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.143 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -97.81 132.84 24.17 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.378 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.447 ' HG3' ' HA3' ' A' ' 237' ' ' GLY . 43.3 Cg_exo -56.52 112.09 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.845 2.363 . . . . 0.0 111.845 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.7 p -101.04 97.18 7.77 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.167 0.508 . . . . 0.0 111.182 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.21 -59.96 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.577 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -108.38 -31.97 7.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.208 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.58 126.9 24.6 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.56 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.41 -46.28 25.52 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.629 2.219 . . . . 0.0 112.255 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 148.31 91.43 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.868 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.699 HG23 HG12 ' A' ' 250' ' ' VAL . 34.5 m -115.05 -26.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.698 0.285 . . . . 0.0 110.928 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.699 HG12 HG23 ' A' ' 249' ' ' VAL . 9.3 p -175.91 -41.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.813 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 50.0 m 56.68 74.77 0.39 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.321 0.581 . . . . 0.0 111.387 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 51.7 m -87.22 93.58 9.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.305 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.44 -46.57 70.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.31 136.07 28.07 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.51 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.12 161.93 35.07 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.459 2.106 . . . . 0.0 111.739 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.0 104.47 0.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.227 0.537 . . . . 0.0 110.078 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.8 p -147.47 150.51 34.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.121 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -65.81 104.19 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.377 0.608 . . . . 0.0 111.025 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -96.52 9.98 39.77 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.771 -0.825 . . . . 8.75 108.771 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 304' ' ' PHE . 35.2 ttmt -59.1 119.49 7.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.104 -1.407 . . . . 6.04 110.113 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.0 141.63 29.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.863 -0.608 . . . . 5.29 110.792 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.72 110.0 21.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.489 -0.778 . . . . 4.77 109.317 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.776 HG23 HD11 ' A' ' 330' ' ' LEU . 3.9 mp -101.77 103.47 14.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.321 -0.622 . . . . 3.94 109.321 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -127.91 164.13 21.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 4.58 112.605 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 102.09 15.71 25.29 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.782 -0.723 . . . . 5.58 111.895 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 270' ' ' LEU . 83.4 mt -92.57 148.74 36.83 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.655 0.264 . . . . 5.92 110.545 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 270' ' ' LEU . 46.0 Cg_endo -69.23 153.74 70.89 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.687 2.258 . . . . 6.94 112.276 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.7 -22.6 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 8.81 111.368 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -83.64 1.04 44.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.948 0.404 . . . . 8.73 111.187 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 267' ' ' PRO . 11.6 tp -87.11 99.37 11.88 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.859 -0.793 . . . . 7.52 108.859 176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 34.2 p-10 -89.68 -179.0 5.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.917 -0.583 . . . . 8.79 111.686 -172.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.485 ' CG ' ' HZ1' ' A' ' 292' ' ' LYS . 2.7 m-20 -52.31 -41.02 62.59 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.595 -0.729 . . . . 7.62 112.158 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.89 -47.75 81.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.19 -42.92 71.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 8.69 111.431 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 82.1 t -64.62 -49.38 80.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.555 -0.293 . . . . 6.64 111.7 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -65.21 -43.36 91.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.841 -0.344 . . . . 7.74 111.228 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.49 -46.97 83.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 9.38 110.638 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.66 -52.82 62.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 7.06 110.501 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.65 -38.62 80.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.043 0.386 . . . . 6.89 112.043 -174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.4 m -61.58 -34.77 76.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.731 0.3 . . . . 8.85 111.106 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.432 ' HB3' ' SD ' ' A' ' 166' ' ' MET . 49.0 m -62.74 -23.2 67.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.864 -178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -106.38 12.55 29.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.073 0.397 . . . . 9.18 112.073 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 154.58 155.41 7.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.762 -1.209 . . . . 9.06 113.462 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.734 ' HD2' HG21 ' A' ' 312' ' ' VAL . 6.9 Cg_exo -72.78 120.69 6.82 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.243 2.629 . . . . 10.14 112.064 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 305' ' ' CYS . 96.1 mt -94.4 141.29 28.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.099 -0.501 . . . . 8.3 110.698 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.7 ptpt -110.94 -32.73 6.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.019 0.438 . . . . 8.65 110.155 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 305' ' ' CYS . . . -132.4 111.5 11.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.536 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.3 124.09 41.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 6.27 110.183 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -140.34 114.87 9.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.308 0.575 . . . . 5.79 110.351 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.5 tp -90.34 125.49 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 6.35 110.247 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.1 116.51 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.127 0.489 . . . . 6.61 110.116 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.485 ' HZ1' ' CG ' ' A' ' 272' ' ' ASP . 61.4 mttm -110.73 154.31 24.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.74 -0.664 . . . . 8.17 110.86 -176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 13.5 t70 -83.29 129.71 35.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.984 -0.747 . . . . 10.33 108.984 172.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.4 m -85.19 -13.27 50.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.426 -0.352 . . . . 10.8 111.887 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.11 -56.43 2.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.987 0.422 . . . . 12.13 111.095 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.467 HG22 ' HG ' ' A' ' 298' ' ' LEU . 48.1 m -83.27 -30.42 27.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 11.16 110.627 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.02 22.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.585 -0.817 . . . . 10.11 112.59 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' A' ' 296' ' ' THR . 84.3 mt -110.11 161.54 15.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.73 0.3 . . . . 10.12 110.418 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 41.9 t -69.52 133.75 48.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.28 -0.637 . . . . 7.73 109.28 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.467 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.2 mmmp? -74.82 -15.88 60.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 8.01 110.858 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 97.76 14.78 39.11 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.612 -0.804 . . . . 6.09 113.049 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 11.0 p90 -154.89 146.62 23.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 6.54 110.779 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.55 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.3 168.02 21.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.882 -0.599 . . . . 4.38 110.718 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.475 ' HB3' ' HG2' ' A' ' 260' ' ' LYS . 91.8 m-85 -114.54 130.21 56.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 4.93 109.557 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 287' ' ' ALA . 35.5 m -141.98 116.57 9.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 5.09 111.608 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.479 ' OE1' ' HD2' ' A' ' 286' ' ' LYS . 39.9 tt0 -100.24 130.62 46.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.821 -0.437 . . . . 7.03 109.821 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' ' OG1' ' A' ' 313' ' ' THR . 47.5 m-85 -88.67 158.51 18.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 7.81 111.07 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 286' ' ' LYS . 58.6 t -79.1 -46.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 10.03 111.118 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.561 ' HB3' HG22 ' A' ' 312' ' ' VAL . 12.6 t70 -93.91 132.55 38.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 10.81 110.446 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -64.79 -28.49 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 112.263 0.468 . . . . 9.77 112.263 -176.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -71.79 -50.05 33.26 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.891 -0.411 . . . . 10.89 109.891 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.734 HG21 ' HD2' ' A' ' 284' ' ' PRO . 20.8 m -66.27 -24.68 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.809 -0.632 . . . . 9.5 110.856 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 317' ' ' ILE . 47.3 m -61.85 -48.16 81.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.13 0.49 . . . . 7.83 110.132 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.81 -35.13 64.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.007 -0.542 . . . . 8.79 110.516 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -63.53 -40.22 96.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.928 -0.578 . . . . 10.51 110.773 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.12 97.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 7.31 110.47 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 313' ' ' THR . 71.7 mt -59.08 -45.38 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 6.44 110.674 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.51 78.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.749 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.31 -49.36 6.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 7.46 113.51 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.509 ' HB3' HD23 ' A' ' 330' ' ' LEU . 98.6 mt -73.57 -49.07 28.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.302 . . . . 6.42 111.814 -173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 7.3 t30 -63.05 115.22 4.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 6.53 110.44 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.92 -20.55 14.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.853 -0.689 . . . . 6.77 112.389 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 20.9 ttt -75.22 141.41 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.146 -0.316 . . . . 7.29 110.146 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -88.66 118.87 28.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.785 0.326 . . . . 7.83 110.525 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.6 mm? -101.79 96.52 7.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.124 -0.489 . . . . 7.01 109.852 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.2 -85.57 0.81 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.901 -0.666 . . . . 8.18 112.058 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.63 -41.06 2.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.737 0.303 . . . . 8.94 111.281 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -91.29 165.64 13.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 7.29 110.807 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.66 136.1 37.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 7.13 109.536 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.856 ' HB2' HD23 ' A' ' 325' ' ' LEU . 33.0 tp -73.83 125.45 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.173 0.511 . . . . 5.63 111.316 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.67 118.63 37.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 5.53 109.614 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 91.1 t -127.32 113.56 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.185 -0.461 . . . . 5.21 109.779 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -138.04 171.87 13.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.122 -0.49 . . . . 6.05 110.01 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 334' ' ' ARG . 47.7 mtm180 -86.59 136.83 32.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.402 -0.222 . . . . 7.58 110.402 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -62.91 -44.55 95.77 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.115 0.483 . . . . 6.04 110.092 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.8 m -95.03 92.78 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.819 -0.628 . . . . 7.57 109.406 172.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.89 -23.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.382 0.611 . . . . 0.0 110.169 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -152.14 -95.81 0.13 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.07 126.62 35.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -107.16 124.6 49.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.411 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 61.76 35.66 16.65 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.641 0.588 . . . . 0.0 111.183 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 149' ' ' ARG . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.889 ' HB2' HG22 ' A' ' 205' ' ' VAL . 56.1 ttp85 75.99 -24.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.773 0.67 . . . . 0.0 111.991 173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -97.53 150.91 20.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 6.52 111.392 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 208' ' ' THR . 23.7 mt -113.19 149.43 33.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.861 -0.609 . . . . 5.24 111.186 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -107.98 102.9 12.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.125 -0.943 . . . . 6.15 108.702 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.551 HG21 ' HZ ' ' A' ' 169' ' ' PHE . 7.4 p -104.11 127.44 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.488 . . . . 4.24 110.301 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.37 -178.75 15.44 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.803 -0.635 . . . . 4.95 111.777 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 10.2 m120 62.01 28.85 17.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.085 0.469 . . . . 0.0 110.899 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.528 HG22 HD22 ' A' ' 224' ' ' LEU . 31.8 pt -78.52 153.61 78.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.466 -0.788 . . . . 5.61 110.728 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.498 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 32.7 Cg_endo -64.35 136.71 52.37 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.556 2.171 . . . . 5.97 112.056 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.19 123.34 20.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 8.47 109.913 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 101.29 4.43 53.35 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.576 -0.821 . . . . 6.96 112.421 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.498 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.3 tp -66.07 130.85 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 6.1 110.147 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.8 p -92.24 155.21 18.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.765 0.317 . . . . 6.62 110.751 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 162' ' ' GLU . 25.6 mp0 -53.69 -46.47 70.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 5.69 110.186 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.96 -55.81 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.325 -0.852 . . . . 7.29 111.153 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.94 93.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.288 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 0.7 OUTLIER -64.94 -47.67 76.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 4.49 110.598 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 21.2 ttt -60.92 -48.83 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 5.76 110.769 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.46 -38.78 88.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 6.51 111.524 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.49 -49.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.614 -0.267 . . . . 5.44 111.068 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 153' ' ' VAL . 50.4 m-85 -65.1 -44.22 89.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.593 -0.276 . . . . 5.03 111.093 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.03 -33.45 75.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.557 -0.292 . . . . 6.3 110.985 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -64.74 -49.93 68.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.227 175.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -60.09 -35.36 75.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 6.25 111.113 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.703 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 6.0 mmt -60.88 -50.16 74.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 7.03 110.529 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -71.06 -44.29 66.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 8.94 111.269 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 78.1 mt -65.13 -35.18 80.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.383 . . . . 8.7 110.985 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.95 -34.38 38.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.627 -0.796 . . . . 8.11 112.104 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.37 47.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.624 . . . . 8.49 111.926 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 6.0 mp -96.19 82.83 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 7.59 109.672 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 185' ' ' PRO . 14.2 m -154.93 143.13 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.908 -0.587 . . . . 8.73 109.425 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.537 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -93.24 -22.1 19.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.734 -0.387 . . . . 9.89 111.442 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.3 145.91 19.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.592 -0.277 . . . . 9.69 110.599 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.91 114.17 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.734 2.29 . . . . 10.74 112.003 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.6 -152.57 24.6 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.825 -0.702 . . . . 8.97 111.942 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -114.54 117.73 42.32 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-O 120.548 0.213 . . . . 7.58 110.865 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.453 ' HG3' HG23 ' A' ' 179' ' ' THR . 28.0 Cg_exo -63.09 -37.83 49.75 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.66 2.24 . . . . 6.4 111.53 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 52.8 t -89.72 112.55 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.836 -0.62 . . . . 5.47 109.824 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.443 ' HB3' HG22 ' A' ' 280' ' ' THR . 86.4 mt -89.96 -39.28 13.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.729 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.1 168.94 19.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.605 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.46 116.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 4.68 110.753 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -98.15 106.96 19.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 6.34 109.614 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.0 mt -91.66 136.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.232 0.539 . . . . 5.85 110.958 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -119.55 96.77 5.34 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.732 -0.84 . . . . 7.34 108.732 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -70.5 -23.97 62.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.569 -0.741 . . . . 7.61 111.697 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.76 -49.92 75.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 9.12 111.498 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 35.2 mmtm -106.19 7.09 31.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 9.1 111.028 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.04 61.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.452 -0.795 . . . . 6.6 111.5 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 52.3 p90 -148.99 171.31 16.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.092 -0.504 . . . . 6.67 109.676 173.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -145.94 142.46 28.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.357 . . . . 4.58 111.158 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 197' ' ' PHE . 70.2 m-85 -92.8 113.44 25.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 6.22 109.869 175.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 151' ' ' LEU . 97.0 mt -83.35 115.76 22.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.211 -0.449 . . . . 4.77 110.253 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.84 108.45 19.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 6.55 109.695 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 37.1 m-85 -99.02 157.33 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.995 0.426 . . . . 6.51 111.287 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -82.94 -24.32 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.387 -0.824 . . . . 8.27 110.765 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 149' ' ' ARG . 98.5 p -134.06 163.0 30.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 7.96 109.991 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.889 HG22 ' HB2' ' A' ' 149' ' ' ARG . 15.7 t -92.1 -15.75 8.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.875 0.845 . . . . 8.73 108.841 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.99 -56.14 6.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.773 -1.103 . . . . 8.5 111.183 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.537 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.5 mt-10 -65.79 -24.28 66.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 7.4 111.704 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 151' ' ' LEU . 13.3 m -48.97 -49.75 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.636 0.585 . . . . 6.13 111.508 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.8 m -61.46 -36.23 79.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.012 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.692 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 1.9 mp0 -70.11 -28.98 65.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.056 -0.258 . . . . 7.75 111.189 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.42 -23.52 62.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.313 0.578 . . . . 5.43 110.337 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 228' ' ' ARG . 86.8 mtp -70.8 -14.77 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.704 -0.68 . . . . 6.29 110.794 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.89 2.54 12.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 6.14 111.254 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -113.02 19.69 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 5.57 110.436 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -61.83 117.63 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.927 -0.579 . . . . 5.92 111.039 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 97.93 16.62 32.69 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.827 -0.702 . . . . 5.74 112.498 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.89 135.61 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 110.036 -0.357 . . . . 5.3 110.036 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 tp -84.27 116.43 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.6 0.714 . . . . 6.8 111.004 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -135.18 118.67 16.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.796 -0.638 . . . . 5.79 110.288 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 60.84 32.47 20.1 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.227 -0.442 . . . . 7.32 111.414 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.91 78.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.844 -0.693 . . . . 7.28 112.632 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 32.6 mm-40 -110.08 132.35 54.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.258 -0.275 . . . . 7.21 110.258 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.5 m -86.37 106.78 17.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.871 -0.418 . . . . 6.14 109.871 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 156' ' ' ILE . 75.9 mt -66.1 111.89 3.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 4.9 110.896 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 86.5 tttt -87.76 114.61 24.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.742 -0.663 . . . . 7.3 109.528 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.6 mt -110.92 105.64 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.937 0.399 . . . . 5.37 110.423 -173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 15.1 mmt85 -129.25 171.2 12.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.067 -0.515 . . . . 6.97 110.324 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 212' ' ' MET . 45.8 mtp180 -104.42 143.68 27.17 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-O 120.594 0.235 . . . . 7.37 111.109 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.09 160.98 14.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.462 2.108 . . . . 7.98 110.769 170.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -86.58 -4.13 59.13 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.516 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.44 42.97 26.79 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.488 0.492 . . . . 0.0 110.398 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -71.87 102.61 2.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.936 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.847 ' HB3' HD22 ' A' ' 241' ' ' ASN . 20.3 mt-30 53.34 70.16 1.93 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.508 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.422 ' HD2' ' HE1' ' A' ' 238' ' ' MET . 73.1 Cg_endo -81.02 132.11 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.191 1.927 . . . . 0.0 111.798 175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.0 mt 73.8 136.78 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.851 0.719 . . . . 0.0 111.393 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.14 -14.49 34.95 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.842 2.361 . . . . 0.0 112.948 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -80.71 72.67 2.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.12 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.422 ' HE1' ' HD2' ' A' ' 234' ' ' PRO . 44.3 ttm -151.09 153.32 34.82 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 50.3 m -64.63 -59.8 3.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -95.21 94.03 7.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 109.866 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.847 HD22 ' HB3' ' A' ' 233' ' ' GLN . 21.3 t-20 -165.84 -52.88 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.844 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 10.3 Cg_endo -91.12 99.33 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.578 2.185 . . . . 0.0 111.647 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -75.55 -19.28 59.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.6 m -89.57 178.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.442 ' O ' ' HD3' ' A' ' 247' ' ' PRO . 78.1 t80 -79.72 -40.65 28.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.579 0.228 . . . . 0.0 110.911 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.52 104.07 9.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 245' ' ' TYR . 67.8 Cg_endo -73.31 172.63 15.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.902 2.401 . . . . 0.0 112.643 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -85.1 154.5 29.05 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.987 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 31.8 m -122.86 174.98 6.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.679 0.276 . . . . 0.0 110.283 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.46 160.02 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.172 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 52.0 m -73.19 93.62 1.87 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.082 0.468 . . . . 0.0 111.115 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 12.0 p -136.08 5.17 3.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.236 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.9 m -75.34 -11.6 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.759 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.99 115.19 52.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.26 -52.34 2.1 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.997 2.465 . . . . 0.0 112.177 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -84.75 104.36 14.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.029 0.442 . . . . 0.0 109.942 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.1 p -76.31 -3.21 35.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.058 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -61.12 101.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.301 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -118.1 13.65 13.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.87 -0.789 . . . . 8.75 108.87 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 35.3 ttmt -62.33 125.38 23.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.462 -1.245 . . . . 6.04 109.934 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 307' ' ' TYR . 69.6 mt -98.86 142.31 30.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.113 -0.494 . . . . 5.29 110.797 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.676 ' HB2' ' HA ' ' A' ' 335' ' ' ALA . 87.3 t80 -95.99 109.47 21.85 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.294 -0.866 . . . . 4.77 108.897 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.34 106.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.863 -0.421 . . . . 3.94 109.863 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.95 171.1 19.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.898 -0.668 . . . . 4.58 111.511 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.2 27.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.654 -0.784 . . . . 5.58 112.068 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 98.4 mt -101.42 143.86 27.42 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.259 -0.275 . . . . 5.92 110.259 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.689 ' HD2' HD22 ' A' ' 270' ' ' LEU . 30.5 Cg_exo -62.33 143.42 93.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.569 2.179 . . . . 6.94 111.98 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.66 -24.43 66.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.615 0.228 . . . . 8.81 111.615 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -85.02 -7.17 59.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.754 0.312 . . . . 8.73 110.836 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.689 HD22 ' HD2' ' A' ' 267' ' ' PRO . 12.1 tp -71.81 106.5 4.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.617 -0.512 . . . . 7.52 109.617 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.6 p-10 -85.9 172.18 10.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 8.79 111.012 -175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.07 -37.69 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 7.62 111.94 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.17 -54.39 44.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.758 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.62 -42.59 95.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 8.69 111.643 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 271' ' ' ASN . 38.9 t -61.49 -47.03 95.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.561 0.22 . . . . 6.64 110.728 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -58.56 -54.0 51.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.586 -0.279 . . . . 7.74 110.72 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -56.75 -51.02 70.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.073 -0.512 . . . . 9.38 111.591 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.0 -42.89 81.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 7.06 110.693 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.581 HD22 HD13 ' A' ' 320' ' ' LEU . 62.1 mt -80.32 -29.05 38.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.484 -0.325 . . . . 6.89 111.26 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.4 m -71.54 -16.73 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 8.85 110.796 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 16.3 m -59.97 -15.03 18.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.917 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.85 9.29 11.27 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.614 0.245 . . . . 9.18 111.23 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.75 146.27 4.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.946 -0.645 . . . . 9.06 112.395 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HA ' HG23 ' A' ' 280' ' ' THR . 50.4 Cg_endo -69.78 141.75 46.0 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.682 2.254 . . . . 10.14 112.733 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 305' ' ' CYS . 86.6 mt -97.57 130.76 44.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 8.3 110.883 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.5 ptpt -93.5 -29.24 15.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.131 0.491 . . . . 8.65 110.028 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -136.42 115.07 11.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.541 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.576 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 76.8 t80 -125.82 122.21 35.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.193 -0.458 . . . . 6.27 110.759 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -140.87 111.6 6.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.51 0.671 . . . . 5.79 110.472 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 303' ' ' ALA . 57.0 tp -85.18 140.11 31.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.386 -0.825 . . . . 6.35 109.778 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.503 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.4 t -88.81 111.34 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.077 0.465 . . . . 6.61 110.123 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -102.35 155.24 18.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 8.17 111.099 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.76 135.42 34.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.66 -0.7 . . . . 10.33 109.907 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.6 m -74.45 -12.94 60.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 10.8 112.036 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -98.03 -68.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 12.13 111.324 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 17.4 m -77.9 -32.35 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 11.16 111.426 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 93.04 6.97 62.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.54 -0.838 . . . . 10.11 112.414 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.32 173.34 11.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.618 0.247 . . . . 10.12 110.339 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -79.38 144.7 33.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.408 -0.36 . . . . 7.73 110.1 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 300' ' ' LYS . 30.8 mmtp -79.15 0.34 28.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.156 0.503 . . . . 8.01 110.436 175.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 97.71 17.13 31.62 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 6.09 113.069 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 291' ' ' VAL . 43.6 p90 -162.73 157.03 21.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.329 0.585 . . . . 6.54 111.261 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -147.46 160.17 42.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.314 -0.857 . . . . 4.38 110.24 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.473 ' HD2' ' HB1' ' A' ' 335' ' ' ALA . 81.8 m-85 -107.43 122.65 47.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.853 -0.795 . . . . 4.93 108.853 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.576 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.9 m -139.01 115.24 10.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 5.09 111.412 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 33.5 tt0 -98.25 135.43 39.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.916 -0.584 . . . . 7.03 110.155 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.414 ' CE1' HD12 ' A' ' 261' ' ' LEU . 26.1 m-85 -90.14 147.31 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.213 -0.448 . . . . 7.81 111.238 -177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.681 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 52.5 t -66.32 -53.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.776 -0.647 . . . . 10.03 110.578 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.466 ' HB3' HG22 ' A' ' 312' ' ' VAL . 27.0 t70 -88.64 137.16 32.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.997 -0.547 . . . . 10.81 110.374 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -79.2 -18.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.148 0.425 . . . . 9.77 112.148 -174.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.61 -40.22 23.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.761 0.315 . . . . 10.89 110.401 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.5 m -69.49 -22.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 9.5 111.439 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 317' ' ' ILE . 21.4 m -55.3 -50.6 69.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.68 0.276 . . . . 7.83 111.563 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.92 -32.82 72.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.014 0.435 . . . . 8.79 110.789 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -66.12 -41.39 90.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 10.51 110.443 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.34 94.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 7.31 110.734 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 313' ' ' THR . 64.4 mt -57.36 -41.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.935 -0.575 . . . . 6.44 110.495 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.54 -43.52 59.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.741 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -75.43 -47.54 12.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.018 -0.611 . . . . 7.46 113.469 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HB2' HG21 ' A' ' 332' ' ' VAL . 87.1 mt -70.56 -43.11 70.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.647 0.261 . . . . 6.42 111.61 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 8.9 t30 -66.43 115.44 6.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.75 0.31 . . . . 6.53 110.272 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.41 -21.55 14.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.925 -0.655 . . . . 6.77 111.514 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.5 ttt -73.85 141.86 46.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.039 -0.356 . . . . 7.29 110.039 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 26.1 tt0 -105.59 125.18 50.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.833 0.349 . . . . 7.83 110.599 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 267' ' ' PRO . 0.4 OUTLIER -117.14 113.4 22.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.94 -0.763 . . . . 7.01 108.94 177.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.86 -88.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.939 -0.648 . . . . 8.18 112.849 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.69 0.26 3.57 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.854 -0.203 . . . . 8.94 111.396 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -130.61 152.08 50.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.915 0.388 . . . . 7.29 111.147 -176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 91.3 mttt -103.83 129.7 51.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.821 -0.627 . . . . 7.13 109.647 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.72 122.77 18.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.037 0.446 . . . . 5.63 112.121 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.53 107.43 19.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.334 -0.987 . . . . 5.53 108.334 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 320' ' ' LEU . 59.4 t -110.81 121.87 64.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 5.21 111.643 -173.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 13.9 pt20 -139.69 -169.09 2.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.941 -1.027 . . . . 6.05 108.77 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -87.14 141.33 28.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.878 -0.416 . . . . 7.58 109.878 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 262' ' ' PHE . . . -70.51 -38.18 74.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 6.04 111.272 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.1 m -78.53 -15.19 58.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 7.57 110.044 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 93.5 t 71.13 -60.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.925 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.01 56.01 0.67 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -101.95 11.45 38.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.662 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.8 tttt 66.34 101.63 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.149 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -64.78 -41.67 95.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.902 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.396 -179.864 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.47 ' HB3' ' NH2' ' A' ' 228' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 205' ' ' VAL . 23.4 ptt85 -117.67 20.64 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.883 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.88 139.91 39.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.978 -0.555 . . . . 6.52 109.91 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.24 137.21 48.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.847 0.356 . . . . 5.24 110.293 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.633 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 74.7 t80 -94.94 104.66 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.847 -0.615 . . . . 6.15 109.46 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 5.8 p -107.32 125.08 63.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.315 0.578 . . . . 4.24 110.642 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -125.69 -178.86 15.48 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.516 -0.765 . . . . 4.95 111.632 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.1 t30 59.8 41.31 18.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 122.029 0.919 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.694 HG22 HD22 ' A' ' 224' ' ' LEU . 32.6 pt -90.42 156.95 45.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.113 -0.949 . . . . 5.61 110.712 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.588 ' HG3' ' HB2' ' A' ' 220' ' ' GLN . 29.6 Cg_endo -63.84 142.32 81.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.669 2.246 . . . . 5.97 112.26 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -80.32 126.99 31.85 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.612 -0.514 . . . . 8.47 109.612 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.49 21.18 41.65 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.623 -0.798 . . . . 6.96 111.999 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.576 HD13 ' HG3' ' A' ' 220' ' ' GLN . 9.3 tp -78.97 139.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.868 0.366 . . . . 6.1 110.691 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 24.7 m -75.52 128.07 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 6.62 110.293 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.523 ' HA ' HD12 ' A' ' 191' ' ' ILE . 44.1 mt-10 -59.69 -47.9 83.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.506 -0.315 . . . . 5.69 110.765 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.96 -42.48 89.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.953 -0.567 . . . . 7.29 110.53 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -63.15 -44.17 96.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.28 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.2 ttm -64.94 -45.72 84.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.507 -0.315 . . . . 4.49 110.653 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.1 ttt -61.33 -50.95 70.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.153 -0.476 . . . . 5.76 111.004 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.02 -32.78 74.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 6.51 110.958 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.499 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 86.3 t80 -59.32 -52.58 65.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 5.44 110.579 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -63.67 -41.69 98.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.426 -0.352 . . . . 5.03 110.786 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 94.4 m-20 -55.77 -48.86 74.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 6.3 110.43 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.5 81.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.22 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 168' ' ' PHE . 17.4 mm100 -64.25 -37.35 87.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.25 111.267 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 86.7 mtp -69.83 -34.87 74.24 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.998 -0.281 . . . . 7.03 110.583 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 98.6 mtt180 -64.7 -50.9 65.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.013 0.435 . . . . 8.94 110.196 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.27 -35.52 81.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.641 -0.709 . . . . 8.7 111.911 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.05 -21.37 59.21 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.603 -0.808 . . . . 8.11 112.59 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.91 40.94 7.36 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.592 -0.813 . . . . 8.49 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.66 3.31 34.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.087 0.47 . . . . 7.59 110.259 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 p -92.34 140.14 29.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 8.73 110.827 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.0 pt20 -95.02 -10.71 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.087 0.47 . . . . 9.89 110.287 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.11 158.71 33.64 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 9.69 110.227 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 154.06 62.59 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.559 2.172 . . . . 10.74 111.822 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 104.37 -145.77 16.1 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.669 -0.777 . . . . 8.97 112.599 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.58 122.5 37.2 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 120.462 0.172 . . . . 7.58 110.571 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.82 -38.61 47.39 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.737 2.291 . . . . 6.4 111.69 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.91 137.26 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.41 -0.589 . . . . 5.47 109.41 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 1.01 HD21 ' HB3' ' A' ' 284' ' ' PRO . 50.9 tp -105.1 -41.63 5.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.644 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -142.56 134.25 26.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.76 117.37 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.232 0.539 . . . . 4.68 110.159 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -124.58 105.81 9.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.823 -0.436 . . . . 6.34 109.823 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 162' ' ' GLU . 55.4 mt -107.23 134.16 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 5.85 111.453 -176.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -109.91 113.85 26.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.542 . . . . 7.34 109.538 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -82.97 -10.91 58.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 7.61 110.81 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -75.91 -59.08 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.161 -0.472 . . . . 9.12 111.051 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.0 mmtm -91.16 -0.79 57.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.405 -0.361 . . . . 9.1 110.686 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 62.2 61.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.748 -0.66 . . . . 6.6 110.912 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 42.7 p90 -148.87 158.68 44.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 6.67 109.446 175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -139.57 147.63 41.42 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.942 0.401 . . . . 4.58 110.856 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.12 109.55 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.772 -0.649 . . . . 6.22 110.008 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.3 mt -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.247 -0.649 . . . . 4.77 109.247 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 127.36 49.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.642 . . . . 6.55 109.268 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -99.03 162.85 12.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.977 0.417 . . . . 6.51 111.203 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -71.93 -25.78 62.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.405 -0.816 . . . . 8.27 110.329 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.1 p -124.56 -170.32 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.582 -0.736 . . . . 7.96 109.595 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 149' ' ' ARG . 39.2 t -113.78 -28.78 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.644 0.735 . . . . 8.73 109.281 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.15 -51.04 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.228 -0.896 . . . . 8.5 111.34 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 50.4 mt-10 -65.24 -35.12 80.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.076 -0.511 . . . . 7.4 110.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -55.12 -50.14 70.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.316 0.579 . . . . 6.13 110.351 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 24.1 m -60.06 -34.13 73.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.698 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -31.59 64.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 7.75 110.277 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -76.03 -7.43 54.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.023 -0.535 . . . . 5.43 111.206 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 85.8 mtp -69.85 -16.65 63.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.411 . . . . 6.29 110.021 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.12 -6.59 50.38 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.674 -0.694 . . . . 6.14 111.049 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.493 ' HD1' HD12 ' A' ' 217' ' ' ILE . 93.3 m-85 -93.75 7.14 45.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 5.57 110.812 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.28 114.29 3.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.98 -0.378 . . . . 5.92 109.98 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 98.36 12.51 44.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.859 -0.686 . . . . 5.74 112.11 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.493 HD12 ' HD1' ' A' ' 214' ' ' PHE . 16.6 tt -71.53 137.19 24.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 5.3 110.044 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.8 tp -85.55 112.03 21.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.459 0.647 . . . . 6.8 110.056 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -133.09 119.4 19.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.841 -0.618 . . . . 5.79 110.579 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.588 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 80.9 mm-40 60.82 29.54 19.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.522 -0.763 . . . . 7.32 111.273 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.78 7.97 83.36 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.857 -0.687 . . . . 7.28 112.857 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -124.76 132.74 53.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.568 -0.372 . . . . 7.21 110.824 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 t -78.86 112.33 15.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.147 -0.686 . . . . 6.14 109.147 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.694 HD22 HG22 ' A' ' 156' ' ' ILE . 46.4 mt -81.9 120.71 25.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.885 0.374 . . . . 4.9 111.352 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 85.5 tttt -84.78 115.97 23.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 7.3 109.543 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.9 mt -121.98 105.89 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.973 0.415 . . . . 5.37 110.886 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.7 mmt180 -132.68 167.5 19.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.045 -0.525 . . . . 6.97 110.412 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 15.7 mtp180 -79.34 128.17 76.38 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.738 -0.467 . . . . 7.37 109.738 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.633 ' HG3' ' HB2' ' A' ' 152' ' ' TYR . 3.6 Cg_exo -73.07 153.81 52.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.797 2.331 . . . . 7.98 112.241 -176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -114.21 -7.81 12.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.7 105.89 18.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.479 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -108.62 -58.48 2.0 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -148.31 94.35 4.24 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.276 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.35 102.05 1.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.819 2.346 . . . . 0.0 111.531 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.754 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 10.0 tt -163.24 -55.79 0.01 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.374 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 235' ' ' LEU . 63.3 Cg_exo -54.39 -43.39 59.16 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.13 -81.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.785 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.6 mtp -71.47 -70.61 0.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.813 0.34 . . . . 0.0 110.732 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 33.9 t -128.78 139.28 52.27 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 236' ' ' PRO . 39.5 mt-10 -88.04 118.52 27.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -74.26 121.18 84.61 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.11 -34.32 92.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.609 2.206 . . . . 0.0 112.139 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.4 t -84.95 144.64 28.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.388 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 64.8 t -116.72 -47.2 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.401 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -98.43 -80.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.1 t -131.64 114.01 15.47 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.411 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.79 -34.17 5.66 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.661 2.241 . . . . 0.0 113.12 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -132.05 135.81 8.39 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.969 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.9 t 64.91 86.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.51 0.672 . . . . 0.0 110.563 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.2 p -110.55 -16.12 9.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.708 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 43.1 m 64.92 -177.05 0.17 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.341 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.6 p -87.68 5.01 41.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.78 125.91 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.697 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.75 132.26 21.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.822 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.2 141.9 57.51 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.826 2.351 . . . . 0.0 111.963 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -88.98 4.49 48.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.3 p -90.19 45.87 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.183 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.58 -18.78 63.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.186 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.879 ' HB3' HG21 ' A' ' 313' ' ' THR . 52.6 m80 63.02 34.93 13.5 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.854 -0.612 . . . . 8.75 111.792 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 305' ' ' CYS . 40.3 ttmt -66.44 121.49 15.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.681 -0.488 . . . . 6.04 109.681 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.43 142.09 31.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.313 0.577 . . . . 5.29 111.476 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.97 107.19 19.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.781 -1.099 . . . . 4.77 108.684 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 3.6 mp -100.3 104.58 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.954 -0.566 . . . . 3.94 109.529 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -118.84 120.5 4.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.589 -0.815 . . . . 4.58 112.691 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 139.2 9.71 0.9 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.096 -0.573 . . . . 5.58 112.296 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.4 144.76 74.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.481 0.182 . . . . 5.92 110.65 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD2' HD22 ' A' ' 270' ' ' LEU . 41.2 Cg_exo -57.63 135.88 72.21 Favored 'Trans proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.77 2.314 . . . . 6.94 112.292 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 9.1 p30 -62.39 -23.55 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.918 -0.583 . . . . 8.81 111.137 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -100.59 12.58 37.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.987 -0.551 . . . . 8.73 111.34 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.444 HD22 ' HD2' ' A' ' 267' ' ' PRO . 26.8 tp -89.32 125.2 35.02 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.779 -0.452 . . . . 7.52 109.779 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.8 p-10 -85.09 157.01 20.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 8.79 111.186 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 2.8 m-20 -52.5 -36.16 54.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.663 -0.699 . . . . 7.62 112.055 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -54.25 -53.06 58.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.431 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -72.62 -40.09 66.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.355 -0.384 . . . . 8.69 111.081 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.9 t -56.83 -47.81 82.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.428 -0.351 . . . . 6.64 110.716 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 36.4 mtmm -59.96 -47.53 85.44 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.477 -0.328 . . . . 7.74 110.815 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -49.74 76.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.106 -0.237 . . . . 9.38 110.965 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.23 -47.16 78.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 7.06 110.763 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.568 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -77.13 -31.5 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.396 -0.365 . . . . 6.89 111.563 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 52.6 m -69.97 -27.97 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 8.85 111.017 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 41.9 m -72.41 4.5 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.542 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -132.53 9.81 4.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.364 -0.38 . . . . 9.18 110.779 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.439 ' HA3' ' HE2' ' A' ' 307' ' ' TYR . . . 160.56 146.32 4.57 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.183 -1.008 . . . . 9.06 113.286 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 1.01 ' HB3' HD21 ' A' ' 187' ' ' LEU . 53.4 Cg_endo -71.04 119.82 6.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.249 2.633 . . . . 10.14 112.534 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.855 HD22 ' HB3' ' A' ' 305' ' ' CYS . 56.0 mt -100.4 103.23 14.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.199 -0.455 . . . . 8.3 110.486 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 308' ' ' VAL . 53.9 pttt -82.29 -20.7 36.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 8.65 110.072 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -138.99 130.2 26.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.411 ' HD1' ' SG ' ' A' ' 305' ' ' CYS . 75.6 t80 -145.21 128.83 17.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.667 0.27 . . . . 6.27 110.638 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -140.6 114.19 8.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.357 0.598 . . . . 5.79 110.983 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 62.4 tp -90.68 131.67 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.458 -0.792 . . . . 6.35 109.188 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.45 121.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.916 0.389 . . . . 6.61 110.798 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.77 157.95 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.004 -0.544 . . . . 8.17 110.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.404 ' HB2' ' CD ' ' A' ' 300' ' ' LYS . 14.5 t70 -91.05 121.64 33.03 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.216 -0.661 . . . . 10.33 109.216 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 47.2 m -71.61 -29.6 64.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.452 0.538 . . . . 10.8 112.452 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.59 -44.72 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.808 -0.357 . . . . 12.13 110.932 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 10.4 m -73.98 -44.73 53.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.144 -0.48 . . . . 11.16 111.306 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 90.59 26.32 23.16 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 10.11 111.889 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 92.3 mt -135.19 168.46 19.11 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.804 -0.443 . . . . 10.12 109.804 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 42.6 t -70.42 145.92 50.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 7.73 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.404 ' CD ' ' HB2' ' A' ' 293' ' ' ASP . 31.5 mmmt -76.32 -20.47 57.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 8.01 110.17 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 107.35 -7.84 37.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.621 -0.799 . . . . 6.09 112.897 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 52.7 p90 -128.4 147.2 50.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.191 0.52 . . . . 6.54 111.534 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -142.3 158.67 43.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.387 -0.824 . . . . 4.38 110.435 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.409 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 93.0 m-85 -111.59 132.38 54.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.238 -0.437 . . . . 4.93 110.079 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.855 ' HB3' HD22 ' A' ' 285' ' ' LEU . 57.4 m -130.89 115.76 16.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.317 -0.401 . . . . 5.09 111.239 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 40.5 tt0 -95.4 119.58 34.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.488 -0.56 . . . . 7.03 109.488 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.439 ' HE2' ' HA3' ' A' ' 283' ' ' GLY . 30.1 m-85 -90.72 148.36 22.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.632 . . . . 7.81 111.845 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 286' ' ' LYS . 53.6 t -77.34 -48.26 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 10.03 110.579 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.659 ' HB3' HG22 ' A' ' 312' ' ' VAL . 18.2 t70 -82.37 157.75 23.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 10.81 109.897 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -110.11 -4.15 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.489 0.551 . . . . 9.77 112.489 -173.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -111.02 -30.48 7.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.963 -0.295 . . . . 10.89 111.482 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 309' ' ' ASP . 34.1 m -71.52 -23.71 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.867 0.321 . . . . 9.5 111.867 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.879 HG21 ' HB3' ' A' ' 259' ' ' HIS . 13.0 m -57.56 -49.37 76.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.945 0.35 . . . . 7.83 111.945 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -64.39 -27.1 68.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.059 0.457 . . . . 8.79 110.748 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.69 -34.74 45.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 10.51 110.413 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.58 99.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 7.31 110.065 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 78.0 mt -57.38 -47.1 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.719 -0.673 . . . . 6.44 110.531 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.87 -33.73 72.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.842 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.92 -44.62 5.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.704 -0.76 . . . . 7.46 112.959 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.39 -51.18 15.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 6.42 111.402 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.735 ' HB2' ' HB ' ' A' ' 332' ' ' VAL . 9.1 t30 -67.6 120.7 14.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.124 -0.489 . . . . 6.53 110.365 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 121.69 -30.17 5.41 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.815 -0.707 . . . . 6.77 111.776 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -74.52 141.0 44.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.21 -0.663 . . . . 7.29 109.21 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 329' ' ' LYS . 29.9 tt0 -107.89 120.91 43.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.966 0.412 . . . . 7.83 111.541 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.38 103.78 16.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 7.01 109.721 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.77 -96.84 0.38 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.011 -0.614 . . . . 8.18 112.265 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.05 2.08 9.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 8.94 110.687 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.69 113.51 26.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 7.29 110.854 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 324' ' ' GLN . 87.8 tttt -72.16 131.23 42.52 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.302 -0.629 . . . . 7.13 109.302 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 263' ' ' ILE . 23.2 tp -77.68 117.16 18.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.961 0.41 . . . . 5.63 111.351 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 329' ' ' LYS . 6.3 mp -98.95 123.6 43.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.355 -0.609 . . . . 5.53 109.355 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.735 ' HB ' ' HB2' ' A' ' 321' ' ' ASN . 57.5 t -125.67 118.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.077 -0.511 . . . . 5.21 110.204 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.75 163.71 34.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.789 -0.819 . . . . 6.05 108.789 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 337' ' ' VAL . 93.9 mtt180 -64.95 141.87 58.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.862 -0.421 . . . . 7.58 109.862 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.43 -51.32 47.67 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.418 0.449 . . . . 6.04 111.876 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 37.0 m -110.52 -20.01 12.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.815 0.341 . . . . 7.57 110.274 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 334' ' ' ARG . 94.5 t 71.64 -65.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.113 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 64.25 55.27 24.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.572 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -59.73 -57.15 14.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.934 0.397 . . . . 0.0 110.686 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -122.05 -40.91 2.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.934 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -107.98 115.9 30.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.689 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.948 0.404 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.07 -50.59 7.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.381 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 199' ' ' PHE . 99.2 mtt180 -106.99 133.32 51.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 6.52 111.034 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 208' ' ' THR . 31.7 mt -92.87 152.92 19.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.449 . . . . 5.24 110.466 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 65.7 t80 -94.14 110.65 22.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.815 -0.63 . . . . 6.15 109.736 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 198' ' ' ALA . 5.9 p -111.1 119.92 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.274 0.559 . . . . 4.24 109.88 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.88 15.06 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.652 -0.704 . . . . 4.95 111.951 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.12 39.74 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.921 0.867 . . . . 0.0 109.188 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 27.8 pt -85.76 146.95 44.86 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.004 -0.998 . . . . 5.61 110.833 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 156' ' ' ILE . 6.9 Cg_exo -74.48 120.5 6.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.896 2.397 . . . . 5.97 111.752 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.418 ' CD2' ' HG2' ' A' ' 193' ' ' GLN . 28.5 t80 -62.24 132.8 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.132 -0.486 . . . . 8.47 109.929 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 114.31 -17.0 19.46 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.67 -0.776 . . . . 6.96 112.597 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.9 tp -78.62 144.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 6.1 110.335 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -88.94 152.82 21.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.366 -0.379 . . . . 6.62 110.864 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.617 ' HA ' HD12 ' A' ' 191' ' ' ILE . 40.4 mt-10 -63.09 -39.82 95.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.126 -0.488 . . . . 5.69 110.75 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -61.99 -47.29 85.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.599 . . . . 7.29 110.788 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.89 86.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.4 tpt -63.21 -47.62 81.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 4.49 110.196 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.426 ' HB2' HG11 ' A' ' 189' ' ' VAL . 22.5 ttt -61.15 -46.38 90.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 5.76 111.307 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.52 -36.28 82.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 6.51 110.854 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.9 -46.9 84.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.967 -0.56 . . . . 5.44 110.516 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.663 ' O ' ' HG2' ' A' ' 173' ' ' MET . 54.9 m-85 -64.31 -46.36 83.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 5.03 110.83 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -54.54 -45.68 73.45 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.719 0.295 . . . . 6.3 110.956 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -60.7 -48.76 80.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.896 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.84 -27.0 64.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 6.25 111.753 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.663 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 32.4 mmt -64.62 -42.69 95.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 7.03 110.016 176.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -70.2 -44.61 68.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.842 -0.617 . . . . 8.94 110.419 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 171' ' ' ALA . 79.8 mt -68.21 -34.49 76.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 8.7 111.446 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.57 -16.3 73.75 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.601 -0.809 . . . . 8.11 112.466 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.78 29.63 34.6 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.685 -0.769 . . . . 8.49 112.147 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.613 HD11 ' HE1' ' A' ' 214' ' ' PHE . 4.5 mp -87.89 -22.52 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.36 0.6 . . . . 7.59 109.838 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 24.0 m -76.21 122.69 24.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.217 -0.902 . . . . 8.73 110.751 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.465 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 4.1 pt20 -80.6 -30.49 36.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.914 0.387 . . . . 9.89 110.932 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.75 124.89 18.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.509 . . . . 9.69 110.253 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.79 128.62 2.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.962 3.108 . . . . 10.74 113.613 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 134.58 -129.63 5.25 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.915 -0.659 . . . . 8.97 112.265 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -123.26 117.95 27.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.724 0.297 . . . . 7.58 111.086 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.88 -27.82 9.94 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.599 2.2 . . . . 6.4 112.047 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.4 t -90.03 133.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 5.47 110.039 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 203' ' ' ARG . 86.9 mt -95.42 -56.3 2.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.6 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.41 157.88 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.528 HG23 HD23 ' A' ' 200' ' ' LEU . 8.2 p -133.93 137.57 52.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.058 -0.519 . . . . 4.68 110.599 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -126.73 111.12 13.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.632 -0.507 . . . . 6.34 109.632 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 162' ' ' GLU . 41.6 mt -104.71 127.23 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 5.85 111.555 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -105.36 97.98 7.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.062 -1.088 . . . . 7.34 108.062 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 158' ' ' PHE . 16.1 tt0 -85.45 -5.28 59.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.971 -0.559 . . . . 7.61 110.307 -172.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.28 -52.64 10.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 9.12 110.204 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 26.1 mmtm -91.98 2.67 56.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 9.1 110.757 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.86 48.53 3.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.332 -0.849 . . . . 6.6 111.712 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.457 ' HB2' ' CE1' ' A' ' 152' ' ' TYR . 34.8 p90 -148.52 151.32 34.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.301 -0.409 . . . . 6.67 110.224 175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.27 157.51 45.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.522 -0.308 . . . . 4.58 110.827 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 150' ' ' ARG . 61.1 m-85 -118.32 119.51 34.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.202 -0.454 . . . . 6.22 110.806 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 31.0 mt -95.32 115.0 26.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.678 -0.692 . . . . 4.77 109.549 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 150' ' ' ARG . 34.1 tt0 -96.41 116.87 29.75 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.51 -0.476 . . . . 6.55 110.384 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.422 ' CD1' HG23 ' A' ' 208' ' ' THR . 27.6 m-85 -93.84 163.91 13.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.683 -0.69 . . . . 6.51 110.612 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.495 ' HA ' HD11 ' A' ' 187' ' ' LEU . 37.0 ptt180 -74.48 -24.19 58.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 8.27 110.788 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 71.3 p -125.44 -161.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.19 -0.459 . . . . 7.96 110.434 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.12 -34.82 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.094 0.473 . . . . 8.73 110.04 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.11 -52.2 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 8.5 111.129 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.465 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 48.2 mt-10 -59.05 -42.54 90.52 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.748 -0.464 . . . . 7.4 109.748 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 151' ' ' LEU . 2.1 m -51.69 -52.43 48.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.465 -0.788 . . . . 6.13 110.818 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.3 m -63.41 -33.67 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.766 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.455 ' HG3' HD23 ' A' ' 178' ' ' LEU . 8.9 tp-100 -71.05 -30.0 66.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 7.75 110.393 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -16.26 63.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 5.43 111.349 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 82.9 mtp -69.78 -13.75 62.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 6.29 111.165 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.25 65.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 6.14 111.097 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.613 ' HE1' HD11 ' A' ' 178' ' ' LEU . 22.5 m-85 -94.13 12.27 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 5.57 111.353 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.84 112.9 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.817 0.341 . . . . 5.92 110.28 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 109.89 1.58 30.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.714 -0.755 . . . . 5.74 112.499 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.533 HD12 ' HD2' ' A' ' 214' ' ' PHE . 15.4 tt -61.44 138.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.926 0.393 . . . . 5.3 110.398 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.11 122.56 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.331 0.586 . . . . 6.8 110.883 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -133.68 106.49 7.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.737 -0.665 . . . . 5.79 110.125 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 60.54 31.27 20.22 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.831 -0.622 . . . . 7.32 111.968 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.44 68.36 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.589 -0.815 . . . . 7.28 112.851 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.456 ' HB2' ' HG3' ' A' ' 157' ' ' PRO . 31.1 mm-40 -120.24 136.06 54.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.212 -0.292 . . . . 7.21 110.212 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.3 m -87.19 108.8 19.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.401 -0.363 . . . . 6.14 110.22 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.73 119.56 11.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.476 . . . . 4.9 110.891 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 83.2 tttt -90.94 116.96 29.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.906 -0.588 . . . . 7.3 109.804 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.07 105.89 19.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.04 0.448 . . . . 5.37 110.131 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 227' ' ' ARG . 8.6 mmt85 -127.61 170.2 12.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.963 -0.562 . . . . 6.97 111.005 -174.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -77.17 144.8 72.01 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.928 -0.578 . . . . 7.37 109.455 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.89 164.47 13.93 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.701 2.267 . . . . 7.98 113.026 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 73.39 15.69 4.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.973 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.3 -32.33 18.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -86.51 142.01 28.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.863 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -79.98 120.79 80.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -57.09 116.53 3.28 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.54 2.16 . . . . 0.0 111.201 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 236' ' ' PRO . 4.0 pp -71.36 141.11 85.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 12.4 Cg_exo -70.37 -28.67 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.938 2.426 . . . . 0.0 112.217 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 104.22 82.93 1.65 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.795 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 20.7 mmt -76.17 -28.0 57.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.479 0.657 . . . . 0.0 109.495 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 43.4 m -144.18 129.65 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.466 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 61.25 79.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.735 0.647 . . . . 0.0 110.332 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -84.8 116.94 67.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.279 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.46 -27.2 39.99 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.927 2.418 . . . . 0.0 112.513 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m -82.47 89.14 6.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.096 0.474 . . . . 0.0 110.328 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.29 147.13 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.234 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -118.03 139.92 50.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.344 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 29.7 m -78.39 140.06 60.18 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 12.4 Cg_exo -71.0 -176.42 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.944 2.429 . . . . 0.0 112.181 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.23 -96.5 0.64 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.22 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.2 t 51.69 74.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.182 0.515 . . . . 0.0 110.208 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.7 t 65.02 90.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.197 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.2 m -58.54 135.29 57.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.639 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.1 t -87.35 144.79 26.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.183 0.516 . . . . 0.0 110.65 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.3 m -122.56 140.26 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.321 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 7.4 p -144.86 122.57 6.47 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.006 0.431 . . . . 0.0 111.061 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 6.6 Cg_exo -73.71 110.11 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.706 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.44 98.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.796 0.685 . . . . 0.0 110.75 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.7 p -75.66 128.18 34.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.143 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -122.95 123.3 40.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.929 0.395 . . . . 0.0 111.299 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.416 ' NE2' ' HB ' ' A' ' 310' ' ' ILE . 64.3 m80 -94.41 23.0 5.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.702 0.763 . . . . 8.75 109.191 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 33.0 ttmt -60.51 113.37 2.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.086 -1.416 . . . . 6.04 109.88 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 307' ' ' TYR . 39.4 mt -90.71 142.29 27.91 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.081 -0.509 . . . . 5.29 110.764 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.476 ' HB3' ' HG3' ' A' ' 333' ' ' GLN . 88.6 t80 -93.6 105.21 17.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.306 -0.861 . . . . 4.77 108.928 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 302' ' ' TYR . 4.5 mp -96.45 100.41 10.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.648 -0.501 . . . . 3.94 109.648 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -116.88 108.37 1.74 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.718 -0.753 . . . . 4.58 112.102 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 330' ' ' LEU . . . 149.68 42.61 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.708 -0.758 . . . . 5.58 112.161 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.522 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.4 mt -119.1 137.97 25.72 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.607 0.242 . . . . 5.92 110.462 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 325' ' ' LEU . 24.9 Cg_exo -64.2 154.11 72.66 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.662 2.241 . . . . 6.94 111.685 174.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 298' ' ' LEU . 21.2 p30 -68.18 -23.72 64.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.431 0.53 . . . . 8.81 112.431 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -83.62 12.08 6.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.0 0.371 . . . . 8.73 112.0 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.08 129.37 36.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.109 0.48 . . . . 7.52 110.341 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.5 p-10 -102.98 179.93 4.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 8.79 110.655 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.37 -37.81 81.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 7.62 111.528 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -63.39 -52.88 59.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.268 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -61.19 -46.46 90.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 8.69 111.817 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 271' ' ' ASN . 61.1 t -63.27 -45.96 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.531 -0.304 . . . . 6.64 111.186 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.47 -50.73 72.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.91 -0.316 . . . . 7.74 110.516 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.86 -50.2 73.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.035 -0.529 . . . . 9.38 111.169 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 278' ' ' LEU . 1.5 tm? -55.81 -50.85 69.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 7.06 110.419 -175.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.794 ' HB2' HD11 ' A' ' 285' ' ' LEU . 84.3 mt -71.36 -37.66 71.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.277 -0.42 . . . . 6.89 111.24 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 284' ' ' PRO . 91.9 m -66.74 -27.81 67.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.51 -0.314 . . . . 8.85 111.118 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 49.1 m -60.39 -25.86 66.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.029 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.43 ' CD2' HD21 ' A' ' 320' ' ' LEU . 90.2 m-85 -108.5 -0.21 20.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.989 0.423 . . . . 9.18 110.603 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 164.82 122.64 0.61 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.712 -0.676 . . . . 9.06 111.634 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 280' ' ' THR . 37.6 Cg_exo -58.69 131.67 43.62 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.042 2.494 . . . . 10.14 113.0 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 279' ' ' LEU . 81.0 mt -94.67 123.75 38.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 8.3 110.981 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -90.24 -22.32 21.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 8.65 109.945 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -137.11 134.7 36.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.922 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.734 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 56.2 t80 -146.32 126.9 14.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.326 -0.397 . . . . 6.27 111.334 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 3.6 p-10 -140.88 121.9 14.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.558 -0.534 . . . . 5.79 109.558 168.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 303' ' ' ALA . 59.1 tp -97.92 125.96 43.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 6.35 109.814 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 302' ' ' TYR . 47.5 t -77.55 112.55 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 6.61 110.221 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -106.89 161.99 14.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.68 -0.691 . . . . 8.17 111.321 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -96.96 135.05 39.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.741 -0.663 . . . . 10.33 109.694 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.0 m -69.86 -40.03 75.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.504 -0.316 . . . . 10.8 111.708 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.31 -48.42 14.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.851 0.357 . . . . 12.13 111.85 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -79.96 -32.23 39.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.238 -0.437 . . . . 11.16 111.66 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 76.8 24.07 68.04 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.583 -0.818 . . . . 10.11 111.982 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 268' ' ' ASN . 89.2 mt -123.24 -178.88 4.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.113 -0.329 . . . . 10.12 110.113 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -77.25 143.73 38.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.728 0.299 . . . . 7.73 110.326 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -74.9 -26.5 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.013 0.435 . . . . 8.01 110.044 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 125.39 -7.37 7.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.415 -0.898 . . . . 6.09 113.105 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 263' ' ' ILE . 22.2 p90 -138.79 156.49 47.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.037 0.446 . . . . 6.54 111.154 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.15 165.77 30.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 4.38 110.739 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.413 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 98.7 m-85 -120.64 126.13 49.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.436 -0.579 . . . . 4.93 109.436 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.734 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 56.7 m -143.71 138.34 28.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.668 0.27 . . . . 5.09 110.915 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -113.48 136.02 53.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.775 -0.454 . . . . 7.03 109.775 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 261' ' ' LEU . 6.0 m-85 -84.19 153.19 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 7.81 111.021 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.568 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 90.2 t -64.85 -41.5 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 10.03 110.477 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.11 136.54 40.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 10.81 109.941 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.82 -1.28 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 111.98 0.363 . . . . 9.77 111.98 -174.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -93.39 -39.5 10.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.213 0.53 . . . . 10.89 109.673 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.38 -20.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.606 -0.724 . . . . 9.5 111.36 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 m -53.72 -47.95 70.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.275 -0.42 . . . . 7.83 112.041 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.62 -37.08 85.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 8.79 111.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -71.0 -35.21 71.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.907 -0.588 . . . . 10.51 110.809 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.37 -44.69 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 7.31 110.135 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 332' ' ' VAL . 83.8 mt -58.16 -50.92 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.833 -0.621 . . . . 6.44 110.77 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.09 71.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.924 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -86.65 -49.6 4.06 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.531 -0.842 . . . . 7.46 112.965 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.43 HD21 ' CD2' ' A' ' 282' ' ' PHE . 96.2 mt -72.54 -40.38 66.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.031 0.382 . . . . 6.42 112.031 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 51.1 t30 -66.39 113.54 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.945 0.402 . . . . 6.53 110.254 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 119.75 -12.4 10.91 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.963 -0.637 . . . . 6.77 112.036 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 62.9 mtt -75.15 -171.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.732 0.301 . . . . 7.29 110.474 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -146.35 123.19 11.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.764 0.316 . . . . 7.83 110.686 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.2 OUTLIER -106.92 112.06 24.84 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.591 -0.892 . . . . 7.01 108.591 176.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 70.56 -104.66 1.42 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.745 -0.741 . . . . 8.18 111.542 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.54 0.5 11.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.721 0.296 . . . . 8.94 111.068 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -112.52 138.96 48.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 7.29 110.945 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.38 138.66 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 7.13 110.4 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.439 HD11 HG23 ' A' ' 263' ' ' ILE . 55.0 tp -90.98 108.0 19.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.702 -0.681 . . . . 5.63 110.477 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.412 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 9.3 mp -105.77 105.53 15.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.212 -0.449 . . . . 5.53 109.94 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 317' ' ' ILE . 73.8 t -109.71 123.74 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.126 -0.488 . . . . 5.21 110.676 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.476 ' HG3' ' HB3' ' A' ' 262' ' ' PHE . 14.1 pt20 -133.79 -169.45 2.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 6.05 109.354 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 337' ' ' VAL . 74.4 ttt180 -105.65 143.86 33.22 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 7.58 109.44 174.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.56 77.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.566 0.222 . . . . 6.04 110.999 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -71.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 7.57 110.589 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 334' ' ' ARG . 9.3 m -131.17 114.6 26.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.348 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -156.62 46.08 0.5 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.123 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -120.82 90.55 3.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.981 0.42 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -89.51 103.58 16.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.955 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -131.05 125.8 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.091 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.289 0 O-C-N 123.638 0.586 . . . . 0.0 111.226 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -117.74 -19.81 9.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 70.4 mtt180 -112.07 146.39 38.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.774 0.321 . . . . 6.52 110.807 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 208' ' ' THR . 84.7 mt -119.46 150.0 40.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.722 -0.672 . . . . 5.24 110.111 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -99.42 109.72 22.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.821 -0.627 . . . . 6.15 109.607 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.4 p -109.05 124.76 65.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.329 0.585 . . . . 4.24 110.582 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.27 -178.77 15.47 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.485 -0.779 . . . . 4.95 111.687 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 62.03 33.0 17.47 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.409 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.463 HG22 HD22 ' A' ' 224' ' ' LEU . 34.4 pt -80.4 156.65 73.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.481 -0.781 . . . . 5.61 110.877 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.469 ' HA ' ' HG3' ' A' ' 222' ' ' GLN . 42.2 Cg_endo -69.49 124.62 11.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.47 2.113 . . . . 5.97 112.399 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -68.35 112.25 5.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.197 -0.668 . . . . 8.47 109.197 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.87 -2.27 8.54 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.628 -0.796 . . . . 6.96 112.006 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 10.9 tp -88.31 146.73 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.92 -0.4 . . . . 6.1 109.92 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.9 p -102.76 163.97 11.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.869 0.366 . . . . 6.62 111.314 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.738 ' HG2' ' HB ' ' A' ' 191' ' ' ILE . 33.2 mt-10 -63.93 -41.02 97.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.655 . . . . 5.69 110.69 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -58.39 -47.17 84.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.372 -0.831 . . . . 7.29 110.748 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.43 91.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.5 ttm -71.78 -36.35 70.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 4.49 110.652 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.412 ' HB2' HG11 ' A' ' 189' ' ' VAL . 1.6 tmt? -61.0 -50.32 73.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.534 . . . . 5.76 109.721 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.42 -41.22 98.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.905 -0.589 . . . . 6.51 111.351 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.61 -53.02 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.933 0.346 . . . . 5.44 111.933 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.659 0.266 . . . . 5.03 111.401 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.14 -37.0 78.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.73 0.3 . . . . 6.3 110.865 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.26 83.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.406 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -61.59 -37.17 82.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.371 -0.377 . . . . 6.25 111.264 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.526 ' HG3' ' HG2' ' A' ' 185' ' ' PRO . 19.1 mmt -63.9 -45.34 89.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.428 -0.351 . . . . 7.03 111.009 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.2 -46.18 61.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 8.94 111.221 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.81 -35.27 74.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.296 -0.411 . . . . 8.7 111.374 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.01 58.93 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.547 -0.835 . . . . 8.11 111.844 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.12 39.14 13.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.881 -0.676 . . . . 8.49 112.193 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.85 -0.77 39.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.077 0.465 . . . . 7.59 110.192 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 p -70.24 130.27 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.647 -0.706 . . . . 8.73 111.062 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.451 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.9 pt20 -84.69 -14.51 48.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.216 0.531 . . . . 9.89 110.236 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.03 29.92 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 9.69 109.871 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.45 111.51 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.465 2.11 . . . . 10.74 111.548 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 160.92 -148.18 15.85 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.878 -0.677 . . . . 8.97 112.059 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -126.39 112.26 23.38 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.689 0.28 . . . . 7.58 110.857 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 203' ' ' ARG . 50.6 Cg_exo -55.48 -45.8 37.06 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.124 2.549 . . . . 6.4 112.433 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.02 107.2 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.562 -0.533 . . . . 5.47 109.562 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.5 tp -90.98 -61.63 1.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.354 -175.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 201' ' ' GLU . . . -113.73 137.85 51.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.611 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 166' ' ' MET . 7.3 p -125.81 132.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.108 0.48 . . . . 4.68 111.365 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -132.86 114.55 14.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 6.34 109.87 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.738 ' HB ' ' HG2' ' A' ' 162' ' ' GLU . 46.9 mt -114.43 125.39 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.866 0.365 . . . . 5.85 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -105.2 98.15 7.9 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.061 -0.718 . . . . 7.34 109.061 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -74.19 -19.49 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.697 . . . . 7.61 110.338 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -58.4 -60.22 4.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.461 -0.79 . . . . 9.12 111.605 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 197' ' ' PHE . 41.9 mmtm -98.59 4.7 48.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.571 -0.286 . . . . 9.1 111.291 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.34 57.17 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.468 0.651 . . . . 6.6 111.36 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 195' ' ' LYS . 50.8 p90 -149.21 152.69 36.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 6.67 109.795 173.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -141.71 157.34 45.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.967 0.413 . . . . 4.58 111.143 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.49 121.68 36.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.66 -0.7 . . . . 6.22 110.233 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 82.5 mt -104.18 116.96 33.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.976 -0.556 . . . . 4.77 109.769 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 35.0 tt0 -97.49 111.77 23.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 6.55 109.756 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -88.5 159.13 18.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.554 . . . . 6.51 111.192 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 185' ' ' PRO . 39.0 ptt180 -70.96 -24.14 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.385 -0.825 . . . . 8.27 111.278 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 60.1 p -125.84 -165.3 1.41 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.253 -0.43 . . . . 7.96 110.863 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.51 -36.53 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.434 0.635 . . . . 8.73 109.423 174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.451 ' HB3' HE22 ' A' ' 180' ' ' GLN . 17.6 t70 -61.51 -53.07 61.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 8.5 111.312 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -64.43 -36.9 85.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 7.4 110.282 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 151' ' ' LEU . 9.8 m -54.26 -52.71 60.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.282 0.563 . . . . 6.13 110.501 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 m -65.65 -28.8 69.36 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.489 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.58 -29.86 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 7.75 109.967 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 214' ' ' PHE . . . -68.1 -13.81 62.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 5.43 111.248 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 81.4 mtp -70.37 -14.87 62.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 6.29 110.374 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.14 -5.36 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 6.14 110.596 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ALA . 94.3 m-85 -97.11 3.78 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 5.57 110.711 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.45 123.15 16.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 5.92 110.581 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.35 53.17 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.86 -0.685 . . . . 5.74 112.112 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.5 tt -72.75 142.51 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.328 . . . . 5.3 110.262 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 6.7 tp -84.63 113.16 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.356 0.598 . . . . 6.8 110.407 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -134.55 114.93 13.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 5.79 110.533 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 61.98 26.6 16.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.796 -0.638 . . . . 7.32 111.22 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 86.69 5.38 81.64 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.88 -0.676 . . . . 7.28 112.737 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 157' ' ' PRO . 29.4 mm-40 -115.53 150.69 36.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.778 0.323 . . . . 7.21 110.701 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -97.78 103.51 15.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.488 -0.56 . . . . 6.14 109.488 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.463 HD22 HG22 ' A' ' 156' ' ' ILE . 70.6 mt -69.79 114.42 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 4.9 111.503 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 76.6 tttt -83.57 114.51 21.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.588 -0.733 . . . . 7.3 109.709 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.14 105.69 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.831 0.348 . . . . 5.37 110.442 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -132.7 168.36 18.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.24 -0.436 . . . . 6.97 110.684 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.67 129.88 78.06 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.346 -0.388 . . . . 7.37 110.4 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 31.9 Cg_exo -58.63 130.76 38.68 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.973 2.448 . . . . 7.98 112.052 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -75.55 -74.45 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.882 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -159.36 111.09 2.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.918 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -123.64 91.41 3.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.432 0.634 . . . . 0.0 110.047 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -109.95 138.63 20.8 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.773 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.5 112.38 0.61 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.996 2.464 . . . . 0.0 112.1 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.2 tp -130.29 94.27 30.67 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.029 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.03 99.58 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.775 2.317 . . . . 0.0 111.674 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -100.89 139.28 14.32 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.779 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 51.1 mtt -87.77 91.85 8.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.048 0.451 . . . . 0.0 110.512 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 26.4 t -77.21 -35.43 55.66 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -95.1 100.76 12.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.203 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.495 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 13.2 m120 -89.93 -48.24 0.39 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.834 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 24.1 Cg_exo -64.63 119.57 6.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.89 1.727 . . . . 0.0 111.979 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.5 t 61.31 78.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.309 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.05 115.21 25.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -126.78 150.83 48.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.923 0.392 . . . . 0.0 110.782 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.85 113.7 16.38 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.865 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.85 -44.58 43.57 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.709 2.273 . . . . 0.0 111.781 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.31 116.93 4.0 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.609 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.78 115.02 16.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.463 0.649 . . . . 0.0 110.736 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.0 105.62 17.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.55 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 43.1 t -115.19 100.92 8.5 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.6 p -85.2 5.7 29.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.698 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.862 HG11 ' HB2' ' A' ' 334' ' ' ARG . 86.9 t -65.58 -57.94 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.355 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 55.6 t 63.18 86.77 0.14 Allowed Pre-proline 0 C--N 1.331 -0.221 0 O-C-N 123.761 0.663 . . . . 0.0 110.343 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 336' ' ' SER . 73.7 Cg_endo -93.15 143.96 2.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.072 2.514 . . . . 0.0 112.783 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.41 -171.14 2.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.2 t -77.52 79.28 4.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 109.753 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -169.17 -45.42 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.61 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.0 m80 66.33 28.81 9.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.445 -0.798 . . . . 8.75 110.512 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 37.5 ttmt -66.26 138.52 57.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.52 -0.763 . . . . 6.04 110.767 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 307' ' ' TYR . 79.7 mt -104.63 141.72 35.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.561 . . . . 5.29 111.007 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.682 ' HB2' ' HB2' ' A' ' 335' ' ' ALA . 87.7 t80 -96.91 119.04 34.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.297 -0.865 . . . . 4.77 109.152 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.73 HG23 HD11 ' A' ' 330' ' ' LEU . 3.7 mp -108.46 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.04 -0.527 . . . . 3.94 109.837 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.4 134.79 8.7 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 4.58 112.374 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 123.8 25.69 1.69 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.903 -0.665 . . . . 5.58 111.949 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 84.8 mt -102.46 138.97 19.82 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.429 -0.211 . . . . 5.92 110.429 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.561 ' HB2' HD13 ' A' ' 270' ' ' LEU . 41.8 Cg_exo -58.12 147.95 80.47 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.611 2.207 . . . . 6.94 111.483 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 299' ' ' SER . 6.4 p30 -73.59 -13.54 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.093 0.405 . . . . 8.81 112.093 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -90.05 0.61 57.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.632 -0.427 . . . . 8.73 111.079 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.0 mp -80.88 117.39 21.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.89 0.376 . . . . 7.52 110.196 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -85.65 174.76 9.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 8.79 110.904 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.33 -37.11 62.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.643 -0.708 . . . . 7.62 112.198 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -53.96 18.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.771 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -62.12 -39.67 93.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.591 0.234 . . . . 8.69 111.14 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 279' ' ' LEU . 94.9 t -62.16 -48.98 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.397 -0.365 . . . . 6.64 110.443 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -56.39 -53.08 61.59 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.519 -0.309 . . . . 7.74 111.047 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -52.67 -52.5 55.57 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.571 0.544 . . . . 9.38 111.809 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 7.06 110.526 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.531 HD22 HD13 ' A' ' 320' ' ' LEU . 64.3 mt -75.69 -32.86 60.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.434 -0.348 . . . . 6.89 111.433 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 16.2 m -74.18 -16.68 60.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.02 0.438 . . . . 8.85 110.816 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 41.2 m -61.53 -14.99 34.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.632 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.12 16.43 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 9.18 111.009 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.57 143.94 3.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.55 -0.833 . . . . 9.06 112.547 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 280' ' ' THR . 58.3 Cg_endo -71.9 140.48 35.16 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.693 2.262 . . . . 10.14 112.809 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 305' ' ' CYS . 97.3 mt -98.15 126.45 43.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 8.3 111.106 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 308' ' ' VAL . 18.7 ptpt -94.32 -18.34 21.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.328 0.585 . . . . 8.65 109.846 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.23 134.23 20.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.083 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.577 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 82.7 t80 -145.56 124.71 12.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.063 -0.517 . . . . 6.27 110.625 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -139.53 108.66 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.541 0.686 . . . . 5.79 110.347 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 303' ' ' ALA . 55.0 tp -79.54 128.35 33.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.242 -0.89 . . . . 6.35 109.112 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' A' ' 303' ' ' ALA . 42.2 t -77.31 111.69 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.059 0.456 . . . . 6.61 109.813 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -107.35 148.9 28.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.635 -0.711 . . . . 8.17 110.498 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.05 136.94 38.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.495 . . . . 10.33 109.738 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 44.0 m -70.07 -28.46 65.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.794 0.294 . . . . 10.8 111.794 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.56 -48.6 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.734 0.302 . . . . 12.13 111.183 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.7 m -75.34 -49.08 20.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.403 -0.362 . . . . 11.16 111.353 -176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 101.51 -26.69 23.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.842 -0.694 . . . . 10.11 111.965 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.12 173.41 10.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.801 0.334 . . . . 10.12 111.128 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ASN . 46.7 t -69.84 148.46 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.8 -0.636 . . . . 7.73 110.862 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.79 -1.01 55.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 8.01 110.163 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 105.13 -3.42 40.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.851 -0.69 . . . . 6.09 112.478 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -147.62 161.16 41.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 6.54 111.33 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -152.38 164.53 37.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 4.38 110.459 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -112.46 130.73 55.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.477 -0.564 . . . . 4.93 109.477 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.577 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 47.8 m -138.68 137.88 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.374 -0.375 . . . . 5.09 110.572 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 29.1 tt0 -120.14 134.1 55.34 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.461 -0.57 . . . . 7.03 109.461 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.563 ' CE1' HD12 ' A' ' 261' ' ' LEU . 20.0 m-85 -91.78 152.32 20.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.004 0.431 . . . . 7.81 111.59 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.528 ' HB ' ' HG2' ' A' ' 284' ' ' PRO . 92.0 t -66.84 -43.49 89.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.563 -0.744 . . . . 10.03 111.284 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -107.67 157.32 18.19 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.912 -0.403 . . . . 10.81 109.912 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.85 -19.51 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.988 0.366 . . . . 9.77 111.988 -175.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -77.3 -37.88 51.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.354 0.597 . . . . 10.89 109.493 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 24.6 m -65.83 -22.04 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.105 -0.952 . . . . 9.5 111.178 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.544 ' O ' HG13 ' A' ' 317' ' ' ILE . 9.5 m -55.25 -50.03 70.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.681 -0.236 . . . . 7.83 111.407 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.64 -37.87 76.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.981 0.419 . . . . 8.79 110.851 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -64.11 -38.77 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.677 -0.692 . . . . 10.51 110.249 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.38 86.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.533 -0.758 . . . . 7.31 110.811 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 313' ' ' THR . 85.1 mt -58.82 -45.66 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 6.44 110.734 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.66 88.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -79.32 -53.04 4.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.88 -0.676 . . . . 7.46 113.075 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.531 HD13 HD22 ' A' ' 279' ' ' LEU . 75.5 mt -67.9 -52.75 32.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.754 0.312 . . . . 6.42 111.702 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 331' ' ' LEU . 44.2 t30 -63.18 114.96 4.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 6.53 110.652 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -26.18 6.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.709 -0.758 . . . . 6.77 112.385 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 65.2 mtt -74.91 168.35 20.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.435 -0.209 . . . . 7.29 110.435 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 329' ' ' LYS . 55.1 mt-30 -125.12 131.06 53.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.969 0.414 . . . . 7.83 110.588 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -109.8 121.92 46.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.33 -0.619 . . . . 7.01 109.33 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 69.36 -96.63 0.49 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.737 -0.744 . . . . 8.18 111.34 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -134.95 7.81 3.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 8.94 110.484 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.47 143.81 45.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.994 0.426 . . . . 7.29 111.0 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 324' ' ' GLN . 87.9 tttt -84.61 136.67 33.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 7.13 110.137 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.73 HD11 HG23 ' A' ' 263' ' ' ILE . 44.3 tp -93.88 124.47 37.9 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 5.63 110.984 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.433 ' HA ' ' OD1' ' A' ' 321' ' ' ASN . 6.8 mp -115.07 124.16 50.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.624 . . . . 5.53 109.557 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.15 131.14 71.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 5.21 110.363 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -156.74 161.43 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 6.05 109.843 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.862 ' HB2' HG11 ' A' ' 253' ' ' VAL . 64.7 mtt85 -64.45 133.19 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.842 0.353 . . . . 7.58 110.651 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 262' ' ' PHE . . . -110.3 106.69 16.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 6.04 110.646 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 255' ' ' PRO . 53.0 m -154.73 -56.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.476 -0.329 . . . . 7.57 111.398 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 336' ' ' SER . 95.5 t 72.47 -60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.929 0.492 . . . . 0.0 111.15 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 120.35 -174.97 15.84 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.805 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -70.27 -27.32 64.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.955 0.407 . . . . 0.0 110.611 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.54 162.34 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.242 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -116.64 127.32 54.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.667 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.622 0.249 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -107.94 -6.13 16.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.604 0.24 . . . . 0.0 111.327 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.7 mtt180 -114.06 138.75 49.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 6.52 110.922 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 208' ' ' THR . 51.2 mt -116.02 152.08 34.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.909 -0.587 . . . . 5.24 110.43 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -106.08 111.23 23.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.854 -0.612 . . . . 6.15 109.698 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.5 p -109.15 131.0 61.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.143 0.497 . . . . 4.24 110.091 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.41 173.26 18.63 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.776 -0.647 . . . . 4.95 111.941 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 t30 62.77 68.84 0.62 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.459 0.647 . . . . 0.0 110.129 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.689 HG22 HD22 ' A' ' 224' ' ' LEU . 37.6 pt -117.63 160.87 36.54 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.392 -0.822 . . . . 5.61 110.29 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.698 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 21.1 Cg_endo -61.92 142.44 93.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.61 2.207 . . . . 5.97 112.441 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -79.56 109.81 14.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 8.47 110.266 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 96.48 36.88 4.97 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.795 -0.717 . . . . 6.96 111.708 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.698 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 5.7 tp -78.71 132.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.125 0.488 . . . . 6.1 111.086 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 164' ' ' ALA . 17.2 m -64.51 116.15 5.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 6.62 109.754 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.509 ' HG2' HD12 ' A' ' 191' ' ' ILE . 41.2 mt-10 -57.38 -47.13 82.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 5.69 110.9 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.43 -43.26 93.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.592 -0.731 . . . . 7.29 110.668 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . -72.57 -37.63 68.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.204 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.7 tpt -60.7 -47.37 86.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.957 0.408 . . . . 4.49 110.338 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.61 -41.52 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 5.76 110.307 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.11 -49.18 78.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.804 -0.635 . . . . 6.51 111.104 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -59.1 -47.33 85.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 5.44 111.133 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.488 ' HZ ' ' HB1' ' A' ' 211' ' ' ALA . 66.5 t80 -62.49 -49.3 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 5.03 110.815 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.433 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 78.7 m-20 -61.43 -37.22 82.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.418 -0.355 . . . . 6.3 110.838 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.08 -45.4 88.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.676 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.94 -30.03 71.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.391 -0.368 . . . . 6.25 111.41 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 214' ' ' PHE . 76.1 mtp -69.01 -45.02 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 7.03 110.171 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 50.9 mtt180 -65.25 -48.3 73.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 8.94 110.76 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.09 -35.33 78.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 8.7 110.947 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.89 -27.0 69.74 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.876 -0.678 . . . . 8.11 112.075 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.65 21.58 18.7 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 8.49 112.373 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.7 mp -108.42 82.12 1.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.213 0.53 . . . . 7.59 110.359 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.601 HG23 ' HG3' ' A' ' 185' ' ' PRO . 3.2 m -157.13 106.84 2.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.242 -0.651 . . . . 8.73 109.242 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.472 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.4 pt20 -73.18 -23.55 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.961 -0.295 . . . . 9.89 111.666 -171.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' THR . . . -145.05 158.43 52.18 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.549 -0.296 . . . . 9.69 110.583 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 151.65 66.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.419 2.08 . . . . 10.74 111.704 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.69 -168.88 20.81 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.71 -0.757 . . . . 8.97 111.775 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 93.3 m-20 -94.98 129.17 36.49 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 110.42 -0.215 . . . . 7.58 110.42 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 179' ' ' THR . 26.7 Cg_exo -63.04 -35.76 63.53 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.594 2.196 . . . . 6.4 111.208 176.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.6 131.48 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.47 110.121 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 281' ' ' SER . 43.6 tp -87.71 -54.49 4.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.728 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.68 153.43 40.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.404 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.35 138.88 48.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.236 -0.438 . . . . 4.68 110.958 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -119.13 105.83 11.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.302 -0.629 . . . . 6.34 109.302 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.509 HD12 ' HG2' ' A' ' 162' ' ' GLU . 62.8 mt -109.3 125.62 66.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.129 0.49 . . . . 5.85 111.249 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -116.2 120.21 38.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.604 -0.725 . . . . 7.34 110.128 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.78 -23.91 23.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.136 -0.484 . . . . 7.61 110.731 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 195' ' ' LYS . 24.0 t70 -57.63 -56.76 17.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.834 -0.621 . . . . 9.12 111.898 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 197' ' ' PHE . 43.6 mmtm -105.29 5.24 31.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.793 0.33 . . . . 9.1 111.095 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 60.35 67.46 0.84 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.528 -0.76 . . . . 6.6 111.517 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 195' ' ' LYS . 54.5 p90 -149.65 162.5 40.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.005 -0.543 . . . . 6.67 109.821 175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -146.68 143.75 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.082 0.468 . . . . 4.58 111.148 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -107.52 120.58 42.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.686 -0.688 . . . . 6.22 109.734 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 76.8 mt -101.68 115.59 30.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.024 -0.535 . . . . 4.77 109.6 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -100.74 121.68 42.07 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.071 -0.344 . . . . 6.55 110.071 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.553 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 48.1 m-85 -99.14 164.15 12.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.144 0.497 . . . . 6.51 110.822 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.67 -22.97 59.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.767 -0.651 . . . . 8.27 111.326 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.8 p -142.83 147.22 35.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.632 0.254 . . . . 7.96 110.913 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.06 -36.17 72.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.953 0.406 . . . . 8.73 110.556 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.37 -58.24 8.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.738 -0.665 . . . . 8.5 111.086 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.472 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 49.4 mt-10 -65.4 -34.25 77.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 7.4 110.871 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 202' ' ' PHE . 81.5 m -53.49 -52.6 59.02 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.22 0.533 . . . . 6.13 110.212 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 m -63.87 -30.97 72.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.947 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -29.57 62.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.979 0.419 . . . . 7.75 110.361 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.488 ' HB1' ' HZ ' ' A' ' 169' ' ' PHE . . . -72.21 -10.11 59.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.529 . . . . 5.43 111.535 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 84.3 mtp -68.02 -20.32 64.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 6.29 110.455 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -76.3 -1.82 28.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 6.14 111.653 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 173' ' ' MET . 94.9 m-85 -97.41 3.33 50.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.739 0.304 . . . . 5.57 110.842 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -57.24 129.66 42.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.055 -0.521 . . . . 5.92 110.914 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.31 25.88 27.28 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.936 -0.649 . . . . 5.74 112.111 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.8 tt -80.8 132.39 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.813 0.34 . . . . 5.3 110.146 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.01 111.23 19.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.542 0.687 . . . . 6.8 111.179 -176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.497 ' HE2' HD13 ' A' ' 160' ' ' ILE . 88.9 t80 -136.07 122.09 20.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.561 -0.745 . . . . 5.79 110.182 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 57.32 33.66 23.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.851 0.358 . . . . 7.32 111.836 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.15 6.47 86.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.919 -0.657 . . . . 7.28 112.606 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.62 131.85 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.718 0.294 . . . . 7.21 110.479 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.6 m -86.08 102.64 14.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.499 -0.556 . . . . 6.14 109.499 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 156' ' ' ILE . 56.7 mt -66.62 115.52 6.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.941 -0.572 . . . . 4.9 110.344 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.3 tttt -90.18 114.7 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.941 -0.572 . . . . 7.3 109.739 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.6 mt -112.84 105.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.421 -0.354 . . . . 5.37 110.207 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.424 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 7.8 mmt85 -128.25 169.46 14.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.205 -0.452 . . . . 6.97 110.786 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -79.78 127.14 78.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.311 -0.404 . . . . 7.37 109.99 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.04 113.7 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.488 2.125 . . . . 7.98 110.863 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -73.65 165.99 24.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.849 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -83.56 76.73 9.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.392 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -84.5 131.01 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.733 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 60.97 77.44 0.36 Allowed Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 123.775 0.672 . . . . 0.0 110.095 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.19 124.36 3.74 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.254 2.636 . . . . 0.0 112.567 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.89 140.35 15.56 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.798 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.65 135.73 54.32 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.35 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -100.13 -116.58 3.93 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.419 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 55.9 mtt 61.59 38.99 15.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.768 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 34.1 m -81.97 31.54 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.508 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -129.18 116.0 18.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.859 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -111.22 141.93 25.35 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.94 17.43 1.31 Allowed 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.709 2.272 . . . . 0.0 113.493 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 9.2 t -115.9 20.53 14.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.406 0.622 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.7 m -72.23 132.27 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.225 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -109.07 121.59 45.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.746 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.31 117.49 53.02 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.674 ' HB2' HG22 ' A' ' 249' ' ' VAL . 24.4 Cg_exo -65.22 -24.65 58.29 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.615 2.21 . . . . 0.0 111.45 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 77.71 26.08 61.48 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.265 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.674 HG22 ' HB2' ' A' ' 247' ' ' PRO . 22.4 m -126.42 125.02 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -97.93 -34.8 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.0 109.497 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.0 m -146.04 -170.33 3.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.717 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 4.5 p -59.48 -36.97 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.724 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.3 158.03 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.034 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 62.6 t -77.38 118.69 73.67 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 5.2 Cg_exo -74.42 164.78 33.23 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.844 2.362 . . . . 0.0 111.635 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.9 -64.3 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.472 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.2 m 55.46 28.85 12.24 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.193 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.82 127.43 32.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 306' ' ' GLU . 23.1 m170 -83.17 -2.07 54.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.521 . . . . 8.75 110.37 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 306' ' ' GLU . 40.8 ttmt -77.25 123.62 26.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.671 -0.695 . . . . 6.04 109.955 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.526 HD12 ' CE1' ' A' ' 307' ' ' TYR . 41.2 mt -101.64 142.68 32.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.925 -0.579 . . . . 5.29 111.014 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -88.42 115.67 26.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.323 -0.853 . . . . 4.77 109.221 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.27 107.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.963 -0.384 . . . . 3.94 109.963 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -110.54 171.71 14.87 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.507 -0.637 . . . . 4.58 111.507 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.44 26.85 45.68 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 5.58 111.694 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.41 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 91.2 mt -90.11 125.95 58.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.766 0.317 . . . . 5.92 110.587 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.673 ' HB2' HD13 ' A' ' 270' ' ' LEU . 27.1 Cg_exo -63.1 134.78 47.6 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.664 2.242 . . . . 6.94 111.681 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -63.4 -20.66 65.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 8.81 112.179 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -86.02 1.59 49.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.566 0.222 . . . . 8.73 111.59 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 267' ' ' PRO . 8.4 mp -91.68 144.59 25.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.132 -0.321 . . . . 7.52 110.132 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 275' ' ' VAL . 32.8 p-10 -106.88 177.19 4.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.271 -0.422 . . . . 8.79 110.436 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 3.8 m-20 -58.36 -38.99 78.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 7.62 111.493 -175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -64.71 -50.87 65.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.08 -40.47 85.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.511 0.195 . . . . 8.69 111.386 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 271' ' ' ASN . 59.1 t -65.96 -48.46 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 6.64 110.728 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 35.7 mtmm -59.27 -53.25 60.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.576 -0.284 . . . . 7.74 111.193 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.27 -43.15 82.83 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.827 0.346 . . . . 9.38 111.063 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.04 -53.3 58.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 7.06 110.201 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.34 -36.11 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.389 -0.369 . . . . 6.89 111.414 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 89.6 m -63.21 -32.23 73.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 8.85 111.291 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 32.2 m -65.62 -14.08 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -116.8 8.32 13.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 9.18 110.388 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 152.91 125.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.745 -0.661 . . . . 9.06 111.91 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.416 ' HA ' HG23 ' A' ' 280' ' ' THR . 35.9 Cg_endo -64.89 139.13 60.75 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.63 2.22 . . . . 10.14 112.712 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 70.6 mt -100.59 133.0 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 8.3 110.329 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.687 ' HB3' HG22 ' A' ' 308' ' ' VAL . 19.6 ptpt -95.83 -18.39 20.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.808 -0.442 . . . . 8.65 109.808 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -149.18 139.79 22.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.182 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.552 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 84.9 t80 -140.41 130.31 24.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.228 -0.442 . . . . 6.27 110.535 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.59 118.57 11.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 5.79 110.083 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 303' ' ' ALA . 60.4 tp -95.66 128.41 42.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 6.35 109.797 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 302' ' ' TYR . 58.9 t -76.21 113.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 6.61 109.992 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.492 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 45.2 mttm -114.63 161.69 17.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.787 -0.642 . . . . 8.17 111.13 -172.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 1.025 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 31.2 t70 -126.46 122.82 36.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.023 -0.535 . . . . 10.33 109.872 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.4 m -65.39 -38.7 90.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.151 0.426 . . . . 10.8 112.151 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.57 82.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.985 0.422 . . . . 12.13 111.311 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 9.9 m -81.12 -35.92 30.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.195 -0.457 . . . . 11.16 111.12 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 84.12 10.05 81.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.035 -0.602 . . . . 10.11 111.983 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.9 mt -129.94 175.32 8.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.798 0.332 . . . . 10.12 110.549 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.5 t -71.99 156.42 39.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.89 -0.596 . . . . 7.73 110.054 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 1.025 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.3 mmmp? -86.33 1.74 49.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.388 -0.369 . . . . 8.01 110.635 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 104.05 4.65 44.64 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.583 -0.817 . . . . 6.09 113.439 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.489 ' CE2' HG21 ' A' ' 291' ' ' VAL . 48.6 p90 -157.4 162.12 39.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.194 0.521 . . . . 6.54 111.57 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.691 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -148.61 170.09 18.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.438 -0.801 . . . . 4.38 110.623 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.582 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 97.4 m-85 -120.31 127.48 52.39 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.314 -0.624 . . . . 4.93 109.314 175.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.552 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 25.9 m -135.04 113.47 11.48 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.499 -0.319 . . . . 5.09 111.125 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 260' ' ' LYS . 27.2 tt0 -88.3 123.53 32.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.913 0.387 . . . . 7.03 110.201 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.526 ' CE1' HD12 ' A' ' 261' ' ' LEU . 13.5 m-85 -80.23 156.76 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.815 -0.629 . . . . 7.81 111.426 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 286' ' ' LYS . 96.8 t -81.45 -55.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 10.03 110.684 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.695 ' HB3' HG22 ' A' ' 312' ' ' VAL . 13.1 t70 -82.12 129.46 34.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 10.81 109.971 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -87.92 0.84 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.252 0.464 . . . . 9.77 112.252 -173.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -103.51 -35.94 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 10.89 110.227 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 309' ' ' ASP . 27.5 m -72.46 -20.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 9.5 111.216 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.495 ' O ' HG13 ' A' ' 317' ' ' ILE . 11.5 m -54.67 -51.55 65.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.394 -0.366 . . . . 7.83 111.961 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -71.24 -24.45 62.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 8.79 110.795 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.94 -45.16 52.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.909 -0.587 . . . . 10.51 109.685 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.8 96.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.679 -0.692 . . . . 7.31 110.117 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 313' ' ' THR . 75.4 mt -57.61 -52.98 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 6.44 110.559 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.36 93.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.647 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -76.6 -43.33 19.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.639 -0.791 . . . . 7.46 113.182 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.64 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.3 mt -82.45 -40.91 20.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.277 0.473 . . . . 6.42 112.277 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -62.84 115.85 4.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.776 0.322 . . . . 6.53 110.643 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.71 -23.85 20.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.961 -0.638 . . . . 6.77 111.89 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 24.9 ttt -78.78 137.79 37.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 7.29 109.741 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -88.04 129.39 35.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.087 0.47 . . . . 7.83 111.077 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.7 tp -96.85 104.01 15.98 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.534 -0.913 . . . . 7.01 108.534 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.44 -74.72 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.037 -0.825 . . . . 8.18 111.037 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.19 5.99 0.15 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.988 0.423 . . . . 8.94 110.088 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HD3' ' HG3' ' A' ' 267' ' ' PRO . 12.6 mptt -101.92 129.64 48.23 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.593 -0.521 . . . . 7.29 109.593 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.64 118.02 15.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.802 0.334 . . . . 7.13 110.471 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 320' ' ' LEU . 19.0 tp -74.53 115.71 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.914 -0.584 . . . . 5.63 109.865 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 4.9 tt -98.47 110.68 23.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.928 -0.768 . . . . 5.53 108.928 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 317' ' ' ILE . 49.1 t -120.77 127.53 75.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.028 0.442 . . . . 5.21 110.864 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -162.08 -178.29 6.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.6 -0.727 . . . . 6.05 109.077 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -73.69 145.03 45.54 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.821 -0.352 . . . . 7.58 110.138 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -67.47 -42.11 83.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.414 -0.357 . . . . 6.04 111.558 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 33.1 m -106.27 -36.47 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.491 -0.322 . . . . 7.57 110.993 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.5 t 72.24 -57.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.289 0.636 . . . . 0.0 111.571 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.27 26.47 1.2 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.385 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -111.58 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -110.03 119.21 38.59 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -109.3 121.57 45.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 178.296 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.557 0.218 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.493 ' HB2' ' HG3' ' A' ' 201' ' ' GLU . 68.9 mtm180 -112.61 18.69 18.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.739 0.304 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 201' ' ' GLU . 83.4 mtt180 -111.23 146.19 37.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.057 0.456 . . . . 6.52 112.113 -173.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 80.2 mt -118.31 154.85 31.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 5.24 109.661 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -100.05 109.99 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.206 -0.452 . . . . 6.15 109.969 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 198' ' ' ALA . 7.2 p -109.01 133.31 54.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.131 0.491 . . . . 4.24 110.453 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -139.31 -179.31 17.38 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.782 -0.645 . . . . 4.95 111.803 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.0 t30 58.24 65.65 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.767 0.794 . . . . 0.0 109.985 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 29.6 pt -115.68 157.69 43.8 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.989 -1.005 . . . . 5.61 110.226 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 160' ' ' ILE . 36.2 Cg_endo -65.67 131.13 26.71 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.484 2.123 . . . . 5.97 112.559 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -72.03 96.22 1.71 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.299 0.571 . . . . 8.47 109.888 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 141.59 -10.15 2.65 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.524 -0.762 . . . . 6.96 111.517 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.708 ' HB ' ' HG2' ' A' ' 157' ' ' PRO . 9.1 tp -66.94 136.18 27.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.911 0.386 . . . . 6.1 110.857 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 74.8 p -89.93 153.26 20.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.099 -0.5 . . . . 6.62 109.703 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.97 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.4 mt-10 -61.81 -40.67 96.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.782 0.325 . . . . 5.69 110.904 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.4 -48.89 73.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.982 -0.554 . . . . 7.29 111.383 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.09 86.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.3 tpt -65.86 -46.68 77.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.234 -0.439 . . . . 4.49 110.23 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 23.1 ttt -61.07 -45.75 93.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 5.76 110.609 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -57.38 -41.97 81.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.577 -0.738 . . . . 6.51 111.048 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.64 -49.38 76.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 5.44 111.009 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.469 ' HE1' HD11 ' A' ' 226' ' ' ILE . 47.8 m-85 -61.19 -45.37 94.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.671 -0.24 . . . . 5.03 111.068 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 95.3 m-20 -57.09 -44.92 83.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 6.3 110.407 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.75 -48.64 78.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.174 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.57 -43.49 98.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 6.25 111.229 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.34 -34.84 78.89 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.939 -0.304 . . . . 7.03 110.644 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 170' ' ' ASN . 95.0 mtt180 -64.31 -52.06 60.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.368 . . . . 8.94 110.787 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.93 -36.09 69.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.223 -0.444 . . . . 8.7 111.266 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.46 -30.85 68.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.955 -0.64 . . . . 8.11 112.043 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.08 36.89 26.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.932 -0.651 . . . . 8.49 112.75 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 210' ' ' GLN . 8.3 mp -101.68 21.42 14.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.185 0.517 . . . . 7.59 110.504 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.1 p -102.93 171.46 7.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.848 -0.615 . . . . 8.73 110.381 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.9 pt20 -110.79 -1.09 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.935 0.398 . . . . 9.89 110.02 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.3 162.71 15.58 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.726 -0.67 . . . . 9.69 110.141 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 170.88 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.503 2.135 . . . . 10.74 111.546 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.73 -153.85 17.87 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.437 -0.887 . . . . 8.97 112.764 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -106.93 114.74 61.25 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.693 0.282 . . . . 7.58 110.794 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.405 ' HD2' ' OD1' ' A' ' 170' ' ' ASN . 36.6 Cg_exo -60.74 -42.84 35.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.981 2.454 . . . . 6.4 112.366 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.06 131.59 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.057 -0.349 . . . . 5.47 110.057 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 203' ' ' ARG . 36.1 tp -109.49 -39.01 5.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.493 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.733 ' HB1' HG11 ' A' ' 312' ' ' VAL . . . -137.19 131.5 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.223 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.57 122.34 64.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.231 0.538 . . . . 4.68 111.426 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.38 106.2 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.873 -0.603 . . . . 6.34 109.568 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -112.53 134.35 55.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.754 0.312 . . . . 5.85 111.049 -177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -114.98 104.38 11.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.634 -0.506 . . . . 7.34 109.634 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.4 -17.78 60.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.82 -0.627 . . . . 7.61 111.315 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.68 -53.38 22.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.56 -0.291 . . . . 9.12 111.09 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 197' ' ' PHE . 47.3 mmtm -90.25 -3.64 57.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.822 0.344 . . . . 9.1 110.433 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 63.6 56.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.399 -0.819 . . . . 6.6 110.841 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 195' ' ' LYS . 22.2 p90 -148.59 162.97 38.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 6.67 109.689 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.516 ' HB3' HG13 ' A' ' 153' ' ' VAL . . . -151.59 148.95 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.974 0.416 . . . . 4.58 111.357 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' A' ' 229' ' ' PRO . 55.5 m-85 -111.4 108.38 17.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.696 -0.684 . . . . 6.22 109.563 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 92.5 mt -97.56 116.06 29.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.975 -0.557 . . . . 4.77 110.322 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 188' ' ' ALA . 25.4 tt0 -99.22 122.02 41.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.54 -0.541 . . . . 6.55 109.54 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' A' ' 208' ' ' THR . 90.1 m-85 -93.69 163.97 13.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.944 -0.571 . . . . 6.51 110.425 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.505 ' HA ' HD22 ' A' ' 187' ' ' LEU . 38.9 ptt180 -69.16 -17.18 63.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.717 -0.674 . . . . 8.27 111.419 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 56.2 p -135.19 -163.64 1.41 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.302 -0.408 . . . . 7.96 110.356 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 1.052 HG11 ' HA2' ' A' ' 248' ' ' GLY . 46.5 t -123.01 -32.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.261 0.553 . . . . 8.73 109.713 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.45 -57.75 11.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.759 -0.655 . . . . 8.5 110.573 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 38.7 mt-10 -60.13 -37.23 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 7.4 109.921 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.461 HG23 ' CD1' ' A' ' 202' ' ' PHE . 12.0 m -54.45 -43.25 71.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 6.13 110.806 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.4 m -59.92 -41.26 91.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.323 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -71.99 -27.77 62.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.382 -0.372 . . . . 7.75 110.909 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 214' ' ' PHE . . . -63.65 -19.04 64.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 5.43 111.173 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 74.9 mtp -70.82 -19.37 62.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.476 -0.329 . . . . 6.29 111.022 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.25 -6.05 51.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 6.14 111.306 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 211' ' ' ALA . 97.5 m-85 -89.63 2.12 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 5.57 110.624 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.11 120.97 10.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 5.92 110.441 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.11 42.09 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.682 -0.771 . . . . 5.74 112.527 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 16.7 tt -63.21 136.08 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 5.3 110.487 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.2 tp -87.99 121.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.277 0.561 . . . . 6.8 110.83 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -134.27 115.01 13.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.807 -0.633 . . . . 5.79 110.571 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 53.08 35.95 20.96 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.952 -0.567 . . . . 7.32 112.077 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.7 2.55 75.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.819 -0.705 . . . . 7.28 113.221 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -119.37 136.19 54.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.123 0.461 . . . . 7.21 110.951 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.6 t -88.75 103.28 15.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.128 -0.693 . . . . 6.14 109.128 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 156' ' ' ILE . 84.2 mt -66.34 121.99 16.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 4.9 111.04 -174.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.59 ' HE2' ' HG3' ' A' ' 227' ' ' ARG . 87.6 tttt -96.85 115.56 27.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 7.3 110.293 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.469 HD11 ' HE1' ' A' ' 169' ' ' PHE . 61.6 mt -115.02 107.14 22.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.921 -0.4 . . . . 5.37 109.921 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.59 ' HG3' ' HE2' ' A' ' 225' ' ' LYS . 8.0 mmt180 -130.98 172.12 12.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.124 0.488 . . . . 6.97 111.51 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 45.1 mtp85 -72.14 131.94 84.84 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.473 -0.785 . . . . 7.37 110.248 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 228' ' ' ARG . 16.9 Cg_exo -66.97 152.59 80.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 7.98 111.361 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.17 135.22 50.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -51.29 135.82 25.86 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.668 0.605 . . . . 0.0 110.755 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -87.81 -56.11 3.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.961 -171.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -100.4 125.66 38.61 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.512 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.09 124.51 12.7 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.877 2.385 . . . . 0.0 112.08 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.945 ' HB2' ' HB3' ' A' ' 238' ' ' MET . 80.8 mt -103.54 128.55 27.18 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 17.2 Cg_exo -67.17 107.51 1.37 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.784 2.323 . . . . 0.0 111.219 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 58.07 3.63 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.226 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.945 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -95.04 177.83 5.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.99 0.424 . . . . 0.0 111.107 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.451 ' HB2' ' HG3' ' A' ' 242' ' ' PRO . 28.9 m -150.66 141.91 23.24 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.98 -57.33 6.35 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.56 87.29 36.36 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 239' ' ' SER . 14.3 Cg_exo -69.57 -43.22 2.95 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.843 2.362 . . . . 0.0 112.149 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.5 t -155.52 -55.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.8 m -96.61 161.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.489 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.97 -63.98 1.26 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 36.7 t -106.89 111.18 63.85 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.43 -33.7 92.73 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.135 2.557 . . . . 0.0 112.695 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 1.052 ' HA2' HG11 ' A' ' 205' ' ' VAL . . . 99.91 -143.01 16.21 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.771 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.62 76.54 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.152 0.501 . . . . 0.0 110.015 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.49 -6.51 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.676 0.751 . . . . 0.0 109.563 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 44.5 t -156.37 140.08 16.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.448 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.1 t -134.19 139.85 46.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.04 0.448 . . . . 0.0 110.621 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.5 t -85.41 114.68 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.661 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 23.9 m -76.37 136.76 68.17 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.164 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.539 ' HB3' HG13 ' A' ' 308' ' ' VAL . 41.8 Cg_endo -68.28 138.77 43.92 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.846 2.364 . . . . 0.0 112.954 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 310' ' ' ILE . 27.8 t70 -91.39 129.92 37.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.183 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.0 p -86.09 162.54 18.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.795 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 66.05 22.12 11.19 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.446 0.641 . . . . 0.0 110.348 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -103.7 16.14 27.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.46 -0.791 . . . . 8.75 109.47 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.776 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 39.7 ttmt -58.65 130.73 48.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.076 -0.966 . . . . 6.04 111.353 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 313' ' ' THR . 83.8 mt -108.38 143.81 36.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.759 -0.655 . . . . 5.29 110.661 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -91.49 120.3 32.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.994 -0.548 . . . . 4.77 110.06 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.1 106.96 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.287 -0.415 . . . . 3.94 109.907 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.65 154.74 16.57 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.845 -0.693 . . . . 4.58 112.043 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 103.06 34.29 4.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 5.58 112.004 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 301' ' ' GLY . 87.2 mt -102.66 138.86 19.74 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.802 0.334 . . . . 5.92 110.85 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 16.8 Cg_exo -68.87 144.53 59.2 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.955 2.437 . . . . 6.94 111.946 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.51 -25.95 63.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.833 0.349 . . . . 8.81 110.852 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -87.75 0.63 55.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.22 -0.445 . . . . 8.73 111.512 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 40.2 tp -86.79 122.59 30.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.165 -0.309 . . . . 7.52 110.165 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 275' ' ' VAL . 29.7 p-10 -78.98 157.11 28.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.123 -0.49 . . . . 8.79 111.245 -177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.67 -32.07 70.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.588 -0.733 . . . . 7.62 111.569 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.81 -53.03 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.66 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.78 -33.54 74.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.391 -0.368 . . . . 8.69 111.208 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 271' ' ' ASN . 20.8 t -64.79 -48.74 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.667 0.27 . . . . 6.64 110.527 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -58.52 -47.24 84.79 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.322 -0.399 . . . . 7.74 110.664 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.67 -47.81 83.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 9.38 110.759 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.06 -51.03 70.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 7.06 110.255 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 285' ' ' LEU . 90.7 mt -66.87 -38.22 85.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.258 -0.428 . . . . 6.89 111.671 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 28.6 m -69.74 -19.62 63.53 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.154 0.502 . . . . 8.85 110.961 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.1 m -73.68 -8.03 54.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.119 0.485 . . . . 0.0 110.656 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 320' ' ' LEU . 97.2 m-85 -121.6 14.53 11.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 9.18 110.156 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 280' ' ' THR . . . 146.32 136.49 2.91 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.765 -0.652 . . . . 9.06 112.058 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.468 ' HD3' ' HG ' ' A' ' 187' ' ' LEU . 24.6 Cg_endo -61.88 135.89 58.38 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.819 2.346 . . . . 10.14 112.316 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 279' ' ' LEU . 99.3 mt -100.11 137.89 37.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.24 -0.436 . . . . 8.3 110.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.433 ' HB3' HG22 ' A' ' 308' ' ' VAL . 17.3 ptpt -98.06 -32.97 11.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.456 -0.572 . . . . 8.65 109.456 175.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 286' ' ' LYS . . . -142.56 132.87 24.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.429 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -133.0 117.57 17.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.917 -0.583 . . . . 6.27 110.22 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -131.97 113.15 13.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.609 0.719 . . . . 5.79 110.379 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 303' ' ' ALA . 62.2 tp -87.38 130.52 34.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.587 -0.733 . . . . 6.35 109.199 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 111.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.81 -0.441 . . . . 6.61 109.81 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.414 ' HZ3' HD23 ' A' ' 290' ' ' LEU . 61.6 mttm -111.06 156.6 21.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.603 -0.726 . . . . 8.17 109.918 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.63 ' HB2' ' HD3' ' A' ' 300' ' ' LYS . 33.9 t70 -88.66 136.31 33.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.984 -0.376 . . . . 10.33 109.984 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.3 m -60.12 -38.12 82.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 10.8 112.021 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.17 -48.03 6.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.03 0.443 . . . . 12.13 111.411 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.7 m -67.68 -38.22 83.41 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.826 -0.625 . . . . 11.16 111.001 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 80.67 4.97 90.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.885 -0.674 . . . . 10.11 112.321 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 61.8 mt -113.08 169.37 8.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.173 -0.306 . . . . 10.12 110.173 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.518 ' HB2' HD21 ' A' ' 290' ' ' LEU . 46.4 t -65.72 146.21 55.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.221 0.534 . . . . 7.73 110.989 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.63 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 30.1 mmmt -87.55 3.24 48.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.813 -0.63 . . . . 8.01 110.372 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 266' ' ' LEU . . . 102.53 4.88 49.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.574 -0.822 . . . . 6.09 113.241 174.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -152.87 156.78 39.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.987 0.422 . . . . 6.54 111.148 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.669 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -145.46 167.03 23.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 4.38 110.879 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.776 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 90.3 m-85 -122.54 130.02 52.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.793 -0.639 . . . . 4.93 109.304 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 35.1 m -142.25 132.5 24.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.033 -0.267 . . . . 5.09 110.938 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.84 132.18 54.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.853 -0.425 . . . . 7.03 109.853 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -88.36 156.5 19.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.606 -0.725 . . . . 7.81 111.34 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 255' ' ' PRO . 79.6 t -82.18 -50.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.633 -0.712 . . . . 10.03 109.552 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.482 ' OD2' HG22 ' A' ' 312' ' ' VAL . 22.0 t70 -77.77 148.96 34.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 10.81 110.217 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.592 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -124.35 20.47 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.415 . . . . 9.77 111.233 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -104.11 -49.45 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.262 0.553 . . . . 10.89 109.83 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.733 HG11 ' HB1' ' A' ' 188' ' ' ALA . 34.0 m -79.21 -20.7 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.298 -0.864 . . . . 9.5 111.396 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.621 HG22 HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -53.81 -50.24 66.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.549 0.574 . . . . 7.83 112.549 -170.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.29 -35.77 80.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.874 0.369 . . . . 8.79 111.188 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.87 -29.15 60.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 10.51 110.302 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.94 -39.2 76.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.185 -0.461 . . . . 7.31 110.033 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 313' ' ' THR . 80.6 mt -57.35 -61.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 6.44 110.443 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.64 -15.98 62.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.468 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.67 -47.46 5.63 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.023 -0.608 . . . . 7.46 112.471 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 282' ' ' PHE . 92.8 mt -79.95 -40.03 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.589 0.233 . . . . 6.42 111.197 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.489 ' OD1' HD12 ' A' ' 331' ' ' LEU . 8.8 t30 -62.01 115.0 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 6.53 110.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.33 -23.63 6.04 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.672 -0.775 . . . . 6.77 111.856 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 66.7 mtt -78.66 171.99 14.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.733 -0.469 . . . . 7.29 109.733 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -117.63 151.75 36.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.723 0.297 . . . . 7.83 110.51 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.61 106.73 7.56 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.998 -0.742 . . . . 7.01 108.998 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 75.5 -94.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.721 -0.752 . . . . 8.18 111.435 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.08 -9.35 5.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 8.94 110.404 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -99.15 159.28 15.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 7.29 110.38 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -98.92 129.35 45.25 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.528 -0.545 . . . . 7.13 109.528 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.01 115.2 9.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 5.63 110.709 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.489 HD12 ' OD1' ' A' ' 321' ' ' ASN . 51.4 tp -108.6 105.79 15.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.322 -0.854 . . . . 5.53 109.832 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.11 115.47 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.724 -0.473 . . . . 5.21 109.724 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -137.76 158.82 43.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.138 0.494 . . . . 6.05 111.011 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 337' ' ' VAL . 21.0 ttt180 -71.78 119.9 16.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.621 -0.718 . . . . 7.58 109.215 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -85.47 -65.32 1.02 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.969 0.359 . . . . 6.04 111.969 -171.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 39.6 m -70.56 -32.46 69.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.882 0.372 . . . . 7.57 110.311 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.709 ' HA ' ' HG2' ' A' ' 334' ' ' ARG . 46.3 t 66.88 -78.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.773 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 76.79 -88.34 0.95 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.577 -174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -152.29 98.47 2.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.637 0.256 . . . . 0.0 110.311 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -79.45 98.63 6.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -139.5 -37.33 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.878 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.722 -179.612 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 150' ' ' ARG . 6.5 ptp180 -101.86 -19.04 15.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.041 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 97.1 mtt180 -114.84 133.28 56.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.867 0.365 . . . . 6.52 111.213 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 199' ' ' PHE . 75.8 mt -98.98 157.8 16.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 5.24 110.766 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.503 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 46.7 t80 -115.31 103.46 10.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 6.15 110.075 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 225' ' ' LYS . 7.7 p -103.06 130.91 52.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.181 0.515 . . . . 4.24 110.12 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.45 16.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.586 -0.734 . . . . 4.95 111.595 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.57 55.24 4.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.693 0.759 . . . . 0.0 109.477 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.566 HG22 HD22 ' A' ' 224' ' ' LEU . 35.5 pt -101.09 147.69 34.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 5.61 110.156 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.11 114.63 2.4 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.695 2.263 . . . . 5.97 112.189 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.4 127.85 34.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.568 . . . . 8.47 110.762 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 103.37 10.67 35.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.845 -0.693 . . . . 6.96 111.692 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.1 tp -81.13 137.78 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 6.1 109.912 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.3 p -87.2 144.64 26.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.407 -0.361 . . . . 6.62 110.755 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.928 ' HA ' HD12 ' A' ' 191' ' ' ILE . 43.2 mt-10 -57.71 -43.46 85.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.631 . . . . 5.69 111.45 -175.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.72 -52.46 64.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 7.29 110.74 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.64 95.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.708 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.457 ' HA ' ' CE ' ' A' ' 165' ' ' MET . 2.1 tpt -60.54 -46.8 88.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 4.49 110.475 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.443 ' HB2' HG11 ' A' ' 189' ' ' VAL . 25.6 ttt -63.28 -47.13 83.6 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.129 -0.487 . . . . 5.76 110.977 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -62.98 -32.04 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 6.51 111.387 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -62.36 -49.1 76.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.565 -0.289 . . . . 5.44 110.619 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 173' ' ' MET . 56.2 m-85 -63.1 -44.9 94.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.555 -0.293 . . . . 5.03 110.798 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.89 -35.94 77.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.35 . . . . 6.3 110.941 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.58 68.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.446 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.52 -31.14 71.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 6.25 111.281 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 169' ' ' PHE . 17.9 mmt -60.95 -51.49 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 7.03 110.17 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -69.2 -48.06 63.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.976 -0.557 . . . . 8.94 110.972 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.35 -35.56 80.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 8.7 111.383 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.53 -29.61 48.09 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.591 -0.814 . . . . 8.11 112.165 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 105.43 0.43 40.46 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.901 -0.666 . . . . 8.49 111.823 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 210' ' ' GLN . 5.3 mp -79.25 84.7 5.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.74 -0.467 . . . . 7.59 109.74 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 34.5 m -159.96 124.38 3.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 8.73 110.147 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.433 ' HG2' ' CD ' ' A' ' 207' ' ' GLU . 3.5 pt20 -90.04 -27.71 19.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 9.89 111.183 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -141.18 139.83 19.89 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.455 -0.339 . . . . 9.69 110.327 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.14 118.12 4.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.951 2.434 . . . . 10.74 112.486 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.56 -155.65 22.33 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.122 -0.561 . . . . 8.97 111.931 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.7 m-20 -101.57 126.24 34.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.684 0.278 . . . . 7.58 111.169 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 184' ' ' ASN . 18.1 Cg_exo -68.76 -32.18 23.9 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 123.01 2.474 . . . . 6.4 111.83 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.3 124.16 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 5.47 110.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.64 -42.07 7.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.035 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.91 159.38 42.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 111.113 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 166' ' ' MET . 9.1 p -140.57 136.63 35.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.211 -0.449 . . . . 4.68 110.84 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 199' ' ' PHE . 41.6 mt-30 -113.86 106.36 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.655 -0.498 . . . . 6.34 109.655 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 162' ' ' GLU . 57.1 mt -111.43 123.98 67.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.191 0.52 . . . . 5.85 111.661 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -127.14 119.24 26.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.569 -0.741 . . . . 7.34 109.49 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -93.17 3.42 55.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.757 0.313 . . . . 7.61 111.384 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.8 -54.59 5.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.093 0.473 . . . . 9.12 109.816 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.624 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 47.3 mmtm -86.52 -7.17 58.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.952 -0.567 . . . . 9.1 109.491 175.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 60.87 70.03 0.64 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.149 -0.932 . . . . 6.6 110.812 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 195' ' ' LYS . 41.2 p90 -149.28 163.0 38.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.209 -0.451 . . . . 6.67 111.227 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 190' ' ' GLN . . . -144.83 126.87 15.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.646 -0.706 . . . . 4.58 110.238 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 190' ' ' GLN . 55.6 m-85 -96.23 126.87 41.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.363 -0.381 . . . . 6.22 110.117 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 79.0 mt -105.57 115.21 29.85 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.052 -0.522 . . . . 4.77 109.998 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.03 118.27 31.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.996 -0.372 . . . . 6.55 109.996 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -95.64 163.91 13.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.761 -0.654 . . . . 6.51 110.814 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.78 -8.32 57.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.311 -0.859 . . . . 8.27 111.014 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 p -142.99 -164.72 1.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 7.96 110.294 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.07 -29.96 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 8.73 109.227 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.02 -55.62 32.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.124 -0.944 . . . . 8.5 111.408 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.433 ' CD ' ' HG2' ' A' ' 180' ' ' GLN . 46.9 mt-10 -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 7.4 110.026 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.487 ' O ' HD11 ' A' ' 151' ' ' LEU . 1.8 m -53.24 -53.44 50.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.569 -0.741 . . . . 6.13 110.807 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 m -60.98 -35.06 75.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.616 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.674 ' HG3' HD23 ' A' ' 178' ' ' LEU . 9.1 tp-100 -73.28 -30.5 63.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.807 -0.633 . . . . 7.75 110.373 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -69.6 -12.81 61.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 5.43 111.23 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 83.4 mtp -69.8 -13.52 62.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 6.29 110.85 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.35 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 6.14 111.358 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.439 ' HE2' HD22 ' A' ' 178' ' ' LEU . 76.4 m-85 -92.71 15.17 15.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 5.57 111.263 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.56 115.48 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.921 -0.4 . . . . 5.92 109.921 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.77 30.1 9.31 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.561 -0.828 . . . . 5.74 112.006 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 13.1 tt -84.82 136.2 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 5.3 110.091 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.46 113.93 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.446 0.641 . . . . 6.8 110.811 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -134.68 119.13 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.848 -0.615 . . . . 5.79 110.593 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 61.43 20.85 11.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.947 -0.57 . . . . 7.32 112.017 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.55 1.82 63.79 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.619 -0.8 . . . . 7.28 112.764 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -119.84 142.88 48.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.939 0.399 . . . . 7.21 111.076 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.0 t -90.24 111.16 22.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.705 -0.679 . . . . 6.14 109.885 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.566 HD22 HG22 ' A' ' 156' ' ' ILE . 77.0 mt -76.93 114.13 15.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.026 0.441 . . . . 4.9 110.695 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 87.7 tttt -94.9 114.59 26.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.96 -0.564 . . . . 7.3 110.394 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.42 109.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 5.37 110.631 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 227' ' ' ARG . 6.8 mmt180 -131.12 171.13 13.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.506 . . . . 6.97 110.621 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 26.8 mtp180 -87.69 127.4 58.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.883 -0.414 . . . . 7.37 109.883 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.689 ' HB2' ' HB3' ' A' ' 232' ' ' TYR . 14.9 Cg_exo -66.48 104.66 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.954 2.436 . . . . 7.98 111.857 -176.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.577 ' HA ' ' NE2' ' A' ' 233' ' ' GLN . 51.2 t-80 -71.98 -37.67 69.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.284 -174.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -79.64 -13.18 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.374 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . 0.689 ' HB3' ' HB2' ' A' ' 229' ' ' PRO . 72.3 t80 -90.88 -11.11 40.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.315 0.579 . . . . 0.0 110.482 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 230' ' ' HIS . 66.7 mt-30 -79.27 138.06 56.08 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.113 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.58 168.62 16.11 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.505 2.137 . . . . 0.0 111.307 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.3 mt 62.74 88.38 0.12 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 121.126 0.488 . . . . 0.0 110.607 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.503 ' HG2' ' H ' ' A' ' 241' ' ' ASN . 6.2 Cg_exo -80.54 47.82 2.68 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.73 2.954 . . . . 0.0 112.965 -176.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.69 -105.9 2.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.902 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 94.7 mmm -88.48 99.12 12.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.677 0.275 . . . . 0.0 110.889 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 19.3 m 66.8 176.9 0.24 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.638 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -73.56 148.0 43.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.503 ' H ' ' HG2' ' A' ' 236' ' ' PRO . 30.5 m-80 -133.65 98.0 15.27 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.173 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 243' ' ' SER . 65.5 Cg_endo -72.48 -7.89 21.65 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.993 2.462 . . . . 0.0 113.371 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 242' ' ' PRO . 45.7 t 74.14 -46.14 0.61 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.716 0.635 . . . . 0.0 110.092 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.57 113.63 36.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 109.849 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.44 -31.05 12.56 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.006 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.8 m -63.27 150.78 88.51 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.49 132.13 49.37 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.932 2.421 . . . . 0.0 112.451 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.24 -171.44 44.58 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.7 172.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.86 0.362 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 9.7 p -121.92 149.91 25.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.654 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.7 t -116.61 83.09 1.9 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.912 0.387 . . . . 0.0 110.204 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 35.1 m -154.56 85.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.15 0.5 . . . . 0.0 110.44 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.69 158.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.485 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.9 m -133.88 114.62 13.02 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.07 -37.2 65.87 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.385 2.057 . . . . 0.0 111.234 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 17.9 t70 70.44 -57.04 0.59 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.734 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 63.1 m -85.35 -4.63 59.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.72 0.295 . . . . 0.0 111.426 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -145.5 93.53 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.962 0.411 . . . . 0.0 110.685 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -154.4 33.78 0.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.681 0.753 . . . . 8.75 109.398 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 304' ' ' PHE . 40.1 ttmt -78.91 116.91 19.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.15 -0.932 . . . . 6.04 111.129 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.777 HD11 HG23 ' A' ' 313' ' ' THR . 68.0 mt -100.89 142.43 32.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.546 -0.752 . . . . 5.29 109.872 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -92.93 123.83 36.47 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.266 -0.424 . . . . 4.77 109.988 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 330' ' ' LEU . 3.1 mp -114.4 110.55 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.839 -0.618 . . . . 3.94 109.413 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.58 130.64 6.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.717 -0.754 . . . . 4.58 112.376 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 124.44 23.47 1.91 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.744 -0.741 . . . . 5.58 111.977 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.5 mt -95.86 141.53 23.3 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.104 -0.332 . . . . 5.92 110.104 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.875 ' HB2' HD13 ' A' ' 270' ' ' LEU . 32.3 Cg_exo -58.47 116.3 3.15 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.535 2.157 . . . . 6.94 111.107 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 299' ' ' SER . 29.7 p-10 -70.23 -5.46 27.68 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.729 0.64 . . . . 8.81 112.729 -170.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.59 -0.444 . . . . 8.73 111.02 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.875 HD13 ' HB2' ' A' ' 267' ' ' PRO . 11.2 mp -86.31 133.39 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 7.52 110.202 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.2 p-10 -79.16 160.04 27.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.984 -0.553 . . . . 8.79 110.536 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.18 -32.09 54.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.757 -0.656 . . . . 7.62 111.501 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.464 ' HB3' ' ND2' ' A' ' 271' ' ' ASN . 17.2 t70 -56.93 -54.81 42.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.602 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -73.93 -33.37 63.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.516 -0.311 . . . . 8.69 111.27 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 271' ' ' ASN . 63.0 t -62.92 -48.6 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.537 -0.301 . . . . 6.64 110.819 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -62.88 -45.39 92.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.262 . . . . 7.74 111.399 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.96 -40.79 98.78 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.739 0.304 . . . . 9.38 110.884 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.63 -49.12 78.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 7.06 109.873 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.86 -37.25 78.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.54 . . . . 6.89 111.426 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 87.0 m -60.72 -31.27 70.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.483 -0.326 . . . . 8.85 110.9 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.3 m -65.62 -15.85 63.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.21 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.58 2.04 17.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.389 . . . . 9.18 110.577 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' A' ' 284' ' ' PRO . . . 157.51 127.13 0.94 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.733 -0.746 . . . . 9.06 112.563 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.408 ' HD3' ' HA2' ' A' ' 283' ' ' GLY . 27.4 Cg_exo -63.04 133.28 40.4 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.926 2.417 . . . . 10.14 112.171 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.16 138.45 39.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.08 -0.509 . . . . 8.3 111.055 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 308' ' ' VAL . 12.2 ptpt -104.39 -12.71 16.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 8.65 109.707 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 306' ' ' GLU . . . -147.72 136.82 22.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.593 ' HD1' ' HG ' ' A' ' 305' ' ' CYS . 72.4 t80 -150.54 126.45 10.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.26 -0.427 . . . . 6.27 110.512 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -140.44 112.08 7.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.362 0.601 . . . . 5.79 110.428 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 303' ' ' ALA . 64.7 tp -80.48 121.36 25.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.53 -0.759 . . . . 6.35 109.793 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.66 113.47 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.361 0.6 . . . . 6.61 110.452 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -113.28 160.27 18.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.369 -0.832 . . . . 8.17 109.846 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.777 ' HB2' ' HE3' ' A' ' 300' ' ' LYS . 11.6 t70 -90.03 113.31 24.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.174 -0.676 . . . . 10.33 109.174 174.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 32.4 m -76.76 -3.2 36.97 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.538 0.57 . . . . 10.8 112.538 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -104.37 -23.1 13.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.926 0.393 . . . . 12.13 110.808 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 4.0 m -106.2 -41.24 5.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.06 -0.518 . . . . 11.16 111.22 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.0 20.72 25.14 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.811 -0.709 . . . . 10.11 112.102 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.97 155.99 29.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.443 -0.206 . . . . 10.12 110.443 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 268' ' ' ASN . 42.2 t -76.56 154.33 34.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.532 -0.304 . . . . 7.73 110.336 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.777 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 32.3 mmtp -94.07 -8.21 40.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.298 -0.41 . . . . 8.01 111.108 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 90.76 6.74 67.23 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.656 -0.783 . . . . 6.09 113.047 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 300' ' ' LYS . 40.7 p90 -141.55 152.54 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.793 0.33 . . . . 6.54 110.533 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB2' HD12 ' A' ' 290' ' ' LEU . . . -149.27 164.07 35.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.108 -0.496 . . . . 4.38 111.185 -176.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' A' ' 260' ' ' LYS . 96.9 m-85 -106.14 123.42 47.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.874 -0.603 . . . . 4.93 109.519 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.593 ' HG ' ' HD1' ' A' ' 288' ' ' PHE . 21.6 m -128.6 121.32 28.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 5.09 110.678 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 287' ' ' ALA . 30.8 tt0 -103.24 114.96 29.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 7.03 110.129 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.49 ' CE1' HD12 ' A' ' 261' ' ' LEU . 25.8 m-85 -84.05 149.58 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 7.81 111.129 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 286' ' ' LYS . 61.3 t -78.89 -55.54 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.9 -0.591 . . . . 10.03 110.684 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 144.94 25.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 10.81 111.225 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -92.88 -19.93 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 9.77 111.356 -178.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.59 -48.35 64.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.907 0.384 . . . . 10.89 110.039 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.82 -23.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 9.5 110.992 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.777 HG23 HD11 ' A' ' 261' ' ' LEU . 98.4 m -55.78 -50.03 71.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.496 -0.32 . . . . 7.83 111.728 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.28 -38.11 89.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 8.79 110.719 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.45 -40.62 85.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 10.51 110.479 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -49.61 71.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 7.31 110.666 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 313' ' ' THR . 74.8 mt -59.01 -49.17 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.578 -0.283 . . . . 6.44 110.798 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.79 69.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -83.73 -43.42 7.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.699 -0.763 . . . . 7.46 112.7 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.427 ' HB3' HD23 ' A' ' 330' ' ' LEU . 96.1 mt -80.92 -42.7 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.544 0.202 . . . . 6.42 111.544 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 49.4 t-20 -72.67 113.89 10.2 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.317 -0.623 . . . . 6.53 109.317 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.5 -7.93 47.12 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.283 -0.727 . . . . 6.77 111.283 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.8 ttt -74.33 135.29 42.53 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 7.29 109.864 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.54 ' HG2' ' HG2' ' A' ' 329' ' ' LYS . 46.0 mt-30 -96.1 117.12 30.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.349 -0.387 . . . . 7.83 110.458 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.82 96.83 6.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.355 -0.609 . . . . 7.01 109.355 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 85.8 -94.54 1.93 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.166 -0.774 . . . . 8.18 111.166 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.81 -19.12 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.996 0.426 . . . . 8.94 110.11 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 158.95 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 7.29 110.419 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.54 ' HG2' ' HG2' ' A' ' 324' ' ' GLN . 99.4 mttt -110.27 142.42 41.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.041 0.448 . . . . 7.13 110.82 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.587 HD11 HG23 ' A' ' 263' ' ' ILE . 55.7 tp -86.29 134.41 33.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.551 -0.75 . . . . 5.63 110.14 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.8 mp -121.28 136.27 54.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.899 0.381 . . . . 5.53 110.434 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.543 HG22 HG13 ' A' ' 263' ' ' ILE . 62.1 t -129.84 125.06 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.855 -0.612 . . . . 5.21 110.201 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.29 144.68 22.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.046 -0.724 . . . . 6.05 109.046 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 337' ' ' VAL . 68.5 ttt180 -64.07 135.21 56.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.637 -0.425 . . . . 7.58 110.518 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -83.17 11.91 5.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 6.04 111.923 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.476 ' H ' ' HG2' ' A' ' 334' ' ' ARG . 9.5 m -126.71 -94.73 0.45 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.644 0.259 . . . . 7.57 110.644 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.61 ' O ' ' HD3' ' A' ' 334' ' ' ARG . 18.5 m -125.06 136.87 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.54 76.63 0.95 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.13 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.92 173.39 11.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -90.16 86.98 6.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -165.28 -55.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.732 179.703 . . . . . . . . 0 0 . 1 stop_ save_